data_1ueq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ueq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 121.803 0.811 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -88.36 -121.35 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.144 -1.597 . . . . 0.0 109.019 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 150.19 -83.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 1 C-N-CA 132.701 4.4 . . . . 0.0 107.022 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' SER . 33.7 t0 -85.65 18.34 2.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.03 -17.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.106 2.962 . . . . 0.0 114.545 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -65.65 -26.3 67.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.139 0.976 . . . . 0.0 111.262 -169.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -82.18 -4.18 56.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.916 -1.04 . . . . 0.0 112.311 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.97 161.75 23.53 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.943 1.247 . . . . 0.0 108.66 169.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -124.23 116.22 22.33 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.81 39.46 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 124.42 1.075 . . . . 0.0 110.742 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -87.8 166.6 14.48 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -126.43 136.01 52.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.178 1.391 . . . . 0.0 107.283 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.24 164.4 38.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.545 1.138 . . . . 0.0 109.687 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.4 m -144.58 163.42 33.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.824 0.821 . . . . 0.0 112.453 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 157.22 43.31 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.884 1.274 . . . . 0.0 107.89 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -114.46 114.14 25.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.52 132.91 43.57 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -85.46 132.55 34.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 163.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 51.3 tttt -73.31 93.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.695 1.998 . . . . 0.0 108.514 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -95.02 115.01 26.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.786 0.834 . . . . 0.0 109.173 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.56 -158.94 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.85 1.66 . . . . 0.0 108.888 -167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 33.8 mtt 23.19 -76.32 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.147 2.979 . . . . 0.0 116.458 162.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.422 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 169.66 168.24 31.31 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -163.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -65.2 152.15 44.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.282 0.541 . . . . 0.0 110.12 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.25 44.05 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.915 -0.936 . . . . 0.0 112.259 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.67 164.72 37.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.499 1.65 . . . . 0.0 107.94 169.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 p -131.26 159.94 36.36 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.74 162.04 17.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.452 1.101 . . . . 0.0 108.847 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.72 146.57 32.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 128.575 2.75 . . . . 0.0 106.374 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.43 151.55 22.73 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 167.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -11.84 4.33 Favored Glycine 0 C--O 1.225 -0.419 0 C-N-CA 127.283 2.373 . . . . 0.0 117.893 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t0 95.59 -42.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 130.434 3.494 . . . . 0.0 108.037 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.79 157.81 89.39 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.674 2.389 . . . . 0.0 111.771 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -89.65 29.95 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.555 3.503 . . . . 0.0 112.692 -170.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -175.56 76.35 0.02 OUTLIER 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -140.44 143.46 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.873 2.469 . . . . 0.0 105.955 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -76.47 128.83 35.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.28 146.91 30.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.52 151.28 50.19 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 122.942 0.497 . . . . 0.0 110.835 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.17 112.1 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -70.57 -42.72 70.73 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 110.377 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 p -151.87 157.44 41.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.076 0.951 . . . . 0.0 109.57 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -92.72 141.7 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 159.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.03 122.07 86.22 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.44 146.23 97.31 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.442 1.428 . . . . 0.0 108.778 169.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 67.76 -2.59 1.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.536 1.534 . . . . 0.0 113.25 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.5 163.68 39.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.524 1.059 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.75 -27.76 75.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.113 2.542 . . . . 0.0 112.996 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.018 0.527 . . . . 0.0 110.081 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.2 87.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.686 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.47 -19.12 62.98 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.54 -4.91 59.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.162 1.346 . . . . 0.0 111.429 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.92 -24.27 1.98 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.17 2.319 . . . . 0.0 113.252 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.07 -35.33 18.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -157.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tpp -69.79 128.69 37.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.9 166.54 19.81 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -90.85 142.01 28.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 -16.6 58.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.691 -1.06 . . . . 0.0 112.361 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.39 139.84 41.83 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.523 1.129 . . . . 0.0 109.837 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.49 123.25 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.409 1.084 . . . . 0.0 108.835 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.08 119.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.555 1.542 . . . . 0.0 108.285 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.91 -57.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.938 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -134.3 152.94 52.09 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mt -130.25 128.36 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 t30 59.63 -73.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.145 2.978 . . . . 0.0 111.994 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -157.51 40.51 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.68 0.792 . . . . 0.0 110.85 165.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.38 132.52 70.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.615 1.966 . . . . 0.0 108.736 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.2 p -72.53 111.73 7.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.703 1.601 . . . . 0.0 111.779 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.49 5.6 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.847 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -18.44 62.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.383 1.901 . . . . 0.0 114.214 -167.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.31 4.69 19.88 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.583 -1.121 . . . . 0.0 112.934 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.48 162.97 22.04 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.707 1.753 . . . . 0.0 109.965 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.0 p -70.67 142.71 51.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -60.04 -22.67 62.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.372 -0.83 . . . . 0.0 110.391 166.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.11 -54.58 45.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.7 -1.25 . . . . 0.0 111.883 167.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.34 -49.86 67.78 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 124.882 1.273 . . . . 0.0 109.792 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 t -61.01 -41.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 120.037 -1.664 . . . . 0.0 112.182 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.4 -37.03 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 120.661 -1.274 . . . . 0.0 109.66 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -35.45 81.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.48 1.036 . . . . 0.0 110.003 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.12 -45.16 86.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.355 1.062 . . . . 0.0 108.258 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -64.29 -41.42 96.88 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.996 0.816 . . . . 0.0 111.322 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.98 -25.43 64.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.438 0.563 . . . . 0.0 112.24 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -66.35 -18.17 65.2 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.025 0.829 . . . . 0.0 111.994 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.36 115.85 62.3 Favored Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.69 170.06 20.59 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 120.716 1.291 . . . . 0.0 110.783 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.61 139.72 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.629 1.172 . . . . 0.0 108.029 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.29 -0.99 88.76 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 117.504 -1.72 . . . . 0.0 113.657 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -100.04 172.58 7.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.038 1.919 . . . . 0.0 108.482 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 p -131.87 159.62 38.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.642 0.777 . . . . 0.0 110.052 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.29 155.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.839 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.84 159.21 21.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 mt -146.06 141.61 27.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -121.75 118.12 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.8 mt -109.26 168.74 9.16 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.907 0.755 . . . . 0.0 109.871 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.9 t -121.75 143.67 49.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.909 1.284 . . . . 0.0 107.67 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -127.25 130.33 49.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.729 1.211 . . . . 0.0 111.68 -163.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 128.05 -21.85 5.47 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.16 139.01 87.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 123.965 0.906 . . . . 0.0 109.176 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.37 178.45 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.402 2.068 . . . . 0.0 110.735 167.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 157.98 20.75 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.306 160.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.438 -1.742 0 N-CA-C 108.307 -1.459 . . . . 0.0 108.307 165.862 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.572 0.701 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -78.77 -112.35 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.555 1.542 . . . . 0.0 111.715 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 147.13 -57.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 131.509 3.924 . . . . 0.0 111.798 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.6 t70 -142.76 20.78 1.99 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.797 0.439 . . . . 0.0 111.387 -166.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.49 -17.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.47 2.308 . . . . 0.0 114.132 -164.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -60.3 -23.42 64.17 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.942 2.497 . . . . 0.0 112.43 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -80.83 -16.12 54.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.419 1.087 . . . . 0.0 112.474 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.02 154.28 33.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.397 0.999 . . . . 0.0 109.13 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -130.01 99.57 5.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.83 176.11 39.89 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.359 1.933 . . . . 0.0 110.079 -166.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -98.64 133.79 42.48 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 117.798 0.799 . . . . 0.0 109.177 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -101.12 142.65 32.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.387 1.075 . . . . 0.0 110.052 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.77 166.64 32.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.097 1.759 . . . . 0.0 109.372 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -147.1 156.54 43.08 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.849 1.26 . . . . 0.0 111.039 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -139.43 157.12 46.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.656 1.582 . . . . 0.0 107.862 168.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.09 111.63 24.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.067 1.347 . . . . 0.0 107.554 170.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.64 135.21 40.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.792 1.178 . . . . 0.0 108.391 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -83.67 151.56 25.22 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.416 0.627 . . . . 0.0 110.073 167.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -79.27 69.42 5.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.941 1.297 . . . . 0.0 109.378 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.29 170.25 9.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.464 1.105 . . . . 0.0 108.646 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 49.62 -92.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.993 2.117 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.2 ptm -118.9 4.3 11.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.33 1.452 . . . . 0.0 111.657 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.78 -176.76 35.16 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -151.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -64.99 149.15 50.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.034 -1.083 . . . . 0.0 110.983 -161.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.98 40.12 3.09 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.53 -176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -146.24 166.22 26.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.167 1.483 . . . . 0.0 109.108 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 p -128.87 159.46 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.277 1.431 . . . . 0.0 108.371 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.45 162.38 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.839 1.256 . . . . 0.0 109.423 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.76 155.08 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.735 2.014 . . . . 0.0 108.034 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.01 155.05 21.38 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 129.606 3.479 . . . . 0.0 111.049 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.1 -93.39 0.02 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 117.294 -2.384 . . . . 0.0 108.292 142.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.33 -65.43 0.08 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.09 166.9 28.95 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.934 1.694 . . . . 0.0 110.819 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.38 45.22 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.041 3.16 . . . . 0.0 111.872 -164.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -157.21 34.47 0.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.316 1.447 . . . . 0.0 109.181 -168.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -139.43 173.62 11.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.953 1.301 . . . . 0.0 113.13 -167.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -88.71 112.89 23.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 125.381 1.472 . . . . 0.0 110.493 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -81.9 134.67 35.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -128.22 156.96 42.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.63 0.65 . . . . 0.0 111.06 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.96 104.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 166.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -54.82 -50.03 69.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.505 1.522 . . . . 0.0 109.145 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 152.4 18.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 109.206 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.5 t -104.04 130.18 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.74 130.28 68.02 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.83 46.09 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.808 3.005 . . . . 0.0 113.36 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -160.54 43.65 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.317 1.847 . . . . 0.0 109.905 164.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.67 166.6 22.96 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 120.718 -1.239 . . . . 0.0 112.443 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.63 -22.07 64.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.563 2.175 . . . . 0.0 112.397 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.8 2.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.962 0.905 . . . . 0.0 109.838 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.06 70.28 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.014 0.926 . . . . 0.0 111.004 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.0 -20.14 65.83 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.892 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -99.33 -30.41 12.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.483 1.492 . . . . 0.0 112.05 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.88 6.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.329 1.442 . . . . 0.0 114.431 166.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -69.87 -15.87 63.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.514 1.157 . . . . 0.0 111.144 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.94 133.67 43.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.08 176.62 8.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 162.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.3 m -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.56 56.48 25.05 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.92 151.49 49.6 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.983 2.113 . . . . 0.0 105.652 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.26 127.16 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 121.401 1.91 . . . . 0.0 109.706 -171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.88 130.2 36.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.551 1.14 . . . . 0.0 108.589 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.4 t -106.4 -61.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.518 1.527 . . . . 0.0 109.211 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -128.83 157.76 40.61 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.397 1.079 . . . . 0.0 109.223 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mt -128.79 117.11 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 47.77 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 128.564 2.746 . . . . 0.0 112.075 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.45 13.7 1.78 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.514 1.526 . . . . 0.0 111.111 -170.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.22 120.9 55.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.47 104.8 2.41 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -101.52 3.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 123.28 0.632 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 pp -58.45 -17.48 21.14 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.81 35.61 2.29 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 126.14 1.828 . . . . 0.0 109.016 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -103.16 165.66 10.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.306 1.053 . . . . 0.0 108.548 161.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.02 161.64 16.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.972 0.909 . . . . 0.0 109.546 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.93 -14.58 23.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.5 1.52 . . . . 0.0 111.934 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.13 -67.56 0.43 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.476 1.489 . . . . 0.0 109.478 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -56.01 -45.4 79.09 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.439 0.696 . . . . 0.0 111.075 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.11 -41.59 93.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 120.292 -1.505 . . . . 0.0 111.447 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.9 -37.34 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.87 -1.144 . . . . 0.0 109.731 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -39.07 93.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.426 1.466 . . . . 0.0 109.939 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.28 -51.1 71.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.667 1.587 . . . . 0.0 108.164 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.38 -42.33 88.08 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.019 0.827 . . . . 0.0 112.483 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.41 -30.88 69.89 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.423 -0.798 . . . . 0.0 111.008 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -70.02 -2.55 13.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.5 114.63 56.25 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.81 179.07 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.072 2.515 . . . . 0.0 110.931 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.35 152.06 7.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 109.137 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.08 -25.78 6.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 124.286 0.946 . . . . 0.0 111.956 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -84.33 142.25 30.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.42 1.11 . . . . 0.0 109.289 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.63 150.48 28.93 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.694 1.598 . . . . 0.0 108.234 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -141.31 141.21 31.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -84.18 155.97 22.3 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.0 mt -142.62 150.08 39.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.42 126.47 58.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.5 mt -119.65 169.5 10.04 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 124.356 1.035 . . . . 0.0 110.265 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.9 t -133.48 117.5 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.836 0.855 . . . . 0.0 111.213 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -85.53 139.41 31.49 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.115 -0.99 . . . . 0.0 110.339 -165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.98 -4.8 16.25 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.073 -0.848 . . . . 0.0 113.582 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.67 117.97 68.88 Favored Pre-proline 0 CA--C 1.526 0.057 0 CA-C-N 119.372 1.586 . . . . 0.0 107.53 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.16 177.23 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.709 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -54.48 149.09 22.07 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.613 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.444 -1.389 0 C-N-CA 122.668 2.245 . . . . 0.0 107.33 167.446 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 10' ' ' THR . 27.8 t80 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 114.261 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 m -82.32 -99.36 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.377 1.471 . . . . 0.0 112.102 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 117.83 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 1 C-N-CA 136.151 5.781 . . . . 0.0 114.167 172.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -125.52 13.63 8.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.507 1.048 . . . . 0.0 111.721 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.3 -20.3 0.07 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.851 2.86 . . . . 0.0 115.399 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -64.27 -22.13 66.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.312 0.96 . . . . 0.0 112.32 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -97.83 20.64 11.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.724 1.21 . . . . 0.0 112.073 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.88 -159.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 162.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -64.04 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.055 1.342 . . . . 0.0 111.661 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.55 -13.69 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.168 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 159.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -86.18 127.38 34.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -127.95 123.4 34.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.773 1.629 . . . . 0.0 108.165 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 154.83 41.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.994 1.718 . . . . 0.0 107.977 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -145.6 152.79 40.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.584 0.354 . . . . 0.0 110.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.52 157.94 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 108.118 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.7 m -127.15 119.34 26.25 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.354 1.462 . . . . 0.0 107.935 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.98 150.39 21.42 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -83.12 158.24 22.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 24.0 tptt -77.1 98.32 5.0 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.5 m -126.1 151.86 46.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.686 0.675 . . . . 0.0 111.793 -159.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 60.4 -79.87 0.02 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.251 2.62 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -149.43 71.62 1.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.421 2.289 . . . . 0.0 107.432 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 73.79 176.14 33.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.82 123.69 21.65 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.458 -1.025 . . . . 0.0 109.357 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.22 51.52 2.1 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.744 1.164 . . . . 0.0 112.775 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.57 165.93 27.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.394 1.877 . . . . 0.0 106.321 160.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -131.8 166.44 21.55 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.462 -0.773 . . . . 0.0 109.279 166.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.29 161.32 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.837 1.655 . . . . 0.0 107.422 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -133.05 150.25 32.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.786 2.035 . . . . 0.0 106.702 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.22 151.8 22.43 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.391 1.948 . . . . 0.0 108.702 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.03 -55.85 9.99 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.357 -0.691 . . . . 0.0 112.611 -158.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.79 -41.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.505 1.922 . . . . 0.0 107.859 166.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.59 164.97 14.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.223 1.409 . . . . 0.0 111.707 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.1 19.19 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.106 3.871 . . . . 0.0 116.218 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.58 5.61 0.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.22 1.008 . . . . 0.0 113.252 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.28 155.33 40.31 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 0.969 . . . . 0.0 108.413 163.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.96 168.41 18.06 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.806 0.812 . . . . 0.0 110.509 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.65 133.85 54.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.714 1.606 . . . . 0.0 107.254 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -128.49 151.82 48.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.11 121.96 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -76.74 -41.92 43.16 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 125.959 1.704 . . . . 0.0 110.501 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.2 p -156.99 161.93 39.58 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.304 1.041 . . . . 0.0 110.432 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.43 120.42 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 126.542 1.937 . . . . 0.0 105.811 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mm -75.49 131.38 77.55 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.22 152.04 82.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.668 2.245 . . . . 0.0 109.648 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 t70 53.92 23.17 3.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.908 0.861 . . . . 0.0 111.924 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.29 163.73 13.15 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.527 1.537 . . . . 0.0 109.712 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.4 -32.54 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.761 2.307 . . . . 0.0 111.865 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.44 -40.88 80.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.119 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.04 81.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.263 0.625 . . . . 0.0 110.596 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.13 -46.72 89.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.298 0.499 . . . . 0.0 110.216 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.32 -31.31 71.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.036 0.534 . . . . 0.0 111.223 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.97 -18.69 29.93 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.474 1.511 . . . . 0.0 113.49 160.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.111 0.955 . . . . 0.0 110.675 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.5 tpp -65.43 123.71 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.01 163.69 29.72 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.239 1.016 . . . . 0.0 108.363 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -88.21 142.56 27.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -167.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.41 -12.96 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.849 -1.528 . . . . 0.0 112.512 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.91 148.89 49.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.677 2.238 . . . . 0.0 108.098 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.3 125.75 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.115 1.366 . . . . 0.0 109.268 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.11 110.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 125.406 1.482 . . . . 0.0 107.422 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.02 -58.82 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.585 0.707 . . . . 0.0 109.664 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.07 155.22 50.43 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.916 1.286 . . . . 0.0 107.851 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -127.08 113.7 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 169.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 t30 69.88 -61.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 129.484 3.114 . . . . 0.0 112.27 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -157.71 5.7 0.13 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.756 1.622 . . . . 0.0 111.682 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.55 131.32 53.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 120.313 -1.492 . . . . 0.0 107.376 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.9 t -78.27 116.55 18.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.74 5.3 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 122.961 0.504 . . . . 0.0 111.576 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -31.59 35.44 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.364 1.866 . . . . 0.0 113.138 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.22 61.1 0.64 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -111.82 162.94 14.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.329 1.052 . . . . 0.0 109.834 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.27 151.61 41.3 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -55.47 -29.81 59.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.088 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.96 71.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.307 1.412 . . . . 0.0 112.268 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -76.57 -57.21 3.99 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -52.72 -41.62 39.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.484 2.713 . . . . 0.0 112.909 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.62 -28.37 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 120.553 -1.342 . . . . 0.0 110.361 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -35.74 73.14 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.439 1.472 . . . . 0.0 108.154 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.69 -36.39 67.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.214 1.005 . . . . 0.0 110.317 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -73.0 -29.6 63.16 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.721 -1.237 . . . . 0.0 111.684 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.81 -19.3 55.21 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.378 0.671 . . . . 0.0 112.237 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.6 m -71.24 -7.5 47.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 113.382 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.01 102.85 19.14 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.306 1.043 . . . . 0.0 108.259 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.7 170.43 16.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 mt -66.95 142.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 107.774 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.82 -2.57 87.3 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.103 -0.832 . . . . 0.0 113.049 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -101.53 171.63 7.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.716 1.258 . . . . 0.0 108.976 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -143.91 155.43 44.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.137 2.175 . . . . 0.0 108.211 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.81 148.24 24.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -82.82 153.38 25.21 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.2 mt -138.17 147.36 43.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 t -127.68 116.45 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.96 164.12 12.91 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -117.65 138.15 52.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 164.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.06 156.14 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.354 1.862 . . . . 0.0 110.095 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.05 -16.18 20.57 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 118.663 -1.076 . . . . 0.0 114.03 157.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -83.53 140.04 41.35 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 118.884 1.342 . . . . 0.0 108.784 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.97 176.87 9.47 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.63 2.887 . . . . 0.0 110.074 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 mt -67.58 145.3 98.19 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 N--CA 1.459 -0.503 0 C-N-CA 121.931 1.754 . . . . 0.0 111.053 -178.513 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 m -88.4 -120.39 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.912 1.285 . . . . 0.0 108.759 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 146.77 -47.64 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.582 1 C-N-CA 133.127 4.571 . . . . 0.0 106.62 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -123.92 124.75 43.3 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -170.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.31 -9.25 3.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.363 1.465 . . . . 0.0 113.422 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -69.99 -21.29 63.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.223 1.009 . . . . 0.0 111.657 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.05 -22.86 63.03 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.11 -0.994 . . . . 0.0 111.092 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.52 152.43 40.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.314 0.578 . . . . 0.0 110.575 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -129.67 111.06 12.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.914 2.086 . . . . 0.0 105.597 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.07 -144.85 5.13 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.8 m -136.61 152.39 50.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 151.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.63 142.83 33.64 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.286 1.434 . . . . 0.0 108.824 -172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -141.21 165.52 27.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.789 0.836 . . . . 0.0 109.168 -171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 m -152.47 154.69 36.02 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.131 0.491 . . . . 0.0 111.865 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -154.2 158.42 40.29 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.33 1.852 . . . . 0.0 107.621 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -121.58 111.97 17.89 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.421 1.488 . . . . 0.0 107.182 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -101.83 131.88 47.91 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.808 -0.557 . . . . 0.0 109.738 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -83.51 132.97 34.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.633 1.573 . . . . 0.0 109.466 172.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.38 107.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 107.86 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.4 t -133.69 -127.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.48 1.512 . . . . 0.0 108.021 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -55.25 102.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.314 1.446 . . . . 0.0 110.542 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 36.2 mtm 45.31 67.88 0.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.134 1.374 . . . . 0.0 110.622 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.15 -126.9 17.18 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.63 141.79 35.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 40.27 1.83 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.666 -0.519 . . . . 0.0 112.579 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -142.71 162.58 35.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.468 1.634 . . . . 0.0 109.11 163.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -123.91 152.23 42.66 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.246 1.818 . . . . 0.0 107.632 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.64 161.99 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.16 0.984 . . . . 0.0 108.478 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -135.71 158.84 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.698 2.399 . . . . 0.0 106.126 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.7 152.53 22.15 Favored Glycine 0 C--O 1.237 0.282 0 C-N-CA 126.025 1.774 . . . . 0.0 108.68 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.06 -77.18 0.14 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.754 0.692 . . . . 0.0 112.612 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -170.21 -50.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.658 0.729 . . . . 0.0 110.302 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -101.07 166.1 13.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.558 1.543 . . . . 0.0 111.169 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.25 43.81 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.778 3.652 . . . . 0.0 110.772 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.0 23.15 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.735 2.014 . . . . 0.0 110.79 -173.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.26 167.84 10.22 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.983 0.913 . . . . 0.0 109.107 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.46 160.99 27.41 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 110.967 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -124.75 132.07 53.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 127.009 2.124 . . . . 0.0 106.552 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -130.39 155.97 45.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.42 112.34 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 165.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -59.9 -49.62 76.96 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 108.686 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -157.58 146.39 19.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.767 1.227 . . . . 0.0 108.474 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.51 143.24 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 159.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -71.54 135.9 83.73 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.72 137.66 25.18 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.365 1.377 . . . . 0.0 109.523 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 51.61 67.62 0.93 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.431 1.092 . . . . 0.0 111.327 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.37 175.01 25.17 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.414 -0.804 . . . . 0.0 111.844 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.99 -35.55 92.79 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 112.221 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.57 81.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.892 1.277 . . . . 0.0 111.714 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.88 67.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.36 0.664 . . . . 0.0 109.897 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.02 -45.88 86.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.638 1.175 . . . . 0.0 111.472 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -68.44 -24.46 64.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.022 0.529 . . . . 0.0 110.862 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.82 15.19 64.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.678 1.132 . . . . 0.0 113.815 169.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.01 -73.7 0.42 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.405 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.94 159.3 26.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -138.37 160.16 40.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.243 1.497 . . . . 0.0 111.518 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.0 133.78 56.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.606 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.31 -14.67 64.04 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.282 1.42 . . . . 0.0 113.765 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.21 150.87 41.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.379 1.59 . . . . 0.0 109.531 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.22 127.54 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.366 1.466 . . . . 0.0 108.959 -176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.46 117.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.289 . . . . 0.0 107.641 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.88 -60.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.569 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -132.0 148.86 52.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -130.71 130.8 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 53.02 -85.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.754 2.422 . . . . 0.0 112.449 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.61 9.99 2.9 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.768 1.167 . . . . 0.0 112.712 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.26 132.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.321 1.448 . . . . 0.0 109.118 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.68 98.44 1.92 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -98.42 8.47 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.908 0.883 . . . . 0.0 110.705 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.25 -21.51 24.09 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.24 22.73 5.0 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.096 1.808 . . . . 0.0 111.692 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.82 30.48 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.739 1.769 . . . . 0.0 109.116 166.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 144.63 48.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.06 -37.3 66.57 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.96 69.23 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.577 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.43 -50.26 11.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.602 1.092 . . . . 0.0 110.065 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.23 -39.44 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.068 1.347 . . . . 0.0 111.432 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.25 -40.58 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 120.851 -1.156 . . . . 0.0 109.735 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -31.32 70.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 110.682 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.97 -46.6 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.126 1.77 . . . . 0.0 109.482 174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.06 -37.38 86.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.994 0.816 . . . . 0.0 109.959 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.2 -24.46 62.22 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.515 -0.741 . . . . 0.0 112.112 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -70.83 -0.22 8.6 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.422 1.089 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.2 t -100.12 101.84 15.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.09 168.01 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.596 1.53 . . . . 0.0 110.919 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.7 142.12 12.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.13 -11.61 35.45 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.589 -1.117 . . . . 0.0 113.69 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -84.58 154.24 22.73 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 120.478 2.139 . . . . 0.0 107.465 165.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -126.03 157.53 37.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.057 1.343 . . . . 0.0 109.338 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.66 147.21 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.39 150.5 26.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 mt -141.44 139.81 33.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.87 123.2 69.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -115.96 164.37 14.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 123.958 0.786 . . . . 0.0 110.172 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 16.9 t -115.89 119.86 37.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 165.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -74.35 156.27 37.27 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.668 1.187 . . . . 0.0 107.993 163.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.35 30.58 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.009 0.822 . . . . 0.0 113.309 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -103.35 126.8 31.17 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.41 172.52 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.393 2.062 . . . . 0.0 111.689 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.15 142.68 98.65 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 122.695 2.264 . . . . 0.0 111.25 -174.392 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.3 t80 . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m -74.02 -110.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.511 1.124 . . . . 0.0 112.369 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 134.61 -51.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 134.296 5.039 . . . . 0.0 109.939 -175.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.3 t0 -125.26 22.49 7.81 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -165.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.17 -11.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 114.922 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 12' ' ' ASP . 29.8 t -62.75 -31.53 72.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.99 1.716 . . . . 0.0 112.605 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.91 -11.95 60.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.8 mt -69.39 145.58 52.76 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.908 1.231 . . . . 0.0 109.944 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.2 142.41 28.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 160.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.58 -173.71 23.35 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.988 0.805 . . . . 0.0 112.812 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.7 m -106.53 129.02 54.55 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -80.21 133.87 36.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 174.47 11.06 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.323 1.449 . . . . 0.0 109.005 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -151.04 163.25 39.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.243 0.217 . . . . 0.0 110.615 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -154.47 158.04 39.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.96 0.886 . . . . 0.0 108.636 166.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.7 m -114.84 117.83 31.81 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 167.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.58 138.5 36.58 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -90.95 129.82 36.94 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.95 103.58 0.18 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.008 1.323 . . . . 0.0 107.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t -129.51 165.83 20.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.523 1.529 . . . . 0.0 107.779 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 44.05 -73.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.733 3.213 . . . . 0.0 113.273 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.5 ptp -142.74 5.94 1.59 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.089 1.756 . . . . 0.0 113.43 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.23 -126.18 2.44 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 120.851 1.66 . . . . 0.0 111.599 -172.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.91 145.98 46.21 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.976 0.91 . . . . 0.0 109.253 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.55 36.23 2.98 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.856 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.427 ' CE1' ' HE2' ' A' ' 63' ' ' MET . 32.3 p90 -149.07 169.09 21.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.099 1.45 . . . . 0.0 108.883 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -131.77 154.21 49.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.373 1.069 . . . . 0.0 108.439 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.81 160.58 17.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.597 1.159 . . . . 0.0 107.898 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 tt -125.25 162.03 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.722 2.009 . . . . 0.0 107.207 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.76 150.7 19.37 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.64 -63.16 3.31 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-O 118.952 -0.916 . . . . 0.0 112.285 -172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.14 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 128.453 2.701 . . . . 0.0 109.09 164.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -89.79 160.7 40.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.399 1.48 . . . . 0.0 112.39 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.97 51.83 3.23 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 125.082 3.855 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.69 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.901 2.08 . . . . 0.0 110.921 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -102.5 154.49 19.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 120.632 -1.292 . . . . 0.0 109.126 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.57 137.43 33.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.162 0.985 . . . . 0.0 108.741 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.82 113.12 24.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.382 1.873 . . . . 0.0 109.173 -174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.72 157.27 16.82 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 122.104 2.229 . . . . 0.0 111.207 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 t -61.08 115.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -55.11 36.93 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.36 -0.838 . . . . 0.0 109.142 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 m -159.66 154.29 24.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.973 0.909 . . . . 0.0 109.582 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.08 133.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 160.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.3 135.15 66.1 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 125.872 1.669 . . . . 0.0 107.574 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.12 147.51 84.09 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.509 1.472 . . . . 0.0 109.074 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 64.3 24.25 13.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.038 0.935 . . . . 0.0 112.509 167.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.97 176.54 19.9 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.798 1.666 . . . . 0.0 112.478 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.25 -12.36 25.37 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.734 2.956 . . . . 0.0 113.497 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.16 -50.71 12.38 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 168.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.32 -54.76 41.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.688 0.795 . . . . 0.0 109.971 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -68.94 -15.4 63.48 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.326 0.966 . . . . 0.0 113.473 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.9 -38.56 73.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.227 1.376 . . . . 0.0 109.415 166.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.04 -28.94 13.66 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.045 1.307 . . . . 0.0 113.057 167.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -93.63 -12.67 28.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.201 1.5 . . . . 0.0 113.836 -160.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.427 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 32.0 ttm -90.53 144.84 25.39 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 120.976 -1.077 . . . . 0.0 108.417 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -137.06 179.04 6.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.523 1.129 . . . . 0.0 108.181 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 m -93.93 149.4 21.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.1 5.92 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -165.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.76 157.07 47.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.46 114.03 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.86 2.064 . . . . 0.0 108.351 -167.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -60.26 115.4 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.247 1.419 . . . . 0.0 108.089 171.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.95 -54.55 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 124.12 0.887 . . . . 0.0 109.974 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.16 154.25 51.69 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.288 1.435 . . . . 0.0 108.684 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.4 mt -135.01 129.2 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 51.22 -89.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.898 2.479 . . . . 0.0 110.896 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -135.14 28.51 3.44 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.396 1.453 . . . . 0.0 112.023 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.98 133.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 120.904 -1.123 . . . . 0.0 109.293 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.35 106.45 12.37 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.879 1.272 . . . . 0.0 110.322 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.47 5.18 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.188 0.995 . . . . 0.0 112.784 -171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -32.04 63.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.41 14.63 13.28 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.612 1.577 . . . . 0.0 110.739 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -68.65 161.85 27.27 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 p -73.23 145.85 45.9 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.38 -41.77 66.23 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 109.113 168.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.26 63.68 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.326 0.966 . . . . 0.0 113.462 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.79 -53.87 6.66 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 120.288 1.404 . . . . 0.0 109.435 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 t -56.0 -39.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.395 1.878 . . . . 0.0 111.662 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.1 -38.36 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 120.93 -1.106 . . . . 0.0 110.068 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -37.26 81.8 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 120.148 1.34 . . . . 0.0 109.182 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.18 -39.41 92.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.659 1.184 . . . . 0.0 109.16 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -69.24 -45.02 70.79 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.95 0.795 . . . . 0.0 111.904 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.07 -29.45 70.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.904 0.775 . . . . 0.0 112.106 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.6 p -56.69 -25.56 54.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.263 1.025 . . . . 0.0 113.548 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.05 109.24 17.66 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -162.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.75 170.19 14.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.635 1.556 . . . . 0.0 110.419 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mt -63.29 144.64 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.71 -4.05 53.33 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 117.654 -1.637 . . . . 0.0 113.99 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -86.52 175.94 8.09 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.867 1.834 . . . . 0.0 108.735 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.48 162.75 28.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.996 1.318 . . . . 0.0 109.999 170.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.04 150.37 24.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 125.331 1.452 . . . . 0.0 108.708 165.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -83.16 159.4 22.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 173.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -145.95 143.75 29.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.81 129.85 74.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -118.47 171.13 8.37 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 124.296 0.997 . . . . 0.0 110.369 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 12.3 t -131.04 119.87 22.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.908 1.283 . . . . 0.0 108.344 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -91.11 140.94 29.34 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.181 1.393 . . . . 0.0 110.467 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.85 -38.01 1.87 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.178 0.894 . . . . 0.0 111.008 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -60.91 120.1 50.74 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.56 0.744 . . . . 0.0 109.316 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.11 177.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.646 2.231 . . . . 0.0 111.802 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.23 151.78 95.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.955 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.452 -0.922 0 C-N-CA 122.517 2.144 . . . . 0.0 110.334 -178.408 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 . . . . . 0 C--O 1.236 0.357 0 CA-C-O 122.227 1.013 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -74.51 -97.97 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.048 1.339 . . . . 0.0 113.928 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 116.67 -34.61 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 1 C-N-CA 136.112 5.765 . . . . 0.0 110.913 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -146.02 18.73 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 112.674 -161.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.3 -22.32 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.034 2.934 . . . . 0.0 114.749 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 t -74.17 -6.26 46.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.364 1.438 . . . . 0.0 113.433 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -80.41 -22.64 41.02 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 119.625 -1.922 . . . . 0.0 111.159 164.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.41 146.15 54.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -131.52 124.54 30.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.85 177.99 15.15 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.1 m -93.17 155.43 17.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.655 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -106.44 132.28 52.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.876 1.67 . . . . 0.0 109.344 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 165.64 12.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 108.475 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -139.02 149.79 45.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.6 1.16 . . . . 0.0 109.019 160.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -155.05 157.15 37.12 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 m -130.31 105.96 8.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.42 134.83 40.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.6 145.62 29.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.55 95.37 1.4 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -84.04 -166.45 1.42 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.548 2.339 . . . . 0.0 110.021 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -58.85 -24.58 62.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -165.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -133.07 53.19 2.03 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 -123.86 26.33 Favored Glycine 0 N--CA 1.441 -0.995 0 O-C-N 121.332 -0.855 . . . . 0.0 111.505 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.97 136.56 49.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.3 51.43 4.37 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.415 0.552 . . . . 0.0 112.169 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.46 173.27 13.28 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.01 1.324 . . . . 0.0 108.781 165.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.58 159.62 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.206 1.403 . . . . 0.0 108.811 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.76 159.51 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.078 1.351 . . . . 0.0 109.658 -174.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.83 155.46 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 128.954 2.902 . . . . 0.0 106.853 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.99 152.25 20.99 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.936 1.731 . . . . 0.0 109.128 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.91 -75.6 0.17 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.373 1.463 . . . . 0.0 111.801 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.92 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.473 1.509 . . . . 0.0 108.22 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -97.3 167.67 11.52 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -167.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.44 55.46 3.65 Favored 'Trans proline' 0 C--N 1.351 0.668 1 C-N-CA 125.312 4.008 . . . . 0.0 111.234 172.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.88 -8.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.956 1.302 . . . . 0.0 112.973 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.09 162.79 15.15 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.13 -0.981 . . . . 0.0 112.783 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.22 134.31 52.44 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.442 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -104.45 135.88 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -130.25 153.68 48.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.203 0.91 . . . . 0.0 110.947 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.0 119.29 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -71.2 -50.32 34.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.985 1.714 . . . . 0.0 110.16 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -152.31 152.6 32.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.041 1.736 . . . . 0.0 108.295 168.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.48 136.27 24.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 160.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.95 142.88 91.12 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 141.82 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.676 1.584 . . . . 0.0 111.016 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 46.84 68.52 0.61 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.814 1.646 . . . . 0.0 110.765 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.41 175.4 26.78 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.944 1.259 . . . . 0.0 110.415 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -64.68 -33.22 55.66 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.598 2.198 . . . . 0.0 112.7 -167.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.69 74.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.28 80.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.406 1.083 . . . . 0.0 111.517 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.69 -34.55 77.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.19 0.596 . . . . 0.0 112.536 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -33.84 75.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.751 0.786 . . . . 0.0 109.169 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.03 6.04 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.987 2.232 . . . . 0.0 114.209 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -65.57 -45.75 82.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.163 0.981 . . . . 0.0 109.246 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 tpp -65.63 122.75 17.95 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.835 0.854 . . . . 0.0 109.25 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.04 159.94 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 108.897 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 m -78.06 149.55 33.93 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.786 -1.196 . . . . 0.0 108.436 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -8.44 77.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.87 0.748 . . . . 0.0 113.71 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.41 158.18 34.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.143 1.472 . . . . 0.0 110.25 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.68 130.02 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.305 1.842 . . . . 0.0 108.741 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.93 126.71 39.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.112 1.365 . . . . 0.0 108.231 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.78 -54.67 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.858 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -135.06 142.03 46.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.11 112.32 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 t30 71.97 -68.86 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.268 3.027 . . . . 0.0 111.322 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -156.47 24.77 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 110.756 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.05 132.27 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 120.491 -1.381 . . . . 0.0 107.513 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 t -69.78 116.38 10.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.987 0.915 . . . . 0.0 108.716 168.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.09 5.37 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.771 0.829 . . . . 0.0 111.787 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.12 -24.01 23.77 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.21 22.94 5.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.856 1.693 . . . . 0.0 110.529 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -75.69 158.47 32.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.352 1.576 . . . . 0.0 109.894 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 t -77.14 149.1 35.66 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.24 -41.38 72.07 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.811 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.51 -32.3 62.78 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.379 1.445 . . . . 0.0 112.403 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -80.34 -47.8 13.93 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 118.86 0.754 . . . . 0.0 110.866 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 t -59.0 -42.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.711 -1.243 . . . . 0.0 110.703 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.58 -44.8 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.324 172.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -37.89 84.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.629 1.558 . . . . 0.0 111.167 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -60.93 -50.52 73.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.212 1.405 . . . . 0.0 108.362 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -64.79 -39.98 94.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.211 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -67.01 -34.25 77.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.444 0.698 . . . . 0.0 110.168 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -70.53 -3.81 19.83 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.38 116.58 65.71 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -60.86 157.23 39.24 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.741 2.294 . . . . 0.0 110.896 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.9 mt -59.85 139.21 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -13.11 59.17 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.424 -1.764 . . . . 0.0 114.299 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -84.21 167.16 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.834 2.317 . . . . 0.0 108.241 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.33 163.56 22.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.655 1.182 . . . . 0.0 110.008 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.0 146.25 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.398 1.479 . . . . 0.0 107.777 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.82 156.51 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.485 1.114 . . . . 0.0 109.524 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.48 109.59 4.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.5 t -89.3 121.15 39.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -116.52 163.77 15.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 124.11 0.881 . . . . 0.0 110.804 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.0 t -116.95 126.73 53.37 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.999 1.32 . . . . 0.0 108.563 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -76.52 156.84 32.59 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.454 1.502 . . . . 0.0 110.552 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.31 -21.93 8.56 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.808 1.194 . . . . 0.0 113.507 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -76.52 159.65 79.05 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 118.364 1.082 . . . . 0.0 109.888 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.23 178.31 6.74 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.986 2.458 . . . . 0.0 111.786 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.1 151.83 94.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 164.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 C-N-CA 121.761 1.641 . . . . 0.0 111.433 174.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 10' ' ' THR . 88.0 t80 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 88.0 m -102.31 -106.25 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 110.297 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 138.41 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 133.851 4.86 . . . . 0.0 110.597 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -123.54 17.26 9.65 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.043 0.838 . . . . 0.0 113.217 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 58.66 -10.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.957 2.903 . . . . 0.0 115.184 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -75.92 -15.75 60.14 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.157 -1.589 . . . . 0.0 113.739 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.09 -16.85 63.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.96 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.01 162.9 28.64 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.535 1.061 . . . . 0.0 110.844 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -126.46 135.3 51.19 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.994 2.118 . . . . 0.0 106.142 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 -158.4 27.64 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -164.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -128.4 143.09 50.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.527 1.131 . . . . 0.0 108.403 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.87 134.99 33.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.567 0.747 . . . . 0.0 109.387 170.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 171.64 7.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.042 1.737 . . . . 0.0 108.301 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.4 p -147.72 153.35 39.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.431 0.693 . . . . 0.0 109.538 162.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.73 158.18 40.6 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.069 1.348 . . . . 0.0 107.393 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 m -131.16 117.03 18.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.91 144.76 26.53 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -82.48 145.12 29.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 163.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -72.04 93.18 1.37 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -80.66 -165.62 0.92 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.831 1.253 . . . . 0.0 110.785 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.33 -47.12 66.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.766 1.627 . . . . 0.0 112.764 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 59.1 mtt -116.43 62.8 0.71 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.171 0.988 . . . . 0.0 108.421 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.24 -118.1 8.38 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.129 164.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.82 137.66 54.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.47 40.92 2.03 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.911 -0.939 . . . . 0.0 112.702 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -145.35 162.05 38.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.68 1.74 . . . . 0.0 109.439 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 p -124.46 158.24 33.29 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.74 162.06 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.919 1.288 . . . . 0.0 108.019 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -134.77 141.74 42.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.26 152.16 23.1 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.48 -2.648 . . . . 0.0 106.48 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 44' ' ' GLU . . . -70.18 3.9 9.6 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-O 118.474 -1.181 . . . . 0.0 114.986 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t70 74.1 -37.17 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.877 2.471 . . . . 0.0 111.643 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.58 135.46 92.78 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 123.557 0.743 . . . . 0.0 109.286 172.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.22 41.65 0.79 Allowed 'Trans proline' 0 CA--C 1.543 0.973 1 C-N-CA 126.263 4.642 . . . . 0.0 112.396 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.55 -2.58 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.565 1.546 . . . . 0.0 112.828 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 1.5 tt0 -75.83 148.62 38.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.507 -1.37 . . . . 0.0 108.082 166.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.62 143.07 40.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.036 1.334 . . . . 0.0 109.12 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.3 141.81 28.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.345 1.058 . . . . 0.0 109.854 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -130.95 154.87 47.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.612 1.165 . . . . 0.0 110.575 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.46 107.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 120.584 -1.322 . . . . 0.0 107.776 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -53.8 53.62 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 125.497 1.519 . . . . 0.0 109.288 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.4 p -154.46 161.41 41.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.391 0.276 . . . . 0.0 110.388 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 126.4 65.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.53 132.12 89.54 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.86 158.7 49.67 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.176 1.917 . . . . 0.0 110.359 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.4 -4.85 0.08 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.838 2.055 . . . . 0.0 114.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.57 172.71 43.09 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.582 1.563 . . . . 0.0 113.509 -165.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.83 -27.73 43.7 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.355 2.037 . . . . 0.0 112.533 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.63 67.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.05 74.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -57.37 -43.29 83.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.756 0.822 . . . . 0.0 112.948 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.54 -18.87 65.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.77 1.168 . . . . 0.0 111.191 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.42 -21.26 18.32 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 126.506 2.003 . . . . 0.0 112.75 164.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -80.78 -28.5 36.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.787 -1.101 . . . . 0.0 111.495 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.2 tpp -74.53 112.9 11.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -134.07 161.37 35.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 m -83.59 136.14 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.52 -5.75 83.63 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.603 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.18 151.28 47.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.484 1.642 . . . . 0.0 108.71 170.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.29 118.24 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.536 1.935 . . . . 0.0 109.084 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.21 105.81 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.935 1.694 . . . . 0.0 108.448 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.17 -58.47 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.993 0.425 . . . . 0.0 110.062 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.77 146.05 51.94 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.5 mt -122.44 120.12 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.75 -68.85 0.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.521 2.328 . . . . 0.0 111.488 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.45 25.91 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.655 1.982 . . . . 0.0 110.621 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.5 t -131.17 130.5 63.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.386 1.474 . . . . 0.0 108.041 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 p -65.94 126.2 27.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.228 0.611 . . . . 0.0 110.349 167.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.92 13.14 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.451 0.7 . . . . 0.0 112.024 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.87 -12.62 59.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.01 25.99 4.29 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.24 149.58 22.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.682 0.753 . . . . 0.0 109.165 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.86 142.0 38.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.695 -1.138 . . . . 0.0 107.943 -170.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -58.42 -23.41 57.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.84 1.656 . . . . 0.0 111.274 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.43 71.62 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.321 0.964 . . . . 0.0 110.808 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.24 -46.8 54.5 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.448 0.699 . . . . 0.0 109.529 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.63 -41.5 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 O-C-N 120.597 -1.314 . . . . 0.0 111.117 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.53 -34.62 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.843 -1.161 . . . . 0.0 110.107 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.14 83.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.779 1.172 . . . . 0.0 109.776 171.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.25 -36.97 77.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.54 1.136 . . . . 0.0 109.739 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.56 -40.94 63.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.593 0.757 . . . . 0.0 111.731 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -56.68 -41.7 77.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.013 0.925 . . . . 0.0 110.305 173.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.1 m -65.16 -2.95 3.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.82 110.72 49.29 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 120.747 1.612 . . . . 0.0 108.105 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.24 169.55 21.29 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.449 2.1 . . . . 0.0 111.374 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.67 148.63 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 121.385 -0.822 . . . . 0.0 109.328 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.5 -11.07 47.26 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.279 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -84.34 156.89 21.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.785 1.792 . . . . 0.0 107.993 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.0 p -125.96 148.82 49.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.441 1.096 . . . . 0.0 108.54 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.93 144.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.719 0.808 . . . . 0.0 109.841 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -82.88 155.21 24.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.27 152.14 45.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.05 111.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.8 mt -102.3 168.1 9.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.88 171.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 38.6 t -123.48 142.42 51.02 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.473 1.109 . . . . 0.0 108.835 167.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -116.73 139.65 50.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 110.728 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.62 -14.67 7.19 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.726 1.155 . . . . 0.0 112.055 168.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.54 142.21 88.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.37 173.99 10.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.501 2.134 . . . . 0.0 110.03 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 162.71 30.95 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.169 0.588 . . . . 0.0 111.501 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo . . . . . 0 N--CA 1.45 -1.037 0 C-N-CA 122.526 2.151 . . . . 0.0 109.003 160.387 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 120.526 0.203 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -64.51 -113.38 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.421 2.688 . . . . 0.0 113.325 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 140.51 -23.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 1 C-N-CA 133.111 4.565 . . . . 0.0 111.661 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -126.96 179.1 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.146 1.378 . . . . 0.0 107.639 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.81 -34.5 6.93 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 126.098 1.759 . . . . 0.0 110.429 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -28.7 70.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.663 1.12 . . . . 0.0 111.523 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.41 -24.33 67.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.002 0.819 . . . . 0.0 112.186 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.14 142.8 57.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.102 0.865 . . . . 0.0 111.144 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 127.62 33.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 162.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.18 -173.3 36.79 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 123.859 0.725 . . . . 0.0 112.721 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -114.08 141.23 47.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 167.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.0 127.49 50.22 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.71 0.804 . . . . 0.0 110.462 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 162.08 17.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.082 1.753 . . . . 0.0 107.985 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -150.18 146.72 27.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.997 -0.439 . . . . 0.0 110.833 162.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -144.13 157.54 44.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -117.09 117.18 28.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.45 145.44 30.27 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -101.58 126.75 48.45 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.473 1.109 . . . . 0.0 109.159 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 25.2 tptt -55.55 109.69 0.59 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.664 1.586 . . . . 0.0 110.197 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.6 p -79.05 -173.65 3.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.597 1.159 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -59.63 -15.59 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.351 1.06 . . . . 0.0 112.747 166.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.7 mtt -132.03 49.22 2.34 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.22 1.373 . . . . 0.0 110.221 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 72.7 -109.81 2.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.026 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -121.32 152.78 38.56 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.39 35.52 2.42 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.155 -1.358 . . . . 0.0 111.849 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.14 167.1 29.62 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.668 1.734 . . . . 0.0 108.621 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.8 p -134.06 161.32 35.17 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.25 162.46 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.459 1.104 . . . . 0.0 109.486 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 14.7 tt -126.7 158.6 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 126.715 2.006 . . . . 0.0 107.468 166.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.65 152.26 22.9 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 157.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.47 -70.86 0.85 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 124.505 1.05 . . . . 0.0 111.171 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -37.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -137.0 176.23 2.93 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.578 1.151 . . . . 0.0 110.249 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -71.32 54.33 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.501 2.8 . . . . 0.0 112.231 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.49 -9.84 0.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.02 1.728 . . . . 0.0 112.361 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -110.79 158.01 19.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.395 1.452 . . . . 0.0 108.691 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -83.57 126.58 32.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.927 0.891 . . . . 0.0 109.173 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mt -80.99 139.72 35.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -134.22 156.77 47.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.294 0.638 . . . . 0.0 110.881 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.03 114.63 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 24.1 ttmt -72.42 -51.58 19.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.647 1.579 . . . . 0.0 109.916 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 m -143.78 162.12 36.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.28 0.632 . . . . 0.0 109.417 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.85 138.91 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 162.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 mm -74.83 127.82 86.35 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.86 133.08 24.54 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 121.908 1.739 . . . . 0.0 109.768 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t0 65.48 13.04 8.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.32 1.448 . . . . 0.0 111.845 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.44 167.67 37.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.181 1.372 . . . . 0.0 111.116 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.23 -34.42 68.07 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.44 2.093 . . . . 0.0 112.716 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.33 91.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.529 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.46 96.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.459 0.704 . . . . 0.0 110.414 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -67.68 -37.43 82.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.986 0.812 . . . . 0.0 112.755 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.27 -24.89 63.13 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.433 -0.792 . . . . 0.0 110.855 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.76 -16.36 26.63 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.865 2.174 . . . . 0.0 113.483 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -81.29 -37.09 29.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.378 1.589 . . . . 0.0 114.163 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpp -70.01 118.37 12.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.52 166.06 24.08 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.999 0.919 . . . . 0.0 109.025 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -100.56 98.96 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.261 1.029 . . . . 0.0 110.491 -150.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.66 -6.7 5.87 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.776 1.655 . . . . 0.0 112.322 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.46 163.15 23.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.404 1.102 . . . . 0.0 110.62 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.9 t -111.87 120.64 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.27 1.828 . . . . 0.0 109.552 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.13 109.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 126.467 1.907 . . . . 0.0 108.881 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.8 t -93.68 -51.83 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.406 0.622 . . . . 0.0 110.086 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -134.96 154.59 51.66 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.075 1.35 . . . . 0.0 108.179 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -134.86 134.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.8 m120 50.46 -92.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.456 1.902 . . . . 0.0 110.072 -169.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -143.17 20.81 1.92 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.222 2.609 . . . . 0.0 108.971 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -128.87 128.49 67.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.325 2.25 . . . . 0.0 107.636 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.35 129.46 36.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.11 11.07 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.058 1.343 . . . . 0.0 110.964 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -20.93 64.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.07 33.83 2.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.763 1.649 . . . . 0.0 109.659 167.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.22 161.42 28.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.681 1.74 . . . . 0.0 109.225 165.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.96 151.37 33.69 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -55.35 -35.13 64.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.136 0.974 . . . . 0.0 110.39 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.4 38.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.116 0.871 . . . . 0.0 110.606 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.88 -48.18 69.53 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.768 0.827 . . . . 0.0 110.846 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.67 -43.1 96.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 125.054 1.341 . . . . 0.0 111.149 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.51 -39.62 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.982 -1.074 . . . . 0.0 109.363 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -38.82 92.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.876 1.217 . . . . 0.0 110.027 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.12 -31.81 73.14 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.134 1.374 . . . . 0.0 111.052 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.61 -46.36 22.34 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.06 0.846 . . . . 0.0 111.546 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.03 -29.86 70.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.216 -0.928 . . . . 0.0 111.586 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 t -63.42 -14.34 49.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.535 1.134 . . . . 0.0 112.746 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.3 t -84.26 112.16 39.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 120.409 1.459 . . . . 0.0 107.198 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.96 169.27 22.99 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.79 1.66 . . . . 0.0 110.869 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.06 139.57 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.54 -10.19 62.59 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.083 -0.843 . . . . 0.0 113.699 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -84.23 172.64 11.68 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.419 1.61 . . . . 0.0 108.735 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 p -134.06 156.21 48.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.205 1.002 . . . . 0.0 110.576 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.44 142.53 32.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.06 0.944 . . . . 0.0 108.849 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.86 143.6 29.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.367 1.867 . . . . 0.0 107.228 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.7 mt -144.79 110.87 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.35 132.07 35.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mt -119.02 162.89 17.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 109.707 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.18 133.96 50.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.996 1.318 . . . . 0.0 108.658 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -102.4 155.42 18.26 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 126.627 1.971 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.81 -8.56 63.62 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.351 0.976 . . . . 0.0 112.775 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.37 151.55 97.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 117.71 0.755 . . . . 0.0 109.604 163.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.5 166.39 28.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.491 2.127 . . . . 0.0 112.104 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.59 157.25 79.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.415 1.486 . . . . 0.0 110.417 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 C-N-CA 122.584 2.189 . . . . 0.0 110.831 176.338 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.121 0.486 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 m -81.76 -109.57 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.018 1.327 . . . . 0.0 112.178 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mtm105 135.71 -67.39 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 1 C-N-CA 133.915 4.886 . . . . 0.0 108.742 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.83 -3.86 9.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.896 -157.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.59 -27.31 0.19 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 128.497 2.719 . . . . 0.0 114.713 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -66.37 -6.44 14.33 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.122 1.328 . . . . 0.0 111.727 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.63 -19.08 65.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.481 1.513 . . . . 0.0 112.41 163.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 mt -91.24 159.18 16.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.236 1.38 . . . . 0.0 108.593 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -3.73 13.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.38 -172.76 38.28 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 126.179 1.847 . . . . 0.0 111.685 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -88.01 156.4 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.463 1.505 . . . . 0.0 108.574 170.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -125.54 130.05 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.801 1.241 . . . . 0.0 109.038 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.86 173.34 6.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 108.172 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.3 p -151.21 142.7 23.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.422 -0.799 . . . . 0.0 109.405 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.3 t -150.62 158.15 43.81 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -121.49 106.0 11.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 107.023 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.86 118.55 34.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -92.41 116.38 28.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -42.95 91.97 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.819 2.448 . . . . 0.0 112.298 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -79.52 111.67 16.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 17.34 -83.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 130.269 3.428 . . . . 0.0 115.209 -168.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.0 mtt -56.38 -21.98 28.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.394 1.478 . . . . 0.0 113.463 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.73 -124.51 5.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 124.829 1.204 . . . . 0.0 110.426 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.58 129.64 50.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.37 49.04 2.93 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -146.73 171.89 14.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.567 1.547 . . . . 0.0 108.356 166.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -134.13 163.38 29.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.606 0.762 . . . . 0.0 109.407 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.58 162.35 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 108.44 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.45 159.91 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 128.244 2.618 . . . . 0.0 107.006 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.16 152.57 22.86 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 128.354 2.883 . . . . 0.0 106.523 167.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.77 -70.54 0.88 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 118.819 1.31 . . . . 0.0 113.091 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -173.82 -52.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -97.56 163.41 19.74 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 124.64 1.176 . . . . 0.0 112.619 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -75.1 48.37 2.0 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 125.099 3.866 . . . . 0.0 112.082 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -150.8 -7.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 110.497 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.32 152.44 19.15 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.874 0.761 . . . . 0.0 112.293 -161.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -57.89 134.22 56.13 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.101 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.4 mt -100.65 126.61 47.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.022 1.729 . . . . 0.0 106.375 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.95 155.05 47.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.017 0.826 . . . . 0.0 110.238 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.95 112.37 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.42 -47.94 71.61 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.123 0.969 . . . . 0.0 109.207 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -155.98 158.53 38.03 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.014 1.326 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.07 145.01 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 165.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -81.62 128.85 67.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 55' ' ' GLY . 42.3 Cg_endo -62.75 160.21 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.755 1.637 . . . . 0.0 110.221 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.4 -12.95 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.996 2.118 . . . . 0.0 114.903 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 53' ' ' PRO . . . -80.46 178.1 54.06 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.667 1.127 . . . . 0.0 112.94 -166.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.87 -37.46 77.45 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.695 2.263 . . . . 0.0 110.79 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.9 76.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.168 0.587 . . . . 0.0 111.649 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.06 -40.97 67.93 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.67 -49.46 76.42 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.06 -35.47 78.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.707 0.289 . . . . 0.0 110.949 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.48 -11.34 39.22 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.878 1.228 . . . . 0.0 113.995 161.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.43 -46.01 88.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.09 1.445 . . . . 0.0 109.709 168.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.5 tpp -66.28 115.91 6.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.37 159.14 42.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -87.88 117.85 27.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.162 -159.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.68 -8.25 39.82 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.535 1.54 . . . . 0.0 113.46 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.43 155.02 26.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.438 1.619 . . . . 0.0 109.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.35 116.82 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.037 1.735 . . . . 0.0 109.375 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.05 118.79 4.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 126.659 1.983 . . . . 0.0 108.052 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.95 -57.62 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.053 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.7 150.74 51.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mt -127.69 123.29 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.16 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.478 3.111 . . . . 0.0 110.518 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.39 -6.53 1.36 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.934 1.694 . . . . 0.0 111.952 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -88.74 124.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.51 120.07 12.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.4 6.56 6.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 124.699 1.2 . . . . 0.0 110.948 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.26 1.0 OUTLIER -58.62 -25.89 63.15 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -166.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.63 11.18 21.29 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.512 2.006 . . . . 0.0 112.368 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 165.38 24.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.321 1.06 . . . . 0.0 110.242 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -75.85 148.51 38.28 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -60.76 -35.57 76.74 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.436 165.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.3 74.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.34 0.973 . . . . 0.0 111.929 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.84 -55.58 8.19 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 118.188 0.449 . . . . 0.0 110.488 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.37 -39.58 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 127.519 2.328 . . . . 0.0 112.162 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.9 -39.08 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 120.94 -1.1 . . . . 0.0 109.242 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -36.46 83.22 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.87 1.214 . . . . 0.0 109.638 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.64 -45.6 93.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.584 1.153 . . . . 0.0 108.722 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -66.2 -31.01 71.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.235 0.614 . . . . 0.0 112.237 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.34 -6.65 59.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.056 1.342 . . . . 0.0 112.963 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -91.02 7.61 39.51 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.213 1.405 . . . . 0.0 113.57 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.2 t -101.18 107.59 50.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.5 172.41 14.49 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.35 2.7 . . . . 0.0 113.33 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.2 mp -70.94 100.15 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.291 1.436 . . . . 0.0 110.665 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.56 -42.09 1.05 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -84.26 160.75 20.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.694 0.759 . . . . 0.0 109.61 -164.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.89 160.54 22.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.582 1.553 . . . . 0.0 108.474 170.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.11 147.15 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.66 157.45 22.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -146.52 116.27 7.22 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.81 123.98 45.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.97 159.01 17.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.794 0.683 . . . . 0.0 110.353 159.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.3 t -105.97 136.16 46.13 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.284 1.434 . . . . 0.0 107.661 165.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -81.52 156.23 25.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.231 1.412 . . . . 0.0 112.43 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.31 35.84 7.84 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.11 151.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -117.3 150.42 46.34 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 161.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.08 171.71 13.25 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.215 1.943 . . . . 0.0 111.208 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.61 143.22 94.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.503 0 C-N-CA 122.821 2.347 . . . . 0.0 114.219 -168.673 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.0 t80 . . . . . 0 CA--C 1.547 0.851 0 CA-C-O 122.377 1.084 . . . . 0.0 113.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -81.86 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.551 1.541 . . . . 0.0 110.617 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 145.85 -60.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.373 4.269 . . . . 0.0 111.398 174.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.58 2.37 26.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.936 1.294 . . . . 0.0 111.029 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.01 -14.15 0.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.8 2.44 . . . . 0.0 113.669 -168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -57.88 -29.16 64.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.36 1.064 . . . . 0.0 113.095 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -77.93 -11.97 59.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.082 -171.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.7 166.12 18.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.198 0.999 . . . . 0.0 110.342 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -128.0 136.42 51.25 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.24 -161.49 25.63 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -107.04 161.52 14.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -119.56 121.31 39.07 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.661 1.584 . . . . 0.0 108.142 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 154.07 41.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.376 1.07 . . . . 0.0 110.576 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.8 p -157.14 163.28 39.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -165.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 t -154.92 157.71 38.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.0 m -101.33 119.82 39.33 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.225 1.01 . . . . 0.0 108.52 158.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -99.11 159.3 15.07 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.792 1.237 . . . . 0.0 108.125 163.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -103.84 143.52 32.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -66.98 99.35 0.64 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -88.47 -163.4 0.96 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.377 2.271 . . . . 0.0 108.487 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -48.49 -65.21 0.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.942 1.297 . . . . 0.0 110.925 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.44 66.81 1.11 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.2 -106.76 0.61 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 124.818 1.199 . . . . 0.0 113.469 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.37 152.25 43.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.0 40.15 2.89 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.328 -1.262 . . . . 0.0 111.753 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.405 ' CD1' ' HE3' ' A' ' 63' ' ' MET . 35.4 p90 -154.92 161.47 41.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.748 1.774 . . . . 0.0 110.316 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 p -130.41 159.93 35.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.977 1.311 . . . . 0.0 109.315 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.82 162.63 26.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 125.208 1.403 . . . . 0.0 109.973 -170.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.18 151.58 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.469 1.508 . . . . 0.0 110.067 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.29 153.37 16.73 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 129.322 3.344 . . . . 0.0 109.333 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.86 -82.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.68 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.028 1.731 . . . . 0.0 109.798 163.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -93.57 162.59 27.14 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.541 1.537 . . . . 0.0 113.473 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.55 43.17 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 125.086 3.857 . . . . 0.0 112.925 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -166.47 12.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.63 1.972 . . . . 0.0 111.683 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 155.13 21.2 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.349 -1.469 . . . . 0.0 110.969 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.93 115.74 23.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.054 0.942 . . . . 0.0 109.491 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.79 140.6 35.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.884 0.766 . . . . 0.0 109.502 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -131.63 157.18 44.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.845 0.748 . . . . 0.0 111.231 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.48 111.02 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 168.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -60.76 -54.65 42.63 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.022 0.929 . . . . 0.0 109.328 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -154.99 164.45 38.88 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.97 0.508 . . . . 0.0 110.672 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.11 145.34 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 160.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.5 123.42 76.65 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 165.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.57 150.95 86.1 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.552 2.168 . . . . 0.0 109.854 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.319 1.0 OUTLIER 58.99 -0.7 0.13 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.996 1.718 . . . . 0.0 115.137 -168.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.05 167.18 54.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.48 1.038 . . . . 0.0 112.563 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.17 -26.52 36.18 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.952 1.768 . . . . 0.0 112.236 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.74 -45.61 78.06 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.781 -0.575 . . . . 0.0 109.807 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.92 97.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.572 0.749 . . . . 0.0 110.96 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -69.69 -26.07 64.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.78 -38.98 76.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.47 1.032 . . . . 0.0 109.238 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.45 20.39 69.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.169 166.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -98.76 -52.05 3.71 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.807 1.804 . . . . 0.0 111.379 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.405 ' HE3' ' CD1' ' A' ' 34' ' ' PHE . 13.7 ttm -80.82 146.77 30.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.558 1.143 . . . . 0.0 109.961 -169.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -134.09 165.1 25.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.385 1.088 . . . . 0.0 110.984 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -75.17 121.28 21.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.227 1.011 . . . . 0.0 108.656 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.05 -20.37 16.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.756 -1.025 . . . . 0.0 112.122 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -63.91 150.64 44.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.079 1.439 . . . . 0.0 109.402 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -101.45 124.45 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.635 1.974 . . . . 0.0 108.813 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.42 128.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 125.353 1.461 . . . . 0.0 107.614 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.27 -56.85 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.899 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -133.09 147.57 52.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.324 1.05 . . . . 0.0 108.841 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mt -130.33 122.51 53.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 53.21 -92.63 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 127.35 2.26 . . . . 0.0 109.719 -162.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.61 1.38 8.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.37 1.468 . . . . 0.0 111.161 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -111.51 131.08 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 -160.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.4 p -74.69 123.28 24.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.62 12.77 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.034 0.934 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -35.31 62.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -162.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.45 16.35 12.72 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.111 1.339 . . . . 0.0 112.624 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 164.91 12.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.874 1.837 . . . . 0.0 110.666 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 p -70.74 137.96 50.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.58 -25.14 64.34 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.594 -0.691 . . . . 0.0 110.546 167.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.51 -57.85 10.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.897 1.226 . . . . 0.0 110.31 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.86 -54.73 42.74 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.574 1.15 . . . . 0.0 110.472 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.4 -42.53 74.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.487 1.515 . . . . 0.0 111.491 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.09 -33.98 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.546 -1.346 . . . . 0.0 110.376 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -39.57 94.42 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.659 1.572 . . . . 0.0 109.361 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.24 -49.18 78.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -64.56 -41.4 96.34 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -55.51 -46.78 76.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.495 0.588 . . . . 0.0 109.585 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.5 p -64.76 -13.55 55.6 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.447 1.276 . . . . 0.0 114.447 -166.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.98 110.93 26.25 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.73 159.95 44.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 120.062 1.058 . . . . 0.0 109.59 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 79.8 mt -57.58 126.76 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.83 50.28 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.805 -1.553 . . . . 0.0 114.163 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -112.13 165.11 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 121.02 2.41 . . . . 0.0 110.327 168.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.6 p -123.25 164.7 18.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.124 1.37 . . . . 0.0 109.755 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.97 150.14 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.007 1.323 . . . . 0.0 108.314 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.83 154.14 23.66 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -146.24 126.27 13.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.37 130.97 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.1 mt -118.45 169.05 10.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.322 1.014 . . . . 0.0 110.046 170.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.6 t -128.37 144.45 51.14 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.5 1.52 . . . . 0.0 108.887 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.11 123.16 39.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.432 1.493 . . . . 0.0 112.686 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.45 -25.44 0.86 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.989 1.28 . . . . 0.0 113.494 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -72.66 158.02 87.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 118.021 0.911 . . . . 0.0 110.856 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.27 175.79 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.006 2.471 . . . . 0.0 111.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mt -71.89 159.09 86.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.273 1.029 . . . . 0.0 109.484 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 123.806 3.004 . . . . 0.0 113.847 -178.755 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.2 t80 . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 122.228 1.013 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 11' ' ' ARG . 5.1 m -78.38 -143.69 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.185 2.194 . . . . 0.0 112.108 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.565 ' H ' HG21 ' A' ' 10' ' ' THR . 0.7 OUTLIER -163.02 -69.38 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 147.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 14' ' ' SER . 9.3 m-20 -89.25 22.94 2.65 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.866 2.066 . . . . 0.0 111.911 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.89 -6.2 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.486 2.314 . . . . 0.0 114.653 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 12' ' ' ASP . 55.0 m -75.41 -24.99 57.2 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.947 1.299 . . . . 0.0 110.628 -168.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.55 -15.77 63.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.392 -1.29 . . . . 0.0 114.007 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 mt -74.64 161.91 29.24 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.253 1.388 . . . . 0.0 110.386 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.87 2.1 3.66 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -165.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.97 -179.27 41.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 162.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.4 m -81.82 154.56 25.85 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.438 0.695 . . . . 0.0 109.423 -172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.68 140.73 46.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.607 1.163 . . . . 0.0 108.346 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 -179.55 4.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.034 1.734 . . . . 0.0 107.658 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -145.14 165.61 27.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.124 -0.36 . . . . 0.0 111.185 163.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -152.85 157.2 40.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 151.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.1 m -104.82 113.93 27.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 160.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.37 138.03 36.2 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -82.06 155.21 25.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 158.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' CE ' ' HA2' ' A' ' 31' ' ' GLY . 5.6 tptt -58.04 161.19 4.22 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 154.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -129.66 -78.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 159.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.39 132.95 46.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -170.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.5 mmt 63.04 -62.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.06 2.144 . . . . 0.0 111.132 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.413 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . -169.47 -154.25 9.04 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -170.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.12 153.74 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 163.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.38 35.17 2.43 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.134 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.17 163.12 37.95 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.906 2.353 . . . . 0.0 111.268 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -125.52 155.1 41.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.112 1.365 . . . . 0.0 109.174 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.96 162.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.383 1.473 . . . . 0.0 109.921 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 tt -136.76 157.76 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 128.324 2.65 . . . . 0.0 108.186 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.58 152.17 22.81 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.527 2.489 . . . . 0.0 107.966 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.09 -71.17 0.81 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.506 1.051 . . . . 0.0 112.725 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 170.27 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.577 1.551 . . . . 0.0 110.691 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.74 158.43 87.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 120.197 1.362 . . . . 0.0 110.228 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.28 43.31 1.28 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.505 3.47 . . . . 0.0 112.263 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.48 37.45 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.732 2.813 . . . . 0.0 108.669 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -113.54 150.3 33.17 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.96 0.904 . . . . 0.0 108.762 167.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -74.91 127.33 32.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.081 0.943 . . . . 0.0 109.112 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.37 142.78 32.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -142.49 162.35 35.69 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.674 0.789 . . . . 0.0 110.865 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.17 114.49 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.02 -50.06 72.17 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.61 0.641 . . . . 0.0 109.285 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.08 154.19 17.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.181 0.926 . . . . 0.0 110.095 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.75 121.42 55.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.51 129.24 90.38 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -85.85 48.24 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.782 2.988 . . . . 0.0 112.605 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.59 57.98 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.981 2.112 . . . . 0.0 107.694 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.12 171.22 44.07 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.104 -0.997 . . . . 0.0 112.632 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.72 -25.28 54.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.387 2.058 . . . . 0.0 112.174 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.02 70.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.984 0.811 . . . . 0.0 111.235 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.29 12.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.202 1.001 . . . . 0.0 108.746 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.08 -29.36 69.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -172.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.67 -26.75 67.19 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.726 -0.609 . . . . 0.0 110.927 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.94 -14.73 9.78 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.93 1.729 . . . . 0.0 113.437 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -83.59 -26.86 29.66 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.325 -1.103 . . . . 0.0 111.385 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.9 tpp -89.36 130.79 35.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.403 0.681 . . . . 0.0 110.173 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -144.0 166.2 25.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.795 1.638 . . . . 0.0 108.861 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.3 m -87.95 144.37 26.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.145 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.72 57.62 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.823 1.192 . . . . 0.0 112.396 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.2 144.05 44.29 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.962 1.381 . . . . 0.0 107.721 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.45 118.35 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.248 1.819 . . . . 0.0 110.062 -162.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.65 110.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.498 1.519 . . . . 0.0 108.871 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.13 -59.94 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.344 0.593 . . . . 0.0 109.796 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -128.71 158.49 38.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.011 1.324 . . . . 0.0 107.566 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.1 122.93 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t30 65.05 -81.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.413 2.285 . . . . 0.0 110.489 168.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.74 36.35 1.16 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.432 1.093 . . . . 0.0 110.554 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.44 132.62 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 120.425 -1.422 . . . . 0.0 109.422 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.7 p -77.82 110.13 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.755 0.822 . . . . 0.0 109.368 165.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.67 -3.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -31.18 51.88 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.03 1.286 . . . . 0.0 114.414 -164.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.76 28.56 5.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.506 1.527 . . . . 0.0 111.008 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 172.22 13.31 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 164.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 p -90.04 153.25 20.71 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -54.93 -36.45 65.28 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.119 1.368 . . . . 0.0 109.741 170.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -64.49 0.79 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.382 1.073 . . . . 0.0 110.902 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.73 -35.87 77.69 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.763 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.58 -40.27 87.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 120.548 -1.345 . . . . 0.0 111.265 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.69 -43.59 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -40.28 84.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.165 0.893 . . . . 0.0 110.499 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.3 mt -64.87 -41.06 95.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.589 1.556 . . . . 0.0 109.265 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -71.21 -39.19 71.9 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.476 1.034 . . . . 0.0 111.177 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -60.88 -36.95 80.52 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.814 0.734 . . . . 0.0 110.406 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -59.81 -13.24 9.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.052 1.741 . . . . 0.0 113.539 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.1 t -87.58 110.59 35.61 Favored Pre-proline 0 C--O 1.239 0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.86 160.15 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.729 1.619 . . . . 0.0 111.736 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.27 138.25 20.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 158.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.86 14.92 76.53 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.396 -1.78 . . . . 0.0 113.677 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -122.73 162.58 21.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.032 2.416 . . . . 0.0 111.413 165.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.72 155.14 30.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.665 1.986 . . . . 0.0 111.334 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.38 157.42 39.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.322 1.449 . . . . 0.0 109.172 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.87 158.69 22.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 mt -145.71 145.83 31.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -123.8 125.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 mt -112.85 165.05 12.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.345 1.028 . . . . 0.0 110.931 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.4 t -119.46 143.91 47.26 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.417 1.487 . . . . 0.0 108.288 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.77 155.85 17.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.446 2.298 . . . . 0.0 111.485 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.47 -2.73 74.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.102 170.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -103.02 103.09 31.86 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 168.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.28 -174.72 1.49 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.769 2.979 . . . . 0.0 113.05 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 mt -65.57 146.03 99.0 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 125.612 1.565 . . . . 0.0 109.964 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 C-N-CA 123.712 2.942 . . . . 0.0 110.786 -173.66 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 . . . . . 0 C--O 1.242 0.662 0 CA-C-O 121.597 0.713 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -73.07 -116.7 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.07 2.148 . . . . 0.0 111.041 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 137.92 -76.13 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 1 C-N-CA 134.271 5.028 . . . . 0.0 106.195 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -95.22 10.95 34.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 15' ' ' GLN . . . 68.64 -27.74 0.15 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.762 -1.836 . . . . 0.0 113.394 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -69.12 17.73 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.362 1.465 . . . . 0.0 113.249 170.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 13' ' ' ALA . 19.5 mm100 -115.2 -11.04 12.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.882 1.673 . . . . 0.0 110.702 168.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.83 162.54 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -138.58 131.14 29.03 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 124.932 1.293 . . . . 0.0 107.925 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.22 -133.47 4.14 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.1 m -133.11 152.53 51.95 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -109.82 145.91 35.93 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.007 0.821 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 170.29 14.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.243 2.217 . . . . 0.0 107.682 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -152.97 154.35 34.81 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 121.883 -0.511 . . . . 0.0 109.833 159.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -144.53 157.68 44.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.411 1.485 . . . . 0.0 109.154 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 114.73 19.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -98.62 146.71 25.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -82.46 132.16 35.21 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 161.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 70.9 tttt -67.25 100.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.977 1.311 . . . . 0.0 107.84 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -89.45 -92.69 0.12 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.047 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -105.87 130.2 53.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 45.7 mtt 58.62 -54.49 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.671 2.388 . . . . 0.0 114.869 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.475 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . -175.48 -167.41 34.51 Favored Glycine 0 N--CA 1.449 -0.449 0 O-C-N 120.744 -1.222 . . . . 0.0 110.808 -148.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -86.02 152.21 23.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.65 0.95 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.743 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.445 ' CE1' ' HE2' ' A' ' 63' ' ' MET . 50.9 p90 -143.54 167.82 21.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.823 1.811 . . . . 0.0 108.307 174.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -125.77 159.88 31.22 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.452 1.501 . . . . 0.0 107.568 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 157.29 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 122.13 0.967 . . . . 0.0 110.333 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -131.02 147.66 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.282 2.233 . . . . 0.0 105.734 165.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.37 21.78 Favored Glycine 0 CA--C 1.507 -0.448 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 154.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.83 -70.06 1.08 Allowed Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -165.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -173.09 -43.77 0.01 OUTLIER 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.116 0.539 . . . . 0.0 111.377 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 161.12 26.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.331 1.052 . . . . 0.0 111.324 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.99 44.83 1.39 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.962 3.775 . . . . 0.0 111.522 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -16.31 1.04 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.089 0.955 . . . . 0.0 111.507 169.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.19 130.37 34.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -59.82 147.14 39.28 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.172 0.986 . . . . 0.0 111.086 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.73 132.58 36.29 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.353 -1.749 . . . . 0.0 106.689 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -129.46 152.87 48.53 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.851 0.86 . . . . 0.0 109.012 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.9 t -62.66 113.58 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -61.86 -55.0 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.765 1.626 . . . . 0.0 109.667 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -155.31 151.17 27.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.85 1.66 . . . . 0.0 108.051 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.63 123.96 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 127.78 86.94 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.75 156.4 66.08 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.894 1.729 . . . . 0.0 109.933 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 76.43 -27.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 127.281 2.232 . . . . 0.0 113.269 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.19 166.6 50.22 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.848 1.213 . . . . 0.0 112.267 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.35 -20.08 48.99 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.229 1.953 . . . . 0.0 112.95 -171.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.38 -51.23 54.47 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.34 89.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.249 1.02 . . . . 0.0 110.426 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.57 -21.05 65.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -87.2 -34.73 18.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.227 1.376 . . . . 0.0 109.963 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.71 -10.67 55.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.392 1.472 . . . . 0.0 114.37 167.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -77.89 -8.53 58.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.953 1.377 . . . . 0.0 113.799 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.445 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 ttm -118.25 139.92 50.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.709 1.604 . . . . 0.0 108.98 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -133.77 172.12 13.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.769 1.271 . . . . 0.0 109.111 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.9 m -78.28 127.28 32.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.73 -15.82 40.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.531 1.062 . . . . 0.0 113.667 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.13 143.8 37.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.436 1.118 . . . . 0.0 109.708 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.23 121.3 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.29 1.836 . . . . 0.0 109.456 -170.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.0 mp -66.03 110.83 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.399 1.879 . . . . 0.0 108.971 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.77 -62.26 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.43 141.24 43.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.581 1.152 . . . . 0.0 109.366 -167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.05 125.55 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 59.48 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.538 2.735 . . . . 0.0 112.18 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.77 11.94 2.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.171 0.896 . . . . 0.0 111.244 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.85 153.48 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 120.344 -1.473 . . . . 0.0 109.032 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.0 p -87.12 138.72 31.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.352 0.978 . . . . 0.0 109.585 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.08 5.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.117 0.967 . . . . 0.0 111.924 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 2.0 pt? -66.14 -22.29 66.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -163.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.87 66.95 0.53 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 104.834 -3.306 . . . . 0.0 104.834 157.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -121.94 168.94 11.31 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.637 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 p -74.49 136.47 42.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -54.32 -32.11 55.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.417 0.687 . . . . 0.0 110.589 162.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.32 -40.18 89.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.455 1.025 . . . . 0.0 112.407 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.23 -44.84 28.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.219 0.918 . . . . 0.0 109.955 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 t -59.95 -42.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 O-C-N 120.179 -1.575 . . . . 0.0 111.205 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.02 -32.45 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 120.738 -1.226 . . . . 0.0 110.792 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -44.56 94.89 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.47 -0.769 . . . . 0.0 109.215 169.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.13 -36.23 81.43 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.701 -166.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -69.83 -22.81 63.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -87.67 -18.41 29.63 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.982 -1.074 . . . . 0.0 110.971 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -65.07 -17.34 64.37 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.472 -0.768 . . . . 0.0 112.639 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.57 121.72 74.89 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.884 1.274 . . . . 0.0 107.762 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.3 159.82 33.75 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.014 1.809 . . . . 0.0 112.31 167.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.33 152.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.184 -0.947 . . . . 0.0 109.316 162.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.05 -9.47 38.83 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.693 1.616 . . . . 0.0 113.154 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -95.55 163.5 13.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.18 1.99 . . . . 0.0 108.975 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 p -116.08 146.78 41.94 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.986 0.914 . . . . 0.0 110.191 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.91 145.12 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 122.843 0.457 . . . . 0.0 109.919 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.34 157.21 22.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 mt -145.94 114.23 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -89.69 127.36 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.2 mt -121.96 168.89 11.38 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.272 0.983 . . . . 0.0 110.551 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.2 t -126.55 141.55 51.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.819 1.247 . . . . 0.0 109.742 171.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.28 155.76 22.52 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 128.653 2.781 . . . . 0.0 109.609 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.75 -30.95 5.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.68 1.61 . . . . 0.0 110.993 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -67.73 139.06 93.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.504 1.122 . . . . 0.0 110.214 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.39 171.67 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.245 1.963 . . . . 0.0 111.191 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.3 161.89 53.35 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 109.896 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 CA--C 1.532 0.387 0 C-N-CA 121.662 1.575 . . . . 0.0 111.581 -179.175 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.2 t80 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.423 0.63 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 13' ' ' ALA . 99.2 m -85.76 -104.46 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.13 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 119.32 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 1 C-N-CA 134.879 5.272 . . . . 0.0 110.8 -172.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -126.38 6.55 7.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -158.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 10' ' ' THR . . . 61.95 -1.43 0.36 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 129.264 3.025 . . . . 0.0 115.74 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 t -84.04 -16.52 43.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.082 1.31 . . . . 0.0 110.975 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.98 67.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.024 -1.465 . . . . 0.0 111.913 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.73 138.06 57.12 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.462 1.483 . . . . 0.0 108.124 -163.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -106.48 126.29 52.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -174.09 30.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.844 2.164 . . . . 0.0 108.323 -167.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 m -95.38 160.4 14.55 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -118.39 131.13 56.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 122.374 1.083 . . . . 0.0 108.31 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.34 163.14 40.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -169.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.33 155.85 43.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.6 t -148.38 157.36 43.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.928 161.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 m -109.32 114.87 28.92 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.32 144.64 27.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -89.16 141.42 28.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -72.75 101.44 3.1 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -74.68 -175.72 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.027 0.83 . . . . 0.0 109.827 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -51.42 -31.76 24.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.278 1.431 . . . . 0.0 112.65 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 mtp -107.86 14.25 25.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.04 1.736 . . . . 0.0 111.766 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.85 -110.48 3.82 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.2 152.34 41.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.702 1.251 . . . . 0.0 110.138 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.86 25.84 5.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.433 1.016 . . . . 0.0 112.944 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CE1' ' HE3' ' A' ' 63' ' ' MET . 32.1 p90 -144.56 173.27 11.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.001 1.401 . . . . 0.0 107.506 176.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -135.64 159.62 41.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.28 1.032 . . . . 0.0 108.624 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.37 162.04 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.519 1.128 . . . . 0.0 108.933 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.1 tt -132.62 156.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.419 2.287 . . . . 0.0 107.423 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.62 153.08 23.41 Favored Glycine 0 N--CA 1.461 0.358 0 C-N-CA 127.909 2.671 . . . . 0.0 107.672 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.51 -75.01 0.35 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -172.39 -59.46 0.02 OUTLIER 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.956 -168.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 163.33 36.5 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 126.745 2.018 . . . . 0.0 109.937 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.94 48.25 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.88 3.053 . . . . 0.0 110.948 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -154.46 -9.83 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.418 -1.277 . . . . 0.0 114.265 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -67.31 143.56 56.34 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.753 1.615 . . . . 0.0 109.85 169.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -78.58 125.72 29.76 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.26 138.57 34.57 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.218 1.807 . . . . 0.0 108.613 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.93 153.2 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.017 0.371 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.9 t -65.76 111.3 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -60.49 -48.86 79.92 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.685 1.594 . . . . 0.0 110.983 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 m -160.92 150.44 17.1 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.355 1.862 . . . . 0.0 107.306 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.7 t -101.83 121.75 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 163.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.96 128.76 84.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' GLY . 60.8 Cg_endo -64.28 152.21 82.28 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.268 1.979 . . . . 0.0 110.332 173.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.59 -15.31 0.07 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.369 2.268 . . . . 0.0 113.369 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 53' ' ' PRO . . . -66.78 161.5 46.53 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.265 -1.522 . . . . 0.0 111.581 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.2 -20.93 55.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 0.0 113.193 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.11 42.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.287 0.635 . . . . 0.0 110.842 171.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.79 90.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.446 0.567 . . . . 0.0 110.11 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -65.15 -6.59 9.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.588 1.155 . . . . 0.0 113.973 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -92.11 -20.02 21.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.686 1.584 . . . . 0.0 110.982 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.14 32.08 82.99 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.826 1.203 . . . . 0.0 114.333 170.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -136.19 -39.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 112.739 -169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.426 ' HE3' ' CE1' ' A' ' 34' ' ' PHE . 23.0 ttm -89.9 140.28 29.77 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -137.27 168.7 19.12 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 125.713 1.883 . . . . 0.0 110.801 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -78.88 160.4 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.87 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.25 -19.3 13.76 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.691 1.138 . . . . 0.0 112.614 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.88 152.97 43.12 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.868 1.334 . . . . 0.0 110.805 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.63 131.71 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.435 1.894 . . . . 0.0 108.347 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.71 126.73 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.751 1.62 . . . . 0.0 108.305 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.19 -60.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 109.556 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -134.5 153.05 52.13 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.392 1.077 . . . . 0.0 108.917 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mt -126.45 108.65 19.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 72.36 -61.95 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 128.824 2.849 . . . . 0.0 110.542 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -149.19 -25.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.859 2.064 . . . . 0.0 110.477 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.83 131.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.243 1.417 . . . . 0.0 108.981 -168.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -65.05 131.89 47.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 108.824 165.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.67 5.47 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 123.375 0.67 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.51 1.124 . . . . 0.0 111.67 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.16 53.54 0.75 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 166.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -95.86 158.48 15.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 156.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -76.05 156.41 33.98 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -56.23 -27.08 53.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.485 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.96 -52.51 65.19 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.082 1.31 . . . . 0.0 110.722 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.7 -42.79 73.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.914 0.486 . . . . 0.0 109.819 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.294 -1.503 . . . . 0.0 111.549 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.32 -40.34 88.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 121.138 -0.976 . . . . 0.0 109.315 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.933 1.242 . . . . 0.0 111.091 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.29 -46.83 75.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -64.85 -40.11 94.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.056 0.844 . . . . 0.0 111.265 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.25 -33.65 75.96 Favored 'General case' 0 C--O 1.231 0.104 0 O-C-N 121.343 -0.848 . . . . 0.0 111.551 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.2 m -56.98 -22.99 42.61 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.886 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.0 114.06 51.82 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 167.0 14.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.415 2.743 . . . . 0.0 111.848 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.4 98.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.772 1.629 . . . . 0.0 108.473 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.18 -17.11 3.39 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.045 1.307 . . . . 0.0 112.65 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.16 164.96 18.83 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 p -120.48 147.2 45.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 109.111 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.1 138.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.536 0.734 . . . . 0.0 109.163 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -83.87 153.81 23.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.269 1.428 . . . . 0.0 109.404 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 mt -144.1 109.37 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.84 121.3 38.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mt -118.57 160.81 21.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 124.508 1.13 . . . . 0.0 109.92 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -107.53 119.17 38.68 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 168.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -84.32 126.02 32.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.675 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.69 -3.47 9.35 Favored Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.096 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -65.8 142.67 98.24 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 163.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.66 175.34 8.98 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 109.866 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.35 161.43 42.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 167.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 C-N-CA 122.357 2.038 . . . . 0.0 111.656 172.59 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 122.785 1.279 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 m -81.54 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 125.898 1.679 . . . . 0.0 110.295 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 130.88 -44.72 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.458 1 C-N-CA 134.363 5.065 . . . . 0.0 110.427 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 14' ' ' SER . 26.0 t0 -124.66 18.14 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -161.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.69 -3.5 0.05 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.914 2.086 . . . . 0.0 114.873 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 12' ' ' ASP . 7.8 t -66.42 -43.25 86.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 120.721 -1.237 . . . . 0.0 111.171 -171.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -78.33 7.09 6.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD23 ' HH ' ' A' ' 106' ' ' TYR . 14.4 mt -73.68 164.75 26.23 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.391 -1.443 . . . . 0.0 108.558 174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -129.35 -1.78 5.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.14 174.07 55.29 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.91 -1.119 . . . . 0.0 110.58 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -86.03 150.41 24.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.038 0.919 . . . . 0.0 108.838 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -100.39 147.43 25.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.673 1.589 . . . . 0.0 109.811 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp -140.36 163.84 31.72 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.252 1.021 . . . . 0.0 109.975 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 p -147.43 119.93 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.147 0.579 . . . . 0.0 112.263 -174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -127.59 150.68 49.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -119.36 114.96 23.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.8 134.98 40.92 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -82.86 140.87 32.66 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 166.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -65.27 101.14 0.52 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -142.51 158.44 43.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.134 1.374 . . . . 0.0 111.546 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 63.42 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 127.346 2.259 . . . . 0.0 110.048 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.7 mtt -141.15 88.42 2.16 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 154.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.78 -110.41 3.15 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.851 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -125.95 140.33 52.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.702 1.251 . . . . 0.0 109.445 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.5 38.89 2.29 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.381 0.991 . . . . 0.0 112.413 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.447 ' CD1' ' HE1' ' A' ' 63' ' ' MET . 29.5 p90 -147.65 169.1 20.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -131.55 166.07 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.08 162.24 25.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 109.021 -171.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 tt -136.71 154.93 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.581 1.952 . . . . 0.0 107.706 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.69 152.22 22.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.0 -2.84 . . . . 0.0 106.0 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.38 -67.8 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 124.574 1.083 . . . . 0.0 111.563 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.79 -30.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.764 1.226 . . . . 0.0 110.766 160.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -116.18 168.87 7.84 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.675 1.19 . . . . 0.0 112.156 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.22 75.4 4.65 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.25 2.633 . . . . 0.0 108.509 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -169.2 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.501 1.92 . . . . 0.0 109.341 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -80.2 137.93 36.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.533 0.682 . . . . 0.0 109.505 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.97 130.49 41.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.385 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.81 137.15 35.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.564 1.146 . . . . 0.0 108.8 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -136.77 151.86 49.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.516 0.726 . . . . 0.0 110.799 -171.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.85 112.43 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -66.37 -52.96 41.5 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.043 1.737 . . . . 0.0 110.273 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -150.84 149.95 30.32 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.345 1.458 . . . . 0.0 107.587 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.08 120.03 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 160.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.75 128.6 93.93 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.57 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.07 1.847 . . . . 0.0 110.147 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.47 56.41 2.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 111.77 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.08 167.3 24.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.138 1.351 . . . . 0.0 110.079 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -69.18 -18.31 39.77 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 0.0 113.739 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.35 4.58 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.19 -37.27 54.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.798 1.639 . . . . 0.0 111.557 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.77 -14.1 58.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.711 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -84.1 -22.25 31.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.832 2.105 . . . . 0.0 111.441 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.52 30.14 71.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.897 163.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -122.05 -26.01 4.83 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.78 1.79 . . . . 0.0 112.701 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.447 ' HE1' ' CD1' ' A' ' 34' ' ' PHE . 24.9 ttm -86.65 141.61 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.644 1.178 . . . . 0.0 108.388 175.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -131.25 169.29 16.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.48 1.133 . . . . 0.0 108.047 165.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.7 m -65.3 145.1 56.63 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.774 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 -18.47 44.58 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.518 1.056 . . . . 0.0 113.918 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.32 143.59 55.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.996 1.398 . . . . 0.0 109.987 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.14 120.98 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.183 1.393 . . . . 0.0 109.249 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.15 114.1 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.266 1.426 . . . . 0.0 107.994 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.57 -60.4 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.157 0.983 . . . . 0.0 109.696 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.66 149.74 52.17 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -120.89 120.95 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 64.52 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.971 1.708 . . . . 0.0 108.284 -172.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -138.89 -10.63 1.32 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.79 1.636 . . . . 0.0 111.34 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.18 127.07 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 107.614 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.8 t -71.78 128.17 34.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 168.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.22 17.4 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 125.773 1.629 . . . . 0.0 109.02 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -35.93 76.46 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 120.719 -1.238 . . . . 0.0 112.251 -166.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.45 38.82 2.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.225 1.869 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 170.0 16.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.283 1.041 . . . . 0.0 110.255 167.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -74.92 139.94 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 164.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -52.31 -45.72 65.68 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.913 0.885 . . . . 0.0 109.33 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -22.29 43.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.31 -51.71 5.42 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 119.51 1.05 . . . . 0.0 111.187 173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.17 -36.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.129 2.172 . . . . 0.0 111.437 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.38 -41.19 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.873 0.869 . . . . 0.0 110.416 171.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -36.92 82.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 108.658 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.49 -38.31 89.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.969 0.908 . . . . 0.0 110.006 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.4 -30.13 65.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.407 1.003 . . . . 0.0 111.247 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -64.71 -37.04 86.24 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.294 0.952 . . . . 0.0 110.123 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.7 p -66.58 -6.17 14.22 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.78 103.83 7.89 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.89 167.14 27.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.866 1.711 . . . . 0.0 111.869 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.88 122.57 9.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.698 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.68 -11.65 46.18 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.956 -1.469 . . . . 0.0 113.891 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -83.51 162.01 21.04 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.419 1.609 . . . . 0.0 108.719 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.0 138.02 50.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.244 1.018 . . . . 0.0 110.92 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 m -129.05 142.66 43.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 C-N-CA 124.36 1.064 . . . . 0.0 109.118 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.61 159.16 22.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.95 114.57 7.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.45 115.52 29.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.96 164.27 12.42 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 124.029 0.83 . . . . 0.0 109.068 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -121.95 129.42 52.49 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.392 1.477 . . . . 0.0 107.15 166.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.55 156.81 36.45 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.488 1.915 . . . . 0.0 109.606 173.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.48 -10.48 73.24 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.13 149.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.531 ' HH ' HD23 ' A' ' 16' ' ' LEU . 33.0 m-85 -64.28 137.63 97.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 150.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.22 175.73 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.253 2.635 . . . . 0.0 109.827 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.8 162.33 9.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 122.682 0.393 . . . . 0.0 109.955 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 C-N-CA 122.012 1.808 . . . . 0.0 111.888 178.407 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.4 t80 . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 121.341 0.591 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -85.43 -112.7 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.47 2.308 . . . . 0.0 110.924 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 142.66 -71.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 1 C-N-CA 134.021 4.928 . . . . 0.0 108.838 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.35 14.57 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.15 0.98 . . . . 0.0 113.509 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 71.58 -12.21 0.66 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.44 2.296 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.211 1.004 . . . . 0.0 111.552 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -83.44 0.61 45.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.204 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.45 140.53 52.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 162.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -105.74 132.09 52.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.45 -165.57 31.44 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -135.07 136.53 42.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -102.84 149.12 24.81 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.838 0.855 . . . . 0.0 110.099 -168.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.83 169.02 18.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.874 2.069 . . . . 0.0 108.664 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.22 142.35 42.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.926 1.29 . . . . 0.0 108.929 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -141.26 157.2 45.54 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.607 -0.683 . . . . 0.0 109.274 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 m -131.59 106.49 8.22 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.97 156.33 16.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -106.79 138.23 43.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 10.1 tttt -61.43 103.45 0.31 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.502 1.521 . . . . 0.0 110.355 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.7 p -83.03 -173.11 4.52 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.637 1.108 . . . . 0.0 110.489 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -37.78 61.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.647 1.179 . . . . 0.0 112.237 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.2 ptm -105.05 13.14 31.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.911 1.285 . . . . 0.0 113.42 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 97.16 -106.36 3.33 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.28 152.2 44.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.77 39.46 3.02 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.92 166.41 28.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.616 1.208 . . . . 0.0 108.323 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -135.45 154.5 51.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.248 1.419 . . . . 0.0 107.705 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.51 160.76 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 109.835 -170.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -136.05 159.82 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.601 2.76 . . . . 0.0 107.388 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.64 152.2 21.16 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -76.77 0.17 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.356 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -171.38 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.752 1.276 . . . . 0.0 113.112 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.54 167.58 22.12 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.729 1.212 . . . . 0.0 110.821 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.85 35.66 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.106 1 C-N-CA 125.753 4.302 . . . . 0.0 113.961 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.31 -15.79 0.29 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.563 1.545 . . . . 0.0 112.282 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.96 165.61 23.85 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 122.063 0.935 . . . . 0.0 111.065 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -71.17 157.5 38.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 mt -116.33 133.43 56.03 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.606 2.363 . . . . 0.0 107.521 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -130.62 154.05 48.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.519 0.728 . . . . 0.0 111.784 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.95 109.71 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 165.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -63.2 -43.31 98.53 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.732 1.613 . . . . 0.0 110.935 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.22 142.39 13.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.867 1.667 . . . . 0.0 108.824 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -92.01 122.67 43.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 161.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.17 132.44 63.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.096 1.358 . . . . 0.0 107.786 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.1 168.36 14.15 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.738 1.626 . . . . 0.0 110.924 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.27 28.0 17.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 111.238 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.02 177.8 16.43 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.055 1.788 . . . . 0.0 113.943 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 -28.22 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.808 2.339 . . . . 0.0 111.904 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.6 59.79 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.05 72.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.658 0.783 . . . . 0.0 112.779 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.56 -19.72 55.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.402 1.001 . . . . 0.0 113.296 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.3 -42.36 14.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.84 0.856 . . . . 0.0 109.776 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.72 2.5 60.94 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.993 1.282 . . . . 0.0 114.508 171.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.01 -7.16 59.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.736 1.768 . . . . 0.0 112.7 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.8 ttp -122.31 141.1 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.753 1.621 . . . . 0.0 109.358 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -140.93 -179.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.461 1.104 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -88.49 133.96 33.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.849 1.26 . . . . 0.0 109.613 -173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.28 -14.04 59.79 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.404 1.478 . . . . 0.0 112.323 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.35 148.25 37.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.982 0.913 . . . . 0.0 110.809 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 t -99.33 122.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.651 1.58 . . . . 0.0 108.606 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.59 106.36 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 109.28 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.75 -57.6 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -132.14 149.54 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.073 0.949 . . . . 0.0 108.914 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.65 116.39 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 170.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.41 -57.05 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 130.624 3.569 . . . . 0.0 113.941 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.42 6.38 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.466 2.306 . . . . 0.0 111.611 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.92 128.31 64.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.009 1.324 . . . . 0.0 108.295 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.4 p -78.27 87.13 4.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 110.746 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 1.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.963 0.905 . . . . 0.0 112.08 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -17.95 45.63 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -167.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.71 22.64 7.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.787 1.184 . . . . 0.0 111.307 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.06 167.72 11.05 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.697 1.249 . . . . 0.0 110.444 -175.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.3 p -72.12 138.59 47.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -53.37 -44.84 68.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.705 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -36.02 69.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.583 1.538 . . . . 0.0 113.477 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.07 -56.98 8.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.893 0.877 . . . . 0.0 109.688 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.59 -42.94 52.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 128.191 2.596 . . . . 0.0 111.633 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.19 -38.93 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 120.734 -1.229 . . . . 0.0 108.871 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -33.74 75.02 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.306 -0.871 . . . . 0.0 111.267 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -50.8 69.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.955 1.302 . . . . 0.0 108.743 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.64 -40.09 93.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.393 0.542 . . . . 0.0 110.957 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -69.5 -31.78 70.24 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.482 -0.761 . . . . 0.0 111.715 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 55.4 p -70.07 -0.46 7.68 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.024 0.829 . . . . 0.0 113.141 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 t -84.4 112.45 41.84 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 168.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.21 175.29 10.46 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.971 1.78 . . . . 0.0 112.037 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 150.49 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.671 1.188 . . . . 0.0 108.17 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.86 -15.69 51.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.246 1.403 . . . . 0.0 112.334 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -96.29 164.2 12.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.419 1.609 . . . . 0.0 110.792 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -132.28 155.61 48.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.899 2.479 . . . . 0.0 108.553 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.86 147.69 21.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.129 0.971 . . . . 0.0 109.971 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.68 153.54 21.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -141.04 148.87 40.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.04 118.94 39.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.41 165.79 12.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 124.095 0.872 . . . . 0.0 110.15 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -127.32 124.6 39.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.269 1.428 . . . . 0.0 108.133 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -102.73 132.44 48.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.413 1.885 . . . . 0.0 108.649 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.61 6.07 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.712 0.672 . . . . 0.0 112.45 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -103.84 130.98 22.44 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 160.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -70.77 172.54 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.549 2.166 . . . . 0.0 111.669 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 mt -70.82 152.5 95.1 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.347 0.493 0 C-N-CA 123.347 2.698 . . . . 0.0 111.558 175.772 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 10' ' ' THR 0.271 27.5 t80 . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 25.1 m -127.6 -98.49 0.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 126.589 1.956 . . . . 0.0 109.945 -173.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 121.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 1 C-N-CA 135.112 5.365 . . . . 0.0 109.786 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.41 0.43 24.84 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.72 -24.68 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.841 2.856 . . . . 0.0 114.178 -169.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -57.59 -34.28 69.07 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -80.78 7.47 10.3 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.018 0.527 . . . . 0.0 112.392 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 mt -77.23 170.61 16.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.495 -1.378 . . . . 0.0 110.287 171.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.01 105.1 7.19 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.154 1.381 . . . . 0.0 109.26 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.37 -179.22 25.39 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.232 1.396 . . . . 0.0 111.561 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -77.9 134.78 37.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.484 0.713 . . . . 0.0 109.306 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.24 138.62 32.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.936 0.894 . . . . 0.0 108.648 169.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.01 173.47 12.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.792 1.237 . . . . 0.0 109.696 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 p -145.59 170.33 16.65 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -155.94 155.56 33.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.363 1.065 . . . . 0.0 109.977 159.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.8 m -102.69 115.19 30.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.777 1.231 . . . . 0.0 108.523 163.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.37 137.33 39.85 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -81.68 137.23 35.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 166.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -64.72 108.83 1.83 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 165.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 t -137.16 161.95 34.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 56.31 -91.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.564 1.946 . . . . 0.0 112.642 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.8 ptm -138.47 30.14 2.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.656 1.582 . . . . 0.0 110.72 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.3 176.47 21.37 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.181 1.372 . . . . 0.0 110.693 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -64.73 147.88 52.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.162 -0.61 . . . . 0.0 109.896 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.45 33.37 1.82 Allowed Glycine 0 C--O 1.222 -0.637 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.469 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -149.81 164.3 35.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.734 1.767 . . . . 0.0 108.465 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -132.93 154.84 50.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.61 159.19 17.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.857 1.263 . . . . 0.0 108.58 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -121.75 164.12 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.922 2.089 . . . . 0.0 107.559 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.07 151.85 17.52 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.2 -14.12 55.66 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.563 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t0 80.52 -36.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.623 2.769 . . . . 0.0 109.93 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -72.46 167.61 31.25 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 125.709 1.604 . . . . 0.0 111.225 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -100.63 32.22 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.379 3.386 . . . . 0.0 113.256 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -158.24 37.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.157 0.983 . . . . 0.0 109.954 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.54 153.79 48.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.324 1.059 . . . . 0.0 112.537 -165.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.78 116.87 15.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.249 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.81 124.15 29.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -115.26 151.94 33.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.324 0.965 . . . . 0.0 109.81 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.46 118.99 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 120.707 -1.246 . . . . 0.0 107.819 165.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -52.11 43.95 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.643 1.977 . . . . 0.0 109.72 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -157.76 153.52 26.69 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.647 1.179 . . . . 0.0 109.644 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.1 t -96.97 113.8 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 164.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.93 130.97 87.74 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.505 1.922 . . . . 0.0 108.192 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.89 161.65 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.378 2.052 . . . . 0.0 111.192 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.61 10.09 0.95 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.431 2.293 . . . . 0.0 113.042 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.51 161.19 21.28 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.587 1.565 . . . . 0.0 110.553 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.96 -25.12 74.05 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 112.837 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.17 70.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.212 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.75 95.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.469 0.708 . . . . 0.0 110.38 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -66.58 -43.22 85.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.29 0.636 . . . . 0.0 110.981 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.28 -38.77 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.266 1.026 . . . . 0.0 111.164 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.89 11.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.686 2.088 . . . . 0.0 115.347 169.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.76 -39.08 87.74 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.292 -1.122 . . . . 0.0 109.963 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 tpp -67.6 131.77 46.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.526 1.131 . . . . 0.0 108.595 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -134.87 161.74 34.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.906 0.86 . . . . 0.0 108.727 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 156.92 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.6 70.88 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.481 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -83.88 162.66 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.827 1.814 . . . . 0.0 109.562 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -116.54 125.73 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 127.185 2.194 . . . . 0.0 108.388 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -73.72 105.21 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 126.917 2.087 . . . . 0.0 108.459 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -84.08 -57.5 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.811 0.815 . . . . 0.0 109.768 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -135.59 139.89 44.21 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -165.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.16 133.76 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 58.51 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 127.756 2.423 . . . . 0.0 113.776 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -150.06 21.97 0.86 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.598 1.559 . . . . 0.0 109.77 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.67 152.51 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.157 1.383 . . . . 0.0 108.205 -162.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.6 p -87.06 137.59 32.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.087 0.955 . . . . 0.0 109.805 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.84 15.28 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.275 1.43 . . . . 0.0 110.49 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 -31.92 66.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 113.315 -159.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.93 49.2 0.93 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.6 1.571 . . . . 0.0 109.41 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -99.16 170.28 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.303 1.041 . . . . 0.0 112.016 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -79.2 133.39 36.69 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.579 -1.325 . . . . 0.0 108.535 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.88 -40.44 66.6 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.273 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.29 76.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.76 1.618 . . . . 0.0 112.074 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.23 -46.37 50.64 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.019 0.928 . . . . 0.0 110.288 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.48 -41.8 93.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 110.769 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.5 t -61.45 -42.79 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.216 172.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.61 75.5 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.11 0.868 . . . . 0.0 110.055 173.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.14 -37.91 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.149 0.98 . . . . 0.0 109.701 -174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -70.2 -32.16 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.923 -0.486 . . . . 0.0 112.014 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -69.14 -33.38 73.35 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.287 0.948 . . . . 0.0 110.987 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -58.91 -16.11 16.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 0.0 113.749 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.6 110.2 25.57 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.763 1.625 . . . . 0.0 107.85 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.25 168.23 21.48 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.419 2.079 . . . . 0.0 110.535 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.29 125.98 7.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 164.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.11 -27.57 19.56 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.122 -1.376 . . . . 0.0 112.734 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.03 145.34 28.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.463 2.131 . . . . 0.0 108.286 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.14 162.09 13.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.379 1.072 . . . . 0.0 110.078 171.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.27 157.96 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 125.081 1.352 . . . . 0.0 109.291 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.03 156.59 16.25 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 110.489 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.86 132.99 22.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.1 t -98.97 123.19 51.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 160.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -108.19 160.7 15.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.248 0.967 . . . . 0.0 109.062 171.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.6 t -118.92 121.71 40.59 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -76.06 156.24 34.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.435 1.094 . . . . 0.0 108.653 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.75 -20.78 11.71 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 117.836 -1.536 . . . . 0.0 114.329 162.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -81.22 141.46 49.92 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 120.254 2.027 . . . . 0.0 107.94 165.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.97 170.27 20.5 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.32 2.013 . . . . 0.0 111.109 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.73 165.08 13.3 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.69 169.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo . . . . . 0 CA--C 1.537 0.673 0 C-N-CA 122.944 2.429 . . . . 0.0 112.78 175.74 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 t80 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.904 0.859 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 m -77.59 -118.49 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.121 1.368 . . . . 0.0 110.2 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 135.73 -23.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 1 C-N-CA 134.215 5.006 . . . . 0.0 113.283 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -142.14 15.57 2.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.85 1.205 . . . . 0.0 113.637 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.5 -6.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.735 2.014 . . . . 0.0 114.514 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -73.8 -25.95 60.38 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.634 -1.291 . . . . 0.0 111.995 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.09 -11.06 60.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.544 1.065 . . . . 0.0 112.532 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.2 140.18 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.27 0.941 . . . . 0.0 109.652 -172.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -117.81 113.22 21.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.82 -175.27 30.66 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.006 -158.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -125.38 139.26 53.82 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -104.34 137.81 41.68 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.769 1.628 . . . . 0.0 110.411 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 175.55 12.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.562 1.945 . . . . 0.0 108.999 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -135.09 170.36 16.02 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 110.413 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -149.61 153.41 37.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.994 1.318 . . . . 0.0 107.883 170.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 m -115.83 105.49 12.75 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.04 132.7 44.16 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -82.87 146.44 28.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -77.65 76.71 4.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.381 1.072 . . . . 0.0 108.252 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -63.01 115.22 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 46.5 -91.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.673 2.389 . . . . 0.0 112.486 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.1 mtp -53.29 -56.09 19.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.612 2.365 . . . . 0.0 111.067 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.72 176.6 21.45 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -148.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -75.98 125.62 29.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.55 55.06 3.72 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.453 0.549 . . . . 0.0 112.056 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -143.02 157.97 44.04 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -125.78 157.87 36.39 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.43 162.92 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.901 1.281 . . . . 0.0 109.36 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 16.3 tt -126.36 146.49 32.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.905 1.682 . . . . 0.0 107.964 171.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.27 151.23 22.1 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.442 1.089 . . . . 0.0 111.064 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 44' ' ' GLU . . . -51.44 -82.86 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 C-N-CA 128.874 3.13 . . . . 0.0 112.512 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.44 -34.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.409 1.084 . . . . 0.0 112.424 -170.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -122.26 165.15 21.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.056 1.342 . . . . 0.0 110.492 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.53 47.4 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.158 3.238 . . . . 0.0 112.624 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -164.58 16.01 0.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.962 2.105 . . . . 0.0 112.128 -172.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 1.5 pp20? -91.62 165.63 13.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.538 2.335 . . . . 0.0 111.634 171.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.75 118.18 35.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.473 1.109 . . . . 0.0 110.336 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.8 mt -80.0 129.46 34.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -128.69 154.25 46.51 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.306 1.042 . . . . 0.0 110.46 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.01 114.81 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -68.22 -52.18 37.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.462 1.505 . . . . 0.0 110.414 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -156.65 151.12 25.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.575 1.15 . . . . 0.0 108.991 172.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -91.62 127.26 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 168.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.55 131.8 87.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -68.26 163.18 37.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.171 1.914 . . . . 0.0 111.2 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.35 49.92 3.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.031 1.732 . . . . 0.0 112.091 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.1 175.7 22.07 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.391 1.472 . . . . 0.0 110.744 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.87 -22.8 31.05 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.814 2.343 . . . . 0.0 113.425 -168.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.22 -51.19 11.36 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.076 0.853 . . . . 0.0 109.04 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.655 1.182 . . . . 0.0 110.314 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.64 -36.31 76.12 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.91 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -74.85 -20.85 59.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.235 0.925 . . . . 0.0 112.01 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.41 61.16 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.183 1.373 . . . . 0.0 115.723 163.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -87.48 -20.66 26.25 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.22 1.51 . . . . 0.0 111.35 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 ttm -110.98 143.92 40.9 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.716 1.606 . . . . 0.0 109.668 -169.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.08 -179.18 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.43 1.492 . . . . 0.0 108.312 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -95.54 158.42 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.36 0.664 . . . . 0.0 109.613 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.83 -14.73 24.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.481 0.563 . . . . 0.0 111.966 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.35 151.69 43.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.117 0.967 . . . . 0.0 109.546 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.23 121.0 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.686 1.595 . . . . 0.0 107.999 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.76 129.32 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.62 -58.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.447 1.092 . . . . 0.0 110.953 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.92 151.27 50.72 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.349 0.66 . . . . 0.0 109.933 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -132.25 117.03 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.23 -73.04 0.05 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.839 2.456 . . . . 0.0 110.026 -170.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -147.51 -10.73 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.1 1.76 . . . . 0.0 110.685 173.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 123.73 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.46 1.504 . . . . 0.0 107.977 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.9 p -67.5 110.13 3.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.414 0.686 . . . . 0.0 109.344 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.45 8.63 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.718 -0.614 . . . . 0.0 111.805 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 1.6 pp -55.19 -33.87 63.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -165.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.79 17.26 10.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 120.025 1.284 . . . . 0.0 111.397 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -73.16 158.06 36.0 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -82.74 146.47 28.99 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -56.53 -32.74 65.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 110.821 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.47 -57.79 10.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.097 -1.002 . . . . 0.0 110.896 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.36 -43.25 81.93 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.39 0.614 . . . . 0.0 109.559 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.99 -41.79 87.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 119.839 -1.788 . . . . 0.0 111.198 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.45 -39.44 80.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.295 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -35.22 80.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.38 0.991 . . . . 0.0 110.144 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.7 -45.51 86.31 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.047 1.739 . . . . 0.0 109.011 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -61.08 -32.6 72.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.513 -0.742 . . . . 0.0 111.247 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -79.75 -19.79 47.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.082 -1.011 . . . . 0.0 112.831 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.8 m -75.12 -6.16 48.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.267 1.427 . . . . 0.0 111.984 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.03 116.67 66.41 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 178.58 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.286 1.991 . . . . 0.0 111.133 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 mt -62.93 144.68 14.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 109.345 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.46 -2.83 51.48 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.7 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -84.22 164.9 18.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.651 1.726 . . . . 0.0 107.788 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 p -127.8 134.24 49.46 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.773 0.715 . . . . 0.0 110.23 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.95 146.88 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.4 148.01 27.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.0 mt -146.69 132.84 19.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.25 130.47 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.56 1.544 . . . . 0.0 108.221 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 164.94 14.22 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 124.324 1.015 . . . . 0.0 110.389 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.7 t -129.1 132.27 47.38 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.271 1.429 . . . . 0.0 108.433 167.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -104.28 122.29 45.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 126.465 1.906 . . . . 0.0 110.573 -172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 138.04 5.08 1.67 Allowed Glycine 0 N--CA 1.464 0.502 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.835 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -91.75 149.03 38.42 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 118.772 1.286 . . . . 0.0 108.237 167.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.58 168.29 24.73 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.139 1.893 . . . . 0.0 110.987 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.77 144.0 63.65 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.533 0.469 0 C-N-CA 123.702 2.935 . . . . 0.0 112.159 169.052 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.237 0.413 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 11' ' ' ARG . 0.3 OUTLIER -73.31 -117.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.484 2.314 . . . . 0.0 112.841 178.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.427 ' H ' ' HB ' ' A' ' 10' ' ' THR . 8.7 mtt180 134.06 -16.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 1 C-N-CA 134.581 5.153 . . . . 0.0 111.827 177.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -145.45 13.21 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.62 4.6 0.56 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.31 1.444 . . . . 0.0 114.415 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -18.41 32.37 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.534 -1.354 . . . . 0.0 111.947 -174.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.85 -18.33 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.99 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.81 157.72 9.21 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.692 1.133 . . . . 0.0 110.299 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -129.12 93.12 3.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.723 1.209 . . . . 0.0 109.796 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.09 -129.72 1.57 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 125.252 1.406 . . . . 0.0 110.041 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.4 m -136.17 145.72 46.08 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.933 1.693 . . . . 0.0 108.459 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -90.43 144.23 26.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.426 0.69 . . . . 0.0 110.401 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.08 165.82 14.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.021 2.128 . . . . 0.0 107.734 173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.5 p -147.19 162.79 38.16 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.347 0.659 . . . . 0.0 109.945 155.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.75 157.46 38.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 170.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.8 m -120.11 108.22 13.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.14 134.56 40.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -82.24 151.19 26.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -85.45 100.99 12.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -64.08 -53.56 47.8 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -159.97 -71.35 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.317 1.047 . . . . 0.0 110.234 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 ptp -50.84 -40.84 56.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 127.198 2.199 . . . . 0.0 113.595 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.83 -125.63 1.89 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -125.86 145.87 50.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.26 1.03 . . . . 0.0 109.82 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.9 46.98 3.72 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.134 0.873 . . . . 0.0 113.353 -174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' CE1' ' HE2' ' A' ' 63' ' ' MET . 43.4 p90 -148.54 163.95 35.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.402 1.481 . . . . 0.0 107.62 169.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.9 p -126.19 163.55 22.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.61 158.86 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.018 1.327 . . . . 0.0 108.281 -168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -129.24 145.03 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.033 1.733 . . . . 0.0 107.926 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.63 22.63 Favored Glycine 0 CA--C 1.518 0.237 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.91 -71.06 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 CA-C-N 117.945 0.872 . . . . 0.0 113.423 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.23 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.276 1.03 . . . . 0.0 109.495 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -113.48 165.7 12.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.17 1.788 . . . . 0.0 110.919 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -79.32 66.79 8.75 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.651 2.901 . . . . 0.0 112.16 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -140.18 -2.09 1.49 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.754 0.822 . . . . 0.0 110.221 146.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -99.35 137.27 38.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.481 -1.387 . . . . 0.0 110.215 -152.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.22 123.71 17.58 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.757 0.823 . . . . 0.0 111.481 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.32 128.8 34.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -134.06 152.66 51.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.346 0.976 . . . . 0.0 110.637 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.34 113.14 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -68.55 -58.18 4.68 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 158.81 40.44 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.959 1.304 . . . . 0.0 109.519 163.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.7 138.2 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.1 1.76 . . . . 0.0 107.256 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 141.12 67.93 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.25 28.2 0.4 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.731 3.621 . . . . 0.0 115.693 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.85 -10.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.204 2.202 . . . . 0.0 111.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.52 158.79 46.02 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.49 -21.69 70.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.384 1.389 . . . . 0.0 110.486 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.39 46.34 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.353 1.461 . . . . 0.0 111.501 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.08 71.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.272 1.029 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -72.78 -22.7 60.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.838 -170.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.37 -12.12 60.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.834 1.197 . . . . 0.0 111.351 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.64 25.83 74.28 Favored Glycine 0 CA--C 1.525 0.664 0 O-C-N 121.053 -1.03 . . . . 0.0 113.293 167.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -128.54 -32.64 2.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.293 1.047 . . . . 0.0 113.525 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.41 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 ttm -95.01 134.66 37.44 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.21 167.67 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.627 1.203 . . . . 0.0 110.675 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -86.76 117.73 25.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.587 1.555 . . . . 0.0 108.604 -168.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.98 32.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.491 1.043 . . . . 0.0 112.411 -171.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -65.89 146.56 54.59 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.271 1.535 . . . . 0.0 108.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.39 115.69 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.346 1.858 . . . . 0.0 108.817 -169.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.84 125.01 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 125.607 1.563 . . . . 0.0 107.847 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.0 -55.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.281 1.033 . . . . 0.0 110.3 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.67 149.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.49 126.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 t30 67.08 -81.43 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 109.258 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -152.16 20.02 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.784 1.233 . . . . 0.0 111.342 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.58 123.47 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.1 p -62.74 120.84 12.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 163.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.58 13.7 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.384 0.674 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.51 -10.9 8.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -166.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.36 9.57 4.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.928 1.252 . . . . 0.0 111.406 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -71.62 159.5 34.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.967 1.883 . . . . 0.0 111.147 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -83.2 154.61 24.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.17 0.588 . . . . 0.0 109.906 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -55.28 -41.63 72.53 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.416 170.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.38 41.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.505 1.957 . . . . 0.0 112.671 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.12 -47.49 11.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.195 0.521 . . . . 0.0 111.951 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.4 -28.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 120.272 -1.517 . . . . 0.0 112.022 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.8 -44.0 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.501 -1.375 . . . . 0.0 108.438 167.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.9 88.98 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.143 1.338 . . . . 0.0 109.3 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.63 -44.82 80.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.353 1.861 . . . . 0.0 109.805 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -69.89 -36.43 75.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.026 0.83 . . . . 0.0 110.26 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -70.3 -17.06 63.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.695 0.798 . . . . 0.0 110.946 174.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 t -96.22 39.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.193 1.797 . . . . 0.0 110.797 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.67 113.8 25.0 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.67 172.65 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.125 1.217 . . . . 0.0 110.075 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.406 ' H ' HD11 ' A' ' 94' ' ' ILE . 5.2 mp -60.06 145.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.03 68.16 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.929 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -130.58 169.92 14.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.665 1.233 . . . . 0.0 108.704 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.08 161.39 31.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.845 1.258 . . . . 0.0 110.976 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.47 147.7 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.589 1.156 . . . . 0.0 108.221 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -83.41 156.9 22.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.34 110.67 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.11 122.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.92 167.31 10.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.953 0.783 . . . . 0.0 110.354 170.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.79 129.19 48.94 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.662 1.185 . . . . 0.0 108.139 165.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -79.84 155.59 27.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.709 1.604 . . . . 0.0 107.184 166.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.17 -19.82 4.83 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.934 169.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.14 156.42 39.01 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 118.726 1.263 . . . . 0.0 109.793 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.38 179.06 3.75 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.969 1.779 . . . . 0.0 110.196 165.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.66 154.33 94.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.819 161.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.643 173.026 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR 0.261 34.1 t80 . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 120.867 0.365 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.43 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 28.4 m -118.53 -107.06 0.38 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 129.475 3.11 . . . . 0.0 108.295 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 131.42 -70.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 1 C-N-CA 134.433 5.093 . . . . 0.0 108.757 169.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.39 -0.35 52.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.001 0.819 . . . . 0.0 113.171 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 79.52 -11.71 1.16 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.839 2.856 . . . . 0.0 112.569 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 m -72.06 -19.28 61.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -166.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -79.29 -12.78 59.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.855 0.752 . . . . 0.0 112.414 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.15 142.74 52.49 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -125.26 122.85 38.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.51 -122.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -135.57 136.66 41.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -91.44 143.87 26.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.758 1.623 . . . . 0.0 110.522 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.48 166.78 31.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.959 1.703 . . . . 0.0 109.551 172.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -146.34 124.47 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.674 0.79 . . . . 0.0 110.696 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -124.46 157.23 35.71 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.946 0.794 . . . . 0.0 109.101 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.5 m -114.59 112.72 23.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.55 150.86 21.26 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -103.91 149.68 24.87 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -84.2 102.6 12.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.6 m -61.73 -56.93 14.43 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.086 0.555 . . . . 0.0 110.316 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.36 -82.07 0.1 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.315 0.646 . . . . 0.0 109.521 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.3 mtt -62.05 -49.68 75.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.814 0.846 . . . . 0.0 109.143 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 180.0 -162.06 28.23 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -83.03 149.43 26.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.09 30.17 2.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.354 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.413 ' CD1' ' HE2' ' A' ' 63' ' ' MET . 44.8 p90 -135.38 165.5 25.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.457 1.628 . . . . 0.0 108.49 172.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -123.36 154.41 39.0 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.006 1.322 . . . . 0.0 107.829 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.51 156.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.077 0.951 . . . . 0.0 108.619 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.54 149.63 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.449 2.3 . . . . 0.0 106.452 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.84 152.34 23.04 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.23 -80.74 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 124.454 1.026 . . . . 0.0 112.725 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 178.49 -62.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.739 1.216 . . . . 0.0 110.431 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -82.26 166.49 36.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.438 1.095 . . . . 0.0 112.507 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.79 57.57 5.69 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 124.224 3.283 . . . . 0.0 111.344 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.45 -4.69 0.11 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.725 1.61 . . . . 0.0 113.354 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -95.28 165.86 12.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.133 0.968 . . . . 0.0 111.947 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -84.55 160.34 20.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 111.16 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.8 mt -124.68 138.23 54.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 126.399 1.88 . . . . 0.0 108.184 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -134.42 155.24 50.65 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.35 0.977 . . . . 0.0 111.044 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.02 109.81 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.46 -50.01 66.97 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.906 1.683 . . . . 0.0 109.982 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -148.31 158.48 44.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 107.147 170.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.9 t -102.44 128.65 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.903 -2.629 . . . . 0.0 103.903 158.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.02 118.95 71.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.31 135.27 45.76 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t0 73.67 0.29 3.59 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.114 1.766 . . . . 0.0 112.617 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.45 163.77 53.03 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.289 -1.507 . . . . 0.0 109.822 165.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.59 -4.91 9.15 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.045 2.497 . . . . 0.0 114.769 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.87 -49.16 6.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.235 0.925 . . . . 0.0 109.919 172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.31 90.04 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.984 0.514 . . . . 0.0 110.588 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.37 -25.24 68.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.086 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 62' ' ' LYS . 15.1 t0 -79.34 -40.75 29.49 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.456 1.025 . . . . 0.0 109.943 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.38 52.93 14.76 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 125.036 1.303 . . . . 0.0 113.019 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 60' ' ' ASP . 2.4 mptt -126.04 -58.9 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.413 ' HE2' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -68.23 161.45 27.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 119.19 0.905 . . . . 0.0 109.264 173.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -143.38 173.52 11.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 167.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -74.8 144.61 43.44 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.926 -167.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.92 81.79 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.434 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -64.89 142.86 58.29 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.897 1.849 . . . . 0.0 108.472 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -97.9 120.87 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.376 1.87 . . . . 0.0 108.868 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.49 118.07 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.18 -54.11 7.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 109.996 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.47 144.88 48.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mt -122.99 111.37 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.3 t30 67.21 -53.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.48 3.112 . . . . 0.0 114.378 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -164.22 6.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.383 2.273 . . . . 0.0 111.247 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.63 121.34 63.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 125.449 1.499 . . . . 0.0 107.66 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.4 p -66.09 120.24 12.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 164.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.05 7.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.457 0.703 . . . . 0.0 111.89 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -9.11 43.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.448 3.099 . . . . 0.0 112.506 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.13 54.47 0.66 Allowed Glycine 0 C--N 1.334 0.463 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 158.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.08 157.83 22.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.99 0.895 . . . . 0.0 111.561 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -77.3 137.63 38.9 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.42 1.088 . . . . 0.0 108.991 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.41 -36.24 73.27 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.03 -1.462 . . . . 0.0 109.622 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.02 41.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.737 1.608 . . . . 0.0 112.694 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.12 -46.38 15.01 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.36 0.664 . . . . 0.0 111.149 176.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.54 -34.62 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 119.163 -2.211 . . . . 0.0 111.664 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.02 -44.48 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.617 1.167 . . . . 0.0 108.98 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -35.6 81.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 110.973 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.1 mt -62.97 -49.07 76.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.48 -42.38 83.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.625 0.77 . . . . 0.0 111.6 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -62.92 -34.75 78.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.32 -0.862 . . . . 0.0 109.834 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.1 t -75.31 27.26 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.601 1.56 . . . . 0.0 112.418 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.2 t -114.33 106.2 53.02 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.67 164.99 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.423 2.748 . . . . 0.0 113.979 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.22 151.47 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 165.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.71 -0.89 60.12 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.566 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -94.12 165.41 12.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.354 1.577 . . . . 0.0 108.175 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -128.63 163.13 25.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.069 1.348 . . . . 0.0 109.357 165.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.82 148.32 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 125.46 1.504 . . . . 0.0 107.986 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.65 152.87 24.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.701 1.601 . . . . 0.0 109.222 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -144.71 115.52 7.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.7 t -89.54 122.85 41.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 170.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.15 161.65 15.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 124.152 0.907 . . . . 0.0 109.556 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.35 119.59 34.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -81.24 147.15 30.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 108.43 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.3 -18.52 7.34 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.625 161.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -70.44 139.13 86.59 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 119.694 1.747 . . . . 0.0 107.587 161.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.23 172.09 12.73 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.459 1.44 . . . . 0.0 110.543 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.68 158.22 61.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.668 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.627 2.218 . . . . 0.0 112.015 -177.187 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.8 t80 . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -78.2 -121.67 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.657 1.583 . . . . 0.0 111.355 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 160.97 -74.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 130.925 3.69 . . . . 0.0 109.108 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -118.73 22.92 11.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.687 1.232 . . . . 0.0 110.971 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 70.24 -23.87 0.16 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 128.17 2.588 . . . . 0.0 113.881 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -65.04 -13.21 57.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.631 1.172 . . . . 0.0 112.86 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -67.26 -22.19 65.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.443 1.097 . . . . 0.0 112.444 166.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.05 148.64 30.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.996 1.271 . . . . 0.0 109.048 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -112.81 -0.31 14.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.56 32.72 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.066 1.317 . . . . 0.0 112.578 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 157.89 33.72 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 124.871 1.268 . . . . 0.0 109.535 -169.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.39 129.04 49.09 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.652 0.781 . . . . 0.0 109.375 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.72 168.4 17.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.917 2.087 . . . . 0.0 108.415 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.9 p -142.99 175.84 9.54 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.438 0.637 . . . . 0.0 111.199 160.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -155.19 157.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.2 m -127.12 105.35 8.52 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.29 136.37 37.86 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -87.48 123.41 32.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.07 125.07 12.81 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.598 1.559 . . . . 0.0 108.236 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -173.74 3.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.78 -54.55 45.01 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.717 -1.239 . . . . 0.0 111.087 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.5 mtp -78.25 13.93 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.922 1.289 . . . . 0.0 113.545 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.16 -147.16 18.48 Favored Glycine 0 C--N 1.331 0.306 0 O-C-N 120.136 -1.602 . . . . 0.0 110.48 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -88.84 146.89 24.69 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 56' ' ' PRO . . . -86.8 42.28 3.15 Favored Glycine 0 C--O 1.222 -0.605 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.705 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -148.43 166.96 26.56 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 119.3 1.55 . . . . 0.0 109.321 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 p -127.28 158.81 36.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.215 1.806 . . . . 0.0 107.935 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.85 162.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.586 1.954 . . . . 0.0 107.283 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.6 tt -138.68 159.98 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.787 1.635 . . . . 0.0 108.26 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.23 154.08 23.8 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 128.802 3.096 . . . . 0.0 110.384 -174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.36 -82.99 0.21 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.482 1.039 . . . . 0.0 111.898 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -177.16 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.77 2.028 . . . . 0.0 111.243 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -125.73 153.11 73.12 Favored Pre-proline 0 C--N 1.342 0.27 0 O-C-N 120.154 -1.591 . . . . 0.0 111.652 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.42 51.35 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.31 1 C-N-CA 125.388 4.058 . . . . 0.0 113.949 168.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -158.43 13.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.096 -1.628 . . . . 0.0 109.516 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -74.89 160.47 30.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 127.411 2.285 . . . . 0.0 110.774 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -93.39 112.61 24.56 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.37 112.75 18.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.68 155.0 30.69 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.23 116.34 2.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -65.53 -54.38 28.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.768 1.227 . . . . 0.0 109.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -155.53 161.42 40.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.993 1.317 . . . . 0.0 108.049 171.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.48 140.59 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 161.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.97 132.11 54.91 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 55' ' ' GLY . 73.1 Cg_endo -68.0 160.51 48.28 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.864 2.376 . . . . 0.0 110.845 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.09 -18.31 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.434 2.294 . . . . 0.0 114.26 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 53' ' ' PRO . . . -70.95 173.67 41.59 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.592 1.568 . . . . 0.0 114.181 -171.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 33' ' ' GLY . 58.0 Cg_endo -66.52 -32.07 40.34 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.939 3.093 . . . . 0.0 111.41 -171.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.742 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.91 -46.33 65.64 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.888 0.875 . . . . 0.0 109.732 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.47 -42.66 99.64 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.268 0.94 . . . . 0.0 112.249 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.79 -6.06 29.67 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.894 0.77 . . . . 0.0 111.371 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.27 29.93 63.68 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.691 1.139 . . . . 0.0 113.465 165.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -136.17 -0.79 2.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.768 1.227 . . . . 0.0 111.982 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.9 tpp -111.29 137.16 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.482 1.513 . . . . 0.0 107.069 169.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.75 167.71 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 108.941 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -77.18 159.68 29.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.495 1.118 . . . . 0.0 109.437 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.95 39.87 96.79 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -132.26 152.88 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.595 1.158 . . . . 0.0 108.074 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.5 117.6 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.688 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mp -66.8 138.63 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.33 -54.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.03 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.37 149.83 51.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.435 1.094 . . . . 0.0 108.699 -175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.58 126.9 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 44.86 -93.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.1 2.16 . . . . 0.0 110.795 -159.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.25 -7.36 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.195 1.398 . . . . 0.0 111.483 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.37 139.82 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -173.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.44 130.3 36.86 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.132 -0.98 . . . . 0.0 109.003 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.94 10.61 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 111.445 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.0 -42.68 60.51 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.686 -1.259 . . . . 0.0 113.284 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.08 36.22 4.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 127.176 2.322 . . . . 0.0 109.905 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.83 -158.86 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.806 0.803 . . . . 0.0 109.683 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.7 t -119.93 143.98 47.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.641 1.11 . . . . 0.0 109.031 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -53.78 -42.41 68.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.532 2.333 . . . . 0.0 110.589 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.96 -29.23 68.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.831 0.741 . . . . 0.0 111.983 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -82.58 -54.85 4.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.373 1.069 . . . . 0.0 109.271 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.97 -44.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 130.053 3.341 . . . . 0.0 112.382 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.46 -32.8 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 120.459 -1.4 . . . . 0.0 109.652 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -34.69 71.99 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.65 1.114 . . . . 0.0 109.435 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.5 -42.96 95.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.985 1.314 . . . . 0.0 109.823 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -62.46 -19.15 63.23 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.291 1.036 . . . . 0.0 112.778 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -91.98 -11.37 36.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.819 1.248 . . . . 0.0 113.109 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 m -75.0 12.8 0.78 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.775 -1.203 . . . . 0.0 112.996 161.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.09 93.22 14.73 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.63 140.77 13.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.911 3.074 . . . . 0.0 109.57 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.1 mp -52.01 125.43 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 118.987 0.812 . . . . 0.0 109.232 -164.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.3 -16.44 11.71 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.46 1.981 . . . . 0.0 113.417 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -94.83 173.65 7.49 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.778 1.789 . . . . 0.0 109.756 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -127.94 167.02 17.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.042 2.537 . . . . 0.0 108.193 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.32 148.85 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.468 1.107 . . . . 0.0 108.596 161.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.4 152.44 25.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 167.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 mt -146.47 119.74 8.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.85 129.22 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -112.05 156.7 21.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.361 1.038 . . . . 0.0 109.4 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.06 128.29 55.57 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -84.62 156.35 21.6 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.138 0.975 . . . . 0.0 109.582 171.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.03 6.3 14.07 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 123.835 0.731 . . . . 0.0 114.391 163.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.46 133.9 23.8 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.53 -178.42 1.51 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.143 2.562 . . . . 0.0 111.15 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.42 158.02 83.64 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.578 0.751 . . . . 0.0 111.086 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 122.849 2.366 . . . . 0.0 112.662 -175.062 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -66.2 161.28 22.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.97 0.908 . . . . 0.0 109.967 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -153.27 167.86 27.95 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.76 -176.85 34.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.093 1.33 . . . . 0.0 112.955 -172.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -153.7 147.45 25.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.598 1.559 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -179.53 -172.41 0.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 129.091 2.957 . . . . 0.0 106.194 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 131.6 179.89 16.54 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mp -145.61 88.13 1.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.097 1.359 . . . . 0.0 107.877 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 t80 53.86 -178.68 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.746 1.618 . . . . 0.0 112.192 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -88.36 -121.35 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.144 -1.597 . . . . 0.0 109.019 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 150.19 -83.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 1 C-N-CA 132.701 4.4 . . . . 0.0 107.022 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' SER . 33.7 t0 -85.65 18.34 2.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.03 -17.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.106 2.962 . . . . 0.0 114.545 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.3 OUTLIER -65.65 -26.3 67.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.139 0.976 . . . . 0.0 111.262 -169.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -82.18 -4.18 56.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.916 -1.04 . . . . 0.0 112.311 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.97 161.75 23.53 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.943 1.247 . . . . 0.0 108.66 169.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -124.23 116.22 22.33 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.81 39.46 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 124.42 1.075 . . . . 0.0 110.742 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -87.8 166.6 14.48 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -126.43 136.01 52.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.178 1.391 . . . . 0.0 107.283 171.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.24 164.4 38.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.545 1.138 . . . . 0.0 109.687 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.4 m -144.58 163.42 33.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.824 0.821 . . . . 0.0 112.453 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 157.22 43.31 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.884 1.274 . . . . 0.0 107.89 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -114.46 114.14 25.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -98.52 132.91 43.57 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -85.46 132.55 34.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 163.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 51.3 tttt -73.31 93.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.695 1.998 . . . . 0.0 108.514 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -95.02 115.01 26.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.786 0.834 . . . . 0.0 109.173 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.56 -158.94 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.85 1.66 . . . . 0.0 108.888 -167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 33.8 mtt 23.19 -76.32 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.147 2.979 . . . . 0.0 116.458 162.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 169.66 168.24 31.31 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -163.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -65.2 152.15 44.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.282 0.541 . . . . 0.0 110.12 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.25 44.05 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.915 -0.936 . . . . 0.0 112.259 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.67 164.72 37.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.499 1.65 . . . . 0.0 107.94 169.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 p -131.26 159.94 36.36 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.74 162.04 17.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.452 1.101 . . . . 0.0 108.847 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.72 146.57 32.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 128.575 2.75 . . . . 0.0 106.374 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.43 151.55 22.73 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 167.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -11.84 4.33 Favored Glycine 0 C--O 1.225 -0.419 0 C-N-CA 127.283 2.373 . . . . 0.0 117.893 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t0 95.59 -42.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 130.434 3.494 . . . . 0.0 108.037 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.79 157.81 89.39 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.674 2.389 . . . . 0.0 111.771 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -89.65 29.95 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.555 3.503 . . . . 0.0 112.692 -170.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -175.56 76.35 0.02 OUTLIER 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -140.44 143.46 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.873 2.469 . . . . 0.0 105.955 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -76.47 128.83 35.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.28 146.91 30.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.52 151.28 50.19 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 122.942 0.497 . . . . 0.0 110.835 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.17 112.1 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -70.57 -42.72 70.73 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 110.377 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 p -151.87 157.44 41.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.076 0.951 . . . . 0.0 109.57 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -92.72 141.7 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 159.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.03 122.07 86.22 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.44 146.23 97.31 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.442 1.428 . . . . 0.0 108.778 169.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 67.76 -2.59 1.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.536 1.534 . . . . 0.0 113.25 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.5 163.68 39.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.524 1.059 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.75 -27.76 75.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.113 2.542 . . . . 0.0 112.996 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.018 0.527 . . . . 0.0 110.081 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.2 87.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.686 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.47 -19.12 62.98 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.54 -4.91 59.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.162 1.346 . . . . 0.0 111.429 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.92 -24.27 1.98 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.17 2.319 . . . . 0.0 113.252 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.07 -35.33 18.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -157.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tpp -69.79 128.69 37.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.9 166.54 19.81 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -90.85 142.01 28.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 -16.6 58.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.691 -1.06 . . . . 0.0 112.361 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -55.39 139.84 41.83 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.523 1.129 . . . . 0.0 109.837 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.49 123.25 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.409 1.084 . . . . 0.0 108.835 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.08 119.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.555 1.542 . . . . 0.0 108.285 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.91 -57.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.938 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -134.3 152.94 52.09 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mt -130.25 128.36 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 t30 59.63 -73.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.145 2.978 . . . . 0.0 111.994 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -157.51 40.51 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.68 0.792 . . . . 0.0 110.85 165.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.38 132.52 70.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.615 1.966 . . . . 0.0 108.736 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.2 p -72.53 111.73 7.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.703 1.601 . . . . 0.0 111.779 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.49 5.6 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.847 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -18.44 62.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.383 1.901 . . . . 0.0 114.214 -167.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.31 4.69 19.88 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.583 -1.121 . . . . 0.0 112.934 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.48 162.97 22.04 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.707 1.753 . . . . 0.0 109.965 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.0 p -70.67 142.71 51.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -60.04 -22.67 62.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.372 -0.83 . . . . 0.0 110.391 166.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.11 -54.58 45.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.7 -1.25 . . . . 0.0 111.883 167.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.34 -49.86 67.78 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 124.882 1.273 . . . . 0.0 109.792 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 t -61.01 -41.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 120.037 -1.664 . . . . 0.0 112.182 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.4 -37.03 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 120.661 -1.274 . . . . 0.0 109.66 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -35.45 81.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.48 1.036 . . . . 0.0 110.003 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.12 -45.16 86.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.355 1.062 . . . . 0.0 108.258 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -64.29 -41.42 96.88 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.996 0.816 . . . . 0.0 111.322 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.98 -25.43 64.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.438 0.563 . . . . 0.0 112.24 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -66.35 -18.17 65.2 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.025 0.829 . . . . 0.0 111.994 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.36 115.85 62.3 Favored Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.69 170.06 20.59 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 120.716 1.291 . . . . 0.0 110.783 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.61 139.72 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.629 1.172 . . . . 0.0 108.029 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.29 -0.99 88.76 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 117.504 -1.72 . . . . 0.0 113.657 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -100.04 172.58 7.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.038 1.919 . . . . 0.0 108.482 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 p -131.87 159.62 38.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.642 0.777 . . . . 0.0 110.052 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.29 155.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.839 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.84 159.21 21.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 mt -146.06 141.61 27.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -121.75 118.12 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.8 mt -109.26 168.74 9.16 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.907 0.755 . . . . 0.0 109.871 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.9 t -121.75 143.67 49.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.909 1.284 . . . . 0.0 107.67 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -127.25 130.33 49.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.729 1.211 . . . . 0.0 111.68 -163.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 128.05 -21.85 5.47 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.16 139.01 87.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 123.965 0.906 . . . . 0.0 109.176 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.37 178.45 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.402 2.068 . . . . 0.0 110.735 167.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 157.98 20.75 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.306 160.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.0 140.43 49.98 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 N-CA-C 108.307 -1.459 . . . . 0.0 108.307 165.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -62.98 132.58 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 151.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.67 110.44 49.28 Favored Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.52 -22.36 21.3 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.48 1.454 . . . . 0.0 112.88 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.98 -61.27 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.889 1.276 . . . . 0.0 109.434 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -157.27 106.27 1.87 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.093 1.357 . . . . 0.0 108.692 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.03 -10.13 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.429 2.753 . . . . 0.0 113.824 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 141.18 97.98 0.0 OUTLIER 'General case' 0 C--N 1.344 0.36 0 C-N-CA 130.0 3.32 . . . . 0.0 109.336 -166.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -129.89 176.45 8.03 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.376 1.87 . . . . 0.0 108.813 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -162.92 163.99 26.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.251 2.22 . . . . 0.0 108.878 162.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.0 -159.39 32.31 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.086 1.327 . . . . 0.0 112.811 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -80.76 60.29 7.8 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.689 3.593 . . . . 0.0 112.288 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.16 132.61 50.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 155.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -71.84 163.54 27.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 163.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.421 -1.766 . . . . 0.0 109.03 178.847 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -74.63 -163.68 0.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.347 1.459 . . . . 0.0 110.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 m -119.46 -170.24 1.9 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.6 1.56 . . . . 0.0 107.58 161.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.5 175.56 21.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.2 m -57.4 147.83 25.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.215 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 t -84.69 -123.5 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.79 -168.39 38.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.44 -77.72 0.57 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 163.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.02 159.52 16.96 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.572 0.701 . . . . 0.0 110.843 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -78.77 -112.35 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.555 1.542 . . . . 0.0 111.715 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 147.13 -57.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 131.509 3.924 . . . . 0.0 111.798 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.6 t70 -142.76 20.78 1.99 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.797 0.439 . . . . 0.0 111.387 -166.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.49 -17.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.47 2.308 . . . . 0.0 114.132 -164.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -60.3 -23.42 64.17 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.942 2.497 . . . . 0.0 112.43 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -80.83 -16.12 54.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.419 1.087 . . . . 0.0 112.474 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.02 154.28 33.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.397 0.999 . . . . 0.0 109.13 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -130.01 99.57 5.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.83 176.11 39.89 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.359 1.933 . . . . 0.0 110.079 -166.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -98.64 133.79 42.48 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 117.798 0.799 . . . . 0.0 109.177 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -101.12 142.65 32.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.387 1.075 . . . . 0.0 110.052 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.77 166.64 32.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.097 1.759 . . . . 0.0 109.372 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -147.1 156.54 43.08 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.849 1.26 . . . . 0.0 111.039 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -139.43 157.12 46.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.656 1.582 . . . . 0.0 107.862 168.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.09 111.63 24.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.067 1.347 . . . . 0.0 107.554 170.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.64 135.21 40.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.792 1.178 . . . . 0.0 108.391 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -83.67 151.56 25.22 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.416 0.627 . . . . 0.0 110.073 167.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -79.27 69.42 5.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.941 1.297 . . . . 0.0 109.378 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.29 170.25 9.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.464 1.105 . . . . 0.0 108.646 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 49.62 -92.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.993 2.117 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.2 ptm -118.9 4.3 11.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.33 1.452 . . . . 0.0 111.657 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.78 -176.76 35.16 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -151.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -64.99 149.15 50.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.034 -1.083 . . . . 0.0 110.983 -161.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.98 40.12 3.09 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.53 -176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -146.24 166.22 26.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.167 1.483 . . . . 0.0 109.108 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 p -128.87 159.46 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.277 1.431 . . . . 0.0 108.371 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.45 162.38 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.839 1.256 . . . . 0.0 109.423 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.76 155.08 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.735 2.014 . . . . 0.0 108.034 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.01 155.05 21.38 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 129.606 3.479 . . . . 0.0 111.049 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.1 -93.39 0.02 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 117.294 -2.384 . . . . 0.0 108.292 142.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.33 -65.43 0.08 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.09 166.9 28.95 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.934 1.694 . . . . 0.0 110.819 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.38 45.22 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.041 3.16 . . . . 0.0 111.872 -164.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -157.21 34.47 0.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.316 1.447 . . . . 0.0 109.181 -168.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -139.43 173.62 11.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.953 1.301 . . . . 0.0 113.13 -167.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -88.71 112.89 23.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 125.381 1.472 . . . . 0.0 110.493 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -81.9 134.67 35.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -128.22 156.96 42.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.63 0.65 . . . . 0.0 111.06 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.96 104.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 166.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -54.82 -50.03 69.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.505 1.522 . . . . 0.0 109.145 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 152.4 18.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 109.206 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.5 t -104.04 130.18 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.74 130.28 68.02 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.83 46.09 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.808 3.005 . . . . 0.0 113.36 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -160.54 43.65 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.317 1.847 . . . . 0.0 109.905 164.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.67 166.6 22.96 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 120.718 -1.239 . . . . 0.0 112.443 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.63 -22.07 64.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.563 2.175 . . . . 0.0 112.397 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.8 2.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.962 0.905 . . . . 0.0 109.838 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.06 70.28 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.014 0.926 . . . . 0.0 111.004 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.0 -20.14 65.83 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.892 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -99.33 -30.41 12.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.483 1.492 . . . . 0.0 112.05 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.88 6.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.329 1.442 . . . . 0.0 114.431 166.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -69.87 -15.87 63.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.514 1.157 . . . . 0.0 111.144 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.94 133.67 43.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.08 176.62 8.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 162.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.3 m -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.56 56.48 25.05 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -128.92 151.49 49.6 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.983 2.113 . . . . 0.0 105.652 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.26 127.16 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 121.401 1.91 . . . . 0.0 109.706 -171.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.88 130.2 36.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.551 1.14 . . . . 0.0 108.589 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.4 t -106.4 -61.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.518 1.527 . . . . 0.0 109.211 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -128.83 157.76 40.61 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.397 1.079 . . . . 0.0 109.223 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mt -128.79 117.11 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 47.77 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 128.564 2.746 . . . . 0.0 112.075 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.45 13.7 1.78 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.514 1.526 . . . . 0.0 111.111 -170.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.22 120.9 55.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.47 104.8 2.41 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -101.52 3.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 123.28 0.632 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 pp -58.45 -17.48 21.14 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.81 35.61 2.29 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 126.14 1.828 . . . . 0.0 109.016 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -103.16 165.66 10.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.306 1.053 . . . . 0.0 108.548 161.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.02 161.64 16.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.972 0.909 . . . . 0.0 109.546 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.93 -14.58 23.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.5 1.52 . . . . 0.0 111.934 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.13 -67.56 0.43 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.476 1.489 . . . . 0.0 109.478 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -56.01 -45.4 79.09 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.439 0.696 . . . . 0.0 111.075 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.11 -41.59 93.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 120.292 -1.505 . . . . 0.0 111.447 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.9 -37.34 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.87 -1.144 . . . . 0.0 109.731 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -39.07 93.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.426 1.466 . . . . 0.0 109.939 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.28 -51.1 71.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.667 1.587 . . . . 0.0 108.164 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.38 -42.33 88.08 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.019 0.827 . . . . 0.0 112.483 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.41 -30.88 69.89 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.423 -0.798 . . . . 0.0 111.008 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -70.02 -2.55 13.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.5 114.63 56.25 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.81 179.07 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.072 2.515 . . . . 0.0 110.931 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.35 152.06 7.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 109.137 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.08 -25.78 6.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 124.286 0.946 . . . . 0.0 111.956 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -84.33 142.25 30.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.42 1.11 . . . . 0.0 109.289 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.63 150.48 28.93 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.694 1.598 . . . . 0.0 108.234 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -141.31 141.21 31.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -84.18 155.97 22.3 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.0 mt -142.62 150.08 39.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.42 126.47 58.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.5 mt -119.65 169.5 10.04 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 124.356 1.035 . . . . 0.0 110.265 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.9 t -133.48 117.5 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.836 0.855 . . . . 0.0 111.213 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -85.53 139.41 31.49 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.115 -0.99 . . . . 0.0 110.339 -165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.98 -4.8 16.25 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.073 -0.848 . . . . 0.0 113.582 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.67 117.97 68.88 Favored Pre-proline 0 CA--C 1.526 0.057 0 CA-C-N 119.372 1.586 . . . . 0.0 107.53 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.16 177.23 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.709 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -54.48 149.09 22.07 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.613 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.52 126.24 13.88 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.668 2.245 . . . . 0.0 107.33 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -66.29 135.19 54.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 163.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -119.4 92.57 46.04 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.52 -16.65 54.81 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 121.946 1.764 . . . . 0.0 113.265 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.36 -43.94 96.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.606 1.562 . . . . 0.0 111.081 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 35.29 92.68 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 129.474 3.109 . . . . 0.0 114.772 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.45 -8.42 20.71 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.852 2.368 . . . . 0.0 115.074 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 159.49 -62.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.595 3.158 . . . . 0.0 108.131 168.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 69.24 162.52 0.22 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.673 2.789 . . . . 0.0 110.168 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 93.6 p -159.03 158.29 32.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.4 140.39 11.0 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.3 -171.51 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.056 3.17 . . . . 0.0 111.15 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.0 p -65.09 81.62 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.281 1.433 . . . . 0.0 110.453 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 87.7 p -146.3 179.68 7.35 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.248 -0.907 . . . . 0.0 109.909 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 N-CA-C 104.859 -3.296 . . . . 0.0 104.859 162.706 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -51.69 142.78 13.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.726 1.61 . . . . 0.0 112.561 -167.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -60.54 160.6 8.73 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 161.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.82 -168.84 28.69 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -167.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 m 65.9 112.5 0.03 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.502 2.321 . . . . 0.0 109.834 -168.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -125.15 164.85 19.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.473 1.909 . . . . 0.0 108.034 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.53 -161.57 17.31 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.94 72.17 1.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 10' ' ' THR . 27.8 t80 52.71 165.12 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 130.99 3.716 . . . . 0.0 114.261 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 m -82.32 -99.36 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.377 1.471 . . . . 0.0 112.102 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 117.83 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 1 C-N-CA 136.151 5.781 . . . . 0.0 114.167 172.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -125.52 13.63 8.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.507 1.048 . . . . 0.0 111.721 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.3 -20.3 0.07 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.851 2.86 . . . . 0.0 115.399 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -64.27 -22.13 66.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.312 0.96 . . . . 0.0 112.32 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -97.83 20.64 11.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.724 1.21 . . . . 0.0 112.073 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.88 -159.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 162.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -64.04 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.055 1.342 . . . . 0.0 111.661 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.55 -13.69 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.168 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 159.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -86.18 127.38 34.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -127.95 123.4 34.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.773 1.629 . . . . 0.0 108.165 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 154.83 41.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.994 1.718 . . . . 0.0 107.977 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -145.6 152.79 40.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.584 0.354 . . . . 0.0 110.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.52 157.94 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 108.118 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.7 m -127.15 119.34 26.25 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.354 1.462 . . . . 0.0 107.935 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.98 150.39 21.42 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -83.12 158.24 22.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 24.0 tptt -77.1 98.32 5.0 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.5 m -126.1 151.86 46.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.686 0.675 . . . . 0.0 111.793 -159.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 60.4 -79.87 0.02 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.251 2.62 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -149.43 71.62 1.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.421 2.289 . . . . 0.0 107.432 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 73.79 176.14 33.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.82 123.69 21.65 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.458 -1.025 . . . . 0.0 109.357 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.22 51.52 2.1 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.744 1.164 . . . . 0.0 112.775 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.57 165.93 27.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.394 1.877 . . . . 0.0 106.321 160.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -131.8 166.44 21.55 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.462 -0.773 . . . . 0.0 109.279 166.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.29 161.32 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.837 1.655 . . . . 0.0 107.422 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -133.05 150.25 32.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.786 2.035 . . . . 0.0 106.702 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.22 151.8 22.43 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.391 1.948 . . . . 0.0 108.702 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.03 -55.85 9.99 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.357 -0.691 . . . . 0.0 112.611 -158.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.79 -41.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.505 1.922 . . . . 0.0 107.859 166.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.59 164.97 14.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.223 1.409 . . . . 0.0 111.707 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.1 19.19 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.106 3.871 . . . . 0.0 116.218 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.58 5.61 0.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.22 1.008 . . . . 0.0 113.252 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.28 155.33 40.31 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 0.969 . . . . 0.0 108.413 163.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.96 168.41 18.06 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.806 0.812 . . . . 0.0 110.509 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.65 133.85 54.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.714 1.606 . . . . 0.0 107.254 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -128.49 151.82 48.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.11 121.96 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -76.74 -41.92 43.16 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 125.959 1.704 . . . . 0.0 110.501 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.2 p -156.99 161.93 39.58 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.304 1.041 . . . . 0.0 110.432 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.43 120.42 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 126.542 1.937 . . . . 0.0 105.811 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mm -75.49 131.38 77.55 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.22 152.04 82.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.668 2.245 . . . . 0.0 109.648 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 t70 53.92 23.17 3.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.908 0.861 . . . . 0.0 111.924 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.29 163.73 13.15 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.527 1.537 . . . . 0.0 109.712 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.4 -32.54 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.761 2.307 . . . . 0.0 111.865 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.44 -40.88 80.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.119 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.04 81.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.263 0.625 . . . . 0.0 110.596 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.13 -46.72 89.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.298 0.499 . . . . 0.0 110.216 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.32 -31.31 71.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.036 0.534 . . . . 0.0 111.223 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.97 -18.69 29.93 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.474 1.511 . . . . 0.0 113.49 160.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.111 0.955 . . . . 0.0 110.675 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.5 tpp -65.43 123.71 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.01 163.69 29.72 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.239 1.016 . . . . 0.0 108.363 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -88.21 142.56 27.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -167.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.41 -12.96 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.849 -1.528 . . . . 0.0 112.512 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.91 148.89 49.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.677 2.238 . . . . 0.0 108.098 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.3 125.75 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.115 1.366 . . . . 0.0 109.268 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.11 110.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 125.406 1.482 . . . . 0.0 107.422 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.02 -58.82 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.585 0.707 . . . . 0.0 109.664 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.07 155.22 50.43 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.916 1.286 . . . . 0.0 107.851 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -127.08 113.7 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 169.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 t30 69.88 -61.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 129.484 3.114 . . . . 0.0 112.27 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -157.71 5.7 0.13 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.756 1.622 . . . . 0.0 111.682 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.55 131.32 53.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 120.313 -1.492 . . . . 0.0 107.376 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.9 t -78.27 116.55 18.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.74 5.3 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 122.961 0.504 . . . . 0.0 111.576 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -31.59 35.44 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.364 1.866 . . . . 0.0 113.138 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.22 61.1 0.64 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -111.82 162.94 14.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.329 1.052 . . . . 0.0 109.834 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.27 151.61 41.3 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -55.47 -29.81 59.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.088 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.96 71.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.307 1.412 . . . . 0.0 112.268 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -76.57 -57.21 3.99 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -52.72 -41.62 39.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.484 2.713 . . . . 0.0 112.909 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.62 -28.37 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 120.553 -1.342 . . . . 0.0 110.361 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -35.74 73.14 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.439 1.472 . . . . 0.0 108.154 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.69 -36.39 67.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.214 1.005 . . . . 0.0 110.317 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -73.0 -29.6 63.16 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.721 -1.237 . . . . 0.0 111.684 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.81 -19.3 55.21 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.378 0.671 . . . . 0.0 112.237 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.6 m -71.24 -7.5 47.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 113.382 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.01 102.85 19.14 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.306 1.043 . . . . 0.0 108.259 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.7 170.43 16.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 mt -66.95 142.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 107.774 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.82 -2.57 87.3 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.103 -0.832 . . . . 0.0 113.049 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -101.53 171.63 7.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.716 1.258 . . . . 0.0 108.976 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -143.91 155.43 44.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.137 2.175 . . . . 0.0 108.211 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.81 148.24 24.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -82.82 153.38 25.21 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.2 mt -138.17 147.36 43.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 t -127.68 116.45 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.96 164.12 12.91 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -117.65 138.15 52.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 164.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.06 156.14 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.354 1.862 . . . . 0.0 110.095 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.05 -16.18 20.57 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 118.663 -1.076 . . . . 0.0 114.03 157.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -83.53 140.04 41.35 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 118.884 1.342 . . . . 0.0 108.784 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.97 176.87 9.47 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.63 2.887 . . . . 0.0 110.074 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 mt -67.58 145.3 98.19 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -72.61 -39.4 2.65 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.931 1.754 . . . . 0.0 111.053 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.22 107.92 0.72 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.166 0.986 . . . . 0.0 108.661 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -89.71 106.22 13.46 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.89 -25.87 11.69 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 120.831 1.021 . . . . 0.0 111.244 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -67.69 -49.22 63.84 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.382 -0.824 . . . . 0.0 111.319 -169.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.28 87.91 6.42 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.51 -24.61 11.87 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.473 1.449 . . . . 0.0 113.661 -153.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 174.5 87.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.596 3.158 . . . . 0.0 103.109 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 58.88 -179.49 0.08 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.319 1.848 . . . . 0.0 112.739 -165.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -124.25 150.41 45.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.7 1.6 . . . . 0.0 108.093 166.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.93 -173.89 53.35 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.449 0.468 . . . . 0.0 112.497 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.62 132.83 36.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.549 2.166 . . . . 0.0 108.675 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.0 p -82.84 68.18 9.21 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.848 0.859 . . . . 0.0 109.068 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m -68.54 -178.48 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.09 0.956 . . . . 0.0 110.86 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.428 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 178.09 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.836 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -80.69 171.03 15.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.707 1.203 . . . . 0.0 110.26 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -82.18 173.79 11.79 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 120.409 -1.432 . . . . 0.0 108.904 153.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.46 -100.44 2.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 150.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 m -152.97 -165.5 2.2 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.203 1.801 . . . . 0.0 106.239 162.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -150.49 109.9 3.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 160.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.73 153.42 24.74 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.505 1.526 . . . . 0.0 110.02 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tt -112.97 -80.14 0.59 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.913 0.857 . . . . 0.0 109.012 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -87.46 169.16 12.46 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 m -88.4 -120.39 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.912 1.285 . . . . 0.0 108.759 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 146.77 -47.64 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.582 1 C-N-CA 133.127 4.571 . . . . 0.0 106.62 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -123.92 124.75 43.3 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -170.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.31 -9.25 3.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.363 1.465 . . . . 0.0 113.422 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -69.99 -21.29 63.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.223 1.009 . . . . 0.0 111.657 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.05 -22.86 63.03 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.11 -0.994 . . . . 0.0 111.092 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.52 152.43 40.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.314 0.578 . . . . 0.0 110.575 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -129.67 111.06 12.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.914 2.086 . . . . 0.0 105.597 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.07 -144.85 5.13 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.8 m -136.61 152.39 50.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 151.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.63 142.83 33.64 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.286 1.434 . . . . 0.0 108.824 -172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -141.21 165.52 27.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.789 0.836 . . . . 0.0 109.168 -171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 m -152.47 154.69 36.02 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.131 0.491 . . . . 0.0 111.865 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -154.2 158.42 40.29 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.33 1.852 . . . . 0.0 107.621 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -121.58 111.97 17.89 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.421 1.488 . . . . 0.0 107.182 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -101.83 131.88 47.91 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.808 -0.557 . . . . 0.0 109.738 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -83.51 132.97 34.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.633 1.573 . . . . 0.0 109.466 172.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.38 107.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 107.86 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.4 t -133.69 -127.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.48 1.512 . . . . 0.0 108.021 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -55.25 102.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.314 1.446 . . . . 0.0 110.542 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 36.2 mtm 45.31 67.88 0.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.134 1.374 . . . . 0.0 110.622 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.15 -126.9 17.18 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.63 141.79 35.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 40.27 1.83 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.666 -0.519 . . . . 0.0 112.579 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -142.71 162.58 35.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.468 1.634 . . . . 0.0 109.11 163.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -123.91 152.23 42.66 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.246 1.818 . . . . 0.0 107.632 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.64 161.99 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.16 0.984 . . . . 0.0 108.478 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -135.71 158.84 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.698 2.399 . . . . 0.0 106.126 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.7 152.53 22.15 Favored Glycine 0 C--O 1.237 0.282 0 C-N-CA 126.025 1.774 . . . . 0.0 108.68 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.06 -77.18 0.14 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.754 0.692 . . . . 0.0 112.612 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -170.21 -50.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.658 0.729 . . . . 0.0 110.302 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -101.07 166.1 13.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.558 1.543 . . . . 0.0 111.169 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.25 43.81 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.778 3.652 . . . . 0.0 110.772 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.0 23.15 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.735 2.014 . . . . 0.0 110.79 -173.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.26 167.84 10.22 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.983 0.913 . . . . 0.0 109.107 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.46 160.99 27.41 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 110.967 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -124.75 132.07 53.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 127.009 2.124 . . . . 0.0 106.552 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -130.39 155.97 45.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.42 112.34 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 165.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -59.9 -49.62 76.96 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 108.686 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 m -157.58 146.39 19.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.767 1.227 . . . . 0.0 108.474 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.51 143.24 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 159.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -71.54 135.9 83.73 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.72 137.66 25.18 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.365 1.377 . . . . 0.0 109.523 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 51.61 67.62 0.93 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.431 1.092 . . . . 0.0 111.327 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.37 175.01 25.17 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.414 -0.804 . . . . 0.0 111.844 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.99 -35.55 92.79 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 112.221 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.57 81.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.892 1.277 . . . . 0.0 111.714 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.88 67.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.36 0.664 . . . . 0.0 109.897 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.02 -45.88 86.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.638 1.175 . . . . 0.0 111.472 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -68.44 -24.46 64.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.022 0.529 . . . . 0.0 110.862 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.82 15.19 64.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.678 1.132 . . . . 0.0 113.815 169.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.01 -73.7 0.42 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.405 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.94 159.3 26.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -138.37 160.16 40.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.243 1.497 . . . . 0.0 111.518 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 55.0 m -60.0 133.78 56.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.606 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.31 -14.67 64.04 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.282 1.42 . . . . 0.0 113.765 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.21 150.87 41.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.379 1.59 . . . . 0.0 109.531 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -96.22 127.54 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.366 1.466 . . . . 0.0 108.959 -176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.46 117.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.289 . . . . 0.0 107.641 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.88 -60.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.569 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -132.0 148.86 52.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -130.71 130.8 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 53.02 -85.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.754 2.422 . . . . 0.0 112.449 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.61 9.99 2.9 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.768 1.167 . . . . 0.0 112.712 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.26 132.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.321 1.448 . . . . 0.0 109.118 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.68 98.44 1.92 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -98.42 8.47 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.908 0.883 . . . . 0.0 110.705 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.25 -21.51 24.09 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -169.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.24 22.73 5.0 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.096 1.808 . . . . 0.0 111.692 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.82 30.48 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.739 1.769 . . . . 0.0 109.116 166.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 144.63 48.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.06 -37.3 66.57 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.96 69.23 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.577 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.43 -50.26 11.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.602 1.092 . . . . 0.0 110.065 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.23 -39.44 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.068 1.347 . . . . 0.0 111.432 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.25 -40.58 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 120.851 -1.156 . . . . 0.0 109.735 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -31.32 70.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 110.682 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.97 -46.6 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.126 1.77 . . . . 0.0 109.482 174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.06 -37.38 86.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.994 0.816 . . . . 0.0 109.959 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.2 -24.46 62.22 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.515 -0.741 . . . . 0.0 112.112 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -70.83 -0.22 8.6 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.422 1.089 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.2 t -100.12 101.84 15.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.09 168.01 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.596 1.53 . . . . 0.0 110.919 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.7 142.12 12.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.13 -11.61 35.45 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.589 -1.117 . . . . 0.0 113.69 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -84.58 154.24 22.73 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 120.478 2.139 . . . . 0.0 107.465 165.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -126.03 157.53 37.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.057 1.343 . . . . 0.0 109.338 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.66 147.21 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.39 150.5 26.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 mt -141.44 139.81 33.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.87 123.2 69.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -115.96 164.37 14.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 123.958 0.786 . . . . 0.0 110.172 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 16.9 t -115.89 119.86 37.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 165.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -74.35 156.27 37.27 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.668 1.187 . . . . 0.0 107.993 163.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.35 30.58 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.009 0.822 . . . . 0.0 113.309 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -103.35 126.8 31.17 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.41 172.52 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.393 2.062 . . . . 0.0 111.689 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.15 142.68 98.65 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.35 -45.97 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.695 2.264 . . . . 0.0 111.25 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.69 117.68 7.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.953 0.901 . . . . 0.0 108.849 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -79.41 108.58 8.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.852 1.661 . . . . 0.0 108.799 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.41 -21.73 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.745 1.63 . . . . 0.0 111.497 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -64.46 -25.79 68.16 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.361 1.064 . . . . 0.0 111.329 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.1 100.25 2.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.93 -51.79 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.116 1.878 . . . . 0.0 110.144 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.22 -74.2 0.06 Allowed 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.848 1.659 . . . . 0.0 107.764 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 90.67 88.76 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 129.72 3.208 . . . . 0.0 111.006 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -60.11 118.54 6.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.723 0.409 . . . . 0.0 109.948 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.09 167.97 16.03 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 154.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.39 133.35 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.354 2.036 . . . . 0.0 110.964 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.0 p -145.93 148.63 33.0 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.726 0.81 . . . . 0.0 109.589 161.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.7 m -159.27 169.4 24.14 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.945 2.498 . . . . 0.0 106.314 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.609 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -175.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.9 m -133.37 179.66 6.07 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.913 1.685 . . . . 0.0 111.258 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 t 57.83 -163.94 0.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.869 1.668 . . . . 0.0 110.438 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.48 152.14 21.1 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.25 153.37 47.82 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.162 1.785 . . . . 0.0 108.262 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -132.93 159.1 40.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.747 1.619 . . . . 0.0 108.104 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 47.83 64.27 3.05 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -161.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.01 103.7 3.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 175.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -54.57 162.45 1.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.299 1.439 . . . . 0.0 111.206 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.1 m -74.02 -110.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.511 1.124 . . . . 0.0 112.369 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 134.61 -51.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 134.296 5.039 . . . . 0.0 109.939 -175.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.3 t0 -125.26 22.49 7.81 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -165.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.17 -11.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 114.922 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 12' ' ' ASP . 29.8 t -62.75 -31.53 72.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.99 1.716 . . . . 0.0 112.605 -169.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.91 -11.95 60.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.8 mt -69.39 145.58 52.76 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.908 1.231 . . . . 0.0 109.944 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.2 142.41 28.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 160.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.58 -173.71 23.35 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.988 0.805 . . . . 0.0 112.812 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.7 m -106.53 129.02 54.55 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -80.21 133.87 36.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 174.47 11.06 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.323 1.449 . . . . 0.0 109.005 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -151.04 163.25 39.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.243 0.217 . . . . 0.0 110.615 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -154.47 158.04 39.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.96 0.886 . . . . 0.0 108.636 166.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.7 m -114.84 117.83 31.81 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 167.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.58 138.5 36.58 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -90.95 129.82 36.94 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.95 103.58 0.18 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.008 1.323 . . . . 0.0 107.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t -129.51 165.83 20.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.523 1.529 . . . . 0.0 107.779 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 44.05 -73.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.733 3.213 . . . . 0.0 113.273 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.5 ptp -142.74 5.94 1.59 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.089 1.756 . . . . 0.0 113.43 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.23 -126.18 2.44 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 120.851 1.66 . . . . 0.0 111.599 -172.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.91 145.98 46.21 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.976 0.91 . . . . 0.0 109.253 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.55 36.23 2.98 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.856 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.427 ' CE1' ' HE2' ' A' ' 63' ' ' MET . 32.3 p90 -149.07 169.09 21.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.099 1.45 . . . . 0.0 108.883 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -131.77 154.21 49.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.373 1.069 . . . . 0.0 108.439 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.81 160.58 17.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.597 1.159 . . . . 0.0 107.898 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 tt -125.25 162.03 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.722 2.009 . . . . 0.0 107.207 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.76 150.7 19.37 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.64 -63.16 3.31 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-O 118.952 -0.916 . . . . 0.0 112.285 -172.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.14 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 128.453 2.701 . . . . 0.0 109.09 164.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -89.79 160.7 40.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.399 1.48 . . . . 0.0 112.39 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.97 51.83 3.23 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 125.082 3.855 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.69 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.901 2.08 . . . . 0.0 110.921 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -102.5 154.49 19.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 120.632 -1.292 . . . . 0.0 109.126 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.57 137.43 33.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.162 0.985 . . . . 0.0 108.741 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.82 113.12 24.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.382 1.873 . . . . 0.0 109.173 -174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.72 157.27 16.82 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 122.104 2.229 . . . . 0.0 111.207 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 t -61.08 115.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -55.11 36.93 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.36 -0.838 . . . . 0.0 109.142 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 m -159.66 154.29 24.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.973 0.909 . . . . 0.0 109.582 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.08 133.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 160.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.3 135.15 66.1 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 125.872 1.669 . . . . 0.0 107.574 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.12 147.51 84.09 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.509 1.472 . . . . 0.0 109.074 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 64.3 24.25 13.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.038 0.935 . . . . 0.0 112.509 167.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.97 176.54 19.9 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.798 1.666 . . . . 0.0 112.478 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.25 -12.36 25.37 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.734 2.956 . . . . 0.0 113.497 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.16 -50.71 12.38 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 168.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.32 -54.76 41.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.688 0.795 . . . . 0.0 109.971 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -68.94 -15.4 63.48 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.326 0.966 . . . . 0.0 113.473 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.9 -38.56 73.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.227 1.376 . . . . 0.0 109.415 166.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.04 -28.94 13.66 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.045 1.307 . . . . 0.0 113.057 167.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -93.63 -12.67 28.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.201 1.5 . . . . 0.0 113.836 -160.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.427 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 32.0 ttm -90.53 144.84 25.39 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 120.976 -1.077 . . . . 0.0 108.417 175.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -137.06 179.04 6.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.523 1.129 . . . . 0.0 108.181 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 m -93.93 149.4 21.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.1 5.92 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -165.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.76 157.07 47.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.46 114.03 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.86 2.064 . . . . 0.0 108.351 -167.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -60.26 115.4 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.247 1.419 . . . . 0.0 108.089 171.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.95 -54.55 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 124.12 0.887 . . . . 0.0 109.974 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.16 154.25 51.69 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.288 1.435 . . . . 0.0 108.684 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.4 mt -135.01 129.2 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 51.22 -89.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.898 2.479 . . . . 0.0 110.896 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -135.14 28.51 3.44 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.396 1.453 . . . . 0.0 112.023 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.98 133.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 120.904 -1.123 . . . . 0.0 109.293 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.35 106.45 12.37 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.879 1.272 . . . . 0.0 110.322 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.47 5.18 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.188 0.995 . . . . 0.0 112.784 -171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -32.04 63.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.41 14.63 13.28 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.612 1.577 . . . . 0.0 110.739 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -68.65 161.85 27.27 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 p -73.23 145.85 45.9 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.38 -41.77 66.23 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 109.113 168.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.26 63.68 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.326 0.966 . . . . 0.0 113.462 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.79 -53.87 6.66 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 120.288 1.404 . . . . 0.0 109.435 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 t -56.0 -39.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.395 1.878 . . . . 0.0 111.662 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.1 -38.36 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 120.93 -1.106 . . . . 0.0 110.068 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -37.26 81.8 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 120.148 1.34 . . . . 0.0 109.182 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.18 -39.41 92.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.659 1.184 . . . . 0.0 109.16 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -69.24 -45.02 70.79 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.95 0.795 . . . . 0.0 111.904 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.07 -29.45 70.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.904 0.775 . . . . 0.0 112.106 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.6 p -56.69 -25.56 54.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.263 1.025 . . . . 0.0 113.548 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.05 109.24 17.66 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -162.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.75 170.19 14.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.635 1.556 . . . . 0.0 110.419 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mt -63.29 144.64 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.71 -4.05 53.33 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 117.654 -1.637 . . . . 0.0 113.99 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -86.52 175.94 8.09 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.867 1.834 . . . . 0.0 108.735 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.48 162.75 28.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.996 1.318 . . . . 0.0 109.999 170.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.04 150.37 24.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 125.331 1.452 . . . . 0.0 108.708 165.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -83.16 159.4 22.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 173.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -145.95 143.75 29.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.81 129.85 74.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.1 mt -118.47 171.13 8.37 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 124.296 0.997 . . . . 0.0 110.369 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 12.3 t -131.04 119.87 22.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.908 1.283 . . . . 0.0 108.344 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.9 ttm180 -91.11 140.94 29.34 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.181 1.393 . . . . 0.0 110.467 -172.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.85 -38.01 1.87 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.178 0.894 . . . . 0.0 111.008 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -60.91 120.1 50.74 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.56 0.744 . . . . 0.0 109.316 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.11 177.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.646 2.231 . . . . 0.0 111.802 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.23 151.78 95.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.955 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.98 -49.73 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.517 2.144 . . . . 0.0 110.334 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -81.26 119.27 23.42 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.82 130.63 23.1 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 167.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.17 -12.99 28.33 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.496 2.131 . . . . 0.0 113.507 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.32 -44.11 38.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.963 0.905 . . . . 0.0 110.736 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -151.37 76.51 7.66 Favored Pre-proline 0 CA--C 1.523 -0.089 0 O-C-N 121.648 -0.658 . . . . 0.0 109.637 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.6 -14.43 36.58 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.427 1.418 . . . . 0.0 111.607 172.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 143.03 118.05 0.0 OUTLIER 'General case' 0 C--N 1.345 0.384 1 C-N-CA 133.54 4.736 . . . . 0.0 106.622 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 168.06 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.452 2.701 . . . . 0.0 109.765 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.15 132.36 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.489 1.515 . . . . 0.0 112.216 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.02 -112.91 0.47 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.09 149.54 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 CA-C-N 120.263 2.031 . . . . 0.0 110.261 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.98 176.73 12.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 159.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.9 t -147.26 136.58 22.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.437 0 N-CA-C 106.86 -2.496 . . . . 0.0 106.86 -173.64 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.859 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m 44.33 -135.3 0.58 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.091 -164.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -52.06 158.28 1.12 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.23 -97.36 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m 42.66 78.44 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.026 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 p -135.08 177.37 7.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.699 1.199 . . . . 0.0 110.338 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.29 175.75 37.39 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.338 0.97 . . . . 0.0 112.599 169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 tp -143.47 -72.41 0.29 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.503 -0.76 . . . . 0.0 109.284 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -67.29 152.17 46.19 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.227 1.013 . . . . 0.0 109.497 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -74.51 -97.97 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.048 1.339 . . . . 0.0 113.928 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 116.67 -34.61 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 1 C-N-CA 136.112 5.765 . . . . 0.0 110.913 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -146.02 18.73 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 112.674 -161.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.3 -22.32 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.034 2.934 . . . . 0.0 114.749 -172.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 t -74.17 -6.26 46.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.364 1.438 . . . . 0.0 113.433 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -80.41 -22.64 41.02 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 119.625 -1.922 . . . . 0.0 111.159 164.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.41 146.15 54.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -131.52 124.54 30.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.85 177.99 15.15 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.1 m -93.17 155.43 17.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.655 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -106.44 132.28 52.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.876 1.67 . . . . 0.0 109.344 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 165.64 12.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 108.475 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -139.02 149.79 45.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.6 1.16 . . . . 0.0 109.019 160.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -155.05 157.15 37.12 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 m -130.31 105.96 8.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.42 134.83 40.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.6 145.62 29.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.55 95.37 1.4 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -84.04 -166.45 1.42 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.548 2.339 . . . . 0.0 110.021 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -58.85 -24.58 62.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -165.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -133.07 53.19 2.03 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 -123.86 26.33 Favored Glycine 0 N--CA 1.441 -0.995 0 O-C-N 121.332 -0.855 . . . . 0.0 111.505 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.97 136.56 49.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.3 51.43 4.37 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.415 0.552 . . . . 0.0 112.169 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.46 173.27 13.28 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.01 1.324 . . . . 0.0 108.781 165.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.58 159.62 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.206 1.403 . . . . 0.0 108.811 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.76 159.51 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.078 1.351 . . . . 0.0 109.658 -174.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.83 155.46 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 128.954 2.902 . . . . 0.0 106.853 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.99 152.25 20.99 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.936 1.731 . . . . 0.0 109.128 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.91 -75.6 0.17 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.373 1.463 . . . . 0.0 111.801 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.92 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.473 1.509 . . . . 0.0 108.22 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -97.3 167.67 11.52 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -167.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.44 55.46 3.65 Favored 'Trans proline' 0 C--N 1.351 0.668 1 C-N-CA 125.312 4.008 . . . . 0.0 111.234 172.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.88 -8.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.956 1.302 . . . . 0.0 112.973 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.09 162.79 15.15 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.13 -0.981 . . . . 0.0 112.783 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.22 134.31 52.44 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.442 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -104.45 135.88 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -130.25 153.68 48.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.203 0.91 . . . . 0.0 110.947 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.0 119.29 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -71.2 -50.32 34.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.985 1.714 . . . . 0.0 110.16 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -152.31 152.6 32.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.041 1.736 . . . . 0.0 108.295 168.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.48 136.27 24.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 160.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.95 142.88 91.12 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 141.82 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.676 1.584 . . . . 0.0 111.016 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 46.84 68.52 0.61 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.814 1.646 . . . . 0.0 110.765 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.41 175.4 26.78 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.944 1.259 . . . . 0.0 110.415 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -64.68 -33.22 55.66 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.598 2.198 . . . . 0.0 112.7 -167.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.69 74.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.28 80.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.406 1.083 . . . . 0.0 111.517 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.69 -34.55 77.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.19 0.596 . . . . 0.0 112.536 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -33.84 75.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.751 0.786 . . . . 0.0 109.169 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.03 6.04 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.987 2.232 . . . . 0.0 114.209 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -65.57 -45.75 82.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.163 0.981 . . . . 0.0 109.246 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 tpp -65.63 122.75 17.95 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.835 0.854 . . . . 0.0 109.25 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.04 159.94 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 108.897 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 m -78.06 149.55 33.93 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.786 -1.196 . . . . 0.0 108.436 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -8.44 77.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.87 0.748 . . . . 0.0 113.71 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.41 158.18 34.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.143 1.472 . . . . 0.0 110.25 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.68 130.02 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.305 1.842 . . . . 0.0 108.741 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.93 126.71 39.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.112 1.365 . . . . 0.0 108.231 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.78 -54.67 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.858 178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -135.06 142.03 46.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.11 112.32 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 t30 71.97 -68.86 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.268 3.027 . . . . 0.0 111.322 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -156.47 24.77 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 110.756 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.05 132.27 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 120.491 -1.381 . . . . 0.0 107.513 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 t -69.78 116.38 10.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.987 0.915 . . . . 0.0 108.716 168.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.09 5.37 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.771 0.829 . . . . 0.0 111.787 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.12 -24.01 23.77 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.21 22.94 5.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.856 1.693 . . . . 0.0 110.529 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -75.69 158.47 32.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.352 1.576 . . . . 0.0 109.894 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 t -77.14 149.1 35.66 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.24 -41.38 72.07 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.811 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.51 -32.3 62.78 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.379 1.445 . . . . 0.0 112.403 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -80.34 -47.8 13.93 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 118.86 0.754 . . . . 0.0 110.866 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 t -59.0 -42.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.711 -1.243 . . . . 0.0 110.703 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.58 -44.8 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.324 172.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -37.89 84.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.629 1.558 . . . . 0.0 111.167 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -60.93 -50.52 73.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.212 1.405 . . . . 0.0 108.362 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -64.79 -39.98 94.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.211 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -67.01 -34.25 77.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.444 0.698 . . . . 0.0 110.168 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -70.53 -3.81 19.83 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.38 116.58 65.71 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -60.86 157.23 39.24 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.741 2.294 . . . . 0.0 110.896 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.9 mt -59.85 139.21 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -13.11 59.17 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.424 -1.764 . . . . 0.0 114.299 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -84.21 167.16 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.834 2.317 . . . . 0.0 108.241 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.33 163.56 22.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.655 1.182 . . . . 0.0 110.008 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.0 146.25 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.398 1.479 . . . . 0.0 107.777 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.82 156.51 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.485 1.114 . . . . 0.0 109.524 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.48 109.59 4.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.5 t -89.3 121.15 39.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -116.52 163.77 15.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 124.11 0.881 . . . . 0.0 110.804 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.0 t -116.95 126.73 53.37 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.999 1.32 . . . . 0.0 108.563 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -76.52 156.84 32.59 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.454 1.502 . . . . 0.0 110.552 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.31 -21.93 8.56 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.808 1.194 . . . . 0.0 113.507 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -76.52 159.65 79.05 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 118.364 1.082 . . . . 0.0 109.888 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.23 178.31 6.74 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.986 2.458 . . . . 0.0 111.786 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.1 151.83 94.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 164.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.72 -25.13 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.761 1.641 . . . . 0.0 111.433 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -118.94 100.75 7.57 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.357 3.063 . . . . 0.0 106.033 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.7 103.5 2.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 124.591 1.157 . . . . 0.0 108.34 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -77.44 -6.75 16.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.106 1.87 . . . . 0.0 112.432 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.18 -24.17 43.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.801 1.641 . . . . 0.0 112.754 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -95.53 118.59 66.11 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.05 -16.46 52.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.601 2.201 . . . . 0.0 113.649 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 144.44 -27.91 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 131.5 3.92 . . . . 0.0 110.466 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . 0.269 5.4 p30 40.0 -122.24 0.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.125 1.77 . . . . 0.0 110.73 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.7 m 37.01 51.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.963 2.505 . . . . 0.0 115.949 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.79 155.08 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.588 160.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.86 163.51 28.61 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.754 2.303 . . . . 0.0 110.494 166.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m 56.99 -176.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.844 1.258 . . . . 0.0 113.889 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 m -108.98 -52.05 2.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.061 1.344 . . . . 0.0 111.006 -172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.705 0 N-CA-C 104.64 -3.384 . . . . 0.0 104.64 165.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.727 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.9 p -63.99 166.9 6.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 163.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -152.53 -55.09 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.64 -161.77 20.66 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.406 1.479 . . . . 0.0 109.729 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . 0.304 89.6 p 59.9 88.78 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.348 3.059 . . . . 0.0 112.913 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -130.16 -7.31 4.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.717 1.607 . . . . 0.0 113.038 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.44 177.31 48.23 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.75 -82.74 0.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -166.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 10' ' ' THR . 88.0 t80 -82.8 179.14 7.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.333 1.453 . . . . 0.0 110.537 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 88.0 m -102.31 -106.25 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 110.297 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 138.41 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 133.851 4.86 . . . . 0.0 110.597 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -123.54 17.26 9.65 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.043 0.838 . . . . 0.0 113.217 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 58.66 -10.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.957 2.903 . . . . 0.0 115.184 -176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -75.92 -15.75 60.14 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.157 -1.589 . . . . 0.0 113.739 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.09 -16.85 63.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.96 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.01 162.9 28.64 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.535 1.061 . . . . 0.0 110.844 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -126.46 135.3 51.19 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.994 2.118 . . . . 0.0 106.142 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 -158.4 27.64 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -164.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -128.4 143.09 50.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.527 1.131 . . . . 0.0 108.403 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -88.87 134.99 33.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.567 0.747 . . . . 0.0 109.387 170.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 171.64 7.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.042 1.737 . . . . 0.0 108.301 173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.4 p -147.72 153.35 39.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.431 0.693 . . . . 0.0 109.538 162.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.73 158.18 40.6 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.069 1.348 . . . . 0.0 107.393 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 m -131.16 117.03 18.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 168.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.91 144.76 26.53 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -82.48 145.12 29.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 163.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -72.04 93.18 1.37 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -80.66 -165.62 0.92 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.831 1.253 . . . . 0.0 110.785 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.33 -47.12 66.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.766 1.627 . . . . 0.0 112.764 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 59.1 mtt -116.43 62.8 0.71 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.171 0.988 . . . . 0.0 108.421 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.24 -118.1 8.38 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.129 164.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.82 137.66 54.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.47 40.92 2.03 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.911 -0.939 . . . . 0.0 112.702 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -145.35 162.05 38.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.68 1.74 . . . . 0.0 109.439 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 p -124.46 158.24 33.29 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.74 162.06 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.919 1.288 . . . . 0.0 108.019 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -134.77 141.74 42.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.26 152.16 23.1 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.48 -2.648 . . . . 0.0 106.48 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 44' ' ' GLU . . . -70.18 3.9 9.6 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-O 118.474 -1.181 . . . . 0.0 114.986 -172.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t70 74.1 -37.17 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.877 2.471 . . . . 0.0 111.643 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.58 135.46 92.78 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 123.557 0.743 . . . . 0.0 109.286 172.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.22 41.65 0.79 Allowed 'Trans proline' 0 CA--C 1.543 0.973 1 C-N-CA 126.263 4.642 . . . . 0.0 112.396 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.55 -2.58 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.565 1.546 . . . . 0.0 112.828 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 39' ' ' GLY . 1.5 tt0 -75.83 148.62 38.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.507 -1.37 . . . . 0.0 108.082 166.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.62 143.07 40.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.036 1.334 . . . . 0.0 109.12 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.3 141.81 28.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.345 1.058 . . . . 0.0 109.854 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -130.95 154.87 47.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.612 1.165 . . . . 0.0 110.575 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.46 107.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 120.584 -1.322 . . . . 0.0 107.776 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -53.8 53.62 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 125.497 1.519 . . . . 0.0 109.288 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.4 p -154.46 161.41 41.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.391 0.276 . . . . 0.0 110.388 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 126.4 65.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.53 132.12 89.54 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.86 158.7 49.67 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.176 1.917 . . . . 0.0 110.359 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.4 -4.85 0.08 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.838 2.055 . . . . 0.0 114.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.57 172.71 43.09 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.582 1.563 . . . . 0.0 113.509 -165.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.83 -27.73 43.7 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.355 2.037 . . . . 0.0 112.533 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.63 67.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.05 74.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -57.37 -43.29 83.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.756 0.822 . . . . 0.0 112.948 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.54 -18.87 65.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.77 1.168 . . . . 0.0 111.191 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.42 -21.26 18.32 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 126.506 2.003 . . . . 0.0 112.75 164.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -80.78 -28.5 36.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.787 -1.101 . . . . 0.0 111.495 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.2 tpp -74.53 112.9 11.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -134.07 161.37 35.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 m -83.59 136.14 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.52 -5.75 83.63 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.603 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.18 151.28 47.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.484 1.642 . . . . 0.0 108.71 170.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.4 t -105.29 118.24 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.536 1.935 . . . . 0.0 109.084 -168.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.21 105.81 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.935 1.694 . . . . 0.0 108.448 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.17 -58.47 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.993 0.425 . . . . 0.0 110.062 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.77 146.05 51.94 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.5 mt -122.44 120.12 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.75 -68.85 0.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.521 2.328 . . . . 0.0 111.488 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.45 25.91 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.655 1.982 . . . . 0.0 110.621 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.5 t -131.17 130.5 63.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.386 1.474 . . . . 0.0 108.041 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 p -65.94 126.2 27.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.228 0.611 . . . . 0.0 110.349 167.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.92 13.14 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.451 0.7 . . . . 0.0 112.024 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.87 -12.62 59.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.01 25.99 4.29 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.24 149.58 22.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.682 0.753 . . . . 0.0 109.165 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.86 142.0 38.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.695 -1.138 . . . . 0.0 107.943 -170.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -58.42 -23.41 57.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.84 1.656 . . . . 0.0 111.274 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.43 71.62 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.321 0.964 . . . . 0.0 110.808 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.24 -46.8 54.5 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.448 0.699 . . . . 0.0 109.529 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.63 -41.5 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 O-C-N 120.597 -1.314 . . . . 0.0 111.117 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.53 -34.62 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.843 -1.161 . . . . 0.0 110.107 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.14 83.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.779 1.172 . . . . 0.0 109.776 171.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.25 -36.97 77.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.54 1.136 . . . . 0.0 109.739 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.56 -40.94 63.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.593 0.757 . . . . 0.0 111.731 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -56.68 -41.7 77.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.013 0.925 . . . . 0.0 110.305 173.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.1 m -65.16 -2.95 3.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.82 110.72 49.29 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 120.747 1.612 . . . . 0.0 108.105 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.24 169.55 21.29 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.449 2.1 . . . . 0.0 111.374 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.67 148.63 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 121.385 -0.822 . . . . 0.0 109.328 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.5 -11.07 47.26 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.279 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -84.34 156.89 21.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.785 1.792 . . . . 0.0 107.993 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.0 p -125.96 148.82 49.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.441 1.096 . . . . 0.0 108.54 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.93 144.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.719 0.808 . . . . 0.0 109.841 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -82.88 155.21 24.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.27 152.14 45.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.05 111.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.8 mt -102.3 168.1 9.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.88 171.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 38.6 t -123.48 142.42 51.02 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.473 1.109 . . . . 0.0 108.835 167.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -116.73 139.65 50.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 110.728 -170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.62 -14.67 7.19 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.726 1.155 . . . . 0.0 112.055 168.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.54 142.21 88.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.37 173.99 10.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.501 2.134 . . . . 0.0 110.03 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 162.71 30.95 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.169 0.588 . . . . 0.0 111.501 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -50.09 122.74 9.71 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.526 2.151 . . . . 0.0 109.003 160.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.18 101.1 0.85 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 158.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.5 111.0 17.41 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -82.85 -22.23 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.264 1.976 . . . . 0.0 112.24 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -70.92 -65.99 0.67 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.424 1.489 . . . . 0.0 109.823 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -161.58 103.38 1.2 Allowed Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.29 -53.97 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.316 1.344 . . . . 0.0 110.595 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -177.61 74.53 0.02 OUTLIER 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.228 2.611 . . . . 0.0 105.971 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -52.36 153.76 2.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.743 0.782 . . . . 0.0 112.821 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.9 t -77.9 150.32 34.12 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.29 -162.98 37.6 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.243 1.877 . . . . 0.0 111.745 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 81.11 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.643 2.895 . . . . 0.0 109.947 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.6 t -79.52 -159.78 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.027 1.331 . . . . 0.0 107.792 160.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.3 m -47.71 135.94 11.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 158.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.639 . . . . 0.0 109.468 173.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 t -64.25 107.4 1.3 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 161.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.1 m -131.3 9.56 4.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.227 1.011 . . . . 0.0 112.126 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.77 174.71 42.82 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.819 0.723 . . . . 0.0 112.3 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.8 m -135.24 151.34 50.51 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 109.188 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 t -144.43 -172.17 3.74 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.284 1.034 . . . . 0.0 109.44 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.68 -88.67 1.1 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mt -141.84 -70.84 0.35 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.01 150.17 4.52 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.427 1.091 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -64.51 -113.38 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.421 2.688 . . . . 0.0 113.325 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 140.51 -23.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 1 C-N-CA 133.111 4.565 . . . . 0.0 111.661 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -126.96 179.1 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.146 1.378 . . . . 0.0 107.639 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.81 -34.5 6.93 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 126.098 1.759 . . . . 0.0 110.429 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -28.7 70.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.663 1.12 . . . . 0.0 111.523 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.41 -24.33 67.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.002 0.819 . . . . 0.0 112.186 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.14 142.8 57.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.102 0.865 . . . . 0.0 111.144 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 127.62 33.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 162.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.18 -173.3 36.79 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 123.859 0.725 . . . . 0.0 112.721 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -114.08 141.23 47.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 167.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.0 127.49 50.22 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.71 0.804 . . . . 0.0 110.462 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.8 162.08 17.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.082 1.753 . . . . 0.0 107.985 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -150.18 146.72 27.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.997 -0.439 . . . . 0.0 110.833 162.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -144.13 157.54 44.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -117.09 117.18 28.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.45 145.44 30.27 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -101.58 126.75 48.45 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.473 1.109 . . . . 0.0 109.159 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 25.2 tptt -55.55 109.69 0.59 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.664 1.586 . . . . 0.0 110.197 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.6 p -79.05 -173.65 3.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.597 1.159 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -59.63 -15.59 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.351 1.06 . . . . 0.0 112.747 166.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.7 mtt -132.03 49.22 2.34 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.22 1.373 . . . . 0.0 110.221 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 72.7 -109.81 2.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.026 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -121.32 152.78 38.56 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.39 35.52 2.42 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.155 -1.358 . . . . 0.0 111.849 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.14 167.1 29.62 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.668 1.734 . . . . 0.0 108.621 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.8 p -134.06 161.32 35.17 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.25 162.46 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.459 1.104 . . . . 0.0 109.486 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 14.7 tt -126.7 158.6 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 126.715 2.006 . . . . 0.0 107.468 166.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.65 152.26 22.9 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 157.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.47 -70.86 0.85 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 124.505 1.05 . . . . 0.0 111.171 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -37.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -137.0 176.23 2.93 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.578 1.151 . . . . 0.0 110.249 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -71.32 54.33 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.501 2.8 . . . . 0.0 112.231 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.49 -9.84 0.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.02 1.728 . . . . 0.0 112.361 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -110.79 158.01 19.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.395 1.452 . . . . 0.0 108.691 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -83.57 126.58 32.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.927 0.891 . . . . 0.0 109.173 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mt -80.99 139.72 35.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -134.22 156.77 47.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.294 0.638 . . . . 0.0 110.881 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -67.03 114.63 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 170.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 24.1 ttmt -72.42 -51.58 19.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.647 1.579 . . . . 0.0 109.916 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 m -143.78 162.12 36.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.28 0.632 . . . . 0.0 109.417 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.85 138.91 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 162.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 mm -74.83 127.82 86.35 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.86 133.08 24.54 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 121.908 1.739 . . . . 0.0 109.768 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t0 65.48 13.04 8.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.32 1.448 . . . . 0.0 111.845 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.44 167.67 37.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.181 1.372 . . . . 0.0 111.116 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.23 -34.42 68.07 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.44 2.093 . . . . 0.0 112.716 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.33 91.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.529 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.46 96.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.459 0.704 . . . . 0.0 110.414 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -67.68 -37.43 82.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.986 0.812 . . . . 0.0 112.755 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.27 -24.89 63.13 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.433 -0.792 . . . . 0.0 110.855 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.76 -16.36 26.63 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.865 2.174 . . . . 0.0 113.483 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -81.29 -37.09 29.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.378 1.589 . . . . 0.0 114.163 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpp -70.01 118.37 12.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.52 166.06 24.08 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.999 0.919 . . . . 0.0 109.025 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -100.56 98.96 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.261 1.029 . . . . 0.0 110.491 -150.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.66 -6.7 5.87 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.776 1.655 . . . . 0.0 112.322 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.46 163.15 23.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.404 1.102 . . . . 0.0 110.62 177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.9 t -111.87 120.64 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.27 1.828 . . . . 0.0 109.552 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.13 109.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 126.467 1.907 . . . . 0.0 108.881 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.8 t -93.68 -51.83 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.406 0.622 . . . . 0.0 110.086 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -134.96 154.59 51.66 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.075 1.35 . . . . 0.0 108.179 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.1 mt -134.86 134.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 171.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.8 m120 50.46 -92.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.456 1.902 . . . . 0.0 110.072 -169.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -143.17 20.81 1.92 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.222 2.609 . . . . 0.0 108.971 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -128.87 128.49 67.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.325 2.25 . . . . 0.0 107.636 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.35 129.46 36.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.5 m -130.11 11.07 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.058 1.343 . . . . 0.0 110.964 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -20.93 64.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.07 33.83 2.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.763 1.649 . . . . 0.0 109.659 167.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.22 161.42 28.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.681 1.74 . . . . 0.0 109.225 165.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.96 151.37 33.69 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -55.35 -35.13 64.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.136 0.974 . . . . 0.0 110.39 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.4 38.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.116 0.871 . . . . 0.0 110.606 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.88 -48.18 69.53 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.768 0.827 . . . . 0.0 110.846 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.67 -43.1 96.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 125.054 1.341 . . . . 0.0 111.149 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.51 -39.62 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.982 -1.074 . . . . 0.0 109.363 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -38.82 92.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.876 1.217 . . . . 0.0 110.027 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.12 -31.81 73.14 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.134 1.374 . . . . 0.0 111.052 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.61 -46.36 22.34 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.06 0.846 . . . . 0.0 111.546 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.03 -29.86 70.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.216 -0.928 . . . . 0.0 111.586 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 t -63.42 -14.34 49.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.535 1.134 . . . . 0.0 112.746 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.3 t -84.26 112.16 39.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 120.409 1.459 . . . . 0.0 107.198 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.96 169.27 22.99 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.79 1.66 . . . . 0.0 110.869 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.06 139.57 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.54 -10.19 62.59 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.083 -0.843 . . . . 0.0 113.699 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -84.23 172.64 11.68 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.419 1.61 . . . . 0.0 108.735 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 p -134.06 156.21 48.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.205 1.002 . . . . 0.0 110.576 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.44 142.53 32.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.06 0.944 . . . . 0.0 108.849 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.86 143.6 29.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.367 1.867 . . . . 0.0 107.228 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.7 mt -144.79 110.87 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.35 132.07 35.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mt -119.02 162.89 17.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 109.707 170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.18 133.96 50.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.996 1.318 . . . . 0.0 108.658 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -102.4 155.42 18.26 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 126.627 1.971 . . . . 0.0 112.279 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.81 -8.56 63.62 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.351 0.976 . . . . 0.0 112.775 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.37 151.55 97.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 117.71 0.755 . . . . 0.0 109.604 163.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.5 166.39 28.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.491 2.127 . . . . 0.0 112.104 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.59 157.25 79.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.415 1.486 . . . . 0.0 110.417 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.22 -45.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.584 2.189 . . . . 0.0 110.831 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.42 109.98 5.75 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -83.89 110.69 27.2 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.224 1.41 . . . . 0.0 107.611 168.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.97 -21.48 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.054 1.836 . . . . 0.0 111.883 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.91 -48.57 9.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.182 -163.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -129.38 70.5 81.82 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.062 0.846 . . . . 0.0 108.904 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.93 -10.75 28.22 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.749 2.299 . . . . 0.0 117.04 -152.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 140.95 -11.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.807 3.643 . . . . 0.0 112.834 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.3 165.76 3.37 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.79 -0.569 . . . . 0.0 109.756 161.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 p -60.47 150.16 32.06 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.445 1.098 . . . . 0.0 110.474 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.35 179.0 51.72 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.687 0.66 . . . . 0.0 111.895 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.45 123.05 12.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.236 2.624 . . . . 0.0 109.221 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.6 m -140.45 172.25 12.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.762 1.225 . . . . 0.0 109.366 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.8 p -84.64 -9.01 58.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.52 1.128 . . . . 0.0 112.22 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 C-N-CA 127.153 2.311 . . . . 0.0 107.472 -174.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 29.06 85.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.875 2.47 . . . . 0.0 114.628 163.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 t -58.71 140.15 55.16 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.49 174.98 23.15 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.67 1.128 . . . . 0.0 111.752 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 m -108.86 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.59 1.556 . . . . 0.0 110.327 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m 59.18 -172.05 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.926 1.29 . . . . 0.0 111.314 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.48 141.76 3.88 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -102.75 -94.73 0.31 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.58 153.64 42.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.113 0.565 . . . . 0.0 110.109 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 m -81.76 -109.57 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.018 1.327 . . . . 0.0 112.178 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mtm105 135.71 -67.39 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 1 C-N-CA 133.915 4.886 . . . . 0.0 108.742 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.83 -3.86 9.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.896 -157.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.59 -27.31 0.19 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 128.497 2.719 . . . . 0.0 114.713 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -66.37 -6.44 14.33 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.122 1.328 . . . . 0.0 111.727 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.63 -19.08 65.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.481 1.513 . . . . 0.0 112.41 163.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 mt -91.24 159.18 16.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.236 1.38 . . . . 0.0 108.593 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -3.73 13.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.38 -172.76 38.28 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 126.179 1.847 . . . . 0.0 111.685 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -88.01 156.4 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.463 1.505 . . . . 0.0 108.574 170.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -125.54 130.05 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.801 1.241 . . . . 0.0 109.038 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.86 173.34 6.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 108.172 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.3 p -151.21 142.7 23.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.422 -0.799 . . . . 0.0 109.405 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.3 t -150.62 158.15 43.81 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -121.49 106.0 11.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 107.023 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.86 118.55 34.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -92.41 116.38 28.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -42.95 91.97 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.819 2.448 . . . . 0.0 112.298 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -79.52 111.67 16.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 17.34 -83.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 130.269 3.428 . . . . 0.0 115.209 -168.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.0 mtt -56.38 -21.98 28.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.394 1.478 . . . . 0.0 113.463 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.73 -124.51 5.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 124.829 1.204 . . . . 0.0 110.426 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.58 129.64 50.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.37 49.04 2.93 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -146.73 171.89 14.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.567 1.547 . . . . 0.0 108.356 166.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -134.13 163.38 29.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.606 0.762 . . . . 0.0 109.407 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.58 162.35 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 108.44 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.45 159.91 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 128.244 2.618 . . . . 0.0 107.006 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.16 152.57 22.86 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 128.354 2.883 . . . . 0.0 106.523 167.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.77 -70.54 0.88 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 118.819 1.31 . . . . 0.0 113.091 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -173.82 -52.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -97.56 163.41 19.74 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 124.64 1.176 . . . . 0.0 112.619 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -75.1 48.37 2.0 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 125.099 3.866 . . . . 0.0 112.082 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -150.8 -7.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 110.497 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.32 152.44 19.15 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.874 0.761 . . . . 0.0 112.293 -161.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -57.89 134.22 56.13 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.101 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.4 mt -100.65 126.61 47.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.022 1.729 . . . . 0.0 106.375 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.95 155.05 47.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.017 0.826 . . . . 0.0 110.238 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.95 112.37 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.42 -47.94 71.61 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.123 0.969 . . . . 0.0 109.207 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -155.98 158.53 38.03 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.014 1.326 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.07 145.01 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 165.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -81.62 128.85 67.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 55' ' ' GLY . 42.3 Cg_endo -62.75 160.21 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.755 1.637 . . . . 0.0 110.221 171.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.4 -12.95 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.996 2.118 . . . . 0.0 114.903 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 53' ' ' PRO . . . -80.46 178.1 54.06 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.667 1.127 . . . . 0.0 112.94 -166.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.87 -37.46 77.45 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.695 2.263 . . . . 0.0 110.79 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.9 76.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.168 0.587 . . . . 0.0 111.649 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.06 -40.97 67.93 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.67 -49.46 76.42 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.06 -35.47 78.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.707 0.289 . . . . 0.0 110.949 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.48 -11.34 39.22 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.878 1.228 . . . . 0.0 113.995 161.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.43 -46.01 88.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.09 1.445 . . . . 0.0 109.709 168.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.5 tpp -66.28 115.91 6.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.37 159.14 42.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -87.88 117.85 27.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.162 -159.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.68 -8.25 39.82 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.535 1.54 . . . . 0.0 113.46 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.43 155.02 26.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.438 1.619 . . . . 0.0 109.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.35 116.82 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.037 1.735 . . . . 0.0 109.375 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.05 118.79 4.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 126.659 1.983 . . . . 0.0 108.052 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.95 -57.62 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.053 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.7 150.74 51.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mt -127.69 123.29 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.16 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.478 3.111 . . . . 0.0 110.518 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.39 -6.53 1.36 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.934 1.694 . . . . 0.0 111.952 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -88.74 124.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.51 120.07 12.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.4 6.56 6.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 124.699 1.2 . . . . 0.0 110.948 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.26 1.0 OUTLIER -58.62 -25.89 63.15 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -166.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.63 11.18 21.29 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.512 2.006 . . . . 0.0 112.368 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 165.38 24.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.321 1.06 . . . . 0.0 110.242 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -75.85 148.51 38.28 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -60.76 -35.57 76.74 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.436 165.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.3 74.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.34 0.973 . . . . 0.0 111.929 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.84 -55.58 8.19 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 118.188 0.449 . . . . 0.0 110.488 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.37 -39.58 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 127.519 2.328 . . . . 0.0 112.162 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.9 -39.08 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 120.94 -1.1 . . . . 0.0 109.242 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -36.46 83.22 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.87 1.214 . . . . 0.0 109.638 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.64 -45.6 93.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.584 1.153 . . . . 0.0 108.722 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -66.2 -31.01 71.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.235 0.614 . . . . 0.0 112.237 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.34 -6.65 59.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.056 1.342 . . . . 0.0 112.963 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -91.02 7.61 39.51 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.213 1.405 . . . . 0.0 113.57 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.2 t -101.18 107.59 50.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.5 172.41 14.49 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.35 2.7 . . . . 0.0 113.33 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.2 mp -70.94 100.15 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.291 1.436 . . . . 0.0 110.665 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.56 -42.09 1.05 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -84.26 160.75 20.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.694 0.759 . . . . 0.0 109.61 -164.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.89 160.54 22.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.582 1.553 . . . . 0.0 108.474 170.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.11 147.15 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.66 157.45 22.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -146.52 116.27 7.22 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.81 123.98 45.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.97 159.01 17.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.794 0.683 . . . . 0.0 110.353 159.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.3 t -105.97 136.16 46.13 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.284 1.434 . . . . 0.0 107.661 165.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -81.52 156.23 25.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.231 1.412 . . . . 0.0 112.43 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.31 35.84 7.84 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.11 151.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -117.3 150.42 46.34 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 161.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.08 171.71 13.25 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.215 1.943 . . . . 0.0 111.208 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.61 143.22 94.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.9 -32.85 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.821 2.347 . . . . 0.0 114.219 -168.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -69.05 109.07 3.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -82.0 115.66 58.76 Favored Pre-proline 0 C--O 1.236 0.358 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.27 -25.61 4.7 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.213 2.609 . . . . 0.0 111.98 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -71.76 -36.06 70.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.866 -169.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -132.98 46.4 2.1 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.289 1.036 . . . . 0.0 112.707 -161.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.73 -11.93 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.435 2.09 . . . . 0.0 116.141 -153.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.09 -76.07 0.11 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.102 1.319 . . . . 0.0 109.427 167.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 70.1 58.02 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.76 2.024 . . . . 0.0 110.524 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 73.4 m -136.21 168.6 19.1 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.633 0.73 . . . . 0.0 112.416 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.18 152.38 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.942 2.21 . . . . 0.0 108.609 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.27 -16.11 13.96 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.023 1.815 . . . . 0.0 113.522 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t 50.18 -165.78 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.256 0.935 . . . . 0.0 110.579 -156.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.7 m -157.59 -42.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.15 1.78 . . . . 0.0 108.916 164.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 C-N-CA 128.3 2.857 . . . . 0.0 106.741 -177.106 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.691 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -143.02 160.82 39.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 161.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -147.84 79.6 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.2 115.17 0.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.725 -2.55 . . . . 0.0 106.725 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -141.7 117.95 10.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.0 m -64.43 -54.12 37.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.635 0.774 . . . . 0.0 109.479 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.0 99.42 2.18 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 104.886 -3.285 . . . . 0.0 104.886 -148.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.77 64.9 0.92 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -174.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 15.0 t80 57.67 170.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.681 2.792 . . . . 0.0 113.427 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -81.86 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.551 1.541 . . . . 0.0 110.617 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 145.85 -60.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.373 4.269 . . . . 0.0 111.398 174.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.58 2.37 26.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.936 1.294 . . . . 0.0 111.029 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.01 -14.15 0.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.8 2.44 . . . . 0.0 113.669 -168.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -57.88 -29.16 64.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.36 1.064 . . . . 0.0 113.095 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -77.93 -11.97 59.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.082 -171.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.7 166.12 18.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.198 0.999 . . . . 0.0 110.342 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -128.0 136.42 51.25 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.24 -161.49 25.63 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -107.04 161.52 14.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -119.56 121.31 39.07 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.661 1.584 . . . . 0.0 108.142 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 154.07 41.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.376 1.07 . . . . 0.0 110.576 -170.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.8 p -157.14 163.28 39.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -165.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 t -154.92 157.71 38.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.0 m -101.33 119.82 39.33 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.225 1.01 . . . . 0.0 108.52 158.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -99.11 159.3 15.07 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.792 1.237 . . . . 0.0 108.125 163.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -103.84 143.52 32.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -66.98 99.35 0.64 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -88.47 -163.4 0.96 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.377 2.271 . . . . 0.0 108.487 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -48.49 -65.21 0.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.942 1.297 . . . . 0.0 110.925 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.44 66.81 1.11 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.2 -106.76 0.61 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 124.818 1.199 . . . . 0.0 113.469 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.37 152.25 43.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.0 40.15 2.89 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.328 -1.262 . . . . 0.0 111.753 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.405 ' CD1' ' HE3' ' A' ' 63' ' ' MET . 35.4 p90 -154.92 161.47 41.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.748 1.774 . . . . 0.0 110.316 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 p -130.41 159.93 35.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.977 1.311 . . . . 0.0 109.315 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.82 162.63 26.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 125.208 1.403 . . . . 0.0 109.973 -170.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.18 151.58 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.469 1.508 . . . . 0.0 110.067 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.29 153.37 16.73 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 129.322 3.344 . . . . 0.0 109.333 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.86 -82.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.68 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.028 1.731 . . . . 0.0 109.798 163.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -93.57 162.59 27.14 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.541 1.537 . . . . 0.0 113.473 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.55 43.17 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 125.086 3.857 . . . . 0.0 112.925 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -166.47 12.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.63 1.972 . . . . 0.0 111.683 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 155.13 21.2 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.349 -1.469 . . . . 0.0 110.969 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.93 115.74 23.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.054 0.942 . . . . 0.0 109.491 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.79 140.6 35.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.884 0.766 . . . . 0.0 109.502 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -131.63 157.18 44.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.845 0.748 . . . . 0.0 111.231 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.48 111.02 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 168.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -60.76 -54.65 42.63 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.022 0.929 . . . . 0.0 109.328 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 53.6 p -154.99 164.45 38.88 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.97 0.508 . . . . 0.0 110.672 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.11 145.34 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 160.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.5 123.42 76.65 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 165.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.57 150.95 86.1 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.552 2.168 . . . . 0.0 109.854 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.319 1.0 OUTLIER 58.99 -0.7 0.13 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.996 1.718 . . . . 0.0 115.137 -168.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.05 167.18 54.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.48 1.038 . . . . 0.0 112.563 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.17 -26.52 36.18 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.952 1.768 . . . . 0.0 112.236 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.74 -45.61 78.06 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.781 -0.575 . . . . 0.0 109.807 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.92 97.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.572 0.749 . . . . 0.0 110.96 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -69.69 -26.07 64.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.78 -38.98 76.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.47 1.032 . . . . 0.0 109.238 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.45 20.39 69.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.169 166.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -98.76 -52.05 3.71 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.807 1.804 . . . . 0.0 111.379 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.405 ' HE3' ' CD1' ' A' ' 34' ' ' PHE . 13.7 ttm -80.82 146.77 30.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.558 1.143 . . . . 0.0 109.961 -169.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -134.09 165.1 25.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.385 1.088 . . . . 0.0 110.984 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.0 m -75.17 121.28 21.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.227 1.011 . . . . 0.0 108.656 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.05 -20.37 16.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.756 -1.025 . . . . 0.0 112.122 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -63.91 150.64 44.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.079 1.439 . . . . 0.0 109.402 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -101.45 124.45 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.635 1.974 . . . . 0.0 108.813 -171.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.42 128.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 125.353 1.461 . . . . 0.0 107.614 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.27 -56.85 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.899 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -133.09 147.57 52.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.324 1.05 . . . . 0.0 108.841 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mt -130.33 122.51 53.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 53.21 -92.63 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 127.35 2.26 . . . . 0.0 109.719 -162.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.61 1.38 8.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.37 1.468 . . . . 0.0 111.161 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -111.51 131.08 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 -160.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.4 p -74.69 123.28 24.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.62 12.77 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.034 0.934 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.33 -35.31 62.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -162.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.45 16.35 12.72 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.111 1.339 . . . . 0.0 112.624 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 164.91 12.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.874 1.837 . . . . 0.0 110.666 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 p -70.74 137.96 50.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.58 -25.14 64.34 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.594 -0.691 . . . . 0.0 110.546 167.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.51 -57.85 10.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.897 1.226 . . . . 0.0 110.31 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.86 -54.73 42.74 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.574 1.15 . . . . 0.0 110.472 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.4 -42.53 74.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.487 1.515 . . . . 0.0 111.491 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.09 -33.98 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.546 -1.346 . . . . 0.0 110.376 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -39.57 94.42 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.659 1.572 . . . . 0.0 109.361 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.24 -49.18 78.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -64.56 -41.4 96.34 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -55.51 -46.78 76.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.495 0.588 . . . . 0.0 109.585 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.5 p -64.76 -13.55 55.6 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.447 1.276 . . . . 0.0 114.447 -166.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.98 110.93 26.25 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.73 159.95 44.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 120.062 1.058 . . . . 0.0 109.59 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 79.8 mt -57.58 126.76 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.83 50.28 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.805 -1.553 . . . . 0.0 114.163 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -112.13 165.11 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 121.02 2.41 . . . . 0.0 110.327 168.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.6 p -123.25 164.7 18.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.124 1.37 . . . . 0.0 109.755 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.97 150.14 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.007 1.323 . . . . 0.0 108.314 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.83 154.14 23.66 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -146.24 126.27 13.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.37 130.97 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.1 mt -118.45 169.05 10.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.322 1.014 . . . . 0.0 110.046 170.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.6 t -128.37 144.45 51.14 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.5 1.52 . . . . 0.0 108.887 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.11 123.16 39.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.432 1.493 . . . . 0.0 112.686 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.45 -25.44 0.86 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.989 1.28 . . . . 0.0 113.494 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -72.66 158.02 87.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 118.021 0.911 . . . . 0.0 110.856 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.27 175.79 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.006 2.471 . . . . 0.0 111.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mt -71.89 159.09 86.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.273 1.029 . . . . 0.0 109.484 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.13 -14.14 9.8 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.806 3.004 . . . . 0.0 113.847 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -117.53 121.13 40.14 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 126.883 2.073 . . . . 0.0 106.525 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.32 103.99 2.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 124.907 1.283 . . . . 0.0 107.895 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.99 -26.83 6.25 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 CA-C-N 120.597 1.249 . . . . 0.0 111.389 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.4 -67.61 0.43 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.299 1.44 . . . . 0.0 109.937 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.65 92.95 48.31 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -172.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.34 -29.74 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.144 1.229 . . . . 0.0 112.772 -173.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -171.62 -62.21 0.02 OUTLIER 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.842 1.657 . . . . 0.0 109.071 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.27 157.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 128.993 2.917 . . . . 0.0 113.354 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t -100.49 171.51 7.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 108.284 165.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.69 -99.14 1.54 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.99 141.92 54.9 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.06 1.84 . . . . 0.0 111.135 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 m -162.02 179.02 8.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.468 2.707 . . . . 0.0 106.996 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 t -152.63 169.55 22.42 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.517 0.727 . . . . 0.0 109.683 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 N-CA-C 106.617 -2.593 . . . . 0.0 106.617 -174.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.75 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -62.34 153.3 31.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.152 0.581 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -71.43 166.54 21.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.097 0.959 . . . . 0.0 110.909 -171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.94 79.93 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.1 t -154.56 116.94 4.29 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 168.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m -137.0 179.23 6.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.533 2.333 . . . . 0.0 106.821 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.87 -120.85 17.7 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -154.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp 19.87 85.23 0.01 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 130.305 3.442 . . . . 0.0 112.895 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -54.88 153.16 6.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.33 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.565 HG21 ' H ' ' A' ' 11' ' ' ARG . 5.1 m -78.38 -143.69 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.185 2.194 . . . . 0.0 112.108 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.565 ' H ' HG21 ' A' ' 10' ' ' THR . 0.7 OUTLIER -163.02 -69.38 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 147.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 14' ' ' SER . 9.3 m-20 -89.25 22.94 2.65 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.866 2.066 . . . . 0.0 111.911 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.89 -6.2 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.486 2.314 . . . . 0.0 114.653 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 12' ' ' ASP . 55.0 m -75.41 -24.99 57.2 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.947 1.299 . . . . 0.0 110.628 -168.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.55 -15.77 63.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.392 -1.29 . . . . 0.0 114.007 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 mt -74.64 161.91 29.24 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.253 1.388 . . . . 0.0 110.386 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.87 2.1 3.66 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -165.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.97 -179.27 41.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 162.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.4 m -81.82 154.56 25.85 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.438 0.695 . . . . 0.0 109.423 -172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.68 140.73 46.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.607 1.163 . . . . 0.0 108.346 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.51 -179.55 4.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.034 1.734 . . . . 0.0 107.658 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -145.14 165.61 27.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.124 -0.36 . . . . 0.0 111.185 163.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -152.85 157.2 40.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 151.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.1 m -104.82 113.93 27.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 160.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.37 138.03 36.2 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -82.06 155.21 25.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 158.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' CE ' ' HA2' ' A' ' 31' ' ' GLY . 5.6 tptt -58.04 161.19 4.22 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 154.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -129.66 -78.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 159.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.39 132.95 46.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -170.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.5 mmt 63.04 -62.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.06 2.144 . . . . 0.0 111.132 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.413 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . -169.47 -154.25 9.04 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -170.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.12 153.74 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 163.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.38 35.17 2.43 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.134 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.17 163.12 37.95 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.906 2.353 . . . . 0.0 111.268 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -125.52 155.1 41.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.112 1.365 . . . . 0.0 109.174 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.96 162.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.383 1.473 . . . . 0.0 109.921 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 tt -136.76 157.76 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 128.324 2.65 . . . . 0.0 108.186 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.58 152.17 22.81 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.527 2.489 . . . . 0.0 107.966 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.09 -71.17 0.81 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.506 1.051 . . . . 0.0 112.725 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 170.27 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.577 1.551 . . . . 0.0 110.691 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.74 158.43 87.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 120.197 1.362 . . . . 0.0 110.228 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.28 43.31 1.28 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.505 3.47 . . . . 0.0 112.263 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.48 37.45 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.732 2.813 . . . . 0.0 108.669 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -113.54 150.3 33.17 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.96 0.904 . . . . 0.0 108.762 167.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -74.91 127.33 32.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.081 0.943 . . . . 0.0 109.112 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.37 142.78 32.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -142.49 162.35 35.69 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.674 0.789 . . . . 0.0 110.865 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.17 114.49 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.02 -50.06 72.17 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.61 0.641 . . . . 0.0 109.285 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.08 154.19 17.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.181 0.926 . . . . 0.0 110.095 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.75 121.42 55.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.51 129.24 90.38 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -85.85 48.24 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.782 2.988 . . . . 0.0 112.605 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.59 57.98 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.981 2.112 . . . . 0.0 107.694 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.12 171.22 44.07 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.104 -0.997 . . . . 0.0 112.632 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.72 -25.28 54.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.387 2.058 . . . . 0.0 112.174 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.02 70.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.984 0.811 . . . . 0.0 111.235 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.29 12.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.202 1.001 . . . . 0.0 108.746 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.08 -29.36 69.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -172.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.67 -26.75 67.19 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.726 -0.609 . . . . 0.0 110.927 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.94 -14.73 9.78 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.93 1.729 . . . . 0.0 113.437 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -83.59 -26.86 29.66 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.325 -1.103 . . . . 0.0 111.385 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.9 tpp -89.36 130.79 35.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.403 0.681 . . . . 0.0 110.173 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -144.0 166.2 25.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.795 1.638 . . . . 0.0 108.861 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.3 m -87.95 144.37 26.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.145 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.72 57.62 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.823 1.192 . . . . 0.0 112.396 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.2 144.05 44.29 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.962 1.381 . . . . 0.0 107.721 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -98.45 118.35 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.248 1.819 . . . . 0.0 110.062 -162.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.65 110.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.498 1.519 . . . . 0.0 108.871 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.13 -59.94 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.344 0.593 . . . . 0.0 109.796 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -128.71 158.49 38.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.011 1.324 . . . . 0.0 107.566 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.1 122.93 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t30 65.05 -81.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.413 2.285 . . . . 0.0 110.489 168.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.74 36.35 1.16 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.432 1.093 . . . . 0.0 110.554 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.44 132.62 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 120.425 -1.422 . . . . 0.0 109.422 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.7 p -77.82 110.13 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.755 0.822 . . . . 0.0 109.368 165.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.67 -3.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -31.18 51.88 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.03 1.286 . . . . 0.0 114.414 -164.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.76 28.56 5.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.506 1.527 . . . . 0.0 111.008 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 172.22 13.31 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 164.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 p -90.04 153.25 20.71 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -54.93 -36.45 65.28 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.119 1.368 . . . . 0.0 109.741 170.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -64.49 0.79 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.382 1.073 . . . . 0.0 110.902 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.73 -35.87 77.69 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.763 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.58 -40.27 87.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 120.548 -1.345 . . . . 0.0 111.265 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.69 -43.59 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -40.28 84.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.165 0.893 . . . . 0.0 110.499 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.3 mt -64.87 -41.06 95.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.589 1.556 . . . . 0.0 109.265 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -71.21 -39.19 71.9 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.476 1.034 . . . . 0.0 111.177 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -60.88 -36.95 80.52 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.814 0.734 . . . . 0.0 110.406 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -59.81 -13.24 9.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.052 1.741 . . . . 0.0 113.539 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.1 t -87.58 110.59 35.61 Favored Pre-proline 0 C--O 1.239 0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.86 160.15 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.729 1.619 . . . . 0.0 111.736 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.27 138.25 20.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 158.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.86 14.92 76.53 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.396 -1.78 . . . . 0.0 113.677 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -122.73 162.58 21.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.032 2.416 . . . . 0.0 111.413 165.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.72 155.14 30.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.665 1.986 . . . . 0.0 111.334 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.38 157.42 39.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.322 1.449 . . . . 0.0 109.172 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.87 158.69 22.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 mt -145.71 145.83 31.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -123.8 125.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 mt -112.85 165.05 12.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.345 1.028 . . . . 0.0 110.931 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.4 t -119.46 143.91 47.26 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.417 1.487 . . . . 0.0 108.288 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.77 155.85 17.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.446 2.298 . . . . 0.0 111.485 -178.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.47 -2.73 74.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.102 170.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -103.02 103.09 31.86 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 168.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.28 -174.72 1.49 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.769 2.979 . . . . 0.0 113.05 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 mt -65.57 146.03 99.0 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 125.612 1.565 . . . . 0.0 109.964 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.92 -45.38 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.712 2.942 . . . . 0.0 110.786 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -63.49 106.39 0.92 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.065 1.746 . . . . 0.0 107.475 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.9 108.83 12.4 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.05 -17.32 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 120.784 1.316 . . . . 0.0 111.795 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -61.69 2.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 109.832 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -148.55 81.67 7.78 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -69.87 -44.19 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 -167.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.12 -48.13 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.968 0.907 . . . . 0.0 110.554 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 52.68 68.81 0.77 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 0.0 111.576 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.6 t -128.95 151.73 49.35 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.598 1.159 . . . . 0.0 108.274 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.05 -107.46 0.61 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 105.421 -3.072 . . . . 0.0 105.421 153.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.71 72.38 4.48 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.852 3.701 . . . . 0.0 111.439 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.3 p -141.52 69.29 1.33 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.502 1.521 . . . . 0.0 108.562 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.9 m -145.89 172.96 12.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.677 2.391 . . . . 0.0 108.222 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.8 0 N-CA-C 104.289 -3.524 . . . . 0.0 104.289 164.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.674 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t -65.14 107.09 1.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.343 1.457 . . . . 0.0 108.19 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 p -143.01 -177.91 5.57 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 109.443 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.41 -94.91 0.1 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.631 -1.787 . . . . 0.0 108.631 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 p -150.6 143.62 24.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.034 0.934 . . . . 0.0 108.626 166.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.39 158.72 44.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.177 0.991 . . . . 0.0 109.907 168.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.96 176.04 16.63 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.224 1.392 . . . . 0.0 110.881 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt -113.87 -83.98 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.45 158.19 21.41 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.72 0.808 . . . . 0.0 109.873 171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 m -73.07 -116.7 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.07 2.148 . . . . 0.0 111.041 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 137.92 -76.13 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 1 C-N-CA 134.271 5.028 . . . . 0.0 106.195 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -95.22 10.95 34.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 15' ' ' GLN . . . 68.64 -27.74 0.15 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.762 -1.836 . . . . 0.0 113.394 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -69.12 17.73 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.362 1.465 . . . . 0.0 113.249 170.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 13' ' ' ALA . 19.5 mm100 -115.2 -11.04 12.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.882 1.673 . . . . 0.0 110.702 168.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.83 162.54 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -138.58 131.14 29.03 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 124.932 1.293 . . . . 0.0 107.925 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.22 -133.47 4.14 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.1 m -133.11 152.53 51.95 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -109.82 145.91 35.93 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.007 0.821 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 170.29 14.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.243 2.217 . . . . 0.0 107.682 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -152.97 154.35 34.81 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 121.883 -0.511 . . . . 0.0 109.833 159.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -144.53 157.68 44.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.411 1.485 . . . . 0.0 109.154 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -124.28 114.73 19.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -98.62 146.71 25.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -82.46 132.16 35.21 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 161.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.475 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 70.9 tttt -67.25 100.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.977 1.311 . . . . 0.0 107.84 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -89.45 -92.69 0.12 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.047 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -105.87 130.2 53.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 45.7 mtt 58.62 -54.49 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.671 2.388 . . . . 0.0 114.869 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.475 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . -175.48 -167.41 34.51 Favored Glycine 0 N--CA 1.449 -0.449 0 O-C-N 120.744 -1.222 . . . . 0.0 110.808 -148.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -86.02 152.21 23.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.65 0.95 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.743 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.445 ' CE1' ' HE2' ' A' ' 63' ' ' MET . 50.9 p90 -143.54 167.82 21.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.823 1.811 . . . . 0.0 108.307 174.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -125.77 159.88 31.22 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.452 1.501 . . . . 0.0 107.568 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 157.29 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 122.13 0.967 . . . . 0.0 110.333 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -131.02 147.66 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.282 2.233 . . . . 0.0 105.734 165.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.37 21.78 Favored Glycine 0 CA--C 1.507 -0.448 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 154.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.83 -70.06 1.08 Allowed Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -165.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -173.09 -43.77 0.01 OUTLIER 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.116 0.539 . . . . 0.0 111.377 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 161.12 26.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.331 1.052 . . . . 0.0 111.324 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.99 44.83 1.39 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.962 3.775 . . . . 0.0 111.522 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -16.31 1.04 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.089 0.955 . . . . 0.0 111.507 169.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.19 130.37 34.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -59.82 147.14 39.28 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.172 0.986 . . . . 0.0 111.086 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.73 132.58 36.29 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.353 -1.749 . . . . 0.0 106.689 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -129.46 152.87 48.53 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.851 0.86 . . . . 0.0 109.012 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.9 t -62.66 113.58 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -61.86 -55.0 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.765 1.626 . . . . 0.0 109.667 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.3 m -155.31 151.17 27.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.85 1.66 . . . . 0.0 108.051 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.63 123.96 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 127.78 86.94 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.75 156.4 66.08 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.894 1.729 . . . . 0.0 109.933 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 76.43 -27.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 127.281 2.232 . . . . 0.0 113.269 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.19 166.6 50.22 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.848 1.213 . . . . 0.0 112.267 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.35 -20.08 48.99 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.229 1.953 . . . . 0.0 112.95 -171.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.38 -51.23 54.47 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.34 89.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.249 1.02 . . . . 0.0 110.426 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.57 -21.05 65.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -87.2 -34.73 18.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.227 1.376 . . . . 0.0 109.963 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.71 -10.67 55.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.392 1.472 . . . . 0.0 114.37 167.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -77.89 -8.53 58.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.953 1.377 . . . . 0.0 113.799 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.445 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 10.7 ttm -118.25 139.92 50.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.709 1.604 . . . . 0.0 108.98 -176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -133.77 172.12 13.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.769 1.271 . . . . 0.0 109.111 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.9 m -78.28 127.28 32.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.73 -15.82 40.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.531 1.062 . . . . 0.0 113.667 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.13 143.8 37.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.436 1.118 . . . . 0.0 109.708 175.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.23 121.3 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.29 1.836 . . . . 0.0 109.456 -170.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.0 mp -66.03 110.83 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.399 1.879 . . . . 0.0 108.971 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.77 -62.26 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.43 141.24 43.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.581 1.152 . . . . 0.0 109.366 -167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.05 125.55 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 59.48 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.538 2.735 . . . . 0.0 112.18 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.77 11.94 2.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.171 0.896 . . . . 0.0 111.244 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.85 153.48 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 120.344 -1.473 . . . . 0.0 109.032 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.0 p -87.12 138.72 31.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.352 0.978 . . . . 0.0 109.585 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.08 5.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.117 0.967 . . . . 0.0 111.924 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' H ' ' CD2' ' A' ' 78' ' ' LEU . 2.0 pt? -66.14 -22.29 66.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -163.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.87 66.95 0.53 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 104.834 -3.306 . . . . 0.0 104.834 157.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -121.94 168.94 11.31 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.637 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 p -74.49 136.47 42.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -54.32 -32.11 55.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.417 0.687 . . . . 0.0 110.589 162.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.32 -40.18 89.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.455 1.025 . . . . 0.0 112.407 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.23 -44.84 28.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.219 0.918 . . . . 0.0 109.955 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 t -59.95 -42.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 O-C-N 120.179 -1.575 . . . . 0.0 111.205 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.02 -32.45 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 120.738 -1.226 . . . . 0.0 110.792 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -44.56 94.89 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.47 -0.769 . . . . 0.0 109.215 169.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.13 -36.23 81.43 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.701 -166.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -69.83 -22.81 63.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -87.67 -18.41 29.63 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.982 -1.074 . . . . 0.0 110.971 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -65.07 -17.34 64.37 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.472 -0.768 . . . . 0.0 112.639 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.57 121.72 74.89 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.884 1.274 . . . . 0.0 107.762 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.3 159.82 33.75 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.014 1.809 . . . . 0.0 112.31 167.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.33 152.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.184 -0.947 . . . . 0.0 109.316 162.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.05 -9.47 38.83 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.693 1.616 . . . . 0.0 113.154 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -95.55 163.5 13.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.18 1.99 . . . . 0.0 108.975 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 p -116.08 146.78 41.94 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.986 0.914 . . . . 0.0 110.191 177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.91 145.12 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 122.843 0.457 . . . . 0.0 109.919 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.34 157.21 22.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 mt -145.94 114.23 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -89.69 127.36 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.2 mt -121.96 168.89 11.38 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.272 0.983 . . . . 0.0 110.551 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.2 t -126.55 141.55 51.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.819 1.247 . . . . 0.0 109.742 171.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.28 155.76 22.52 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 128.653 2.781 . . . . 0.0 109.609 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.75 -30.95 5.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.68 1.61 . . . . 0.0 110.993 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -67.73 139.06 93.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.504 1.122 . . . . 0.0 110.214 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.39 171.67 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.245 1.963 . . . . 0.0 111.191 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.0 mt -66.3 161.89 53.35 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 109.896 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.62 -43.39 0.47 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 121.662 1.575 . . . . 0.0 111.581 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -78.93 145.86 33.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.65 1.18 . . . . 0.0 109.304 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -110.56 92.69 14.59 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 -16.6 29.38 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.149 1.233 . . . . 0.0 112.236 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -56.04 18.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.311 0.96 . . . . 0.0 109.328 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -169.33 113.96 0.52 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.789 168.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -86.66 -17.42 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.826 2.35 . . . . 0.0 114.445 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 167.56 67.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.516 2.326 . . . . 0.0 106.032 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 66.98 167.93 0.23 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.517 2.327 . . . . 0.0 113.878 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 t -143.73 -178.63 6.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 122.921 1.343 . . . . 0.0 112.24 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.87 159.61 32.92 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.592 2.52 . . . . 0.0 107.939 159.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.55 156.96 53.46 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.195 1.93 . . . . 0.0 109.593 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 t -160.58 115.17 2.18 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 p -139.12 -164.34 1.64 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.307 1.843 . . . . 0.0 108.453 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 146.798 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.775 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -148.18 148.76 30.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m 48.55 44.59 20.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.7 1.2 . . . . 0.0 111.102 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.12 -99.3 1.23 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.694 0.664 . . . . 0.0 111.574 -166.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m 66.65 -64.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.497 1.919 . . . . 0.0 112.34 -167.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 126.92 29.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.433 1.493 . . . . 0.0 111.344 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.0 97.11 0.62 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 123.564 0.602 . . . . 0.0 112.355 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.46 -15.87 55.72 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.886 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -70.3 163.28 26.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.196 0.907 . . . . 0.0 109.852 170.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 13' ' ' ALA . 99.2 m -85.76 -104.46 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.13 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 119.32 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 1 C-N-CA 134.879 5.272 . . . . 0.0 110.8 -172.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -126.38 6.55 7.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -158.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' H ' HG22 ' A' ' 10' ' ' THR . . . 61.95 -1.43 0.36 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 129.264 3.025 . . . . 0.0 115.74 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 t -84.04 -16.52 43.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.082 1.31 . . . . 0.0 110.975 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.98 67.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.024 -1.465 . . . . 0.0 111.913 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.73 138.06 57.12 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.462 1.483 . . . . 0.0 108.124 -163.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -106.48 126.29 52.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -174.09 30.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.844 2.164 . . . . 0.0 108.323 -167.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 m -95.38 160.4 14.55 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -118.39 131.13 56.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 122.374 1.083 . . . . 0.0 108.31 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.34 163.14 40.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -169.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.33 155.85 43.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.6 t -148.38 157.36 43.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.928 161.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 m -109.32 114.87 28.92 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.32 144.64 27.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -89.16 141.42 28.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -72.75 101.44 3.1 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -74.68 -175.72 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.027 0.83 . . . . 0.0 109.827 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -51.42 -31.76 24.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.278 1.431 . . . . 0.0 112.65 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 mtp -107.86 14.25 25.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.04 1.736 . . . . 0.0 111.766 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.85 -110.48 3.82 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.2 152.34 41.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.702 1.251 . . . . 0.0 110.138 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.86 25.84 5.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.433 1.016 . . . . 0.0 112.944 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' CE1' ' HE3' ' A' ' 63' ' ' MET . 32.1 p90 -144.56 173.27 11.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.001 1.401 . . . . 0.0 107.506 176.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -135.64 159.62 41.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.28 1.032 . . . . 0.0 108.624 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.37 162.04 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.519 1.128 . . . . 0.0 108.933 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.1 tt -132.62 156.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.419 2.287 . . . . 0.0 107.423 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.62 153.08 23.41 Favored Glycine 0 N--CA 1.461 0.358 0 C-N-CA 127.909 2.671 . . . . 0.0 107.672 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.51 -75.01 0.35 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -172.39 -59.46 0.02 OUTLIER 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.956 -168.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 163.33 36.5 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 126.745 2.018 . . . . 0.0 109.937 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.94 48.25 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.88 3.053 . . . . 0.0 110.948 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -154.46 -9.83 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.418 -1.277 . . . . 0.0 114.265 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -67.31 143.56 56.34 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.753 1.615 . . . . 0.0 109.85 169.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -78.58 125.72 29.76 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.26 138.57 34.57 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.218 1.807 . . . . 0.0 108.613 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.93 153.2 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.017 0.371 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.9 t -65.76 111.3 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -60.49 -48.86 79.92 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.685 1.594 . . . . 0.0 110.983 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 m -160.92 150.44 17.1 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.355 1.862 . . . . 0.0 107.306 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.7 t -101.83 121.75 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 163.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.96 128.76 84.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' GLY . 60.8 Cg_endo -64.28 152.21 82.28 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.268 1.979 . . . . 0.0 110.332 173.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.59 -15.31 0.07 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.369 2.268 . . . . 0.0 113.369 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 53' ' ' PRO . . . -66.78 161.5 46.53 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.265 -1.522 . . . . 0.0 111.581 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.2 -20.93 55.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 0.0 113.193 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.11 42.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.287 0.635 . . . . 0.0 110.842 171.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.79 90.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.446 0.567 . . . . 0.0 110.11 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -65.15 -6.59 9.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.588 1.155 . . . . 0.0 113.973 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -92.11 -20.02 21.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.686 1.584 . . . . 0.0 110.982 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.14 32.08 82.99 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.826 1.203 . . . . 0.0 114.333 170.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -136.19 -39.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 112.739 -169.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.426 ' HE3' ' CE1' ' A' ' 34' ' ' PHE . 23.0 ttm -89.9 140.28 29.77 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -137.27 168.7 19.12 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 125.713 1.883 . . . . 0.0 110.801 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -78.88 160.4 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.87 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.25 -19.3 13.76 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.691 1.138 . . . . 0.0 112.614 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.88 152.97 43.12 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.868 1.334 . . . . 0.0 110.805 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.63 131.71 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.435 1.894 . . . . 0.0 108.347 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.71 126.73 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.751 1.62 . . . . 0.0 108.305 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.19 -60.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 109.556 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -134.5 153.05 52.13 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.392 1.077 . . . . 0.0 108.917 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mt -126.45 108.65 19.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 72.36 -61.95 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 128.824 2.849 . . . . 0.0 110.542 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -149.19 -25.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.859 2.064 . . . . 0.0 110.477 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.83 131.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.243 1.417 . . . . 0.0 108.981 -168.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -65.05 131.89 47.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 108.824 165.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.67 5.47 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 123.375 0.67 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.51 1.124 . . . . 0.0 111.67 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.16 53.54 0.75 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 166.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -95.86 158.48 15.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 156.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -76.05 156.41 33.98 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -56.23 -27.08 53.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.485 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.96 -52.51 65.19 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.082 1.31 . . . . 0.0 110.722 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.7 -42.79 73.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.914 0.486 . . . . 0.0 109.819 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.294 -1.503 . . . . 0.0 111.549 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.32 -40.34 88.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 121.138 -0.976 . . . . 0.0 109.315 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.933 1.242 . . . . 0.0 111.091 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.29 -46.83 75.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -64.85 -40.11 94.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.056 0.844 . . . . 0.0 111.265 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.25 -33.65 75.96 Favored 'General case' 0 C--O 1.231 0.104 0 O-C-N 121.343 -0.848 . . . . 0.0 111.551 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.2 m -56.98 -22.99 42.61 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.886 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.0 114.06 51.82 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 167.0 14.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.415 2.743 . . . . 0.0 111.848 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.4 98.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.772 1.629 . . . . 0.0 108.473 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.18 -17.11 3.39 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.045 1.307 . . . . 0.0 112.65 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.16 164.96 18.83 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 p -120.48 147.2 45.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 109.111 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.1 138.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.536 0.734 . . . . 0.0 109.163 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -83.87 153.81 23.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.269 1.428 . . . . 0.0 109.404 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 mt -144.1 109.37 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.84 121.3 38.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.5 mt -118.57 160.81 21.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 124.508 1.13 . . . . 0.0 109.92 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -107.53 119.17 38.68 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 168.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -84.32 126.02 32.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.675 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.69 -3.47 9.35 Favored Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.096 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -65.8 142.67 98.24 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 163.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.66 175.34 8.98 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 109.866 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.35 161.43 42.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 167.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.61 -40.14 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.357 2.038 . . . . 0.0 111.656 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -120.51 142.01 49.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.223 2.209 . . . . 0.0 109.247 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.04 107.18 54.32 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.52 1.528 . . . . 0.0 110.2 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.5 -20.4 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.217 1.944 . . . . 0.0 112.588 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.47 -35.21 77.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.866 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.19 90.36 50.45 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 125.62 1.568 . . . . 0.0 107.861 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.1 -34.53 4.9 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.773 1.648 . . . . 0.0 111.226 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.74 -44.73 0.05 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 m120 65.81 138.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.822 2.449 . . . . 0.0 112.758 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 m -174.82 113.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.406 1.482 . . . . 0.0 109.902 166.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.55 129.19 8.89 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 159.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 -9.49 24.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.223 2.615 . . . . 0.0 113.082 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 m -152.02 -48.45 0.11 Allowed 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -153.68 -16.58 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.853 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -173.123 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -145.81 172.7 12.93 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.09 0.945 . . . . 0.0 109.014 -167.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -149.66 157.92 43.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 157.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.83 151.47 27.97 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -159.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -154.9 76.08 0.99 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.466 1.506 . . . . 0.0 108.85 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -66.95 162.79 21.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.793 -0.567 . . . . 0.0 111.362 172.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.86 -114.22 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 106.331 -2.708 . . . . 0.0 106.331 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.93 -45.55 1.04 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 167.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -54.63 155.42 4.15 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.785 1.279 . . . . 0.0 111.084 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 m -81.54 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 125.898 1.679 . . . . 0.0 110.295 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 130.88 -44.72 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.458 1 C-N-CA 134.363 5.065 . . . . 0.0 110.427 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 14' ' ' SER . 26.0 t0 -124.66 18.14 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -161.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.69 -3.5 0.05 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.914 2.086 . . . . 0.0 114.873 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.432 ' H ' ' C ' ' A' ' 12' ' ' ASP . 7.8 t -66.42 -43.25 86.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 120.721 -1.237 . . . . 0.0 111.171 -171.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -78.33 7.09 6.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD23 ' HH ' ' A' ' 106' ' ' TYR . 14.4 mt -73.68 164.75 26.23 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.391 -1.443 . . . . 0.0 108.558 174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -129.35 -1.78 5.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.14 174.07 55.29 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.91 -1.119 . . . . 0.0 110.58 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -86.03 150.41 24.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.038 0.919 . . . . 0.0 108.838 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -100.39 147.43 25.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.673 1.589 . . . . 0.0 109.811 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mp -140.36 163.84 31.72 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.252 1.021 . . . . 0.0 109.975 -172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 p -147.43 119.93 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.147 0.579 . . . . 0.0 112.263 -174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -127.59 150.68 49.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -119.36 114.96 23.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.8 134.98 40.92 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -82.86 140.87 32.66 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 166.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -65.27 101.14 0.52 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -142.51 158.44 43.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.134 1.374 . . . . 0.0 111.546 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 63.42 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 127.346 2.259 . . . . 0.0 110.048 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.7 mtt -141.15 88.42 2.16 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 154.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.78 -110.41 3.15 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.851 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -125.95 140.33 52.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.702 1.251 . . . . 0.0 109.445 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.5 38.89 2.29 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.381 0.991 . . . . 0.0 112.413 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.447 ' CD1' ' HE1' ' A' ' 63' ' ' MET . 29.5 p90 -147.65 169.1 20.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -131.55 166.07 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.08 162.24 25.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 109.021 -171.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 tt -136.71 154.93 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.581 1.952 . . . . 0.0 107.706 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.69 152.22 22.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.0 -2.84 . . . . 0.0 106.0 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.38 -67.8 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 124.574 1.083 . . . . 0.0 111.563 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.79 -30.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.764 1.226 . . . . 0.0 110.766 160.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -116.18 168.87 7.84 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.675 1.19 . . . . 0.0 112.156 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.22 75.4 4.65 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.25 2.633 . . . . 0.0 108.509 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -169.2 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.501 1.92 . . . . 0.0 109.341 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -80.2 137.93 36.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.533 0.682 . . . . 0.0 109.505 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.97 130.49 41.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.385 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.81 137.15 35.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.564 1.146 . . . . 0.0 108.8 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -136.77 151.86 49.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.516 0.726 . . . . 0.0 110.799 -171.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.85 112.43 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -66.37 -52.96 41.5 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.043 1.737 . . . . 0.0 110.273 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -150.84 149.95 30.32 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.345 1.458 . . . . 0.0 107.587 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.08 120.03 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 160.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.75 128.6 93.93 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.57 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.07 1.847 . . . . 0.0 110.147 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.47 56.41 2.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 111.77 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.08 167.3 24.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.138 1.351 . . . . 0.0 110.079 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -69.18 -18.31 39.77 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 0.0 113.739 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.35 4.58 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.19 -37.27 54.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.798 1.639 . . . . 0.0 111.557 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.77 -14.1 58.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.711 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -84.1 -22.25 31.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.832 2.105 . . . . 0.0 111.441 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.52 30.14 71.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.897 163.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -122.05 -26.01 4.83 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.78 1.79 . . . . 0.0 112.701 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.447 ' HE1' ' CD1' ' A' ' 34' ' ' PHE . 24.9 ttm -86.65 141.61 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.644 1.178 . . . . 0.0 108.388 175.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -131.25 169.29 16.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.48 1.133 . . . . 0.0 108.047 165.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.7 m -65.3 145.1 56.63 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.774 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 -18.47 44.58 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.518 1.056 . . . . 0.0 113.918 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.32 143.59 55.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.996 1.398 . . . . 0.0 109.987 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.14 120.98 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.183 1.393 . . . . 0.0 109.249 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.15 114.1 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.266 1.426 . . . . 0.0 107.994 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.57 -60.4 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.157 0.983 . . . . 0.0 109.696 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.66 149.74 52.17 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -120.89 120.95 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 64.52 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.971 1.708 . . . . 0.0 108.284 -172.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -138.89 -10.63 1.32 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.79 1.636 . . . . 0.0 111.34 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.18 127.07 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 107.614 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.8 t -71.78 128.17 34.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 168.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.22 17.4 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 125.773 1.629 . . . . 0.0 109.02 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -35.93 76.46 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 120.719 -1.238 . . . . 0.0 112.251 -166.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.45 38.82 2.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.225 1.869 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 170.0 16.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.283 1.041 . . . . 0.0 110.255 167.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -74.92 139.94 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 164.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -52.31 -45.72 65.68 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.913 0.885 . . . . 0.0 109.33 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -22.29 43.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.31 -51.71 5.42 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 119.51 1.05 . . . . 0.0 111.187 173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.17 -36.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.129 2.172 . . . . 0.0 111.437 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.38 -41.19 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.873 0.869 . . . . 0.0 110.416 171.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -36.92 82.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 108.658 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.49 -38.31 89.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.969 0.908 . . . . 0.0 110.006 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.4 -30.13 65.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.407 1.003 . . . . 0.0 111.247 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -64.71 -37.04 86.24 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.294 0.952 . . . . 0.0 110.123 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.7 p -66.58 -6.17 14.22 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.78 103.83 7.89 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.89 167.14 27.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.866 1.711 . . . . 0.0 111.869 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.88 122.57 9.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.698 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.68 -11.65 46.18 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.956 -1.469 . . . . 0.0 113.891 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -83.51 162.01 21.04 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.419 1.609 . . . . 0.0 108.719 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.0 138.02 50.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.244 1.018 . . . . 0.0 110.92 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 m -129.05 142.66 43.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 C-N-CA 124.36 1.064 . . . . 0.0 109.118 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.61 159.16 22.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.95 114.57 7.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.45 115.52 29.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.96 164.27 12.42 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 124.029 0.83 . . . . 0.0 109.068 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -121.95 129.42 52.49 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.392 1.477 . . . . 0.0 107.15 166.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.55 156.81 36.45 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.488 1.915 . . . . 0.0 109.606 173.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.48 -10.48 73.24 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.13 149.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.531 ' HH ' HD23 ' A' ' 16' ' ' LEU . 33.0 m-85 -64.28 137.63 97.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 150.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.22 175.73 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.253 2.635 . . . . 0.0 109.827 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.8 162.33 9.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 122.682 0.393 . . . . 0.0 109.955 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.36 -48.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.012 1.808 . . . . 0.0 111.888 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -109.98 129.2 55.7 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.346 1.459 . . . . 0.0 108.862 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -111.63 115.8 51.03 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 125.488 1.515 . . . . 0.0 108.19 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.91 -15.88 29.44 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.244 1.296 . . . . 0.0 110.967 160.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -90.72 -7.09 53.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.371 1.068 . . . . 0.0 112.249 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -48.94 83.16 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.912 -1.518 . . . . 0.0 111.577 173.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.63 -63.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.864 1.709 . . . . 0.0 111.63 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 163.18 110.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 127.883 2.473 . . . . 0.0 107.126 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -142.55 -134.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -170.68 89.04 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.111 1.778 . . . . 0.0 109.157 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.93 157.18 27.02 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.336 -0.853 . . . . 0.0 112.431 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.22 62.13 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.849 3.033 . . . . 0.0 111.803 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.4 m -59.99 150.23 29.7 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.949 163.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 m 166.46 127.11 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 128.697 2.799 . . . . 0.0 107.99 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 115.853 -2.637 . . . . 0.0 110.64 169.353 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.574 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 t -158.59 165.67 33.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -156.54 101.8 2.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 168.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.94 179.24 53.39 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 t -146.66 177.05 9.38 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.356 0.598 . . . . 0.0 110.14 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -123.61 170.77 10.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.185 2.194 . . . . 0.0 108.814 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.86 46.74 Favored Glycine 0 CA--C 1.52 0.401 0 O-C-N 120.945 -1.097 . . . . 0.0 111.075 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.78 -90.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 159.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -64.02 159.04 20.98 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.187 2.595 . . . . 0.0 110.829 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -85.43 -112.7 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.47 2.308 . . . . 0.0 110.924 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 142.66 -71.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 1 C-N-CA 134.021 4.928 . . . . 0.0 108.838 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.35 14.57 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.15 0.98 . . . . 0.0 113.509 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 71.58 -12.21 0.66 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.44 2.296 . . . . 0.0 113.814 -171.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.211 1.004 . . . . 0.0 111.552 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -83.44 0.61 45.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.204 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.45 140.53 52.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 162.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -105.74 132.09 52.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.45 -165.57 31.44 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -135.07 136.53 42.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -102.84 149.12 24.81 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.838 0.855 . . . . 0.0 110.099 -168.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.83 169.02 18.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.874 2.069 . . . . 0.0 108.664 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.22 142.35 42.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.926 1.29 . . . . 0.0 108.929 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -141.26 157.2 45.54 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.607 -0.683 . . . . 0.0 109.274 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 m -131.59 106.49 8.22 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.97 156.33 16.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -106.79 138.23 43.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 10.1 tttt -61.43 103.45 0.31 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.502 1.521 . . . . 0.0 110.355 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.7 p -83.03 -173.11 4.52 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.637 1.108 . . . . 0.0 110.489 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -37.78 61.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.647 1.179 . . . . 0.0 112.237 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.2 ptm -105.05 13.14 31.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.911 1.285 . . . . 0.0 113.42 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 97.16 -106.36 3.33 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.28 152.2 44.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.77 39.46 3.02 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.92 166.41 28.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.616 1.208 . . . . 0.0 108.323 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -135.45 154.5 51.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.248 1.419 . . . . 0.0 107.705 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.51 160.76 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 109.835 -170.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -136.05 159.82 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.601 2.76 . . . . 0.0 107.388 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.64 152.2 21.16 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -76.77 0.17 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.356 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -171.38 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.752 1.276 . . . . 0.0 113.112 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.54 167.58 22.12 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.729 1.212 . . . . 0.0 110.821 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.85 35.66 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.106 1 C-N-CA 125.753 4.302 . . . . 0.0 113.961 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.31 -15.79 0.29 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.563 1.545 . . . . 0.0 112.282 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.96 165.61 23.85 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 122.063 0.935 . . . . 0.0 111.065 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -71.17 157.5 38.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 mt -116.33 133.43 56.03 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.606 2.363 . . . . 0.0 107.521 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -130.62 154.05 48.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.519 0.728 . . . . 0.0 111.784 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.95 109.71 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 165.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -63.2 -43.31 98.53 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.732 1.613 . . . . 0.0 110.935 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.22 142.39 13.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.867 1.667 . . . . 0.0 108.824 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.7 t -92.01 122.67 43.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 161.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.17 132.44 63.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.096 1.358 . . . . 0.0 107.786 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.1 168.36 14.15 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.738 1.626 . . . . 0.0 110.924 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.27 28.0 17.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 111.238 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.02 177.8 16.43 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.055 1.788 . . . . 0.0 113.943 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 -28.22 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.808 2.339 . . . . 0.0 111.904 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.6 59.79 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.05 72.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.658 0.783 . . . . 0.0 112.779 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.56 -19.72 55.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.402 1.001 . . . . 0.0 113.296 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.3 -42.36 14.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.84 0.856 . . . . 0.0 109.776 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.72 2.5 60.94 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.993 1.282 . . . . 0.0 114.508 171.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.01 -7.16 59.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.736 1.768 . . . . 0.0 112.7 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.8 ttp -122.31 141.1 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.753 1.621 . . . . 0.0 109.358 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -140.93 -179.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.461 1.104 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 71.3 m -88.49 133.96 33.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.849 1.26 . . . . 0.0 109.613 -173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.28 -14.04 59.79 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.404 1.478 . . . . 0.0 112.323 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.35 148.25 37.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.982 0.913 . . . . 0.0 110.809 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 t -99.33 122.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.651 1.58 . . . . 0.0 108.606 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.59 106.36 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 109.28 174.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 t -80.75 -57.6 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -132.14 149.54 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.073 0.949 . . . . 0.0 108.914 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.65 116.39 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 170.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.41 -57.05 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 130.624 3.569 . . . . 0.0 113.941 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.42 6.38 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.466 2.306 . . . . 0.0 111.611 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.92 128.31 64.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.009 1.324 . . . . 0.0 108.295 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.4 p -78.27 87.13 4.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 110.746 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 1.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.963 0.905 . . . . 0.0 112.08 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -17.95 45.63 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -167.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.71 22.64 7.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.787 1.184 . . . . 0.0 111.307 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.06 167.72 11.05 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.697 1.249 . . . . 0.0 110.444 -175.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.3 p -72.12 138.59 47.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -53.37 -44.84 68.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.705 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -36.02 69.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.583 1.538 . . . . 0.0 113.477 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.07 -56.98 8.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.893 0.877 . . . . 0.0 109.688 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.59 -42.94 52.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 128.191 2.596 . . . . 0.0 111.633 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.19 -38.93 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 120.734 -1.229 . . . . 0.0 108.871 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -33.74 75.02 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.306 -0.871 . . . . 0.0 111.267 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -50.8 69.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.955 1.302 . . . . 0.0 108.743 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.64 -40.09 93.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.393 0.542 . . . . 0.0 110.957 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -69.5 -31.78 70.24 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.482 -0.761 . . . . 0.0 111.715 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 55.4 p -70.07 -0.46 7.68 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.024 0.829 . . . . 0.0 113.141 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 t -84.4 112.45 41.84 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 168.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.21 175.29 10.46 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.971 1.78 . . . . 0.0 112.037 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 150.49 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.671 1.188 . . . . 0.0 108.17 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.86 -15.69 51.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.246 1.403 . . . . 0.0 112.334 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -96.29 164.2 12.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.419 1.609 . . . . 0.0 110.792 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -132.28 155.61 48.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.899 2.479 . . . . 0.0 108.553 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.86 147.69 21.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.129 0.971 . . . . 0.0 109.971 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.68 153.54 21.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -141.04 148.87 40.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.04 118.94 39.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.41 165.79 12.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 124.095 0.872 . . . . 0.0 110.15 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -127.32 124.6 39.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.269 1.428 . . . . 0.0 108.133 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -102.73 132.44 48.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.413 1.885 . . . . 0.0 108.649 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.61 6.07 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.712 0.672 . . . . 0.0 112.45 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -103.84 130.98 22.44 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 160.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -70.77 172.54 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.549 2.166 . . . . 0.0 111.669 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 mt -70.82 152.5 95.1 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.46 -28.56 2.23 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.347 2.698 . . . . 0.0 111.558 175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -80.33 105.23 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.71 107.8 50.66 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.47 -24.95 4.05 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 121.84 1.693 . . . . 0.0 114.007 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.54 -62.39 1.62 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.848 0.859 . . . . 0.0 109.092 -170.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -164.02 73.95 1.72 Allowed Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.28 1.432 . . . . 0.0 108.489 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.81 -42.0 21.72 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.433 2.756 . . . . 0.0 112.531 -172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.51 108.18 0.8 Allowed 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -141.74 167.74 21.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.897 0.879 . . . . 0.0 109.997 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 m -136.18 102.09 4.89 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.18 154.99 52.38 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 170.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.32 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.37 2.047 . . . . 0.0 110.359 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -120.83 118.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.8 m 59.53 -169.33 0.14 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.124 0.97 . . . . 0.0 110.832 -164.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 C-N-CA 127.801 2.62 . . . . 0.0 106.733 -177.466 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 p -104.07 140.69 37.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.047 1.339 . . . . 0.0 110.284 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 m -58.58 -50.28 74.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.06 -81.99 0.98 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -163.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 t -59.82 158.06 11.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.212 0.529 . . . . 0.0 111.281 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -99.01 -37.06 9.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.121 1.368 . . . . 0.0 109.674 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.59 162.01 16.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -157.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp 39.48 87.81 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.33 1.852 . . . . 0.0 111.283 -163.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 10' ' ' THR 0.271 27.5 t80 57.98 -148.41 0.48 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 108.929 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 25.1 m -127.6 -98.49 0.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 126.589 1.956 . . . . 0.0 109.945 -173.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 121.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 1 C-N-CA 135.112 5.365 . . . . 0.0 109.786 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.41 0.43 24.84 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.72 -24.68 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.841 2.856 . . . . 0.0 114.178 -169.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -57.59 -34.28 69.07 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -80.78 7.47 10.3 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.018 0.527 . . . . 0.0 112.392 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 mt -77.23 170.61 16.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.495 -1.378 . . . . 0.0 110.287 171.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.01 105.1 7.19 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.154 1.381 . . . . 0.0 109.26 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.37 -179.22 25.39 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.232 1.396 . . . . 0.0 111.561 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -77.9 134.78 37.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.484 0.713 . . . . 0.0 109.306 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.24 138.62 32.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.936 0.894 . . . . 0.0 108.648 169.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.01 173.47 12.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.792 1.237 . . . . 0.0 109.696 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 p -145.59 170.33 16.65 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -155.94 155.56 33.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.363 1.065 . . . . 0.0 109.977 159.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.8 m -102.69 115.19 30.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.777 1.231 . . . . 0.0 108.523 163.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.37 137.33 39.85 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -81.68 137.23 35.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 166.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -64.72 108.83 1.83 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 165.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 t -137.16 161.95 34.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 56.31 -91.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.564 1.946 . . . . 0.0 112.642 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.8 ptm -138.47 30.14 2.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.656 1.582 . . . . 0.0 110.72 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.3 176.47 21.37 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.181 1.372 . . . . 0.0 110.693 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -64.73 147.88 52.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.162 -0.61 . . . . 0.0 109.896 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.45 33.37 1.82 Allowed Glycine 0 C--O 1.222 -0.637 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.469 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -149.81 164.3 35.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.734 1.767 . . . . 0.0 108.465 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -132.93 154.84 50.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.61 159.19 17.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.857 1.263 . . . . 0.0 108.58 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -121.75 164.12 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.922 2.089 . . . . 0.0 107.559 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.07 151.85 17.52 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.2 -14.12 55.66 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.563 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t0 80.52 -36.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.623 2.769 . . . . 0.0 109.93 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -72.46 167.61 31.25 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 125.709 1.604 . . . . 0.0 111.225 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -100.63 32.22 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.379 3.386 . . . . 0.0 113.256 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -158.24 37.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.157 0.983 . . . . 0.0 109.954 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.54 153.79 48.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.324 1.059 . . . . 0.0 112.537 -165.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.78 116.87 15.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.249 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.81 124.15 29.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -115.26 151.94 33.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.324 0.965 . . . . 0.0 109.81 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.46 118.99 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 120.707 -1.246 . . . . 0.0 107.819 165.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -52.11 43.95 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.643 1.977 . . . . 0.0 109.72 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -157.76 153.52 26.69 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.647 1.179 . . . . 0.0 109.644 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.1 t -96.97 113.8 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 164.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.93 130.97 87.74 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.505 1.922 . . . . 0.0 108.192 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.89 161.65 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.378 2.052 . . . . 0.0 111.192 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.61 10.09 0.95 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.431 2.293 . . . . 0.0 113.042 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.51 161.19 21.28 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.587 1.565 . . . . 0.0 110.553 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.96 -25.12 74.05 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 112.837 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.17 70.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.212 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.75 95.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.469 0.708 . . . . 0.0 110.38 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -66.58 -43.22 85.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.29 0.636 . . . . 0.0 110.981 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.28 -38.77 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.266 1.026 . . . . 0.0 111.164 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.89 11.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.686 2.088 . . . . 0.0 115.347 169.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.76 -39.08 87.74 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.292 -1.122 . . . . 0.0 109.963 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 tpp -67.6 131.77 46.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.526 1.131 . . . . 0.0 108.595 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -134.87 161.74 34.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.906 0.86 . . . . 0.0 108.727 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 156.92 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.6 70.88 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.481 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -83.88 162.66 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.827 1.814 . . . . 0.0 109.562 168.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -116.54 125.73 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 127.185 2.194 . . . . 0.0 108.388 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -73.72 105.21 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 126.917 2.087 . . . . 0.0 108.459 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -84.08 -57.5 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.811 0.815 . . . . 0.0 109.768 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -135.59 139.89 44.21 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -165.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.16 133.76 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 58.51 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 127.756 2.423 . . . . 0.0 113.776 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -150.06 21.97 0.86 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.598 1.559 . . . . 0.0 109.77 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.67 152.51 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.157 1.383 . . . . 0.0 108.205 -162.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.6 p -87.06 137.59 32.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.087 0.955 . . . . 0.0 109.805 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.84 15.28 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.275 1.43 . . . . 0.0 110.49 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 -31.92 66.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 113.315 -159.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.93 49.2 0.93 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.6 1.571 . . . . 0.0 109.41 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -99.16 170.28 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.303 1.041 . . . . 0.0 112.016 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -79.2 133.39 36.69 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.579 -1.325 . . . . 0.0 108.535 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.88 -40.44 66.6 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.273 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.29 76.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.76 1.618 . . . . 0.0 112.074 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.23 -46.37 50.64 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.019 0.928 . . . . 0.0 110.288 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.48 -41.8 93.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 110.769 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.5 t -61.45 -42.79 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.216 172.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.61 75.5 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.11 0.868 . . . . 0.0 110.055 173.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.14 -37.91 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.149 0.98 . . . . 0.0 109.701 -174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -70.2 -32.16 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.923 -0.486 . . . . 0.0 112.014 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -69.14 -33.38 73.35 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.287 0.948 . . . . 0.0 110.987 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -58.91 -16.11 16.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 0.0 113.749 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.6 110.2 25.57 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.763 1.625 . . . . 0.0 107.85 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.25 168.23 21.48 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.419 2.079 . . . . 0.0 110.535 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.29 125.98 7.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 164.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.11 -27.57 19.56 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.122 -1.376 . . . . 0.0 112.734 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.03 145.34 28.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.463 2.131 . . . . 0.0 108.286 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.14 162.09 13.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.379 1.072 . . . . 0.0 110.078 171.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.27 157.96 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 125.081 1.352 . . . . 0.0 109.291 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.03 156.59 16.25 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 110.489 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.6 mt -143.86 132.99 22.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.1 t -98.97 123.19 51.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 160.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 mt -108.19 160.7 15.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.248 0.967 . . . . 0.0 109.062 171.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.6 t -118.92 121.71 40.59 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -76.06 156.24 34.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.435 1.094 . . . . 0.0 108.653 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.75 -20.78 11.71 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 117.836 -1.536 . . . . 0.0 114.329 162.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -81.22 141.46 49.92 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 120.254 2.027 . . . . 0.0 107.94 165.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.97 170.27 20.5 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.32 2.013 . . . . 0.0 111.109 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.73 165.08 13.3 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.69 169.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -95.39 -22.3 0.2 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.944 2.429 . . . . 0.0 112.78 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -119.67 126.93 52.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.626 2.77 . . . . 0.0 108.359 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -106.51 121.85 43.87 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 171.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.06 -58.07 0.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.987 2.458 . . . . 0.0 110.598 169.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.53 -74.75 0.1 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.661 1.184 . . . . 0.0 110.743 -169.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -128.81 65.74 73.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 111.349 -162.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.42 -0.92 8.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 125.007 3.805 . . . . 0.0 114.6 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 162.97 79.88 0.0 OUTLIER 'General case' 0 C--O 1.233 0.218 0 C-N-CA 130.548 3.539 . . . . 0.0 105.949 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -135.54 126.51 27.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.0 p -141.34 155.46 45.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.914 0.387 . . . . 0.0 110.503 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.24 101.17 2.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 117.85 -1.528 . . . . 0.0 109.325 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.42 168.52 17.73 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.094 1.862 . . . . 0.0 110.338 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.3 t -148.77 121.64 8.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 t 64.32 177.76 0.18 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.901 1.28 . . . . 0.0 110.849 -163.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.614 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 142.288 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -81.81 -27.66 33.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.483 1.141 . . . . 0.0 111.527 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 t -65.89 138.69 58.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.46 174.3 45.0 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -167.21 178.61 5.52 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.6 t -65.18 168.72 6.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.221 0.608 . . . . 0.0 110.392 166.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.3 156.68 15.65 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.07 91.97 1.67 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.809 1.244 . . . . 0.0 107.971 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 t80 53.1 172.57 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.928 2.891 . . . . 0.0 112.738 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 m -77.59 -118.49 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.121 1.368 . . . . 0.0 110.2 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 135.73 -23.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 1 C-N-CA 134.215 5.006 . . . . 0.0 113.283 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -142.14 15.57 2.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.85 1.205 . . . . 0.0 113.637 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.5 -6.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.735 2.014 . . . . 0.0 114.514 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -73.8 -25.95 60.38 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.634 -1.291 . . . . 0.0 111.995 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.09 -11.06 60.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.544 1.065 . . . . 0.0 112.532 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.2 140.18 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.27 0.941 . . . . 0.0 109.652 -172.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -117.81 113.22 21.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.82 -175.27 30.66 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.006 -158.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -125.38 139.26 53.82 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -104.34 137.81 41.68 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.769 1.628 . . . . 0.0 110.411 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 175.55 12.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.562 1.945 . . . . 0.0 108.999 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -135.09 170.36 16.02 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 110.413 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -149.61 153.41 37.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.994 1.318 . . . . 0.0 107.883 170.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 m -115.83 105.49 12.75 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.04 132.7 44.16 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -82.87 146.44 28.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -77.65 76.71 4.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.381 1.072 . . . . 0.0 108.252 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -63.01 115.22 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 46.5 -91.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.673 2.389 . . . . 0.0 112.486 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.1 mtp -53.29 -56.09 19.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.612 2.365 . . . . 0.0 111.067 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.72 176.6 21.45 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -148.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -75.98 125.62 29.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.55 55.06 3.72 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.453 0.549 . . . . 0.0 112.056 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -143.02 157.97 44.04 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -125.78 157.87 36.39 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.43 162.92 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.901 1.281 . . . . 0.0 109.36 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 16.3 tt -126.36 146.49 32.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.905 1.682 . . . . 0.0 107.964 171.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.27 151.23 22.1 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.442 1.089 . . . . 0.0 111.064 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 44' ' ' GLU . . . -51.44 -82.86 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 C-N-CA 128.874 3.13 . . . . 0.0 112.512 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.44 -34.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.409 1.084 . . . . 0.0 112.424 -170.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -122.26 165.15 21.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.056 1.342 . . . . 0.0 110.492 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.53 47.4 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.158 3.238 . . . . 0.0 112.624 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -164.58 16.01 0.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.962 2.105 . . . . 0.0 112.128 -172.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 1.5 pp20? -91.62 165.63 13.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.538 2.335 . . . . 0.0 111.634 171.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.75 118.18 35.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.473 1.109 . . . . 0.0 110.336 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.8 mt -80.0 129.46 34.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -128.69 154.25 46.51 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.306 1.042 . . . . 0.0 110.46 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.01 114.81 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -68.22 -52.18 37.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.462 1.505 . . . . 0.0 110.414 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -156.65 151.12 25.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.575 1.15 . . . . 0.0 108.991 172.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -91.62 127.26 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 168.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.55 131.8 87.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -68.26 163.18 37.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.171 1.914 . . . . 0.0 111.2 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.35 49.92 3.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.031 1.732 . . . . 0.0 112.091 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.1 175.7 22.07 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.391 1.472 . . . . 0.0 110.744 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.87 -22.8 31.05 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.814 2.343 . . . . 0.0 113.425 -168.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.22 -51.19 11.36 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.076 0.853 . . . . 0.0 109.04 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.655 1.182 . . . . 0.0 110.314 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.64 -36.31 76.12 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.91 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -74.85 -20.85 59.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.235 0.925 . . . . 0.0 112.01 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.41 61.16 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.183 1.373 . . . . 0.0 115.723 163.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -87.48 -20.66 26.25 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.22 1.51 . . . . 0.0 111.35 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 ttm -110.98 143.92 40.9 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.716 1.606 . . . . 0.0 109.668 -169.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.08 -179.18 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.43 1.492 . . . . 0.0 108.312 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -95.54 158.42 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.36 0.664 . . . . 0.0 109.613 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.83 -14.73 24.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.481 0.563 . . . . 0.0 111.966 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.35 151.69 43.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.117 0.967 . . . . 0.0 109.546 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.23 121.0 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.686 1.595 . . . . 0.0 107.999 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.76 129.32 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.62 -58.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.447 1.092 . . . . 0.0 110.953 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.92 151.27 50.72 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.349 0.66 . . . . 0.0 109.933 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -132.25 117.03 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.23 -73.04 0.05 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.839 2.456 . . . . 0.0 110.026 -170.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -147.51 -10.73 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.1 1.76 . . . . 0.0 110.685 173.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 123.73 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.46 1.504 . . . . 0.0 107.977 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.9 p -67.5 110.13 3.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.414 0.686 . . . . 0.0 109.344 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.45 8.63 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.718 -0.614 . . . . 0.0 111.805 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 1.6 pp -55.19 -33.87 63.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -165.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.79 17.26 10.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 120.025 1.284 . . . . 0.0 111.397 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -73.16 158.06 36.0 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -82.74 146.47 28.99 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -56.53 -32.74 65.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 110.821 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.47 -57.79 10.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.097 -1.002 . . . . 0.0 110.896 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.36 -43.25 81.93 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.39 0.614 . . . . 0.0 109.559 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.99 -41.79 87.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 119.839 -1.788 . . . . 0.0 111.198 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.45 -39.44 80.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.295 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -35.22 80.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.38 0.991 . . . . 0.0 110.144 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.7 -45.51 86.31 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.047 1.739 . . . . 0.0 109.011 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -61.08 -32.6 72.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.513 -0.742 . . . . 0.0 111.247 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -79.75 -19.79 47.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.082 -1.011 . . . . 0.0 112.831 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.8 m -75.12 -6.16 48.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.267 1.427 . . . . 0.0 111.984 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.03 116.67 66.41 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 178.58 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.286 1.991 . . . . 0.0 111.133 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 mt -62.93 144.68 14.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 109.345 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.46 -2.83 51.48 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.7 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -84.22 164.9 18.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.651 1.726 . . . . 0.0 107.788 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 p -127.8 134.24 49.46 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.773 0.715 . . . . 0.0 110.23 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.95 146.88 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.4 148.01 27.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.0 mt -146.69 132.84 19.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -174.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.25 130.47 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.56 1.544 . . . . 0.0 108.221 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 164.94 14.22 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 124.324 1.015 . . . . 0.0 110.389 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.7 t -129.1 132.27 47.38 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.271 1.429 . . . . 0.0 108.433 167.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -104.28 122.29 45.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 126.465 1.906 . . . . 0.0 110.573 -172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 138.04 5.08 1.67 Allowed Glycine 0 N--CA 1.464 0.502 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.835 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -91.75 149.03 38.42 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 118.772 1.286 . . . . 0.0 108.237 167.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.58 168.29 24.73 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.139 1.893 . . . . 0.0 110.987 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.77 144.0 63.65 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.16 -24.67 10.84 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.702 2.935 . . . . 0.0 112.159 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.58 100.41 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.902 1.681 . . . . 0.0 108.943 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 113.42 32.21 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.19 -15.37 20.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.825 2.35 . . . . 0.0 114.725 -169.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -119.49 -32.71 4.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.021 1.328 . . . . 0.0 108.615 172.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t0 66.01 175.5 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.484 1.114 . . . . 0.0 109.381 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.92 -13.72 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.679 2.253 . . . . 0.0 110.924 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 154.88 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.302 1 C-N-CA 132.084 4.154 . . . . 0.0 106.733 170.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 66.61 158.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.551 1.94 . . . . 0.0 111.27 -169.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t 46.27 31.21 1.17 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.415 1.486 . . . . 0.0 112.087 -169.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.26 -94.94 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.776 0.703 . . . . 0.0 112.355 -157.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.01 99.24 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-N 120.038 1.919 . . . . 0.0 109.24 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.3 m -155.92 169.82 23.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.786 2.035 . . . . 0.0 108.571 167.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.5 p -133.87 71.61 1.46 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.6 0.714 . . . . 0.0 110.472 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -62.75 171.11 2.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.057 0.928 . . . . 0.0 110.443 172.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.5 t -133.85 121.56 21.95 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 -65.5 2.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 124.595 1.093 . . . . 0.0 111.38 -171.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -127.46 75.98 1.63 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -65.63 140.29 58.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.81 139.88 14.83 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.52 -63.37 0.43 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.67 1.188 . . . . 0.0 109.544 170.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.77 155.68 40.16 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.336 0.516 . . . . 0.0 110.374 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 11' ' ' ARG . 0.3 OUTLIER -73.31 -117.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.484 2.314 . . . . 0.0 112.841 178.26 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.427 ' H ' ' HB ' ' A' ' 10' ' ' THR . 8.7 mtt180 134.06 -16.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 1 C-N-CA 134.581 5.153 . . . . 0.0 111.827 177.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -145.45 13.21 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.62 4.6 0.56 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.31 1.444 . . . . 0.0 114.415 -176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -18.41 32.37 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.534 -1.354 . . . . 0.0 111.947 -174.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.85 -18.33 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.99 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.81 157.72 9.21 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.692 1.133 . . . . 0.0 110.299 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -129.12 93.12 3.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.723 1.209 . . . . 0.0 109.796 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.09 -129.72 1.57 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 125.252 1.406 . . . . 0.0 110.041 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.4 m -136.17 145.72 46.08 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.933 1.693 . . . . 0.0 108.459 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -90.43 144.23 26.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.426 0.69 . . . . 0.0 110.401 176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.08 165.82 14.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.021 2.128 . . . . 0.0 107.734 173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.5 p -147.19 162.79 38.16 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.347 0.659 . . . . 0.0 109.945 155.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.75 157.46 38.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 170.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.8 m -120.11 108.22 13.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.14 134.56 40.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -82.24 151.19 26.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -85.45 100.99 12.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -64.08 -53.56 47.8 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -159.97 -71.35 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.317 1.047 . . . . 0.0 110.234 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 ptp -50.84 -40.84 56.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 127.198 2.199 . . . . 0.0 113.595 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.83 -125.63 1.89 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -125.86 145.87 50.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.26 1.03 . . . . 0.0 109.82 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.9 46.98 3.72 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.134 0.873 . . . . 0.0 113.353 -174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' CE1' ' HE2' ' A' ' 63' ' ' MET . 43.4 p90 -148.54 163.95 35.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.402 1.481 . . . . 0.0 107.62 169.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.9 p -126.19 163.55 22.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.61 158.86 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.018 1.327 . . . . 0.0 108.281 -168.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -129.24 145.03 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.033 1.733 . . . . 0.0 107.926 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.63 22.63 Favored Glycine 0 CA--C 1.518 0.237 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.91 -71.06 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 CA-C-N 117.945 0.872 . . . . 0.0 113.423 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.23 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.276 1.03 . . . . 0.0 109.495 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -113.48 165.7 12.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.17 1.788 . . . . 0.0 110.919 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -79.32 66.79 8.75 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.651 2.901 . . . . 0.0 112.16 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -140.18 -2.09 1.49 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.754 0.822 . . . . 0.0 110.221 146.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -99.35 137.27 38.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.481 -1.387 . . . . 0.0 110.215 -152.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.22 123.71 17.58 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.757 0.823 . . . . 0.0 111.481 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.32 128.8 34.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -134.06 152.66 51.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.346 0.976 . . . . 0.0 110.637 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.34 113.14 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -68.55 -58.18 4.68 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -154.5 158.81 40.44 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.959 1.304 . . . . 0.0 109.519 163.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.7 138.2 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.1 1.76 . . . . 0.0 107.256 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 141.12 67.93 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.25 28.2 0.4 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.731 3.621 . . . . 0.0 115.693 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.85 -10.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.204 2.202 . . . . 0.0 111.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.52 158.79 46.02 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.49 -21.69 70.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.384 1.389 . . . . 0.0 110.486 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.39 46.34 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.353 1.461 . . . . 0.0 111.501 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.08 71.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.272 1.029 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -72.78 -22.7 60.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.838 -170.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.37 -12.12 60.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.834 1.197 . . . . 0.0 111.351 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.64 25.83 74.28 Favored Glycine 0 CA--C 1.525 0.664 0 O-C-N 121.053 -1.03 . . . . 0.0 113.293 167.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -128.54 -32.64 2.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.293 1.047 . . . . 0.0 113.525 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.41 ' HE2' ' CE1' ' A' ' 34' ' ' PHE . 22.8 ttm -95.01 134.66 37.44 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.21 167.67 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.627 1.203 . . . . 0.0 110.675 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.5 m -86.76 117.73 25.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.587 1.555 . . . . 0.0 108.604 -168.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.98 32.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.491 1.043 . . . . 0.0 112.411 -171.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -65.89 146.56 54.59 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.271 1.535 . . . . 0.0 108.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.39 115.69 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.346 1.858 . . . . 0.0 108.817 -169.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.84 125.01 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 125.607 1.563 . . . . 0.0 107.847 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.0 -55.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.281 1.033 . . . . 0.0 110.3 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.67 149.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.49 126.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 t30 67.08 -81.43 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 109.258 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -152.16 20.02 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.784 1.233 . . . . 0.0 111.342 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.58 123.47 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.1 p -62.74 120.84 12.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 163.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.58 13.7 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.384 0.674 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.51 -10.9 8.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -166.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.36 9.57 4.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.928 1.252 . . . . 0.0 111.406 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -71.62 159.5 34.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.967 1.883 . . . . 0.0 111.147 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -83.2 154.61 24.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.17 0.588 . . . . 0.0 109.906 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -55.28 -41.63 72.53 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.416 170.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.38 41.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.505 1.957 . . . . 0.0 112.671 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.12 -47.49 11.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.195 0.521 . . . . 0.0 111.951 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.4 -28.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 120.272 -1.517 . . . . 0.0 112.022 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.8 -44.0 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.501 -1.375 . . . . 0.0 108.438 167.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.9 88.98 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.143 1.338 . . . . 0.0 109.3 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.63 -44.82 80.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.353 1.861 . . . . 0.0 109.805 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -69.89 -36.43 75.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.026 0.83 . . . . 0.0 110.26 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -70.3 -17.06 63.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.695 0.798 . . . . 0.0 110.946 174.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 t -96.22 39.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.193 1.797 . . . . 0.0 110.797 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.67 113.8 25.0 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.67 172.65 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.125 1.217 . . . . 0.0 110.075 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.406 ' H ' HD11 ' A' ' 94' ' ' ILE . 5.2 mp -60.06 145.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.03 68.16 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.929 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -130.58 169.92 14.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.665 1.233 . . . . 0.0 108.704 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.08 161.39 31.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.845 1.258 . . . . 0.0 110.976 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.47 147.7 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.589 1.156 . . . . 0.0 108.221 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -83.41 156.9 22.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.34 110.67 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.11 122.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.92 167.31 10.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.953 0.783 . . . . 0.0 110.354 170.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.79 129.19 48.94 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.662 1.185 . . . . 0.0 108.139 165.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -79.84 155.59 27.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.709 1.604 . . . . 0.0 107.184 166.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.17 -19.82 4.83 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.934 169.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.14 156.42 39.01 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 118.726 1.263 . . . . 0.0 109.793 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.38 179.06 3.75 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.969 1.779 . . . . 0.0 110.196 165.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.66 154.33 94.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.819 161.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.08 -30.92 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.643 173.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -80.24 148.57 30.75 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.398 2.279 . . . . 0.0 110.014 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -132.15 115.92 15.36 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.68 -13.97 24.57 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.489 1.459 . . . . 0.0 111.844 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.79 -73.34 0.09 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.847 1.659 . . . . 0.0 110.407 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -120.48 79.73 29.5 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.01 -28.66 23.8 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 120.985 1.124 . . . . 0.0 111.61 -163.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.58 -28.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.989 1.316 . . . . 0.0 111.17 161.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 48.07 -153.62 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.25 1.82 . . . . 0.0 111.842 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.7 p 57.43 -178.49 0.06 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.78 2.832 . . . . 0.0 115.757 165.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.64 -125.37 2.5 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.516 -1.714 . . . . 0.0 112.084 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.54 -41.05 54.12 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.129 3.219 . . . . 0.0 114.736 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.7 p -147.53 168.34 22.2 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.439 0.696 . . . . 0.0 109.653 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -107.43 141.3 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 150.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.335 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -164.296 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -127.97 92.12 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.331 1.452 . . . . 0.0 107.326 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -73.38 171.49 13.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.878 1.271 . . . . 0.0 113.185 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.12 90.18 0.61 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.226 -2.349 . . . . 0.0 107.226 163.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.5 m -64.7 170.4 4.16 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.524 0.73 . . . . 0.0 112.173 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m -68.11 157.43 35.32 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.889 159.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.85 137.56 8.34 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 -169.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 45.94 83.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.499 2.32 . . . . 0.0 110.938 -171.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 10' ' ' THR 0.261 34.1 t80 58.76 -150.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.578 2.351 . . . . 0.0 110.383 177.732 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.43 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 28.4 m -118.53 -107.06 0.38 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 129.475 3.11 . . . . 0.0 108.295 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 131.42 -70.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 1 C-N-CA 134.433 5.093 . . . . 0.0 108.757 169.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.39 -0.35 52.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.001 0.819 . . . . 0.0 113.171 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 79.52 -11.71 1.16 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.839 2.856 . . . . 0.0 112.569 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 m -72.06 -19.28 61.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -166.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -79.29 -12.78 59.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.855 0.752 . . . . 0.0 112.414 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.15 142.74 52.49 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -125.26 122.85 38.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.51 -122.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -135.57 136.66 41.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -91.44 143.87 26.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.758 1.623 . . . . 0.0 110.522 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.48 166.78 31.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.959 1.703 . . . . 0.0 109.551 172.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -146.34 124.47 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.674 0.79 . . . . 0.0 110.696 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -124.46 157.23 35.71 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.946 0.794 . . . . 0.0 109.101 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.5 m -114.59 112.72 23.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.55 150.86 21.26 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -103.91 149.68 24.87 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -84.2 102.6 12.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.6 m -61.73 -56.93 14.43 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.086 0.555 . . . . 0.0 110.316 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.36 -82.07 0.1 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.315 0.646 . . . . 0.0 109.521 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.3 mtt -62.05 -49.68 75.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.814 0.846 . . . . 0.0 109.143 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 180.0 -162.06 28.23 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -83.03 149.43 26.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.09 30.17 2.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.354 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.413 ' CD1' ' HE2' ' A' ' 63' ' ' MET . 44.8 p90 -135.38 165.5 25.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.457 1.628 . . . . 0.0 108.49 172.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -123.36 154.41 39.0 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.006 1.322 . . . . 0.0 107.829 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.51 156.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.077 0.951 . . . . 0.0 108.619 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.54 149.63 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.449 2.3 . . . . 0.0 106.452 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.84 152.34 23.04 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.23 -80.74 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 124.454 1.026 . . . . 0.0 112.725 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 178.49 -62.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.739 1.216 . . . . 0.0 110.431 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -82.26 166.49 36.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.438 1.095 . . . . 0.0 112.507 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.79 57.57 5.69 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 124.224 3.283 . . . . 0.0 111.344 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.45 -4.69 0.11 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.725 1.61 . . . . 0.0 113.354 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -95.28 165.86 12.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.133 0.968 . . . . 0.0 111.947 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -84.55 160.34 20.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 111.16 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.8 mt -124.68 138.23 54.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 126.399 1.88 . . . . 0.0 108.184 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -134.42 155.24 50.65 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.35 0.977 . . . . 0.0 111.044 173.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.02 109.81 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.46 -50.01 66.97 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.906 1.683 . . . . 0.0 109.982 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -148.31 158.48 44.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 107.147 170.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.9 t -102.44 128.65 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.903 -2.629 . . . . 0.0 103.903 158.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.02 118.95 71.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 173.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.31 135.27 45.76 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t0 73.67 0.29 3.59 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.114 1.766 . . . . 0.0 112.617 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.45 163.77 53.03 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.289 -1.507 . . . . 0.0 109.822 165.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.59 -4.91 9.15 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.045 2.497 . . . . 0.0 114.769 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.87 -49.16 6.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.235 0.925 . . . . 0.0 109.919 172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.31 90.04 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.984 0.514 . . . . 0.0 110.588 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.37 -25.24 68.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.086 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.412 ' CG ' ' HZ1' ' A' ' 62' ' ' LYS . 15.1 t0 -79.34 -40.75 29.49 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.456 1.025 . . . . 0.0 109.943 176.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.38 52.93 14.76 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 125.036 1.303 . . . . 0.0 113.019 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HZ1' ' CG ' ' A' ' 60' ' ' ASP . 2.4 mptt -126.04 -58.9 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 170.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.413 ' HE2' ' CD1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -68.23 161.45 27.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 119.19 0.905 . . . . 0.0 109.264 173.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -143.38 173.52 11.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 167.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -74.8 144.61 43.44 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.926 -167.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.92 81.79 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.434 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -64.89 142.86 58.29 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.897 1.849 . . . . 0.0 108.472 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.2 t -97.9 120.87 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.376 1.87 . . . . 0.0 108.868 -169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.49 118.07 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.18 -54.11 7.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 109.996 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.47 144.88 48.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mt -122.99 111.37 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.3 t30 67.21 -53.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.48 3.112 . . . . 0.0 114.378 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -164.22 6.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.383 2.273 . . . . 0.0 111.247 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.63 121.34 63.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 125.449 1.499 . . . . 0.0 107.66 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.4 p -66.09 120.24 12.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 164.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.05 7.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.457 0.703 . . . . 0.0 111.89 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -9.11 43.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.448 3.099 . . . . 0.0 112.506 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.13 54.47 0.66 Allowed Glycine 0 C--N 1.334 0.463 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 158.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.08 157.83 22.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.99 0.895 . . . . 0.0 111.561 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -77.3 137.63 38.9 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.42 1.088 . . . . 0.0 108.991 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.41 -36.24 73.27 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.03 -1.462 . . . . 0.0 109.622 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.02 41.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.737 1.608 . . . . 0.0 112.694 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.12 -46.38 15.01 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.36 0.664 . . . . 0.0 111.149 176.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -61.54 -34.62 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 119.163 -2.211 . . . . 0.0 111.664 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.02 -44.48 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.617 1.167 . . . . 0.0 108.98 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -35.6 81.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 110.973 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.1 mt -62.97 -49.07 76.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.48 -42.38 83.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.625 0.77 . . . . 0.0 111.6 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -62.92 -34.75 78.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.32 -0.862 . . . . 0.0 109.834 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.1 t -75.31 27.26 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.601 1.56 . . . . 0.0 112.418 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.2 t -114.33 106.2 53.02 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.67 164.99 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.423 2.748 . . . . 0.0 113.979 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.22 151.47 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 165.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.71 -0.89 60.12 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.566 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -94.12 165.41 12.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.354 1.577 . . . . 0.0 108.175 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -128.63 163.13 25.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.069 1.348 . . . . 0.0 109.357 165.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.82 148.32 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 125.46 1.504 . . . . 0.0 107.986 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.65 152.87 24.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.701 1.601 . . . . 0.0 109.222 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -144.71 115.52 7.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.7 t -89.54 122.85 41.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 170.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.15 161.65 15.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 124.152 0.907 . . . . 0.0 109.556 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.35 119.59 34.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -81.24 147.15 30.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 108.43 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.3 -18.52 7.34 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.625 161.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -70.44 139.13 86.59 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 119.694 1.747 . . . . 0.0 107.587 161.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.23 172.09 12.73 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.459 1.44 . . . . 0.0 110.543 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.68 158.22 61.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.668 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.25 -37.11 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.627 2.218 . . . . 0.0 112.015 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -119.9 132.44 55.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.22 1.808 . . . . 0.0 109.324 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -95.11 99.13 3.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 125.537 1.535 . . . . 0.0 108.548 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.44 -23.74 23.33 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 120.929 1.368 . . . . 0.0 111.94 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.71 -23.0 56.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.617 1.967 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.74 77.14 7.21 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.4 -18.94 5.64 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.748 2.299 . . . . 0.0 114.899 -171.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.29 -58.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.801 1.64 . . . . 0.0 111.742 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.6 p30 51.16 179.29 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.861 3.264 . . . . 0.0 115.273 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.3 t -131.54 169.82 15.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.379 2.271 . . . . 0.0 105.381 152.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.61 -79.82 0.49 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 166.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.12 151.97 44.91 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.055 1.837 . . . . 0.0 110.594 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 m -163.55 -177.83 5.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.328 3.051 . . . . 0.0 106.097 167.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 m -105.6 157.78 17.16 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.004 0.82 . . . . 0.0 109.483 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.789 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -61.25 166.7 3.6 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 118.063 0.931 . . . . 0.0 112.278 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -127.16 142.11 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.012 0.925 . . . . 0.0 110.444 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.23 149.34 16.84 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 p -129.29 176.53 7.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.599 1.559 . . . . 0.0 110.562 -165.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 t -133.66 -91.67 0.35 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.16 114.37 6.68 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.61 77.99 1.6 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.5 157.04 17.99 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.845 0.858 . . . . 0.0 109.867 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -78.2 -121.67 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.657 1.583 . . . . 0.0 111.355 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 160.97 -74.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 130.925 3.69 . . . . 0.0 109.108 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -118.73 22.92 11.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.687 1.232 . . . . 0.0 110.971 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 70.24 -23.87 0.16 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 128.17 2.588 . . . . 0.0 113.881 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -65.04 -13.21 57.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.631 1.172 . . . . 0.0 112.86 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -67.26 -22.19 65.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.443 1.097 . . . . 0.0 112.444 166.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.05 148.64 30.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.996 1.271 . . . . 0.0 109.048 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -112.81 -0.31 14.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.56 32.72 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.066 1.317 . . . . 0.0 112.578 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 157.89 33.72 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 124.871 1.268 . . . . 0.0 109.535 -169.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.39 129.04 49.09 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.652 0.781 . . . . 0.0 109.375 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.72 168.4 17.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.917 2.087 . . . . 0.0 108.415 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.9 p -142.99 175.84 9.54 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.438 0.637 . . . . 0.0 111.199 160.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -155.19 157.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.2 m -127.12 105.35 8.52 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.29 136.37 37.86 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -87.48 123.41 32.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.07 125.07 12.81 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.598 1.559 . . . . 0.0 108.236 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -173.74 3.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.78 -54.55 45.01 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.717 -1.239 . . . . 0.0 111.087 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.5 mtp -78.25 13.93 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.922 1.289 . . . . 0.0 113.545 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.16 -147.16 18.48 Favored Glycine 0 C--N 1.331 0.306 0 O-C-N 120.136 -1.602 . . . . 0.0 110.48 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -88.84 146.89 24.69 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 56' ' ' PRO . . . -86.8 42.28 3.15 Favored Glycine 0 C--O 1.222 -0.605 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.705 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -148.43 166.96 26.56 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 119.3 1.55 . . . . 0.0 109.321 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 p -127.28 158.81 36.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.215 1.806 . . . . 0.0 107.935 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.85 162.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.586 1.954 . . . . 0.0 107.283 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.6 tt -138.68 159.98 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.787 1.635 . . . . 0.0 108.26 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.23 154.08 23.8 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 128.802 3.096 . . . . 0.0 110.384 -174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.36 -82.99 0.21 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.482 1.039 . . . . 0.0 111.898 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -177.16 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.77 2.028 . . . . 0.0 111.243 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -125.73 153.11 73.12 Favored Pre-proline 0 C--N 1.342 0.27 0 O-C-N 120.154 -1.591 . . . . 0.0 111.652 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.42 51.35 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.31 1 C-N-CA 125.388 4.058 . . . . 0.0 113.949 168.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -158.43 13.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.096 -1.628 . . . . 0.0 109.516 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -74.89 160.47 30.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 127.411 2.285 . . . . 0.0 110.774 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -93.39 112.61 24.56 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.37 112.75 18.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.68 155.0 30.69 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.23 116.34 2.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -65.53 -54.38 28.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.768 1.227 . . . . 0.0 109.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -155.53 161.42 40.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.993 1.317 . . . . 0.0 108.049 171.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.48 140.59 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 161.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.97 132.11 54.91 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.479 ' C ' ' H ' ' A' ' 55' ' ' GLY . 73.1 Cg_endo -68.0 160.51 48.28 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.864 2.376 . . . . 0.0 110.845 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.09 -18.31 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.434 2.294 . . . . 0.0 114.26 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 53' ' ' PRO . . . -70.95 173.67 41.59 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.592 1.568 . . . . 0.0 114.181 -171.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 33' ' ' GLY . 58.0 Cg_endo -66.52 -32.07 40.34 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.939 3.093 . . . . 0.0 111.41 -171.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.742 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.91 -46.33 65.64 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.888 0.875 . . . . 0.0 109.732 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.47 -42.66 99.64 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.268 0.94 . . . . 0.0 112.249 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.79 -6.06 29.67 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.894 0.77 . . . . 0.0 111.371 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.27 29.93 63.68 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.691 1.139 . . . . 0.0 113.465 165.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -136.17 -0.79 2.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.768 1.227 . . . . 0.0 111.982 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.9 tpp -111.29 137.16 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.482 1.513 . . . . 0.0 107.069 169.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.75 167.71 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 108.941 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -77.18 159.68 29.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.495 1.118 . . . . 0.0 109.437 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.95 39.87 96.79 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -132.26 152.88 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.595 1.158 . . . . 0.0 108.074 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.5 117.6 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.688 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mp -66.8 138.63 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.2 t -122.33 -54.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.03 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.37 149.83 51.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.435 1.094 . . . . 0.0 108.699 -175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.58 126.9 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 44.86 -93.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.1 2.16 . . . . 0.0 110.795 -159.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.25 -7.36 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.195 1.398 . . . . 0.0 111.483 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.37 139.82 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -173.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.44 130.3 36.86 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.132 -0.98 . . . . 0.0 109.003 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.94 10.61 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 111.445 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.0 -42.68 60.51 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.686 -1.259 . . . . 0.0 113.284 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.08 36.22 4.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 127.176 2.322 . . . . 0.0 109.905 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.83 -158.86 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.806 0.803 . . . . 0.0 109.683 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.7 t -119.93 143.98 47.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.641 1.11 . . . . 0.0 109.031 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -53.78 -42.41 68.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.532 2.333 . . . . 0.0 110.589 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.96 -29.23 68.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.831 0.741 . . . . 0.0 111.983 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -82.58 -54.85 4.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.373 1.069 . . . . 0.0 109.271 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.97 -44.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 130.053 3.341 . . . . 0.0 112.382 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.46 -32.8 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 120.459 -1.4 . . . . 0.0 109.652 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -34.69 71.99 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.65 1.114 . . . . 0.0 109.435 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.5 -42.96 95.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.985 1.314 . . . . 0.0 109.823 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -62.46 -19.15 63.23 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.291 1.036 . . . . 0.0 112.778 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -91.98 -11.37 36.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.819 1.248 . . . . 0.0 113.109 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 m -75.0 12.8 0.78 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.775 -1.203 . . . . 0.0 112.996 161.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.09 93.22 14.73 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.63 140.77 13.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.911 3.074 . . . . 0.0 109.57 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.1 mp -52.01 125.43 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 118.987 0.812 . . . . 0.0 109.232 -164.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.3 -16.44 11.71 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.46 1.981 . . . . 0.0 113.417 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -94.83 173.65 7.49 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.778 1.789 . . . . 0.0 109.756 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -127.94 167.02 17.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.042 2.537 . . . . 0.0 108.193 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.32 148.85 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.468 1.107 . . . . 0.0 108.596 161.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.4 152.44 25.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 167.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 mt -146.47 119.74 8.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.85 129.22 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mt -112.05 156.7 21.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.361 1.038 . . . . 0.0 109.4 166.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.06 128.29 55.57 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -84.62 156.35 21.6 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.138 0.975 . . . . 0.0 109.582 171.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.03 6.3 14.07 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 123.835 0.731 . . . . 0.0 114.391 163.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.46 133.9 23.8 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.53 -178.42 1.51 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.143 2.562 . . . . 0.0 111.15 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.42 158.02 83.64 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.578 0.751 . . . . 0.0 111.086 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.31 -26.9 7.0 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.849 2.366 . . . . 0.0 112.662 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -119.57 142.79 48.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.594 1.957 . . . . 0.0 108.091 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -130.91 92.9 32.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 124.427 1.091 . . . . 0.0 108.968 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.57 -5.42 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.339 2.693 . . . . 0.0 113.306 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -72.96 -37.07 67.22 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.354 -1.466 . . . . 0.0 109.709 171.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.5 78.01 76.43 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 125.661 1.584 . . . . 0.0 108.719 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.44 -63.62 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.023 3.149 . . . . 0.0 112.098 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.28 60.02 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.662 1.585 . . . . 0.0 106.943 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 81.2 136.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.319 2.648 . . . . 0.0 108.34 -164.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.35 74.85 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.641 1.576 . . . . 0.0 108.408 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -116.72 63.32 0.37 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.099 -1.389 . . . . 0.0 113.493 -173.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.08 158.39 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 120.55 2.175 . . . . 0.0 109.286 165.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.1 m -136.53 172.39 13.08 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.1 m -140.45 147.47 39.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.285 1.434 . . . . 0.0 109.08 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.65 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 119.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 121.803 0.811 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -88.36 -121.35 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.144 -1.597 . . . . 0.0 109.019 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 150.19 -83.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 1 C-N-CA 132.701 4.4 . . . . 0.0 107.022 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.65 18.34 2.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.03 -17.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.106 2.962 . . . . 0.0 114.545 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -26.3 67.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.139 0.976 . . . . 0.0 111.262 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -82.18 -4.18 56.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.916 -1.04 . . . . 0.0 112.311 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.97 161.75 23.53 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.943 1.247 . . . . 0.0 108.66 169.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -124.23 116.22 22.33 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.81 39.46 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 124.42 1.075 . . . . 0.0 110.742 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -87.8 166.6 14.48 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' C ' HD13 ' A' ' 21' ' ' LEU . 12.2 m-85 -126.43 136.01 52.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.178 1.391 . . . . 0.0 107.283 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -153.24 164.4 38.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.545 1.138 . . . . 0.0 109.687 -174.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.4 m -144.58 163.42 33.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.824 0.821 . . . . 0.0 112.453 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 157.22 43.31 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.884 1.274 . . . . 0.0 107.89 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -114.46 114.14 25.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' ALA . 5.9 mt -98.52 132.91 43.57 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -85.46 132.55 34.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 163.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 51.3 tttt -73.31 93.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.695 1.998 . . . . 0.0 108.514 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -95.02 115.01 26.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.786 0.834 . . . . 0.0 109.173 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.56 -158.94 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.85 1.66 . . . . 0.0 108.888 -167.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 33.8 mtt 23.19 -76.32 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.147 2.979 . . . . 0.0 116.458 162.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 169.66 168.24 31.31 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -163.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -65.2 152.15 44.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.282 0.541 . . . . 0.0 110.12 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.25 44.05 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.915 -0.936 . . . . 0.0 112.259 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.67 164.72 37.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.499 1.65 . . . . 0.0 107.94 169.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 p -131.26 159.94 36.36 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.74 162.04 17.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.452 1.101 . . . . 0.0 108.847 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.72 146.57 32.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 128.575 2.75 . . . . 0.0 106.374 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.43 151.55 22.73 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 167.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -11.84 4.33 Favored Glycine 0 C--O 1.225 -0.419 0 C-N-CA 127.283 2.373 . . . . 0.0 117.893 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t0 95.59 -42.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 130.434 3.494 . . . . 0.0 108.037 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.79 157.81 89.39 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.674 2.389 . . . . 0.0 111.771 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -89.65 29.95 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.555 3.503 . . . . 0.0 112.692 -170.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -175.56 76.35 0.02 OUTLIER 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -140.44 143.46 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.873 2.469 . . . . 0.0 105.955 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -76.47 128.83 35.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.28 146.91 30.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.52 151.28 50.19 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 122.942 0.497 . . . . 0.0 110.835 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.17 112.1 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -70.57 -42.72 70.73 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 110.377 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 p -151.87 157.44 41.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.076 0.951 . . . . 0.0 109.57 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -92.72 141.7 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 159.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.03 122.07 86.22 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.44 146.23 97.31 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.442 1.428 . . . . 0.0 108.778 169.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 67.76 -2.59 1.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.536 1.534 . . . . 0.0 113.25 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.5 163.68 39.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.524 1.059 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.75 -27.76 75.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.113 2.542 . . . . 0.0 112.996 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.018 0.527 . . . . 0.0 110.081 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.2 87.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.686 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.47 -19.12 62.98 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.54 -4.91 59.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.162 1.346 . . . . 0.0 111.429 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.92 -24.27 1.98 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.17 2.319 . . . . 0.0 113.252 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.07 -35.33 18.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -157.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tpp -69.79 128.69 37.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.9 166.54 19.81 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -90.85 142.01 28.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 -16.6 58.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.691 -1.06 . . . . 0.0 112.361 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.482 ' HB3' HD13 ' A' ' 102' ' ' LEU . 84.3 m-20 -55.39 139.84 41.83 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.523 1.129 . . . . 0.0 109.837 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.49 123.25 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.409 1.084 . . . . 0.0 108.835 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.08 119.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.555 1.542 . . . . 0.0 108.285 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.91 -57.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.938 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -134.3 152.94 52.09 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mt -130.25 128.36 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 t30 59.63 -73.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.145 2.978 . . . . 0.0 111.994 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -157.51 40.51 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.68 0.792 . . . . 0.0 110.85 165.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.38 132.52 70.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.615 1.966 . . . . 0.0 108.736 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.2 p -72.53 111.73 7.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.703 1.601 . . . . 0.0 111.779 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.49 5.6 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.847 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -18.44 62.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.383 1.901 . . . . 0.0 114.214 -167.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.31 4.69 19.88 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.583 -1.121 . . . . 0.0 112.934 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.48 162.97 22.04 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.707 1.753 . . . . 0.0 109.965 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.0 p -70.67 142.71 51.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -60.04 -22.67 62.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.372 -0.83 . . . . 0.0 110.391 166.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.11 -54.58 45.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.7 -1.25 . . . . 0.0 111.883 167.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.34 -49.86 67.78 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 124.882 1.273 . . . . 0.0 109.792 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 t -61.01 -41.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 120.037 -1.664 . . . . 0.0 112.182 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.4 -37.03 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 120.661 -1.274 . . . . 0.0 109.66 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -35.45 81.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.48 1.036 . . . . 0.0 110.003 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.12 -45.16 86.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.355 1.062 . . . . 0.0 108.258 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -64.29 -41.42 96.88 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.996 0.816 . . . . 0.0 111.322 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.98 -25.43 64.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.438 0.563 . . . . 0.0 112.24 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -66.35 -18.17 65.2 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.025 0.829 . . . . 0.0 111.994 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.36 115.85 62.3 Favored Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.69 170.06 20.59 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 120.716 1.291 . . . . 0.0 110.783 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.61 139.72 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.629 1.172 . . . . 0.0 108.029 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.29 -0.99 88.76 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 117.504 -1.72 . . . . 0.0 113.657 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -100.04 172.58 7.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.038 1.919 . . . . 0.0 108.482 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 p -131.87 159.62 38.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.642 0.777 . . . . 0.0 110.052 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.29 155.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.839 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.84 159.21 21.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 mt -146.06 141.61 27.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -121.75 118.12 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 67' ' ' ASP . 8.8 mt -109.26 168.74 9.16 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.907 0.755 . . . . 0.0 109.871 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.9 t -121.75 143.67 49.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.909 1.284 . . . . 0.0 107.67 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 13.4 ttm180 -127.25 130.33 49.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.729 1.211 . . . . 0.0 111.68 -163.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 128.05 -21.85 5.47 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.16 139.01 87.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 123.965 0.906 . . . . 0.0 109.176 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.37 178.45 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.402 2.068 . . . . 0.0 110.735 167.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 157.98 20.75 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.306 160.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.438 -1.742 0 N-CA-C 108.307 -1.459 . . . . 0.0 108.307 165.862 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.572 0.701 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -78.77 -112.35 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.555 1.542 . . . . 0.0 111.715 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 147.13 -57.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 131.509 3.924 . . . . 0.0 111.798 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.6 t70 -142.76 20.78 1.99 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.797 0.439 . . . . 0.0 111.387 -166.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 61.49 -17.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.47 2.308 . . . . 0.0 114.132 -164.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -60.3 -23.42 64.17 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.942 2.497 . . . . 0.0 112.43 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -80.83 -16.12 54.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.419 1.087 . . . . 0.0 112.474 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.02 154.28 33.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.397 0.999 . . . . 0.0 109.13 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -130.01 99.57 5.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.83 176.11 39.89 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.359 1.933 . . . . 0.0 110.079 -166.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -98.64 133.79 42.48 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 117.798 0.799 . . . . 0.0 109.177 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.603 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 16.6 m-85 -101.12 142.65 32.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.387 1.075 . . . . 0.0 110.052 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.77 166.64 32.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.097 1.759 . . . . 0.0 109.372 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -147.1 156.54 43.08 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.849 1.26 . . . . 0.0 111.039 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -139.43 157.12 46.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.656 1.582 . . . . 0.0 107.862 168.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.09 111.63 24.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.067 1.347 . . . . 0.0 107.554 170.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.64 135.21 40.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.792 1.178 . . . . 0.0 108.391 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -83.67 151.56 25.22 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.416 0.627 . . . . 0.0 110.073 167.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -79.27 69.42 5.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.941 1.297 . . . . 0.0 109.378 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.29 170.25 9.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.464 1.105 . . . . 0.0 108.646 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 49.62 -92.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.993 2.117 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.2 ptm -118.9 4.3 11.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.33 1.452 . . . . 0.0 111.657 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.78 -176.76 35.16 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -151.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -64.99 149.15 50.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.034 -1.083 . . . . 0.0 110.983 -161.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.98 40.12 3.09 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.53 -176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -146.24 166.22 26.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.167 1.483 . . . . 0.0 109.108 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 p -128.87 159.46 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.277 1.431 . . . . 0.0 108.371 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.45 162.38 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.839 1.256 . . . . 0.0 109.423 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.76 155.08 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.735 2.014 . . . . 0.0 108.034 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.01 155.05 21.38 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 129.606 3.479 . . . . 0.0 111.049 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.1 -93.39 0.02 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 117.294 -2.384 . . . . 0.0 108.292 142.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.33 -65.43 0.08 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.09 166.9 28.95 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.934 1.694 . . . . 0.0 110.819 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.38 45.22 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.041 3.16 . . . . 0.0 111.872 -164.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -157.21 34.47 0.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.316 1.447 . . . . 0.0 109.181 -168.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -139.43 173.62 11.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.953 1.301 . . . . 0.0 113.13 -167.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -88.71 112.89 23.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 125.381 1.472 . . . . 0.0 110.493 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -81.9 134.67 35.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG2' HG22 ' A' ' 68' ' ' VAL . 27.9 mt-30 -128.22 156.96 42.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.63 0.65 . . . . 0.0 111.06 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.96 104.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 166.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -54.82 -50.03 69.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.505 1.522 . . . . 0.0 109.145 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 152.4 18.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 109.206 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.5 t -104.04 130.18 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.74 130.28 68.02 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.83 46.09 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.808 3.005 . . . . 0.0 113.36 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -160.54 43.65 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.317 1.847 . . . . 0.0 109.905 164.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.67 166.6 22.96 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 120.718 -1.239 . . . . 0.0 112.443 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.63 -22.07 64.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.563 2.175 . . . . 0.0 112.397 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.8 2.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.962 0.905 . . . . 0.0 109.838 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.06 70.28 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.014 0.926 . . . . 0.0 111.004 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.0 -20.14 65.83 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.892 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -99.33 -30.41 12.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.483 1.492 . . . . 0.0 112.05 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.88 6.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.329 1.442 . . . . 0.0 114.431 166.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -69.87 -15.87 63.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.514 1.157 . . . . 0.0 111.144 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.94 133.67 43.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.08 176.62 8.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 162.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.3 m -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.56 56.48 25.05 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.599 ' HB3' HD13 ' A' ' 102' ' ' LEU . 3.0 m-20 -128.92 151.49 49.6 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.983 2.113 . . . . 0.0 105.652 175.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' A' ' 47' ' ' GLN . 44.1 t -101.26 127.16 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 121.401 1.91 . . . . 0.0 109.706 -171.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.88 130.2 36.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.551 1.14 . . . . 0.0 108.589 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 17.4 t -106.4 -61.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.518 1.527 . . . . 0.0 109.211 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -128.83 157.76 40.61 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.397 1.079 . . . . 0.0 109.223 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mt -128.79 117.11 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 47.77 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 128.564 2.746 . . . . 0.0 112.075 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.45 13.7 1.78 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.514 1.526 . . . . 0.0 111.111 -170.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.22 120.9 55.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.47 104.8 2.41 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -101.52 3.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 123.28 0.632 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 78' ' ' LEU . 1.6 pp -58.45 -17.48 21.14 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.81 35.61 2.29 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 126.14 1.828 . . . . 0.0 109.016 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -103.16 165.66 10.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.306 1.053 . . . . 0.0 108.548 161.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.02 161.64 16.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.972 0.909 . . . . 0.0 109.546 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.93 -14.58 23.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.5 1.52 . . . . 0.0 111.934 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.13 -67.56 0.43 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.476 1.489 . . . . 0.0 109.478 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -56.01 -45.4 79.09 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.439 0.696 . . . . 0.0 111.075 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.11 -41.59 93.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 120.292 -1.505 . . . . 0.0 111.447 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.9 -37.34 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.87 -1.144 . . . . 0.0 109.731 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -39.07 93.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.426 1.466 . . . . 0.0 109.939 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.28 -51.1 71.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.667 1.587 . . . . 0.0 108.164 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.38 -42.33 88.08 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.019 0.827 . . . . 0.0 112.483 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.41 -30.88 69.89 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.423 -0.798 . . . . 0.0 111.008 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -70.02 -2.55 13.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.5 114.63 56.25 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.81 179.07 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.072 2.515 . . . . 0.0 110.931 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.35 152.06 7.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 109.137 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.08 -25.78 6.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 124.286 0.946 . . . . 0.0 111.956 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -84.33 142.25 30.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.42 1.11 . . . . 0.0 109.289 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.63 150.48 28.93 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.694 1.598 . . . . 0.0 108.234 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -141.31 141.21 31.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -84.18 155.97 22.3 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.0 mt -142.62 150.08 39.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.42 126.47 58.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 67' ' ' ASP . 14.5 mt -119.65 169.5 10.04 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 124.356 1.035 . . . . 0.0 110.265 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.9 t -133.48 117.5 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.836 0.855 . . . . 0.0 111.213 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -85.53 139.41 31.49 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.115 -0.99 . . . . 0.0 110.339 -165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.98 -4.8 16.25 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.073 -0.848 . . . . 0.0 113.582 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.67 117.97 68.88 Favored Pre-proline 0 CA--C 1.526 0.057 0 CA-C-N 119.372 1.586 . . . . 0.0 107.53 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.16 177.23 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.709 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -54.48 149.09 22.07 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.613 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.444 -1.389 0 C-N-CA 122.668 2.245 . . . . 0.0 107.33 167.446 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 10' ' ' THR . 27.8 t80 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 114.261 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 m -82.32 -99.36 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.377 1.471 . . . . 0.0 112.102 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 117.83 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 1 C-N-CA 136.151 5.781 . . . . 0.0 114.167 172.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -125.52 13.63 8.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.507 1.048 . . . . 0.0 111.721 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.3 -20.3 0.07 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.851 2.86 . . . . 0.0 115.399 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -64.27 -22.13 66.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.312 0.96 . . . . 0.0 112.32 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -97.83 20.64 11.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.724 1.21 . . . . 0.0 112.073 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.88 -159.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 162.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -64.04 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.055 1.342 . . . . 0.0 111.661 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.55 -13.69 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.168 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 159.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -86.18 127.38 34.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -127.95 123.4 34.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.773 1.629 . . . . 0.0 108.165 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 154.83 41.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.994 1.718 . . . . 0.0 107.977 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -145.6 152.79 40.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.584 0.354 . . . . 0.0 110.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.52 157.94 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 108.118 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.7 m -127.15 119.34 26.25 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.354 1.462 . . . . 0.0 107.935 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.98 150.39 21.42 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -83.12 158.24 22.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 24.0 tptt -77.1 98.32 5.0 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.5 m -126.1 151.86 46.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.686 0.675 . . . . 0.0 111.793 -159.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 60.4 -79.87 0.02 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.251 2.62 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -149.43 71.62 1.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.421 2.289 . . . . 0.0 107.432 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 73.79 176.14 33.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.82 123.69 21.65 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.458 -1.025 . . . . 0.0 109.357 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.22 51.52 2.1 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.744 1.164 . . . . 0.0 112.775 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.57 165.93 27.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.394 1.877 . . . . 0.0 106.321 160.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -131.8 166.44 21.55 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.462 -0.773 . . . . 0.0 109.279 166.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.29 161.32 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.837 1.655 . . . . 0.0 107.422 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -133.05 150.25 32.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.786 2.035 . . . . 0.0 106.702 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.22 151.8 22.43 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.391 1.948 . . . . 0.0 108.702 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.03 -55.85 9.99 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.357 -0.691 . . . . 0.0 112.611 -158.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.79 -41.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.505 1.922 . . . . 0.0 107.859 166.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.59 164.97 14.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.223 1.409 . . . . 0.0 111.707 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.1 19.19 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.106 3.871 . . . . 0.0 116.218 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.58 5.61 0.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.22 1.008 . . . . 0.0 113.252 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.28 155.33 40.31 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 0.969 . . . . 0.0 108.413 163.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.96 168.41 18.06 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.806 0.812 . . . . 0.0 110.509 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.65 133.85 54.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.714 1.606 . . . . 0.0 107.254 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -128.49 151.82 48.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.11 121.96 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -76.74 -41.92 43.16 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 125.959 1.704 . . . . 0.0 110.501 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.2 p -156.99 161.93 39.58 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.304 1.041 . . . . 0.0 110.432 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.43 120.42 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 126.542 1.937 . . . . 0.0 105.811 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mm -75.49 131.38 77.55 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.22 152.04 82.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.668 2.245 . . . . 0.0 109.648 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 t70 53.92 23.17 3.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.908 0.861 . . . . 0.0 111.924 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.29 163.73 13.15 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.527 1.537 . . . . 0.0 109.712 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.4 -32.54 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.761 2.307 . . . . 0.0 111.865 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.44 -40.88 80.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.119 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.04 81.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.263 0.625 . . . . 0.0 110.596 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.13 -46.72 89.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.298 0.499 . . . . 0.0 110.216 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.32 -31.31 71.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.036 0.534 . . . . 0.0 111.223 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.97 -18.69 29.93 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.474 1.511 . . . . 0.0 113.49 160.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.111 0.955 . . . . 0.0 110.675 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.5 tpp -65.43 123.71 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.01 163.69 29.72 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.239 1.016 . . . . 0.0 108.363 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -88.21 142.56 27.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -167.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.41 -12.96 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.849 -1.528 . . . . 0.0 112.512 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.467 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.7 m-20 -68.91 148.89 49.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.677 2.238 . . . . 0.0 108.098 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.3 125.75 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.115 1.366 . . . . 0.0 109.268 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.11 110.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 125.406 1.482 . . . . 0.0 107.422 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.02 -58.82 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.585 0.707 . . . . 0.0 109.664 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.07 155.22 50.43 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.916 1.286 . . . . 0.0 107.851 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -127.08 113.7 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 169.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 t30 69.88 -61.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 129.484 3.114 . . . . 0.0 112.27 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -157.71 5.7 0.13 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.756 1.622 . . . . 0.0 111.682 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.55 131.32 53.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 120.313 -1.492 . . . . 0.0 107.376 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.9 t -78.27 116.55 18.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.74 5.3 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 122.961 0.504 . . . . 0.0 111.576 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -31.59 35.44 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.364 1.866 . . . . 0.0 113.138 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.22 61.1 0.64 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -111.82 162.94 14.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.329 1.052 . . . . 0.0 109.834 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.27 151.61 41.3 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -55.47 -29.81 59.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.088 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.96 71.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.307 1.412 . . . . 0.0 112.268 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -76.57 -57.21 3.99 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -52.72 -41.62 39.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.484 2.713 . . . . 0.0 112.909 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.62 -28.37 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 120.553 -1.342 . . . . 0.0 110.361 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -35.74 73.14 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.439 1.472 . . . . 0.0 108.154 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.69 -36.39 67.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.214 1.005 . . . . 0.0 110.317 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -73.0 -29.6 63.16 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.721 -1.237 . . . . 0.0 111.684 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.81 -19.3 55.21 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.378 0.671 . . . . 0.0 112.237 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.6 m -71.24 -7.5 47.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 113.382 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.01 102.85 19.14 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.306 1.043 . . . . 0.0 108.259 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.7 170.43 16.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 mt -66.95 142.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 107.774 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.82 -2.57 87.3 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.103 -0.832 . . . . 0.0 113.049 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -101.53 171.63 7.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.716 1.258 . . . . 0.0 108.976 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -143.91 155.43 44.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.137 2.175 . . . . 0.0 108.211 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.81 148.24 24.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -82.82 153.38 25.21 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.2 mt -138.17 147.36 43.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 t -127.68 116.45 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.2 mt -109.96 164.12 12.91 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -117.65 138.15 52.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 164.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.06 156.14 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.354 1.862 . . . . 0.0 110.095 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.05 -16.18 20.57 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 118.663 -1.076 . . . . 0.0 114.03 157.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -83.53 140.04 41.35 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 118.884 1.342 . . . . 0.0 108.784 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.97 176.87 9.47 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.63 2.887 . . . . 0.0 110.074 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 mt -67.58 145.3 98.19 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 N--CA 1.459 -0.503 0 C-N-CA 121.931 1.754 . . . . 0.0 111.053 -178.513 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 m -88.4 -120.39 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.912 1.285 . . . . 0.0 108.759 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 146.77 -47.64 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.582 1 C-N-CA 133.127 4.571 . . . . 0.0 106.62 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -123.92 124.75 43.3 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -170.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.31 -9.25 3.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.363 1.465 . . . . 0.0 113.422 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -69.99 -21.29 63.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.223 1.009 . . . . 0.0 111.657 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.05 -22.86 63.03 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.11 -0.994 . . . . 0.0 111.092 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.52 152.43 40.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.314 0.578 . . . . 0.0 110.575 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -129.67 111.06 12.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.914 2.086 . . . . 0.0 105.597 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.07 -144.85 5.13 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.8 m -136.61 152.39 50.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 151.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.63 142.83 33.64 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.286 1.434 . . . . 0.0 108.824 -172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 104' ' ' ARG . 2.0 mp -141.21 165.52 27.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.789 0.836 . . . . 0.0 109.168 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 m -152.47 154.69 36.02 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.131 0.491 . . . . 0.0 111.865 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -154.2 158.42 40.29 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.33 1.852 . . . . 0.0 107.621 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -121.58 111.97 17.89 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.421 1.488 . . . . 0.0 107.182 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -101.83 131.88 47.91 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.808 -0.557 . . . . 0.0 109.738 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -83.51 132.97 34.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.633 1.573 . . . . 0.0 109.466 172.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 33.1 tptt -62.38 107.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 107.86 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.4 t -133.69 -127.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.48 1.512 . . . . 0.0 108.021 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -55.25 102.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.314 1.446 . . . . 0.0 110.542 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 36.2 mtm 45.31 67.88 0.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.134 1.374 . . . . 0.0 110.622 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 70.15 -126.9 17.18 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.63 141.79 35.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 40.27 1.83 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.666 -0.519 . . . . 0.0 112.579 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -142.71 162.58 35.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.468 1.634 . . . . 0.0 109.11 163.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -123.91 152.23 42.66 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.246 1.818 . . . . 0.0 107.632 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.64 161.99 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.16 0.984 . . . . 0.0 108.478 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -135.71 158.84 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.698 2.399 . . . . 0.0 106.126 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.7 152.53 22.15 Favored Glycine 0 C--O 1.237 0.282 0 C-N-CA 126.025 1.774 . . . . 0.0 108.68 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.06 -77.18 0.14 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.754 0.692 . . . . 0.0 112.612 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -170.21 -50.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.658 0.729 . . . . 0.0 110.302 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -101.07 166.1 13.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.558 1.543 . . . . 0.0 111.169 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.25 43.81 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.778 3.652 . . . . 0.0 110.772 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.0 23.15 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.735 2.014 . . . . 0.0 110.79 -173.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.26 167.84 10.22 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.983 0.913 . . . . 0.0 109.107 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.46 160.99 27.41 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 110.967 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -124.75 132.07 53.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 127.009 2.124 . . . . 0.0 106.552 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.9 mt-30 -130.39 155.97 45.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.42 112.34 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 165.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -59.9 -49.62 76.96 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 108.686 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 65' ' ' THR . 3.9 m -157.58 146.39 19.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.767 1.227 . . . . 0.0 108.474 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.51 143.24 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 159.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -71.54 135.9 83.73 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.72 137.66 25.18 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.365 1.377 . . . . 0.0 109.523 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 51.61 67.62 0.93 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.431 1.092 . . . . 0.0 111.327 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.37 175.01 25.17 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.414 -0.804 . . . . 0.0 111.844 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.99 -35.55 92.79 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 112.221 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' A' ' 63' ' ' MET . . . -67.3 -36.57 81.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.892 1.277 . . . . 0.0 111.714 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.88 67.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.36 0.664 . . . . 0.0 109.897 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.02 -45.88 86.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.638 1.175 . . . . 0.0 111.472 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -68.44 -24.46 64.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.022 0.529 . . . . 0.0 110.862 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.82 15.19 64.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.678 1.132 . . . . 0.0 113.815 169.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.01 -73.7 0.42 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.405 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -79.94 159.3 26.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -138.37 160.16 40.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.243 1.497 . . . . 0.0 111.518 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 50' ' ' SER . 55.0 m -60.0 133.78 56.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.606 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.31 -14.67 64.04 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.282 1.42 . . . . 0.0 113.765 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.21 150.87 41.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.379 1.59 . . . . 0.0 109.531 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG22 ' HG2' ' A' ' 47' ' ' GLN . 38.2 t -96.22 127.54 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.366 1.466 . . . . 0.0 108.959 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.46 117.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.289 . . . . 0.0 107.641 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.88 -60.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.569 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -132.0 148.86 52.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -130.71 130.8 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 53.02 -85.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.754 2.422 . . . . 0.0 112.449 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.61 9.99 2.9 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.768 1.167 . . . . 0.0 112.712 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.26 132.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.321 1.448 . . . . 0.0 109.118 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.68 98.44 1.92 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -98.42 8.47 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.908 0.883 . . . . 0.0 110.705 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -56.25 -21.51 24.09 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -169.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.24 22.73 5.0 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.096 1.808 . . . . 0.0 111.692 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.82 30.48 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.739 1.769 . . . . 0.0 109.116 166.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 144.63 48.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.06 -37.3 66.57 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.96 69.23 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.577 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.43 -50.26 11.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.602 1.092 . . . . 0.0 110.065 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.23 -39.44 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.068 1.347 . . . . 0.0 111.432 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.25 -40.58 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 120.851 -1.156 . . . . 0.0 109.735 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -31.32 70.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 110.682 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.97 -46.6 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.126 1.77 . . . . 0.0 109.482 174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.06 -37.38 86.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.994 0.816 . . . . 0.0 109.959 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.2 -24.46 62.22 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.515 -0.741 . . . . 0.0 112.112 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -70.83 -0.22 8.6 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.422 1.089 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.2 t -100.12 101.84 15.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.09 168.01 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.596 1.53 . . . . 0.0 110.919 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.7 142.12 12.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.13 -11.61 35.45 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.589 -1.117 . . . . 0.0 113.69 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -84.58 154.24 22.73 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 120.478 2.139 . . . . 0.0 107.465 165.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -126.03 157.53 37.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.057 1.343 . . . . 0.0 109.338 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.66 147.21 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.39 150.5 26.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 mt -141.44 139.81 33.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.87 123.2 69.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -115.96 164.37 14.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 123.958 0.786 . . . . 0.0 110.172 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 16.9 t -115.89 119.86 37.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 165.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 21' ' ' LEU . 7.0 ttm180 -74.35 156.27 37.27 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.668 1.187 . . . . 0.0 107.993 163.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.35 30.58 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.009 0.822 . . . . 0.0 113.309 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -103.35 126.8 31.17 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.41 172.52 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.393 2.062 . . . . 0.0 111.689 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.15 142.68 98.65 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 122.695 2.264 . . . . 0.0 111.25 -174.392 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 19.3 t80 . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 15' ' ' GLN . 9.1 m -74.02 -110.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.511 1.124 . . . . 0.0 112.369 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 134.61 -51.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 134.296 5.039 . . . . 0.0 109.939 -175.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -125.26 22.49 7.81 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -165.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.17 -11.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 114.922 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 t -62.75 -31.53 72.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.99 1.716 . . . . 0.0 112.605 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HB2' HG23 ' A' ' 10' ' ' THR . 9.3 mm-40 -72.91 -11.95 60.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.8 mt -69.39 145.58 52.76 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.908 1.231 . . . . 0.0 109.944 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.2 142.41 28.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 160.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.58 -173.71 23.35 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.988 0.805 . . . . 0.0 112.812 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.7 m -106.53 129.02 54.55 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -80.21 133.87 36.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -145.23 174.47 11.06 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.323 1.449 . . . . 0.0 109.005 177.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -151.04 163.25 39.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.243 0.217 . . . . 0.0 110.615 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -154.47 158.04 39.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.96 0.886 . . . . 0.0 108.636 166.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.7 m -114.84 117.83 31.81 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 167.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.58 138.5 36.58 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -90.95 129.82 36.94 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.95 103.58 0.18 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.008 1.323 . . . . 0.0 107.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t -129.51 165.83 20.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.523 1.529 . . . . 0.0 107.779 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 44.05 -73.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.733 3.213 . . . . 0.0 113.273 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.5 ptp -142.74 5.94 1.59 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.089 1.756 . . . . 0.0 113.43 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.23 -126.18 2.44 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 120.851 1.66 . . . . 0.0 111.599 -172.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.91 145.98 46.21 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.976 0.91 . . . . 0.0 109.253 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.55 36.23 2.98 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.856 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -149.07 169.09 21.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.099 1.45 . . . . 0.0 108.883 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -131.77 154.21 49.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.373 1.069 . . . . 0.0 108.439 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.81 160.58 17.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.597 1.159 . . . . 0.0 107.898 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 tt -125.25 162.03 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.722 2.009 . . . . 0.0 107.207 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.76 150.7 19.37 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.64 -63.16 3.31 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-O 118.952 -0.916 . . . . 0.0 112.285 -172.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.14 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 128.453 2.701 . . . . 0.0 109.09 164.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -89.79 160.7 40.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.399 1.48 . . . . 0.0 112.39 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.97 51.83 3.23 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 125.082 3.855 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.69 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.901 2.08 . . . . 0.0 110.921 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -102.5 154.49 19.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 120.632 -1.292 . . . . 0.0 109.126 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.57 137.43 33.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.162 0.985 . . . . 0.0 108.741 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.82 113.12 24.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.382 1.873 . . . . 0.0 109.173 -174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.72 157.27 16.82 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 122.104 2.229 . . . . 0.0 111.207 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 t -61.08 115.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -55.11 36.93 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.36 -0.838 . . . . 0.0 109.142 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 m -159.66 154.29 24.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.973 0.909 . . . . 0.0 109.582 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.08 133.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 160.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.3 135.15 66.1 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 125.872 1.669 . . . . 0.0 107.574 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.12 147.51 84.09 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.509 1.472 . . . . 0.0 109.074 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 64.3 24.25 13.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.038 0.935 . . . . 0.0 112.509 167.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.97 176.54 19.9 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.798 1.666 . . . . 0.0 112.478 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.25 -12.36 25.37 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.734 2.956 . . . . 0.0 113.497 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.16 -50.71 12.38 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 168.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.32 -54.76 41.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.688 0.795 . . . . 0.0 109.971 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -68.94 -15.4 63.48 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.326 0.966 . . . . 0.0 113.473 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.9 -38.56 73.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.227 1.376 . . . . 0.0 109.415 166.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.04 -28.94 13.66 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.045 1.307 . . . . 0.0 113.057 167.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -93.63 -12.67 28.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.201 1.5 . . . . 0.0 113.836 -160.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.0 ttm -90.53 144.84 25.39 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 120.976 -1.077 . . . . 0.0 108.417 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -137.06 179.04 6.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.523 1.129 . . . . 0.0 108.181 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 m -93.93 149.4 21.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.1 5.92 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -165.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -134.76 157.07 47.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.46 114.03 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.86 2.064 . . . . 0.0 108.351 -167.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -60.26 115.4 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.247 1.419 . . . . 0.0 108.089 171.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.95 -54.55 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 124.12 0.887 . . . . 0.0 109.974 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.16 154.25 51.69 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.288 1.435 . . . . 0.0 108.684 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 77' ' ' VAL . 46.4 mt -135.01 129.2 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 51.22 -89.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.898 2.479 . . . . 0.0 110.896 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -135.14 28.51 3.44 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.396 1.453 . . . . 0.0 112.023 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.98 133.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 120.904 -1.123 . . . . 0.0 109.293 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.35 106.45 12.37 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.879 1.272 . . . . 0.0 110.322 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 72' ' ' ILE . 28.7 m -108.47 5.18 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.188 0.995 . . . . 0.0 112.784 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -56.06 -32.04 63.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.41 14.63 13.28 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.612 1.577 . . . . 0.0 110.739 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -68.65 161.85 27.27 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 p -73.23 145.85 45.9 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.38 -41.77 66.23 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 109.113 168.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.26 63.68 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.326 0.966 . . . . 0.0 113.462 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.79 -53.87 6.66 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 120.288 1.404 . . . . 0.0 109.435 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 t -56.0 -39.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.395 1.878 . . . . 0.0 111.662 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.1 -38.36 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 120.93 -1.106 . . . . 0.0 110.068 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -37.26 81.8 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 120.148 1.34 . . . . 0.0 109.182 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.18 -39.41 92.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.659 1.184 . . . . 0.0 109.16 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -69.24 -45.02 70.79 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.95 0.795 . . . . 0.0 111.904 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.07 -29.45 70.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.904 0.775 . . . . 0.0 112.106 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.6 p -56.69 -25.56 54.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.263 1.025 . . . . 0.0 113.548 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.05 109.24 17.66 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -162.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.75 170.19 14.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.635 1.556 . . . . 0.0 110.419 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mt -63.29 144.64 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.71 -4.05 53.33 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 117.654 -1.637 . . . . 0.0 113.99 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -86.52 175.94 8.09 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.867 1.834 . . . . 0.0 108.735 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.48 162.75 28.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.996 1.318 . . . . 0.0 109.999 170.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.04 150.37 24.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 125.331 1.452 . . . . 0.0 108.708 165.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -83.16 159.4 22.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 173.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -145.95 143.75 29.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.81 129.85 74.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 67' ' ' ASP . 27.1 mt -118.47 171.13 8.37 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 124.296 0.997 . . . . 0.0 110.369 168.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 12.3 t -131.04 119.87 22.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.908 1.283 . . . . 0.0 108.344 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 21' ' ' LEU . 18.9 ttm180 -91.11 140.94 29.34 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.181 1.393 . . . . 0.0 110.467 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.85 -38.01 1.87 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.178 0.894 . . . . 0.0 111.008 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -60.91 120.1 50.74 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.56 0.744 . . . . 0.0 109.316 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.11 177.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.646 2.231 . . . . 0.0 111.802 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.23 151.78 95.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.955 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.452 -0.922 0 C-N-CA 122.517 2.144 . . . . 0.0 110.334 -178.408 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 . . . . . 0 C--O 1.236 0.357 0 CA-C-O 122.227 1.013 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -74.51 -97.97 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.048 1.339 . . . . 0.0 113.928 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 116.67 -34.61 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 1 C-N-CA 136.112 5.765 . . . . 0.0 110.913 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -146.02 18.73 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 112.674 -161.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 62.3 -22.32 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.034 2.934 . . . . 0.0 114.749 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 t -74.17 -6.26 46.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.364 1.438 . . . . 0.0 113.433 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -80.41 -22.64 41.02 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 119.625 -1.922 . . . . 0.0 111.159 164.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.41 146.15 54.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -131.52 124.54 30.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.85 177.99 15.15 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.1 m -93.17 155.43 17.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.655 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 12.7 m-85 -106.44 132.28 52.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.876 1.67 . . . . 0.0 109.344 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 165.64 12.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 108.475 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -139.02 149.79 45.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.6 1.16 . . . . 0.0 109.019 160.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -155.05 157.15 37.12 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 m -130.31 105.96 8.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.42 134.83 40.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.6 145.62 29.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.55 95.37 1.4 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -84.04 -166.45 1.42 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.548 2.339 . . . . 0.0 110.021 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -58.85 -24.58 62.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -165.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -133.07 53.19 2.03 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 -123.86 26.33 Favored Glycine 0 N--CA 1.441 -0.995 0 O-C-N 121.332 -0.855 . . . . 0.0 111.505 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.97 136.56 49.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.3 51.43 4.37 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.415 0.552 . . . . 0.0 112.169 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.46 173.27 13.28 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.01 1.324 . . . . 0.0 108.781 165.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.58 159.62 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.206 1.403 . . . . 0.0 108.811 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.76 159.51 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.078 1.351 . . . . 0.0 109.658 -174.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.83 155.46 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 128.954 2.902 . . . . 0.0 106.853 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.99 152.25 20.99 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.936 1.731 . . . . 0.0 109.128 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.91 -75.6 0.17 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.373 1.463 . . . . 0.0 111.801 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.92 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.473 1.509 . . . . 0.0 108.22 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -97.3 167.67 11.52 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -167.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.44 55.46 3.65 Favored 'Trans proline' 0 C--N 1.351 0.668 1 C-N-CA 125.312 4.008 . . . . 0.0 111.234 172.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.88 -8.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.956 1.302 . . . . 0.0 112.973 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.09 162.79 15.15 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.13 -0.981 . . . . 0.0 112.783 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.22 134.31 52.44 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.442 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 85' ' ' VAL . 16.8 mt -104.45 135.88 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -130.25 153.68 48.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.203 0.91 . . . . 0.0 110.947 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.0 119.29 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -71.2 -50.32 34.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.985 1.714 . . . . 0.0 110.16 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -152.31 152.6 32.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.041 1.736 . . . . 0.0 108.295 168.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.48 136.27 24.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 160.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.95 142.88 91.12 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 141.82 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.676 1.584 . . . . 0.0 111.016 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 46.84 68.52 0.61 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.814 1.646 . . . . 0.0 110.765 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.41 175.4 26.78 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.944 1.259 . . . . 0.0 110.415 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -64.68 -33.22 55.66 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.598 2.198 . . . . 0.0 112.7 -167.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.69 74.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.28 80.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.406 1.083 . . . . 0.0 111.517 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.69 -34.55 77.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.19 0.596 . . . . 0.0 112.536 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -33.84 75.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.751 0.786 . . . . 0.0 109.169 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.03 6.04 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.987 2.232 . . . . 0.0 114.209 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -65.57 -45.75 82.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.163 0.981 . . . . 0.0 109.246 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 tpp -65.63 122.75 17.95 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.835 0.854 . . . . 0.0 109.25 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.04 159.94 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 108.897 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 m -78.06 149.55 33.93 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.786 -1.196 . . . . 0.0 108.436 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -8.44 77.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.87 0.748 . . . . 0.0 113.71 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.41 158.18 34.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.143 1.472 . . . . 0.0 110.25 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.68 130.02 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.305 1.842 . . . . 0.0 108.741 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.93 126.71 39.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.112 1.365 . . . . 0.0 108.231 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.409 HG11 ' HB2' ' A' ' 13' ' ' ALA . 2.6 t -110.78 -54.67 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.858 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -135.06 142.03 46.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.11 112.32 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 t30 71.97 -68.86 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.268 3.027 . . . . 0.0 111.322 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -156.47 24.77 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 110.756 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.05 132.27 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 120.491 -1.381 . . . . 0.0 107.513 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 t -69.78 116.38 10.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.987 0.915 . . . . 0.0 108.716 168.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.09 5.37 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.771 0.829 . . . . 0.0 111.787 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -55.12 -24.01 23.77 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.21 22.94 5.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.856 1.693 . . . . 0.0 110.529 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -75.69 158.47 32.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.352 1.576 . . . . 0.0 109.894 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 t -77.14 149.1 35.66 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.24 -41.38 72.07 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.811 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.51 -32.3 62.78 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.379 1.445 . . . . 0.0 112.403 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -80.34 -47.8 13.93 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 118.86 0.754 . . . . 0.0 110.866 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG21 ' CD1' ' A' ' 46' ' ' LEU . 4.1 t -59.0 -42.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.711 -1.243 . . . . 0.0 110.703 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.58 -44.8 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.324 172.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -37.89 84.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.629 1.558 . . . . 0.0 111.167 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -60.93 -50.52 73.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.212 1.405 . . . . 0.0 108.362 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -64.79 -39.98 94.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.211 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -67.01 -34.25 77.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.444 0.698 . . . . 0.0 110.168 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -70.53 -3.81 19.83 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.38 116.58 65.71 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -60.86 157.23 39.24 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.741 2.294 . . . . 0.0 110.896 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.9 mt -59.85 139.21 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -13.11 59.17 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.424 -1.764 . . . . 0.0 114.299 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -84.21 167.16 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.834 2.317 . . . . 0.0 108.241 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.33 163.56 22.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.655 1.182 . . . . 0.0 110.008 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.0 146.25 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.398 1.479 . . . . 0.0 107.777 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.82 156.51 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.485 1.114 . . . . 0.0 109.524 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.48 109.59 4.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.5 t -89.3 121.15 39.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -116.52 163.77 15.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 124.11 0.881 . . . . 0.0 110.804 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.0 t -116.95 126.73 53.37 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.999 1.32 . . . . 0.0 108.563 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -76.52 156.84 32.59 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.454 1.502 . . . . 0.0 110.552 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.31 -21.93 8.56 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.808 1.194 . . . . 0.0 113.507 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -76.52 159.65 79.05 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 118.364 1.082 . . . . 0.0 109.888 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.23 178.31 6.74 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.986 2.458 . . . . 0.0 111.786 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.1 151.83 94.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 164.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 C-N-CA 121.761 1.641 . . . . 0.0 111.433 174.683 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 10' ' ' THR . 88.0 t80 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 88.0 m -102.31 -106.25 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 110.297 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 138.41 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 133.851 4.86 . . . . 0.0 110.597 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -123.54 17.26 9.65 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.043 0.838 . . . . 0.0 113.217 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 58.66 -10.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.957 2.903 . . . . 0.0 115.184 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -75.92 -15.75 60.14 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.157 -1.589 . . . . 0.0 113.739 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.09 -16.85 63.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.96 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.01 162.9 28.64 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.535 1.061 . . . . 0.0 110.844 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -126.46 135.3 51.19 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.994 2.118 . . . . 0.0 106.142 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 -158.4 27.64 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -164.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -128.4 143.09 50.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.527 1.131 . . . . 0.0 108.403 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.9 m-85 -88.87 134.99 33.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.567 0.747 . . . . 0.0 109.387 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -113.09 171.64 7.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.042 1.737 . . . . 0.0 108.301 173.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.4 p -147.72 153.35 39.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.431 0.693 . . . . 0.0 109.538 162.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.73 158.18 40.6 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.069 1.348 . . . . 0.0 107.393 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 97' ' ' SER . 11.1 m -131.16 117.03 18.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 168.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.91 144.76 26.53 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -82.48 145.12 29.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 163.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -72.04 93.18 1.37 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -80.66 -165.62 0.92 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.831 1.253 . . . . 0.0 110.785 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.33 -47.12 66.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.766 1.627 . . . . 0.0 112.764 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 59.1 mtt -116.43 62.8 0.71 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.171 0.988 . . . . 0.0 108.421 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.24 -118.1 8.38 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.129 164.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.82 137.66 54.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.47 40.92 2.03 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.911 -0.939 . . . . 0.0 112.702 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -145.35 162.05 38.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.68 1.74 . . . . 0.0 109.439 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 p -124.46 158.24 33.29 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.74 162.06 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.919 1.288 . . . . 0.0 108.019 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -134.77 141.74 42.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.26 152.16 23.1 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.48 -2.648 . . . . 0.0 106.48 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.18 3.9 9.6 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-O 118.474 -1.181 . . . . 0.0 114.986 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t70 74.1 -37.17 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.877 2.471 . . . . 0.0 111.643 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.58 135.46 92.78 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 123.557 0.743 . . . . 0.0 109.286 172.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.22 41.65 0.79 Allowed 'Trans proline' 0 CA--C 1.543 0.973 1 C-N-CA 126.263 4.642 . . . . 0.0 112.396 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.55 -2.58 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.565 1.546 . . . . 0.0 112.828 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.83 148.62 38.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.507 -1.37 . . . . 0.0 108.082 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.62 143.07 40.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.036 1.334 . . . . 0.0 109.12 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.3 141.81 28.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.345 1.058 . . . . 0.0 109.854 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' HG22 ' A' ' 68' ' ' VAL . 33.5 mt-30 -130.95 154.87 47.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.612 1.165 . . . . 0.0 110.575 169.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.46 107.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 120.584 -1.322 . . . . 0.0 107.776 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -53.8 53.62 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 125.497 1.519 . . . . 0.0 109.288 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.4 p -154.46 161.41 41.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.391 0.276 . . . . 0.0 110.388 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 126.4 65.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.53 132.12 89.54 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.86 158.7 49.67 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.176 1.917 . . . . 0.0 110.359 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.4 -4.85 0.08 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.838 2.055 . . . . 0.0 114.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.57 172.71 43.09 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.582 1.563 . . . . 0.0 113.509 -165.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.83 -27.73 43.7 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.355 2.037 . . . . 0.0 112.533 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.63 67.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.05 74.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -57.37 -43.29 83.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.756 0.822 . . . . 0.0 112.948 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.54 -18.87 65.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.77 1.168 . . . . 0.0 111.191 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.42 -21.26 18.32 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 126.506 2.003 . . . . 0.0 112.75 164.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -80.78 -28.5 36.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.787 -1.101 . . . . 0.0 111.495 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.2 tpp -74.53 112.9 11.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -134.07 161.37 35.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 m -83.59 136.14 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.52 -5.75 83.63 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.603 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -66.18 151.28 47.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.484 1.642 . . . . 0.0 108.71 170.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.456 HG22 ' HG2' ' A' ' 47' ' ' GLN . 53.4 t -105.29 118.24 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.536 1.935 . . . . 0.0 109.084 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.21 105.81 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.935 1.694 . . . . 0.0 108.448 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.17 -58.47 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.993 0.425 . . . . 0.0 110.062 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.77 146.05 51.94 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.5 mt -122.44 120.12 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.75 -68.85 0.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.521 2.328 . . . . 0.0 111.488 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.45 25.91 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.655 1.982 . . . . 0.0 110.621 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.5 t -131.17 130.5 63.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.386 1.474 . . . . 0.0 108.041 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 p -65.94 126.2 27.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.228 0.611 . . . . 0.0 110.349 167.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.92 13.14 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.451 0.7 . . . . 0.0 112.024 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.87 -12.62 59.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.01 25.99 4.29 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.24 149.58 22.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.682 0.753 . . . . 0.0 109.165 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.86 142.0 38.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.695 -1.138 . . . . 0.0 107.943 -170.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -58.42 -23.41 57.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.84 1.656 . . . . 0.0 111.274 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.43 71.62 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.321 0.964 . . . . 0.0 110.808 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.24 -46.8 54.5 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.448 0.699 . . . . 0.0 109.529 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.63 -41.5 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 O-C-N 120.597 -1.314 . . . . 0.0 111.117 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.53 -34.62 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.843 -1.161 . . . . 0.0 110.107 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.14 83.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.779 1.172 . . . . 0.0 109.776 171.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.25 -36.97 77.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.54 1.136 . . . . 0.0 109.739 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.56 -40.94 63.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.593 0.757 . . . . 0.0 111.731 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -56.68 -41.7 77.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.013 0.925 . . . . 0.0 110.305 173.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.1 m -65.16 -2.95 3.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.82 110.72 49.29 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 120.747 1.612 . . . . 0.0 108.105 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.24 169.55 21.29 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.449 2.1 . . . . 0.0 111.374 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.67 148.63 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 121.385 -0.822 . . . . 0.0 109.328 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.5 -11.07 47.26 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.279 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -84.34 156.89 21.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.785 1.792 . . . . 0.0 107.993 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.503 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.0 p -125.96 148.82 49.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.441 1.096 . . . . 0.0 108.54 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.93 144.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.719 0.808 . . . . 0.0 109.841 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -82.88 155.21 24.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.27 152.14 45.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.05 111.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 67' ' ' ASP . 13.8 mt -102.3 168.1 9.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.88 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 38.6 t -123.48 142.42 51.02 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.473 1.109 . . . . 0.0 108.835 167.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.659 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 ttm180 -116.73 139.65 50.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 110.728 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.62 -14.67 7.19 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.726 1.155 . . . . 0.0 112.055 168.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.54 142.21 88.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.37 173.99 10.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.501 2.134 . . . . 0.0 110.03 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 162.71 30.95 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.169 0.588 . . . . 0.0 111.501 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo . . . . . 0 N--CA 1.45 -1.037 0 C-N-CA 122.526 2.151 . . . . 0.0 109.003 160.387 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 120.526 0.203 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -64.51 -113.38 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.421 2.688 . . . . 0.0 113.325 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 140.51 -23.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 1 C-N-CA 133.111 4.565 . . . . 0.0 111.661 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -126.96 179.1 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.146 1.378 . . . . 0.0 107.639 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.81 -34.5 6.93 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 126.098 1.759 . . . . 0.0 110.429 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -28.7 70.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.663 1.12 . . . . 0.0 111.523 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.41 -24.33 67.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.002 0.819 . . . . 0.0 112.186 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.14 142.8 57.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.102 0.865 . . . . 0.0 111.144 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 127.62 33.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 162.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.18 -173.3 36.79 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 123.859 0.725 . . . . 0.0 112.721 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -114.08 141.23 47.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 167.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.0 127.49 50.22 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.71 0.804 . . . . 0.0 110.462 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -115.8 162.08 17.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.082 1.753 . . . . 0.0 107.985 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -150.18 146.72 27.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.997 -0.439 . . . . 0.0 110.833 162.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -144.13 157.54 44.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -117.09 117.18 28.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.45 145.44 30.27 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -101.58 126.75 48.45 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.473 1.109 . . . . 0.0 109.159 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 25.2 tptt -55.55 109.69 0.59 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.664 1.586 . . . . 0.0 110.197 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.6 p -79.05 -173.65 3.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.597 1.159 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -59.63 -15.59 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.351 1.06 . . . . 0.0 112.747 166.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.7 mtt -132.03 49.22 2.34 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.22 1.373 . . . . 0.0 110.221 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 72.7 -109.81 2.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.026 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -121.32 152.78 38.56 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.39 35.52 2.42 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.155 -1.358 . . . . 0.0 111.849 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.14 167.1 29.62 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.668 1.734 . . . . 0.0 108.621 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.8 p -134.06 161.32 35.17 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.25 162.46 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.459 1.104 . . . . 0.0 109.486 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 14.7 tt -126.7 158.6 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 126.715 2.006 . . . . 0.0 107.468 166.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.65 152.26 22.9 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 157.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.47 -70.86 0.85 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 124.505 1.05 . . . . 0.0 111.171 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -37.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -137.0 176.23 2.93 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.578 1.151 . . . . 0.0 110.249 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -71.32 54.33 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.501 2.8 . . . . 0.0 112.231 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.49 -9.84 0.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.02 1.728 . . . . 0.0 112.361 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -110.79 158.01 19.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.395 1.452 . . . . 0.0 108.691 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -83.57 126.58 32.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.927 0.891 . . . . 0.0 109.173 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mt -80.99 139.72 35.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -134.22 156.77 47.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.294 0.638 . . . . 0.0 110.881 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 102' ' ' LEU . 38.5 t -67.03 114.63 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 24.1 ttmt -72.42 -51.58 19.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.647 1.579 . . . . 0.0 109.916 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 m -143.78 162.12 36.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.28 0.632 . . . . 0.0 109.417 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.85 138.91 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 162.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 mm -74.83 127.82 86.35 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.86 133.08 24.54 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 121.908 1.739 . . . . 0.0 109.768 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t0 65.48 13.04 8.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.32 1.448 . . . . 0.0 111.845 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.44 167.67 37.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.181 1.372 . . . . 0.0 111.116 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.23 -34.42 68.07 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.44 2.093 . . . . 0.0 112.716 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.33 91.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.529 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.46 96.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.459 0.704 . . . . 0.0 110.414 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -67.68 -37.43 82.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.986 0.812 . . . . 0.0 112.755 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.27 -24.89 63.13 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.433 -0.792 . . . . 0.0 110.855 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.76 -16.36 26.63 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.865 2.174 . . . . 0.0 113.483 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -81.29 -37.09 29.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.378 1.589 . . . . 0.0 114.163 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpp -70.01 118.37 12.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.52 166.06 24.08 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.999 0.919 . . . . 0.0 109.025 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -100.56 98.96 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.261 1.029 . . . . 0.0 110.491 -150.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.66 -6.7 5.87 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.776 1.655 . . . . 0.0 112.322 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 102' ' ' LEU . 2.8 m-20 -68.46 163.15 23.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.404 1.102 . . . . 0.0 110.62 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.9 t -111.87 120.64 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.27 1.828 . . . . 0.0 109.552 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.13 109.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 126.467 1.907 . . . . 0.0 108.881 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.8 t -93.68 -51.83 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.406 0.622 . . . . 0.0 110.086 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -134.96 154.59 51.66 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.075 1.35 . . . . 0.0 108.179 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.422 HG13 HG21 ' A' ' 77' ' ' VAL . 54.1 mt -134.86 134.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 50.46 -92.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.456 1.902 . . . . 0.0 110.072 -169.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -143.17 20.81 1.92 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.222 2.609 . . . . 0.0 108.971 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -128.87 128.49 67.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.325 2.25 . . . . 0.0 107.636 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.35 129.46 36.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 72' ' ' ILE . 30.5 m -130.11 11.07 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.058 1.343 . . . . 0.0 110.964 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -20.93 64.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.07 33.83 2.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.763 1.649 . . . . 0.0 109.659 167.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.22 161.42 28.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.681 1.74 . . . . 0.0 109.225 165.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.96 151.37 33.69 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -55.35 -35.13 64.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.136 0.974 . . . . 0.0 110.39 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.4 38.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.116 0.871 . . . . 0.0 110.606 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.88 -48.18 69.53 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.768 0.827 . . . . 0.0 110.846 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.67 -43.1 96.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 125.054 1.341 . . . . 0.0 111.149 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.51 -39.62 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.982 -1.074 . . . . 0.0 109.363 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -38.82 92.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.876 1.217 . . . . 0.0 110.027 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.12 -31.81 73.14 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.134 1.374 . . . . 0.0 111.052 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.61 -46.36 22.34 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.06 0.846 . . . . 0.0 111.546 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.03 -29.86 70.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.216 -0.928 . . . . 0.0 111.586 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 t -63.42 -14.34 49.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.535 1.134 . . . . 0.0 112.746 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.3 t -84.26 112.16 39.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 120.409 1.459 . . . . 0.0 107.198 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.96 169.27 22.99 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.79 1.66 . . . . 0.0 110.869 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.06 139.57 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.54 -10.19 62.59 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.083 -0.843 . . . . 0.0 113.699 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -84.23 172.64 11.68 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.419 1.61 . . . . 0.0 108.735 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 p -134.06 156.21 48.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.205 1.002 . . . . 0.0 110.576 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.44 142.53 32.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.06 0.944 . . . . 0.0 108.849 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.86 143.6 29.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.367 1.867 . . . . 0.0 107.228 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.7 mt -144.79 110.87 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.35 132.07 35.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.679 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.9 mt -119.02 162.89 17.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 109.707 170.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.18 133.96 50.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.996 1.318 . . . . 0.0 108.658 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' A' ' 21' ' ' LEU . 10.6 ttm180 -102.4 155.42 18.26 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 126.627 1.971 . . . . 0.0 112.279 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.81 -8.56 63.62 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.351 0.976 . . . . 0.0 112.775 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.37 151.55 97.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 117.71 0.755 . . . . 0.0 109.604 163.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.5 166.39 28.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.491 2.127 . . . . 0.0 112.104 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.59 157.25 79.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.415 1.486 . . . . 0.0 110.417 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 C-N-CA 122.584 2.189 . . . . 0.0 110.831 176.338 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.121 0.486 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 m -81.76 -109.57 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.018 1.327 . . . . 0.0 112.178 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mtm105 135.71 -67.39 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 1 C-N-CA 133.915 4.886 . . . . 0.0 108.742 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.83 -3.86 9.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.896 -157.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.59 -27.31 0.19 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 128.497 2.719 . . . . 0.0 114.713 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -66.37 -6.44 14.33 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.122 1.328 . . . . 0.0 111.727 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.63 -19.08 65.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.481 1.513 . . . . 0.0 112.41 163.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 mt -91.24 159.18 16.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.236 1.38 . . . . 0.0 108.593 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -3.73 13.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.38 -172.76 38.28 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 126.179 1.847 . . . . 0.0 111.685 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -88.01 156.4 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.463 1.505 . . . . 0.0 108.574 170.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -125.54 130.05 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.801 1.241 . . . . 0.0 109.038 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.86 173.34 6.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 108.172 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.3 p -151.21 142.7 23.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.422 -0.799 . . . . 0.0 109.405 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.3 t -150.62 158.15 43.81 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -121.49 106.0 11.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 107.023 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.86 118.55 34.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -92.41 116.38 28.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -42.95 91.97 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.819 2.448 . . . . 0.0 112.298 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -79.52 111.67 16.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 17.34 -83.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 130.269 3.428 . . . . 0.0 115.209 -168.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.0 mtt -56.38 -21.98 28.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.394 1.478 . . . . 0.0 113.463 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.73 -124.51 5.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 124.829 1.204 . . . . 0.0 110.426 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.58 129.64 50.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.37 49.04 2.93 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -146.73 171.89 14.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.567 1.547 . . . . 0.0 108.356 166.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -134.13 163.38 29.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.606 0.762 . . . . 0.0 109.407 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.58 162.35 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 108.44 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.45 159.91 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 128.244 2.618 . . . . 0.0 107.006 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.16 152.57 22.86 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 128.354 2.883 . . . . 0.0 106.523 167.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.77 -70.54 0.88 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 118.819 1.31 . . . . 0.0 113.091 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -173.82 -52.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -97.56 163.41 19.74 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 124.64 1.176 . . . . 0.0 112.619 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -75.1 48.37 2.0 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 125.099 3.866 . . . . 0.0 112.082 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -150.8 -7.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 110.497 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.32 152.44 19.15 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.874 0.761 . . . . 0.0 112.293 -161.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -57.89 134.22 56.13 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.101 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.4 mt -100.65 126.61 47.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.022 1.729 . . . . 0.0 106.375 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.95 155.05 47.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.017 0.826 . . . . 0.0 110.238 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.95 112.37 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.42 -47.94 71.61 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.123 0.969 . . . . 0.0 109.207 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -155.98 158.53 38.03 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.014 1.326 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.07 145.01 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 165.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -81.62 128.85 67.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.75 160.21 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.755 1.637 . . . . 0.0 110.221 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.4 -12.95 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.996 2.118 . . . . 0.0 114.903 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 178.1 54.06 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.667 1.127 . . . . 0.0 112.94 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.87 -37.46 77.45 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.695 2.263 . . . . 0.0 110.79 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.9 76.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.168 0.587 . . . . 0.0 111.649 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.06 -40.97 67.93 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.67 -49.46 76.42 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.06 -35.47 78.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.707 0.289 . . . . 0.0 110.949 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.48 -11.34 39.22 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.878 1.228 . . . . 0.0 113.995 161.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.43 -46.01 88.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.09 1.445 . . . . 0.0 109.709 168.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.5 tpp -66.28 115.91 6.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.37 159.14 42.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -87.88 117.85 27.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.162 -159.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.68 -8.25 39.82 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.535 1.54 . . . . 0.0 113.46 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.43 155.02 26.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.438 1.619 . . . . 0.0 109.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.35 116.82 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.037 1.735 . . . . 0.0 109.375 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.05 118.79 4.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 126.659 1.983 . . . . 0.0 108.052 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.95 -57.62 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.053 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.7 150.74 51.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mt -127.69 123.29 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.16 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.478 3.111 . . . . 0.0 110.518 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.39 -6.53 1.36 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.934 1.694 . . . . 0.0 111.952 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -88.74 124.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.51 120.07 12.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.4 6.56 6.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 124.699 1.2 . . . . 0.0 110.948 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 78' ' ' LEU 0.26 1.0 OUTLIER -58.62 -25.89 63.15 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -166.21 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.63 11.18 21.29 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.512 2.006 . . . . 0.0 112.368 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 165.38 24.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.321 1.06 . . . . 0.0 110.242 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -75.85 148.51 38.28 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -60.76 -35.57 76.74 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.436 165.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.3 74.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.34 0.973 . . . . 0.0 111.929 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.84 -55.58 8.19 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 118.188 0.449 . . . . 0.0 110.488 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.37 -39.58 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 127.519 2.328 . . . . 0.0 112.162 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.9 -39.08 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 120.94 -1.1 . . . . 0.0 109.242 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -36.46 83.22 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.87 1.214 . . . . 0.0 109.638 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.64 -45.6 93.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.584 1.153 . . . . 0.0 108.722 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -66.2 -31.01 71.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.235 0.614 . . . . 0.0 112.237 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.34 -6.65 59.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.056 1.342 . . . . 0.0 112.963 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -91.02 7.61 39.51 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.213 1.405 . . . . 0.0 113.57 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.2 t -101.18 107.59 50.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.5 172.41 14.49 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.35 2.7 . . . . 0.0 113.33 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 94' ' ' ILE . 4.2 mp -70.94 100.15 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.291 1.436 . . . . 0.0 110.665 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.56 -42.09 1.05 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -84.26 160.75 20.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.694 0.759 . . . . 0.0 109.61 -164.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.89 160.54 22.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.582 1.553 . . . . 0.0 108.474 170.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.11 147.15 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.66 157.45 22.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -146.52 116.27 7.22 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.81 123.98 45.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.97 159.01 17.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.794 0.683 . . . . 0.0 110.353 159.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.3 t -105.97 136.16 46.13 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.284 1.434 . . . . 0.0 107.661 165.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -81.52 156.23 25.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.231 1.412 . . . . 0.0 112.43 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.31 35.84 7.84 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.11 151.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -117.3 150.42 46.34 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 161.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.08 171.71 13.25 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.215 1.943 . . . . 0.0 111.208 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.61 143.22 94.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.503 0 C-N-CA 122.821 2.347 . . . . 0.0 114.219 -168.673 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 15.0 t80 . . . . . 0 CA--C 1.547 0.851 0 CA-C-O 122.377 1.084 . . . . 0.0 113.427 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -81.86 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.551 1.541 . . . . 0.0 110.617 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 145.85 -60.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.373 4.269 . . . . 0.0 111.398 174.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.58 2.37 26.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.936 1.294 . . . . 0.0 111.029 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.01 -14.15 0.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.8 2.44 . . . . 0.0 113.669 -168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -57.88 -29.16 64.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.36 1.064 . . . . 0.0 113.095 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -77.93 -11.97 59.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.082 -171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.7 166.12 18.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.198 0.999 . . . . 0.0 110.342 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -128.0 136.42 51.25 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.24 -161.49 25.63 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -107.04 161.52 14.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -119.56 121.31 39.07 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.661 1.584 . . . . 0.0 108.142 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.424 HD13 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -145.74 154.07 41.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.376 1.07 . . . . 0.0 110.576 -170.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.8 p -157.14 163.28 39.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -165.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 t -154.92 157.71 38.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.0 m -101.33 119.82 39.33 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.225 1.01 . . . . 0.0 108.52 158.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -99.11 159.3 15.07 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.792 1.237 . . . . 0.0 108.125 163.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -103.84 143.52 32.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -66.98 99.35 0.64 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -88.47 -163.4 0.96 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.377 2.271 . . . . 0.0 108.487 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -48.49 -65.21 0.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.942 1.297 . . . . 0.0 110.925 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.44 66.81 1.11 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.2 -106.76 0.61 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 124.818 1.199 . . . . 0.0 113.469 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.37 152.25 43.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.0 40.15 2.89 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.328 -1.262 . . . . 0.0 111.753 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -154.92 161.47 41.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.748 1.774 . . . . 0.0 110.316 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 p -130.41 159.93 35.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.977 1.311 . . . . 0.0 109.315 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.82 162.63 26.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 125.208 1.403 . . . . 0.0 109.973 -170.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.18 151.58 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.469 1.508 . . . . 0.0 110.067 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.29 153.37 16.73 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 129.322 3.344 . . . . 0.0 109.333 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.86 -82.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.68 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.028 1.731 . . . . 0.0 109.798 163.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -93.57 162.59 27.14 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.541 1.537 . . . . 0.0 113.473 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.55 43.17 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 125.086 3.857 . . . . 0.0 112.925 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -166.47 12.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.63 1.972 . . . . 0.0 111.683 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 155.13 21.2 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.349 -1.469 . . . . 0.0 110.969 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.93 115.74 23.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.054 0.942 . . . . 0.0 109.491 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.79 140.6 35.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.884 0.766 . . . . 0.0 109.502 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.422 ' HG2' HG22 ' A' ' 68' ' ' VAL . 39.9 mt-30 -131.63 157.18 44.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.845 0.748 . . . . 0.0 111.231 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.48 111.02 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 168.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -60.76 -54.65 42.63 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.022 0.929 . . . . 0.0 109.328 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 65' ' ' THR . 53.6 p -154.99 164.45 38.88 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.97 0.508 . . . . 0.0 110.672 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.11 145.34 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 160.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.5 123.42 76.65 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 165.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.57 150.95 86.1 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.552 2.168 . . . . 0.0 109.854 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.319 1.0 OUTLIER 58.99 -0.7 0.13 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.996 1.718 . . . . 0.0 115.137 -168.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.05 167.18 54.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.48 1.038 . . . . 0.0 112.563 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.17 -26.52 36.18 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.952 1.768 . . . . 0.0 112.236 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.74 -45.61 78.06 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.781 -0.575 . . . . 0.0 109.807 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.92 97.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.572 0.749 . . . . 0.0 110.96 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -69.69 -26.07 64.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.78 -38.98 76.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.47 1.032 . . . . 0.0 109.238 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.45 20.39 69.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.169 166.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -98.76 -52.05 3.71 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.807 1.804 . . . . 0.0 111.379 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.7 ttm -80.82 146.77 30.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.558 1.143 . . . . 0.0 109.961 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -134.09 165.1 25.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.385 1.088 . . . . 0.0 110.984 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 50' ' ' SER . 28.0 m -75.17 121.28 21.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.227 1.011 . . . . 0.0 108.656 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.05 -20.37 16.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.756 -1.025 . . . . 0.0 112.122 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 102' ' ' LEU . 14.9 m-20 -63.91 150.64 44.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.079 1.439 . . . . 0.0 109.402 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 47' ' ' GLN . 51.3 t -101.45 124.45 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.635 1.974 . . . . 0.0 108.813 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.42 128.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 125.353 1.461 . . . . 0.0 107.614 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.27 -56.85 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.899 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -133.09 147.57 52.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.324 1.05 . . . . 0.0 108.841 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mt -130.33 122.51 53.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 53.21 -92.63 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 127.35 2.26 . . . . 0.0 109.719 -162.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.61 1.38 8.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.37 1.468 . . . . 0.0 111.161 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -111.51 131.08 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 -160.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.4 p -74.69 123.28 24.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.62 12.77 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.034 0.934 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -54.33 -35.31 62.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -162.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.45 16.35 12.72 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.111 1.339 . . . . 0.0 112.624 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 164.91 12.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.874 1.837 . . . . 0.0 110.666 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 p -70.74 137.96 50.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.58 -25.14 64.34 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.594 -0.691 . . . . 0.0 110.546 167.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.51 -57.85 10.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.897 1.226 . . . . 0.0 110.31 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.86 -54.73 42.74 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.574 1.15 . . . . 0.0 110.472 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.4 -42.53 74.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.487 1.515 . . . . 0.0 111.491 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.09 -33.98 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.546 -1.346 . . . . 0.0 110.376 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -39.57 94.42 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.659 1.572 . . . . 0.0 109.361 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.24 -49.18 78.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -64.56 -41.4 96.34 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -55.51 -46.78 76.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.495 0.588 . . . . 0.0 109.585 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.5 p -64.76 -13.55 55.6 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.447 1.276 . . . . 0.0 114.447 -166.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.98 110.93 26.25 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.73 159.95 44.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 120.062 1.058 . . . . 0.0 109.59 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 79.8 mt -57.58 126.76 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.83 50.28 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.805 -1.553 . . . . 0.0 114.163 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -112.13 165.11 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 121.02 2.41 . . . . 0.0 110.327 168.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.6 p -123.25 164.7 18.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.124 1.37 . . . . 0.0 109.755 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.97 150.14 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.007 1.323 . . . . 0.0 108.314 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.83 154.14 23.66 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -146.24 126.27 13.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.37 130.97 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 67' ' ' ASP . 15.1 mt -118.45 169.05 10.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.322 1.014 . . . . 0.0 110.046 170.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.6 t -128.37 144.45 51.14 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.5 1.52 . . . . 0.0 108.887 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.11 123.16 39.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.432 1.493 . . . . 0.0 112.686 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.45 -25.44 0.86 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.989 1.28 . . . . 0.0 113.494 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -72.66 158.02 87.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 118.021 0.911 . . . . 0.0 110.856 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.27 175.79 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.006 2.471 . . . . 0.0 111.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mt -71.89 159.09 86.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.273 1.029 . . . . 0.0 109.484 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 123.806 3.004 . . . . 0.0 113.847 -178.755 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.2 t80 . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 122.228 1.013 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 11' ' ' ARG . 5.1 m -78.38 -143.69 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.185 2.194 . . . . 0.0 112.108 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.624 ' H ' HG22 ' A' ' 10' ' ' THR . 0.7 OUTLIER -163.02 -69.38 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 147.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.25 22.94 2.65 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.866 2.066 . . . . 0.0 111.911 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 10' ' ' THR . . . 55.89 -6.2 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.486 2.314 . . . . 0.0 114.653 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 m -75.41 -24.99 57.2 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.947 1.299 . . . . 0.0 110.628 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.55 -15.77 63.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.392 -1.29 . . . . 0.0 114.007 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 mt -74.64 161.91 29.24 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.253 1.388 . . . . 0.0 110.386 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.87 2.1 3.66 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -165.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.97 -179.27 41.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 162.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.4 m -81.82 154.56 25.85 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.438 0.695 . . . . 0.0 109.423 -172.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 6.2 m-85 -111.68 140.73 46.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.607 1.163 . . . . 0.0 108.346 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -122.51 -179.55 4.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.034 1.734 . . . . 0.0 107.658 -177.266 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -145.14 165.61 27.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.124 -0.36 . . . . 0.0 111.185 163.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -152.85 157.2 40.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 151.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.1 m -104.82 113.93 27.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 160.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.37 138.03 36.2 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -82.06 155.21 25.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 158.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' CE ' ' HA2' ' A' ' 31' ' ' GLY . 5.6 tptt -58.04 161.19 4.22 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 154.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -129.66 -78.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 159.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.39 132.95 46.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -170.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.5 mmt 63.04 -62.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.06 2.144 . . . . 0.0 111.132 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . -169.47 -154.25 9.04 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -170.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.12 153.74 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 163.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.38 35.17 2.43 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.134 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.17 163.12 37.95 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.906 2.353 . . . . 0.0 111.268 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -125.52 155.1 41.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.112 1.365 . . . . 0.0 109.174 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.96 162.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.383 1.473 . . . . 0.0 109.921 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 tt -136.76 157.76 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 128.324 2.65 . . . . 0.0 108.186 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.58 152.17 22.81 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.527 2.489 . . . . 0.0 107.966 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.09 -71.17 0.81 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.506 1.051 . . . . 0.0 112.725 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 170.27 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.577 1.551 . . . . 0.0 110.691 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.74 158.43 87.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 120.197 1.362 . . . . 0.0 110.228 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.28 43.31 1.28 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.505 3.47 . . . . 0.0 112.263 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.48 37.45 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.732 2.813 . . . . 0.0 108.669 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -113.54 150.3 33.17 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.96 0.904 . . . . 0.0 108.762 167.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -74.91 127.33 32.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.081 0.943 . . . . 0.0 109.112 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.37 142.78 32.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG2' HG22 ' A' ' 68' ' ' VAL . 53.3 mt-30 -142.49 162.35 35.69 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.674 0.789 . . . . 0.0 110.865 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.17 114.49 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.02 -50.06 72.17 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.61 0.641 . . . . 0.0 109.285 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.08 154.19 17.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.181 0.926 . . . . 0.0 110.095 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.75 121.42 55.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.51 129.24 90.38 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -85.85 48.24 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.782 2.988 . . . . 0.0 112.605 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.59 57.98 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.981 2.112 . . . . 0.0 107.694 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.12 171.22 44.07 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.104 -0.997 . . . . 0.0 112.632 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.72 -25.28 54.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.387 2.058 . . . . 0.0 112.174 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.02 70.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.984 0.811 . . . . 0.0 111.235 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.29 12.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.202 1.001 . . . . 0.0 108.746 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.08 -29.36 69.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -172.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.67 -26.75 67.19 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.726 -0.609 . . . . 0.0 110.927 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.94 -14.73 9.78 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.93 1.729 . . . . 0.0 113.437 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -83.59 -26.86 29.66 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.325 -1.103 . . . . 0.0 111.385 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.9 tpp -89.36 130.79 35.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.403 0.681 . . . . 0.0 110.173 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -144.0 166.2 25.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.795 1.638 . . . . 0.0 108.861 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.3 m -87.95 144.37 26.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.145 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.72 57.62 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.823 1.192 . . . . 0.0 112.396 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.2 144.05 44.29 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.962 1.381 . . . . 0.0 107.721 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 47' ' ' GLN . 69.5 t -98.45 118.35 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.248 1.819 . . . . 0.0 110.062 -162.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.65 110.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.498 1.519 . . . . 0.0 108.871 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 3.5 t -96.13 -59.94 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.344 0.593 . . . . 0.0 109.796 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -128.71 158.49 38.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.011 1.324 . . . . 0.0 107.566 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.1 122.93 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t30 65.05 -81.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.413 2.285 . . . . 0.0 110.489 168.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.74 36.35 1.16 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.432 1.093 . . . . 0.0 110.554 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.44 132.62 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 120.425 -1.422 . . . . 0.0 109.422 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.7 p -77.82 110.13 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.755 0.822 . . . . 0.0 109.368 165.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.67 -3.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -54.16 -31.18 51.88 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.03 1.286 . . . . 0.0 114.414 -164.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.76 28.56 5.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.506 1.527 . . . . 0.0 111.008 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 172.22 13.31 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 164.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 p -90.04 153.25 20.71 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -54.93 -36.45 65.28 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.119 1.368 . . . . 0.0 109.741 170.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -64.49 0.79 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.382 1.073 . . . . 0.0 110.902 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.73 -35.87 77.69 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.763 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.58 -40.27 87.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 120.548 -1.345 . . . . 0.0 111.265 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.69 -43.59 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -40.28 84.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.165 0.893 . . . . 0.0 110.499 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.3 mt -64.87 -41.06 95.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.589 1.556 . . . . 0.0 109.265 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -71.21 -39.19 71.9 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.476 1.034 . . . . 0.0 111.177 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -60.88 -36.95 80.52 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.814 0.734 . . . . 0.0 110.406 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -59.81 -13.24 9.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.052 1.741 . . . . 0.0 113.539 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.1 t -87.58 110.59 35.61 Favored Pre-proline 0 C--O 1.239 0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.86 160.15 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.729 1.619 . . . . 0.0 111.736 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.27 138.25 20.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 158.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.86 14.92 76.53 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.396 -1.78 . . . . 0.0 113.677 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -122.73 162.58 21.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.032 2.416 . . . . 0.0 111.413 165.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.72 155.14 30.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.665 1.986 . . . . 0.0 111.334 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.38 157.42 39.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.322 1.449 . . . . 0.0 109.172 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.87 158.69 22.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 mt -145.71 145.83 31.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -123.8 125.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 mt -112.85 165.05 12.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.345 1.028 . . . . 0.0 110.931 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.4 t -119.46 143.91 47.26 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.417 1.487 . . . . 0.0 108.288 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -100.77 155.85 17.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.446 2.298 . . . . 0.0 111.485 -178.09 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.47 -2.73 74.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.102 170.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -103.02 103.09 31.86 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 168.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.28 -174.72 1.49 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.769 2.979 . . . . 0.0 113.05 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 mt -65.57 146.03 99.0 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 125.612 1.565 . . . . 0.0 109.964 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 C-N-CA 123.712 2.942 . . . . 0.0 110.786 -173.66 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 . . . . . 0 C--O 1.242 0.662 0 CA-C-O 121.597 0.713 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 15' ' ' GLN . 11.6 m -73.07 -116.7 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.07 2.148 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 137.92 -76.13 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 1 C-N-CA 134.271 5.028 . . . . 0.0 106.195 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -95.22 10.95 34.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' THR . . . 68.64 -27.74 0.15 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.762 -1.836 . . . . 0.0 113.394 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -69.12 17.73 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.362 1.465 . . . . 0.0 113.249 170.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' HB2' HG23 ' A' ' 10' ' ' THR . 19.5 mm100 -115.2 -11.04 12.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.882 1.673 . . . . 0.0 110.702 168.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.83 162.54 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -138.58 131.14 29.03 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 124.932 1.293 . . . . 0.0 107.925 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.22 -133.47 4.14 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.1 m -133.11 152.53 51.95 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -109.82 145.91 35.93 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.007 0.821 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -130.02 170.29 14.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.243 2.217 . . . . 0.0 107.682 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -152.97 154.35 34.81 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 121.883 -0.511 . . . . 0.0 109.833 159.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -144.53 157.68 44.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.411 1.485 . . . . 0.0 109.154 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 97' ' ' SER . 6.8 m -124.28 114.73 19.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -98.62 146.71 25.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -82.46 132.16 35.21 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 161.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 70.9 tttt -67.25 100.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.977 1.311 . . . . 0.0 107.84 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -89.45 -92.69 0.12 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.047 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -105.87 130.2 53.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 45.7 mtt 58.62 -54.49 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.671 2.388 . . . . 0.0 114.869 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . -175.48 -167.41 34.51 Favored Glycine 0 N--CA 1.449 -0.449 0 O-C-N 120.744 -1.222 . . . . 0.0 110.808 -148.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -86.02 152.21 23.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.65 0.95 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.743 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.54 167.82 21.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.823 1.811 . . . . 0.0 108.307 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -125.77 159.88 31.22 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.452 1.501 . . . . 0.0 107.568 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 157.29 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 122.13 0.967 . . . . 0.0 110.333 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -131.02 147.66 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.282 2.233 . . . . 0.0 105.734 165.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.37 21.78 Favored Glycine 0 CA--C 1.507 -0.448 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 154.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.83 -70.06 1.08 Allowed Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -165.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -173.09 -43.77 0.01 OUTLIER 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.116 0.539 . . . . 0.0 111.377 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 161.12 26.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.331 1.052 . . . . 0.0 111.324 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.99 44.83 1.39 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.962 3.775 . . . . 0.0 111.522 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -16.31 1.04 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.089 0.955 . . . . 0.0 111.507 169.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.19 130.37 34.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -59.82 147.14 39.28 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.172 0.986 . . . . 0.0 111.086 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.73 132.58 36.29 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.353 -1.749 . . . . 0.0 106.689 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -129.46 152.87 48.53 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.851 0.86 . . . . 0.0 109.012 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.9 t -62.66 113.58 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -61.86 -55.0 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.765 1.626 . . . . 0.0 109.667 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.536 ' HA ' HG23 ' A' ' 65' ' ' THR . 4.3 m -155.31 151.17 27.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.85 1.66 . . . . 0.0 108.051 168.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.63 123.96 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 127.78 86.94 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.75 156.4 66.08 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.894 1.729 . . . . 0.0 109.933 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 76.43 -27.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 127.281 2.232 . . . . 0.0 113.269 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.19 166.6 50.22 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.848 1.213 . . . . 0.0 112.267 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.35 -20.08 48.99 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.229 1.953 . . . . 0.0 112.95 -171.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.38 -51.23 54.47 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.34 89.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.249 1.02 . . . . 0.0 110.426 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.57 -21.05 65.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -87.2 -34.73 18.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.227 1.376 . . . . 0.0 109.963 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.71 -10.67 55.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.392 1.472 . . . . 0.0 114.37 167.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -77.89 -8.53 58.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.953 1.377 . . . . 0.0 113.799 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.7 ttm -118.25 139.92 50.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.709 1.604 . . . . 0.0 108.98 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -133.77 172.12 13.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.769 1.271 . . . . 0.0 109.111 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.551 HG22 HD21 ' A' ' 108' ' ' LEU . 71.9 m -78.28 127.28 32.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.73 -15.82 40.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.531 1.062 . . . . 0.0 113.667 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HB3' HD13 ' A' ' 102' ' ' LEU . 4.3 m-20 -57.13 143.8 37.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.436 1.118 . . . . 0.0 109.708 175.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.23 121.3 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.29 1.836 . . . . 0.0 109.456 -170.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.0 mp -66.03 110.83 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.399 1.879 . . . . 0.0 108.971 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.77 -62.26 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.43 141.24 43.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.581 1.152 . . . . 0.0 109.366 -167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.05 125.55 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 59.48 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.538 2.735 . . . . 0.0 112.18 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.77 11.94 2.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.171 0.896 . . . . 0.0 111.244 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.85 153.48 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 120.344 -1.473 . . . . 0.0 109.032 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.0 p -87.12 138.72 31.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.352 0.978 . . . . 0.0 109.585 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.08 5.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.117 0.967 . . . . 0.0 111.924 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -66.14 -22.29 66.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -163.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.87 66.95 0.53 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 104.834 -3.306 . . . . 0.0 104.834 157.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -121.94 168.94 11.31 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.637 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 p -74.49 136.47 42.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -54.32 -32.11 55.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.417 0.687 . . . . 0.0 110.589 162.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.32 -40.18 89.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.455 1.025 . . . . 0.0 112.407 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.23 -44.84 28.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.219 0.918 . . . . 0.0 109.955 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 t -59.95 -42.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 O-C-N 120.179 -1.575 . . . . 0.0 111.205 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.02 -32.45 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 120.738 -1.226 . . . . 0.0 110.792 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -44.56 94.89 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.47 -0.769 . . . . 0.0 109.215 169.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.13 -36.23 81.43 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.701 -166.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -69.83 -22.81 63.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -87.67 -18.41 29.63 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.982 -1.074 . . . . 0.0 110.971 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -65.07 -17.34 64.37 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.472 -0.768 . . . . 0.0 112.639 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.57 121.72 74.89 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.884 1.274 . . . . 0.0 107.762 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.3 159.82 33.75 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.014 1.809 . . . . 0.0 112.31 167.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.33 152.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.184 -0.947 . . . . 0.0 109.316 162.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.05 -9.47 38.83 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.693 1.616 . . . . 0.0 113.154 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -95.55 163.5 13.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.18 1.99 . . . . 0.0 108.975 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 24' ' ' THR . 20.8 p -116.08 146.78 41.94 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.986 0.914 . . . . 0.0 110.191 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.91 145.12 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 122.843 0.457 . . . . 0.0 109.919 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.34 157.21 22.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 mt -145.94 114.23 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -89.69 127.36 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 67' ' ' ASP . 19.2 mt -121.96 168.89 11.38 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.272 0.983 . . . . 0.0 110.551 173.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.2 t -126.55 141.55 51.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.819 1.247 . . . . 0.0 109.742 171.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.669 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -111.28 155.76 22.52 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 128.653 2.781 . . . . 0.0 109.609 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.75 -30.95 5.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.68 1.61 . . . . 0.0 110.993 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -67.73 139.06 93.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.504 1.122 . . . . 0.0 110.214 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.39 171.67 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.245 1.963 . . . . 0.0 111.191 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 65' ' ' THR . 20.0 mt -66.3 161.89 53.35 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 109.896 173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 CA--C 1.532 0.387 0 C-N-CA 121.662 1.575 . . . . 0.0 111.581 -179.175 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.2 t80 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.423 0.63 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.2 m -85.76 -104.46 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.13 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 119.32 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 1 C-N-CA 134.879 5.272 . . . . 0.0 110.8 -172.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -126.38 6.55 7.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -158.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.95 -1.43 0.36 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 129.264 3.025 . . . . 0.0 115.74 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 t -84.04 -16.52 43.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.082 1.31 . . . . 0.0 110.975 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.98 67.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.024 -1.465 . . . . 0.0 111.913 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.73 138.06 57.12 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.462 1.483 . . . . 0.0 108.124 -163.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -106.48 126.29 52.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -174.09 30.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.844 2.164 . . . . 0.0 108.323 -167.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 m -95.38 160.4 14.55 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.41 ' C ' HD23 ' A' ' 21' ' ' LEU . 6.5 m-85 -118.39 131.13 56.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 122.374 1.083 . . . . 0.0 108.31 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -153.34 163.14 40.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -169.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.33 155.85 43.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.6 t -148.38 157.36 43.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.928 161.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 m -109.32 114.87 28.92 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 57' ' ' ALA . 3.3 mt -98.32 144.64 27.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -89.16 141.42 28.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 16.3 tptt -72.75 101.44 3.1 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -74.68 -175.72 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.027 0.83 . . . . 0.0 109.827 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -51.42 -31.76 24.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.278 1.431 . . . . 0.0 112.65 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 mtp -107.86 14.25 25.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.04 1.736 . . . . 0.0 111.766 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 90.85 -110.48 3.82 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.2 152.34 41.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.702 1.251 . . . . 0.0 110.138 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.86 25.84 5.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.433 1.016 . . . . 0.0 112.944 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.56 173.27 11.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.001 1.401 . . . . 0.0 107.506 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -135.64 159.62 41.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.28 1.032 . . . . 0.0 108.624 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.37 162.04 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.519 1.128 . . . . 0.0 108.933 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.1 tt -132.62 156.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.419 2.287 . . . . 0.0 107.423 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.62 153.08 23.41 Favored Glycine 0 N--CA 1.461 0.358 0 C-N-CA 127.909 2.671 . . . . 0.0 107.672 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.51 -75.01 0.35 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -172.39 -59.46 0.02 OUTLIER 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.956 -168.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 163.33 36.5 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 126.745 2.018 . . . . 0.0 109.937 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.94 48.25 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.88 3.053 . . . . 0.0 110.948 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -154.46 -9.83 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.418 -1.277 . . . . 0.0 114.265 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -67.31 143.56 56.34 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.753 1.615 . . . . 0.0 109.85 169.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -78.58 125.72 29.76 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.26 138.57 34.57 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.218 1.807 . . . . 0.0 108.613 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.93 153.2 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.017 0.371 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.9 t -65.76 111.3 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -60.49 -48.86 79.92 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.685 1.594 . . . . 0.0 110.983 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 m -160.92 150.44 17.1 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.355 1.862 . . . . 0.0 107.306 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.7 t -101.83 121.75 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 163.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.96 128.76 84.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.28 152.21 82.28 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.268 1.979 . . . . 0.0 110.332 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.59 -15.31 0.07 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.369 2.268 . . . . 0.0 113.369 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.78 161.5 46.53 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.265 -1.522 . . . . 0.0 111.581 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.2 -20.93 55.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 0.0 113.193 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -69.09 -51.11 42.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.287 0.635 . . . . 0.0 110.842 171.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.79 90.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.446 0.567 . . . . 0.0 110.11 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -65.15 -6.59 9.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.588 1.155 . . . . 0.0 113.973 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -92.11 -20.02 21.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.686 1.584 . . . . 0.0 110.982 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.14 32.08 82.99 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.826 1.203 . . . . 0.0 114.333 170.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -136.19 -39.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 112.739 -169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 ttm -89.9 140.28 29.77 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -137.27 168.7 19.12 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 125.713 1.883 . . . . 0.0 110.801 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -78.88 160.4 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.87 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.25 -19.3 13.76 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.691 1.138 . . . . 0.0 112.614 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.8 m-20 -70.88 152.97 43.12 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.868 1.334 . . . . 0.0 110.805 -173.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.63 131.71 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.435 1.894 . . . . 0.0 108.347 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.71 126.73 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.751 1.62 . . . . 0.0 108.305 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.19 -60.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 109.556 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -134.5 153.05 52.13 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.392 1.077 . . . . 0.0 108.917 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mt -126.45 108.65 19.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 72.36 -61.95 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 128.824 2.849 . . . . 0.0 110.542 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -149.19 -25.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.859 2.064 . . . . 0.0 110.477 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.83 131.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.243 1.417 . . . . 0.0 108.981 -168.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -65.05 131.89 47.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 108.824 165.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.67 5.47 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 123.375 0.67 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.51 1.124 . . . . 0.0 111.67 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.16 53.54 0.75 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 166.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -95.86 158.48 15.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 156.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -76.05 156.41 33.98 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -56.23 -27.08 53.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.485 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.96 -52.51 65.19 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.082 1.31 . . . . 0.0 110.722 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.7 -42.79 73.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.914 0.486 . . . . 0.0 109.819 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.294 -1.503 . . . . 0.0 111.549 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.32 -40.34 88.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 121.138 -0.976 . . . . 0.0 109.315 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.933 1.242 . . . . 0.0 111.091 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.29 -46.83 75.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -64.85 -40.11 94.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.056 0.844 . . . . 0.0 111.265 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.25 -33.65 75.96 Favored 'General case' 0 C--O 1.231 0.104 0 O-C-N 121.343 -0.848 . . . . 0.0 111.551 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.2 m -56.98 -22.99 42.61 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.886 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.0 114.06 51.82 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 167.0 14.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.415 2.743 . . . . 0.0 111.848 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.4 98.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.772 1.629 . . . . 0.0 108.473 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.18 -17.11 3.39 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.045 1.307 . . . . 0.0 112.65 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.16 164.96 18.83 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 p -120.48 147.2 45.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 109.111 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.1 138.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.536 0.734 . . . . 0.0 109.163 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -83.87 153.81 23.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.269 1.428 . . . . 0.0 109.404 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 mt -144.1 109.37 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.84 121.3 38.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 67' ' ' ASP . 7.5 mt -118.57 160.81 21.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 124.508 1.13 . . . . 0.0 109.92 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -107.53 119.17 38.68 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 168.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 21' ' ' LEU . 16.6 ttm180 -84.32 126.02 32.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.675 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.69 -3.47 9.35 Favored Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.096 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -65.8 142.67 98.24 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 163.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.66 175.34 8.98 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 109.866 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.35 161.43 42.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 167.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 C-N-CA 122.357 2.038 . . . . 0.0 111.656 172.59 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 122.785 1.279 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 m -81.54 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 125.898 1.679 . . . . 0.0 110.295 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 130.88 -44.72 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.458 1 C-N-CA 134.363 5.065 . . . . 0.0 110.427 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -124.66 18.14 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -161.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.69 -3.5 0.05 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.914 2.086 . . . . 0.0 114.873 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -66.42 -43.25 86.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 120.721 -1.237 . . . . 0.0 111.171 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -78.33 7.09 6.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.68 164.75 26.23 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.391 -1.443 . . . . 0.0 108.558 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -129.35 -1.78 5.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.14 174.07 55.29 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.91 -1.119 . . . . 0.0 110.58 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -86.03 150.41 24.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.038 0.919 . . . . 0.0 108.838 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -100.39 147.43 25.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.673 1.589 . . . . 0.0 109.811 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 mp -140.36 163.84 31.72 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.252 1.021 . . . . 0.0 109.975 -172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 p -147.43 119.93 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.147 0.579 . . . . 0.0 112.263 -174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -127.59 150.68 49.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -119.36 114.96 23.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.8 134.98 40.92 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -82.86 140.87 32.66 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 166.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -65.27 101.14 0.52 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -142.51 158.44 43.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.134 1.374 . . . . 0.0 111.546 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 63.42 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 127.346 2.259 . . . . 0.0 110.048 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.7 mtt -141.15 88.42 2.16 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 154.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.78 -110.41 3.15 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.851 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -125.95 140.33 52.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.702 1.251 . . . . 0.0 109.445 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.5 38.89 2.29 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.381 0.991 . . . . 0.0 112.413 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.65 169.1 20.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -131.55 166.07 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.08 162.24 25.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 109.021 -171.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 tt -136.71 154.93 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.581 1.952 . . . . 0.0 107.706 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.69 152.22 22.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.0 -2.84 . . . . 0.0 106.0 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.38 -67.8 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 124.574 1.083 . . . . 0.0 111.563 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.79 -30.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.764 1.226 . . . . 0.0 110.766 160.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -116.18 168.87 7.84 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.675 1.19 . . . . 0.0 112.156 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.22 75.4 4.65 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.25 2.633 . . . . 0.0 108.509 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -169.2 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.501 1.92 . . . . 0.0 109.341 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -80.2 137.93 36.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.533 0.682 . . . . 0.0 109.505 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.97 130.49 41.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.385 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.81 137.15 35.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.564 1.146 . . . . 0.0 108.8 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -136.77 151.86 49.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.516 0.726 . . . . 0.0 110.799 -171.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.85 112.43 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -66.37 -52.96 41.5 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.043 1.737 . . . . 0.0 110.273 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -150.84 149.95 30.32 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.345 1.458 . . . . 0.0 107.587 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.08 120.03 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 160.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.75 128.6 93.93 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.57 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.07 1.847 . . . . 0.0 110.147 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.47 56.41 2.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 111.77 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.08 167.3 24.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.138 1.351 . . . . 0.0 110.079 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -69.18 -18.31 39.77 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 0.0 113.739 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.35 4.58 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.19 -37.27 54.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.798 1.639 . . . . 0.0 111.557 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.77 -14.1 58.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.711 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -84.1 -22.25 31.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.832 2.105 . . . . 0.0 111.441 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.52 30.14 71.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.897 163.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -122.05 -26.01 4.83 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.78 1.79 . . . . 0.0 112.701 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -86.65 141.61 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.644 1.178 . . . . 0.0 108.388 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -131.25 169.29 16.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.48 1.133 . . . . 0.0 108.047 165.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.7 m -65.3 145.1 56.63 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.774 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 -18.47 44.58 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.518 1.056 . . . . 0.0 113.918 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.32 143.59 55.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.996 1.398 . . . . 0.0 109.987 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.14 120.98 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.183 1.393 . . . . 0.0 109.249 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.2 mp -71.15 114.1 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.266 1.426 . . . . 0.0 107.994 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.57 -60.4 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.157 0.983 . . . . 0.0 109.696 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.66 149.74 52.17 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -120.89 120.95 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 64.52 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.971 1.708 . . . . 0.0 108.284 -172.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -138.89 -10.63 1.32 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.79 1.636 . . . . 0.0 111.34 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.18 127.07 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 107.614 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.8 t -71.78 128.17 34.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 168.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.22 17.4 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 125.773 1.629 . . . . 0.0 109.02 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -35.93 76.46 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 120.719 -1.238 . . . . 0.0 112.251 -166.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.45 38.82 2.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.225 1.869 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 170.0 16.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.283 1.041 . . . . 0.0 110.255 167.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -74.92 139.94 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 164.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -52.31 -45.72 65.68 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.913 0.885 . . . . 0.0 109.33 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -22.29 43.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.31 -51.71 5.42 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 119.51 1.05 . . . . 0.0 111.187 173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.17 -36.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.129 2.172 . . . . 0.0 111.437 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.38 -41.19 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.873 0.869 . . . . 0.0 110.416 171.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -36.92 82.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 108.658 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.49 -38.31 89.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.969 0.908 . . . . 0.0 110.006 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.4 -30.13 65.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.407 1.003 . . . . 0.0 111.247 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -64.71 -37.04 86.24 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.294 0.952 . . . . 0.0 110.123 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.7 p -66.58 -6.17 14.22 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.78 103.83 7.89 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.89 167.14 27.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.866 1.711 . . . . 0.0 111.869 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.88 122.57 9.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.698 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.68 -11.65 46.18 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.956 -1.469 . . . . 0.0 113.891 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -83.51 162.01 21.04 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.419 1.609 . . . . 0.0 108.719 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.0 138.02 50.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.244 1.018 . . . . 0.0 110.92 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 m -129.05 142.66 43.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 C-N-CA 124.36 1.064 . . . . 0.0 109.118 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.61 159.16 22.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.95 114.57 7.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.45 115.52 29.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.96 164.27 12.42 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 124.029 0.83 . . . . 0.0 109.068 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -121.95 129.42 52.49 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.392 1.477 . . . . 0.0 107.15 166.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.56 ' HB2' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.55 156.81 36.45 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.488 1.915 . . . . 0.0 109.606 173.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.48 -10.48 73.24 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.13 149.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -64.28 137.63 97.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 150.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.22 175.73 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.253 2.635 . . . . 0.0 109.827 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.8 162.33 9.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 122.682 0.393 . . . . 0.0 109.955 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 C-N-CA 122.012 1.808 . . . . 0.0 111.888 178.407 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.4 t80 . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 121.341 0.591 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -85.43 -112.7 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.47 2.308 . . . . 0.0 110.924 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 142.66 -71.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 1 C-N-CA 134.021 4.928 . . . . 0.0 108.838 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.35 14.57 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.15 0.98 . . . . 0.0 113.509 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 71.58 -12.21 0.66 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.44 2.296 . . . . 0.0 113.814 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.211 1.004 . . . . 0.0 111.552 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -83.44 0.61 45.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.204 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.45 140.53 52.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 162.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -105.74 132.09 52.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.45 -165.57 31.44 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -135.07 136.53 42.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 70' ' ' VAL . 22.7 m-85 -102.84 149.12 24.81 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.838 0.855 . . . . 0.0 110.099 -168.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.83 169.02 18.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.874 2.069 . . . . 0.0 108.664 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.22 142.35 42.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.926 1.29 . . . . 0.0 108.929 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -141.26 157.2 45.54 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.607 -0.683 . . . . 0.0 109.274 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 m -131.59 106.49 8.22 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.97 156.33 16.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -106.79 138.23 43.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 10.1 tttt -61.43 103.45 0.31 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.502 1.521 . . . . 0.0 110.355 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.7 p -83.03 -173.11 4.52 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.637 1.108 . . . . 0.0 110.489 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -37.78 61.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.647 1.179 . . . . 0.0 112.237 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.2 ptm -105.05 13.14 31.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.911 1.285 . . . . 0.0 113.42 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.609 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 97.16 -106.36 3.33 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.28 152.2 44.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.77 39.46 3.02 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.92 166.41 28.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.616 1.208 . . . . 0.0 108.323 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -135.45 154.5 51.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.248 1.419 . . . . 0.0 107.705 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.51 160.76 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 109.835 -170.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -136.05 159.82 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.601 2.76 . . . . 0.0 107.388 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.64 152.2 21.16 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -76.77 0.17 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.356 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -171.38 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.752 1.276 . . . . 0.0 113.112 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.54 167.58 22.12 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.729 1.212 . . . . 0.0 110.821 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.85 35.66 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.106 1 C-N-CA 125.753 4.302 . . . . 0.0 113.961 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.31 -15.79 0.29 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.563 1.545 . . . . 0.0 112.282 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.96 165.61 23.85 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 122.063 0.935 . . . . 0.0 111.065 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -71.17 157.5 38.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 mt -116.33 133.43 56.03 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.606 2.363 . . . . 0.0 107.521 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -130.62 154.05 48.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.519 0.728 . . . . 0.0 111.784 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.95 109.71 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 165.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -63.2 -43.31 98.53 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.732 1.613 . . . . 0.0 110.935 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.22 142.39 13.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.867 1.667 . . . . 0.0 108.824 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 64' ' ' GLU . 19.7 t -92.01 122.67 43.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 161.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.17 132.44 63.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.096 1.358 . . . . 0.0 107.786 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.1 168.36 14.15 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.738 1.626 . . . . 0.0 110.924 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.27 28.0 17.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 111.238 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.02 177.8 16.43 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.055 1.788 . . . . 0.0 113.943 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 -28.22 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.808 2.339 . . . . 0.0 111.904 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.6 59.79 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.05 72.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.658 0.783 . . . . 0.0 112.779 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.56 -19.72 55.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.402 1.001 . . . . 0.0 113.296 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.3 -42.36 14.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.84 0.856 . . . . 0.0 109.776 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.72 2.5 60.94 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.993 1.282 . . . . 0.0 114.508 171.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.01 -7.16 59.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.736 1.768 . . . . 0.0 112.7 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.8 ttp -122.31 141.1 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.753 1.621 . . . . 0.0 109.358 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.828 ' HA ' HG21 ' A' ' 51' ' ' VAL . 3.6 pt-20 -140.93 -179.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.461 1.104 . . . . 0.0 110.065 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 HD21 ' A' ' 108' ' ' LEU . 71.3 m -88.49 133.96 33.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.849 1.26 . . . . 0.0 109.613 -173.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.28 -14.04 59.79 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.404 1.478 . . . . 0.0 112.323 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 102' ' ' LEU . 29.5 m-20 -60.35 148.25 37.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.982 0.913 . . . . 0.0 110.809 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 t -99.33 122.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.651 1.58 . . . . 0.0 108.606 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 102' ' ' LEU . 4.7 mp -74.59 106.36 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 109.28 174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' PHE . 6.7 t -80.75 -57.6 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -132.14 149.54 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.073 0.949 . . . . 0.0 108.914 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.65 116.39 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 170.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.41 -57.05 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 130.624 3.569 . . . . 0.0 113.941 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.42 6.38 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.466 2.306 . . . . 0.0 111.611 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.92 128.31 64.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.009 1.324 . . . . 0.0 108.295 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.4 p -78.27 87.13 4.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 110.746 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 1.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.963 0.905 . . . . 0.0 112.08 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -17.95 45.63 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -167.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.71 22.64 7.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.787 1.184 . . . . 0.0 111.307 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.06 167.72 11.05 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.697 1.249 . . . . 0.0 110.444 -175.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.3 p -72.12 138.59 47.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -53.37 -44.84 68.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.705 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -36.02 69.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.583 1.538 . . . . 0.0 113.477 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.07 -56.98 8.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.893 0.877 . . . . 0.0 109.688 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.59 -42.94 52.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 128.191 2.596 . . . . 0.0 111.633 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.19 -38.93 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 120.734 -1.229 . . . . 0.0 108.871 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -33.74 75.02 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.306 -0.871 . . . . 0.0 111.267 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -50.8 69.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.955 1.302 . . . . 0.0 108.743 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.64 -40.09 93.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.393 0.542 . . . . 0.0 110.957 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -69.5 -31.78 70.24 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.482 -0.761 . . . . 0.0 111.715 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 55.4 p -70.07 -0.46 7.68 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.024 0.829 . . . . 0.0 113.141 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 t -84.4 112.45 41.84 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 168.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.21 175.29 10.46 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.971 1.78 . . . . 0.0 112.037 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 150.49 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.671 1.188 . . . . 0.0 108.17 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.86 -15.69 51.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.246 1.403 . . . . 0.0 112.334 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -96.29 164.2 12.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.419 1.609 . . . . 0.0 110.792 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -132.28 155.61 48.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.899 2.479 . . . . 0.0 108.553 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.86 147.69 21.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.129 0.971 . . . . 0.0 109.971 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.68 153.54 21.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -141.04 148.87 40.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.04 118.94 39.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.0 mt -114.41 165.79 12.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 124.095 0.872 . . . . 0.0 110.15 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -127.32 124.6 39.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.269 1.428 . . . . 0.0 108.133 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -102.73 132.44 48.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.413 1.885 . . . . 0.0 108.649 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.61 6.07 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.712 0.672 . . . . 0.0 112.45 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -103.84 130.98 22.44 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 160.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -70.77 172.54 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.549 2.166 . . . . 0.0 111.669 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD21 HG22 ' A' ' 65' ' ' THR . 10.7 mt -70.82 152.5 95.1 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.347 0.493 0 C-N-CA 123.347 2.698 . . . . 0.0 111.558 175.772 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 10' ' ' THR 0.271 27.5 t80 . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.433 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 25.1 m -127.6 -98.49 0.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 126.589 1.956 . . . . 0.0 109.945 -173.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 121.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 1 C-N-CA 135.112 5.365 . . . . 0.0 109.786 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.41 0.43 24.84 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.72 -24.68 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.841 2.856 . . . . 0.0 114.178 -169.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -57.59 -34.28 69.07 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -80.78 7.47 10.3 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.018 0.527 . . . . 0.0 112.392 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 mt -77.23 170.61 16.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.495 -1.378 . . . . 0.0 110.287 171.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.01 105.1 7.19 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.154 1.381 . . . . 0.0 109.26 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.37 -179.22 25.39 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.232 1.396 . . . . 0.0 111.561 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -77.9 134.78 37.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.484 0.713 . . . . 0.0 109.306 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.24 138.62 32.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.936 0.894 . . . . 0.0 108.648 169.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.01 173.47 12.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.792 1.237 . . . . 0.0 109.696 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 p -145.59 170.33 16.65 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -155.94 155.56 33.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.363 1.065 . . . . 0.0 109.977 159.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.8 m -102.69 115.19 30.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.777 1.231 . . . . 0.0 108.523 163.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.37 137.33 39.85 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -81.68 137.23 35.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 166.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -64.72 108.83 1.83 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 165.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 t -137.16 161.95 34.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 56.31 -91.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.564 1.946 . . . . 0.0 112.642 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.8 ptm -138.47 30.14 2.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.656 1.582 . . . . 0.0 110.72 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.3 176.47 21.37 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.181 1.372 . . . . 0.0 110.693 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -64.73 147.88 52.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.162 -0.61 . . . . 0.0 109.896 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.45 33.37 1.82 Allowed Glycine 0 C--O 1.222 -0.637 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.469 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -149.81 164.3 35.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.734 1.767 . . . . 0.0 108.465 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -132.93 154.84 50.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.61 159.19 17.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.857 1.263 . . . . 0.0 108.58 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -121.75 164.12 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.922 2.089 . . . . 0.0 107.559 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.07 151.85 17.52 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.2 -14.12 55.66 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.563 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t0 80.52 -36.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.623 2.769 . . . . 0.0 109.93 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -72.46 167.61 31.25 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 125.709 1.604 . . . . 0.0 111.225 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -100.63 32.22 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.379 3.386 . . . . 0.0 113.256 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -158.24 37.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.157 0.983 . . . . 0.0 109.954 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.54 153.79 48.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.324 1.059 . . . . 0.0 112.537 -165.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.78 116.87 15.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.249 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.81 124.15 29.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -115.26 151.94 33.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.324 0.965 . . . . 0.0 109.81 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.46 118.99 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 120.707 -1.246 . . . . 0.0 107.819 165.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -52.11 43.95 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.643 1.977 . . . . 0.0 109.72 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -157.76 153.52 26.69 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.647 1.179 . . . . 0.0 109.644 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.1 t -96.97 113.8 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 164.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.93 130.97 87.74 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.505 1.922 . . . . 0.0 108.192 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.89 161.65 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.378 2.052 . . . . 0.0 111.192 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.61 10.09 0.95 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.431 2.293 . . . . 0.0 113.042 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.51 161.19 21.28 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.587 1.565 . . . . 0.0 110.553 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.96 -25.12 74.05 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 112.837 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.17 70.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.212 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.75 95.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.469 0.708 . . . . 0.0 110.38 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -66.58 -43.22 85.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.29 0.636 . . . . 0.0 110.981 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.28 -38.77 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.266 1.026 . . . . 0.0 111.164 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.89 11.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.686 2.088 . . . . 0.0 115.347 169.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.76 -39.08 87.74 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.292 -1.122 . . . . 0.0 109.963 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 tpp -67.6 131.77 46.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.526 1.131 . . . . 0.0 108.595 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -134.87 161.74 34.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.906 0.86 . . . . 0.0 108.727 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 156.92 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.6 70.88 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.481 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 102' ' ' LEU . 65.6 m-20 -83.88 162.66 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.827 1.814 . . . . 0.0 109.562 168.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -116.54 125.73 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 127.185 2.194 . . . . 0.0 108.388 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -73.72 105.21 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 126.917 2.087 . . . . 0.0 108.459 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -84.08 -57.5 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.811 0.815 . . . . 0.0 109.768 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -135.59 139.89 44.21 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -165.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.16 133.76 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 58.51 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 127.756 2.423 . . . . 0.0 113.776 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -150.06 21.97 0.86 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.598 1.559 . . . . 0.0 109.77 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.67 152.51 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.157 1.383 . . . . 0.0 108.205 -162.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.6 p -87.06 137.59 32.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.087 0.955 . . . . 0.0 109.805 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.84 15.28 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.275 1.43 . . . . 0.0 110.49 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 -31.92 66.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 113.315 -159.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.93 49.2 0.93 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.6 1.571 . . . . 0.0 109.41 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -99.16 170.28 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.303 1.041 . . . . 0.0 112.016 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -79.2 133.39 36.69 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.579 -1.325 . . . . 0.0 108.535 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.88 -40.44 66.6 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.273 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.29 76.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.76 1.618 . . . . 0.0 112.074 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.23 -46.37 50.64 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.019 0.928 . . . . 0.0 110.288 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.48 -41.8 93.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 110.769 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.5 t -61.45 -42.79 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.216 172.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.61 75.5 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.11 0.868 . . . . 0.0 110.055 173.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.14 -37.91 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.149 0.98 . . . . 0.0 109.701 -174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' HE1' HD21 ' A' ' 100' ' ' LEU . 49.6 m-85 -70.2 -32.16 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.923 -0.486 . . . . 0.0 112.014 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -69.14 -33.38 73.35 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.287 0.948 . . . . 0.0 110.987 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -58.91 -16.11 16.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 0.0 113.749 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.6 110.2 25.57 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.763 1.625 . . . . 0.0 107.85 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.25 168.23 21.48 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.419 2.079 . . . . 0.0 110.535 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.29 125.98 7.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 164.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.11 -27.57 19.56 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.122 -1.376 . . . . 0.0 112.734 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.03 145.34 28.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.463 2.131 . . . . 0.0 108.286 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.14 162.09 13.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.379 1.072 . . . . 0.0 110.078 171.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.27 157.96 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 125.081 1.352 . . . . 0.0 109.291 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.03 156.59 16.25 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 110.489 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.424 HD21 ' HE1' ' A' ' 89' ' ' PHE . 19.6 mt -143.86 132.99 22.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.1 t -98.97 123.19 51.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 160.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 67' ' ' ASP . 2.5 mt -108.19 160.7 15.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.248 0.967 . . . . 0.0 109.062 171.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.6 t -118.92 121.71 40.59 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -76.06 156.24 34.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.435 1.094 . . . . 0.0 108.653 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.75 -20.78 11.71 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 117.836 -1.536 . . . . 0.0 114.329 162.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -81.22 141.46 49.92 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 120.254 2.027 . . . . 0.0 107.94 165.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.97 170.27 20.5 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.32 2.013 . . . . 0.0 111.109 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.73 165.08 13.3 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.69 169.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo . . . . . 0 CA--C 1.537 0.673 0 C-N-CA 122.944 2.429 . . . . 0.0 112.78 175.74 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 t80 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.904 0.859 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 m -77.59 -118.49 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.121 1.368 . . . . 0.0 110.2 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 135.73 -23.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 1 C-N-CA 134.215 5.006 . . . . 0.0 113.283 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -142.14 15.57 2.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.85 1.205 . . . . 0.0 113.637 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.5 -6.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.735 2.014 . . . . 0.0 114.514 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -73.8 -25.95 60.38 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.634 -1.291 . . . . 0.0 111.995 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.09 -11.06 60.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.544 1.065 . . . . 0.0 112.532 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.2 140.18 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.27 0.941 . . . . 0.0 109.652 -172.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -117.81 113.22 21.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.82 -175.27 30.66 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.006 -158.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -125.38 139.26 53.82 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -104.34 137.81 41.68 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.769 1.628 . . . . 0.0 110.411 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 175.55 12.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.562 1.945 . . . . 0.0 108.999 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -135.09 170.36 16.02 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 110.413 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -149.61 153.41 37.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.994 1.318 . . . . 0.0 107.883 170.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 m -115.83 105.49 12.75 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.04 132.7 44.16 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -82.87 146.44 28.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -77.65 76.71 4.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.381 1.072 . . . . 0.0 108.252 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -63.01 115.22 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 46.5 -91.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.673 2.389 . . . . 0.0 112.486 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.1 mtp -53.29 -56.09 19.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.612 2.365 . . . . 0.0 111.067 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.72 176.6 21.45 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -148.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -75.98 125.62 29.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.55 55.06 3.72 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.453 0.549 . . . . 0.0 112.056 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -143.02 157.97 44.04 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -125.78 157.87 36.39 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.43 162.92 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.901 1.281 . . . . 0.0 109.36 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 16.3 tt -126.36 146.49 32.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.905 1.682 . . . . 0.0 107.964 171.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.27 151.23 22.1 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.442 1.089 . . . . 0.0 111.064 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 44' ' ' GLU . . . -51.44 -82.86 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 C-N-CA 128.874 3.13 . . . . 0.0 112.512 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.44 -34.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.409 1.084 . . . . 0.0 112.424 -170.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -122.26 165.15 21.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.056 1.342 . . . . 0.0 110.492 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.53 47.4 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.158 3.238 . . . . 0.0 112.624 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -164.58 16.01 0.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.962 2.105 . . . . 0.0 112.128 -172.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 1.5 pp20? -91.62 165.63 13.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.538 2.335 . . . . 0.0 111.634 171.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.75 118.18 35.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.473 1.109 . . . . 0.0 110.336 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.8 mt -80.0 129.46 34.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -128.69 154.25 46.51 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.306 1.042 . . . . 0.0 110.46 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.01 114.81 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -68.22 -52.18 37.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.462 1.505 . . . . 0.0 110.414 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -156.65 151.12 25.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.575 1.15 . . . . 0.0 108.991 172.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -91.62 127.26 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 168.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.55 131.8 87.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -68.26 163.18 37.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.171 1.914 . . . . 0.0 111.2 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.35 49.92 3.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.031 1.732 . . . . 0.0 112.091 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.1 175.7 22.07 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.391 1.472 . . . . 0.0 110.744 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.87 -22.8 31.05 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.814 2.343 . . . . 0.0 113.425 -168.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.22 -51.19 11.36 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.076 0.853 . . . . 0.0 109.04 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.655 1.182 . . . . 0.0 110.314 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.64 -36.31 76.12 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.91 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -74.85 -20.85 59.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.235 0.925 . . . . 0.0 112.01 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.41 61.16 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.183 1.373 . . . . 0.0 115.723 163.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -87.48 -20.66 26.25 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.22 1.51 . . . . 0.0 111.35 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 ttm -110.98 143.92 40.9 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.716 1.606 . . . . 0.0 109.668 -169.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.08 -179.18 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.43 1.492 . . . . 0.0 108.312 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -95.54 158.42 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.36 0.664 . . . . 0.0 109.613 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.83 -14.73 24.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.481 0.563 . . . . 0.0 111.966 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 102' ' ' LEU . 12.4 m-20 -64.35 151.69 43.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.117 0.967 . . . . 0.0 109.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.23 121.0 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.686 1.595 . . . . 0.0 107.999 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.76 129.32 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.62 -58.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.447 1.092 . . . . 0.0 110.953 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.92 151.27 50.72 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.349 0.66 . . . . 0.0 109.933 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -132.25 117.03 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.23 -73.04 0.05 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.839 2.456 . . . . 0.0 110.026 -170.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -147.51 -10.73 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.1 1.76 . . . . 0.0 110.685 173.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 123.73 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.46 1.504 . . . . 0.0 107.977 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.9 p -67.5 110.13 3.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.414 0.686 . . . . 0.0 109.344 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.45 8.63 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.718 -0.614 . . . . 0.0 111.805 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 1.6 pp -55.19 -33.87 63.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -165.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.79 17.26 10.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 120.025 1.284 . . . . 0.0 111.397 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -73.16 158.06 36.0 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -82.74 146.47 28.99 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -56.53 -32.74 65.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 110.821 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.47 -57.79 10.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.097 -1.002 . . . . 0.0 110.896 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.36 -43.25 81.93 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.39 0.614 . . . . 0.0 109.559 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.99 -41.79 87.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 119.839 -1.788 . . . . 0.0 111.198 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.45 -39.44 80.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.295 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -35.22 80.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.38 0.991 . . . . 0.0 110.144 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.7 -45.51 86.31 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.047 1.739 . . . . 0.0 109.011 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -61.08 -32.6 72.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.513 -0.742 . . . . 0.0 111.247 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -79.75 -19.79 47.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.082 -1.011 . . . . 0.0 112.831 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.8 m -75.12 -6.16 48.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.267 1.427 . . . . 0.0 111.984 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.03 116.67 66.41 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 178.58 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.286 1.991 . . . . 0.0 111.133 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 mt -62.93 144.68 14.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 109.345 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.46 -2.83 51.48 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.7 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -84.22 164.9 18.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.651 1.726 . . . . 0.0 107.788 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 p -127.8 134.24 49.46 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.773 0.715 . . . . 0.0 110.23 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.95 146.88 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.4 148.01 27.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.0 mt -146.69 132.84 19.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.25 130.47 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.56 1.544 . . . . 0.0 108.221 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 67' ' ' ASP . 11.1 mt -117.7 164.94 14.22 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 124.324 1.015 . . . . 0.0 110.389 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.7 t -129.1 132.27 47.38 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.271 1.429 . . . . 0.0 108.433 167.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -104.28 122.29 45.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 126.465 1.906 . . . . 0.0 110.573 -172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 138.04 5.08 1.67 Allowed Glycine 0 N--CA 1.464 0.502 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.835 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -91.75 149.03 38.42 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 118.772 1.286 . . . . 0.0 108.237 167.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.58 168.29 24.73 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.139 1.893 . . . . 0.0 110.987 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.77 144.0 63.65 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.533 0.469 0 C-N-CA 123.702 2.935 . . . . 0.0 112.159 169.052 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.237 0.413 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -73.31 -117.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.484 2.314 . . . . 0.0 112.841 178.26 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 10' ' ' THR . 8.7 mtt180 134.06 -16.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 1 C-N-CA 134.581 5.153 . . . . 0.0 111.827 177.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -145.45 13.21 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 59.62 4.6 0.56 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.31 1.444 . . . . 0.0 114.415 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -18.41 32.37 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.534 -1.354 . . . . 0.0 111.947 -174.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.85 -18.33 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.99 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.81 157.72 9.21 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.692 1.133 . . . . 0.0 110.299 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -129.12 93.12 3.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.723 1.209 . . . . 0.0 109.796 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.09 -129.72 1.57 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 125.252 1.406 . . . . 0.0 110.041 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.4 m -136.17 145.72 46.08 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.933 1.693 . . . . 0.0 108.459 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.456 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 m-85 -90.43 144.23 26.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.426 0.69 . . . . 0.0 110.401 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -120.08 165.82 14.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.021 2.128 . . . . 0.0 107.734 173.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.5 p -147.19 162.79 38.16 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.347 0.659 . . . . 0.0 109.945 155.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.75 157.46 38.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 170.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.8 m -120.11 108.22 13.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.14 134.56 40.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -82.24 151.19 26.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -85.45 100.99 12.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -64.08 -53.56 47.8 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -159.97 -71.35 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.317 1.047 . . . . 0.0 110.234 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 ptp -50.84 -40.84 56.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 127.198 2.199 . . . . 0.0 113.595 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.83 -125.63 1.89 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -125.86 145.87 50.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.26 1.03 . . . . 0.0 109.82 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.9 46.98 3.72 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.134 0.873 . . . . 0.0 113.353 -174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -148.54 163.95 35.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.402 1.481 . . . . 0.0 107.62 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.9 p -126.19 163.55 22.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.61 158.86 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.018 1.327 . . . . 0.0 108.281 -168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -129.24 145.03 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.033 1.733 . . . . 0.0 107.926 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.63 22.63 Favored Glycine 0 CA--C 1.518 0.237 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.91 -71.06 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 CA-C-N 117.945 0.872 . . . . 0.0 113.423 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.23 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.276 1.03 . . . . 0.0 109.495 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -113.48 165.7 12.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.17 1.788 . . . . 0.0 110.919 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -79.32 66.79 8.75 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.651 2.901 . . . . 0.0 112.16 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -140.18 -2.09 1.49 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.754 0.822 . . . . 0.0 110.221 146.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -99.35 137.27 38.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.481 -1.387 . . . . 0.0 110.215 -152.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.22 123.71 17.58 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.757 0.823 . . . . 0.0 111.481 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.32 128.8 34.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -134.06 152.66 51.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.346 0.976 . . . . 0.0 110.637 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.34 113.14 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -68.55 -58.18 4.68 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 65' ' ' THR . 69.0 m -154.5 158.81 40.44 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.959 1.304 . . . . 0.0 109.519 163.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.7 138.2 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.1 1.76 . . . . 0.0 107.256 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 141.12 67.93 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.25 28.2 0.4 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.731 3.621 . . . . 0.0 115.693 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.85 -10.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.204 2.202 . . . . 0.0 111.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.52 158.79 46.02 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.49 -21.69 70.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.384 1.389 . . . . 0.0 110.486 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.39 46.34 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.353 1.461 . . . . 0.0 111.501 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.08 71.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.272 1.029 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -72.78 -22.7 60.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.838 -170.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.37 -12.12 60.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.834 1.197 . . . . 0.0 111.351 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.64 25.83 74.28 Favored Glycine 0 CA--C 1.525 0.664 0 O-C-N 121.053 -1.03 . . . . 0.0 113.293 167.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -128.54 -32.64 2.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.293 1.047 . . . . 0.0 113.525 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.8 ttm -95.01 134.66 37.44 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.21 167.67 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.627 1.203 . . . . 0.0 110.675 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 50' ' ' SER . 23.5 m -86.76 117.73 25.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.587 1.555 . . . . 0.0 108.604 -168.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.98 32.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.491 1.043 . . . . 0.0 112.411 -171.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -65.89 146.56 54.59 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.271 1.535 . . . . 0.0 108.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.39 115.69 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.346 1.858 . . . . 0.0 108.817 -169.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.84 125.01 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 125.607 1.563 . . . . 0.0 107.847 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.0 -55.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.281 1.033 . . . . 0.0 110.3 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.67 149.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.49 126.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 t30 67.08 -81.43 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 109.258 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -152.16 20.02 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.784 1.233 . . . . 0.0 111.342 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.58 123.47 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.1 p -62.74 120.84 12.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 163.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.58 13.7 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.384 0.674 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.51 -10.9 8.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -166.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.36 9.57 4.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.928 1.252 . . . . 0.0 111.406 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -71.62 159.5 34.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.967 1.883 . . . . 0.0 111.147 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -83.2 154.61 24.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.17 0.588 . . . . 0.0 109.906 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -55.28 -41.63 72.53 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.416 170.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.38 41.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.505 1.957 . . . . 0.0 112.671 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.12 -47.49 11.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.195 0.521 . . . . 0.0 111.951 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.1 t -63.4 -28.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 120.272 -1.517 . . . . 0.0 112.022 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.8 -44.0 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.501 -1.375 . . . . 0.0 108.438 167.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.9 88.98 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.143 1.338 . . . . 0.0 109.3 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 85' ' ' VAL . 13.4 mt -66.63 -44.82 80.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.353 1.861 . . . . 0.0 109.805 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -69.89 -36.43 75.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.026 0.83 . . . . 0.0 110.26 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -70.3 -17.06 63.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.695 0.798 . . . . 0.0 110.946 174.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 t -96.22 39.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.193 1.797 . . . . 0.0 110.797 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.67 113.8 25.0 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.67 172.65 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.125 1.217 . . . . 0.0 110.075 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.2 mp -60.06 145.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.03 68.16 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.929 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -130.58 169.92 14.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.665 1.233 . . . . 0.0 108.704 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.08 161.39 31.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.845 1.258 . . . . 0.0 110.976 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.47 147.7 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.589 1.156 . . . . 0.0 108.221 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -83.41 156.9 22.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.34 110.67 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.11 122.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.92 167.31 10.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.953 0.783 . . . . 0.0 110.354 170.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.79 129.19 48.94 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.662 1.185 . . . . 0.0 108.139 165.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.595 ' HB2' HD21 ' A' ' 21' ' ' LEU . 5.3 ttm180 -79.84 155.59 27.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.709 1.604 . . . . 0.0 107.184 166.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.17 -19.82 4.83 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.934 169.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.14 156.42 39.01 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 118.726 1.263 . . . . 0.0 109.793 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.38 179.06 3.75 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.969 1.779 . . . . 0.0 110.196 165.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.66 154.33 94.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.819 161.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.643 173.026 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 10' ' ' THR 0.261 34.1 t80 . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 120.867 0.365 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 28.4 m -118.53 -107.06 0.38 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 129.475 3.11 . . . . 0.0 108.295 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 131.42 -70.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 1 C-N-CA 134.433 5.093 . . . . 0.0 108.757 169.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.39 -0.35 52.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.001 0.819 . . . . 0.0 113.171 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 79.52 -11.71 1.16 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.839 2.856 . . . . 0.0 112.569 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 m -72.06 -19.28 61.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -166.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -79.29 -12.78 59.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.855 0.752 . . . . 0.0 112.414 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.15 142.74 52.49 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -125.26 122.85 38.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.51 -122.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -135.57 136.66 41.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -91.44 143.87 26.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.758 1.623 . . . . 0.0 110.522 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.48 166.78 31.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.959 1.703 . . . . 0.0 109.551 172.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -146.34 124.47 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.674 0.79 . . . . 0.0 110.696 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -124.46 157.23 35.71 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.946 0.794 . . . . 0.0 109.101 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.5 m -114.59 112.72 23.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.55 150.86 21.26 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -103.91 149.68 24.87 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -84.2 102.6 12.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.6 m -61.73 -56.93 14.43 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.086 0.555 . . . . 0.0 110.316 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.36 -82.07 0.1 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.315 0.646 . . . . 0.0 109.521 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.3 mtt -62.05 -49.68 75.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.814 0.846 . . . . 0.0 109.143 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 180.0 -162.06 28.23 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -83.03 149.43 26.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.09 30.17 2.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.354 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -135.38 165.5 25.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.457 1.628 . . . . 0.0 108.49 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -123.36 154.41 39.0 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.006 1.322 . . . . 0.0 107.829 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.51 156.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.077 0.951 . . . . 0.0 108.619 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.54 149.63 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.449 2.3 . . . . 0.0 106.452 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.84 152.34 23.04 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.23 -80.74 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 124.454 1.026 . . . . 0.0 112.725 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 178.49 -62.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.739 1.216 . . . . 0.0 110.431 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -82.26 166.49 36.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.438 1.095 . . . . 0.0 112.507 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.79 57.57 5.69 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 124.224 3.283 . . . . 0.0 111.344 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.45 -4.69 0.11 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.725 1.61 . . . . 0.0 113.354 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -95.28 165.86 12.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.133 0.968 . . . . 0.0 111.947 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -84.55 160.34 20.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 111.16 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.8 mt -124.68 138.23 54.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 126.399 1.88 . . . . 0.0 108.184 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.6 mt-30 -134.42 155.24 50.65 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.35 0.977 . . . . 0.0 111.044 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.02 109.81 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.46 -50.01 66.97 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.906 1.683 . . . . 0.0 109.982 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -148.31 158.48 44.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 107.147 170.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.9 t -102.44 128.65 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.903 -2.629 . . . . 0.0 103.903 158.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.02 118.95 71.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.31 135.27 45.76 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t0 73.67 0.29 3.59 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.114 1.766 . . . . 0.0 112.617 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.45 163.77 53.03 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.289 -1.507 . . . . 0.0 109.822 165.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.59 -4.91 9.15 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.045 2.497 . . . . 0.0 114.769 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.87 -49.16 6.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.235 0.925 . . . . 0.0 109.919 172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.31 90.04 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.984 0.514 . . . . 0.0 110.588 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.37 -25.24 68.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.086 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.34 -40.75 29.49 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.456 1.025 . . . . 0.0 109.943 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.38 52.93 14.76 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 125.036 1.303 . . . . 0.0 113.019 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -126.04 -58.9 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 170.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 161.45 27.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 119.19 0.905 . . . . 0.0 109.264 173.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -143.38 173.52 11.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 167.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -74.8 144.61 43.44 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.926 -167.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.92 81.79 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.434 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -64.89 142.86 58.29 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.897 1.849 . . . . 0.0 108.472 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 47' ' ' GLN . 76.2 t -97.9 120.87 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.376 1.87 . . . . 0.0 108.868 -169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.49 118.07 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.18 -54.11 7.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 109.996 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.47 144.88 48.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mt -122.99 111.37 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.3 t30 67.21 -53.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.48 3.112 . . . . 0.0 114.378 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -164.22 6.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.383 2.273 . . . . 0.0 111.247 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.63 121.34 63.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 125.449 1.499 . . . . 0.0 107.66 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.4 p -66.09 120.24 12.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 164.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.05 7.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.457 0.703 . . . . 0.0 111.89 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -9.11 43.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.448 3.099 . . . . 0.0 112.506 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.13 54.47 0.66 Allowed Glycine 0 C--N 1.334 0.463 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 158.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.08 157.83 22.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.99 0.895 . . . . 0.0 111.561 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -77.3 137.63 38.9 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.42 1.088 . . . . 0.0 108.991 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.41 -36.24 73.27 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.03 -1.462 . . . . 0.0 109.622 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.02 41.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.737 1.608 . . . . 0.0 112.694 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.12 -46.38 15.01 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.36 0.664 . . . . 0.0 111.149 176.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.9 t -61.54 -34.62 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 119.163 -2.211 . . . . 0.0 111.664 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.02 -44.48 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.617 1.167 . . . . 0.0 108.98 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -35.6 81.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 110.973 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 85' ' ' VAL . 44.1 mt -62.97 -49.07 76.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.48 -42.38 83.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.625 0.77 . . . . 0.0 111.6 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -62.92 -34.75 78.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.32 -0.862 . . . . 0.0 109.834 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.1 t -75.31 27.26 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.601 1.56 . . . . 0.0 112.418 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.2 t -114.33 106.2 53.02 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.67 164.99 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.423 2.748 . . . . 0.0 113.979 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.22 151.47 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 165.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.71 -0.89 60.12 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.566 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -94.12 165.41 12.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.354 1.577 . . . . 0.0 108.175 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -128.63 163.13 25.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.069 1.348 . . . . 0.0 109.357 165.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.82 148.32 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 125.46 1.504 . . . . 0.0 107.986 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.65 152.87 24.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.701 1.601 . . . . 0.0 109.222 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -144.71 115.52 7.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.7 t -89.54 122.85 41.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 170.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.15 161.65 15.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 124.152 0.907 . . . . 0.0 109.556 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.35 119.59 34.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -81.24 147.15 30.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 108.43 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.3 -18.52 7.34 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.625 161.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -70.44 139.13 86.59 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 119.694 1.747 . . . . 0.0 107.587 161.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.23 172.09 12.73 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.459 1.44 . . . . 0.0 110.543 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.68 158.22 61.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.668 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.627 2.218 . . . . 0.0 112.015 -177.187 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.8 t80 . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -78.2 -121.67 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.657 1.583 . . . . 0.0 111.355 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 160.97 -74.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 130.925 3.69 . . . . 0.0 109.108 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -118.73 22.92 11.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.687 1.232 . . . . 0.0 110.971 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 70.24 -23.87 0.16 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 128.17 2.588 . . . . 0.0 113.881 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -65.04 -13.21 57.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.631 1.172 . . . . 0.0 112.86 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -67.26 -22.19 65.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.443 1.097 . . . . 0.0 112.444 166.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.05 148.64 30.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.996 1.271 . . . . 0.0 109.048 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -112.81 -0.31 14.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.56 32.72 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.066 1.317 . . . . 0.0 112.578 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 157.89 33.72 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 124.871 1.268 . . . . 0.0 109.535 -169.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.39 129.04 49.09 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.652 0.781 . . . . 0.0 109.375 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.72 168.4 17.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.917 2.087 . . . . 0.0 108.415 -178.562 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.9 p -142.99 175.84 9.54 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.438 0.637 . . . . 0.0 111.199 160.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.406 HG21 ' HE2' ' A' ' 63' ' ' MET . 8.5 t -155.19 157.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.2 m -127.12 105.35 8.52 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.29 136.37 37.86 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -87.48 123.41 32.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.07 125.07 12.81 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.598 1.559 . . . . 0.0 108.236 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -173.74 3.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.78 -54.55 45.01 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.717 -1.239 . . . . 0.0 111.087 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.5 mtp -78.25 13.93 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.922 1.289 . . . . 0.0 113.545 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.16 -147.16 18.48 Favored Glycine 0 C--N 1.331 0.306 0 O-C-N 120.136 -1.602 . . . . 0.0 110.48 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -88.84 146.89 24.69 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 56' ' ' PRO . . . -86.8 42.28 3.15 Favored Glycine 0 C--O 1.222 -0.605 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.705 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -148.43 166.96 26.56 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 119.3 1.55 . . . . 0.0 109.321 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 p -127.28 158.81 36.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.215 1.806 . . . . 0.0 107.935 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.85 162.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.586 1.954 . . . . 0.0 107.283 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.6 tt -138.68 159.98 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.787 1.635 . . . . 0.0 108.26 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.23 154.08 23.8 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 128.802 3.096 . . . . 0.0 110.384 -174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.36 -82.99 0.21 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.482 1.039 . . . . 0.0 111.898 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -177.16 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.77 2.028 . . . . 0.0 111.243 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -125.73 153.11 73.12 Favored Pre-proline 0 C--N 1.342 0.27 0 O-C-N 120.154 -1.591 . . . . 0.0 111.652 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.42 51.35 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.31 1 C-N-CA 125.388 4.058 . . . . 0.0 113.949 168.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -158.43 13.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.096 -1.628 . . . . 0.0 109.516 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -74.89 160.47 30.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 127.411 2.285 . . . . 0.0 110.774 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -93.39 112.61 24.56 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.37 112.75 18.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.68 155.0 30.69 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.23 116.34 2.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -65.53 -54.38 28.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.768 1.227 . . . . 0.0 109.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 65' ' ' THR . 13.8 m -155.53 161.42 40.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.993 1.317 . . . . 0.0 108.049 171.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.48 140.59 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 161.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.97 132.11 54.91 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.0 160.51 48.28 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.864 2.376 . . . . 0.0 110.845 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.09 -18.31 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.434 2.294 . . . . 0.0 114.26 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.95 173.67 41.59 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.592 1.568 . . . . 0.0 114.181 -171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 33' ' ' GLY . 58.0 Cg_endo -66.52 -32.07 40.34 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.939 3.093 . . . . 0.0 111.41 -171.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.742 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.91 -46.33 65.64 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.888 0.875 . . . . 0.0 109.732 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.47 -42.66 99.64 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.268 0.94 . . . . 0.0 112.249 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.79 -6.06 29.67 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.894 0.77 . . . . 0.0 111.371 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.27 29.93 63.68 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.691 1.139 . . . . 0.0 113.465 165.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -136.17 -0.79 2.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.768 1.227 . . . . 0.0 111.982 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.406 ' HE2' HG21 ' A' ' 23' ' ' THR . 25.9 tpp -111.29 137.16 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.482 1.513 . . . . 0.0 107.069 169.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.75 167.71 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 108.941 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 50' ' ' SER . 43.3 m -77.18 159.68 29.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.495 1.118 . . . . 0.0 109.437 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.95 39.87 96.79 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -132.26 152.88 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.595 1.158 . . . . 0.0 108.074 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.5 117.6 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.688 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.1 mp -66.8 138.63 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 10.2 t -122.33 -54.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.37 149.83 51.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.435 1.094 . . . . 0.0 108.699 -175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.58 126.9 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 44.86 -93.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.1 2.16 . . . . 0.0 110.795 -159.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.25 -7.36 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.195 1.398 . . . . 0.0 111.483 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.37 139.82 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -173.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.44 130.3 36.86 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.132 -0.98 . . . . 0.0 109.003 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.94 10.61 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 111.445 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.0 -42.68 60.51 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.686 -1.259 . . . . 0.0 113.284 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.08 36.22 4.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 127.176 2.322 . . . . 0.0 109.905 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.83 -158.86 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.806 0.803 . . . . 0.0 109.683 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.7 t -119.93 143.98 47.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.641 1.11 . . . . 0.0 109.031 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -53.78 -42.41 68.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.532 2.333 . . . . 0.0 110.589 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.96 -29.23 68.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.831 0.741 . . . . 0.0 111.983 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -82.58 -54.85 4.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.373 1.069 . . . . 0.0 109.271 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.97 -44.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 130.053 3.341 . . . . 0.0 112.382 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.46 -32.8 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 120.459 -1.4 . . . . 0.0 109.652 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -34.69 71.99 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.65 1.114 . . . . 0.0 109.435 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.5 -42.96 95.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.985 1.314 . . . . 0.0 109.823 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -62.46 -19.15 63.23 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.291 1.036 . . . . 0.0 112.778 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -91.98 -11.37 36.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.819 1.248 . . . . 0.0 113.109 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 m -75.0 12.8 0.78 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.775 -1.203 . . . . 0.0 112.996 161.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.09 93.22 14.73 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.63 140.77 13.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.911 3.074 . . . . 0.0 109.57 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.1 mp -52.01 125.43 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 118.987 0.812 . . . . 0.0 109.232 -164.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.3 -16.44 11.71 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.46 1.981 . . . . 0.0 113.417 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -94.83 173.65 7.49 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.778 1.789 . . . . 0.0 109.756 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -127.94 167.02 17.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.042 2.537 . . . . 0.0 108.193 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.32 148.85 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.468 1.107 . . . . 0.0 108.596 161.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.4 152.44 25.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 167.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 mt -146.47 119.74 8.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.85 129.22 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 67' ' ' ASP . 10.3 mt -112.05 156.7 21.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.361 1.038 . . . . 0.0 109.4 166.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.06 128.29 55.57 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -84.62 156.35 21.6 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.138 0.975 . . . . 0.0 109.582 171.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.03 6.3 14.07 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 123.835 0.731 . . . . 0.0 114.391 163.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.46 133.9 23.8 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.53 -178.42 1.51 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.143 2.562 . . . . 0.0 111.15 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.42 158.02 83.64 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.578 0.751 . . . . 0.0 111.086 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 122.849 2.366 . . . . 0.0 112.662 -175.062 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -66.2 161.28 22.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.97 0.908 . . . . 0.0 109.967 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -153.27 167.86 27.95 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.76 -176.85 34.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.093 1.33 . . . . 0.0 112.955 -172.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -153.7 147.45 25.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.598 1.559 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -179.53 -172.41 0.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 129.091 2.957 . . . . 0.0 106.194 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 131.6 179.89 16.54 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mp -145.61 88.13 1.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.097 1.359 . . . . 0.0 107.877 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 t80 53.86 -178.68 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.746 1.618 . . . . 0.0 112.192 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -88.36 -121.35 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.144 -1.597 . . . . 0.0 109.019 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 150.19 -83.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 1 C-N-CA 132.701 4.4 . . . . 0.0 107.022 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.65 18.34 2.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.03 -17.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.106 2.962 . . . . 0.0 114.545 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -26.3 67.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.139 0.976 . . . . 0.0 111.262 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -82.18 -4.18 56.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.916 -1.04 . . . . 0.0 112.311 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.97 161.75 23.53 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.943 1.247 . . . . 0.0 108.66 169.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -124.23 116.22 22.33 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.81 39.46 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 124.42 1.075 . . . . 0.0 110.742 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -87.8 166.6 14.48 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' C ' HD13 ' A' ' 21' ' ' LEU . 12.2 m-85 -126.43 136.01 52.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.178 1.391 . . . . 0.0 107.283 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -153.24 164.4 38.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.545 1.138 . . . . 0.0 109.687 -174.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.4 m -144.58 163.42 33.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.824 0.821 . . . . 0.0 112.453 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 157.22 43.31 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.884 1.274 . . . . 0.0 107.89 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -114.46 114.14 25.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' ALA . 5.9 mt -98.52 132.91 43.57 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -85.46 132.55 34.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 163.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 51.3 tttt -73.31 93.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.695 1.998 . . . . 0.0 108.514 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -95.02 115.01 26.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.786 0.834 . . . . 0.0 109.173 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.56 -158.94 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.85 1.66 . . . . 0.0 108.888 -167.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 33.8 mtt 23.19 -76.32 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.147 2.979 . . . . 0.0 116.458 162.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 169.66 168.24 31.31 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -163.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -65.2 152.15 44.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.282 0.541 . . . . 0.0 110.12 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.25 44.05 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.915 -0.936 . . . . 0.0 112.259 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.67 164.72 37.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.499 1.65 . . . . 0.0 107.94 169.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 p -131.26 159.94 36.36 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.74 162.04 17.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.452 1.101 . . . . 0.0 108.847 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.72 146.57 32.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 128.575 2.75 . . . . 0.0 106.374 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.43 151.55 22.73 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 167.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -11.84 4.33 Favored Glycine 0 C--O 1.225 -0.419 0 C-N-CA 127.283 2.373 . . . . 0.0 117.893 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t0 95.59 -42.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 130.434 3.494 . . . . 0.0 108.037 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.79 157.81 89.39 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.674 2.389 . . . . 0.0 111.771 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -89.65 29.95 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.555 3.503 . . . . 0.0 112.692 -170.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -175.56 76.35 0.02 OUTLIER 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -140.44 143.46 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.873 2.469 . . . . 0.0 105.955 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -76.47 128.83 35.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -175.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.28 146.91 30.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.52 151.28 50.19 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 122.942 0.497 . . . . 0.0 110.835 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.17 112.1 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -70.57 -42.72 70.73 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 110.377 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 p -151.87 157.44 41.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.076 0.951 . . . . 0.0 109.57 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -92.72 141.7 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 159.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.03 122.07 86.22 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.44 146.23 97.31 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.442 1.428 . . . . 0.0 108.778 169.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 67.76 -2.59 1.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.536 1.534 . . . . 0.0 113.25 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.5 163.68 39.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.524 1.059 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.75 -27.76 75.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.113 2.542 . . . . 0.0 112.996 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.018 0.527 . . . . 0.0 110.081 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.2 87.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.686 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.47 -19.12 62.98 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.54 -4.91 59.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.162 1.346 . . . . 0.0 111.429 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.92 -24.27 1.98 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.17 2.319 . . . . 0.0 113.252 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.07 -35.33 18.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -157.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tpp -69.79 128.69 37.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.9 166.54 19.81 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -90.85 142.01 28.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 -16.6 58.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.691 -1.06 . . . . 0.0 112.361 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.482 ' HB3' HD13 ' A' ' 102' ' ' LEU . 84.3 m-20 -55.39 139.84 41.83 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.523 1.129 . . . . 0.0 109.837 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.49 123.25 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.409 1.084 . . . . 0.0 108.835 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.08 119.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.555 1.542 . . . . 0.0 108.285 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.91 -57.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.938 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -134.3 152.94 52.09 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mt -130.25 128.36 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 t30 59.63 -73.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.145 2.978 . . . . 0.0 111.994 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -157.51 40.51 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.68 0.792 . . . . 0.0 110.85 165.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.38 132.52 70.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.615 1.966 . . . . 0.0 108.736 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.2 p -72.53 111.73 7.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.703 1.601 . . . . 0.0 111.779 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.49 5.6 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.847 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -18.44 62.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.383 1.901 . . . . 0.0 114.214 -167.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.31 4.69 19.88 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.583 -1.121 . . . . 0.0 112.934 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.48 162.97 22.04 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.707 1.753 . . . . 0.0 109.965 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.0 p -70.67 142.71 51.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -60.04 -22.67 62.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.372 -0.83 . . . . 0.0 110.391 166.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.11 -54.58 45.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.7 -1.25 . . . . 0.0 111.883 167.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.34 -49.86 67.78 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 124.882 1.273 . . . . 0.0 109.792 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 t -61.01 -41.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 120.037 -1.664 . . . . 0.0 112.182 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.4 -37.03 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 120.661 -1.274 . . . . 0.0 109.66 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -35.45 81.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.48 1.036 . . . . 0.0 110.003 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.12 -45.16 86.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.355 1.062 . . . . 0.0 108.258 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -64.29 -41.42 96.88 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.996 0.816 . . . . 0.0 111.322 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.98 -25.43 64.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.438 0.563 . . . . 0.0 112.24 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -66.35 -18.17 65.2 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.025 0.829 . . . . 0.0 111.994 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.36 115.85 62.3 Favored Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.69 170.06 20.59 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 120.716 1.291 . . . . 0.0 110.783 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.61 139.72 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.629 1.172 . . . . 0.0 108.029 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.29 -0.99 88.76 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 117.504 -1.72 . . . . 0.0 113.657 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -100.04 172.58 7.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.038 1.919 . . . . 0.0 108.482 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 p -131.87 159.62 38.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.642 0.777 . . . . 0.0 110.052 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.29 155.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.839 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.84 159.21 21.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 mt -146.06 141.61 27.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -121.75 118.12 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 67' ' ' ASP . 8.8 mt -109.26 168.74 9.16 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.907 0.755 . . . . 0.0 109.871 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.9 t -121.75 143.67 49.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.909 1.284 . . . . 0.0 107.67 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 13.4 ttm180 -127.25 130.33 49.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.729 1.211 . . . . 0.0 111.68 -163.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 128.05 -21.85 5.47 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.16 139.01 87.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 123.965 0.906 . . . . 0.0 109.176 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.37 178.45 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.402 2.068 . . . . 0.0 110.735 167.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 157.98 20.75 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.306 160.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.0 140.43 49.98 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 N-CA-C 108.307 -1.459 . . . . 0.0 108.307 165.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -62.98 132.58 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 151.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.67 110.44 49.28 Favored Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.52 -22.36 21.3 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.48 1.454 . . . . 0.0 112.88 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.98 -61.27 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.889 1.276 . . . . 0.0 109.434 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -157.27 106.27 1.87 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.093 1.357 . . . . 0.0 108.692 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.03 -10.13 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.429 2.753 . . . . 0.0 113.824 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 141.18 97.98 0.0 OUTLIER 'General case' 0 C--N 1.344 0.36 0 C-N-CA 130.0 3.32 . . . . 0.0 109.336 -166.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -129.89 176.45 8.03 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.376 1.87 . . . . 0.0 108.813 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -162.92 163.99 26.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.251 2.22 . . . . 0.0 108.878 162.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.0 -159.39 32.31 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.086 1.327 . . . . 0.0 112.811 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -80.76 60.29 7.8 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.689 3.593 . . . . 0.0 112.288 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.16 132.61 50.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 155.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -71.84 163.54 27.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 163.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.421 -1.766 . . . . 0.0 109.03 178.847 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -74.63 -163.68 0.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.347 1.459 . . . . 0.0 110.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 m -119.46 -170.24 1.9 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.6 1.56 . . . . 0.0 107.58 161.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.5 175.56 21.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.2 m -57.4 147.83 25.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.215 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 t -84.69 -123.5 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.79 -168.39 38.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.44 -77.72 0.57 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 163.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.02 159.52 16.96 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.572 0.701 . . . . 0.0 110.843 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -78.77 -112.35 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.555 1.542 . . . . 0.0 111.715 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 147.13 -57.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 131.509 3.924 . . . . 0.0 111.798 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.6 t70 -142.76 20.78 1.99 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.797 0.439 . . . . 0.0 111.387 -166.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 61.49 -17.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.47 2.308 . . . . 0.0 114.132 -164.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -60.3 -23.42 64.17 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.942 2.497 . . . . 0.0 112.43 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -80.83 -16.12 54.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.419 1.087 . . . . 0.0 112.474 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.02 154.28 33.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.397 0.999 . . . . 0.0 109.13 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -130.01 99.57 5.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.83 176.11 39.89 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.359 1.933 . . . . 0.0 110.079 -166.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -98.64 133.79 42.48 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 117.798 0.799 . . . . 0.0 109.177 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.603 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 16.6 m-85 -101.12 142.65 32.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.387 1.075 . . . . 0.0 110.052 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.77 166.64 32.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.097 1.759 . . . . 0.0 109.372 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -147.1 156.54 43.08 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.849 1.26 . . . . 0.0 111.039 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -139.43 157.12 46.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.656 1.582 . . . . 0.0 107.862 168.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.09 111.63 24.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.067 1.347 . . . . 0.0 107.554 170.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.64 135.21 40.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.792 1.178 . . . . 0.0 108.391 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -83.67 151.56 25.22 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.416 0.627 . . . . 0.0 110.073 167.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -79.27 69.42 5.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.941 1.297 . . . . 0.0 109.378 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.29 170.25 9.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.464 1.105 . . . . 0.0 108.646 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 49.62 -92.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.993 2.117 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.2 ptm -118.9 4.3 11.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.33 1.452 . . . . 0.0 111.657 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.78 -176.76 35.16 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -151.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -64.99 149.15 50.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.034 -1.083 . . . . 0.0 110.983 -161.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.98 40.12 3.09 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.53 -176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -146.24 166.22 26.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.167 1.483 . . . . 0.0 109.108 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 p -128.87 159.46 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.277 1.431 . . . . 0.0 108.371 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.45 162.38 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.839 1.256 . . . . 0.0 109.423 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.76 155.08 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.735 2.014 . . . . 0.0 108.034 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.01 155.05 21.38 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 129.606 3.479 . . . . 0.0 111.049 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.1 -93.39 0.02 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 117.294 -2.384 . . . . 0.0 108.292 142.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.33 -65.43 0.08 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.09 166.9 28.95 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.934 1.694 . . . . 0.0 110.819 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.38 45.22 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.041 3.16 . . . . 0.0 111.872 -164.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -157.21 34.47 0.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.316 1.447 . . . . 0.0 109.181 -168.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -139.43 173.62 11.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.953 1.301 . . . . 0.0 113.13 -167.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -88.71 112.89 23.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 125.381 1.472 . . . . 0.0 110.493 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -81.9 134.67 35.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG2' HG22 ' A' ' 68' ' ' VAL . 27.9 mt-30 -128.22 156.96 42.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.63 0.65 . . . . 0.0 111.06 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.96 104.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 166.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -54.82 -50.03 69.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.505 1.522 . . . . 0.0 109.145 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 152.4 18.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 109.206 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.5 t -104.04 130.18 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.74 130.28 68.02 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.83 46.09 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.808 3.005 . . . . 0.0 113.36 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -160.54 43.65 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.317 1.847 . . . . 0.0 109.905 164.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.67 166.6 22.96 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 120.718 -1.239 . . . . 0.0 112.443 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.63 -22.07 64.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.563 2.175 . . . . 0.0 112.397 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.8 2.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.962 0.905 . . . . 0.0 109.838 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.06 70.28 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.014 0.926 . . . . 0.0 111.004 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.0 -20.14 65.83 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.892 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -99.33 -30.41 12.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.483 1.492 . . . . 0.0 112.05 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.88 6.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.329 1.442 . . . . 0.0 114.431 166.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -69.87 -15.87 63.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.514 1.157 . . . . 0.0 111.144 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.94 133.67 43.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.08 176.62 8.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 162.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.3 m -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.56 56.48 25.05 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' HB3' HD13 ' A' ' 102' ' ' LEU . 3.0 m-20 -128.92 151.49 49.6 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.983 2.113 . . . . 0.0 105.652 175.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' A' ' 47' ' ' GLN . 44.1 t -101.26 127.16 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 121.401 1.91 . . . . 0.0 109.706 -171.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.88 130.2 36.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.551 1.14 . . . . 0.0 108.589 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 17.4 t -106.4 -61.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.518 1.527 . . . . 0.0 109.211 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -128.83 157.76 40.61 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.397 1.079 . . . . 0.0 109.223 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mt -128.79 117.11 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 47.77 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 128.564 2.746 . . . . 0.0 112.075 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.45 13.7 1.78 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.514 1.526 . . . . 0.0 111.111 -170.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.22 120.9 55.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.47 104.8 2.41 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -101.52 3.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 123.28 0.632 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.545 ' C ' HD12 ' A' ' 78' ' ' LEU . 1.6 pp -58.45 -17.48 21.14 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.81 35.61 2.29 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 126.14 1.828 . . . . 0.0 109.016 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -103.16 165.66 10.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.306 1.053 . . . . 0.0 108.548 161.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.02 161.64 16.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.972 0.909 . . . . 0.0 109.546 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.93 -14.58 23.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.5 1.52 . . . . 0.0 111.934 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.13 -67.56 0.43 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.476 1.489 . . . . 0.0 109.478 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -56.01 -45.4 79.09 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.439 0.696 . . . . 0.0 111.075 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.11 -41.59 93.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 120.292 -1.505 . . . . 0.0 111.447 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.9 -37.34 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.87 -1.144 . . . . 0.0 109.731 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -39.07 93.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.426 1.466 . . . . 0.0 109.939 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.28 -51.1 71.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.667 1.587 . . . . 0.0 108.164 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.38 -42.33 88.08 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.019 0.827 . . . . 0.0 112.483 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.41 -30.88 69.89 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.423 -0.798 . . . . 0.0 111.008 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -70.02 -2.55 13.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.5 114.63 56.25 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.81 179.07 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.072 2.515 . . . . 0.0 110.931 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.35 152.06 7.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 109.137 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.08 -25.78 6.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 124.286 0.946 . . . . 0.0 111.956 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -84.33 142.25 30.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.42 1.11 . . . . 0.0 109.289 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.63 150.48 28.93 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.694 1.598 . . . . 0.0 108.234 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -141.31 141.21 31.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -84.18 155.97 22.3 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.0 mt -142.62 150.08 39.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.42 126.47 58.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 67' ' ' ASP . 14.5 mt -119.65 169.5 10.04 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 124.356 1.035 . . . . 0.0 110.265 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.9 t -133.48 117.5 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.836 0.855 . . . . 0.0 111.213 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -85.53 139.41 31.49 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.115 -0.99 . . . . 0.0 110.339 -165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.98 -4.8 16.25 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.073 -0.848 . . . . 0.0 113.582 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.67 117.97 68.88 Favored Pre-proline 0 CA--C 1.526 0.057 0 CA-C-N 119.372 1.586 . . . . 0.0 107.53 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.16 177.23 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.709 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -54.48 149.09 22.07 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.613 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.52 126.24 13.88 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.668 2.245 . . . . 0.0 107.33 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -66.29 135.19 54.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 163.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -119.4 92.57 46.04 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.52 -16.65 54.81 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 121.946 1.764 . . . . 0.0 113.265 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.36 -43.94 96.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.606 1.562 . . . . 0.0 111.081 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 35.29 92.68 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 129.474 3.109 . . . . 0.0 114.772 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.45 -8.42 20.71 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.852 2.368 . . . . 0.0 115.074 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 159.49 -62.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.595 3.158 . . . . 0.0 108.131 168.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 69.24 162.52 0.22 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.673 2.789 . . . . 0.0 110.168 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 93.6 p -159.03 158.29 32.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.4 140.39 11.0 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.3 -171.51 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.056 3.17 . . . . 0.0 111.15 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.0 p -65.09 81.62 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.281 1.433 . . . . 0.0 110.453 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 87.7 p -146.3 179.68 7.35 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.248 -0.907 . . . . 0.0 109.909 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 N-CA-C 104.859 -3.296 . . . . 0.0 104.859 162.706 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -51.69 142.78 13.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.726 1.61 . . . . 0.0 112.561 -167.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -60.54 160.6 8.73 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 161.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.82 -168.84 28.69 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -167.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 m 65.9 112.5 0.03 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.502 2.321 . . . . 0.0 109.834 -168.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -125.15 164.85 19.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.473 1.909 . . . . 0.0 108.034 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.53 -161.57 17.31 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.94 72.17 1.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 10' ' ' THR . 27.8 t80 52.71 165.12 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 130.99 3.716 . . . . 0.0 114.261 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 m -82.32 -99.36 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.377 1.471 . . . . 0.0 112.102 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 117.83 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 1 C-N-CA 136.151 5.781 . . . . 0.0 114.167 172.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -125.52 13.63 8.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.507 1.048 . . . . 0.0 111.721 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.3 -20.3 0.07 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.851 2.86 . . . . 0.0 115.399 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -64.27 -22.13 66.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.312 0.96 . . . . 0.0 112.32 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -97.83 20.64 11.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.724 1.21 . . . . 0.0 112.073 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.88 -159.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 162.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -64.04 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.055 1.342 . . . . 0.0 111.661 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.55 -13.69 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.168 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 159.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -86.18 127.38 34.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -127.95 123.4 34.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.773 1.629 . . . . 0.0 108.165 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 154.83 41.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.994 1.718 . . . . 0.0 107.977 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -145.6 152.79 40.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.584 0.354 . . . . 0.0 110.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.52 157.94 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 108.118 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.7 m -127.15 119.34 26.25 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.354 1.462 . . . . 0.0 107.935 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.98 150.39 21.42 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -83.12 158.24 22.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 24.0 tptt -77.1 98.32 5.0 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.5 m -126.1 151.86 46.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.686 0.675 . . . . 0.0 111.793 -159.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 60.4 -79.87 0.02 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.251 2.62 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -149.43 71.62 1.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.421 2.289 . . . . 0.0 107.432 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 73.79 176.14 33.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.82 123.69 21.65 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.458 -1.025 . . . . 0.0 109.357 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.22 51.52 2.1 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.744 1.164 . . . . 0.0 112.775 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.57 165.93 27.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.394 1.877 . . . . 0.0 106.321 160.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -131.8 166.44 21.55 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.462 -0.773 . . . . 0.0 109.279 166.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.29 161.32 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.837 1.655 . . . . 0.0 107.422 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -133.05 150.25 32.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.786 2.035 . . . . 0.0 106.702 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.22 151.8 22.43 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.391 1.948 . . . . 0.0 108.702 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.03 -55.85 9.99 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.357 -0.691 . . . . 0.0 112.611 -158.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.79 -41.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.505 1.922 . . . . 0.0 107.859 166.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.59 164.97 14.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.223 1.409 . . . . 0.0 111.707 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.1 19.19 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.106 3.871 . . . . 0.0 116.218 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.58 5.61 0.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.22 1.008 . . . . 0.0 113.252 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.28 155.33 40.31 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 0.969 . . . . 0.0 108.413 163.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.96 168.41 18.06 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.806 0.812 . . . . 0.0 110.509 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.65 133.85 54.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.714 1.606 . . . . 0.0 107.254 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -128.49 151.82 48.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.11 121.96 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -76.74 -41.92 43.16 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 125.959 1.704 . . . . 0.0 110.501 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.2 p -156.99 161.93 39.58 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.304 1.041 . . . . 0.0 110.432 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.43 120.42 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 126.542 1.937 . . . . 0.0 105.811 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mm -75.49 131.38 77.55 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.22 152.04 82.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.668 2.245 . . . . 0.0 109.648 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 t70 53.92 23.17 3.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.908 0.861 . . . . 0.0 111.924 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.29 163.73 13.15 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.527 1.537 . . . . 0.0 109.712 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.4 -32.54 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.761 2.307 . . . . 0.0 111.865 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.44 -40.88 80.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.119 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.04 81.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.263 0.625 . . . . 0.0 110.596 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.13 -46.72 89.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.298 0.499 . . . . 0.0 110.216 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.32 -31.31 71.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.036 0.534 . . . . 0.0 111.223 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.97 -18.69 29.93 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.474 1.511 . . . . 0.0 113.49 160.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.111 0.955 . . . . 0.0 110.675 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.5 tpp -65.43 123.71 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.01 163.69 29.72 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.239 1.016 . . . . 0.0 108.363 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -88.21 142.56 27.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -167.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.41 -12.96 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.849 -1.528 . . . . 0.0 112.512 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.467 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.7 m-20 -68.91 148.89 49.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.677 2.238 . . . . 0.0 108.098 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.3 125.75 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.115 1.366 . . . . 0.0 109.268 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.11 110.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 125.406 1.482 . . . . 0.0 107.422 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.02 -58.82 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.585 0.707 . . . . 0.0 109.664 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.07 155.22 50.43 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.916 1.286 . . . . 0.0 107.851 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -127.08 113.7 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 169.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 t30 69.88 -61.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 129.484 3.114 . . . . 0.0 112.27 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -157.71 5.7 0.13 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.756 1.622 . . . . 0.0 111.682 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.55 131.32 53.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 120.313 -1.492 . . . . 0.0 107.376 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.9 t -78.27 116.55 18.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.74 5.3 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 122.961 0.504 . . . . 0.0 111.576 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -31.59 35.44 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.364 1.866 . . . . 0.0 113.138 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.22 61.1 0.64 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -111.82 162.94 14.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.329 1.052 . . . . 0.0 109.834 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.27 151.61 41.3 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -55.47 -29.81 59.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.088 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.96 71.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.307 1.412 . . . . 0.0 112.268 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -76.57 -57.21 3.99 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -52.72 -41.62 39.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.484 2.713 . . . . 0.0 112.909 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.62 -28.37 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 120.553 -1.342 . . . . 0.0 110.361 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -35.74 73.14 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.439 1.472 . . . . 0.0 108.154 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.69 -36.39 67.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.214 1.005 . . . . 0.0 110.317 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -73.0 -29.6 63.16 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.721 -1.237 . . . . 0.0 111.684 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.81 -19.3 55.21 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.378 0.671 . . . . 0.0 112.237 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.6 m -71.24 -7.5 47.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 113.382 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.01 102.85 19.14 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.306 1.043 . . . . 0.0 108.259 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.7 170.43 16.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 mt -66.95 142.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 107.774 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.82 -2.57 87.3 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.103 -0.832 . . . . 0.0 113.049 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -101.53 171.63 7.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.716 1.258 . . . . 0.0 108.976 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -143.91 155.43 44.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.137 2.175 . . . . 0.0 108.211 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.81 148.24 24.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -82.82 153.38 25.21 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.2 mt -138.17 147.36 43.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 t -127.68 116.45 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.2 mt -109.96 164.12 12.91 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -117.65 138.15 52.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 164.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.06 156.14 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.354 1.862 . . . . 0.0 110.095 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.05 -16.18 20.57 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 118.663 -1.076 . . . . 0.0 114.03 157.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -83.53 140.04 41.35 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 118.884 1.342 . . . . 0.0 108.784 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.97 176.87 9.47 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.63 2.887 . . . . 0.0 110.074 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 mt -67.58 145.3 98.19 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -72.61 -39.4 2.65 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.931 1.754 . . . . 0.0 111.053 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.22 107.92 0.72 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.166 0.986 . . . . 0.0 108.661 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -89.71 106.22 13.46 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.89 -25.87 11.69 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 120.831 1.021 . . . . 0.0 111.244 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -67.69 -49.22 63.84 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.382 -0.824 . . . . 0.0 111.319 -169.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.28 87.91 6.42 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.51 -24.61 11.87 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.473 1.449 . . . . 0.0 113.661 -153.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 174.5 87.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.596 3.158 . . . . 0.0 103.109 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 58.88 -179.49 0.08 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.319 1.848 . . . . 0.0 112.739 -165.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -124.25 150.41 45.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.7 1.6 . . . . 0.0 108.093 166.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.93 -173.89 53.35 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.449 0.468 . . . . 0.0 112.497 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.62 132.83 36.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.549 2.166 . . . . 0.0 108.675 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.0 p -82.84 68.18 9.21 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.848 0.859 . . . . 0.0 109.068 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m -68.54 -178.48 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.09 0.956 . . . . 0.0 110.86 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.428 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 178.09 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.836 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -80.69 171.03 15.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.707 1.203 . . . . 0.0 110.26 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -82.18 173.79 11.79 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 120.409 -1.432 . . . . 0.0 108.904 153.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.46 -100.44 2.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 150.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 m -152.97 -165.5 2.2 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.203 1.801 . . . . 0.0 106.239 162.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -150.49 109.9 3.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 160.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.73 153.42 24.74 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.505 1.526 . . . . 0.0 110.02 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tt -112.97 -80.14 0.59 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.913 0.857 . . . . 0.0 109.012 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -87.46 169.16 12.46 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 m -88.4 -120.39 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.912 1.285 . . . . 0.0 108.759 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 146.77 -47.64 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.582 1 C-N-CA 133.127 4.571 . . . . 0.0 106.62 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -123.92 124.75 43.3 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -170.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.31 -9.25 3.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.363 1.465 . . . . 0.0 113.422 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -69.99 -21.29 63.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.223 1.009 . . . . 0.0 111.657 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.05 -22.86 63.03 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.11 -0.994 . . . . 0.0 111.092 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.52 152.43 40.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.314 0.578 . . . . 0.0 110.575 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -129.67 111.06 12.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.914 2.086 . . . . 0.0 105.597 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.07 -144.85 5.13 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.8 m -136.61 152.39 50.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 151.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.63 142.83 33.64 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.286 1.434 . . . . 0.0 108.824 -172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 104' ' ' ARG . 2.0 mp -141.21 165.52 27.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.789 0.836 . . . . 0.0 109.168 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 m -152.47 154.69 36.02 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.131 0.491 . . . . 0.0 111.865 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -154.2 158.42 40.29 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.33 1.852 . . . . 0.0 107.621 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -121.58 111.97 17.89 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.421 1.488 . . . . 0.0 107.182 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -101.83 131.88 47.91 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.808 -0.557 . . . . 0.0 109.738 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -83.51 132.97 34.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.633 1.573 . . . . 0.0 109.466 172.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 33.1 tptt -62.38 107.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 107.86 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.4 t -133.69 -127.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.48 1.512 . . . . 0.0 108.021 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -55.25 102.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.314 1.446 . . . . 0.0 110.542 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 36.2 mtm 45.31 67.88 0.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.134 1.374 . . . . 0.0 110.622 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 70.15 -126.9 17.18 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.63 141.79 35.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 40.27 1.83 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.666 -0.519 . . . . 0.0 112.579 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -142.71 162.58 35.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.468 1.634 . . . . 0.0 109.11 163.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -123.91 152.23 42.66 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.246 1.818 . . . . 0.0 107.632 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.64 161.99 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.16 0.984 . . . . 0.0 108.478 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -135.71 158.84 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.698 2.399 . . . . 0.0 106.126 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.7 152.53 22.15 Favored Glycine 0 C--O 1.237 0.282 0 C-N-CA 126.025 1.774 . . . . 0.0 108.68 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.06 -77.18 0.14 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.754 0.692 . . . . 0.0 112.612 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -170.21 -50.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.658 0.729 . . . . 0.0 110.302 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -101.07 166.1 13.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.558 1.543 . . . . 0.0 111.169 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.25 43.81 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.778 3.652 . . . . 0.0 110.772 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.0 23.15 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.735 2.014 . . . . 0.0 110.79 -173.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.26 167.84 10.22 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.983 0.913 . . . . 0.0 109.107 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.46 160.99 27.41 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 110.967 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -124.75 132.07 53.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 127.009 2.124 . . . . 0.0 106.552 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.9 mt-30 -130.39 155.97 45.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.42 112.34 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 165.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -59.9 -49.62 76.96 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 108.686 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 65' ' ' THR . 3.9 m -157.58 146.39 19.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.767 1.227 . . . . 0.0 108.474 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.51 143.24 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 159.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -71.54 135.9 83.73 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.72 137.66 25.18 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.365 1.377 . . . . 0.0 109.523 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 51.61 67.62 0.93 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.431 1.092 . . . . 0.0 111.327 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.37 175.01 25.17 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.414 -0.804 . . . . 0.0 111.844 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.99 -35.55 92.79 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 112.221 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' A' ' 63' ' ' MET . . . -67.3 -36.57 81.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.892 1.277 . . . . 0.0 111.714 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.88 67.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.36 0.664 . . . . 0.0 109.897 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.02 -45.88 86.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.638 1.175 . . . . 0.0 111.472 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -68.44 -24.46 64.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.022 0.529 . . . . 0.0 110.862 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.82 15.19 64.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.678 1.132 . . . . 0.0 113.815 169.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.01 -73.7 0.42 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.405 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -79.94 159.3 26.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -138.37 160.16 40.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.243 1.497 . . . . 0.0 111.518 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 50' ' ' SER . 55.0 m -60.0 133.78 56.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.606 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.31 -14.67 64.04 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.282 1.42 . . . . 0.0 113.765 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.21 150.87 41.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.379 1.59 . . . . 0.0 109.531 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG22 ' HG2' ' A' ' 47' ' ' GLN . 38.2 t -96.22 127.54 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.366 1.466 . . . . 0.0 108.959 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.46 117.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.289 . . . . 0.0 107.641 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.88 -60.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.569 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -132.0 148.86 52.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -130.71 130.8 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 53.02 -85.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.754 2.422 . . . . 0.0 112.449 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.61 9.99 2.9 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.768 1.167 . . . . 0.0 112.712 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.26 132.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.321 1.448 . . . . 0.0 109.118 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.68 98.44 1.92 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -98.42 8.47 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.908 0.883 . . . . 0.0 110.705 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -56.25 -21.51 24.09 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -169.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.24 22.73 5.0 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.096 1.808 . . . . 0.0 111.692 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.82 30.48 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.739 1.769 . . . . 0.0 109.116 166.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 144.63 48.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.06 -37.3 66.57 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.96 69.23 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.577 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.43 -50.26 11.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.602 1.092 . . . . 0.0 110.065 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.23 -39.44 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.068 1.347 . . . . 0.0 111.432 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.25 -40.58 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 120.851 -1.156 . . . . 0.0 109.735 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -31.32 70.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 110.682 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.97 -46.6 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.126 1.77 . . . . 0.0 109.482 174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.06 -37.38 86.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.994 0.816 . . . . 0.0 109.959 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.2 -24.46 62.22 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.515 -0.741 . . . . 0.0 112.112 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -70.83 -0.22 8.6 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.422 1.089 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.2 t -100.12 101.84 15.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.09 168.01 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.596 1.53 . . . . 0.0 110.919 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.7 142.12 12.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.13 -11.61 35.45 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.589 -1.117 . . . . 0.0 113.69 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -84.58 154.24 22.73 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 120.478 2.139 . . . . 0.0 107.465 165.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -126.03 157.53 37.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.057 1.343 . . . . 0.0 109.338 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.66 147.21 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.39 150.5 26.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 mt -141.44 139.81 33.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.87 123.2 69.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -115.96 164.37 14.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 123.958 0.786 . . . . 0.0 110.172 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 16.9 t -115.89 119.86 37.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 165.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 21' ' ' LEU . 7.0 ttm180 -74.35 156.27 37.27 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.668 1.187 . . . . 0.0 107.993 163.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.35 30.58 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.009 0.822 . . . . 0.0 113.309 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -103.35 126.8 31.17 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.41 172.52 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.393 2.062 . . . . 0.0 111.689 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.15 142.68 98.65 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.35 -45.97 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.695 2.264 . . . . 0.0 111.25 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.69 117.68 7.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.953 0.901 . . . . 0.0 108.849 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -79.41 108.58 8.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.852 1.661 . . . . 0.0 108.799 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.41 -21.73 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.745 1.63 . . . . 0.0 111.497 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -64.46 -25.79 68.16 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.361 1.064 . . . . 0.0 111.329 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.1 100.25 2.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.93 -51.79 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.116 1.878 . . . . 0.0 110.144 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.22 -74.2 0.06 Allowed 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.848 1.659 . . . . 0.0 107.764 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 90.67 88.76 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 129.72 3.208 . . . . 0.0 111.006 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -60.11 118.54 6.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.723 0.409 . . . . 0.0 109.948 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.09 167.97 16.03 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 154.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.39 133.35 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.354 2.036 . . . . 0.0 110.964 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.0 p -145.93 148.63 33.0 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.726 0.81 . . . . 0.0 109.589 161.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.7 m -159.27 169.4 24.14 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.945 2.498 . . . . 0.0 106.314 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.609 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -175.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.9 m -133.37 179.66 6.07 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.913 1.685 . . . . 0.0 111.258 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 t 57.83 -163.94 0.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.869 1.668 . . . . 0.0 110.438 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.48 152.14 21.1 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.25 153.37 47.82 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.162 1.785 . . . . 0.0 108.262 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -132.93 159.1 40.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.747 1.619 . . . . 0.0 108.104 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 47.83 64.27 3.05 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -161.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.01 103.7 3.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 175.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 19.3 t80 -54.57 162.45 1.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.299 1.439 . . . . 0.0 111.206 177.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 15' ' ' GLN . 9.1 m -74.02 -110.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.511 1.124 . . . . 0.0 112.369 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 134.61 -51.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 134.296 5.039 . . . . 0.0 109.939 -175.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -125.26 22.49 7.81 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -165.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.17 -11.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 114.922 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 t -62.75 -31.53 72.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.99 1.716 . . . . 0.0 112.605 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HB2' HG23 ' A' ' 10' ' ' THR . 9.3 mm-40 -72.91 -11.95 60.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.8 mt -69.39 145.58 52.76 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.908 1.231 . . . . 0.0 109.944 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.2 142.41 28.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 160.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.58 -173.71 23.35 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.988 0.805 . . . . 0.0 112.812 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.7 m -106.53 129.02 54.55 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -80.21 133.87 36.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -145.23 174.47 11.06 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.323 1.449 . . . . 0.0 109.005 177.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -151.04 163.25 39.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.243 0.217 . . . . 0.0 110.615 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -154.47 158.04 39.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.96 0.886 . . . . 0.0 108.636 166.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.7 m -114.84 117.83 31.81 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 167.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.58 138.5 36.58 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -90.95 129.82 36.94 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.95 103.58 0.18 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.008 1.323 . . . . 0.0 107.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t -129.51 165.83 20.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.523 1.529 . . . . 0.0 107.779 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 44.05 -73.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.733 3.213 . . . . 0.0 113.273 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.5 ptp -142.74 5.94 1.59 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.089 1.756 . . . . 0.0 113.43 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.23 -126.18 2.44 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 120.851 1.66 . . . . 0.0 111.599 -172.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.91 145.98 46.21 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.976 0.91 . . . . 0.0 109.253 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.55 36.23 2.98 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.856 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -149.07 169.09 21.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.099 1.45 . . . . 0.0 108.883 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -131.77 154.21 49.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.373 1.069 . . . . 0.0 108.439 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.81 160.58 17.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.597 1.159 . . . . 0.0 107.898 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 tt -125.25 162.03 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.722 2.009 . . . . 0.0 107.207 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.76 150.7 19.37 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.64 -63.16 3.31 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-O 118.952 -0.916 . . . . 0.0 112.285 -172.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.14 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 128.453 2.701 . . . . 0.0 109.09 164.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -89.79 160.7 40.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.399 1.48 . . . . 0.0 112.39 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.97 51.83 3.23 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 125.082 3.855 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.69 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.901 2.08 . . . . 0.0 110.921 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -102.5 154.49 19.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 120.632 -1.292 . . . . 0.0 109.126 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.57 137.43 33.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.162 0.985 . . . . 0.0 108.741 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.82 113.12 24.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.382 1.873 . . . . 0.0 109.173 -174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.72 157.27 16.82 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 122.104 2.229 . . . . 0.0 111.207 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 t -61.08 115.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -55.11 36.93 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.36 -0.838 . . . . 0.0 109.142 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 m -159.66 154.29 24.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.973 0.909 . . . . 0.0 109.582 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.08 133.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 160.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.3 135.15 66.1 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 125.872 1.669 . . . . 0.0 107.574 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.12 147.51 84.09 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.509 1.472 . . . . 0.0 109.074 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 64.3 24.25 13.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.038 0.935 . . . . 0.0 112.509 167.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.97 176.54 19.9 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.798 1.666 . . . . 0.0 112.478 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.25 -12.36 25.37 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.734 2.956 . . . . 0.0 113.497 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.16 -50.71 12.38 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 168.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.32 -54.76 41.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.688 0.795 . . . . 0.0 109.971 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -68.94 -15.4 63.48 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.326 0.966 . . . . 0.0 113.473 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.9 -38.56 73.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.227 1.376 . . . . 0.0 109.415 166.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.04 -28.94 13.66 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.045 1.307 . . . . 0.0 113.057 167.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -93.63 -12.67 28.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.201 1.5 . . . . 0.0 113.836 -160.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.0 ttm -90.53 144.84 25.39 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 120.976 -1.077 . . . . 0.0 108.417 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -137.06 179.04 6.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.523 1.129 . . . . 0.0 108.181 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 m -93.93 149.4 21.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.1 5.92 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -165.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -134.76 157.07 47.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.46 114.03 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.86 2.064 . . . . 0.0 108.351 -167.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -60.26 115.4 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.247 1.419 . . . . 0.0 108.089 171.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.95 -54.55 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 124.12 0.887 . . . . 0.0 109.974 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.16 154.25 51.69 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.288 1.435 . . . . 0.0 108.684 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 77' ' ' VAL . 46.4 mt -135.01 129.2 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 51.22 -89.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.898 2.479 . . . . 0.0 110.896 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -135.14 28.51 3.44 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.396 1.453 . . . . 0.0 112.023 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.98 133.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 120.904 -1.123 . . . . 0.0 109.293 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.35 106.45 12.37 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.879 1.272 . . . . 0.0 110.322 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 72' ' ' ILE . 28.7 m -108.47 5.18 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.188 0.995 . . . . 0.0 112.784 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -56.06 -32.04 63.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.41 14.63 13.28 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.612 1.577 . . . . 0.0 110.739 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -68.65 161.85 27.27 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 p -73.23 145.85 45.9 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.38 -41.77 66.23 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 109.113 168.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.26 63.68 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.326 0.966 . . . . 0.0 113.462 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.79 -53.87 6.66 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 120.288 1.404 . . . . 0.0 109.435 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 t -56.0 -39.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.395 1.878 . . . . 0.0 111.662 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.1 -38.36 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 120.93 -1.106 . . . . 0.0 110.068 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -37.26 81.8 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 120.148 1.34 . . . . 0.0 109.182 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.18 -39.41 92.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.659 1.184 . . . . 0.0 109.16 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -69.24 -45.02 70.79 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.95 0.795 . . . . 0.0 111.904 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.07 -29.45 70.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.904 0.775 . . . . 0.0 112.106 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.6 p -56.69 -25.56 54.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.263 1.025 . . . . 0.0 113.548 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.05 109.24 17.66 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -162.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.75 170.19 14.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.635 1.556 . . . . 0.0 110.419 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mt -63.29 144.64 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.71 -4.05 53.33 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 117.654 -1.637 . . . . 0.0 113.99 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -86.52 175.94 8.09 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.867 1.834 . . . . 0.0 108.735 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.48 162.75 28.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.996 1.318 . . . . 0.0 109.999 170.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.04 150.37 24.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 125.331 1.452 . . . . 0.0 108.708 165.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -83.16 159.4 22.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 173.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -145.95 143.75 29.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.81 129.85 74.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 67' ' ' ASP . 27.1 mt -118.47 171.13 8.37 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 124.296 0.997 . . . . 0.0 110.369 168.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 12.3 t -131.04 119.87 22.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.908 1.283 . . . . 0.0 108.344 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 21' ' ' LEU . 18.9 ttm180 -91.11 140.94 29.34 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.181 1.393 . . . . 0.0 110.467 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.85 -38.01 1.87 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.178 0.894 . . . . 0.0 111.008 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -60.91 120.1 50.74 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.56 0.744 . . . . 0.0 109.316 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.11 177.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.646 2.231 . . . . 0.0 111.802 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.23 151.78 95.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.955 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.98 -49.73 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.517 2.144 . . . . 0.0 110.334 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -81.26 119.27 23.42 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.82 130.63 23.1 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 167.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.17 -12.99 28.33 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.496 2.131 . . . . 0.0 113.507 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.32 -44.11 38.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.963 0.905 . . . . 0.0 110.736 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -151.37 76.51 7.66 Favored Pre-proline 0 CA--C 1.523 -0.089 0 O-C-N 121.648 -0.658 . . . . 0.0 109.637 174.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.6 -14.43 36.58 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.427 1.418 . . . . 0.0 111.607 172.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 143.03 118.05 0.0 OUTLIER 'General case' 0 C--N 1.345 0.384 1 C-N-CA 133.54 4.736 . . . . 0.0 106.622 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.7 p30 168.06 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.452 2.701 . . . . 0.0 109.765 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.15 132.36 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.489 1.515 . . . . 0.0 112.216 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.02 -112.91 0.47 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.09 149.54 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 CA-C-N 120.263 2.031 . . . . 0.0 110.261 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.98 176.73 12.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 159.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.9 t -147.26 136.58 22.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.437 0 N-CA-C 106.86 -2.496 . . . . 0.0 106.86 -173.64 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.859 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m 44.33 -135.3 0.58 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.091 -164.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -52.06 158.28 1.12 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.23 -97.36 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m 42.66 78.44 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.026 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 p -135.08 177.37 7.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.699 1.199 . . . . 0.0 110.338 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.29 175.75 37.39 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.338 0.97 . . . . 0.0 112.599 169.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 tp -143.47 -72.41 0.29 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.503 -0.76 . . . . 0.0 109.284 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -67.29 152.17 46.19 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.227 1.013 . . . . 0.0 109.497 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -74.51 -97.97 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.048 1.339 . . . . 0.0 113.928 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 116.67 -34.61 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 1 C-N-CA 136.112 5.765 . . . . 0.0 110.913 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -146.02 18.73 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 112.674 -161.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 62.3 -22.32 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.034 2.934 . . . . 0.0 114.749 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 t -74.17 -6.26 46.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.364 1.438 . . . . 0.0 113.433 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -80.41 -22.64 41.02 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 119.625 -1.922 . . . . 0.0 111.159 164.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.41 146.15 54.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -131.52 124.54 30.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.85 177.99 15.15 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.1 m -93.17 155.43 17.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.655 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 12.7 m-85 -106.44 132.28 52.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.876 1.67 . . . . 0.0 109.344 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 165.64 12.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 108.475 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -139.02 149.79 45.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.6 1.16 . . . . 0.0 109.019 160.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -155.05 157.15 37.12 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 m -130.31 105.96 8.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.42 134.83 40.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.6 145.62 29.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.55 95.37 1.4 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -84.04 -166.45 1.42 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.548 2.339 . . . . 0.0 110.021 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -58.85 -24.58 62.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -165.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -133.07 53.19 2.03 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 -123.86 26.33 Favored Glycine 0 N--CA 1.441 -0.995 0 O-C-N 121.332 -0.855 . . . . 0.0 111.505 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.97 136.56 49.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.3 51.43 4.37 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.415 0.552 . . . . 0.0 112.169 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.46 173.27 13.28 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.01 1.324 . . . . 0.0 108.781 165.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.58 159.62 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.206 1.403 . . . . 0.0 108.811 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.76 159.51 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.078 1.351 . . . . 0.0 109.658 -174.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.83 155.46 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 128.954 2.902 . . . . 0.0 106.853 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.99 152.25 20.99 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.936 1.731 . . . . 0.0 109.128 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.91 -75.6 0.17 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.373 1.463 . . . . 0.0 111.801 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.92 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.473 1.509 . . . . 0.0 108.22 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -97.3 167.67 11.52 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -167.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.44 55.46 3.65 Favored 'Trans proline' 0 C--N 1.351 0.668 1 C-N-CA 125.312 4.008 . . . . 0.0 111.234 172.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.88 -8.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.956 1.302 . . . . 0.0 112.973 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.09 162.79 15.15 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.13 -0.981 . . . . 0.0 112.783 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.22 134.31 52.44 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.442 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 85' ' ' VAL . 16.8 mt -104.45 135.88 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -130.25 153.68 48.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.203 0.91 . . . . 0.0 110.947 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.0 119.29 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -71.2 -50.32 34.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.985 1.714 . . . . 0.0 110.16 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -152.31 152.6 32.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.041 1.736 . . . . 0.0 108.295 168.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.48 136.27 24.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 160.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.95 142.88 91.12 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 141.82 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.676 1.584 . . . . 0.0 111.016 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 46.84 68.52 0.61 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.814 1.646 . . . . 0.0 110.765 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.41 175.4 26.78 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.944 1.259 . . . . 0.0 110.415 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -64.68 -33.22 55.66 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.598 2.198 . . . . 0.0 112.7 -167.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.69 74.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.28 80.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.406 1.083 . . . . 0.0 111.517 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.69 -34.55 77.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.19 0.596 . . . . 0.0 112.536 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -33.84 75.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.751 0.786 . . . . 0.0 109.169 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.03 6.04 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.987 2.232 . . . . 0.0 114.209 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -65.57 -45.75 82.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.163 0.981 . . . . 0.0 109.246 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 tpp -65.63 122.75 17.95 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.835 0.854 . . . . 0.0 109.25 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.04 159.94 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 108.897 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 m -78.06 149.55 33.93 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.786 -1.196 . . . . 0.0 108.436 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -8.44 77.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.87 0.748 . . . . 0.0 113.71 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.41 158.18 34.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.143 1.472 . . . . 0.0 110.25 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.68 130.02 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.305 1.842 . . . . 0.0 108.741 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.93 126.71 39.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.112 1.365 . . . . 0.0 108.231 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.409 HG11 ' HB2' ' A' ' 13' ' ' ALA . 2.6 t -110.78 -54.67 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.858 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -135.06 142.03 46.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.11 112.32 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 t30 71.97 -68.86 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.268 3.027 . . . . 0.0 111.322 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -156.47 24.77 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 110.756 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.05 132.27 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 120.491 -1.381 . . . . 0.0 107.513 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 t -69.78 116.38 10.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.987 0.915 . . . . 0.0 108.716 168.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.09 5.37 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.771 0.829 . . . . 0.0 111.787 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' C ' HD12 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -55.12 -24.01 23.77 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.21 22.94 5.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.856 1.693 . . . . 0.0 110.529 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -75.69 158.47 32.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.352 1.576 . . . . 0.0 109.894 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 t -77.14 149.1 35.66 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.24 -41.38 72.07 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.811 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.51 -32.3 62.78 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.379 1.445 . . . . 0.0 112.403 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -80.34 -47.8 13.93 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 118.86 0.754 . . . . 0.0 110.866 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG21 ' CD1' ' A' ' 46' ' ' LEU . 4.1 t -59.0 -42.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.711 -1.243 . . . . 0.0 110.703 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.58 -44.8 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.324 172.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -37.89 84.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.629 1.558 . . . . 0.0 111.167 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -60.93 -50.52 73.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.212 1.405 . . . . 0.0 108.362 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -64.79 -39.98 94.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.211 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -67.01 -34.25 77.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.444 0.698 . . . . 0.0 110.168 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -70.53 -3.81 19.83 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.38 116.58 65.71 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -60.86 157.23 39.24 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.741 2.294 . . . . 0.0 110.896 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.9 mt -59.85 139.21 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -13.11 59.17 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.424 -1.764 . . . . 0.0 114.299 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -84.21 167.16 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.834 2.317 . . . . 0.0 108.241 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.33 163.56 22.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.655 1.182 . . . . 0.0 110.008 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.0 146.25 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.398 1.479 . . . . 0.0 107.777 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.82 156.51 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.485 1.114 . . . . 0.0 109.524 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.48 109.59 4.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.5 t -89.3 121.15 39.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -116.52 163.77 15.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 124.11 0.881 . . . . 0.0 110.804 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.0 t -116.95 126.73 53.37 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.999 1.32 . . . . 0.0 108.563 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -76.52 156.84 32.59 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.454 1.502 . . . . 0.0 110.552 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.31 -21.93 8.56 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.808 1.194 . . . . 0.0 113.507 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -76.52 159.65 79.05 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 118.364 1.082 . . . . 0.0 109.888 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.23 178.31 6.74 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.986 2.458 . . . . 0.0 111.786 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.1 151.83 94.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 164.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.72 -25.13 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.761 1.641 . . . . 0.0 111.433 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -118.94 100.75 7.57 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.357 3.063 . . . . 0.0 106.033 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.7 103.5 2.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 124.591 1.157 . . . . 0.0 108.34 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -77.44 -6.75 16.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.106 1.87 . . . . 0.0 112.432 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.18 -24.17 43.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.801 1.641 . . . . 0.0 112.754 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -95.53 118.59 66.11 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.05 -16.46 52.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.601 2.201 . . . . 0.0 113.649 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 144.44 -27.91 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 131.5 3.92 . . . . 0.0 110.466 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . 0.269 5.4 p30 40.0 -122.24 0.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.125 1.77 . . . . 0.0 110.73 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.7 m 37.01 51.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.963 2.505 . . . . 0.0 115.949 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.79 155.08 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.588 160.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.86 163.51 28.61 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.754 2.303 . . . . 0.0 110.494 166.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m 56.99 -176.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.844 1.258 . . . . 0.0 113.889 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 m -108.98 -52.05 2.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.061 1.344 . . . . 0.0 111.006 -172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.705 0 N-CA-C 104.64 -3.384 . . . . 0.0 104.64 165.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.727 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.9 p -63.99 166.9 6.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 163.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -152.53 -55.09 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.64 -161.77 20.66 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.406 1.479 . . . . 0.0 109.729 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . 0.304 89.6 p 59.9 88.78 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.348 3.059 . . . . 0.0 112.913 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -130.16 -7.31 4.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.717 1.607 . . . . 0.0 113.038 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.44 177.31 48.23 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.75 -82.74 0.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -166.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 10' ' ' THR . 88.0 t80 -82.8 179.14 7.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.333 1.453 . . . . 0.0 110.537 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 88.0 m -102.31 -106.25 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 110.297 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 138.41 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 133.851 4.86 . . . . 0.0 110.597 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -123.54 17.26 9.65 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.043 0.838 . . . . 0.0 113.217 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 58.66 -10.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.957 2.903 . . . . 0.0 115.184 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -75.92 -15.75 60.14 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.157 -1.589 . . . . 0.0 113.739 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.09 -16.85 63.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.96 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.01 162.9 28.64 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.535 1.061 . . . . 0.0 110.844 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -126.46 135.3 51.19 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.994 2.118 . . . . 0.0 106.142 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 -158.4 27.64 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -164.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -128.4 143.09 50.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.527 1.131 . . . . 0.0 108.403 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.9 m-85 -88.87 134.99 33.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.567 0.747 . . . . 0.0 109.387 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -113.09 171.64 7.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.042 1.737 . . . . 0.0 108.301 173.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.4 p -147.72 153.35 39.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.431 0.693 . . . . 0.0 109.538 162.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.73 158.18 40.6 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.069 1.348 . . . . 0.0 107.393 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 97' ' ' SER . 11.1 m -131.16 117.03 18.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 168.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.91 144.76 26.53 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -82.48 145.12 29.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 163.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -72.04 93.18 1.37 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -80.66 -165.62 0.92 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.831 1.253 . . . . 0.0 110.785 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.33 -47.12 66.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.766 1.627 . . . . 0.0 112.764 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 59.1 mtt -116.43 62.8 0.71 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.171 0.988 . . . . 0.0 108.421 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.24 -118.1 8.38 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.129 164.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.82 137.66 54.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.47 40.92 2.03 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.911 -0.939 . . . . 0.0 112.702 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -145.35 162.05 38.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.68 1.74 . . . . 0.0 109.439 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 p -124.46 158.24 33.29 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.74 162.06 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.919 1.288 . . . . 0.0 108.019 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -134.77 141.74 42.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.26 152.16 23.1 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.48 -2.648 . . . . 0.0 106.48 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.18 3.9 9.6 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-O 118.474 -1.181 . . . . 0.0 114.986 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t70 74.1 -37.17 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.877 2.471 . . . . 0.0 111.643 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.58 135.46 92.78 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 123.557 0.743 . . . . 0.0 109.286 172.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.22 41.65 0.79 Allowed 'Trans proline' 0 CA--C 1.543 0.973 1 C-N-CA 126.263 4.642 . . . . 0.0 112.396 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.55 -2.58 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.565 1.546 . . . . 0.0 112.828 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.83 148.62 38.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.507 -1.37 . . . . 0.0 108.082 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.62 143.07 40.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.036 1.334 . . . . 0.0 109.12 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.3 141.81 28.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.345 1.058 . . . . 0.0 109.854 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' HG22 ' A' ' 68' ' ' VAL . 33.5 mt-30 -130.95 154.87 47.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.612 1.165 . . . . 0.0 110.575 169.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.46 107.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 120.584 -1.322 . . . . 0.0 107.776 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -53.8 53.62 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 125.497 1.519 . . . . 0.0 109.288 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.4 p -154.46 161.41 41.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.391 0.276 . . . . 0.0 110.388 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 126.4 65.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.53 132.12 89.54 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.86 158.7 49.67 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.176 1.917 . . . . 0.0 110.359 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.4 -4.85 0.08 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.838 2.055 . . . . 0.0 114.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.57 172.71 43.09 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.582 1.563 . . . . 0.0 113.509 -165.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.83 -27.73 43.7 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.355 2.037 . . . . 0.0 112.533 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.63 67.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.05 74.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -57.37 -43.29 83.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.756 0.822 . . . . 0.0 112.948 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.54 -18.87 65.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.77 1.168 . . . . 0.0 111.191 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.42 -21.26 18.32 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 126.506 2.003 . . . . 0.0 112.75 164.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -80.78 -28.5 36.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.787 -1.101 . . . . 0.0 111.495 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.2 tpp -74.53 112.9 11.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -134.07 161.37 35.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 m -83.59 136.14 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.52 -5.75 83.63 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.603 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -66.18 151.28 47.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.484 1.642 . . . . 0.0 108.71 170.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.456 HG22 ' HG2' ' A' ' 47' ' ' GLN . 53.4 t -105.29 118.24 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.536 1.935 . . . . 0.0 109.084 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.21 105.81 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.935 1.694 . . . . 0.0 108.448 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.17 -58.47 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.993 0.425 . . . . 0.0 110.062 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.77 146.05 51.94 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.5 mt -122.44 120.12 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.75 -68.85 0.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.521 2.328 . . . . 0.0 111.488 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.45 25.91 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.655 1.982 . . . . 0.0 110.621 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.5 t -131.17 130.5 63.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.386 1.474 . . . . 0.0 108.041 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 p -65.94 126.2 27.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.228 0.611 . . . . 0.0 110.349 167.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.92 13.14 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.451 0.7 . . . . 0.0 112.024 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.87 -12.62 59.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.01 25.99 4.29 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.24 149.58 22.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.682 0.753 . . . . 0.0 109.165 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.86 142.0 38.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.695 -1.138 . . . . 0.0 107.943 -170.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -58.42 -23.41 57.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.84 1.656 . . . . 0.0 111.274 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.43 71.62 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.321 0.964 . . . . 0.0 110.808 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.24 -46.8 54.5 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.448 0.699 . . . . 0.0 109.529 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.63 -41.5 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 O-C-N 120.597 -1.314 . . . . 0.0 111.117 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.53 -34.62 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.843 -1.161 . . . . 0.0 110.107 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.14 83.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.779 1.172 . . . . 0.0 109.776 171.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.25 -36.97 77.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.54 1.136 . . . . 0.0 109.739 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.56 -40.94 63.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.593 0.757 . . . . 0.0 111.731 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -56.68 -41.7 77.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.013 0.925 . . . . 0.0 110.305 173.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.1 m -65.16 -2.95 3.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.82 110.72 49.29 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 120.747 1.612 . . . . 0.0 108.105 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.24 169.55 21.29 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.449 2.1 . . . . 0.0 111.374 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.67 148.63 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 121.385 -0.822 . . . . 0.0 109.328 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.5 -11.07 47.26 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.279 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -84.34 156.89 21.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.785 1.792 . . . . 0.0 107.993 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.503 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.0 p -125.96 148.82 49.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.441 1.096 . . . . 0.0 108.54 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.93 144.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.719 0.808 . . . . 0.0 109.841 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -82.88 155.21 24.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.27 152.14 45.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.05 111.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 67' ' ' ASP . 13.8 mt -102.3 168.1 9.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.88 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 38.6 t -123.48 142.42 51.02 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.473 1.109 . . . . 0.0 108.835 167.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.659 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 ttm180 -116.73 139.65 50.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 110.728 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.62 -14.67 7.19 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.726 1.155 . . . . 0.0 112.055 168.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.54 142.21 88.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.37 173.99 10.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.501 2.134 . . . . 0.0 110.03 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 162.71 30.95 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.169 0.588 . . . . 0.0 111.501 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -50.09 122.74 9.71 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.526 2.151 . . . . 0.0 109.003 160.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.18 101.1 0.85 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 158.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.5 111.0 17.41 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -82.85 -22.23 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.264 1.976 . . . . 0.0 112.24 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -70.92 -65.99 0.67 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.424 1.489 . . . . 0.0 109.823 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -161.58 103.38 1.2 Allowed Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.29 -53.97 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.316 1.344 . . . . 0.0 110.595 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -177.61 74.53 0.02 OUTLIER 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.228 2.611 . . . . 0.0 105.971 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -52.36 153.76 2.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.743 0.782 . . . . 0.0 112.821 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.9 t -77.9 150.32 34.12 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.29 -162.98 37.6 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.243 1.877 . . . . 0.0 111.745 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 81.11 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.643 2.895 . . . . 0.0 109.947 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.6 t -79.52 -159.78 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.027 1.331 . . . . 0.0 107.792 160.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.3 m -47.71 135.94 11.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 158.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.639 . . . . 0.0 109.468 173.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 t -64.25 107.4 1.3 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 161.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.1 m -131.3 9.56 4.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.227 1.011 . . . . 0.0 112.126 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.77 174.71 42.82 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.819 0.723 . . . . 0.0 112.3 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.8 m -135.24 151.34 50.51 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 109.188 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 t -144.43 -172.17 3.74 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.284 1.034 . . . . 0.0 109.44 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.68 -88.67 1.1 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mt -141.84 -70.84 0.35 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.01 150.17 4.52 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.427 1.091 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -64.51 -113.38 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.421 2.688 . . . . 0.0 113.325 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 140.51 -23.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 1 C-N-CA 133.111 4.565 . . . . 0.0 111.661 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -126.96 179.1 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.146 1.378 . . . . 0.0 107.639 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.81 -34.5 6.93 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 126.098 1.759 . . . . 0.0 110.429 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -28.7 70.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.663 1.12 . . . . 0.0 111.523 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.41 -24.33 67.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.002 0.819 . . . . 0.0 112.186 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.14 142.8 57.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.102 0.865 . . . . 0.0 111.144 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 127.62 33.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 162.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.18 -173.3 36.79 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 123.859 0.725 . . . . 0.0 112.721 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -114.08 141.23 47.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 167.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.0 127.49 50.22 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.71 0.804 . . . . 0.0 110.462 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -115.8 162.08 17.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.082 1.753 . . . . 0.0 107.985 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -150.18 146.72 27.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.997 -0.439 . . . . 0.0 110.833 162.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -144.13 157.54 44.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -117.09 117.18 28.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.45 145.44 30.27 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -101.58 126.75 48.45 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.473 1.109 . . . . 0.0 109.159 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 25.2 tptt -55.55 109.69 0.59 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.664 1.586 . . . . 0.0 110.197 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.6 p -79.05 -173.65 3.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.597 1.159 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -59.63 -15.59 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.351 1.06 . . . . 0.0 112.747 166.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.7 mtt -132.03 49.22 2.34 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.22 1.373 . . . . 0.0 110.221 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 72.7 -109.81 2.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.026 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -121.32 152.78 38.56 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.39 35.52 2.42 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.155 -1.358 . . . . 0.0 111.849 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.14 167.1 29.62 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.668 1.734 . . . . 0.0 108.621 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.8 p -134.06 161.32 35.17 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.25 162.46 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.459 1.104 . . . . 0.0 109.486 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 14.7 tt -126.7 158.6 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 126.715 2.006 . . . . 0.0 107.468 166.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.65 152.26 22.9 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 157.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.47 -70.86 0.85 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 124.505 1.05 . . . . 0.0 111.171 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -37.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -137.0 176.23 2.93 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.578 1.151 . . . . 0.0 110.249 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -71.32 54.33 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.501 2.8 . . . . 0.0 112.231 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.49 -9.84 0.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.02 1.728 . . . . 0.0 112.361 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -110.79 158.01 19.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.395 1.452 . . . . 0.0 108.691 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -83.57 126.58 32.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.927 0.891 . . . . 0.0 109.173 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mt -80.99 139.72 35.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -134.22 156.77 47.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.294 0.638 . . . . 0.0 110.881 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 102' ' ' LEU . 38.5 t -67.03 114.63 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 24.1 ttmt -72.42 -51.58 19.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.647 1.579 . . . . 0.0 109.916 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 m -143.78 162.12 36.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.28 0.632 . . . . 0.0 109.417 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.85 138.91 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 162.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 mm -74.83 127.82 86.35 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.86 133.08 24.54 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 121.908 1.739 . . . . 0.0 109.768 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t0 65.48 13.04 8.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.32 1.448 . . . . 0.0 111.845 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.44 167.67 37.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.181 1.372 . . . . 0.0 111.116 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.23 -34.42 68.07 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.44 2.093 . . . . 0.0 112.716 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.33 91.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.529 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.46 96.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.459 0.704 . . . . 0.0 110.414 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -67.68 -37.43 82.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.986 0.812 . . . . 0.0 112.755 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.27 -24.89 63.13 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.433 -0.792 . . . . 0.0 110.855 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.76 -16.36 26.63 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.865 2.174 . . . . 0.0 113.483 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -81.29 -37.09 29.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.378 1.589 . . . . 0.0 114.163 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpp -70.01 118.37 12.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.52 166.06 24.08 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.999 0.919 . . . . 0.0 109.025 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -100.56 98.96 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.261 1.029 . . . . 0.0 110.491 -150.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.66 -6.7 5.87 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.776 1.655 . . . . 0.0 112.322 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 102' ' ' LEU . 2.8 m-20 -68.46 163.15 23.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.404 1.102 . . . . 0.0 110.62 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.9 t -111.87 120.64 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.27 1.828 . . . . 0.0 109.552 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.13 109.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 126.467 1.907 . . . . 0.0 108.881 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.8 t -93.68 -51.83 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.406 0.622 . . . . 0.0 110.086 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -134.96 154.59 51.66 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.075 1.35 . . . . 0.0 108.179 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.422 HG13 HG21 ' A' ' 77' ' ' VAL . 54.1 mt -134.86 134.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 50.46 -92.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.456 1.902 . . . . 0.0 110.072 -169.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -143.17 20.81 1.92 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.222 2.609 . . . . 0.0 108.971 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -128.87 128.49 67.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.325 2.25 . . . . 0.0 107.636 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.35 129.46 36.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 72' ' ' ILE . 30.5 m -130.11 11.07 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.058 1.343 . . . . 0.0 110.964 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -20.93 64.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.07 33.83 2.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.763 1.649 . . . . 0.0 109.659 167.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.22 161.42 28.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.681 1.74 . . . . 0.0 109.225 165.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.96 151.37 33.69 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -55.35 -35.13 64.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.136 0.974 . . . . 0.0 110.39 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.4 38.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.116 0.871 . . . . 0.0 110.606 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.88 -48.18 69.53 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.768 0.827 . . . . 0.0 110.846 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.67 -43.1 96.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 125.054 1.341 . . . . 0.0 111.149 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.51 -39.62 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.982 -1.074 . . . . 0.0 109.363 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -38.82 92.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.876 1.217 . . . . 0.0 110.027 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.12 -31.81 73.14 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.134 1.374 . . . . 0.0 111.052 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.61 -46.36 22.34 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.06 0.846 . . . . 0.0 111.546 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.03 -29.86 70.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.216 -0.928 . . . . 0.0 111.586 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 t -63.42 -14.34 49.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.535 1.134 . . . . 0.0 112.746 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.3 t -84.26 112.16 39.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 120.409 1.459 . . . . 0.0 107.198 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.96 169.27 22.99 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.79 1.66 . . . . 0.0 110.869 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.06 139.57 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.54 -10.19 62.59 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.083 -0.843 . . . . 0.0 113.699 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -84.23 172.64 11.68 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.419 1.61 . . . . 0.0 108.735 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 p -134.06 156.21 48.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.205 1.002 . . . . 0.0 110.576 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.44 142.53 32.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.06 0.944 . . . . 0.0 108.849 173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.86 143.6 29.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.367 1.867 . . . . 0.0 107.228 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.7 mt -144.79 110.87 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.35 132.07 35.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.679 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.9 mt -119.02 162.89 17.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 109.707 170.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.18 133.96 50.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.996 1.318 . . . . 0.0 108.658 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' A' ' 21' ' ' LEU . 10.6 ttm180 -102.4 155.42 18.26 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 126.627 1.971 . . . . 0.0 112.279 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.81 -8.56 63.62 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.351 0.976 . . . . 0.0 112.775 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.37 151.55 97.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 117.71 0.755 . . . . 0.0 109.604 163.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.5 166.39 28.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.491 2.127 . . . . 0.0 112.104 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.59 157.25 79.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.415 1.486 . . . . 0.0 110.417 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.22 -45.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.584 2.189 . . . . 0.0 110.831 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.42 109.98 5.75 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -83.89 110.69 27.2 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.224 1.41 . . . . 0.0 107.611 168.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.97 -21.48 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.054 1.836 . . . . 0.0 111.883 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.91 -48.57 9.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.182 -163.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -129.38 70.5 81.82 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.062 0.846 . . . . 0.0 108.904 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.93 -10.75 28.22 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.749 2.299 . . . . 0.0 117.04 -152.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 140.95 -11.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.807 3.643 . . . . 0.0 112.834 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -60.3 165.76 3.37 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.79 -0.569 . . . . 0.0 109.756 161.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 p -60.47 150.16 32.06 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.445 1.098 . . . . 0.0 110.474 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.35 179.0 51.72 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.687 0.66 . . . . 0.0 111.895 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.45 123.05 12.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.236 2.624 . . . . 0.0 109.221 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.6 m -140.45 172.25 12.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.762 1.225 . . . . 0.0 109.366 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.8 p -84.64 -9.01 58.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.52 1.128 . . . . 0.0 112.22 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 C-N-CA 127.153 2.311 . . . . 0.0 107.472 -174.787 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 29.06 85.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.875 2.47 . . . . 0.0 114.628 163.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 t -58.71 140.15 55.16 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.49 174.98 23.15 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.67 1.128 . . . . 0.0 111.752 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 m -108.86 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.59 1.556 . . . . 0.0 110.327 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m 59.18 -172.05 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.926 1.29 . . . . 0.0 111.314 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.48 141.76 3.88 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -102.75 -94.73 0.31 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.58 153.64 42.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.113 0.565 . . . . 0.0 110.109 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 m -81.76 -109.57 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.018 1.327 . . . . 0.0 112.178 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mtm105 135.71 -67.39 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 1 C-N-CA 133.915 4.886 . . . . 0.0 108.742 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.83 -3.86 9.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.896 -157.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.59 -27.31 0.19 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 128.497 2.719 . . . . 0.0 114.713 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -66.37 -6.44 14.33 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.122 1.328 . . . . 0.0 111.727 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.63 -19.08 65.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.481 1.513 . . . . 0.0 112.41 163.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 mt -91.24 159.18 16.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.236 1.38 . . . . 0.0 108.593 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -3.73 13.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.38 -172.76 38.28 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 126.179 1.847 . . . . 0.0 111.685 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -88.01 156.4 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.463 1.505 . . . . 0.0 108.574 170.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -125.54 130.05 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.801 1.241 . . . . 0.0 109.038 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.86 173.34 6.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 108.172 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.3 p -151.21 142.7 23.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.422 -0.799 . . . . 0.0 109.405 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.3 t -150.62 158.15 43.81 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -121.49 106.0 11.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 107.023 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.86 118.55 34.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -92.41 116.38 28.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -42.95 91.97 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.819 2.448 . . . . 0.0 112.298 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -79.52 111.67 16.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 17.34 -83.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 130.269 3.428 . . . . 0.0 115.209 -168.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.0 mtt -56.38 -21.98 28.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.394 1.478 . . . . 0.0 113.463 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.73 -124.51 5.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 124.829 1.204 . . . . 0.0 110.426 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.58 129.64 50.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.37 49.04 2.93 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -146.73 171.89 14.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.567 1.547 . . . . 0.0 108.356 166.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -134.13 163.38 29.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.606 0.762 . . . . 0.0 109.407 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.58 162.35 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 108.44 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.45 159.91 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 128.244 2.618 . . . . 0.0 107.006 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.16 152.57 22.86 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 128.354 2.883 . . . . 0.0 106.523 167.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.77 -70.54 0.88 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 118.819 1.31 . . . . 0.0 113.091 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -173.82 -52.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -97.56 163.41 19.74 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 124.64 1.176 . . . . 0.0 112.619 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -75.1 48.37 2.0 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 125.099 3.866 . . . . 0.0 112.082 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -150.8 -7.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 110.497 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.32 152.44 19.15 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.874 0.761 . . . . 0.0 112.293 -161.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -57.89 134.22 56.13 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.101 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.4 mt -100.65 126.61 47.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.022 1.729 . . . . 0.0 106.375 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.95 155.05 47.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.017 0.826 . . . . 0.0 110.238 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.95 112.37 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.42 -47.94 71.61 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.123 0.969 . . . . 0.0 109.207 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -155.98 158.53 38.03 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.014 1.326 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.07 145.01 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 165.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -81.62 128.85 67.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.75 160.21 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.755 1.637 . . . . 0.0 110.221 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.4 -12.95 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.996 2.118 . . . . 0.0 114.903 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 178.1 54.06 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.667 1.127 . . . . 0.0 112.94 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.87 -37.46 77.45 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.695 2.263 . . . . 0.0 110.79 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.9 76.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.168 0.587 . . . . 0.0 111.649 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.06 -40.97 67.93 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.67 -49.46 76.42 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.06 -35.47 78.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.707 0.289 . . . . 0.0 110.949 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.48 -11.34 39.22 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.878 1.228 . . . . 0.0 113.995 161.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.43 -46.01 88.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.09 1.445 . . . . 0.0 109.709 168.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.5 tpp -66.28 115.91 6.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.37 159.14 42.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -87.88 117.85 27.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.162 -159.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.68 -8.25 39.82 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.535 1.54 . . . . 0.0 113.46 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.43 155.02 26.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.438 1.619 . . . . 0.0 109.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.35 116.82 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.037 1.735 . . . . 0.0 109.375 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.05 118.79 4.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 126.659 1.983 . . . . 0.0 108.052 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.95 -57.62 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.053 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.7 150.74 51.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mt -127.69 123.29 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.16 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.478 3.111 . . . . 0.0 110.518 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.39 -6.53 1.36 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.934 1.694 . . . . 0.0 111.952 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -88.74 124.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.51 120.07 12.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.4 6.56 6.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 124.699 1.2 . . . . 0.0 110.948 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.49 ' C ' HD12 ' A' ' 78' ' ' LEU 0.26 1.0 OUTLIER -58.62 -25.89 63.15 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -166.21 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.63 11.18 21.29 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.512 2.006 . . . . 0.0 112.368 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 165.38 24.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.321 1.06 . . . . 0.0 110.242 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -75.85 148.51 38.28 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -60.76 -35.57 76.74 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.436 165.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.3 74.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.34 0.973 . . . . 0.0 111.929 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.84 -55.58 8.19 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 118.188 0.449 . . . . 0.0 110.488 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.37 -39.58 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 127.519 2.328 . . . . 0.0 112.162 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.9 -39.08 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 120.94 -1.1 . . . . 0.0 109.242 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -36.46 83.22 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.87 1.214 . . . . 0.0 109.638 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.64 -45.6 93.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.584 1.153 . . . . 0.0 108.722 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -66.2 -31.01 71.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.235 0.614 . . . . 0.0 112.237 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.34 -6.65 59.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.056 1.342 . . . . 0.0 112.963 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -91.02 7.61 39.51 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.213 1.405 . . . . 0.0 113.57 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.2 t -101.18 107.59 50.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.5 172.41 14.49 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.35 2.7 . . . . 0.0 113.33 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 94' ' ' ILE . 4.2 mp -70.94 100.15 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.291 1.436 . . . . 0.0 110.665 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.56 -42.09 1.05 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -84.26 160.75 20.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.694 0.759 . . . . 0.0 109.61 -164.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.89 160.54 22.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.582 1.553 . . . . 0.0 108.474 170.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.11 147.15 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.66 157.45 22.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -146.52 116.27 7.22 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.81 123.98 45.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.97 159.01 17.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.794 0.683 . . . . 0.0 110.353 159.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.3 t -105.97 136.16 46.13 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.284 1.434 . . . . 0.0 107.661 165.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -81.52 156.23 25.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.231 1.412 . . . . 0.0 112.43 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.31 35.84 7.84 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.11 151.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -117.3 150.42 46.34 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 161.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.08 171.71 13.25 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.215 1.943 . . . . 0.0 111.208 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.61 143.22 94.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.9 -32.85 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.821 2.347 . . . . 0.0 114.219 -168.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -69.05 109.07 3.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -82.0 115.66 58.76 Favored Pre-proline 0 C--O 1.236 0.358 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.27 -25.61 4.7 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.213 2.609 . . . . 0.0 111.98 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -71.76 -36.06 70.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.866 -169.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -132.98 46.4 2.1 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.289 1.036 . . . . 0.0 112.707 -161.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.73 -11.93 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.435 2.09 . . . . 0.0 116.141 -153.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.09 -76.07 0.11 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.102 1.319 . . . . 0.0 109.427 167.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 70.1 58.02 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.76 2.024 . . . . 0.0 110.524 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 73.4 m -136.21 168.6 19.1 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.633 0.73 . . . . 0.0 112.416 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.18 152.38 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.942 2.21 . . . . 0.0 108.609 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.27 -16.11 13.96 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.023 1.815 . . . . 0.0 113.522 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t 50.18 -165.78 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.256 0.935 . . . . 0.0 110.579 -156.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.7 m -157.59 -42.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.15 1.78 . . . . 0.0 108.916 164.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 C-N-CA 128.3 2.857 . . . . 0.0 106.741 -177.106 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.691 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -143.02 160.82 39.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 161.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -147.84 79.6 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.2 115.17 0.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.725 -2.55 . . . . 0.0 106.725 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -141.7 117.95 10.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.0 m -64.43 -54.12 37.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.635 0.774 . . . . 0.0 109.479 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.0 99.42 2.18 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 104.886 -3.285 . . . . 0.0 104.886 -148.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.77 64.9 0.92 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -174.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 15.0 t80 57.67 170.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.681 2.792 . . . . 0.0 113.427 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -81.86 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.551 1.541 . . . . 0.0 110.617 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 145.85 -60.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.373 4.269 . . . . 0.0 111.398 174.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.58 2.37 26.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.936 1.294 . . . . 0.0 111.029 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.01 -14.15 0.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.8 2.44 . . . . 0.0 113.669 -168.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -57.88 -29.16 64.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.36 1.064 . . . . 0.0 113.095 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -77.93 -11.97 59.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.082 -171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.7 166.12 18.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.198 0.999 . . . . 0.0 110.342 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -128.0 136.42 51.25 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.24 -161.49 25.63 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -107.04 161.52 14.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -119.56 121.31 39.07 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.661 1.584 . . . . 0.0 108.142 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 HD13 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -145.74 154.07 41.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.376 1.07 . . . . 0.0 110.576 -170.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.8 p -157.14 163.28 39.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -165.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 t -154.92 157.71 38.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.0 m -101.33 119.82 39.33 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.225 1.01 . . . . 0.0 108.52 158.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -99.11 159.3 15.07 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.792 1.237 . . . . 0.0 108.125 163.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -103.84 143.52 32.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -66.98 99.35 0.64 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -88.47 -163.4 0.96 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.377 2.271 . . . . 0.0 108.487 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -48.49 -65.21 0.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.942 1.297 . . . . 0.0 110.925 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.44 66.81 1.11 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.2 -106.76 0.61 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 124.818 1.199 . . . . 0.0 113.469 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.37 152.25 43.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.0 40.15 2.89 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.328 -1.262 . . . . 0.0 111.753 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -154.92 161.47 41.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.748 1.774 . . . . 0.0 110.316 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 p -130.41 159.93 35.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.977 1.311 . . . . 0.0 109.315 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.82 162.63 26.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 125.208 1.403 . . . . 0.0 109.973 -170.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.18 151.58 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.469 1.508 . . . . 0.0 110.067 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.29 153.37 16.73 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 129.322 3.344 . . . . 0.0 109.333 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.86 -82.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.68 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.028 1.731 . . . . 0.0 109.798 163.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -93.57 162.59 27.14 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.541 1.537 . . . . 0.0 113.473 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.55 43.17 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 125.086 3.857 . . . . 0.0 112.925 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -166.47 12.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.63 1.972 . . . . 0.0 111.683 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 155.13 21.2 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.349 -1.469 . . . . 0.0 110.969 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.93 115.74 23.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.054 0.942 . . . . 0.0 109.491 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.79 140.6 35.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.884 0.766 . . . . 0.0 109.502 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.422 ' HG2' HG22 ' A' ' 68' ' ' VAL . 39.9 mt-30 -131.63 157.18 44.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.845 0.748 . . . . 0.0 111.231 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.48 111.02 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 168.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -60.76 -54.65 42.63 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.022 0.929 . . . . 0.0 109.328 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 65' ' ' THR . 53.6 p -154.99 164.45 38.88 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.97 0.508 . . . . 0.0 110.672 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.11 145.34 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 160.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.5 123.42 76.65 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 165.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.57 150.95 86.1 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.552 2.168 . . . . 0.0 109.854 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.319 1.0 OUTLIER 58.99 -0.7 0.13 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.996 1.718 . . . . 0.0 115.137 -168.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.05 167.18 54.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.48 1.038 . . . . 0.0 112.563 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.17 -26.52 36.18 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.952 1.768 . . . . 0.0 112.236 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.74 -45.61 78.06 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.781 -0.575 . . . . 0.0 109.807 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.92 97.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.572 0.749 . . . . 0.0 110.96 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -69.69 -26.07 64.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.78 -38.98 76.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.47 1.032 . . . . 0.0 109.238 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.45 20.39 69.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.169 166.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -98.76 -52.05 3.71 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.807 1.804 . . . . 0.0 111.379 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.7 ttm -80.82 146.77 30.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.558 1.143 . . . . 0.0 109.961 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -134.09 165.1 25.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.385 1.088 . . . . 0.0 110.984 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 50' ' ' SER . 28.0 m -75.17 121.28 21.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.227 1.011 . . . . 0.0 108.656 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.05 -20.37 16.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.756 -1.025 . . . . 0.0 112.122 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 102' ' ' LEU . 14.9 m-20 -63.91 150.64 44.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.079 1.439 . . . . 0.0 109.402 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 47' ' ' GLN . 51.3 t -101.45 124.45 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.635 1.974 . . . . 0.0 108.813 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.42 128.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 125.353 1.461 . . . . 0.0 107.614 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.27 -56.85 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.899 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -133.09 147.57 52.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.324 1.05 . . . . 0.0 108.841 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mt -130.33 122.51 53.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 53.21 -92.63 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 127.35 2.26 . . . . 0.0 109.719 -162.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.61 1.38 8.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.37 1.468 . . . . 0.0 111.161 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -111.51 131.08 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 -160.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.4 p -74.69 123.28 24.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.62 12.77 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.034 0.934 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -54.33 -35.31 62.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -162.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.45 16.35 12.72 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.111 1.339 . . . . 0.0 112.624 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 164.91 12.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.874 1.837 . . . . 0.0 110.666 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 p -70.74 137.96 50.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.58 -25.14 64.34 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.594 -0.691 . . . . 0.0 110.546 167.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.51 -57.85 10.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.897 1.226 . . . . 0.0 110.31 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.86 -54.73 42.74 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.574 1.15 . . . . 0.0 110.472 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.4 -42.53 74.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.487 1.515 . . . . 0.0 111.491 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.09 -33.98 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.546 -1.346 . . . . 0.0 110.376 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -39.57 94.42 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.659 1.572 . . . . 0.0 109.361 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.24 -49.18 78.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -64.56 -41.4 96.34 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -55.51 -46.78 76.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.495 0.588 . . . . 0.0 109.585 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.5 p -64.76 -13.55 55.6 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.447 1.276 . . . . 0.0 114.447 -166.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.98 110.93 26.25 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.73 159.95 44.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 120.062 1.058 . . . . 0.0 109.59 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 79.8 mt -57.58 126.76 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.83 50.28 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.805 -1.553 . . . . 0.0 114.163 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -112.13 165.11 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 121.02 2.41 . . . . 0.0 110.327 168.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.6 p -123.25 164.7 18.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.124 1.37 . . . . 0.0 109.755 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.97 150.14 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.007 1.323 . . . . 0.0 108.314 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.83 154.14 23.66 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -146.24 126.27 13.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.37 130.97 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 67' ' ' ASP . 15.1 mt -118.45 169.05 10.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.322 1.014 . . . . 0.0 110.046 170.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.6 t -128.37 144.45 51.14 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.5 1.52 . . . . 0.0 108.887 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.11 123.16 39.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.432 1.493 . . . . 0.0 112.686 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.45 -25.44 0.86 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.989 1.28 . . . . 0.0 113.494 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -72.66 158.02 87.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 118.021 0.911 . . . . 0.0 110.856 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.27 175.79 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.006 2.471 . . . . 0.0 111.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mt -71.89 159.09 86.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.273 1.029 . . . . 0.0 109.484 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.13 -14.14 9.8 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.806 3.004 . . . . 0.0 113.847 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -117.53 121.13 40.14 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 126.883 2.073 . . . . 0.0 106.525 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.32 103.99 2.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 124.907 1.283 . . . . 0.0 107.895 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.99 -26.83 6.25 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 CA-C-N 120.597 1.249 . . . . 0.0 111.389 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.4 -67.61 0.43 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.299 1.44 . . . . 0.0 109.937 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.65 92.95 48.31 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.34 -29.74 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.144 1.229 . . . . 0.0 112.772 -173.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -171.62 -62.21 0.02 OUTLIER 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.842 1.657 . . . . 0.0 109.071 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.27 157.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 128.993 2.917 . . . . 0.0 113.354 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t -100.49 171.51 7.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 108.284 165.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.69 -99.14 1.54 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.99 141.92 54.9 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.06 1.84 . . . . 0.0 111.135 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 m -162.02 179.02 8.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.468 2.707 . . . . 0.0 106.996 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 t -152.63 169.55 22.42 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.517 0.727 . . . . 0.0 109.683 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 N-CA-C 106.617 -2.593 . . . . 0.0 106.617 -174.914 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.75 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -62.34 153.3 31.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.152 0.581 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -71.43 166.54 21.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.097 0.959 . . . . 0.0 110.909 -171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.94 79.93 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.1 t -154.56 116.94 4.29 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 168.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m -137.0 179.23 6.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.533 2.333 . . . . 0.0 106.821 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.87 -120.85 17.7 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -154.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp 19.87 85.23 0.01 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 130.305 3.442 . . . . 0.0 112.895 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -54.88 153.16 6.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.33 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 11' ' ' ARG . 5.1 m -78.38 -143.69 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.185 2.194 . . . . 0.0 112.108 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.624 ' H ' HG22 ' A' ' 10' ' ' THR . 0.7 OUTLIER -163.02 -69.38 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 147.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.25 22.94 2.65 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.866 2.066 . . . . 0.0 111.911 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 10' ' ' THR . . . 55.89 -6.2 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.486 2.314 . . . . 0.0 114.653 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 m -75.41 -24.99 57.2 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.947 1.299 . . . . 0.0 110.628 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.55 -15.77 63.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.392 -1.29 . . . . 0.0 114.007 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 mt -74.64 161.91 29.24 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.253 1.388 . . . . 0.0 110.386 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.87 2.1 3.66 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -165.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.97 -179.27 41.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 162.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.4 m -81.82 154.56 25.85 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.438 0.695 . . . . 0.0 109.423 -172.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 6.2 m-85 -111.68 140.73 46.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.607 1.163 . . . . 0.0 108.346 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -122.51 -179.55 4.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.034 1.734 . . . . 0.0 107.658 -177.266 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -145.14 165.61 27.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.124 -0.36 . . . . 0.0 111.185 163.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -152.85 157.2 40.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 151.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.1 m -104.82 113.93 27.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 160.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.37 138.03 36.2 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -82.06 155.21 25.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 158.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' CE ' ' HA2' ' A' ' 31' ' ' GLY . 5.6 tptt -58.04 161.19 4.22 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 154.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -129.66 -78.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 159.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.39 132.95 46.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -170.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.5 mmt 63.04 -62.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.06 2.144 . . . . 0.0 111.132 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . -169.47 -154.25 9.04 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -170.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.12 153.74 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 163.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.38 35.17 2.43 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.134 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.17 163.12 37.95 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.906 2.353 . . . . 0.0 111.268 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -125.52 155.1 41.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.112 1.365 . . . . 0.0 109.174 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.96 162.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.383 1.473 . . . . 0.0 109.921 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 tt -136.76 157.76 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 128.324 2.65 . . . . 0.0 108.186 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.58 152.17 22.81 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.527 2.489 . . . . 0.0 107.966 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.09 -71.17 0.81 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.506 1.051 . . . . 0.0 112.725 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 170.27 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.577 1.551 . . . . 0.0 110.691 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.74 158.43 87.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 120.197 1.362 . . . . 0.0 110.228 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.28 43.31 1.28 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.505 3.47 . . . . 0.0 112.263 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.48 37.45 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.732 2.813 . . . . 0.0 108.669 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -113.54 150.3 33.17 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.96 0.904 . . . . 0.0 108.762 167.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -74.91 127.33 32.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.081 0.943 . . . . 0.0 109.112 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.37 142.78 32.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG2' HG22 ' A' ' 68' ' ' VAL . 53.3 mt-30 -142.49 162.35 35.69 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.674 0.789 . . . . 0.0 110.865 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.17 114.49 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.02 -50.06 72.17 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.61 0.641 . . . . 0.0 109.285 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.08 154.19 17.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.181 0.926 . . . . 0.0 110.095 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.75 121.42 55.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.51 129.24 90.38 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -85.85 48.24 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.782 2.988 . . . . 0.0 112.605 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.59 57.98 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.981 2.112 . . . . 0.0 107.694 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.12 171.22 44.07 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.104 -0.997 . . . . 0.0 112.632 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.72 -25.28 54.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.387 2.058 . . . . 0.0 112.174 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.02 70.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.984 0.811 . . . . 0.0 111.235 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.29 12.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.202 1.001 . . . . 0.0 108.746 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.08 -29.36 69.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -172.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.67 -26.75 67.19 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.726 -0.609 . . . . 0.0 110.927 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.94 -14.73 9.78 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.93 1.729 . . . . 0.0 113.437 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -83.59 -26.86 29.66 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.325 -1.103 . . . . 0.0 111.385 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.9 tpp -89.36 130.79 35.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.403 0.681 . . . . 0.0 110.173 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -144.0 166.2 25.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.795 1.638 . . . . 0.0 108.861 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.3 m -87.95 144.37 26.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.145 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.72 57.62 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.823 1.192 . . . . 0.0 112.396 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.2 144.05 44.29 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.962 1.381 . . . . 0.0 107.721 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 47' ' ' GLN . 69.5 t -98.45 118.35 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.248 1.819 . . . . 0.0 110.062 -162.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.65 110.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.498 1.519 . . . . 0.0 108.871 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 3.5 t -96.13 -59.94 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.344 0.593 . . . . 0.0 109.796 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -128.71 158.49 38.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.011 1.324 . . . . 0.0 107.566 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.1 122.93 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t30 65.05 -81.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.413 2.285 . . . . 0.0 110.489 168.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.74 36.35 1.16 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.432 1.093 . . . . 0.0 110.554 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.44 132.62 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 120.425 -1.422 . . . . 0.0 109.422 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.7 p -77.82 110.13 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.755 0.822 . . . . 0.0 109.368 165.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.67 -3.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -54.16 -31.18 51.88 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.03 1.286 . . . . 0.0 114.414 -164.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.76 28.56 5.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.506 1.527 . . . . 0.0 111.008 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 172.22 13.31 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 164.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 p -90.04 153.25 20.71 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -54.93 -36.45 65.28 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.119 1.368 . . . . 0.0 109.741 170.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -64.49 0.79 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.382 1.073 . . . . 0.0 110.902 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.73 -35.87 77.69 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.763 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.58 -40.27 87.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 120.548 -1.345 . . . . 0.0 111.265 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.69 -43.59 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -40.28 84.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.165 0.893 . . . . 0.0 110.499 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.3 mt -64.87 -41.06 95.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.589 1.556 . . . . 0.0 109.265 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -71.21 -39.19 71.9 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.476 1.034 . . . . 0.0 111.177 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -60.88 -36.95 80.52 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.814 0.734 . . . . 0.0 110.406 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -59.81 -13.24 9.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.052 1.741 . . . . 0.0 113.539 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.1 t -87.58 110.59 35.61 Favored Pre-proline 0 C--O 1.239 0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.86 160.15 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.729 1.619 . . . . 0.0 111.736 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.27 138.25 20.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 158.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.86 14.92 76.53 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.396 -1.78 . . . . 0.0 113.677 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -122.73 162.58 21.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.032 2.416 . . . . 0.0 111.413 165.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.72 155.14 30.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.665 1.986 . . . . 0.0 111.334 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.38 157.42 39.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.322 1.449 . . . . 0.0 109.172 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.87 158.69 22.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 mt -145.71 145.83 31.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -123.8 125.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 mt -112.85 165.05 12.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.345 1.028 . . . . 0.0 110.931 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.4 t -119.46 143.91 47.26 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.417 1.487 . . . . 0.0 108.288 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -100.77 155.85 17.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.446 2.298 . . . . 0.0 111.485 -178.09 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.47 -2.73 74.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.102 170.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -103.02 103.09 31.86 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 168.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.28 -174.72 1.49 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.769 2.979 . . . . 0.0 113.05 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 mt -65.57 146.03 99.0 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 125.612 1.565 . . . . 0.0 109.964 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.92 -45.38 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.712 2.942 . . . . 0.0 110.786 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -63.49 106.39 0.92 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.065 1.746 . . . . 0.0 107.475 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.9 108.83 12.4 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.05 -17.32 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 120.784 1.316 . . . . 0.0 111.795 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -61.69 2.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 109.832 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -148.55 81.67 7.78 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -69.87 -44.19 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 -167.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.12 -48.13 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.968 0.907 . . . . 0.0 110.554 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 52.68 68.81 0.77 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 0.0 111.576 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.6 t -128.95 151.73 49.35 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.598 1.159 . . . . 0.0 108.274 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.05 -107.46 0.61 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 105.421 -3.072 . . . . 0.0 105.421 153.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.71 72.38 4.48 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.852 3.701 . . . . 0.0 111.439 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.3 p -141.52 69.29 1.33 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.502 1.521 . . . . 0.0 108.562 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.9 m -145.89 172.96 12.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.677 2.391 . . . . 0.0 108.222 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.8 0 N-CA-C 104.289 -3.524 . . . . 0.0 104.289 164.866 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.674 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t -65.14 107.09 1.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.343 1.457 . . . . 0.0 108.19 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 p -143.01 -177.91 5.57 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 109.443 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.41 -94.91 0.1 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.631 -1.787 . . . . 0.0 108.631 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 p -150.6 143.62 24.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.034 0.934 . . . . 0.0 108.626 166.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.39 158.72 44.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.177 0.991 . . . . 0.0 109.907 168.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.96 176.04 16.63 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.224 1.392 . . . . 0.0 110.881 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt -113.87 -83.98 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.45 158.19 21.41 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.72 0.808 . . . . 0.0 109.873 171.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 15' ' ' GLN . 11.6 m -73.07 -116.7 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.07 2.148 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 137.92 -76.13 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 1 C-N-CA 134.271 5.028 . . . . 0.0 106.195 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -95.22 10.95 34.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' THR . . . 68.64 -27.74 0.15 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.762 -1.836 . . . . 0.0 113.394 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -69.12 17.73 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.362 1.465 . . . . 0.0 113.249 170.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' HB2' HG23 ' A' ' 10' ' ' THR . 19.5 mm100 -115.2 -11.04 12.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.882 1.673 . . . . 0.0 110.702 168.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.83 162.54 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -138.58 131.14 29.03 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 124.932 1.293 . . . . 0.0 107.925 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.22 -133.47 4.14 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.1 m -133.11 152.53 51.95 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -109.82 145.91 35.93 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.007 0.821 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -130.02 170.29 14.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.243 2.217 . . . . 0.0 107.682 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -152.97 154.35 34.81 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 121.883 -0.511 . . . . 0.0 109.833 159.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -144.53 157.68 44.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.411 1.485 . . . . 0.0 109.154 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 97' ' ' SER . 6.8 m -124.28 114.73 19.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -98.62 146.71 25.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -82.46 132.16 35.21 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 161.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 70.9 tttt -67.25 100.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.977 1.311 . . . . 0.0 107.84 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -89.45 -92.69 0.12 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.047 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -105.87 130.2 53.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 45.7 mtt 58.62 -54.49 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.671 2.388 . . . . 0.0 114.869 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . -175.48 -167.41 34.51 Favored Glycine 0 N--CA 1.449 -0.449 0 O-C-N 120.744 -1.222 . . . . 0.0 110.808 -148.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -86.02 152.21 23.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.65 0.95 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.743 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.54 167.82 21.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.823 1.811 . . . . 0.0 108.307 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -125.77 159.88 31.22 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.452 1.501 . . . . 0.0 107.568 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 157.29 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 122.13 0.967 . . . . 0.0 110.333 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -131.02 147.66 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.282 2.233 . . . . 0.0 105.734 165.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.37 21.78 Favored Glycine 0 CA--C 1.507 -0.448 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 154.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.83 -70.06 1.08 Allowed Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -165.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -173.09 -43.77 0.01 OUTLIER 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.116 0.539 . . . . 0.0 111.377 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 161.12 26.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.331 1.052 . . . . 0.0 111.324 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.99 44.83 1.39 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.962 3.775 . . . . 0.0 111.522 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -16.31 1.04 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.089 0.955 . . . . 0.0 111.507 169.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.19 130.37 34.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -59.82 147.14 39.28 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.172 0.986 . . . . 0.0 111.086 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.73 132.58 36.29 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.353 -1.749 . . . . 0.0 106.689 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -129.46 152.87 48.53 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.851 0.86 . . . . 0.0 109.012 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.9 t -62.66 113.58 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -61.86 -55.0 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.765 1.626 . . . . 0.0 109.667 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.536 ' HA ' HG23 ' A' ' 65' ' ' THR . 4.3 m -155.31 151.17 27.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.85 1.66 . . . . 0.0 108.051 168.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.63 123.96 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 127.78 86.94 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.75 156.4 66.08 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.894 1.729 . . . . 0.0 109.933 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 76.43 -27.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 127.281 2.232 . . . . 0.0 113.269 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.19 166.6 50.22 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.848 1.213 . . . . 0.0 112.267 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.35 -20.08 48.99 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.229 1.953 . . . . 0.0 112.95 -171.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.38 -51.23 54.47 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.34 89.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.249 1.02 . . . . 0.0 110.426 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.57 -21.05 65.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -87.2 -34.73 18.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.227 1.376 . . . . 0.0 109.963 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.71 -10.67 55.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.392 1.472 . . . . 0.0 114.37 167.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -77.89 -8.53 58.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.953 1.377 . . . . 0.0 113.799 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.7 ttm -118.25 139.92 50.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.709 1.604 . . . . 0.0 108.98 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -133.77 172.12 13.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.769 1.271 . . . . 0.0 109.111 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.551 HG22 HD21 ' A' ' 108' ' ' LEU . 71.9 m -78.28 127.28 32.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.73 -15.82 40.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.531 1.062 . . . . 0.0 113.667 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HB3' HD13 ' A' ' 102' ' ' LEU . 4.3 m-20 -57.13 143.8 37.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.436 1.118 . . . . 0.0 109.708 175.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.23 121.3 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.29 1.836 . . . . 0.0 109.456 -170.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.0 mp -66.03 110.83 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.399 1.879 . . . . 0.0 108.971 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.77 -62.26 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.43 141.24 43.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.581 1.152 . . . . 0.0 109.366 -167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.05 125.55 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 59.48 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.538 2.735 . . . . 0.0 112.18 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.77 11.94 2.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.171 0.896 . . . . 0.0 111.244 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.85 153.48 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 120.344 -1.473 . . . . 0.0 109.032 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.0 p -87.12 138.72 31.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.352 0.978 . . . . 0.0 109.585 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.08 5.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.117 0.967 . . . . 0.0 111.924 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -66.14 -22.29 66.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -163.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.87 66.95 0.53 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 104.834 -3.306 . . . . 0.0 104.834 157.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -121.94 168.94 11.31 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.637 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 p -74.49 136.47 42.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -54.32 -32.11 55.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.417 0.687 . . . . 0.0 110.589 162.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.32 -40.18 89.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.455 1.025 . . . . 0.0 112.407 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.23 -44.84 28.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.219 0.918 . . . . 0.0 109.955 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 t -59.95 -42.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 O-C-N 120.179 -1.575 . . . . 0.0 111.205 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.02 -32.45 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 120.738 -1.226 . . . . 0.0 110.792 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -44.56 94.89 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.47 -0.769 . . . . 0.0 109.215 169.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.13 -36.23 81.43 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.701 -166.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -69.83 -22.81 63.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -87.67 -18.41 29.63 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.982 -1.074 . . . . 0.0 110.971 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -65.07 -17.34 64.37 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.472 -0.768 . . . . 0.0 112.639 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.57 121.72 74.89 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.884 1.274 . . . . 0.0 107.762 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.3 159.82 33.75 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.014 1.809 . . . . 0.0 112.31 167.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.33 152.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.184 -0.947 . . . . 0.0 109.316 162.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.05 -9.47 38.83 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.693 1.616 . . . . 0.0 113.154 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -95.55 163.5 13.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.18 1.99 . . . . 0.0 108.975 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 24' ' ' THR . 20.8 p -116.08 146.78 41.94 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.986 0.914 . . . . 0.0 110.191 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.91 145.12 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 122.843 0.457 . . . . 0.0 109.919 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.34 157.21 22.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 mt -145.94 114.23 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -89.69 127.36 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 67' ' ' ASP . 19.2 mt -121.96 168.89 11.38 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.272 0.983 . . . . 0.0 110.551 173.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.2 t -126.55 141.55 51.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.819 1.247 . . . . 0.0 109.742 171.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.669 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -111.28 155.76 22.52 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 128.653 2.781 . . . . 0.0 109.609 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.75 -30.95 5.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.68 1.61 . . . . 0.0 110.993 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -67.73 139.06 93.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.504 1.122 . . . . 0.0 110.214 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.39 171.67 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.245 1.963 . . . . 0.0 111.191 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 65' ' ' THR . 20.0 mt -66.3 161.89 53.35 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 109.896 173.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.62 -43.39 0.47 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 121.662 1.575 . . . . 0.0 111.581 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -78.93 145.86 33.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.65 1.18 . . . . 0.0 109.304 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -110.56 92.69 14.59 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 -16.6 29.38 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.149 1.233 . . . . 0.0 112.236 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -56.04 18.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.311 0.96 . . . . 0.0 109.328 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -169.33 113.96 0.52 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.789 168.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -86.66 -17.42 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.826 2.35 . . . . 0.0 114.445 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 167.56 67.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.516 2.326 . . . . 0.0 106.032 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 66.98 167.93 0.23 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.517 2.327 . . . . 0.0 113.878 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 t -143.73 -178.63 6.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 122.921 1.343 . . . . 0.0 112.24 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.87 159.61 32.92 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.592 2.52 . . . . 0.0 107.939 159.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.55 156.96 53.46 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.195 1.93 . . . . 0.0 109.593 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 t -160.58 115.17 2.18 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 p -139.12 -164.34 1.64 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.307 1.843 . . . . 0.0 108.453 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 146.798 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.775 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -148.18 148.76 30.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m 48.55 44.59 20.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.7 1.2 . . . . 0.0 111.102 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.12 -99.3 1.23 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.694 0.664 . . . . 0.0 111.574 -166.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m 66.65 -64.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.497 1.919 . . . . 0.0 112.34 -167.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 126.92 29.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.433 1.493 . . . . 0.0 111.344 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.0 97.11 0.62 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 123.564 0.602 . . . . 0.0 112.355 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.46 -15.87 55.72 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.886 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -70.3 163.28 26.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.196 0.907 . . . . 0.0 109.852 170.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.2 m -85.76 -104.46 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.13 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 119.32 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 1 C-N-CA 134.879 5.272 . . . . 0.0 110.8 -172.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -126.38 6.55 7.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -158.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.95 -1.43 0.36 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 129.264 3.025 . . . . 0.0 115.74 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 t -84.04 -16.52 43.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.082 1.31 . . . . 0.0 110.975 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.98 67.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.024 -1.465 . . . . 0.0 111.913 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.73 138.06 57.12 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.462 1.483 . . . . 0.0 108.124 -163.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -106.48 126.29 52.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -174.09 30.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.844 2.164 . . . . 0.0 108.323 -167.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 m -95.38 160.4 14.55 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' C ' HD23 ' A' ' 21' ' ' LEU . 6.5 m-85 -118.39 131.13 56.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 122.374 1.083 . . . . 0.0 108.31 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -153.34 163.14 40.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -169.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.33 155.85 43.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.6 t -148.38 157.36 43.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.928 161.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 m -109.32 114.87 28.92 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 57' ' ' ALA . 3.3 mt -98.32 144.64 27.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -89.16 141.42 28.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 16.3 tptt -72.75 101.44 3.1 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -74.68 -175.72 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.027 0.83 . . . . 0.0 109.827 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -51.42 -31.76 24.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.278 1.431 . . . . 0.0 112.65 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 mtp -107.86 14.25 25.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.04 1.736 . . . . 0.0 111.766 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 90.85 -110.48 3.82 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.2 152.34 41.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.702 1.251 . . . . 0.0 110.138 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.86 25.84 5.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.433 1.016 . . . . 0.0 112.944 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.56 173.27 11.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.001 1.401 . . . . 0.0 107.506 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -135.64 159.62 41.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.28 1.032 . . . . 0.0 108.624 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.37 162.04 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.519 1.128 . . . . 0.0 108.933 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.1 tt -132.62 156.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.419 2.287 . . . . 0.0 107.423 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.62 153.08 23.41 Favored Glycine 0 N--CA 1.461 0.358 0 C-N-CA 127.909 2.671 . . . . 0.0 107.672 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.51 -75.01 0.35 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -172.39 -59.46 0.02 OUTLIER 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.956 -168.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 163.33 36.5 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 126.745 2.018 . . . . 0.0 109.937 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.94 48.25 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.88 3.053 . . . . 0.0 110.948 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -154.46 -9.83 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.418 -1.277 . . . . 0.0 114.265 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -67.31 143.56 56.34 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.753 1.615 . . . . 0.0 109.85 169.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -78.58 125.72 29.76 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.26 138.57 34.57 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.218 1.807 . . . . 0.0 108.613 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.93 153.2 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.017 0.371 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.9 t -65.76 111.3 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -60.49 -48.86 79.92 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.685 1.594 . . . . 0.0 110.983 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 m -160.92 150.44 17.1 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.355 1.862 . . . . 0.0 107.306 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.7 t -101.83 121.75 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 163.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.96 128.76 84.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.28 152.21 82.28 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.268 1.979 . . . . 0.0 110.332 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.59 -15.31 0.07 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.369 2.268 . . . . 0.0 113.369 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.78 161.5 46.53 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.265 -1.522 . . . . 0.0 111.581 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.2 -20.93 55.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 0.0 113.193 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -69.09 -51.11 42.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.287 0.635 . . . . 0.0 110.842 171.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.79 90.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.446 0.567 . . . . 0.0 110.11 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -65.15 -6.59 9.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.588 1.155 . . . . 0.0 113.973 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -92.11 -20.02 21.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.686 1.584 . . . . 0.0 110.982 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.14 32.08 82.99 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.826 1.203 . . . . 0.0 114.333 170.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -136.19 -39.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 112.739 -169.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 ttm -89.9 140.28 29.77 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -137.27 168.7 19.12 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 125.713 1.883 . . . . 0.0 110.801 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -78.88 160.4 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.87 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.25 -19.3 13.76 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.691 1.138 . . . . 0.0 112.614 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.8 m-20 -70.88 152.97 43.12 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.868 1.334 . . . . 0.0 110.805 -173.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.63 131.71 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.435 1.894 . . . . 0.0 108.347 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.71 126.73 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.751 1.62 . . . . 0.0 108.305 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.19 -60.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 109.556 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -134.5 153.05 52.13 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.392 1.077 . . . . 0.0 108.917 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mt -126.45 108.65 19.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 72.36 -61.95 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 128.824 2.849 . . . . 0.0 110.542 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -149.19 -25.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.859 2.064 . . . . 0.0 110.477 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.83 131.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.243 1.417 . . . . 0.0 108.981 -168.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -65.05 131.89 47.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 108.824 165.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.67 5.47 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 123.375 0.67 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.51 1.124 . . . . 0.0 111.67 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.16 53.54 0.75 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 166.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -95.86 158.48 15.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 156.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -76.05 156.41 33.98 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -56.23 -27.08 53.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.485 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.96 -52.51 65.19 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.082 1.31 . . . . 0.0 110.722 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.7 -42.79 73.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.914 0.486 . . . . 0.0 109.819 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.294 -1.503 . . . . 0.0 111.549 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.32 -40.34 88.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 121.138 -0.976 . . . . 0.0 109.315 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.933 1.242 . . . . 0.0 111.091 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.29 -46.83 75.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -64.85 -40.11 94.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.056 0.844 . . . . 0.0 111.265 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.25 -33.65 75.96 Favored 'General case' 0 C--O 1.231 0.104 0 O-C-N 121.343 -0.848 . . . . 0.0 111.551 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.2 m -56.98 -22.99 42.61 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.886 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.0 114.06 51.82 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 167.0 14.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.415 2.743 . . . . 0.0 111.848 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.4 98.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.772 1.629 . . . . 0.0 108.473 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.18 -17.11 3.39 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.045 1.307 . . . . 0.0 112.65 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.16 164.96 18.83 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 p -120.48 147.2 45.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 109.111 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.1 138.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.536 0.734 . . . . 0.0 109.163 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -83.87 153.81 23.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.269 1.428 . . . . 0.0 109.404 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 mt -144.1 109.37 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.84 121.3 38.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 67' ' ' ASP . 7.5 mt -118.57 160.81 21.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 124.508 1.13 . . . . 0.0 109.92 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -107.53 119.17 38.68 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 168.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 21' ' ' LEU . 16.6 ttm180 -84.32 126.02 32.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.675 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.69 -3.47 9.35 Favored Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.096 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -65.8 142.67 98.24 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 163.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.66 175.34 8.98 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 109.866 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.35 161.43 42.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 167.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.61 -40.14 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.357 2.038 . . . . 0.0 111.656 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -120.51 142.01 49.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.223 2.209 . . . . 0.0 109.247 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.04 107.18 54.32 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.52 1.528 . . . . 0.0 110.2 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.5 -20.4 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.217 1.944 . . . . 0.0 112.588 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.47 -35.21 77.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.866 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.19 90.36 50.45 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 125.62 1.568 . . . . 0.0 107.861 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.1 -34.53 4.9 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.773 1.648 . . . . 0.0 111.226 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.74 -44.73 0.05 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 m120 65.81 138.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.822 2.449 . . . . 0.0 112.758 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 m -174.82 113.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.406 1.482 . . . . 0.0 109.902 166.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.55 129.19 8.89 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 159.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 -9.49 24.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.223 2.615 . . . . 0.0 113.082 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 m -152.02 -48.45 0.11 Allowed 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -153.68 -16.58 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.853 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -173.123 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -145.81 172.7 12.93 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.09 0.945 . . . . 0.0 109.014 -167.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -149.66 157.92 43.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 157.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.83 151.47 27.97 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -159.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -154.9 76.08 0.99 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.466 1.506 . . . . 0.0 108.85 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -66.95 162.79 21.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.793 -0.567 . . . . 0.0 111.362 172.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.86 -114.22 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 106.331 -2.708 . . . . 0.0 106.331 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.93 -45.55 1.04 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 167.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -54.63 155.42 4.15 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.785 1.279 . . . . 0.0 111.084 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 m -81.54 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 125.898 1.679 . . . . 0.0 110.295 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 130.88 -44.72 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.458 1 C-N-CA 134.363 5.065 . . . . 0.0 110.427 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -124.66 18.14 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -161.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.69 -3.5 0.05 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.914 2.086 . . . . 0.0 114.873 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -66.42 -43.25 86.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 120.721 -1.237 . . . . 0.0 111.171 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -78.33 7.09 6.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.68 164.75 26.23 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.391 -1.443 . . . . 0.0 108.558 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -129.35 -1.78 5.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.14 174.07 55.29 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.91 -1.119 . . . . 0.0 110.58 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -86.03 150.41 24.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.038 0.919 . . . . 0.0 108.838 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -100.39 147.43 25.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.673 1.589 . . . . 0.0 109.811 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 mp -140.36 163.84 31.72 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.252 1.021 . . . . 0.0 109.975 -172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 p -147.43 119.93 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.147 0.579 . . . . 0.0 112.263 -174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -127.59 150.68 49.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -119.36 114.96 23.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.8 134.98 40.92 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -82.86 140.87 32.66 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 166.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -65.27 101.14 0.52 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -142.51 158.44 43.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.134 1.374 . . . . 0.0 111.546 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 63.42 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 127.346 2.259 . . . . 0.0 110.048 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.7 mtt -141.15 88.42 2.16 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 154.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.78 -110.41 3.15 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.851 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -125.95 140.33 52.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.702 1.251 . . . . 0.0 109.445 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.5 38.89 2.29 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.381 0.991 . . . . 0.0 112.413 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.65 169.1 20.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -131.55 166.07 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.08 162.24 25.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 109.021 -171.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 tt -136.71 154.93 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.581 1.952 . . . . 0.0 107.706 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.69 152.22 22.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.0 -2.84 . . . . 0.0 106.0 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.38 -67.8 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 124.574 1.083 . . . . 0.0 111.563 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.79 -30.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.764 1.226 . . . . 0.0 110.766 160.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -116.18 168.87 7.84 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.675 1.19 . . . . 0.0 112.156 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.22 75.4 4.65 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.25 2.633 . . . . 0.0 108.509 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -169.2 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.501 1.92 . . . . 0.0 109.341 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -80.2 137.93 36.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.533 0.682 . . . . 0.0 109.505 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.97 130.49 41.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.385 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.81 137.15 35.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.564 1.146 . . . . 0.0 108.8 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -136.77 151.86 49.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.516 0.726 . . . . 0.0 110.799 -171.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.85 112.43 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -66.37 -52.96 41.5 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.043 1.737 . . . . 0.0 110.273 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -150.84 149.95 30.32 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.345 1.458 . . . . 0.0 107.587 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.08 120.03 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 160.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.75 128.6 93.93 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.57 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.07 1.847 . . . . 0.0 110.147 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.47 56.41 2.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 111.77 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.08 167.3 24.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.138 1.351 . . . . 0.0 110.079 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -69.18 -18.31 39.77 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 0.0 113.739 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.35 4.58 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.19 -37.27 54.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.798 1.639 . . . . 0.0 111.557 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.77 -14.1 58.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.711 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -84.1 -22.25 31.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.832 2.105 . . . . 0.0 111.441 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.52 30.14 71.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.897 163.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -122.05 -26.01 4.83 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.78 1.79 . . . . 0.0 112.701 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -86.65 141.61 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.644 1.178 . . . . 0.0 108.388 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -131.25 169.29 16.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.48 1.133 . . . . 0.0 108.047 165.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.7 m -65.3 145.1 56.63 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.774 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 -18.47 44.58 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.518 1.056 . . . . 0.0 113.918 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.32 143.59 55.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.996 1.398 . . . . 0.0 109.987 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.14 120.98 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.183 1.393 . . . . 0.0 109.249 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.2 mp -71.15 114.1 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.266 1.426 . . . . 0.0 107.994 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.57 -60.4 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.157 0.983 . . . . 0.0 109.696 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.66 149.74 52.17 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -120.89 120.95 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 64.52 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.971 1.708 . . . . 0.0 108.284 -172.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -138.89 -10.63 1.32 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.79 1.636 . . . . 0.0 111.34 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.18 127.07 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 107.614 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.8 t -71.78 128.17 34.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 168.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.22 17.4 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 125.773 1.629 . . . . 0.0 109.02 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -35.93 76.46 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 120.719 -1.238 . . . . 0.0 112.251 -166.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.45 38.82 2.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.225 1.869 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 170.0 16.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.283 1.041 . . . . 0.0 110.255 167.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -74.92 139.94 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 164.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -52.31 -45.72 65.68 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.913 0.885 . . . . 0.0 109.33 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -22.29 43.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.31 -51.71 5.42 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 119.51 1.05 . . . . 0.0 111.187 173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.17 -36.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.129 2.172 . . . . 0.0 111.437 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.38 -41.19 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.873 0.869 . . . . 0.0 110.416 171.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -36.92 82.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 108.658 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.49 -38.31 89.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.969 0.908 . . . . 0.0 110.006 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.4 -30.13 65.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.407 1.003 . . . . 0.0 111.247 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -64.71 -37.04 86.24 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.294 0.952 . . . . 0.0 110.123 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.7 p -66.58 -6.17 14.22 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.78 103.83 7.89 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.89 167.14 27.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.866 1.711 . . . . 0.0 111.869 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.88 122.57 9.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.698 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.68 -11.65 46.18 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.956 -1.469 . . . . 0.0 113.891 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -83.51 162.01 21.04 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.419 1.609 . . . . 0.0 108.719 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.0 138.02 50.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.244 1.018 . . . . 0.0 110.92 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 m -129.05 142.66 43.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 C-N-CA 124.36 1.064 . . . . 0.0 109.118 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.61 159.16 22.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.95 114.57 7.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.45 115.52 29.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.96 164.27 12.42 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 124.029 0.83 . . . . 0.0 109.068 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -121.95 129.42 52.49 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.392 1.477 . . . . 0.0 107.15 166.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.56 ' HB2' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.55 156.81 36.45 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.488 1.915 . . . . 0.0 109.606 173.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.48 -10.48 73.24 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.13 149.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -64.28 137.63 97.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 150.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.22 175.73 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.253 2.635 . . . . 0.0 109.827 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.8 162.33 9.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 122.682 0.393 . . . . 0.0 109.955 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.36 -48.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.012 1.808 . . . . 0.0 111.888 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -109.98 129.2 55.7 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.346 1.459 . . . . 0.0 108.862 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -111.63 115.8 51.03 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 125.488 1.515 . . . . 0.0 108.19 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.91 -15.88 29.44 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.244 1.296 . . . . 0.0 110.967 160.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -90.72 -7.09 53.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.371 1.068 . . . . 0.0 112.249 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -48.94 83.16 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.912 -1.518 . . . . 0.0 111.577 173.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.63 -63.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.864 1.709 . . . . 0.0 111.63 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 163.18 110.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 127.883 2.473 . . . . 0.0 107.126 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -142.55 -134.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -170.68 89.04 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.111 1.778 . . . . 0.0 109.157 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.93 157.18 27.02 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.336 -0.853 . . . . 0.0 112.431 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.22 62.13 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.849 3.033 . . . . 0.0 111.803 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.4 m -59.99 150.23 29.7 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.949 163.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 m 166.46 127.11 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 128.697 2.799 . . . . 0.0 107.99 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 115.853 -2.637 . . . . 0.0 110.64 169.353 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.574 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 t -158.59 165.67 33.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -156.54 101.8 2.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 168.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.94 179.24 53.39 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 t -146.66 177.05 9.38 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.356 0.598 . . . . 0.0 110.14 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -123.61 170.77 10.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.185 2.194 . . . . 0.0 108.814 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.86 46.74 Favored Glycine 0 CA--C 1.52 0.401 0 O-C-N 120.945 -1.097 . . . . 0.0 111.075 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.78 -90.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 159.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -64.02 159.04 20.98 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.187 2.595 . . . . 0.0 110.829 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -85.43 -112.7 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.47 2.308 . . . . 0.0 110.924 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 142.66 -71.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 1 C-N-CA 134.021 4.928 . . . . 0.0 108.838 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.35 14.57 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.15 0.98 . . . . 0.0 113.509 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 71.58 -12.21 0.66 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.44 2.296 . . . . 0.0 113.814 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.211 1.004 . . . . 0.0 111.552 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -83.44 0.61 45.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.204 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.45 140.53 52.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 162.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -105.74 132.09 52.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.45 -165.57 31.44 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -135.07 136.53 42.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 70' ' ' VAL . 22.7 m-85 -102.84 149.12 24.81 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.838 0.855 . . . . 0.0 110.099 -168.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.83 169.02 18.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.874 2.069 . . . . 0.0 108.664 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.22 142.35 42.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.926 1.29 . . . . 0.0 108.929 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -141.26 157.2 45.54 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.607 -0.683 . . . . 0.0 109.274 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 m -131.59 106.49 8.22 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.97 156.33 16.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -106.79 138.23 43.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 10.1 tttt -61.43 103.45 0.31 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.502 1.521 . . . . 0.0 110.355 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.7 p -83.03 -173.11 4.52 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.637 1.108 . . . . 0.0 110.489 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -37.78 61.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.647 1.179 . . . . 0.0 112.237 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.2 ptm -105.05 13.14 31.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.911 1.285 . . . . 0.0 113.42 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.609 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 97.16 -106.36 3.33 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.28 152.2 44.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.77 39.46 3.02 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.92 166.41 28.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.616 1.208 . . . . 0.0 108.323 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -135.45 154.5 51.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.248 1.419 . . . . 0.0 107.705 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.51 160.76 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 109.835 -170.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -136.05 159.82 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.601 2.76 . . . . 0.0 107.388 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.64 152.2 21.16 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -76.77 0.17 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.356 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -171.38 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.752 1.276 . . . . 0.0 113.112 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.54 167.58 22.12 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.729 1.212 . . . . 0.0 110.821 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.85 35.66 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.106 1 C-N-CA 125.753 4.302 . . . . 0.0 113.961 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.31 -15.79 0.29 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.563 1.545 . . . . 0.0 112.282 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.96 165.61 23.85 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 122.063 0.935 . . . . 0.0 111.065 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -71.17 157.5 38.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 mt -116.33 133.43 56.03 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.606 2.363 . . . . 0.0 107.521 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -130.62 154.05 48.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.519 0.728 . . . . 0.0 111.784 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.95 109.71 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 165.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -63.2 -43.31 98.53 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.732 1.613 . . . . 0.0 110.935 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.22 142.39 13.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.867 1.667 . . . . 0.0 108.824 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 64' ' ' GLU . 19.7 t -92.01 122.67 43.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 161.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.17 132.44 63.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.096 1.358 . . . . 0.0 107.786 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.1 168.36 14.15 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.738 1.626 . . . . 0.0 110.924 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.27 28.0 17.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 111.238 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.02 177.8 16.43 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.055 1.788 . . . . 0.0 113.943 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 -28.22 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.808 2.339 . . . . 0.0 111.904 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.6 59.79 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.05 72.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.658 0.783 . . . . 0.0 112.779 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.56 -19.72 55.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.402 1.001 . . . . 0.0 113.296 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.3 -42.36 14.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.84 0.856 . . . . 0.0 109.776 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.72 2.5 60.94 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.993 1.282 . . . . 0.0 114.508 171.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.01 -7.16 59.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.736 1.768 . . . . 0.0 112.7 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.8 ttp -122.31 141.1 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.753 1.621 . . . . 0.0 109.358 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.828 ' HA ' HG21 ' A' ' 51' ' ' VAL . 3.6 pt-20 -140.93 -179.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.461 1.104 . . . . 0.0 110.065 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 HD21 ' A' ' 108' ' ' LEU . 71.3 m -88.49 133.96 33.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.849 1.26 . . . . 0.0 109.613 -173.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.28 -14.04 59.79 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.404 1.478 . . . . 0.0 112.323 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 102' ' ' LEU . 29.5 m-20 -60.35 148.25 37.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.982 0.913 . . . . 0.0 110.809 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 t -99.33 122.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.651 1.58 . . . . 0.0 108.606 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 102' ' ' LEU . 4.7 mp -74.59 106.36 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 109.28 174.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' PHE . 6.7 t -80.75 -57.6 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -132.14 149.54 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.073 0.949 . . . . 0.0 108.914 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.65 116.39 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 170.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.41 -57.05 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 130.624 3.569 . . . . 0.0 113.941 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.42 6.38 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.466 2.306 . . . . 0.0 111.611 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.92 128.31 64.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.009 1.324 . . . . 0.0 108.295 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.4 p -78.27 87.13 4.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 110.746 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 1.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.963 0.905 . . . . 0.0 112.08 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -17.95 45.63 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -167.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.71 22.64 7.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.787 1.184 . . . . 0.0 111.307 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.06 167.72 11.05 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.697 1.249 . . . . 0.0 110.444 -175.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.3 p -72.12 138.59 47.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -53.37 -44.84 68.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.705 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -36.02 69.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.583 1.538 . . . . 0.0 113.477 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.07 -56.98 8.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.893 0.877 . . . . 0.0 109.688 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.59 -42.94 52.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 128.191 2.596 . . . . 0.0 111.633 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.19 -38.93 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 120.734 -1.229 . . . . 0.0 108.871 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -33.74 75.02 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.306 -0.871 . . . . 0.0 111.267 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -50.8 69.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.955 1.302 . . . . 0.0 108.743 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.64 -40.09 93.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.393 0.542 . . . . 0.0 110.957 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -69.5 -31.78 70.24 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.482 -0.761 . . . . 0.0 111.715 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 55.4 p -70.07 -0.46 7.68 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.024 0.829 . . . . 0.0 113.141 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 t -84.4 112.45 41.84 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 168.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.21 175.29 10.46 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.971 1.78 . . . . 0.0 112.037 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 150.49 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.671 1.188 . . . . 0.0 108.17 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.86 -15.69 51.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.246 1.403 . . . . 0.0 112.334 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -96.29 164.2 12.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.419 1.609 . . . . 0.0 110.792 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -132.28 155.61 48.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.899 2.479 . . . . 0.0 108.553 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.86 147.69 21.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.129 0.971 . . . . 0.0 109.971 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.68 153.54 21.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -141.04 148.87 40.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.04 118.94 39.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.0 mt -114.41 165.79 12.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 124.095 0.872 . . . . 0.0 110.15 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -127.32 124.6 39.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.269 1.428 . . . . 0.0 108.133 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -102.73 132.44 48.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.413 1.885 . . . . 0.0 108.649 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.61 6.07 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.712 0.672 . . . . 0.0 112.45 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -103.84 130.98 22.44 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 160.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -70.77 172.54 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.549 2.166 . . . . 0.0 111.669 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.415 HD21 HG22 ' A' ' 65' ' ' THR . 10.7 mt -70.82 152.5 95.1 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.46 -28.56 2.23 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.347 2.698 . . . . 0.0 111.558 175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -80.33 105.23 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.71 107.8 50.66 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.47 -24.95 4.05 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 121.84 1.693 . . . . 0.0 114.007 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.54 -62.39 1.62 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.848 0.859 . . . . 0.0 109.092 -170.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -164.02 73.95 1.72 Allowed Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.28 1.432 . . . . 0.0 108.489 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.81 -42.0 21.72 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.433 2.756 . . . . 0.0 112.531 -172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.51 108.18 0.8 Allowed 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -141.74 167.74 21.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.897 0.879 . . . . 0.0 109.997 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 m -136.18 102.09 4.89 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.18 154.99 52.38 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 170.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.32 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.37 2.047 . . . . 0.0 110.359 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -120.83 118.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.8 m 59.53 -169.33 0.14 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.124 0.97 . . . . 0.0 110.832 -164.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 C-N-CA 127.801 2.62 . . . . 0.0 106.733 -177.466 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 p -104.07 140.69 37.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.047 1.339 . . . . 0.0 110.284 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 m -58.58 -50.28 74.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.06 -81.99 0.98 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -163.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 t -59.82 158.06 11.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.212 0.529 . . . . 0.0 111.281 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -99.01 -37.06 9.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.121 1.368 . . . . 0.0 109.674 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.59 162.01 16.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -157.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp 39.48 87.81 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.33 1.852 . . . . 0.0 111.283 -163.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 10' ' ' THR 0.271 27.5 t80 57.98 -148.41 0.48 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 108.929 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.433 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 25.1 m -127.6 -98.49 0.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 126.589 1.956 . . . . 0.0 109.945 -173.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 121.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 1 C-N-CA 135.112 5.365 . . . . 0.0 109.786 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.41 0.43 24.84 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.72 -24.68 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.841 2.856 . . . . 0.0 114.178 -169.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -57.59 -34.28 69.07 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -80.78 7.47 10.3 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.018 0.527 . . . . 0.0 112.392 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 mt -77.23 170.61 16.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.495 -1.378 . . . . 0.0 110.287 171.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.01 105.1 7.19 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.154 1.381 . . . . 0.0 109.26 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.37 -179.22 25.39 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.232 1.396 . . . . 0.0 111.561 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -77.9 134.78 37.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.484 0.713 . . . . 0.0 109.306 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.24 138.62 32.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.936 0.894 . . . . 0.0 108.648 169.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.01 173.47 12.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.792 1.237 . . . . 0.0 109.696 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 p -145.59 170.33 16.65 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -155.94 155.56 33.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.363 1.065 . . . . 0.0 109.977 159.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.8 m -102.69 115.19 30.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.777 1.231 . . . . 0.0 108.523 163.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.37 137.33 39.85 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -81.68 137.23 35.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 166.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -64.72 108.83 1.83 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 165.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 t -137.16 161.95 34.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 56.31 -91.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.564 1.946 . . . . 0.0 112.642 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.8 ptm -138.47 30.14 2.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.656 1.582 . . . . 0.0 110.72 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.3 176.47 21.37 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.181 1.372 . . . . 0.0 110.693 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -64.73 147.88 52.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.162 -0.61 . . . . 0.0 109.896 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.45 33.37 1.82 Allowed Glycine 0 C--O 1.222 -0.637 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.469 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -149.81 164.3 35.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.734 1.767 . . . . 0.0 108.465 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -132.93 154.84 50.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.61 159.19 17.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.857 1.263 . . . . 0.0 108.58 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -121.75 164.12 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.922 2.089 . . . . 0.0 107.559 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.07 151.85 17.52 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.2 -14.12 55.66 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.563 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t0 80.52 -36.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.623 2.769 . . . . 0.0 109.93 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -72.46 167.61 31.25 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 125.709 1.604 . . . . 0.0 111.225 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -100.63 32.22 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.379 3.386 . . . . 0.0 113.256 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -158.24 37.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.157 0.983 . . . . 0.0 109.954 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.54 153.79 48.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.324 1.059 . . . . 0.0 112.537 -165.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.78 116.87 15.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.249 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.81 124.15 29.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -115.26 151.94 33.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.324 0.965 . . . . 0.0 109.81 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.46 118.99 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 120.707 -1.246 . . . . 0.0 107.819 165.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -52.11 43.95 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.643 1.977 . . . . 0.0 109.72 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -157.76 153.52 26.69 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.647 1.179 . . . . 0.0 109.644 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.1 t -96.97 113.8 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 164.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.93 130.97 87.74 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.505 1.922 . . . . 0.0 108.192 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.89 161.65 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.378 2.052 . . . . 0.0 111.192 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.61 10.09 0.95 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.431 2.293 . . . . 0.0 113.042 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.51 161.19 21.28 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.587 1.565 . . . . 0.0 110.553 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.96 -25.12 74.05 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 112.837 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.17 70.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.212 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.75 95.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.469 0.708 . . . . 0.0 110.38 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -66.58 -43.22 85.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.29 0.636 . . . . 0.0 110.981 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.28 -38.77 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.266 1.026 . . . . 0.0 111.164 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.89 11.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.686 2.088 . . . . 0.0 115.347 169.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.76 -39.08 87.74 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.292 -1.122 . . . . 0.0 109.963 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 tpp -67.6 131.77 46.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.526 1.131 . . . . 0.0 108.595 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -134.87 161.74 34.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.906 0.86 . . . . 0.0 108.727 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 156.92 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.6 70.88 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.481 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 102' ' ' LEU . 65.6 m-20 -83.88 162.66 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.827 1.814 . . . . 0.0 109.562 168.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -116.54 125.73 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 127.185 2.194 . . . . 0.0 108.388 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -73.72 105.21 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 126.917 2.087 . . . . 0.0 108.459 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -84.08 -57.5 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.811 0.815 . . . . 0.0 109.768 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -135.59 139.89 44.21 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -165.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.16 133.76 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 58.51 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 127.756 2.423 . . . . 0.0 113.776 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -150.06 21.97 0.86 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.598 1.559 . . . . 0.0 109.77 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.67 152.51 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.157 1.383 . . . . 0.0 108.205 -162.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.6 p -87.06 137.59 32.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.087 0.955 . . . . 0.0 109.805 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.84 15.28 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.275 1.43 . . . . 0.0 110.49 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 -31.92 66.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 113.315 -159.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.93 49.2 0.93 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.6 1.571 . . . . 0.0 109.41 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -99.16 170.28 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.303 1.041 . . . . 0.0 112.016 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -79.2 133.39 36.69 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.579 -1.325 . . . . 0.0 108.535 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.88 -40.44 66.6 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.273 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.29 76.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.76 1.618 . . . . 0.0 112.074 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.23 -46.37 50.64 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.019 0.928 . . . . 0.0 110.288 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.48 -41.8 93.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 110.769 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.5 t -61.45 -42.79 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.216 172.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.61 75.5 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.11 0.868 . . . . 0.0 110.055 173.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.14 -37.91 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.149 0.98 . . . . 0.0 109.701 -174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' HE1' HD21 ' A' ' 100' ' ' LEU . 49.6 m-85 -70.2 -32.16 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.923 -0.486 . . . . 0.0 112.014 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -69.14 -33.38 73.35 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.287 0.948 . . . . 0.0 110.987 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -58.91 -16.11 16.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 0.0 113.749 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.6 110.2 25.57 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.763 1.625 . . . . 0.0 107.85 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.25 168.23 21.48 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.419 2.079 . . . . 0.0 110.535 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.29 125.98 7.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 164.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.11 -27.57 19.56 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.122 -1.376 . . . . 0.0 112.734 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.03 145.34 28.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.463 2.131 . . . . 0.0 108.286 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.14 162.09 13.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.379 1.072 . . . . 0.0 110.078 171.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.27 157.96 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 125.081 1.352 . . . . 0.0 109.291 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.03 156.59 16.25 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 110.489 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.424 HD21 ' HE1' ' A' ' 89' ' ' PHE . 19.6 mt -143.86 132.99 22.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.1 t -98.97 123.19 51.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 160.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 67' ' ' ASP . 2.5 mt -108.19 160.7 15.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.248 0.967 . . . . 0.0 109.062 171.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.6 t -118.92 121.71 40.59 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -76.06 156.24 34.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.435 1.094 . . . . 0.0 108.653 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.75 -20.78 11.71 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 117.836 -1.536 . . . . 0.0 114.329 162.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -81.22 141.46 49.92 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 120.254 2.027 . . . . 0.0 107.94 165.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.97 170.27 20.5 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.32 2.013 . . . . 0.0 111.109 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.73 165.08 13.3 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.69 169.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -95.39 -22.3 0.2 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.944 2.429 . . . . 0.0 112.78 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -119.67 126.93 52.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.626 2.77 . . . . 0.0 108.359 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -106.51 121.85 43.87 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 171.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.06 -58.07 0.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.987 2.458 . . . . 0.0 110.598 169.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.53 -74.75 0.1 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.661 1.184 . . . . 0.0 110.743 -169.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -128.81 65.74 73.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 111.349 -162.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.42 -0.92 8.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 125.007 3.805 . . . . 0.0 114.6 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 162.97 79.88 0.0 OUTLIER 'General case' 0 C--O 1.233 0.218 0 C-N-CA 130.548 3.539 . . . . 0.0 105.949 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -135.54 126.51 27.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.0 p -141.34 155.46 45.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.914 0.387 . . . . 0.0 110.503 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.24 101.17 2.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 117.85 -1.528 . . . . 0.0 109.325 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.42 168.52 17.73 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.094 1.862 . . . . 0.0 110.338 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.3 t -148.77 121.64 8.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 t 64.32 177.76 0.18 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.901 1.28 . . . . 0.0 110.849 -163.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.614 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 142.288 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -81.81 -27.66 33.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.483 1.141 . . . . 0.0 111.527 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 t -65.89 138.69 58.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.46 174.3 45.0 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -167.21 178.61 5.52 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.6 t -65.18 168.72 6.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.221 0.608 . . . . 0.0 110.392 166.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.3 156.68 15.65 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.07 91.97 1.67 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.809 1.244 . . . . 0.0 107.971 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 t80 53.1 172.57 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.928 2.891 . . . . 0.0 112.738 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 m -77.59 -118.49 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.121 1.368 . . . . 0.0 110.2 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 135.73 -23.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 1 C-N-CA 134.215 5.006 . . . . 0.0 113.283 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -142.14 15.57 2.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.85 1.205 . . . . 0.0 113.637 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.5 -6.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.735 2.014 . . . . 0.0 114.514 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -73.8 -25.95 60.38 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.634 -1.291 . . . . 0.0 111.995 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.09 -11.06 60.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.544 1.065 . . . . 0.0 112.532 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.2 140.18 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.27 0.941 . . . . 0.0 109.652 -172.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -117.81 113.22 21.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.82 -175.27 30.66 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.006 -158.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -125.38 139.26 53.82 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -104.34 137.81 41.68 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.769 1.628 . . . . 0.0 110.411 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 175.55 12.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.562 1.945 . . . . 0.0 108.999 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -135.09 170.36 16.02 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 110.413 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -149.61 153.41 37.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.994 1.318 . . . . 0.0 107.883 170.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 m -115.83 105.49 12.75 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.04 132.7 44.16 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -82.87 146.44 28.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -77.65 76.71 4.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.381 1.072 . . . . 0.0 108.252 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -63.01 115.22 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 46.5 -91.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.673 2.389 . . . . 0.0 112.486 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.1 mtp -53.29 -56.09 19.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.612 2.365 . . . . 0.0 111.067 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.72 176.6 21.45 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -148.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -75.98 125.62 29.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.55 55.06 3.72 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.453 0.549 . . . . 0.0 112.056 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -143.02 157.97 44.04 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -125.78 157.87 36.39 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.43 162.92 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.901 1.281 . . . . 0.0 109.36 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 16.3 tt -126.36 146.49 32.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.905 1.682 . . . . 0.0 107.964 171.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.27 151.23 22.1 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.442 1.089 . . . . 0.0 111.064 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 44' ' ' GLU . . . -51.44 -82.86 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 C-N-CA 128.874 3.13 . . . . 0.0 112.512 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.44 -34.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.409 1.084 . . . . 0.0 112.424 -170.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -122.26 165.15 21.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.056 1.342 . . . . 0.0 110.492 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.53 47.4 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.158 3.238 . . . . 0.0 112.624 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -164.58 16.01 0.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.962 2.105 . . . . 0.0 112.128 -172.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 1.5 pp20? -91.62 165.63 13.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.538 2.335 . . . . 0.0 111.634 171.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.75 118.18 35.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.473 1.109 . . . . 0.0 110.336 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.8 mt -80.0 129.46 34.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -128.69 154.25 46.51 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.306 1.042 . . . . 0.0 110.46 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.01 114.81 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -68.22 -52.18 37.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.462 1.505 . . . . 0.0 110.414 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -156.65 151.12 25.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.575 1.15 . . . . 0.0 108.991 172.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -91.62 127.26 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 168.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.55 131.8 87.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -68.26 163.18 37.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.171 1.914 . . . . 0.0 111.2 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.35 49.92 3.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.031 1.732 . . . . 0.0 112.091 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.1 175.7 22.07 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.391 1.472 . . . . 0.0 110.744 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.87 -22.8 31.05 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.814 2.343 . . . . 0.0 113.425 -168.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.22 -51.19 11.36 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.076 0.853 . . . . 0.0 109.04 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.655 1.182 . . . . 0.0 110.314 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.64 -36.31 76.12 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.91 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -74.85 -20.85 59.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.235 0.925 . . . . 0.0 112.01 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.41 61.16 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.183 1.373 . . . . 0.0 115.723 163.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -87.48 -20.66 26.25 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.22 1.51 . . . . 0.0 111.35 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 ttm -110.98 143.92 40.9 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.716 1.606 . . . . 0.0 109.668 -169.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.08 -179.18 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.43 1.492 . . . . 0.0 108.312 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -95.54 158.42 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.36 0.664 . . . . 0.0 109.613 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.83 -14.73 24.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.481 0.563 . . . . 0.0 111.966 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 102' ' ' LEU . 12.4 m-20 -64.35 151.69 43.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.117 0.967 . . . . 0.0 109.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.23 121.0 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.686 1.595 . . . . 0.0 107.999 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.76 129.32 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.62 -58.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.447 1.092 . . . . 0.0 110.953 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.92 151.27 50.72 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.349 0.66 . . . . 0.0 109.933 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -132.25 117.03 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.23 -73.04 0.05 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.839 2.456 . . . . 0.0 110.026 -170.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -147.51 -10.73 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.1 1.76 . . . . 0.0 110.685 173.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 123.73 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.46 1.504 . . . . 0.0 107.977 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.9 p -67.5 110.13 3.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.414 0.686 . . . . 0.0 109.344 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.45 8.63 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.718 -0.614 . . . . 0.0 111.805 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 1.6 pp -55.19 -33.87 63.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -165.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.79 17.26 10.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 120.025 1.284 . . . . 0.0 111.397 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -73.16 158.06 36.0 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -82.74 146.47 28.99 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -56.53 -32.74 65.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 110.821 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.47 -57.79 10.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.097 -1.002 . . . . 0.0 110.896 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.36 -43.25 81.93 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.39 0.614 . . . . 0.0 109.559 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.99 -41.79 87.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 119.839 -1.788 . . . . 0.0 111.198 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.45 -39.44 80.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.295 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -35.22 80.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.38 0.991 . . . . 0.0 110.144 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.7 -45.51 86.31 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.047 1.739 . . . . 0.0 109.011 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -61.08 -32.6 72.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.513 -0.742 . . . . 0.0 111.247 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -79.75 -19.79 47.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.082 -1.011 . . . . 0.0 112.831 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.8 m -75.12 -6.16 48.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.267 1.427 . . . . 0.0 111.984 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.03 116.67 66.41 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 178.58 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.286 1.991 . . . . 0.0 111.133 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 mt -62.93 144.68 14.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 109.345 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.46 -2.83 51.48 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.7 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -84.22 164.9 18.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.651 1.726 . . . . 0.0 107.788 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 p -127.8 134.24 49.46 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.773 0.715 . . . . 0.0 110.23 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.95 146.88 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.4 148.01 27.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.0 mt -146.69 132.84 19.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -174.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.25 130.47 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.56 1.544 . . . . 0.0 108.221 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 67' ' ' ASP . 11.1 mt -117.7 164.94 14.22 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 124.324 1.015 . . . . 0.0 110.389 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.7 t -129.1 132.27 47.38 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.271 1.429 . . . . 0.0 108.433 167.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -104.28 122.29 45.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 126.465 1.906 . . . . 0.0 110.573 -172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 138.04 5.08 1.67 Allowed Glycine 0 N--CA 1.464 0.502 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.835 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -91.75 149.03 38.42 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 118.772 1.286 . . . . 0.0 108.237 167.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.58 168.29 24.73 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.139 1.893 . . . . 0.0 110.987 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.77 144.0 63.65 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.16 -24.67 10.84 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.702 2.935 . . . . 0.0 112.159 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.58 100.41 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.902 1.681 . . . . 0.0 108.943 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 113.42 32.21 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.19 -15.37 20.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.825 2.35 . . . . 0.0 114.725 -169.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -119.49 -32.71 4.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.021 1.328 . . . . 0.0 108.615 172.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t0 66.01 175.5 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.484 1.114 . . . . 0.0 109.381 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.92 -13.72 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.679 2.253 . . . . 0.0 110.924 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 154.88 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.302 1 C-N-CA 132.084 4.154 . . . . 0.0 106.733 170.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 66.61 158.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.551 1.94 . . . . 0.0 111.27 -169.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t 46.27 31.21 1.17 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.415 1.486 . . . . 0.0 112.087 -169.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.26 -94.94 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.776 0.703 . . . . 0.0 112.355 -157.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.01 99.24 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-N 120.038 1.919 . . . . 0.0 109.24 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.3 m -155.92 169.82 23.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.786 2.035 . . . . 0.0 108.571 167.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.5 p -133.87 71.61 1.46 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.6 0.714 . . . . 0.0 110.472 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -62.75 171.11 2.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.057 0.928 . . . . 0.0 110.443 172.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.5 t -133.85 121.56 21.95 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 -65.5 2.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 124.595 1.093 . . . . 0.0 111.38 -171.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -127.46 75.98 1.63 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -65.63 140.29 58.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.81 139.88 14.83 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.52 -63.37 0.43 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.67 1.188 . . . . 0.0 109.544 170.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.77 155.68 40.16 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.336 0.516 . . . . 0.0 110.374 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -73.31 -117.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.484 2.314 . . . . 0.0 112.841 178.26 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 10' ' ' THR . 8.7 mtt180 134.06 -16.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 1 C-N-CA 134.581 5.153 . . . . 0.0 111.827 177.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -145.45 13.21 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 59.62 4.6 0.56 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.31 1.444 . . . . 0.0 114.415 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -18.41 32.37 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.534 -1.354 . . . . 0.0 111.947 -174.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.85 -18.33 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.99 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.81 157.72 9.21 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.692 1.133 . . . . 0.0 110.299 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -129.12 93.12 3.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.723 1.209 . . . . 0.0 109.796 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.09 -129.72 1.57 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 125.252 1.406 . . . . 0.0 110.041 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.4 m -136.17 145.72 46.08 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.933 1.693 . . . . 0.0 108.459 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.456 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 m-85 -90.43 144.23 26.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.426 0.69 . . . . 0.0 110.401 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -120.08 165.82 14.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.021 2.128 . . . . 0.0 107.734 173.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.5 p -147.19 162.79 38.16 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.347 0.659 . . . . 0.0 109.945 155.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.75 157.46 38.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 170.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.8 m -120.11 108.22 13.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.14 134.56 40.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -82.24 151.19 26.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -85.45 100.99 12.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -64.08 -53.56 47.8 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -159.97 -71.35 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.317 1.047 . . . . 0.0 110.234 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 ptp -50.84 -40.84 56.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 127.198 2.199 . . . . 0.0 113.595 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.83 -125.63 1.89 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -125.86 145.87 50.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.26 1.03 . . . . 0.0 109.82 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.9 46.98 3.72 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.134 0.873 . . . . 0.0 113.353 -174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -148.54 163.95 35.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.402 1.481 . . . . 0.0 107.62 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.9 p -126.19 163.55 22.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.61 158.86 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.018 1.327 . . . . 0.0 108.281 -168.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -129.24 145.03 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.033 1.733 . . . . 0.0 107.926 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.63 22.63 Favored Glycine 0 CA--C 1.518 0.237 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.91 -71.06 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 CA-C-N 117.945 0.872 . . . . 0.0 113.423 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.23 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.276 1.03 . . . . 0.0 109.495 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -113.48 165.7 12.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.17 1.788 . . . . 0.0 110.919 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -79.32 66.79 8.75 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.651 2.901 . . . . 0.0 112.16 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -140.18 -2.09 1.49 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.754 0.822 . . . . 0.0 110.221 146.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -99.35 137.27 38.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.481 -1.387 . . . . 0.0 110.215 -152.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.22 123.71 17.58 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.757 0.823 . . . . 0.0 111.481 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.32 128.8 34.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -134.06 152.66 51.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.346 0.976 . . . . 0.0 110.637 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.34 113.14 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -68.55 -58.18 4.68 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 65' ' ' THR . 69.0 m -154.5 158.81 40.44 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.959 1.304 . . . . 0.0 109.519 163.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.7 138.2 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.1 1.76 . . . . 0.0 107.256 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 141.12 67.93 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.25 28.2 0.4 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.731 3.621 . . . . 0.0 115.693 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.85 -10.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.204 2.202 . . . . 0.0 111.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.52 158.79 46.02 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.49 -21.69 70.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.384 1.389 . . . . 0.0 110.486 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.39 46.34 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.353 1.461 . . . . 0.0 111.501 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.08 71.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.272 1.029 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -72.78 -22.7 60.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.838 -170.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.37 -12.12 60.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.834 1.197 . . . . 0.0 111.351 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.64 25.83 74.28 Favored Glycine 0 CA--C 1.525 0.664 0 O-C-N 121.053 -1.03 . . . . 0.0 113.293 167.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -128.54 -32.64 2.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.293 1.047 . . . . 0.0 113.525 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.8 ttm -95.01 134.66 37.44 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.21 167.67 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.627 1.203 . . . . 0.0 110.675 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 50' ' ' SER . 23.5 m -86.76 117.73 25.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.587 1.555 . . . . 0.0 108.604 -168.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.98 32.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.491 1.043 . . . . 0.0 112.411 -171.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -65.89 146.56 54.59 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.271 1.535 . . . . 0.0 108.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.39 115.69 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.346 1.858 . . . . 0.0 108.817 -169.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.84 125.01 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 125.607 1.563 . . . . 0.0 107.847 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.0 -55.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.281 1.033 . . . . 0.0 110.3 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.67 149.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.49 126.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 t30 67.08 -81.43 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 109.258 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -152.16 20.02 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.784 1.233 . . . . 0.0 111.342 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.58 123.47 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.1 p -62.74 120.84 12.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 163.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.58 13.7 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.384 0.674 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.51 -10.9 8.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -166.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.36 9.57 4.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.928 1.252 . . . . 0.0 111.406 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -71.62 159.5 34.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.967 1.883 . . . . 0.0 111.147 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -83.2 154.61 24.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.17 0.588 . . . . 0.0 109.906 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -55.28 -41.63 72.53 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.416 170.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.38 41.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.505 1.957 . . . . 0.0 112.671 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.12 -47.49 11.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.195 0.521 . . . . 0.0 111.951 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.1 t -63.4 -28.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 120.272 -1.517 . . . . 0.0 112.022 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.8 -44.0 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.501 -1.375 . . . . 0.0 108.438 167.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.9 88.98 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.143 1.338 . . . . 0.0 109.3 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 85' ' ' VAL . 13.4 mt -66.63 -44.82 80.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.353 1.861 . . . . 0.0 109.805 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -69.89 -36.43 75.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.026 0.83 . . . . 0.0 110.26 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -70.3 -17.06 63.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.695 0.798 . . . . 0.0 110.946 174.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 t -96.22 39.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.193 1.797 . . . . 0.0 110.797 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.67 113.8 25.0 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.67 172.65 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.125 1.217 . . . . 0.0 110.075 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.2 mp -60.06 145.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.03 68.16 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.929 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -130.58 169.92 14.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.665 1.233 . . . . 0.0 108.704 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.08 161.39 31.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.845 1.258 . . . . 0.0 110.976 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.47 147.7 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.589 1.156 . . . . 0.0 108.221 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -83.41 156.9 22.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.34 110.67 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.11 122.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.92 167.31 10.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.953 0.783 . . . . 0.0 110.354 170.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.79 129.19 48.94 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.662 1.185 . . . . 0.0 108.139 165.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.595 ' HB2' HD21 ' A' ' 21' ' ' LEU . 5.3 ttm180 -79.84 155.59 27.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.709 1.604 . . . . 0.0 107.184 166.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.17 -19.82 4.83 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.934 169.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.14 156.42 39.01 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 118.726 1.263 . . . . 0.0 109.793 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.38 179.06 3.75 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.969 1.779 . . . . 0.0 110.196 165.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.66 154.33 94.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.819 161.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.08 -30.92 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.643 173.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -80.24 148.57 30.75 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.398 2.279 . . . . 0.0 110.014 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -132.15 115.92 15.36 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.68 -13.97 24.57 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.489 1.459 . . . . 0.0 111.844 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.79 -73.34 0.09 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.847 1.659 . . . . 0.0 110.407 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -120.48 79.73 29.5 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.01 -28.66 23.8 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 120.985 1.124 . . . . 0.0 111.61 -163.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.58 -28.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.989 1.316 . . . . 0.0 111.17 161.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 48.07 -153.62 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.25 1.82 . . . . 0.0 111.842 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.7 p 57.43 -178.49 0.06 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.78 2.832 . . . . 0.0 115.757 165.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.64 -125.37 2.5 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.516 -1.714 . . . . 0.0 112.084 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.54 -41.05 54.12 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.129 3.219 . . . . 0.0 114.736 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.7 p -147.53 168.34 22.2 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.439 0.696 . . . . 0.0 109.653 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -107.43 141.3 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 150.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.335 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -164.296 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -127.97 92.12 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.331 1.452 . . . . 0.0 107.326 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -73.38 171.49 13.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.878 1.271 . . . . 0.0 113.185 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.12 90.18 0.61 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.226 -2.349 . . . . 0.0 107.226 163.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.5 m -64.7 170.4 4.16 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.524 0.73 . . . . 0.0 112.173 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m -68.11 157.43 35.32 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.889 159.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.85 137.56 8.34 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 -169.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 45.94 83.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.499 2.32 . . . . 0.0 110.938 -171.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 10' ' ' THR 0.261 34.1 t80 58.76 -150.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.578 2.351 . . . . 0.0 110.383 177.732 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 28.4 m -118.53 -107.06 0.38 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 129.475 3.11 . . . . 0.0 108.295 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 131.42 -70.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 1 C-N-CA 134.433 5.093 . . . . 0.0 108.757 169.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.39 -0.35 52.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.001 0.819 . . . . 0.0 113.171 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 79.52 -11.71 1.16 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.839 2.856 . . . . 0.0 112.569 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 m -72.06 -19.28 61.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -166.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -79.29 -12.78 59.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.855 0.752 . . . . 0.0 112.414 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.15 142.74 52.49 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -125.26 122.85 38.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.51 -122.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -135.57 136.66 41.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -91.44 143.87 26.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.758 1.623 . . . . 0.0 110.522 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.48 166.78 31.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.959 1.703 . . . . 0.0 109.551 172.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -146.34 124.47 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.674 0.79 . . . . 0.0 110.696 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -124.46 157.23 35.71 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.946 0.794 . . . . 0.0 109.101 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.5 m -114.59 112.72 23.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.55 150.86 21.26 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -103.91 149.68 24.87 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -84.2 102.6 12.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.6 m -61.73 -56.93 14.43 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.086 0.555 . . . . 0.0 110.316 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.36 -82.07 0.1 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.315 0.646 . . . . 0.0 109.521 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.3 mtt -62.05 -49.68 75.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.814 0.846 . . . . 0.0 109.143 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 180.0 -162.06 28.23 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -83.03 149.43 26.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.09 30.17 2.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.354 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -135.38 165.5 25.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.457 1.628 . . . . 0.0 108.49 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -123.36 154.41 39.0 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.006 1.322 . . . . 0.0 107.829 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.51 156.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.077 0.951 . . . . 0.0 108.619 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.54 149.63 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.449 2.3 . . . . 0.0 106.452 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.84 152.34 23.04 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.23 -80.74 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 124.454 1.026 . . . . 0.0 112.725 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 178.49 -62.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.739 1.216 . . . . 0.0 110.431 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -82.26 166.49 36.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.438 1.095 . . . . 0.0 112.507 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.79 57.57 5.69 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 124.224 3.283 . . . . 0.0 111.344 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.45 -4.69 0.11 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.725 1.61 . . . . 0.0 113.354 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -95.28 165.86 12.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.133 0.968 . . . . 0.0 111.947 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -84.55 160.34 20.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 111.16 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.8 mt -124.68 138.23 54.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 126.399 1.88 . . . . 0.0 108.184 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.6 mt-30 -134.42 155.24 50.65 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.35 0.977 . . . . 0.0 111.044 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.02 109.81 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.46 -50.01 66.97 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.906 1.683 . . . . 0.0 109.982 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -148.31 158.48 44.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 107.147 170.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.9 t -102.44 128.65 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.903 -2.629 . . . . 0.0 103.903 158.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.02 118.95 71.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 173.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.31 135.27 45.76 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t0 73.67 0.29 3.59 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.114 1.766 . . . . 0.0 112.617 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.45 163.77 53.03 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.289 -1.507 . . . . 0.0 109.822 165.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.59 -4.91 9.15 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.045 2.497 . . . . 0.0 114.769 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.87 -49.16 6.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.235 0.925 . . . . 0.0 109.919 172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.31 90.04 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.984 0.514 . . . . 0.0 110.588 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.37 -25.24 68.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.086 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.34 -40.75 29.49 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.456 1.025 . . . . 0.0 109.943 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.38 52.93 14.76 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 125.036 1.303 . . . . 0.0 113.019 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -126.04 -58.9 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 170.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 161.45 27.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 119.19 0.905 . . . . 0.0 109.264 173.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -143.38 173.52 11.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 167.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -74.8 144.61 43.44 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.926 -167.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.92 81.79 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.434 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -64.89 142.86 58.29 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.897 1.849 . . . . 0.0 108.472 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 47' ' ' GLN . 76.2 t -97.9 120.87 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.376 1.87 . . . . 0.0 108.868 -169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.49 118.07 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.18 -54.11 7.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 109.996 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.47 144.88 48.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mt -122.99 111.37 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.3 t30 67.21 -53.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.48 3.112 . . . . 0.0 114.378 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -164.22 6.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.383 2.273 . . . . 0.0 111.247 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.63 121.34 63.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 125.449 1.499 . . . . 0.0 107.66 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.4 p -66.09 120.24 12.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 164.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.05 7.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.457 0.703 . . . . 0.0 111.89 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -9.11 43.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.448 3.099 . . . . 0.0 112.506 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.13 54.47 0.66 Allowed Glycine 0 C--N 1.334 0.463 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 158.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.08 157.83 22.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.99 0.895 . . . . 0.0 111.561 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -77.3 137.63 38.9 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.42 1.088 . . . . 0.0 108.991 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.41 -36.24 73.27 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.03 -1.462 . . . . 0.0 109.622 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.02 41.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.737 1.608 . . . . 0.0 112.694 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.12 -46.38 15.01 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.36 0.664 . . . . 0.0 111.149 176.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.9 t -61.54 -34.62 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 119.163 -2.211 . . . . 0.0 111.664 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.02 -44.48 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.617 1.167 . . . . 0.0 108.98 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -35.6 81.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 110.973 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 85' ' ' VAL . 44.1 mt -62.97 -49.07 76.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.48 -42.38 83.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.625 0.77 . . . . 0.0 111.6 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -62.92 -34.75 78.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.32 -0.862 . . . . 0.0 109.834 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.1 t -75.31 27.26 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.601 1.56 . . . . 0.0 112.418 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.2 t -114.33 106.2 53.02 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.67 164.99 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.423 2.748 . . . . 0.0 113.979 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.22 151.47 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 165.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.71 -0.89 60.12 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.566 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -94.12 165.41 12.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.354 1.577 . . . . 0.0 108.175 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -128.63 163.13 25.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.069 1.348 . . . . 0.0 109.357 165.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.82 148.32 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 125.46 1.504 . . . . 0.0 107.986 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.65 152.87 24.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.701 1.601 . . . . 0.0 109.222 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -144.71 115.52 7.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.7 t -89.54 122.85 41.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 170.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.15 161.65 15.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 124.152 0.907 . . . . 0.0 109.556 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.35 119.59 34.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -81.24 147.15 30.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 108.43 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.3 -18.52 7.34 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.625 161.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -70.44 139.13 86.59 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 119.694 1.747 . . . . 0.0 107.587 161.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.23 172.09 12.73 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.459 1.44 . . . . 0.0 110.543 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.68 158.22 61.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.668 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.25 -37.11 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.627 2.218 . . . . 0.0 112.015 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -119.9 132.44 55.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.22 1.808 . . . . 0.0 109.324 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -95.11 99.13 3.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 125.537 1.535 . . . . 0.0 108.548 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.44 -23.74 23.33 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 120.929 1.368 . . . . 0.0 111.94 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.71 -23.0 56.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.617 1.967 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.74 77.14 7.21 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.4 -18.94 5.64 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.748 2.299 . . . . 0.0 114.899 -171.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.29 -58.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.801 1.64 . . . . 0.0 111.742 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.6 p30 51.16 179.29 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.861 3.264 . . . . 0.0 115.273 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.3 t -131.54 169.82 15.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.379 2.271 . . . . 0.0 105.381 152.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.61 -79.82 0.49 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 166.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.12 151.97 44.91 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.055 1.837 . . . . 0.0 110.594 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 m -163.55 -177.83 5.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.328 3.051 . . . . 0.0 106.097 167.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 m -105.6 157.78 17.16 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.004 0.82 . . . . 0.0 109.483 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.789 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -61.25 166.7 3.6 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 118.063 0.931 . . . . 0.0 112.278 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -127.16 142.11 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.012 0.925 . . . . 0.0 110.444 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.23 149.34 16.84 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 p -129.29 176.53 7.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.599 1.559 . . . . 0.0 110.562 -165.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 t -133.66 -91.67 0.35 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.16 114.37 6.68 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.61 77.99 1.6 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.5 157.04 17.99 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.845 0.858 . . . . 0.0 109.867 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -78.2 -121.67 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.657 1.583 . . . . 0.0 111.355 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 160.97 -74.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 130.925 3.69 . . . . 0.0 109.108 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -118.73 22.92 11.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.687 1.232 . . . . 0.0 110.971 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 70.24 -23.87 0.16 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 128.17 2.588 . . . . 0.0 113.881 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -65.04 -13.21 57.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.631 1.172 . . . . 0.0 112.86 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -67.26 -22.19 65.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.443 1.097 . . . . 0.0 112.444 166.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.05 148.64 30.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.996 1.271 . . . . 0.0 109.048 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -112.81 -0.31 14.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.56 32.72 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.066 1.317 . . . . 0.0 112.578 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 157.89 33.72 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 124.871 1.268 . . . . 0.0 109.535 -169.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.39 129.04 49.09 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.652 0.781 . . . . 0.0 109.375 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.72 168.4 17.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.917 2.087 . . . . 0.0 108.415 -178.562 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.9 p -142.99 175.84 9.54 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.438 0.637 . . . . 0.0 111.199 160.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.406 HG21 ' HE2' ' A' ' 63' ' ' MET . 8.5 t -155.19 157.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.2 m -127.12 105.35 8.52 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.29 136.37 37.86 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -87.48 123.41 32.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.07 125.07 12.81 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.598 1.559 . . . . 0.0 108.236 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -173.74 3.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.78 -54.55 45.01 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.717 -1.239 . . . . 0.0 111.087 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.5 mtp -78.25 13.93 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.922 1.289 . . . . 0.0 113.545 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.16 -147.16 18.48 Favored Glycine 0 C--N 1.331 0.306 0 O-C-N 120.136 -1.602 . . . . 0.0 110.48 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -88.84 146.89 24.69 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 56' ' ' PRO . . . -86.8 42.28 3.15 Favored Glycine 0 C--O 1.222 -0.605 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.705 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -148.43 166.96 26.56 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 119.3 1.55 . . . . 0.0 109.321 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 p -127.28 158.81 36.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.215 1.806 . . . . 0.0 107.935 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.85 162.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.586 1.954 . . . . 0.0 107.283 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.6 tt -138.68 159.98 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.787 1.635 . . . . 0.0 108.26 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.23 154.08 23.8 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 128.802 3.096 . . . . 0.0 110.384 -174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.36 -82.99 0.21 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.482 1.039 . . . . 0.0 111.898 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -177.16 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.77 2.028 . . . . 0.0 111.243 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -125.73 153.11 73.12 Favored Pre-proline 0 C--N 1.342 0.27 0 O-C-N 120.154 -1.591 . . . . 0.0 111.652 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.42 51.35 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.31 1 C-N-CA 125.388 4.058 . . . . 0.0 113.949 168.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -158.43 13.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.096 -1.628 . . . . 0.0 109.516 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -74.89 160.47 30.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 127.411 2.285 . . . . 0.0 110.774 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -93.39 112.61 24.56 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.37 112.75 18.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.68 155.0 30.69 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.23 116.34 2.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -65.53 -54.38 28.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.768 1.227 . . . . 0.0 109.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 65' ' ' THR . 13.8 m -155.53 161.42 40.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.993 1.317 . . . . 0.0 108.049 171.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.48 140.59 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 161.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.97 132.11 54.91 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.0 160.51 48.28 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.864 2.376 . . . . 0.0 110.845 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.09 -18.31 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.434 2.294 . . . . 0.0 114.26 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.95 173.67 41.59 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.592 1.568 . . . . 0.0 114.181 -171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 33' ' ' GLY . 58.0 Cg_endo -66.52 -32.07 40.34 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.939 3.093 . . . . 0.0 111.41 -171.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.742 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.91 -46.33 65.64 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.888 0.875 . . . . 0.0 109.732 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.47 -42.66 99.64 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.268 0.94 . . . . 0.0 112.249 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.79 -6.06 29.67 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.894 0.77 . . . . 0.0 111.371 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.27 29.93 63.68 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.691 1.139 . . . . 0.0 113.465 165.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -136.17 -0.79 2.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.768 1.227 . . . . 0.0 111.982 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.406 ' HE2' HG21 ' A' ' 23' ' ' THR . 25.9 tpp -111.29 137.16 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.482 1.513 . . . . 0.0 107.069 169.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.75 167.71 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 108.941 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 50' ' ' SER . 43.3 m -77.18 159.68 29.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.495 1.118 . . . . 0.0 109.437 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.95 39.87 96.79 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -132.26 152.88 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.595 1.158 . . . . 0.0 108.074 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.5 117.6 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.688 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.1 mp -66.8 138.63 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 10.2 t -122.33 -54.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.37 149.83 51.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.435 1.094 . . . . 0.0 108.699 -175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.58 126.9 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 44.86 -93.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.1 2.16 . . . . 0.0 110.795 -159.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.25 -7.36 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.195 1.398 . . . . 0.0 111.483 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.37 139.82 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -173.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.44 130.3 36.86 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.132 -0.98 . . . . 0.0 109.003 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.94 10.61 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 111.445 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.0 -42.68 60.51 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.686 -1.259 . . . . 0.0 113.284 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.08 36.22 4.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 127.176 2.322 . . . . 0.0 109.905 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.83 -158.86 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.806 0.803 . . . . 0.0 109.683 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.7 t -119.93 143.98 47.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.641 1.11 . . . . 0.0 109.031 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -53.78 -42.41 68.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.532 2.333 . . . . 0.0 110.589 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.96 -29.23 68.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.831 0.741 . . . . 0.0 111.983 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -82.58 -54.85 4.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.373 1.069 . . . . 0.0 109.271 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.97 -44.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 130.053 3.341 . . . . 0.0 112.382 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.46 -32.8 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 120.459 -1.4 . . . . 0.0 109.652 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -34.69 71.99 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.65 1.114 . . . . 0.0 109.435 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.5 -42.96 95.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.985 1.314 . . . . 0.0 109.823 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -62.46 -19.15 63.23 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.291 1.036 . . . . 0.0 112.778 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -91.98 -11.37 36.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.819 1.248 . . . . 0.0 113.109 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 m -75.0 12.8 0.78 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.775 -1.203 . . . . 0.0 112.996 161.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.09 93.22 14.73 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.63 140.77 13.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.911 3.074 . . . . 0.0 109.57 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.1 mp -52.01 125.43 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 118.987 0.812 . . . . 0.0 109.232 -164.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.3 -16.44 11.71 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.46 1.981 . . . . 0.0 113.417 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -94.83 173.65 7.49 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.778 1.789 . . . . 0.0 109.756 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -127.94 167.02 17.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.042 2.537 . . . . 0.0 108.193 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.32 148.85 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.468 1.107 . . . . 0.0 108.596 161.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.4 152.44 25.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 167.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 mt -146.47 119.74 8.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.85 129.22 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 67' ' ' ASP . 10.3 mt -112.05 156.7 21.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.361 1.038 . . . . 0.0 109.4 166.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.06 128.29 55.57 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -84.62 156.35 21.6 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.138 0.975 . . . . 0.0 109.582 171.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.03 6.3 14.07 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 123.835 0.731 . . . . 0.0 114.391 163.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.46 133.9 23.8 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.53 -178.42 1.51 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.143 2.562 . . . . 0.0 111.15 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.42 158.02 83.64 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.578 0.751 . . . . 0.0 111.086 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.31 -26.9 7.0 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.849 2.366 . . . . 0.0 112.662 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -119.57 142.79 48.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.594 1.957 . . . . 0.0 108.091 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -130.91 92.9 32.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 124.427 1.091 . . . . 0.0 108.968 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.57 -5.42 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.339 2.693 . . . . 0.0 113.306 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -72.96 -37.07 67.22 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.354 -1.466 . . . . 0.0 109.709 171.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.5 78.01 76.43 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 125.661 1.584 . . . . 0.0 108.719 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.44 -63.62 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.023 3.149 . . . . 0.0 112.098 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.28 60.02 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.662 1.585 . . . . 0.0 106.943 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 81.2 136.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.319 2.648 . . . . 0.0 108.34 -164.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.35 74.85 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.641 1.576 . . . . 0.0 108.408 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -116.72 63.32 0.37 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.099 -1.389 . . . . 0.0 113.493 -173.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.08 158.39 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 120.55 2.175 . . . . 0.0 109.286 165.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.1 m -136.53 172.39 13.08 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.1 m -140.45 147.47 39.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.285 1.434 . . . . 0.0 109.08 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.65 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 119.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 t80 . . . . . 0 CA--C 1.548 0.895 0 CA-C-O 121.803 0.811 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -88.36 -121.35 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.144 -1.597 . . . . 0.0 109.019 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 150.19 -83.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 1 C-N-CA 132.701 4.4 . . . . 0.0 107.022 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.65 18.34 2.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.03 -17.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.106 2.962 . . . . 0.0 114.545 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -26.3 67.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.139 0.976 . . . . 0.0 111.262 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -82.18 -4.18 56.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.916 -1.04 . . . . 0.0 112.311 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.97 161.75 23.53 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.943 1.247 . . . . 0.0 108.66 169.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -124.23 116.22 22.33 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.81 39.46 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 124.42 1.075 . . . . 0.0 110.742 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -87.8 166.6 14.48 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' C ' HD13 ' A' ' 21' ' ' LEU . 12.2 m-85 -126.43 136.01 52.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.178 1.391 . . . . 0.0 107.283 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -153.24 164.4 38.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.545 1.138 . . . . 0.0 109.687 -174.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.4 m -144.58 163.42 33.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.824 0.821 . . . . 0.0 112.453 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 157.22 43.31 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.884 1.274 . . . . 0.0 107.89 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -114.46 114.14 25.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' ALA . 5.9 mt -98.52 132.91 43.57 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -85.46 132.55 34.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 163.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 51.3 tttt -73.31 93.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.695 1.998 . . . . 0.0 108.514 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -95.02 115.01 26.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.786 0.834 . . . . 0.0 109.173 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.56 -158.94 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.85 1.66 . . . . 0.0 108.888 -167.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 33.8 mtt 23.19 -76.32 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.147 2.979 . . . . 0.0 116.458 162.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 169.66 168.24 31.31 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -163.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -65.2 152.15 44.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.282 0.541 . . . . 0.0 110.12 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.25 44.05 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.915 -0.936 . . . . 0.0 112.259 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.67 164.72 37.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.499 1.65 . . . . 0.0 107.94 169.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 p -131.26 159.94 36.36 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.74 162.04 17.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.452 1.101 . . . . 0.0 108.847 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.72 146.57 32.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 128.575 2.75 . . . . 0.0 106.374 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.43 151.55 22.73 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 167.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -11.84 4.33 Favored Glycine 0 C--O 1.225 -0.419 0 C-N-CA 127.283 2.373 . . . . 0.0 117.893 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t0 95.59 -42.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 130.434 3.494 . . . . 0.0 108.037 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.79 157.81 89.39 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.674 2.389 . . . . 0.0 111.771 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -89.65 29.95 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.555 3.503 . . . . 0.0 112.692 -170.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -175.56 76.35 0.02 OUTLIER 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -140.44 143.46 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.873 2.469 . . . . 0.0 105.955 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -76.47 128.83 35.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.28 146.91 30.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.52 151.28 50.19 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 122.942 0.497 . . . . 0.0 110.835 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.17 112.1 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -70.57 -42.72 70.73 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 110.377 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 p -151.87 157.44 41.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.076 0.951 . . . . 0.0 109.57 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -92.72 141.7 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 159.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.03 122.07 86.22 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.44 146.23 97.31 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.442 1.428 . . . . 0.0 108.778 169.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 67.76 -2.59 1.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.536 1.534 . . . . 0.0 113.25 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.5 163.68 39.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.524 1.059 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.75 -27.76 75.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.113 2.542 . . . . 0.0 112.996 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.018 0.527 . . . . 0.0 110.081 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.2 87.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.686 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.47 -19.12 62.98 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.54 -4.91 59.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.162 1.346 . . . . 0.0 111.429 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.92 -24.27 1.98 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.17 2.319 . . . . 0.0 113.252 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.07 -35.33 18.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -157.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tpp -69.79 128.69 37.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.9 166.54 19.81 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -90.85 142.01 28.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 -16.6 58.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.691 -1.06 . . . . 0.0 112.361 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.482 ' HB3' HD13 ' A' ' 102' ' ' LEU . 84.3 m-20 -55.39 139.84 41.83 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.523 1.129 . . . . 0.0 109.837 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.49 123.25 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.409 1.084 . . . . 0.0 108.835 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.08 119.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.555 1.542 . . . . 0.0 108.285 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.91 -57.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.938 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -134.3 152.94 52.09 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mt -130.25 128.36 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 t30 59.63 -73.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.145 2.978 . . . . 0.0 111.994 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -157.51 40.51 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.68 0.792 . . . . 0.0 110.85 165.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.38 132.52 70.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.615 1.966 . . . . 0.0 108.736 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.2 p -72.53 111.73 7.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.703 1.601 . . . . 0.0 111.779 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.49 5.6 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.847 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -18.44 62.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.383 1.901 . . . . 0.0 114.214 -167.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.31 4.69 19.88 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.583 -1.121 . . . . 0.0 112.934 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.48 162.97 22.04 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.707 1.753 . . . . 0.0 109.965 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.0 p -70.67 142.71 51.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -60.04 -22.67 62.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.372 -0.83 . . . . 0.0 110.391 166.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.11 -54.58 45.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.7 -1.25 . . . . 0.0 111.883 167.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.34 -49.86 67.78 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 124.882 1.273 . . . . 0.0 109.792 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 t -61.01 -41.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 120.037 -1.664 . . . . 0.0 112.182 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.4 -37.03 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 120.661 -1.274 . . . . 0.0 109.66 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -35.45 81.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.48 1.036 . . . . 0.0 110.003 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.12 -45.16 86.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.355 1.062 . . . . 0.0 108.258 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -64.29 -41.42 96.88 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.996 0.816 . . . . 0.0 111.322 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.98 -25.43 64.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.438 0.563 . . . . 0.0 112.24 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -66.35 -18.17 65.2 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.025 0.829 . . . . 0.0 111.994 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.36 115.85 62.3 Favored Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.69 170.06 20.59 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 120.716 1.291 . . . . 0.0 110.783 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.61 139.72 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.629 1.172 . . . . 0.0 108.029 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.29 -0.99 88.76 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 117.504 -1.72 . . . . 0.0 113.657 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -100.04 172.58 7.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.038 1.919 . . . . 0.0 108.482 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 p -131.87 159.62 38.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.642 0.777 . . . . 0.0 110.052 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.29 155.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.839 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.84 159.21 21.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 mt -146.06 141.61 27.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -121.75 118.12 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 67' ' ' ASP . 8.8 mt -109.26 168.74 9.16 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.907 0.755 . . . . 0.0 109.871 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.9 t -121.75 143.67 49.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.909 1.284 . . . . 0.0 107.67 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 13.4 ttm180 -127.25 130.33 49.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.729 1.211 . . . . 0.0 111.68 -163.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 128.05 -21.85 5.47 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.16 139.01 87.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 123.965 0.906 . . . . 0.0 109.176 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.37 178.45 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.402 2.068 . . . . 0.0 110.735 167.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 157.98 20.75 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.306 160.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.438 -1.742 0 N-CA-C 108.307 -1.459 . . . . 0.0 108.307 165.862 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.236 0.352 0 CA-C-O 121.572 0.701 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -78.77 -112.35 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.555 1.542 . . . . 0.0 111.715 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 147.13 -57.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 131.509 3.924 . . . . 0.0 111.798 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.6 t70 -142.76 20.78 1.99 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.797 0.439 . . . . 0.0 111.387 -166.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 61.49 -17.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.47 2.308 . . . . 0.0 114.132 -164.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -60.3 -23.42 64.17 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.942 2.497 . . . . 0.0 112.43 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -80.83 -16.12 54.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.419 1.087 . . . . 0.0 112.474 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.02 154.28 33.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.397 0.999 . . . . 0.0 109.13 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -130.01 99.57 5.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.83 176.11 39.89 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.359 1.933 . . . . 0.0 110.079 -166.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -98.64 133.79 42.48 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 117.798 0.799 . . . . 0.0 109.177 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.603 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 16.6 m-85 -101.12 142.65 32.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.387 1.075 . . . . 0.0 110.052 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.77 166.64 32.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.097 1.759 . . . . 0.0 109.372 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -147.1 156.54 43.08 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.849 1.26 . . . . 0.0 111.039 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -139.43 157.12 46.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.656 1.582 . . . . 0.0 107.862 168.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.09 111.63 24.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.067 1.347 . . . . 0.0 107.554 170.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.64 135.21 40.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.792 1.178 . . . . 0.0 108.391 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -83.67 151.56 25.22 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.416 0.627 . . . . 0.0 110.073 167.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -79.27 69.42 5.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.941 1.297 . . . . 0.0 109.378 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.29 170.25 9.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.464 1.105 . . . . 0.0 108.646 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 49.62 -92.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.993 2.117 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.2 ptm -118.9 4.3 11.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.33 1.452 . . . . 0.0 111.657 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.78 -176.76 35.16 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -151.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -64.99 149.15 50.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.034 -1.083 . . . . 0.0 110.983 -161.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.98 40.12 3.09 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.53 -176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -146.24 166.22 26.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.167 1.483 . . . . 0.0 109.108 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 p -128.87 159.46 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.277 1.431 . . . . 0.0 108.371 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.45 162.38 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.839 1.256 . . . . 0.0 109.423 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.76 155.08 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.735 2.014 . . . . 0.0 108.034 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.01 155.05 21.38 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 129.606 3.479 . . . . 0.0 111.049 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.1 -93.39 0.02 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 117.294 -2.384 . . . . 0.0 108.292 142.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.33 -65.43 0.08 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.09 166.9 28.95 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.934 1.694 . . . . 0.0 110.819 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.38 45.22 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.041 3.16 . . . . 0.0 111.872 -164.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -157.21 34.47 0.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.316 1.447 . . . . 0.0 109.181 -168.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -139.43 173.62 11.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.953 1.301 . . . . 0.0 113.13 -167.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -88.71 112.89 23.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 125.381 1.472 . . . . 0.0 110.493 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -81.9 134.67 35.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG2' HG22 ' A' ' 68' ' ' VAL . 27.9 mt-30 -128.22 156.96 42.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.63 0.65 . . . . 0.0 111.06 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.96 104.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 166.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -54.82 -50.03 69.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.505 1.522 . . . . 0.0 109.145 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 152.4 18.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 109.206 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.5 t -104.04 130.18 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.74 130.28 68.02 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.83 46.09 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.808 3.005 . . . . 0.0 113.36 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -160.54 43.65 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.317 1.847 . . . . 0.0 109.905 164.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.67 166.6 22.96 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 120.718 -1.239 . . . . 0.0 112.443 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.63 -22.07 64.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.563 2.175 . . . . 0.0 112.397 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.8 2.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.962 0.905 . . . . 0.0 109.838 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.06 70.28 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.014 0.926 . . . . 0.0 111.004 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.0 -20.14 65.83 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.892 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -99.33 -30.41 12.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.483 1.492 . . . . 0.0 112.05 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.88 6.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.329 1.442 . . . . 0.0 114.431 166.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -69.87 -15.87 63.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.514 1.157 . . . . 0.0 111.144 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.94 133.67 43.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.08 176.62 8.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 162.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.3 m -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.56 56.48 25.05 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.599 ' HB3' HD13 ' A' ' 102' ' ' LEU . 3.0 m-20 -128.92 151.49 49.6 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.983 2.113 . . . . 0.0 105.652 175.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' A' ' 47' ' ' GLN . 44.1 t -101.26 127.16 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 121.401 1.91 . . . . 0.0 109.706 -171.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.88 130.2 36.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.551 1.14 . . . . 0.0 108.589 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 17.4 t -106.4 -61.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.518 1.527 . . . . 0.0 109.211 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -128.83 157.76 40.61 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.397 1.079 . . . . 0.0 109.223 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mt -128.79 117.11 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 47.77 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 128.564 2.746 . . . . 0.0 112.075 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.45 13.7 1.78 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.514 1.526 . . . . 0.0 111.111 -170.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.22 120.9 55.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.47 104.8 2.41 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -101.52 3.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 123.28 0.632 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 78' ' ' LEU . 1.6 pp -58.45 -17.48 21.14 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.81 35.61 2.29 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 126.14 1.828 . . . . 0.0 109.016 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -103.16 165.66 10.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.306 1.053 . . . . 0.0 108.548 161.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.02 161.64 16.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.972 0.909 . . . . 0.0 109.546 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.93 -14.58 23.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.5 1.52 . . . . 0.0 111.934 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.13 -67.56 0.43 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.476 1.489 . . . . 0.0 109.478 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -56.01 -45.4 79.09 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.439 0.696 . . . . 0.0 111.075 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.11 -41.59 93.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 120.292 -1.505 . . . . 0.0 111.447 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.9 -37.34 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.87 -1.144 . . . . 0.0 109.731 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -39.07 93.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.426 1.466 . . . . 0.0 109.939 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.28 -51.1 71.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.667 1.587 . . . . 0.0 108.164 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.38 -42.33 88.08 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.019 0.827 . . . . 0.0 112.483 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.41 -30.88 69.89 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.423 -0.798 . . . . 0.0 111.008 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -70.02 -2.55 13.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.5 114.63 56.25 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.81 179.07 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.072 2.515 . . . . 0.0 110.931 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.35 152.06 7.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 109.137 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.08 -25.78 6.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 124.286 0.946 . . . . 0.0 111.956 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -84.33 142.25 30.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.42 1.11 . . . . 0.0 109.289 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.63 150.48 28.93 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.694 1.598 . . . . 0.0 108.234 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -141.31 141.21 31.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -84.18 155.97 22.3 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.0 mt -142.62 150.08 39.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.42 126.47 58.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 67' ' ' ASP . 14.5 mt -119.65 169.5 10.04 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 124.356 1.035 . . . . 0.0 110.265 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.9 t -133.48 117.5 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.836 0.855 . . . . 0.0 111.213 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -85.53 139.41 31.49 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.115 -0.99 . . . . 0.0 110.339 -165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.98 -4.8 16.25 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.073 -0.848 . . . . 0.0 113.582 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.67 117.97 68.88 Favored Pre-proline 0 CA--C 1.526 0.057 0 CA-C-N 119.372 1.586 . . . . 0.0 107.53 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.16 177.23 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.709 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -54.48 149.09 22.07 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.613 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.444 -1.389 0 C-N-CA 122.668 2.245 . . . . 0.0 107.33 167.446 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 10' ' ' THR . 27.8 t80 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 122.655 1.217 . . . . 0.0 114.261 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 m -82.32 -99.36 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.377 1.471 . . . . 0.0 112.102 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 117.83 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 1 C-N-CA 136.151 5.781 . . . . 0.0 114.167 172.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -125.52 13.63 8.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.507 1.048 . . . . 0.0 111.721 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.3 -20.3 0.07 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.851 2.86 . . . . 0.0 115.399 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -64.27 -22.13 66.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.312 0.96 . . . . 0.0 112.32 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -97.83 20.64 11.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.724 1.21 . . . . 0.0 112.073 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.88 -159.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 162.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -64.04 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.055 1.342 . . . . 0.0 111.661 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.55 -13.69 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.168 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 159.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -86.18 127.38 34.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -127.95 123.4 34.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.773 1.629 . . . . 0.0 108.165 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 154.83 41.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.994 1.718 . . . . 0.0 107.977 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -145.6 152.79 40.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.584 0.354 . . . . 0.0 110.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.52 157.94 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 108.118 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.7 m -127.15 119.34 26.25 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.354 1.462 . . . . 0.0 107.935 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.98 150.39 21.42 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -83.12 158.24 22.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 24.0 tptt -77.1 98.32 5.0 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.5 m -126.1 151.86 46.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.686 0.675 . . . . 0.0 111.793 -159.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 60.4 -79.87 0.02 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.251 2.62 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -149.43 71.62 1.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.421 2.289 . . . . 0.0 107.432 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 73.79 176.14 33.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.82 123.69 21.65 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.458 -1.025 . . . . 0.0 109.357 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.22 51.52 2.1 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.744 1.164 . . . . 0.0 112.775 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.57 165.93 27.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.394 1.877 . . . . 0.0 106.321 160.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -131.8 166.44 21.55 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.462 -0.773 . . . . 0.0 109.279 166.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.29 161.32 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.837 1.655 . . . . 0.0 107.422 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -133.05 150.25 32.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.786 2.035 . . . . 0.0 106.702 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.22 151.8 22.43 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.391 1.948 . . . . 0.0 108.702 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.03 -55.85 9.99 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.357 -0.691 . . . . 0.0 112.611 -158.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.79 -41.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.505 1.922 . . . . 0.0 107.859 166.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.59 164.97 14.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.223 1.409 . . . . 0.0 111.707 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.1 19.19 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.106 3.871 . . . . 0.0 116.218 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.58 5.61 0.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.22 1.008 . . . . 0.0 113.252 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.28 155.33 40.31 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 0.969 . . . . 0.0 108.413 163.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.96 168.41 18.06 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.806 0.812 . . . . 0.0 110.509 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.65 133.85 54.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.714 1.606 . . . . 0.0 107.254 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -128.49 151.82 48.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.11 121.96 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -76.74 -41.92 43.16 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 125.959 1.704 . . . . 0.0 110.501 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.2 p -156.99 161.93 39.58 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.304 1.041 . . . . 0.0 110.432 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.43 120.42 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 126.542 1.937 . . . . 0.0 105.811 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mm -75.49 131.38 77.55 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.22 152.04 82.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.668 2.245 . . . . 0.0 109.648 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 t70 53.92 23.17 3.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.908 0.861 . . . . 0.0 111.924 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.29 163.73 13.15 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.527 1.537 . . . . 0.0 109.712 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.4 -32.54 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.761 2.307 . . . . 0.0 111.865 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.44 -40.88 80.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.119 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.04 81.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.263 0.625 . . . . 0.0 110.596 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.13 -46.72 89.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.298 0.499 . . . . 0.0 110.216 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.32 -31.31 71.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.036 0.534 . . . . 0.0 111.223 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.97 -18.69 29.93 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.474 1.511 . . . . 0.0 113.49 160.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.111 0.955 . . . . 0.0 110.675 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.5 tpp -65.43 123.71 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.01 163.69 29.72 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.239 1.016 . . . . 0.0 108.363 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -88.21 142.56 27.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -167.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.41 -12.96 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.849 -1.528 . . . . 0.0 112.512 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.467 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.7 m-20 -68.91 148.89 49.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.677 2.238 . . . . 0.0 108.098 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.3 125.75 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.115 1.366 . . . . 0.0 109.268 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.11 110.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 125.406 1.482 . . . . 0.0 107.422 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.02 -58.82 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.585 0.707 . . . . 0.0 109.664 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.07 155.22 50.43 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.916 1.286 . . . . 0.0 107.851 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -127.08 113.7 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 169.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 t30 69.88 -61.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 129.484 3.114 . . . . 0.0 112.27 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -157.71 5.7 0.13 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.756 1.622 . . . . 0.0 111.682 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.55 131.32 53.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 120.313 -1.492 . . . . 0.0 107.376 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.9 t -78.27 116.55 18.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.74 5.3 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 122.961 0.504 . . . . 0.0 111.576 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -31.59 35.44 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.364 1.866 . . . . 0.0 113.138 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.22 61.1 0.64 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -111.82 162.94 14.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.329 1.052 . . . . 0.0 109.834 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.27 151.61 41.3 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -55.47 -29.81 59.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.088 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.96 71.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.307 1.412 . . . . 0.0 112.268 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -76.57 -57.21 3.99 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -52.72 -41.62 39.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.484 2.713 . . . . 0.0 112.909 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.62 -28.37 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 120.553 -1.342 . . . . 0.0 110.361 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -35.74 73.14 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.439 1.472 . . . . 0.0 108.154 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.69 -36.39 67.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.214 1.005 . . . . 0.0 110.317 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -73.0 -29.6 63.16 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.721 -1.237 . . . . 0.0 111.684 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.81 -19.3 55.21 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.378 0.671 . . . . 0.0 112.237 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.6 m -71.24 -7.5 47.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 113.382 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.01 102.85 19.14 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.306 1.043 . . . . 0.0 108.259 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.7 170.43 16.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 mt -66.95 142.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 107.774 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.82 -2.57 87.3 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.103 -0.832 . . . . 0.0 113.049 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -101.53 171.63 7.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.716 1.258 . . . . 0.0 108.976 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -143.91 155.43 44.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.137 2.175 . . . . 0.0 108.211 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.81 148.24 24.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -82.82 153.38 25.21 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.2 mt -138.17 147.36 43.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 t -127.68 116.45 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.2 mt -109.96 164.12 12.91 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -117.65 138.15 52.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 164.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.06 156.14 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.354 1.862 . . . . 0.0 110.095 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.05 -16.18 20.57 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 118.663 -1.076 . . . . 0.0 114.03 157.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -83.53 140.04 41.35 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 118.884 1.342 . . . . 0.0 108.784 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.97 176.87 9.47 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.63 2.887 . . . . 0.0 110.074 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 mt -67.58 145.3 98.19 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 N--CA 1.459 -0.503 0 C-N-CA 121.931 1.754 . . . . 0.0 111.053 -178.513 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 m -88.4 -120.39 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.912 1.285 . . . . 0.0 108.759 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 146.77 -47.64 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.582 1 C-N-CA 133.127 4.571 . . . . 0.0 106.62 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -123.92 124.75 43.3 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -170.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.31 -9.25 3.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.363 1.465 . . . . 0.0 113.422 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -69.99 -21.29 63.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.223 1.009 . . . . 0.0 111.657 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.05 -22.86 63.03 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.11 -0.994 . . . . 0.0 111.092 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.52 152.43 40.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.314 0.578 . . . . 0.0 110.575 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -129.67 111.06 12.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.914 2.086 . . . . 0.0 105.597 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.07 -144.85 5.13 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.8 m -136.61 152.39 50.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 151.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.63 142.83 33.64 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.286 1.434 . . . . 0.0 108.824 -172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 104' ' ' ARG . 2.0 mp -141.21 165.52 27.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.789 0.836 . . . . 0.0 109.168 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 m -152.47 154.69 36.02 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.131 0.491 . . . . 0.0 111.865 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -154.2 158.42 40.29 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.33 1.852 . . . . 0.0 107.621 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -121.58 111.97 17.89 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.421 1.488 . . . . 0.0 107.182 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -101.83 131.88 47.91 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.808 -0.557 . . . . 0.0 109.738 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -83.51 132.97 34.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.633 1.573 . . . . 0.0 109.466 172.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 33.1 tptt -62.38 107.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 107.86 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.4 t -133.69 -127.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.48 1.512 . . . . 0.0 108.021 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -55.25 102.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.314 1.446 . . . . 0.0 110.542 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 36.2 mtm 45.31 67.88 0.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.134 1.374 . . . . 0.0 110.622 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 70.15 -126.9 17.18 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.63 141.79 35.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 40.27 1.83 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.666 -0.519 . . . . 0.0 112.579 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -142.71 162.58 35.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.468 1.634 . . . . 0.0 109.11 163.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -123.91 152.23 42.66 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.246 1.818 . . . . 0.0 107.632 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.64 161.99 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.16 0.984 . . . . 0.0 108.478 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -135.71 158.84 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.698 2.399 . . . . 0.0 106.126 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.7 152.53 22.15 Favored Glycine 0 C--O 1.237 0.282 0 C-N-CA 126.025 1.774 . . . . 0.0 108.68 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.06 -77.18 0.14 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.754 0.692 . . . . 0.0 112.612 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -170.21 -50.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.658 0.729 . . . . 0.0 110.302 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -101.07 166.1 13.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.558 1.543 . . . . 0.0 111.169 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.25 43.81 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.778 3.652 . . . . 0.0 110.772 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.0 23.15 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.735 2.014 . . . . 0.0 110.79 -173.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.26 167.84 10.22 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.983 0.913 . . . . 0.0 109.107 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.46 160.99 27.41 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 110.967 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -124.75 132.07 53.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 127.009 2.124 . . . . 0.0 106.552 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.9 mt-30 -130.39 155.97 45.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.42 112.34 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 165.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -59.9 -49.62 76.96 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 108.686 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 65' ' ' THR . 3.9 m -157.58 146.39 19.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.767 1.227 . . . . 0.0 108.474 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.51 143.24 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 159.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -71.54 135.9 83.73 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.72 137.66 25.18 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.365 1.377 . . . . 0.0 109.523 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 51.61 67.62 0.93 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.431 1.092 . . . . 0.0 111.327 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.37 175.01 25.17 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.414 -0.804 . . . . 0.0 111.844 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.99 -35.55 92.79 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 112.221 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' A' ' 63' ' ' MET . . . -67.3 -36.57 81.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.892 1.277 . . . . 0.0 111.714 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.88 67.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.36 0.664 . . . . 0.0 109.897 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.02 -45.88 86.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.638 1.175 . . . . 0.0 111.472 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -68.44 -24.46 64.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.022 0.529 . . . . 0.0 110.862 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.82 15.19 64.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.678 1.132 . . . . 0.0 113.815 169.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.01 -73.7 0.42 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.405 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -79.94 159.3 26.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -138.37 160.16 40.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.243 1.497 . . . . 0.0 111.518 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 50' ' ' SER . 55.0 m -60.0 133.78 56.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.606 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.31 -14.67 64.04 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.282 1.42 . . . . 0.0 113.765 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.21 150.87 41.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.379 1.59 . . . . 0.0 109.531 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG22 ' HG2' ' A' ' 47' ' ' GLN . 38.2 t -96.22 127.54 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.366 1.466 . . . . 0.0 108.959 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.46 117.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.289 . . . . 0.0 107.641 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.88 -60.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.569 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -132.0 148.86 52.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -130.71 130.8 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 53.02 -85.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.754 2.422 . . . . 0.0 112.449 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.61 9.99 2.9 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.768 1.167 . . . . 0.0 112.712 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.26 132.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.321 1.448 . . . . 0.0 109.118 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.68 98.44 1.92 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -98.42 8.47 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.908 0.883 . . . . 0.0 110.705 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -56.25 -21.51 24.09 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -169.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.24 22.73 5.0 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.096 1.808 . . . . 0.0 111.692 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.82 30.48 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.739 1.769 . . . . 0.0 109.116 166.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 144.63 48.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.06 -37.3 66.57 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.96 69.23 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.577 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.43 -50.26 11.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.602 1.092 . . . . 0.0 110.065 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.23 -39.44 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.068 1.347 . . . . 0.0 111.432 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.25 -40.58 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 120.851 -1.156 . . . . 0.0 109.735 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -31.32 70.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 110.682 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.97 -46.6 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.126 1.77 . . . . 0.0 109.482 174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.06 -37.38 86.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.994 0.816 . . . . 0.0 109.959 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.2 -24.46 62.22 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.515 -0.741 . . . . 0.0 112.112 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -70.83 -0.22 8.6 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.422 1.089 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.2 t -100.12 101.84 15.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.09 168.01 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.596 1.53 . . . . 0.0 110.919 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.7 142.12 12.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.13 -11.61 35.45 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.589 -1.117 . . . . 0.0 113.69 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -84.58 154.24 22.73 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 120.478 2.139 . . . . 0.0 107.465 165.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -126.03 157.53 37.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.057 1.343 . . . . 0.0 109.338 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.66 147.21 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.39 150.5 26.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 mt -141.44 139.81 33.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.87 123.2 69.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -115.96 164.37 14.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 123.958 0.786 . . . . 0.0 110.172 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 16.9 t -115.89 119.86 37.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 165.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 21' ' ' LEU . 7.0 ttm180 -74.35 156.27 37.27 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.668 1.187 . . . . 0.0 107.993 163.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.35 30.58 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.009 0.822 . . . . 0.0 113.309 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -103.35 126.8 31.17 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.41 172.52 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.393 2.062 . . . . 0.0 111.689 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.15 142.68 98.65 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 122.695 2.264 . . . . 0.0 111.25 -174.392 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 19.3 t80 . . . . . 0 CA--C 1.544 0.714 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 15' ' ' GLN . 9.1 m -74.02 -110.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.511 1.124 . . . . 0.0 112.369 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 134.61 -51.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 134.296 5.039 . . . . 0.0 109.939 -175.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -125.26 22.49 7.81 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -165.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.17 -11.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 114.922 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 t -62.75 -31.53 72.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.99 1.716 . . . . 0.0 112.605 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HB2' HG23 ' A' ' 10' ' ' THR . 9.3 mm-40 -72.91 -11.95 60.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.8 mt -69.39 145.58 52.76 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.908 1.231 . . . . 0.0 109.944 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.2 142.41 28.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 160.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.58 -173.71 23.35 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.988 0.805 . . . . 0.0 112.812 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.7 m -106.53 129.02 54.55 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -80.21 133.87 36.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -145.23 174.47 11.06 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.323 1.449 . . . . 0.0 109.005 177.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -151.04 163.25 39.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.243 0.217 . . . . 0.0 110.615 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -154.47 158.04 39.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.96 0.886 . . . . 0.0 108.636 166.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.7 m -114.84 117.83 31.81 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 167.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.58 138.5 36.58 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -90.95 129.82 36.94 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.95 103.58 0.18 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.008 1.323 . . . . 0.0 107.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t -129.51 165.83 20.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.523 1.529 . . . . 0.0 107.779 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 44.05 -73.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.733 3.213 . . . . 0.0 113.273 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.5 ptp -142.74 5.94 1.59 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.089 1.756 . . . . 0.0 113.43 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.23 -126.18 2.44 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 120.851 1.66 . . . . 0.0 111.599 -172.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.91 145.98 46.21 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.976 0.91 . . . . 0.0 109.253 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.55 36.23 2.98 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.856 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -149.07 169.09 21.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.099 1.45 . . . . 0.0 108.883 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -131.77 154.21 49.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.373 1.069 . . . . 0.0 108.439 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.81 160.58 17.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.597 1.159 . . . . 0.0 107.898 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 tt -125.25 162.03 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.722 2.009 . . . . 0.0 107.207 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.76 150.7 19.37 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.64 -63.16 3.31 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-O 118.952 -0.916 . . . . 0.0 112.285 -172.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.14 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 128.453 2.701 . . . . 0.0 109.09 164.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -89.79 160.7 40.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.399 1.48 . . . . 0.0 112.39 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.97 51.83 3.23 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 125.082 3.855 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.69 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.901 2.08 . . . . 0.0 110.921 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -102.5 154.49 19.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 120.632 -1.292 . . . . 0.0 109.126 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.57 137.43 33.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.162 0.985 . . . . 0.0 108.741 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.82 113.12 24.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.382 1.873 . . . . 0.0 109.173 -174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.72 157.27 16.82 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 122.104 2.229 . . . . 0.0 111.207 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 t -61.08 115.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -55.11 36.93 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.36 -0.838 . . . . 0.0 109.142 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 m -159.66 154.29 24.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.973 0.909 . . . . 0.0 109.582 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.08 133.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 160.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.3 135.15 66.1 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 125.872 1.669 . . . . 0.0 107.574 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.12 147.51 84.09 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.509 1.472 . . . . 0.0 109.074 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 64.3 24.25 13.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.038 0.935 . . . . 0.0 112.509 167.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.97 176.54 19.9 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.798 1.666 . . . . 0.0 112.478 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.25 -12.36 25.37 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.734 2.956 . . . . 0.0 113.497 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.16 -50.71 12.38 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 168.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.32 -54.76 41.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.688 0.795 . . . . 0.0 109.971 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -68.94 -15.4 63.48 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.326 0.966 . . . . 0.0 113.473 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.9 -38.56 73.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.227 1.376 . . . . 0.0 109.415 166.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.04 -28.94 13.66 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.045 1.307 . . . . 0.0 113.057 167.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -93.63 -12.67 28.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.201 1.5 . . . . 0.0 113.836 -160.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.0 ttm -90.53 144.84 25.39 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 120.976 -1.077 . . . . 0.0 108.417 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -137.06 179.04 6.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.523 1.129 . . . . 0.0 108.181 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 m -93.93 149.4 21.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.1 5.92 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -165.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -134.76 157.07 47.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.46 114.03 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.86 2.064 . . . . 0.0 108.351 -167.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -60.26 115.4 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.247 1.419 . . . . 0.0 108.089 171.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.95 -54.55 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 124.12 0.887 . . . . 0.0 109.974 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.16 154.25 51.69 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.288 1.435 . . . . 0.0 108.684 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 77' ' ' VAL . 46.4 mt -135.01 129.2 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 51.22 -89.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.898 2.479 . . . . 0.0 110.896 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -135.14 28.51 3.44 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.396 1.453 . . . . 0.0 112.023 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.98 133.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 120.904 -1.123 . . . . 0.0 109.293 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.35 106.45 12.37 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.879 1.272 . . . . 0.0 110.322 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 72' ' ' ILE . 28.7 m -108.47 5.18 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.188 0.995 . . . . 0.0 112.784 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -56.06 -32.04 63.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.41 14.63 13.28 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.612 1.577 . . . . 0.0 110.739 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -68.65 161.85 27.27 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 p -73.23 145.85 45.9 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.38 -41.77 66.23 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 109.113 168.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.26 63.68 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.326 0.966 . . . . 0.0 113.462 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.79 -53.87 6.66 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 120.288 1.404 . . . . 0.0 109.435 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 t -56.0 -39.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.395 1.878 . . . . 0.0 111.662 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.1 -38.36 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 120.93 -1.106 . . . . 0.0 110.068 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -37.26 81.8 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 120.148 1.34 . . . . 0.0 109.182 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.18 -39.41 92.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.659 1.184 . . . . 0.0 109.16 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -69.24 -45.02 70.79 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.95 0.795 . . . . 0.0 111.904 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.07 -29.45 70.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.904 0.775 . . . . 0.0 112.106 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.6 p -56.69 -25.56 54.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.263 1.025 . . . . 0.0 113.548 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.05 109.24 17.66 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -162.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.75 170.19 14.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.635 1.556 . . . . 0.0 110.419 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mt -63.29 144.64 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.71 -4.05 53.33 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 117.654 -1.637 . . . . 0.0 113.99 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -86.52 175.94 8.09 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.867 1.834 . . . . 0.0 108.735 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.48 162.75 28.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.996 1.318 . . . . 0.0 109.999 170.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.04 150.37 24.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 125.331 1.452 . . . . 0.0 108.708 165.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -83.16 159.4 22.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 173.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -145.95 143.75 29.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.81 129.85 74.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 67' ' ' ASP . 27.1 mt -118.47 171.13 8.37 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 124.296 0.997 . . . . 0.0 110.369 168.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 12.3 t -131.04 119.87 22.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.908 1.283 . . . . 0.0 108.344 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 21' ' ' LEU . 18.9 ttm180 -91.11 140.94 29.34 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.181 1.393 . . . . 0.0 110.467 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.85 -38.01 1.87 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.178 0.894 . . . . 0.0 111.008 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -60.91 120.1 50.74 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.56 0.744 . . . . 0.0 109.316 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.11 177.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.646 2.231 . . . . 0.0 111.802 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.23 151.78 95.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.955 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 N--CA 1.452 -0.922 0 C-N-CA 122.517 2.144 . . . . 0.0 110.334 -178.408 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 . . . . . 0 C--O 1.236 0.357 0 CA-C-O 122.227 1.013 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -74.51 -97.97 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.048 1.339 . . . . 0.0 113.928 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 116.67 -34.61 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 1 C-N-CA 136.112 5.765 . . . . 0.0 110.913 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -146.02 18.73 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 112.674 -161.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 62.3 -22.32 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.034 2.934 . . . . 0.0 114.749 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 t -74.17 -6.26 46.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.364 1.438 . . . . 0.0 113.433 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -80.41 -22.64 41.02 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 119.625 -1.922 . . . . 0.0 111.159 164.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.41 146.15 54.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -131.52 124.54 30.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.85 177.99 15.15 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.1 m -93.17 155.43 17.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.655 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 12.7 m-85 -106.44 132.28 52.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.876 1.67 . . . . 0.0 109.344 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 165.64 12.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 108.475 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -139.02 149.79 45.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.6 1.16 . . . . 0.0 109.019 160.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -155.05 157.15 37.12 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 m -130.31 105.96 8.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.42 134.83 40.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.6 145.62 29.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.55 95.37 1.4 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -84.04 -166.45 1.42 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.548 2.339 . . . . 0.0 110.021 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -58.85 -24.58 62.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -165.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -133.07 53.19 2.03 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 -123.86 26.33 Favored Glycine 0 N--CA 1.441 -0.995 0 O-C-N 121.332 -0.855 . . . . 0.0 111.505 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.97 136.56 49.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.3 51.43 4.37 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.415 0.552 . . . . 0.0 112.169 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.46 173.27 13.28 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.01 1.324 . . . . 0.0 108.781 165.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.58 159.62 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.206 1.403 . . . . 0.0 108.811 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.76 159.51 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.078 1.351 . . . . 0.0 109.658 -174.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.83 155.46 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 128.954 2.902 . . . . 0.0 106.853 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.99 152.25 20.99 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.936 1.731 . . . . 0.0 109.128 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.91 -75.6 0.17 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.373 1.463 . . . . 0.0 111.801 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.92 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.473 1.509 . . . . 0.0 108.22 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -97.3 167.67 11.52 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -167.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.44 55.46 3.65 Favored 'Trans proline' 0 C--N 1.351 0.668 1 C-N-CA 125.312 4.008 . . . . 0.0 111.234 172.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.88 -8.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.956 1.302 . . . . 0.0 112.973 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.09 162.79 15.15 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.13 -0.981 . . . . 0.0 112.783 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.22 134.31 52.44 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.442 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 85' ' ' VAL . 16.8 mt -104.45 135.88 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -130.25 153.68 48.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.203 0.91 . . . . 0.0 110.947 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.0 119.29 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -71.2 -50.32 34.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.985 1.714 . . . . 0.0 110.16 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -152.31 152.6 32.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.041 1.736 . . . . 0.0 108.295 168.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.48 136.27 24.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 160.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.95 142.88 91.12 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 141.82 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.676 1.584 . . . . 0.0 111.016 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 46.84 68.52 0.61 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.814 1.646 . . . . 0.0 110.765 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.41 175.4 26.78 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.944 1.259 . . . . 0.0 110.415 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -64.68 -33.22 55.66 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.598 2.198 . . . . 0.0 112.7 -167.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.69 74.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.28 80.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.406 1.083 . . . . 0.0 111.517 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.69 -34.55 77.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.19 0.596 . . . . 0.0 112.536 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -33.84 75.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.751 0.786 . . . . 0.0 109.169 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.03 6.04 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.987 2.232 . . . . 0.0 114.209 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -65.57 -45.75 82.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.163 0.981 . . . . 0.0 109.246 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 tpp -65.63 122.75 17.95 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.835 0.854 . . . . 0.0 109.25 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.04 159.94 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 108.897 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 m -78.06 149.55 33.93 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.786 -1.196 . . . . 0.0 108.436 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -8.44 77.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.87 0.748 . . . . 0.0 113.71 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.41 158.18 34.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.143 1.472 . . . . 0.0 110.25 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.68 130.02 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.305 1.842 . . . . 0.0 108.741 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.93 126.71 39.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.112 1.365 . . . . 0.0 108.231 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.409 HG11 ' HB2' ' A' ' 13' ' ' ALA . 2.6 t -110.78 -54.67 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.858 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -135.06 142.03 46.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.11 112.32 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 t30 71.97 -68.86 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.268 3.027 . . . . 0.0 111.322 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -156.47 24.77 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 110.756 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.05 132.27 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 120.491 -1.381 . . . . 0.0 107.513 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 t -69.78 116.38 10.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.987 0.915 . . . . 0.0 108.716 168.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.09 5.37 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.771 0.829 . . . . 0.0 111.787 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -55.12 -24.01 23.77 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.21 22.94 5.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.856 1.693 . . . . 0.0 110.529 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -75.69 158.47 32.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.352 1.576 . . . . 0.0 109.894 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 t -77.14 149.1 35.66 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.24 -41.38 72.07 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.811 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.51 -32.3 62.78 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.379 1.445 . . . . 0.0 112.403 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -80.34 -47.8 13.93 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 118.86 0.754 . . . . 0.0 110.866 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG21 ' CD1' ' A' ' 46' ' ' LEU . 4.1 t -59.0 -42.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.711 -1.243 . . . . 0.0 110.703 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.58 -44.8 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.324 172.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -37.89 84.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.629 1.558 . . . . 0.0 111.167 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -60.93 -50.52 73.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.212 1.405 . . . . 0.0 108.362 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -64.79 -39.98 94.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.211 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -67.01 -34.25 77.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.444 0.698 . . . . 0.0 110.168 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -70.53 -3.81 19.83 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.38 116.58 65.71 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -60.86 157.23 39.24 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.741 2.294 . . . . 0.0 110.896 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.9 mt -59.85 139.21 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -13.11 59.17 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.424 -1.764 . . . . 0.0 114.299 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -84.21 167.16 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.834 2.317 . . . . 0.0 108.241 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.33 163.56 22.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.655 1.182 . . . . 0.0 110.008 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.0 146.25 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.398 1.479 . . . . 0.0 107.777 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.82 156.51 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.485 1.114 . . . . 0.0 109.524 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.48 109.59 4.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.5 t -89.3 121.15 39.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -116.52 163.77 15.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 124.11 0.881 . . . . 0.0 110.804 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.0 t -116.95 126.73 53.37 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.999 1.32 . . . . 0.0 108.563 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -76.52 156.84 32.59 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.454 1.502 . . . . 0.0 110.552 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.31 -21.93 8.56 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.808 1.194 . . . . 0.0 113.507 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -76.52 159.65 79.05 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 118.364 1.082 . . . . 0.0 109.888 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.23 178.31 6.74 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.986 2.458 . . . . 0.0 111.786 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.1 151.83 94.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 164.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.46 -0.446 0 C-N-CA 121.761 1.641 . . . . 0.0 111.433 174.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 10' ' ' THR . 88.0 t80 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 88.0 m -102.31 -106.25 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 110.297 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 138.41 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 133.851 4.86 . . . . 0.0 110.597 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -123.54 17.26 9.65 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.043 0.838 . . . . 0.0 113.217 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 58.66 -10.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.957 2.903 . . . . 0.0 115.184 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -75.92 -15.75 60.14 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.157 -1.589 . . . . 0.0 113.739 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.09 -16.85 63.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.96 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.01 162.9 28.64 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.535 1.061 . . . . 0.0 110.844 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -126.46 135.3 51.19 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.994 2.118 . . . . 0.0 106.142 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 -158.4 27.64 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -164.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -128.4 143.09 50.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.527 1.131 . . . . 0.0 108.403 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.438 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.9 m-85 -88.87 134.99 33.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.567 0.747 . . . . 0.0 109.387 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -113.09 171.64 7.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.042 1.737 . . . . 0.0 108.301 173.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.4 p -147.72 153.35 39.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.431 0.693 . . . . 0.0 109.538 162.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.73 158.18 40.6 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.069 1.348 . . . . 0.0 107.393 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 97' ' ' SER . 11.1 m -131.16 117.03 18.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 168.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.91 144.76 26.53 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -82.48 145.12 29.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 163.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -72.04 93.18 1.37 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -80.66 -165.62 0.92 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.831 1.253 . . . . 0.0 110.785 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.33 -47.12 66.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.766 1.627 . . . . 0.0 112.764 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 59.1 mtt -116.43 62.8 0.71 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.171 0.988 . . . . 0.0 108.421 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.24 -118.1 8.38 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.129 164.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.82 137.66 54.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.47 40.92 2.03 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.911 -0.939 . . . . 0.0 112.702 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -145.35 162.05 38.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.68 1.74 . . . . 0.0 109.439 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 p -124.46 158.24 33.29 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.74 162.06 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.919 1.288 . . . . 0.0 108.019 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -134.77 141.74 42.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.26 152.16 23.1 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.48 -2.648 . . . . 0.0 106.48 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.18 3.9 9.6 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-O 118.474 -1.181 . . . . 0.0 114.986 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t70 74.1 -37.17 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.877 2.471 . . . . 0.0 111.643 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.58 135.46 92.78 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 123.557 0.743 . . . . 0.0 109.286 172.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.22 41.65 0.79 Allowed 'Trans proline' 0 CA--C 1.543 0.973 1 C-N-CA 126.263 4.642 . . . . 0.0 112.396 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.55 -2.58 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.565 1.546 . . . . 0.0 112.828 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.83 148.62 38.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.507 -1.37 . . . . 0.0 108.082 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.62 143.07 40.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.036 1.334 . . . . 0.0 109.12 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.3 141.81 28.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.345 1.058 . . . . 0.0 109.854 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' HG22 ' A' ' 68' ' ' VAL . 33.5 mt-30 -130.95 154.87 47.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.612 1.165 . . . . 0.0 110.575 169.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.46 107.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 120.584 -1.322 . . . . 0.0 107.776 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -53.8 53.62 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 125.497 1.519 . . . . 0.0 109.288 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.4 p -154.46 161.41 41.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.391 0.276 . . . . 0.0 110.388 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 126.4 65.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.53 132.12 89.54 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.86 158.7 49.67 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.176 1.917 . . . . 0.0 110.359 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.4 -4.85 0.08 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.838 2.055 . . . . 0.0 114.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.57 172.71 43.09 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.582 1.563 . . . . 0.0 113.509 -165.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.83 -27.73 43.7 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.355 2.037 . . . . 0.0 112.533 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.63 67.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.05 74.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -57.37 -43.29 83.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.756 0.822 . . . . 0.0 112.948 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.54 -18.87 65.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.77 1.168 . . . . 0.0 111.191 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.42 -21.26 18.32 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 126.506 2.003 . . . . 0.0 112.75 164.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -80.78 -28.5 36.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.787 -1.101 . . . . 0.0 111.495 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.2 tpp -74.53 112.9 11.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -134.07 161.37 35.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 m -83.59 136.14 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.52 -5.75 83.63 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.603 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.404 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -66.18 151.28 47.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.484 1.642 . . . . 0.0 108.71 170.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.456 HG22 ' HG2' ' A' ' 47' ' ' GLN . 53.4 t -105.29 118.24 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.536 1.935 . . . . 0.0 109.084 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.21 105.81 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.935 1.694 . . . . 0.0 108.448 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.17 -58.47 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.993 0.425 . . . . 0.0 110.062 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.77 146.05 51.94 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.5 mt -122.44 120.12 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.75 -68.85 0.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.521 2.328 . . . . 0.0 111.488 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.45 25.91 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.655 1.982 . . . . 0.0 110.621 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.5 t -131.17 130.5 63.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.386 1.474 . . . . 0.0 108.041 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 p -65.94 126.2 27.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.228 0.611 . . . . 0.0 110.349 167.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.92 13.14 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.451 0.7 . . . . 0.0 112.024 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.87 -12.62 59.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.01 25.99 4.29 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.24 149.58 22.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.682 0.753 . . . . 0.0 109.165 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.86 142.0 38.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.695 -1.138 . . . . 0.0 107.943 -170.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -58.42 -23.41 57.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.84 1.656 . . . . 0.0 111.274 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.43 71.62 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.321 0.964 . . . . 0.0 110.808 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.24 -46.8 54.5 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.448 0.699 . . . . 0.0 109.529 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.63 -41.5 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 O-C-N 120.597 -1.314 . . . . 0.0 111.117 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.53 -34.62 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.843 -1.161 . . . . 0.0 110.107 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.14 83.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.779 1.172 . . . . 0.0 109.776 171.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.25 -36.97 77.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.54 1.136 . . . . 0.0 109.739 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.56 -40.94 63.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.593 0.757 . . . . 0.0 111.731 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -56.68 -41.7 77.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.013 0.925 . . . . 0.0 110.305 173.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.1 m -65.16 -2.95 3.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.82 110.72 49.29 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 120.747 1.612 . . . . 0.0 108.105 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.24 169.55 21.29 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.449 2.1 . . . . 0.0 111.374 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.67 148.63 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 121.385 -0.822 . . . . 0.0 109.328 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.5 -11.07 47.26 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.279 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -84.34 156.89 21.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.785 1.792 . . . . 0.0 107.993 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.503 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.0 p -125.96 148.82 49.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.441 1.096 . . . . 0.0 108.54 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.93 144.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.719 0.808 . . . . 0.0 109.841 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -82.88 155.21 24.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.27 152.14 45.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.05 111.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 67' ' ' ASP . 13.8 mt -102.3 168.1 9.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.88 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 38.6 t -123.48 142.42 51.02 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.473 1.109 . . . . 0.0 108.835 167.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.659 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 ttm180 -116.73 139.65 50.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 110.728 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.62 -14.67 7.19 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.726 1.155 . . . . 0.0 112.055 168.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.54 142.21 88.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.37 173.99 10.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.501 2.134 . . . . 0.0 110.03 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 162.71 30.95 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.169 0.588 . . . . 0.0 111.501 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo . . . . . 0 N--CA 1.45 -1.037 0 C-N-CA 122.526 2.151 . . . . 0.0 109.003 160.387 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 120.526 0.203 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -64.51 -113.38 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.421 2.688 . . . . 0.0 113.325 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 140.51 -23.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 1 C-N-CA 133.111 4.565 . . . . 0.0 111.661 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -126.96 179.1 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.146 1.378 . . . . 0.0 107.639 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.81 -34.5 6.93 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 126.098 1.759 . . . . 0.0 110.429 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -28.7 70.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.663 1.12 . . . . 0.0 111.523 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.41 -24.33 67.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.002 0.819 . . . . 0.0 112.186 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.14 142.8 57.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.102 0.865 . . . . 0.0 111.144 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 127.62 33.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 162.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.18 -173.3 36.79 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 123.859 0.725 . . . . 0.0 112.721 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -114.08 141.23 47.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 167.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.0 127.49 50.22 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.71 0.804 . . . . 0.0 110.462 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -115.8 162.08 17.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.082 1.753 . . . . 0.0 107.985 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -150.18 146.72 27.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.997 -0.439 . . . . 0.0 110.833 162.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -144.13 157.54 44.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -117.09 117.18 28.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.45 145.44 30.27 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -101.58 126.75 48.45 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.473 1.109 . . . . 0.0 109.159 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 25.2 tptt -55.55 109.69 0.59 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.664 1.586 . . . . 0.0 110.197 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.6 p -79.05 -173.65 3.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.597 1.159 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -59.63 -15.59 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.351 1.06 . . . . 0.0 112.747 166.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.7 mtt -132.03 49.22 2.34 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.22 1.373 . . . . 0.0 110.221 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 72.7 -109.81 2.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.026 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -121.32 152.78 38.56 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.39 35.52 2.42 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.155 -1.358 . . . . 0.0 111.849 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.14 167.1 29.62 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.668 1.734 . . . . 0.0 108.621 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.8 p -134.06 161.32 35.17 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.25 162.46 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.459 1.104 . . . . 0.0 109.486 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 14.7 tt -126.7 158.6 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 126.715 2.006 . . . . 0.0 107.468 166.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.65 152.26 22.9 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 157.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.47 -70.86 0.85 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 124.505 1.05 . . . . 0.0 111.171 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -37.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -137.0 176.23 2.93 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.578 1.151 . . . . 0.0 110.249 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -71.32 54.33 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.501 2.8 . . . . 0.0 112.231 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.49 -9.84 0.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.02 1.728 . . . . 0.0 112.361 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -110.79 158.01 19.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.395 1.452 . . . . 0.0 108.691 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -83.57 126.58 32.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.927 0.891 . . . . 0.0 109.173 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mt -80.99 139.72 35.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -134.22 156.77 47.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.294 0.638 . . . . 0.0 110.881 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 102' ' ' LEU . 38.5 t -67.03 114.63 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 24.1 ttmt -72.42 -51.58 19.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.647 1.579 . . . . 0.0 109.916 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 m -143.78 162.12 36.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.28 0.632 . . . . 0.0 109.417 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.85 138.91 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 162.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 mm -74.83 127.82 86.35 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.86 133.08 24.54 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 121.908 1.739 . . . . 0.0 109.768 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t0 65.48 13.04 8.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.32 1.448 . . . . 0.0 111.845 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.44 167.67 37.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.181 1.372 . . . . 0.0 111.116 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.23 -34.42 68.07 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.44 2.093 . . . . 0.0 112.716 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.33 91.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.529 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.46 96.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.459 0.704 . . . . 0.0 110.414 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -67.68 -37.43 82.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.986 0.812 . . . . 0.0 112.755 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.27 -24.89 63.13 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.433 -0.792 . . . . 0.0 110.855 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.76 -16.36 26.63 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.865 2.174 . . . . 0.0 113.483 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -81.29 -37.09 29.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.378 1.589 . . . . 0.0 114.163 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpp -70.01 118.37 12.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.52 166.06 24.08 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.999 0.919 . . . . 0.0 109.025 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -100.56 98.96 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.261 1.029 . . . . 0.0 110.491 -150.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.66 -6.7 5.87 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.776 1.655 . . . . 0.0 112.322 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 102' ' ' LEU . 2.8 m-20 -68.46 163.15 23.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.404 1.102 . . . . 0.0 110.62 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.9 t -111.87 120.64 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.27 1.828 . . . . 0.0 109.552 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.13 109.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 126.467 1.907 . . . . 0.0 108.881 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.8 t -93.68 -51.83 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.406 0.622 . . . . 0.0 110.086 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -134.96 154.59 51.66 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.075 1.35 . . . . 0.0 108.179 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.422 HG13 HG21 ' A' ' 77' ' ' VAL . 54.1 mt -134.86 134.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.593 HD21 HG12 ' A' ' 98' ' ' VAL . 20.8 m120 50.46 -92.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.456 1.902 . . . . 0.0 110.072 -169.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -143.17 20.81 1.92 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.222 2.609 . . . . 0.0 108.971 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -128.87 128.49 67.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.325 2.25 . . . . 0.0 107.636 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.35 129.46 36.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 72' ' ' ILE . 30.5 m -130.11 11.07 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.058 1.343 . . . . 0.0 110.964 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -20.93 64.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.07 33.83 2.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.763 1.649 . . . . 0.0 109.659 167.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.22 161.42 28.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.681 1.74 . . . . 0.0 109.225 165.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.96 151.37 33.69 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -55.35 -35.13 64.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.136 0.974 . . . . 0.0 110.39 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.4 38.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.116 0.871 . . . . 0.0 110.606 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.88 -48.18 69.53 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.768 0.827 . . . . 0.0 110.846 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.67 -43.1 96.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 125.054 1.341 . . . . 0.0 111.149 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.51 -39.62 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.982 -1.074 . . . . 0.0 109.363 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -38.82 92.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.876 1.217 . . . . 0.0 110.027 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.12 -31.81 73.14 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.134 1.374 . . . . 0.0 111.052 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.61 -46.36 22.34 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.06 0.846 . . . . 0.0 111.546 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.03 -29.86 70.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.216 -0.928 . . . . 0.0 111.586 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 t -63.42 -14.34 49.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.535 1.134 . . . . 0.0 112.746 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.3 t -84.26 112.16 39.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 120.409 1.459 . . . . 0.0 107.198 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.96 169.27 22.99 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.79 1.66 . . . . 0.0 110.869 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.06 139.57 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.54 -10.19 62.59 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.083 -0.843 . . . . 0.0 113.699 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -84.23 172.64 11.68 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.419 1.61 . . . . 0.0 108.735 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 p -134.06 156.21 48.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.205 1.002 . . . . 0.0 110.576 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 73' ' ' ASN . 28.9 m -139.44 142.53 32.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.06 0.944 . . . . 0.0 108.849 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.86 143.6 29.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.367 1.867 . . . . 0.0 107.228 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.7 mt -144.79 110.87 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.35 132.07 35.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.679 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.9 mt -119.02 162.89 17.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 109.707 170.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.18 133.96 50.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.996 1.318 . . . . 0.0 108.658 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' A' ' 21' ' ' LEU . 10.6 ttm180 -102.4 155.42 18.26 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 126.627 1.971 . . . . 0.0 112.279 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.81 -8.56 63.62 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.351 0.976 . . . . 0.0 112.775 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.37 151.55 97.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 117.71 0.755 . . . . 0.0 109.604 163.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.5 166.39 28.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.491 2.127 . . . . 0.0 112.104 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.59 157.25 79.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.415 1.486 . . . . 0.0 110.417 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.456 -0.731 0 C-N-CA 122.584 2.189 . . . . 0.0 110.831 176.338 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 . . . . . 0 C--O 1.236 0.361 0 CA-C-O 121.121 0.486 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 m -81.76 -109.57 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.018 1.327 . . . . 0.0 112.178 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mtm105 135.71 -67.39 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 1 C-N-CA 133.915 4.886 . . . . 0.0 108.742 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.83 -3.86 9.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.896 -157.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.59 -27.31 0.19 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 128.497 2.719 . . . . 0.0 114.713 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -66.37 -6.44 14.33 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.122 1.328 . . . . 0.0 111.727 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.63 -19.08 65.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.481 1.513 . . . . 0.0 112.41 163.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 mt -91.24 159.18 16.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.236 1.38 . . . . 0.0 108.593 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -3.73 13.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.38 -172.76 38.28 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 126.179 1.847 . . . . 0.0 111.685 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -88.01 156.4 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.463 1.505 . . . . 0.0 108.574 170.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -125.54 130.05 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.801 1.241 . . . . 0.0 109.038 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.86 173.34 6.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 108.172 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.3 p -151.21 142.7 23.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.422 -0.799 . . . . 0.0 109.405 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.3 t -150.62 158.15 43.81 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -121.49 106.0 11.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 107.023 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.86 118.55 34.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -92.41 116.38 28.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -42.95 91.97 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.819 2.448 . . . . 0.0 112.298 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -79.52 111.67 16.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 17.34 -83.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 130.269 3.428 . . . . 0.0 115.209 -168.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.0 mtt -56.38 -21.98 28.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.394 1.478 . . . . 0.0 113.463 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.73 -124.51 5.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 124.829 1.204 . . . . 0.0 110.426 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.58 129.64 50.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.37 49.04 2.93 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -146.73 171.89 14.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.567 1.547 . . . . 0.0 108.356 166.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -134.13 163.38 29.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.606 0.762 . . . . 0.0 109.407 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.58 162.35 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 108.44 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.45 159.91 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 128.244 2.618 . . . . 0.0 107.006 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.16 152.57 22.86 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 128.354 2.883 . . . . 0.0 106.523 167.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.77 -70.54 0.88 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 118.819 1.31 . . . . 0.0 113.091 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -173.82 -52.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -97.56 163.41 19.74 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 124.64 1.176 . . . . 0.0 112.619 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -75.1 48.37 2.0 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 125.099 3.866 . . . . 0.0 112.082 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -150.8 -7.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 110.497 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.32 152.44 19.15 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.874 0.761 . . . . 0.0 112.293 -161.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -57.89 134.22 56.13 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.101 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.4 mt -100.65 126.61 47.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.022 1.729 . . . . 0.0 106.375 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.95 155.05 47.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.017 0.826 . . . . 0.0 110.238 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.95 112.37 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.42 -47.94 71.61 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.123 0.969 . . . . 0.0 109.207 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -155.98 158.53 38.03 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.014 1.326 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.07 145.01 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 165.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -81.62 128.85 67.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.75 160.21 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.755 1.637 . . . . 0.0 110.221 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.4 -12.95 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.996 2.118 . . . . 0.0 114.903 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 178.1 54.06 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.667 1.127 . . . . 0.0 112.94 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.87 -37.46 77.45 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.695 2.263 . . . . 0.0 110.79 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.9 76.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.168 0.587 . . . . 0.0 111.649 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.06 -40.97 67.93 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.67 -49.46 76.42 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.06 -35.47 78.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.707 0.289 . . . . 0.0 110.949 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.48 -11.34 39.22 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.878 1.228 . . . . 0.0 113.995 161.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.43 -46.01 88.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.09 1.445 . . . . 0.0 109.709 168.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.5 tpp -66.28 115.91 6.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.37 159.14 42.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -87.88 117.85 27.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.162 -159.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.68 -8.25 39.82 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.535 1.54 . . . . 0.0 113.46 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.43 155.02 26.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.438 1.619 . . . . 0.0 109.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.35 116.82 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.037 1.735 . . . . 0.0 109.375 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.05 118.79 4.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 126.659 1.983 . . . . 0.0 108.052 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.95 -57.62 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.053 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.7 150.74 51.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mt -127.69 123.29 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.16 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.478 3.111 . . . . 0.0 110.518 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.39 -6.53 1.36 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.934 1.694 . . . . 0.0 111.952 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -88.74 124.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.51 120.07 12.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.4 6.56 6.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 124.699 1.2 . . . . 0.0 110.948 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 78' ' ' LEU 0.26 1.0 OUTLIER -58.62 -25.89 63.15 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -166.21 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.63 11.18 21.29 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.512 2.006 . . . . 0.0 112.368 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 165.38 24.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.321 1.06 . . . . 0.0 110.242 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -75.85 148.51 38.28 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -60.76 -35.57 76.74 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.436 165.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.3 74.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.34 0.973 . . . . 0.0 111.929 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.84 -55.58 8.19 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 118.188 0.449 . . . . 0.0 110.488 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.37 -39.58 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 127.519 2.328 . . . . 0.0 112.162 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.9 -39.08 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 120.94 -1.1 . . . . 0.0 109.242 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -36.46 83.22 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.87 1.214 . . . . 0.0 109.638 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.64 -45.6 93.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.584 1.153 . . . . 0.0 108.722 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -66.2 -31.01 71.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.235 0.614 . . . . 0.0 112.237 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.34 -6.65 59.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.056 1.342 . . . . 0.0 112.963 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -91.02 7.61 39.51 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.213 1.405 . . . . 0.0 113.57 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.2 t -101.18 107.59 50.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.5 172.41 14.49 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.35 2.7 . . . . 0.0 113.33 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 94' ' ' ILE . 4.2 mp -70.94 100.15 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.291 1.436 . . . . 0.0 110.665 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.56 -42.09 1.05 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -84.26 160.75 20.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.694 0.759 . . . . 0.0 109.61 -164.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.89 160.54 22.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.582 1.553 . . . . 0.0 108.474 170.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.11 147.15 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.66 157.45 22.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -146.52 116.27 7.22 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.81 123.98 45.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.97 159.01 17.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.794 0.683 . . . . 0.0 110.353 159.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.3 t -105.97 136.16 46.13 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.284 1.434 . . . . 0.0 107.661 165.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -81.52 156.23 25.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.231 1.412 . . . . 0.0 112.43 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.31 35.84 7.84 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.11 151.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -117.3 150.42 46.34 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 161.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.08 171.71 13.25 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.215 1.943 . . . . 0.0 111.208 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.61 143.22 94.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.459 -0.503 0 C-N-CA 122.821 2.347 . . . . 0.0 114.219 -168.673 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 15.0 t80 . . . . . 0 CA--C 1.547 0.851 0 CA-C-O 122.377 1.084 . . . . 0.0 113.427 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -81.86 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.551 1.541 . . . . 0.0 110.617 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 145.85 -60.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.373 4.269 . . . . 0.0 111.398 174.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.58 2.37 26.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.936 1.294 . . . . 0.0 111.029 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.01 -14.15 0.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.8 2.44 . . . . 0.0 113.669 -168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -57.88 -29.16 64.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.36 1.064 . . . . 0.0 113.095 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -77.93 -11.97 59.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.082 -171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.7 166.12 18.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.198 0.999 . . . . 0.0 110.342 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -128.0 136.42 51.25 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.24 -161.49 25.63 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -107.04 161.52 14.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -119.56 121.31 39.07 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.661 1.584 . . . . 0.0 108.142 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -145.74 154.07 41.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.376 1.07 . . . . 0.0 110.576 -170.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.8 p -157.14 163.28 39.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -165.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 t -154.92 157.71 38.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.0 m -101.33 119.82 39.33 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.225 1.01 . . . . 0.0 108.52 158.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -99.11 159.3 15.07 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.792 1.237 . . . . 0.0 108.125 163.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -103.84 143.52 32.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -66.98 99.35 0.64 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -88.47 -163.4 0.96 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.377 2.271 . . . . 0.0 108.487 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -48.49 -65.21 0.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.942 1.297 . . . . 0.0 110.925 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.44 66.81 1.11 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.2 -106.76 0.61 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 124.818 1.199 . . . . 0.0 113.469 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.37 152.25 43.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.0 40.15 2.89 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.328 -1.262 . . . . 0.0 111.753 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -154.92 161.47 41.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.748 1.774 . . . . 0.0 110.316 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 p -130.41 159.93 35.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.977 1.311 . . . . 0.0 109.315 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.82 162.63 26.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 125.208 1.403 . . . . 0.0 109.973 -170.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.18 151.58 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.469 1.508 . . . . 0.0 110.067 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.29 153.37 16.73 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 129.322 3.344 . . . . 0.0 109.333 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.86 -82.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.68 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.028 1.731 . . . . 0.0 109.798 163.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -93.57 162.59 27.14 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.541 1.537 . . . . 0.0 113.473 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.55 43.17 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 125.086 3.857 . . . . 0.0 112.925 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -166.47 12.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.63 1.972 . . . . 0.0 111.683 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 155.13 21.2 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.349 -1.469 . . . . 0.0 110.969 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.93 115.74 23.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.054 0.942 . . . . 0.0 109.491 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.79 140.6 35.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.884 0.766 . . . . 0.0 109.502 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.422 ' HG2' HG22 ' A' ' 68' ' ' VAL . 39.9 mt-30 -131.63 157.18 44.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.845 0.748 . . . . 0.0 111.231 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.48 111.02 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 168.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -60.76 -54.65 42.63 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.022 0.929 . . . . 0.0 109.328 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 65' ' ' THR . 53.6 p -154.99 164.45 38.88 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.97 0.508 . . . . 0.0 110.672 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.11 145.34 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 160.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.5 123.42 76.65 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 165.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.57 150.95 86.1 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.552 2.168 . . . . 0.0 109.854 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.319 1.0 OUTLIER 58.99 -0.7 0.13 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.996 1.718 . . . . 0.0 115.137 -168.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.05 167.18 54.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.48 1.038 . . . . 0.0 112.563 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.17 -26.52 36.18 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.952 1.768 . . . . 0.0 112.236 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.74 -45.61 78.06 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.781 -0.575 . . . . 0.0 109.807 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.92 97.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.572 0.749 . . . . 0.0 110.96 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -69.69 -26.07 64.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.78 -38.98 76.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.47 1.032 . . . . 0.0 109.238 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.45 20.39 69.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.169 166.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -98.76 -52.05 3.71 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.807 1.804 . . . . 0.0 111.379 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.7 ttm -80.82 146.77 30.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.558 1.143 . . . . 0.0 109.961 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -134.09 165.1 25.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.385 1.088 . . . . 0.0 110.984 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 50' ' ' SER . 28.0 m -75.17 121.28 21.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.227 1.011 . . . . 0.0 108.656 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.05 -20.37 16.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.756 -1.025 . . . . 0.0 112.122 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 102' ' ' LEU . 14.9 m-20 -63.91 150.64 44.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.079 1.439 . . . . 0.0 109.402 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 47' ' ' GLN . 51.3 t -101.45 124.45 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.635 1.974 . . . . 0.0 108.813 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.42 128.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 125.353 1.461 . . . . 0.0 107.614 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.27 -56.85 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.899 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -133.09 147.57 52.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.324 1.05 . . . . 0.0 108.841 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mt -130.33 122.51 53.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 53.21 -92.63 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 127.35 2.26 . . . . 0.0 109.719 -162.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.61 1.38 8.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.37 1.468 . . . . 0.0 111.161 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -111.51 131.08 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 -160.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.4 p -74.69 123.28 24.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.62 12.77 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.034 0.934 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -54.33 -35.31 62.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -162.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.45 16.35 12.72 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.111 1.339 . . . . 0.0 112.624 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 164.91 12.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.874 1.837 . . . . 0.0 110.666 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 p -70.74 137.96 50.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.58 -25.14 64.34 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.594 -0.691 . . . . 0.0 110.546 167.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.51 -57.85 10.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.897 1.226 . . . . 0.0 110.31 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.86 -54.73 42.74 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.574 1.15 . . . . 0.0 110.472 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.4 -42.53 74.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.487 1.515 . . . . 0.0 111.491 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.09 -33.98 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.546 -1.346 . . . . 0.0 110.376 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -39.57 94.42 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.659 1.572 . . . . 0.0 109.361 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.24 -49.18 78.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -64.56 -41.4 96.34 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -55.51 -46.78 76.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.495 0.588 . . . . 0.0 109.585 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.5 p -64.76 -13.55 55.6 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.447 1.276 . . . . 0.0 114.447 -166.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.98 110.93 26.25 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.73 159.95 44.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 120.062 1.058 . . . . 0.0 109.59 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 79.8 mt -57.58 126.76 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.83 50.28 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.805 -1.553 . . . . 0.0 114.163 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -112.13 165.11 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 121.02 2.41 . . . . 0.0 110.327 168.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.6 p -123.25 164.7 18.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.124 1.37 . . . . 0.0 109.755 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.97 150.14 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.007 1.323 . . . . 0.0 108.314 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.83 154.14 23.66 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -146.24 126.27 13.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.37 130.97 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 67' ' ' ASP . 15.1 mt -118.45 169.05 10.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.322 1.014 . . . . 0.0 110.046 170.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.6 t -128.37 144.45 51.14 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.5 1.52 . . . . 0.0 108.887 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.11 123.16 39.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.432 1.493 . . . . 0.0 112.686 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.45 -25.44 0.86 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.989 1.28 . . . . 0.0 113.494 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -72.66 158.02 87.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 118.021 0.911 . . . . 0.0 110.856 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.27 175.79 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.006 2.471 . . . . 0.0 111.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mt -71.89 159.09 86.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.273 1.029 . . . . 0.0 109.484 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.345 0.351 0 C-N-CA 123.806 3.004 . . . . 0.0 113.847 -178.755 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.2 t80 . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 122.228 1.013 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 11' ' ' ARG . 5.1 m -78.38 -143.69 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.185 2.194 . . . . 0.0 112.108 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.624 ' H ' HG22 ' A' ' 10' ' ' THR . 0.7 OUTLIER -163.02 -69.38 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 147.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.25 22.94 2.65 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.866 2.066 . . . . 0.0 111.911 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 10' ' ' THR . . . 55.89 -6.2 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.486 2.314 . . . . 0.0 114.653 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 m -75.41 -24.99 57.2 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.947 1.299 . . . . 0.0 110.628 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.55 -15.77 63.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.392 -1.29 . . . . 0.0 114.007 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 mt -74.64 161.91 29.24 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.253 1.388 . . . . 0.0 110.386 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.87 2.1 3.66 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -165.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.97 -179.27 41.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 162.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.4 m -81.82 154.56 25.85 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.438 0.695 . . . . 0.0 109.423 -172.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 6.2 m-85 -111.68 140.73 46.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.607 1.163 . . . . 0.0 108.346 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -122.51 -179.55 4.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.034 1.734 . . . . 0.0 107.658 -177.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -145.14 165.61 27.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.124 -0.36 . . . . 0.0 111.185 163.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -152.85 157.2 40.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 151.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.1 m -104.82 113.93 27.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 160.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.37 138.03 36.2 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -82.06 155.21 25.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 158.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.435 ' CE ' ' HA2' ' A' ' 31' ' ' GLY . 5.6 tptt -58.04 161.19 4.22 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 154.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -129.66 -78.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 159.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.39 132.95 46.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -170.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.5 mmt 63.04 -62.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.06 2.144 . . . . 0.0 111.132 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . -169.47 -154.25 9.04 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -170.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.12 153.74 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 163.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.38 35.17 2.43 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.134 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.17 163.12 37.95 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.906 2.353 . . . . 0.0 111.268 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -125.52 155.1 41.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.112 1.365 . . . . 0.0 109.174 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.96 162.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.383 1.473 . . . . 0.0 109.921 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 tt -136.76 157.76 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 128.324 2.65 . . . . 0.0 108.186 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.58 152.17 22.81 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.527 2.489 . . . . 0.0 107.966 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.09 -71.17 0.81 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.506 1.051 . . . . 0.0 112.725 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 170.27 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.577 1.551 . . . . 0.0 110.691 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.74 158.43 87.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 120.197 1.362 . . . . 0.0 110.228 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.28 43.31 1.28 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.505 3.47 . . . . 0.0 112.263 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.48 37.45 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.732 2.813 . . . . 0.0 108.669 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -113.54 150.3 33.17 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.96 0.904 . . . . 0.0 108.762 167.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -74.91 127.33 32.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.081 0.943 . . . . 0.0 109.112 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.37 142.78 32.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG2' HG22 ' A' ' 68' ' ' VAL . 53.3 mt-30 -142.49 162.35 35.69 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.674 0.789 . . . . 0.0 110.865 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.17 114.49 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.02 -50.06 72.17 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.61 0.641 . . . . 0.0 109.285 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.08 154.19 17.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.181 0.926 . . . . 0.0 110.095 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.75 121.42 55.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.51 129.24 90.38 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -85.85 48.24 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.782 2.988 . . . . 0.0 112.605 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.59 57.98 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.981 2.112 . . . . 0.0 107.694 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.12 171.22 44.07 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.104 -0.997 . . . . 0.0 112.632 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.72 -25.28 54.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.387 2.058 . . . . 0.0 112.174 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.02 70.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.984 0.811 . . . . 0.0 111.235 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.29 12.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.202 1.001 . . . . 0.0 108.746 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.08 -29.36 69.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -172.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.67 -26.75 67.19 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.726 -0.609 . . . . 0.0 110.927 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.94 -14.73 9.78 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.93 1.729 . . . . 0.0 113.437 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -83.59 -26.86 29.66 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.325 -1.103 . . . . 0.0 111.385 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.9 tpp -89.36 130.79 35.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.403 0.681 . . . . 0.0 110.173 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -144.0 166.2 25.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.795 1.638 . . . . 0.0 108.861 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.3 m -87.95 144.37 26.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.145 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.72 57.62 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.823 1.192 . . . . 0.0 112.396 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.2 144.05 44.29 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.962 1.381 . . . . 0.0 107.721 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 47' ' ' GLN . 69.5 t -98.45 118.35 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.248 1.819 . . . . 0.0 110.062 -162.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.65 110.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.498 1.519 . . . . 0.0 108.871 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 3.5 t -96.13 -59.94 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.344 0.593 . . . . 0.0 109.796 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -128.71 158.49 38.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.011 1.324 . . . . 0.0 107.566 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.1 122.93 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t30 65.05 -81.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.413 2.285 . . . . 0.0 110.489 168.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.74 36.35 1.16 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.432 1.093 . . . . 0.0 110.554 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.44 132.62 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 120.425 -1.422 . . . . 0.0 109.422 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.7 p -77.82 110.13 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.755 0.822 . . . . 0.0 109.368 165.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.67 -3.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -54.16 -31.18 51.88 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.03 1.286 . . . . 0.0 114.414 -164.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.76 28.56 5.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.506 1.527 . . . . 0.0 111.008 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 172.22 13.31 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 164.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 p -90.04 153.25 20.71 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -54.93 -36.45 65.28 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.119 1.368 . . . . 0.0 109.741 170.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -64.49 0.79 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.382 1.073 . . . . 0.0 110.902 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.73 -35.87 77.69 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.763 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.58 -40.27 87.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 120.548 -1.345 . . . . 0.0 111.265 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.69 -43.59 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -40.28 84.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.165 0.893 . . . . 0.0 110.499 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.3 mt -64.87 -41.06 95.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.589 1.556 . . . . 0.0 109.265 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -71.21 -39.19 71.9 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.476 1.034 . . . . 0.0 111.177 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -60.88 -36.95 80.52 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.814 0.734 . . . . 0.0 110.406 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -59.81 -13.24 9.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.052 1.741 . . . . 0.0 113.539 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.1 t -87.58 110.59 35.61 Favored Pre-proline 0 C--O 1.239 0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.86 160.15 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.729 1.619 . . . . 0.0 111.736 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.27 138.25 20.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 158.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.86 14.92 76.53 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.396 -1.78 . . . . 0.0 113.677 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -122.73 162.58 21.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.032 2.416 . . . . 0.0 111.413 165.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.72 155.14 30.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.665 1.986 . . . . 0.0 111.334 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.38 157.42 39.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.322 1.449 . . . . 0.0 109.172 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.87 158.69 22.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 mt -145.71 145.83 31.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -123.8 125.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 mt -112.85 165.05 12.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.345 1.028 . . . . 0.0 110.931 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.4 t -119.46 143.91 47.26 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.417 1.487 . . . . 0.0 108.288 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -100.77 155.85 17.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.446 2.298 . . . . 0.0 111.485 -178.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.47 -2.73 74.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.102 170.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -103.02 103.09 31.86 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 168.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.28 -174.72 1.49 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.769 2.979 . . . . 0.0 113.05 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 mt -65.57 146.03 99.0 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 125.612 1.565 . . . . 0.0 109.964 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 C-N-CA 123.712 2.942 . . . . 0.0 110.786 -173.66 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 . . . . . 0 C--O 1.242 0.662 0 CA-C-O 121.597 0.713 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 15' ' ' GLN . 11.6 m -73.07 -116.7 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.07 2.148 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 137.92 -76.13 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 1 C-N-CA 134.271 5.028 . . . . 0.0 106.195 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -95.22 10.95 34.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' THR . . . 68.64 -27.74 0.15 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.762 -1.836 . . . . 0.0 113.394 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -69.12 17.73 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.362 1.465 . . . . 0.0 113.249 170.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' HB2' HG23 ' A' ' 10' ' ' THR . 19.5 mm100 -115.2 -11.04 12.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.882 1.673 . . . . 0.0 110.702 168.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.83 162.54 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -138.58 131.14 29.03 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 124.932 1.293 . . . . 0.0 107.925 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.22 -133.47 4.14 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.1 m -133.11 152.53 51.95 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -109.82 145.91 35.93 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.007 0.821 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -130.02 170.29 14.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.243 2.217 . . . . 0.0 107.682 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -152.97 154.35 34.81 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 121.883 -0.511 . . . . 0.0 109.833 159.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -144.53 157.68 44.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.411 1.485 . . . . 0.0 109.154 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 97' ' ' SER . 6.8 m -124.28 114.73 19.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -98.62 146.71 25.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -82.46 132.16 35.21 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 161.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 70.9 tttt -67.25 100.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.977 1.311 . . . . 0.0 107.84 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -89.45 -92.69 0.12 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.047 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -105.87 130.2 53.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 45.7 mtt 58.62 -54.49 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.671 2.388 . . . . 0.0 114.869 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . -175.48 -167.41 34.51 Favored Glycine 0 N--CA 1.449 -0.449 0 O-C-N 120.744 -1.222 . . . . 0.0 110.808 -148.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -86.02 152.21 23.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.65 0.95 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.743 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.54 167.82 21.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.823 1.811 . . . . 0.0 108.307 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -125.77 159.88 31.22 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.452 1.501 . . . . 0.0 107.568 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 157.29 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 122.13 0.967 . . . . 0.0 110.333 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -131.02 147.66 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.282 2.233 . . . . 0.0 105.734 165.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.37 21.78 Favored Glycine 0 CA--C 1.507 -0.448 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 154.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.83 -70.06 1.08 Allowed Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -165.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -173.09 -43.77 0.01 OUTLIER 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.116 0.539 . . . . 0.0 111.377 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 161.12 26.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.331 1.052 . . . . 0.0 111.324 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.99 44.83 1.39 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.962 3.775 . . . . 0.0 111.522 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -16.31 1.04 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.089 0.955 . . . . 0.0 111.507 169.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.19 130.37 34.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -59.82 147.14 39.28 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.172 0.986 . . . . 0.0 111.086 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.73 132.58 36.29 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.353 -1.749 . . . . 0.0 106.689 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -129.46 152.87 48.53 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.851 0.86 . . . . 0.0 109.012 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.9 t -62.66 113.58 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -61.86 -55.0 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.765 1.626 . . . . 0.0 109.667 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.536 ' HA ' HG23 ' A' ' 65' ' ' THR . 4.3 m -155.31 151.17 27.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.85 1.66 . . . . 0.0 108.051 168.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.63 123.96 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 127.78 86.94 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.75 156.4 66.08 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.894 1.729 . . . . 0.0 109.933 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 76.43 -27.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 127.281 2.232 . . . . 0.0 113.269 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.19 166.6 50.22 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.848 1.213 . . . . 0.0 112.267 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.35 -20.08 48.99 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.229 1.953 . . . . 0.0 112.95 -171.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.38 -51.23 54.47 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.34 89.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.249 1.02 . . . . 0.0 110.426 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.57 -21.05 65.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -87.2 -34.73 18.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.227 1.376 . . . . 0.0 109.963 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.71 -10.67 55.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.392 1.472 . . . . 0.0 114.37 167.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -77.89 -8.53 58.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.953 1.377 . . . . 0.0 113.799 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.7 ttm -118.25 139.92 50.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.709 1.604 . . . . 0.0 108.98 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -133.77 172.12 13.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.769 1.271 . . . . 0.0 109.111 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.551 HG22 HD21 ' A' ' 108' ' ' LEU . 71.9 m -78.28 127.28 32.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.73 -15.82 40.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.531 1.062 . . . . 0.0 113.667 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HB3' HD13 ' A' ' 102' ' ' LEU . 4.3 m-20 -57.13 143.8 37.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.436 1.118 . . . . 0.0 109.708 175.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.23 121.3 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.29 1.836 . . . . 0.0 109.456 -170.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.0 mp -66.03 110.83 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.399 1.879 . . . . 0.0 108.971 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.77 -62.26 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.43 141.24 43.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.581 1.152 . . . . 0.0 109.366 -167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.05 125.55 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 59.48 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.538 2.735 . . . . 0.0 112.18 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.77 11.94 2.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.171 0.896 . . . . 0.0 111.244 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.85 153.48 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 120.344 -1.473 . . . . 0.0 109.032 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.0 p -87.12 138.72 31.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.352 0.978 . . . . 0.0 109.585 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.08 5.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.117 0.967 . . . . 0.0 111.924 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -66.14 -22.29 66.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -163.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.87 66.95 0.53 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 104.834 -3.306 . . . . 0.0 104.834 157.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -121.94 168.94 11.31 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.637 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 p -74.49 136.47 42.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -54.32 -32.11 55.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.417 0.687 . . . . 0.0 110.589 162.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.32 -40.18 89.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.455 1.025 . . . . 0.0 112.407 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.23 -44.84 28.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.219 0.918 . . . . 0.0 109.955 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 t -59.95 -42.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 O-C-N 120.179 -1.575 . . . . 0.0 111.205 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.02 -32.45 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 120.738 -1.226 . . . . 0.0 110.792 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -44.56 94.89 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.47 -0.769 . . . . 0.0 109.215 169.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.13 -36.23 81.43 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.701 -166.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -69.83 -22.81 63.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -87.67 -18.41 29.63 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.982 -1.074 . . . . 0.0 110.971 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -65.07 -17.34 64.37 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.472 -0.768 . . . . 0.0 112.639 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.57 121.72 74.89 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.884 1.274 . . . . 0.0 107.762 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.3 159.82 33.75 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.014 1.809 . . . . 0.0 112.31 167.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.33 152.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.184 -0.947 . . . . 0.0 109.316 162.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.05 -9.47 38.83 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.693 1.616 . . . . 0.0 113.154 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -95.55 163.5 13.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.18 1.99 . . . . 0.0 108.975 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 24' ' ' THR . 20.8 p -116.08 146.78 41.94 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.986 0.914 . . . . 0.0 110.191 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.91 145.12 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 122.843 0.457 . . . . 0.0 109.919 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.34 157.21 22.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 mt -145.94 114.23 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -89.69 127.36 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 67' ' ' ASP . 19.2 mt -121.96 168.89 11.38 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.272 0.983 . . . . 0.0 110.551 173.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.2 t -126.55 141.55 51.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.819 1.247 . . . . 0.0 109.742 171.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.669 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -111.28 155.76 22.52 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 128.653 2.781 . . . . 0.0 109.609 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.75 -30.95 5.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.68 1.61 . . . . 0.0 110.993 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -67.73 139.06 93.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.504 1.122 . . . . 0.0 110.214 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.39 171.67 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.245 1.963 . . . . 0.0 111.191 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 65' ' ' THR . 20.0 mt -66.3 161.89 53.35 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 109.896 173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 CA--C 1.532 0.387 0 C-N-CA 121.662 1.575 . . . . 0.0 111.581 -179.175 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.2 t80 . . . . . 0 C--O 1.235 0.301 0 CA-C-O 121.423 0.63 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.2 m -85.76 -104.46 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.13 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 119.32 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 1 C-N-CA 134.879 5.272 . . . . 0.0 110.8 -172.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -126.38 6.55 7.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -158.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.95 -1.43 0.36 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 129.264 3.025 . . . . 0.0 115.74 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 t -84.04 -16.52 43.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.082 1.31 . . . . 0.0 110.975 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.98 67.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.024 -1.465 . . . . 0.0 111.913 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.73 138.06 57.12 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.462 1.483 . . . . 0.0 108.124 -163.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -106.48 126.29 52.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -174.09 30.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.844 2.164 . . . . 0.0 108.323 -167.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 m -95.38 160.4 14.55 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.41 ' C ' HD23 ' A' ' 21' ' ' LEU . 6.5 m-85 -118.39 131.13 56.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 122.374 1.083 . . . . 0.0 108.31 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -153.34 163.14 40.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -169.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.33 155.85 43.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.6 t -148.38 157.36 43.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.928 161.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 m -109.32 114.87 28.92 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 57' ' ' ALA . 3.3 mt -98.32 144.64 27.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -89.16 141.42 28.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 16.3 tptt -72.75 101.44 3.1 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -74.68 -175.72 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.027 0.83 . . . . 0.0 109.827 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -51.42 -31.76 24.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.278 1.431 . . . . 0.0 112.65 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 mtp -107.86 14.25 25.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.04 1.736 . . . . 0.0 111.766 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 90.85 -110.48 3.82 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.2 152.34 41.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.702 1.251 . . . . 0.0 110.138 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.86 25.84 5.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.433 1.016 . . . . 0.0 112.944 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.56 173.27 11.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.001 1.401 . . . . 0.0 107.506 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -135.64 159.62 41.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.28 1.032 . . . . 0.0 108.624 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.37 162.04 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.519 1.128 . . . . 0.0 108.933 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.1 tt -132.62 156.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.419 2.287 . . . . 0.0 107.423 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.62 153.08 23.41 Favored Glycine 0 N--CA 1.461 0.358 0 C-N-CA 127.909 2.671 . . . . 0.0 107.672 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.51 -75.01 0.35 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -172.39 -59.46 0.02 OUTLIER 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.956 -168.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 163.33 36.5 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 126.745 2.018 . . . . 0.0 109.937 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.94 48.25 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.88 3.053 . . . . 0.0 110.948 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -154.46 -9.83 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.418 -1.277 . . . . 0.0 114.265 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -67.31 143.56 56.34 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.753 1.615 . . . . 0.0 109.85 169.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -78.58 125.72 29.76 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.26 138.57 34.57 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.218 1.807 . . . . 0.0 108.613 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.93 153.2 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.017 0.371 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.9 t -65.76 111.3 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -60.49 -48.86 79.92 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.685 1.594 . . . . 0.0 110.983 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 m -160.92 150.44 17.1 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.355 1.862 . . . . 0.0 107.306 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.7 t -101.83 121.75 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 163.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.96 128.76 84.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.28 152.21 82.28 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.268 1.979 . . . . 0.0 110.332 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.59 -15.31 0.07 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.369 2.268 . . . . 0.0 113.369 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.78 161.5 46.53 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.265 -1.522 . . . . 0.0 111.581 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.2 -20.93 55.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 0.0 113.193 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -69.09 -51.11 42.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.287 0.635 . . . . 0.0 110.842 171.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.79 90.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.446 0.567 . . . . 0.0 110.11 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -65.15 -6.59 9.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.588 1.155 . . . . 0.0 113.973 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -92.11 -20.02 21.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.686 1.584 . . . . 0.0 110.982 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.14 32.08 82.99 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.826 1.203 . . . . 0.0 114.333 170.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -136.19 -39.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 112.739 -169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 ttm -89.9 140.28 29.77 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -137.27 168.7 19.12 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 125.713 1.883 . . . . 0.0 110.801 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -78.88 160.4 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.87 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.25 -19.3 13.76 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.691 1.138 . . . . 0.0 112.614 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.8 m-20 -70.88 152.97 43.12 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.868 1.334 . . . . 0.0 110.805 -173.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.63 131.71 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.435 1.894 . . . . 0.0 108.347 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.71 126.73 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.751 1.62 . . . . 0.0 108.305 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.19 -60.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 109.556 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -134.5 153.05 52.13 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.392 1.077 . . . . 0.0 108.917 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mt -126.45 108.65 19.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 72.36 -61.95 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 128.824 2.849 . . . . 0.0 110.542 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -149.19 -25.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.859 2.064 . . . . 0.0 110.477 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.83 131.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.243 1.417 . . . . 0.0 108.981 -168.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -65.05 131.89 47.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 108.824 165.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.67 5.47 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 123.375 0.67 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.51 1.124 . . . . 0.0 111.67 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.16 53.54 0.75 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 166.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -95.86 158.48 15.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 156.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -76.05 156.41 33.98 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -56.23 -27.08 53.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.485 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.96 -52.51 65.19 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.082 1.31 . . . . 0.0 110.722 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.7 -42.79 73.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.914 0.486 . . . . 0.0 109.819 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.294 -1.503 . . . . 0.0 111.549 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.32 -40.34 88.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 121.138 -0.976 . . . . 0.0 109.315 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.933 1.242 . . . . 0.0 111.091 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.29 -46.83 75.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -64.85 -40.11 94.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.056 0.844 . . . . 0.0 111.265 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.25 -33.65 75.96 Favored 'General case' 0 C--O 1.231 0.104 0 O-C-N 121.343 -0.848 . . . . 0.0 111.551 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.2 m -56.98 -22.99 42.61 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.886 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.0 114.06 51.82 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 167.0 14.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.415 2.743 . . . . 0.0 111.848 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.4 98.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.772 1.629 . . . . 0.0 108.473 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.18 -17.11 3.39 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.045 1.307 . . . . 0.0 112.65 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.16 164.96 18.83 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 p -120.48 147.2 45.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 109.111 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.1 138.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.536 0.734 . . . . 0.0 109.163 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -83.87 153.81 23.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.269 1.428 . . . . 0.0 109.404 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 mt -144.1 109.37 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.84 121.3 38.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 67' ' ' ASP . 7.5 mt -118.57 160.81 21.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 124.508 1.13 . . . . 0.0 109.92 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -107.53 119.17 38.68 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 168.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 21' ' ' LEU . 16.6 ttm180 -84.32 126.02 32.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.675 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.69 -3.47 9.35 Favored Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.096 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -65.8 142.67 98.24 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 163.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.66 175.34 8.98 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 109.866 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.35 161.43 42.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 167.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 C-N-CA 122.357 2.038 . . . . 0.0 111.656 172.59 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.5 t80 . . . . . 0 C--O 1.243 0.731 0 CA-C-O 122.785 1.279 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 m -81.54 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 125.898 1.679 . . . . 0.0 110.295 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 130.88 -44.72 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.458 1 C-N-CA 134.363 5.065 . . . . 0.0 110.427 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -124.66 18.14 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -161.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.69 -3.5 0.05 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.914 2.086 . . . . 0.0 114.873 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -66.42 -43.25 86.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 120.721 -1.237 . . . . 0.0 111.171 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -78.33 7.09 6.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.68 164.75 26.23 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.391 -1.443 . . . . 0.0 108.558 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -129.35 -1.78 5.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.14 174.07 55.29 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.91 -1.119 . . . . 0.0 110.58 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -86.03 150.41 24.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.038 0.919 . . . . 0.0 108.838 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -100.39 147.43 25.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.673 1.589 . . . . 0.0 109.811 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 mp -140.36 163.84 31.72 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.252 1.021 . . . . 0.0 109.975 -172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 p -147.43 119.93 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.147 0.579 . . . . 0.0 112.263 -174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -127.59 150.68 49.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -119.36 114.96 23.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.8 134.98 40.92 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -82.86 140.87 32.66 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 166.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -65.27 101.14 0.52 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -142.51 158.44 43.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.134 1.374 . . . . 0.0 111.546 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 63.42 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 127.346 2.259 . . . . 0.0 110.048 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.7 mtt -141.15 88.42 2.16 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 154.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.78 -110.41 3.15 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.851 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -125.95 140.33 52.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.702 1.251 . . . . 0.0 109.445 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.5 38.89 2.29 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.381 0.991 . . . . 0.0 112.413 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.65 169.1 20.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -131.55 166.07 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.08 162.24 25.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 109.021 -171.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 tt -136.71 154.93 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.581 1.952 . . . . 0.0 107.706 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.69 152.22 22.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.0 -2.84 . . . . 0.0 106.0 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.38 -67.8 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 124.574 1.083 . . . . 0.0 111.563 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.79 -30.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.764 1.226 . . . . 0.0 110.766 160.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -116.18 168.87 7.84 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.675 1.19 . . . . 0.0 112.156 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.22 75.4 4.65 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.25 2.633 . . . . 0.0 108.509 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -169.2 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.501 1.92 . . . . 0.0 109.341 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -80.2 137.93 36.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.533 0.682 . . . . 0.0 109.505 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.97 130.49 41.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.385 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.81 137.15 35.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.564 1.146 . . . . 0.0 108.8 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -136.77 151.86 49.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.516 0.726 . . . . 0.0 110.799 -171.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.85 112.43 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -66.37 -52.96 41.5 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.043 1.737 . . . . 0.0 110.273 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -150.84 149.95 30.32 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.345 1.458 . . . . 0.0 107.587 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.08 120.03 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 160.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.75 128.6 93.93 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.57 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.07 1.847 . . . . 0.0 110.147 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.47 56.41 2.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 111.77 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.08 167.3 24.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.138 1.351 . . . . 0.0 110.079 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -69.18 -18.31 39.77 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 0.0 113.739 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.35 4.58 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.19 -37.27 54.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.798 1.639 . . . . 0.0 111.557 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.77 -14.1 58.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.711 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -84.1 -22.25 31.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.832 2.105 . . . . 0.0 111.441 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.52 30.14 71.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.897 163.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -122.05 -26.01 4.83 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.78 1.79 . . . . 0.0 112.701 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -86.65 141.61 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.644 1.178 . . . . 0.0 108.388 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -131.25 169.29 16.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.48 1.133 . . . . 0.0 108.047 165.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.7 m -65.3 145.1 56.63 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.774 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 -18.47 44.58 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.518 1.056 . . . . 0.0 113.918 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.32 143.59 55.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.996 1.398 . . . . 0.0 109.987 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.14 120.98 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.183 1.393 . . . . 0.0 109.249 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.2 mp -71.15 114.1 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.266 1.426 . . . . 0.0 107.994 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.57 -60.4 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.157 0.983 . . . . 0.0 109.696 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.66 149.74 52.17 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -120.89 120.95 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 64.52 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.971 1.708 . . . . 0.0 108.284 -172.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -138.89 -10.63 1.32 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.79 1.636 . . . . 0.0 111.34 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.18 127.07 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 107.614 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.8 t -71.78 128.17 34.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 168.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.22 17.4 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 125.773 1.629 . . . . 0.0 109.02 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -35.93 76.46 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 120.719 -1.238 . . . . 0.0 112.251 -166.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.45 38.82 2.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.225 1.869 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 170.0 16.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.283 1.041 . . . . 0.0 110.255 167.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -74.92 139.94 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 164.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -52.31 -45.72 65.68 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.913 0.885 . . . . 0.0 109.33 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -22.29 43.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.31 -51.71 5.42 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 119.51 1.05 . . . . 0.0 111.187 173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.17 -36.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.129 2.172 . . . . 0.0 111.437 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.38 -41.19 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.873 0.869 . . . . 0.0 110.416 171.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -36.92 82.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 108.658 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.49 -38.31 89.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.969 0.908 . . . . 0.0 110.006 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.4 -30.13 65.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.407 1.003 . . . . 0.0 111.247 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -64.71 -37.04 86.24 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.294 0.952 . . . . 0.0 110.123 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.7 p -66.58 -6.17 14.22 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.78 103.83 7.89 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.89 167.14 27.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.866 1.711 . . . . 0.0 111.869 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.88 122.57 9.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.698 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.68 -11.65 46.18 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.956 -1.469 . . . . 0.0 113.891 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -83.51 162.01 21.04 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.419 1.609 . . . . 0.0 108.719 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.0 138.02 50.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.244 1.018 . . . . 0.0 110.92 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 m -129.05 142.66 43.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 C-N-CA 124.36 1.064 . . . . 0.0 109.118 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.61 159.16 22.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.95 114.57 7.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.45 115.52 29.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.96 164.27 12.42 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 124.029 0.83 . . . . 0.0 109.068 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -121.95 129.42 52.49 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.392 1.477 . . . . 0.0 107.15 166.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.56 ' HB2' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.55 156.81 36.45 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.488 1.915 . . . . 0.0 109.606 173.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.48 -10.48 73.24 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.13 149.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -64.28 137.63 97.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 150.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.22 175.73 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.253 2.635 . . . . 0.0 109.827 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.8 162.33 9.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 122.682 0.393 . . . . 0.0 109.955 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.457 -0.641 0 C-N-CA 122.012 1.808 . . . . 0.0 111.888 178.407 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.4 t80 . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 121.341 0.591 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -85.43 -112.7 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.47 2.308 . . . . 0.0 110.924 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 142.66 -71.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 1 C-N-CA 134.021 4.928 . . . . 0.0 108.838 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.35 14.57 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.15 0.98 . . . . 0.0 113.509 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 71.58 -12.21 0.66 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.44 2.296 . . . . 0.0 113.814 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.211 1.004 . . . . 0.0 111.552 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -83.44 0.61 45.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.204 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.45 140.53 52.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 162.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -105.74 132.09 52.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.45 -165.57 31.44 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -135.07 136.53 42.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 70' ' ' VAL . 22.7 m-85 -102.84 149.12 24.81 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.838 0.855 . . . . 0.0 110.099 -168.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.83 169.02 18.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.874 2.069 . . . . 0.0 108.664 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.22 142.35 42.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.926 1.29 . . . . 0.0 108.929 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -141.26 157.2 45.54 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.607 -0.683 . . . . 0.0 109.274 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 m -131.59 106.49 8.22 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.97 156.33 16.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -106.79 138.23 43.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 10.1 tttt -61.43 103.45 0.31 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.502 1.521 . . . . 0.0 110.355 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.7 p -83.03 -173.11 4.52 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.637 1.108 . . . . 0.0 110.489 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -37.78 61.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.647 1.179 . . . . 0.0 112.237 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.2 ptm -105.05 13.14 31.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.911 1.285 . . . . 0.0 113.42 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.609 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 97.16 -106.36 3.33 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.28 152.2 44.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.77 39.46 3.02 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.92 166.41 28.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.616 1.208 . . . . 0.0 108.323 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -135.45 154.5 51.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.248 1.419 . . . . 0.0 107.705 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.51 160.76 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 109.835 -170.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -136.05 159.82 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.601 2.76 . . . . 0.0 107.388 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.64 152.2 21.16 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -76.77 0.17 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.356 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -171.38 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.752 1.276 . . . . 0.0 113.112 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.54 167.58 22.12 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.729 1.212 . . . . 0.0 110.821 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.85 35.66 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.106 1 C-N-CA 125.753 4.302 . . . . 0.0 113.961 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.31 -15.79 0.29 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.563 1.545 . . . . 0.0 112.282 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.96 165.61 23.85 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 122.063 0.935 . . . . 0.0 111.065 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -71.17 157.5 38.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 mt -116.33 133.43 56.03 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.606 2.363 . . . . 0.0 107.521 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -130.62 154.05 48.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.519 0.728 . . . . 0.0 111.784 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.95 109.71 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 165.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -63.2 -43.31 98.53 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.732 1.613 . . . . 0.0 110.935 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.22 142.39 13.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.867 1.667 . . . . 0.0 108.824 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 64' ' ' GLU . 19.7 t -92.01 122.67 43.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 161.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.17 132.44 63.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.096 1.358 . . . . 0.0 107.786 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.1 168.36 14.15 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.738 1.626 . . . . 0.0 110.924 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.27 28.0 17.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 111.238 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.02 177.8 16.43 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.055 1.788 . . . . 0.0 113.943 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 -28.22 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.808 2.339 . . . . 0.0 111.904 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.6 59.79 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.05 72.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.658 0.783 . . . . 0.0 112.779 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.56 -19.72 55.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.402 1.001 . . . . 0.0 113.296 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.3 -42.36 14.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.84 0.856 . . . . 0.0 109.776 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.72 2.5 60.94 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.993 1.282 . . . . 0.0 114.508 171.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.01 -7.16 59.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.736 1.768 . . . . 0.0 112.7 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.8 ttp -122.31 141.1 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.753 1.621 . . . . 0.0 109.358 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.828 ' HA ' HG21 ' A' ' 51' ' ' VAL . 3.6 pt-20 -140.93 -179.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.461 1.104 . . . . 0.0 110.065 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 HD21 ' A' ' 108' ' ' LEU . 71.3 m -88.49 133.96 33.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.849 1.26 . . . . 0.0 109.613 -173.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.28 -14.04 59.79 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.404 1.478 . . . . 0.0 112.323 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 102' ' ' LEU . 29.5 m-20 -60.35 148.25 37.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.982 0.913 . . . . 0.0 110.809 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 t -99.33 122.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.651 1.58 . . . . 0.0 108.606 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 102' ' ' LEU . 4.7 mp -74.59 106.36 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 109.28 174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' PHE . 6.7 t -80.75 -57.6 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -132.14 149.54 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.073 0.949 . . . . 0.0 108.914 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.65 116.39 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 170.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.41 -57.05 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 130.624 3.569 . . . . 0.0 113.941 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.42 6.38 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.466 2.306 . . . . 0.0 111.611 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.92 128.31 64.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.009 1.324 . . . . 0.0 108.295 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.4 p -78.27 87.13 4.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 110.746 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 1.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.963 0.905 . . . . 0.0 112.08 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -17.95 45.63 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -167.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.71 22.64 7.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.787 1.184 . . . . 0.0 111.307 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.06 167.72 11.05 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.697 1.249 . . . . 0.0 110.444 -175.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.3 p -72.12 138.59 47.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -53.37 -44.84 68.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.705 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -36.02 69.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.583 1.538 . . . . 0.0 113.477 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.07 -56.98 8.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.893 0.877 . . . . 0.0 109.688 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.59 -42.94 52.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 128.191 2.596 . . . . 0.0 111.633 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.19 -38.93 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 120.734 -1.229 . . . . 0.0 108.871 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -33.74 75.02 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.306 -0.871 . . . . 0.0 111.267 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -50.8 69.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.955 1.302 . . . . 0.0 108.743 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.64 -40.09 93.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.393 0.542 . . . . 0.0 110.957 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -69.5 -31.78 70.24 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.482 -0.761 . . . . 0.0 111.715 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 55.4 p -70.07 -0.46 7.68 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.024 0.829 . . . . 0.0 113.141 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 t -84.4 112.45 41.84 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 168.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.21 175.29 10.46 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.971 1.78 . . . . 0.0 112.037 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 150.49 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.671 1.188 . . . . 0.0 108.17 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.86 -15.69 51.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.246 1.403 . . . . 0.0 112.334 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -96.29 164.2 12.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.419 1.609 . . . . 0.0 110.792 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -132.28 155.61 48.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.899 2.479 . . . . 0.0 108.553 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.86 147.69 21.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.129 0.971 . . . . 0.0 109.971 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.68 153.54 21.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -141.04 148.87 40.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.04 118.94 39.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.0 mt -114.41 165.79 12.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 124.095 0.872 . . . . 0.0 110.15 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -127.32 124.6 39.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.269 1.428 . . . . 0.0 108.133 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -102.73 132.44 48.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.413 1.885 . . . . 0.0 108.649 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.61 6.07 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.712 0.672 . . . . 0.0 112.45 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -103.84 130.98 22.44 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 160.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -70.77 172.54 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.549 2.166 . . . . 0.0 111.669 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD21 HG22 ' A' ' 65' ' ' THR . 10.7 mt -70.82 152.5 95.1 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 C--N 1.347 0.493 0 C-N-CA 123.347 2.698 . . . . 0.0 111.558 175.772 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 10' ' ' THR 0.271 27.5 t80 . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.433 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 25.1 m -127.6 -98.49 0.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 126.589 1.956 . . . . 0.0 109.945 -173.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 121.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 1 C-N-CA 135.112 5.365 . . . . 0.0 109.786 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.41 0.43 24.84 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.72 -24.68 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.841 2.856 . . . . 0.0 114.178 -169.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -57.59 -34.28 69.07 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -80.78 7.47 10.3 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.018 0.527 . . . . 0.0 112.392 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 mt -77.23 170.61 16.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.495 -1.378 . . . . 0.0 110.287 171.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.01 105.1 7.19 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.154 1.381 . . . . 0.0 109.26 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.37 -179.22 25.39 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.232 1.396 . . . . 0.0 111.561 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -77.9 134.78 37.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.484 0.713 . . . . 0.0 109.306 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.24 138.62 32.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.936 0.894 . . . . 0.0 108.648 169.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.01 173.47 12.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.792 1.237 . . . . 0.0 109.696 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 p -145.59 170.33 16.65 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -155.94 155.56 33.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.363 1.065 . . . . 0.0 109.977 159.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.8 m -102.69 115.19 30.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.777 1.231 . . . . 0.0 108.523 163.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.37 137.33 39.85 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -81.68 137.23 35.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 166.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -64.72 108.83 1.83 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 165.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 t -137.16 161.95 34.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 56.31 -91.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.564 1.946 . . . . 0.0 112.642 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.8 ptm -138.47 30.14 2.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.656 1.582 . . . . 0.0 110.72 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.3 176.47 21.37 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.181 1.372 . . . . 0.0 110.693 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -64.73 147.88 52.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.162 -0.61 . . . . 0.0 109.896 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.45 33.37 1.82 Allowed Glycine 0 C--O 1.222 -0.637 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.469 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -149.81 164.3 35.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.734 1.767 . . . . 0.0 108.465 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -132.93 154.84 50.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.61 159.19 17.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.857 1.263 . . . . 0.0 108.58 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -121.75 164.12 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.922 2.089 . . . . 0.0 107.559 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.07 151.85 17.52 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.2 -14.12 55.66 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.563 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t0 80.52 -36.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.623 2.769 . . . . 0.0 109.93 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -72.46 167.61 31.25 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 125.709 1.604 . . . . 0.0 111.225 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -100.63 32.22 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.379 3.386 . . . . 0.0 113.256 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -158.24 37.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.157 0.983 . . . . 0.0 109.954 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.54 153.79 48.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.324 1.059 . . . . 0.0 112.537 -165.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.78 116.87 15.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.249 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.81 124.15 29.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -115.26 151.94 33.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.324 0.965 . . . . 0.0 109.81 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.46 118.99 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 120.707 -1.246 . . . . 0.0 107.819 165.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -52.11 43.95 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.643 1.977 . . . . 0.0 109.72 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -157.76 153.52 26.69 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.647 1.179 . . . . 0.0 109.644 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.1 t -96.97 113.8 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 164.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.93 130.97 87.74 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.505 1.922 . . . . 0.0 108.192 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.89 161.65 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.378 2.052 . . . . 0.0 111.192 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.61 10.09 0.95 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.431 2.293 . . . . 0.0 113.042 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.51 161.19 21.28 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.587 1.565 . . . . 0.0 110.553 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.96 -25.12 74.05 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 112.837 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.17 70.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.212 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.75 95.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.469 0.708 . . . . 0.0 110.38 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -66.58 -43.22 85.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.29 0.636 . . . . 0.0 110.981 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.28 -38.77 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.266 1.026 . . . . 0.0 111.164 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.89 11.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.686 2.088 . . . . 0.0 115.347 169.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.76 -39.08 87.74 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.292 -1.122 . . . . 0.0 109.963 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 tpp -67.6 131.77 46.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.526 1.131 . . . . 0.0 108.595 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -134.87 161.74 34.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.906 0.86 . . . . 0.0 108.727 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 156.92 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.6 70.88 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.481 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 102' ' ' LEU . 65.6 m-20 -83.88 162.66 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.827 1.814 . . . . 0.0 109.562 168.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -116.54 125.73 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 127.185 2.194 . . . . 0.0 108.388 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -73.72 105.21 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 126.917 2.087 . . . . 0.0 108.459 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -84.08 -57.5 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.811 0.815 . . . . 0.0 109.768 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -135.59 139.89 44.21 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -165.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.16 133.76 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 58.51 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 127.756 2.423 . . . . 0.0 113.776 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -150.06 21.97 0.86 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.598 1.559 . . . . 0.0 109.77 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.67 152.51 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.157 1.383 . . . . 0.0 108.205 -162.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.6 p -87.06 137.59 32.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.087 0.955 . . . . 0.0 109.805 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.84 15.28 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.275 1.43 . . . . 0.0 110.49 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 -31.92 66.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 113.315 -159.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.93 49.2 0.93 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.6 1.571 . . . . 0.0 109.41 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -99.16 170.28 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.303 1.041 . . . . 0.0 112.016 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -79.2 133.39 36.69 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.579 -1.325 . . . . 0.0 108.535 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.88 -40.44 66.6 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.273 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.29 76.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.76 1.618 . . . . 0.0 112.074 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.23 -46.37 50.64 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.019 0.928 . . . . 0.0 110.288 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.48 -41.8 93.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 110.769 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.5 t -61.45 -42.79 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.216 172.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.61 75.5 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.11 0.868 . . . . 0.0 110.055 173.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.14 -37.91 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.149 0.98 . . . . 0.0 109.701 -174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' HE1' HD21 ' A' ' 100' ' ' LEU . 49.6 m-85 -70.2 -32.16 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.923 -0.486 . . . . 0.0 112.014 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -69.14 -33.38 73.35 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.287 0.948 . . . . 0.0 110.987 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -58.91 -16.11 16.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 0.0 113.749 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.6 110.2 25.57 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.763 1.625 . . . . 0.0 107.85 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.25 168.23 21.48 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.419 2.079 . . . . 0.0 110.535 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.29 125.98 7.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 164.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.11 -27.57 19.56 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.122 -1.376 . . . . 0.0 112.734 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.03 145.34 28.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.463 2.131 . . . . 0.0 108.286 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.14 162.09 13.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.379 1.072 . . . . 0.0 110.078 171.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.27 157.96 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 125.081 1.352 . . . . 0.0 109.291 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.03 156.59 16.25 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 110.489 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.424 HD21 ' HE1' ' A' ' 89' ' ' PHE . 19.6 mt -143.86 132.99 22.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.1 t -98.97 123.19 51.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 160.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 67' ' ' ASP . 2.5 mt -108.19 160.7 15.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.248 0.967 . . . . 0.0 109.062 171.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.6 t -118.92 121.71 40.59 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -76.06 156.24 34.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.435 1.094 . . . . 0.0 108.653 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.75 -20.78 11.71 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 117.836 -1.536 . . . . 0.0 114.329 162.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -81.22 141.46 49.92 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 120.254 2.027 . . . . 0.0 107.94 165.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.97 170.27 20.5 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.32 2.013 . . . . 0.0 111.109 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.73 165.08 13.3 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.69 169.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo . . . . . 0 CA--C 1.537 0.673 0 C-N-CA 122.944 2.429 . . . . 0.0 112.78 175.74 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 t80 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.904 0.859 . . . . 0.0 112.738 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 m -77.59 -118.49 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.121 1.368 . . . . 0.0 110.2 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 135.73 -23.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 1 C-N-CA 134.215 5.006 . . . . 0.0 113.283 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -142.14 15.57 2.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.85 1.205 . . . . 0.0 113.637 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.5 -6.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.735 2.014 . . . . 0.0 114.514 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -73.8 -25.95 60.38 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.634 -1.291 . . . . 0.0 111.995 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.09 -11.06 60.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.544 1.065 . . . . 0.0 112.532 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.2 140.18 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.27 0.941 . . . . 0.0 109.652 -172.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -117.81 113.22 21.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.82 -175.27 30.66 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.006 -158.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -125.38 139.26 53.82 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -104.34 137.81 41.68 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.769 1.628 . . . . 0.0 110.411 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 175.55 12.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.562 1.945 . . . . 0.0 108.999 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -135.09 170.36 16.02 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 110.413 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -149.61 153.41 37.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.994 1.318 . . . . 0.0 107.883 170.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 m -115.83 105.49 12.75 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.04 132.7 44.16 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -82.87 146.44 28.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -77.65 76.71 4.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.381 1.072 . . . . 0.0 108.252 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -63.01 115.22 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 46.5 -91.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.673 2.389 . . . . 0.0 112.486 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.1 mtp -53.29 -56.09 19.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.612 2.365 . . . . 0.0 111.067 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.72 176.6 21.45 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -148.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -75.98 125.62 29.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.55 55.06 3.72 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.453 0.549 . . . . 0.0 112.056 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -143.02 157.97 44.04 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -125.78 157.87 36.39 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.43 162.92 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.901 1.281 . . . . 0.0 109.36 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.445 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 16.3 tt -126.36 146.49 32.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.905 1.682 . . . . 0.0 107.964 171.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.27 151.23 22.1 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.442 1.089 . . . . 0.0 111.064 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 44' ' ' GLU . . . -51.44 -82.86 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 C-N-CA 128.874 3.13 . . . . 0.0 112.512 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.44 -34.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.409 1.084 . . . . 0.0 112.424 -170.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -122.26 165.15 21.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.056 1.342 . . . . 0.0 110.492 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.53 47.4 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.158 3.238 . . . . 0.0 112.624 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -164.58 16.01 0.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.962 2.105 . . . . 0.0 112.128 -172.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 1.5 pp20? -91.62 165.63 13.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.538 2.335 . . . . 0.0 111.634 171.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.75 118.18 35.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.473 1.109 . . . . 0.0 110.336 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.8 mt -80.0 129.46 34.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -128.69 154.25 46.51 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.306 1.042 . . . . 0.0 110.46 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.01 114.81 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -68.22 -52.18 37.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.462 1.505 . . . . 0.0 110.414 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -156.65 151.12 25.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.575 1.15 . . . . 0.0 108.991 172.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -91.62 127.26 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 168.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.55 131.8 87.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -68.26 163.18 37.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.171 1.914 . . . . 0.0 111.2 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.35 49.92 3.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.031 1.732 . . . . 0.0 112.091 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.1 175.7 22.07 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.391 1.472 . . . . 0.0 110.744 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.87 -22.8 31.05 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.814 2.343 . . . . 0.0 113.425 -168.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.22 -51.19 11.36 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.076 0.853 . . . . 0.0 109.04 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.655 1.182 . . . . 0.0 110.314 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.64 -36.31 76.12 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.91 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -74.85 -20.85 59.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.235 0.925 . . . . 0.0 112.01 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.41 61.16 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.183 1.373 . . . . 0.0 115.723 163.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -87.48 -20.66 26.25 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.22 1.51 . . . . 0.0 111.35 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 ttm -110.98 143.92 40.9 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.716 1.606 . . . . 0.0 109.668 -169.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.08 -179.18 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.43 1.492 . . . . 0.0 108.312 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -95.54 158.42 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.36 0.664 . . . . 0.0 109.613 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.83 -14.73 24.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.481 0.563 . . . . 0.0 111.966 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 102' ' ' LEU . 12.4 m-20 -64.35 151.69 43.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.117 0.967 . . . . 0.0 109.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.23 121.0 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.686 1.595 . . . . 0.0 107.999 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.76 129.32 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.62 -58.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.447 1.092 . . . . 0.0 110.953 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.92 151.27 50.72 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.349 0.66 . . . . 0.0 109.933 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -132.25 117.03 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.23 -73.04 0.05 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.839 2.456 . . . . 0.0 110.026 -170.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -147.51 -10.73 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.1 1.76 . . . . 0.0 110.685 173.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 123.73 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.46 1.504 . . . . 0.0 107.977 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.9 p -67.5 110.13 3.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.414 0.686 . . . . 0.0 109.344 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.45 8.63 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.718 -0.614 . . . . 0.0 111.805 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 1.6 pp -55.19 -33.87 63.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -165.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.79 17.26 10.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 120.025 1.284 . . . . 0.0 111.397 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -73.16 158.06 36.0 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -82.74 146.47 28.99 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -56.53 -32.74 65.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 110.821 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.47 -57.79 10.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.097 -1.002 . . . . 0.0 110.896 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.36 -43.25 81.93 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.39 0.614 . . . . 0.0 109.559 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.99 -41.79 87.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 119.839 -1.788 . . . . 0.0 111.198 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.45 -39.44 80.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.295 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -35.22 80.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.38 0.991 . . . . 0.0 110.144 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.7 -45.51 86.31 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.047 1.739 . . . . 0.0 109.011 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -61.08 -32.6 72.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.513 -0.742 . . . . 0.0 111.247 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -79.75 -19.79 47.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.082 -1.011 . . . . 0.0 112.831 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.8 m -75.12 -6.16 48.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.267 1.427 . . . . 0.0 111.984 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.03 116.67 66.41 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 178.58 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.286 1.991 . . . . 0.0 111.133 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 mt -62.93 144.68 14.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 109.345 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.46 -2.83 51.48 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.7 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -84.22 164.9 18.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.651 1.726 . . . . 0.0 107.788 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 p -127.8 134.24 49.46 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.773 0.715 . . . . 0.0 110.23 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.95 146.88 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.4 148.01 27.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.0 mt -146.69 132.84 19.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.25 130.47 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.56 1.544 . . . . 0.0 108.221 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 67' ' ' ASP . 11.1 mt -117.7 164.94 14.22 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 124.324 1.015 . . . . 0.0 110.389 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.7 t -129.1 132.27 47.38 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.271 1.429 . . . . 0.0 108.433 167.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -104.28 122.29 45.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 126.465 1.906 . . . . 0.0 110.573 -172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 138.04 5.08 1.67 Allowed Glycine 0 N--CA 1.464 0.502 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.835 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -91.75 149.03 38.42 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 118.772 1.286 . . . . 0.0 108.237 167.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.58 168.29 24.73 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.139 1.893 . . . . 0.0 110.987 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.77 144.0 63.65 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.533 0.469 0 C-N-CA 123.702 2.935 . . . . 0.0 112.159 169.052 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.4 t80 . . . . . 0 C--O 1.237 0.413 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -73.31 -117.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.484 2.314 . . . . 0.0 112.841 178.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 10' ' ' THR . 8.7 mtt180 134.06 -16.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 1 C-N-CA 134.581 5.153 . . . . 0.0 111.827 177.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -145.45 13.21 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 59.62 4.6 0.56 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.31 1.444 . . . . 0.0 114.415 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -18.41 32.37 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.534 -1.354 . . . . 0.0 111.947 -174.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.85 -18.33 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.99 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.81 157.72 9.21 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.692 1.133 . . . . 0.0 110.299 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -129.12 93.12 3.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.723 1.209 . . . . 0.0 109.796 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.09 -129.72 1.57 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 125.252 1.406 . . . . 0.0 110.041 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.4 m -136.17 145.72 46.08 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.933 1.693 . . . . 0.0 108.459 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.456 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 m-85 -90.43 144.23 26.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.426 0.69 . . . . 0.0 110.401 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -120.08 165.82 14.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.021 2.128 . . . . 0.0 107.734 173.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.5 p -147.19 162.79 38.16 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.347 0.659 . . . . 0.0 109.945 155.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.75 157.46 38.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 170.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.8 m -120.11 108.22 13.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.14 134.56 40.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -82.24 151.19 26.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -85.45 100.99 12.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -64.08 -53.56 47.8 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -159.97 -71.35 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.317 1.047 . . . . 0.0 110.234 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 ptp -50.84 -40.84 56.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 127.198 2.199 . . . . 0.0 113.595 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.83 -125.63 1.89 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -125.86 145.87 50.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.26 1.03 . . . . 0.0 109.82 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.9 46.98 3.72 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.134 0.873 . . . . 0.0 113.353 -174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -148.54 163.95 35.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.402 1.481 . . . . 0.0 107.62 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.9 p -126.19 163.55 22.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.61 158.86 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.018 1.327 . . . . 0.0 108.281 -168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -129.24 145.03 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.033 1.733 . . . . 0.0 107.926 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.63 22.63 Favored Glycine 0 CA--C 1.518 0.237 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.91 -71.06 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 CA-C-N 117.945 0.872 . . . . 0.0 113.423 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.23 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.276 1.03 . . . . 0.0 109.495 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -113.48 165.7 12.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.17 1.788 . . . . 0.0 110.919 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -79.32 66.79 8.75 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.651 2.901 . . . . 0.0 112.16 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -140.18 -2.09 1.49 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.754 0.822 . . . . 0.0 110.221 146.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -99.35 137.27 38.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.481 -1.387 . . . . 0.0 110.215 -152.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.22 123.71 17.58 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.757 0.823 . . . . 0.0 111.481 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.32 128.8 34.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -134.06 152.66 51.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.346 0.976 . . . . 0.0 110.637 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.34 113.14 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -68.55 -58.18 4.68 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 65' ' ' THR . 69.0 m -154.5 158.81 40.44 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.959 1.304 . . . . 0.0 109.519 163.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.7 138.2 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.1 1.76 . . . . 0.0 107.256 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 141.12 67.93 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.25 28.2 0.4 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.731 3.621 . . . . 0.0 115.693 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.85 -10.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.204 2.202 . . . . 0.0 111.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.52 158.79 46.02 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.49 -21.69 70.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.384 1.389 . . . . 0.0 110.486 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.39 46.34 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.353 1.461 . . . . 0.0 111.501 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.08 71.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.272 1.029 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -72.78 -22.7 60.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.838 -170.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.37 -12.12 60.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.834 1.197 . . . . 0.0 111.351 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.64 25.83 74.28 Favored Glycine 0 CA--C 1.525 0.664 0 O-C-N 121.053 -1.03 . . . . 0.0 113.293 167.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -128.54 -32.64 2.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.293 1.047 . . . . 0.0 113.525 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.8 ttm -95.01 134.66 37.44 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.21 167.67 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.627 1.203 . . . . 0.0 110.675 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 50' ' ' SER . 23.5 m -86.76 117.73 25.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.587 1.555 . . . . 0.0 108.604 -168.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.98 32.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.491 1.043 . . . . 0.0 112.411 -171.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -65.89 146.56 54.59 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.271 1.535 . . . . 0.0 108.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.39 115.69 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.346 1.858 . . . . 0.0 108.817 -169.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.84 125.01 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 125.607 1.563 . . . . 0.0 107.847 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.0 -55.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.281 1.033 . . . . 0.0 110.3 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.67 149.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.49 126.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 t30 67.08 -81.43 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 109.258 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -152.16 20.02 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.784 1.233 . . . . 0.0 111.342 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.58 123.47 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.1 p -62.74 120.84 12.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 163.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.58 13.7 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.384 0.674 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.51 -10.9 8.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -166.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.36 9.57 4.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.928 1.252 . . . . 0.0 111.406 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -71.62 159.5 34.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.967 1.883 . . . . 0.0 111.147 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -83.2 154.61 24.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.17 0.588 . . . . 0.0 109.906 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -55.28 -41.63 72.53 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.416 170.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.38 41.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.505 1.957 . . . . 0.0 112.671 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.12 -47.49 11.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.195 0.521 . . . . 0.0 111.951 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.1 t -63.4 -28.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 120.272 -1.517 . . . . 0.0 112.022 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.8 -44.0 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.501 -1.375 . . . . 0.0 108.438 167.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.9 88.98 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.143 1.338 . . . . 0.0 109.3 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 85' ' ' VAL . 13.4 mt -66.63 -44.82 80.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.353 1.861 . . . . 0.0 109.805 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -69.89 -36.43 75.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.026 0.83 . . . . 0.0 110.26 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -70.3 -17.06 63.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.695 0.798 . . . . 0.0 110.946 174.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 t -96.22 39.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.193 1.797 . . . . 0.0 110.797 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.67 113.8 25.0 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.67 172.65 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.125 1.217 . . . . 0.0 110.075 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.2 mp -60.06 145.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.03 68.16 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.929 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -130.58 169.92 14.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.665 1.233 . . . . 0.0 108.704 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.08 161.39 31.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.845 1.258 . . . . 0.0 110.976 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.47 147.7 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.589 1.156 . . . . 0.0 108.221 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -83.41 156.9 22.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.34 110.67 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.11 122.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.92 167.31 10.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.953 0.783 . . . . 0.0 110.354 170.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.79 129.19 48.94 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.662 1.185 . . . . 0.0 108.139 165.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.595 ' HB2' HD21 ' A' ' 21' ' ' LEU . 5.3 ttm180 -79.84 155.59 27.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.709 1.604 . . . . 0.0 107.184 166.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.17 -19.82 4.83 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.934 169.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.14 156.42 39.01 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 118.726 1.263 . . . . 0.0 109.793 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.38 179.06 3.75 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.969 1.779 . . . . 0.0 110.196 165.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.66 154.33 94.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.819 161.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.643 173.026 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 10' ' ' THR 0.261 34.1 t80 . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 120.867 0.365 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 28.4 m -118.53 -107.06 0.38 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 129.475 3.11 . . . . 0.0 108.295 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 131.42 -70.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 1 C-N-CA 134.433 5.093 . . . . 0.0 108.757 169.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.39 -0.35 52.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.001 0.819 . . . . 0.0 113.171 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 79.52 -11.71 1.16 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.839 2.856 . . . . 0.0 112.569 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 m -72.06 -19.28 61.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -166.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -79.29 -12.78 59.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.855 0.752 . . . . 0.0 112.414 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.15 142.74 52.49 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -125.26 122.85 38.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.51 -122.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -135.57 136.66 41.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -91.44 143.87 26.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.758 1.623 . . . . 0.0 110.522 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.48 166.78 31.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.959 1.703 . . . . 0.0 109.551 172.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -146.34 124.47 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.674 0.79 . . . . 0.0 110.696 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -124.46 157.23 35.71 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.946 0.794 . . . . 0.0 109.101 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.5 m -114.59 112.72 23.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.55 150.86 21.26 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -103.91 149.68 24.87 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -84.2 102.6 12.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.6 m -61.73 -56.93 14.43 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.086 0.555 . . . . 0.0 110.316 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.36 -82.07 0.1 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.315 0.646 . . . . 0.0 109.521 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.3 mtt -62.05 -49.68 75.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.814 0.846 . . . . 0.0 109.143 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 180.0 -162.06 28.23 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -83.03 149.43 26.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.09 30.17 2.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.354 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -135.38 165.5 25.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.457 1.628 . . . . 0.0 108.49 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -123.36 154.41 39.0 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.006 1.322 . . . . 0.0 107.829 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.51 156.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.077 0.951 . . . . 0.0 108.619 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.54 149.63 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.449 2.3 . . . . 0.0 106.452 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.84 152.34 23.04 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.23 -80.74 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 124.454 1.026 . . . . 0.0 112.725 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 178.49 -62.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.739 1.216 . . . . 0.0 110.431 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -82.26 166.49 36.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.438 1.095 . . . . 0.0 112.507 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.79 57.57 5.69 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 124.224 3.283 . . . . 0.0 111.344 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.45 -4.69 0.11 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.725 1.61 . . . . 0.0 113.354 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -95.28 165.86 12.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.133 0.968 . . . . 0.0 111.947 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -84.55 160.34 20.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 111.16 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.8 mt -124.68 138.23 54.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 126.399 1.88 . . . . 0.0 108.184 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.6 mt-30 -134.42 155.24 50.65 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.35 0.977 . . . . 0.0 111.044 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.02 109.81 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.46 -50.01 66.97 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.906 1.683 . . . . 0.0 109.982 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -148.31 158.48 44.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 107.147 170.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.9 t -102.44 128.65 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.903 -2.629 . . . . 0.0 103.903 158.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.02 118.95 71.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.31 135.27 45.76 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t0 73.67 0.29 3.59 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.114 1.766 . . . . 0.0 112.617 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.45 163.77 53.03 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.289 -1.507 . . . . 0.0 109.822 165.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.59 -4.91 9.15 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.045 2.497 . . . . 0.0 114.769 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.87 -49.16 6.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.235 0.925 . . . . 0.0 109.919 172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.31 90.04 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.984 0.514 . . . . 0.0 110.588 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.37 -25.24 68.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.086 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.34 -40.75 29.49 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.456 1.025 . . . . 0.0 109.943 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.38 52.93 14.76 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 125.036 1.303 . . . . 0.0 113.019 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -126.04 -58.9 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 170.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 161.45 27.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 119.19 0.905 . . . . 0.0 109.264 173.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -143.38 173.52 11.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 167.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -74.8 144.61 43.44 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.926 -167.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.92 81.79 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.434 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -64.89 142.86 58.29 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.897 1.849 . . . . 0.0 108.472 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 47' ' ' GLN . 76.2 t -97.9 120.87 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.376 1.87 . . . . 0.0 108.868 -169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.49 118.07 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.18 -54.11 7.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 109.996 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.47 144.88 48.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mt -122.99 111.37 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.3 t30 67.21 -53.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.48 3.112 . . . . 0.0 114.378 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -164.22 6.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.383 2.273 . . . . 0.0 111.247 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.63 121.34 63.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 125.449 1.499 . . . . 0.0 107.66 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.4 p -66.09 120.24 12.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 164.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.05 7.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.457 0.703 . . . . 0.0 111.89 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -9.11 43.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.448 3.099 . . . . 0.0 112.506 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.13 54.47 0.66 Allowed Glycine 0 C--N 1.334 0.463 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 158.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.08 157.83 22.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.99 0.895 . . . . 0.0 111.561 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -77.3 137.63 38.9 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.42 1.088 . . . . 0.0 108.991 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.41 -36.24 73.27 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.03 -1.462 . . . . 0.0 109.622 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.02 41.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.737 1.608 . . . . 0.0 112.694 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.12 -46.38 15.01 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.36 0.664 . . . . 0.0 111.149 176.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.9 t -61.54 -34.62 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 119.163 -2.211 . . . . 0.0 111.664 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.02 -44.48 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.617 1.167 . . . . 0.0 108.98 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -35.6 81.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 110.973 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 85' ' ' VAL . 44.1 mt -62.97 -49.07 76.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.48 -42.38 83.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.625 0.77 . . . . 0.0 111.6 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -62.92 -34.75 78.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.32 -0.862 . . . . 0.0 109.834 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.1 t -75.31 27.26 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.601 1.56 . . . . 0.0 112.418 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.2 t -114.33 106.2 53.02 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.67 164.99 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.423 2.748 . . . . 0.0 113.979 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.22 151.47 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 165.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.71 -0.89 60.12 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.566 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -94.12 165.41 12.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.354 1.577 . . . . 0.0 108.175 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -128.63 163.13 25.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.069 1.348 . . . . 0.0 109.357 165.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.82 148.32 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 125.46 1.504 . . . . 0.0 107.986 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.65 152.87 24.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.701 1.601 . . . . 0.0 109.222 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -144.71 115.52 7.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.7 t -89.54 122.85 41.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 170.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.15 161.65 15.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 124.152 0.907 . . . . 0.0 109.556 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.35 119.59 34.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -81.24 147.15 30.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 108.43 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.3 -18.52 7.34 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.625 161.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -70.44 139.13 86.59 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 119.694 1.747 . . . . 0.0 107.587 161.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.23 172.09 12.73 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.459 1.44 . . . . 0.0 110.543 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.68 158.22 61.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.668 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.459 -0.544 0 C-N-CA 122.627 2.218 . . . . 0.0 112.015 -177.187 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.8 t80 . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.11 0.481 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -78.2 -121.67 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.657 1.583 . . . . 0.0 111.355 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 160.97 -74.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 130.925 3.69 . . . . 0.0 109.108 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -118.73 22.92 11.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.687 1.232 . . . . 0.0 110.971 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 70.24 -23.87 0.16 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 128.17 2.588 . . . . 0.0 113.881 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -65.04 -13.21 57.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.631 1.172 . . . . 0.0 112.86 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -67.26 -22.19 65.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.443 1.097 . . . . 0.0 112.444 166.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.05 148.64 30.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.996 1.271 . . . . 0.0 109.048 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -112.81 -0.31 14.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.56 32.72 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.066 1.317 . . . . 0.0 112.578 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 157.89 33.72 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 124.871 1.268 . . . . 0.0 109.535 -169.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.39 129.04 49.09 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.652 0.781 . . . . 0.0 109.375 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.72 168.4 17.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.917 2.087 . . . . 0.0 108.415 -178.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.9 p -142.99 175.84 9.54 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.438 0.637 . . . . 0.0 111.199 160.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.406 HG21 ' HE2' ' A' ' 63' ' ' MET . 8.5 t -155.19 157.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.2 m -127.12 105.35 8.52 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.29 136.37 37.86 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -87.48 123.41 32.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.07 125.07 12.81 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.598 1.559 . . . . 0.0 108.236 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -173.74 3.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.78 -54.55 45.01 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.717 -1.239 . . . . 0.0 111.087 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.5 mtp -78.25 13.93 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.922 1.289 . . . . 0.0 113.545 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.16 -147.16 18.48 Favored Glycine 0 C--N 1.331 0.306 0 O-C-N 120.136 -1.602 . . . . 0.0 110.48 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -88.84 146.89 24.69 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 56' ' ' PRO . . . -86.8 42.28 3.15 Favored Glycine 0 C--O 1.222 -0.605 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.705 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -148.43 166.96 26.56 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 119.3 1.55 . . . . 0.0 109.321 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 p -127.28 158.81 36.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.215 1.806 . . . . 0.0 107.935 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.85 162.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.586 1.954 . . . . 0.0 107.283 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.6 tt -138.68 159.98 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.787 1.635 . . . . 0.0 108.26 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.23 154.08 23.8 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 128.802 3.096 . . . . 0.0 110.384 -174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.36 -82.99 0.21 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.482 1.039 . . . . 0.0 111.898 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -177.16 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.77 2.028 . . . . 0.0 111.243 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -125.73 153.11 73.12 Favored Pre-proline 0 C--N 1.342 0.27 0 O-C-N 120.154 -1.591 . . . . 0.0 111.652 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.42 51.35 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.31 1 C-N-CA 125.388 4.058 . . . . 0.0 113.949 168.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -158.43 13.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.096 -1.628 . . . . 0.0 109.516 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -74.89 160.47 30.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 127.411 2.285 . . . . 0.0 110.774 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -93.39 112.61 24.56 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.37 112.75 18.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.68 155.0 30.69 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.23 116.34 2.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -65.53 -54.38 28.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.768 1.227 . . . . 0.0 109.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 65' ' ' THR . 13.8 m -155.53 161.42 40.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.993 1.317 . . . . 0.0 108.049 171.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.48 140.59 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 161.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.97 132.11 54.91 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.0 160.51 48.28 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.864 2.376 . . . . 0.0 110.845 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.09 -18.31 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.434 2.294 . . . . 0.0 114.26 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.95 173.67 41.59 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.592 1.568 . . . . 0.0 114.181 -171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 33' ' ' GLY . 58.0 Cg_endo -66.52 -32.07 40.34 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.939 3.093 . . . . 0.0 111.41 -171.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.742 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.91 -46.33 65.64 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.888 0.875 . . . . 0.0 109.732 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.47 -42.66 99.64 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.268 0.94 . . . . 0.0 112.249 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.79 -6.06 29.67 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.894 0.77 . . . . 0.0 111.371 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.27 29.93 63.68 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.691 1.139 . . . . 0.0 113.465 165.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -136.17 -0.79 2.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.768 1.227 . . . . 0.0 111.982 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.406 ' HE2' HG21 ' A' ' 23' ' ' THR . 25.9 tpp -111.29 137.16 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.482 1.513 . . . . 0.0 107.069 169.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.75 167.71 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 108.941 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 50' ' ' SER . 43.3 m -77.18 159.68 29.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.495 1.118 . . . . 0.0 109.437 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.95 39.87 96.79 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -132.26 152.88 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.595 1.158 . . . . 0.0 108.074 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.5 117.6 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.688 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.1 mp -66.8 138.63 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 10.2 t -122.33 -54.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.37 149.83 51.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.435 1.094 . . . . 0.0 108.699 -175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.58 126.9 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 44.86 -93.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.1 2.16 . . . . 0.0 110.795 -159.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.25 -7.36 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.195 1.398 . . . . 0.0 111.483 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.37 139.82 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -173.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.44 130.3 36.86 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.132 -0.98 . . . . 0.0 109.003 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.94 10.61 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 111.445 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.0 -42.68 60.51 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.686 -1.259 . . . . 0.0 113.284 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.08 36.22 4.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 127.176 2.322 . . . . 0.0 109.905 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.83 -158.86 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.806 0.803 . . . . 0.0 109.683 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.7 t -119.93 143.98 47.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.641 1.11 . . . . 0.0 109.031 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -53.78 -42.41 68.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.532 2.333 . . . . 0.0 110.589 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.96 -29.23 68.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.831 0.741 . . . . 0.0 111.983 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -82.58 -54.85 4.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.373 1.069 . . . . 0.0 109.271 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.97 -44.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 130.053 3.341 . . . . 0.0 112.382 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.46 -32.8 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 120.459 -1.4 . . . . 0.0 109.652 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -34.69 71.99 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.65 1.114 . . . . 0.0 109.435 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.5 -42.96 95.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.985 1.314 . . . . 0.0 109.823 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -62.46 -19.15 63.23 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.291 1.036 . . . . 0.0 112.778 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -91.98 -11.37 36.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.819 1.248 . . . . 0.0 113.109 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 m -75.0 12.8 0.78 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.775 -1.203 . . . . 0.0 112.996 161.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.09 93.22 14.73 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.63 140.77 13.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.911 3.074 . . . . 0.0 109.57 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.1 mp -52.01 125.43 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 118.987 0.812 . . . . 0.0 109.232 -164.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.3 -16.44 11.71 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.46 1.981 . . . . 0.0 113.417 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -94.83 173.65 7.49 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.778 1.789 . . . . 0.0 109.756 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -127.94 167.02 17.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.042 2.537 . . . . 0.0 108.193 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.32 148.85 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.468 1.107 . . . . 0.0 108.596 161.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.4 152.44 25.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 167.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 mt -146.47 119.74 8.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.85 129.22 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 67' ' ' ASP . 10.3 mt -112.05 156.7 21.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.361 1.038 . . . . 0.0 109.4 166.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.06 128.29 55.57 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -84.62 156.35 21.6 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.138 0.975 . . . . 0.0 109.582 171.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.03 6.3 14.07 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 123.835 0.731 . . . . 0.0 114.391 163.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.46 133.9 23.8 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.53 -178.42 1.51 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.143 2.562 . . . . 0.0 111.15 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.42 158.02 83.64 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.578 0.751 . . . . 0.0 111.086 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 C--N 1.347 0.459 0 C-N-CA 122.849 2.366 . . . . 0.0 112.662 -175.062 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -66.2 161.28 22.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.97 0.908 . . . . 0.0 109.967 166.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 t -153.27 167.86 27.95 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.76 -176.85 34.34 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.093 1.33 . . . . 0.0 112.955 -172.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -153.7 147.45 25.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.598 1.559 . . . . 0.0 108.399 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -179.53 -172.41 0.22 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 129.091 2.957 . . . . 0.0 106.194 165.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 131.6 179.89 16.54 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 mp -145.61 88.13 1.83 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.097 1.359 . . . . 0.0 107.877 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 14.8 t80 53.86 -178.68 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.746 1.618 . . . . 0.0 112.192 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -88.36 -121.35 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.144 -1.597 . . . . 0.0 109.019 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 150.19 -83.32 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.698 1 C-N-CA 132.701 4.4 . . . . 0.0 107.022 173.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -85.65 18.34 2.88 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -168.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 59.03 -17.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 129.106 2.962 . . . . 0.0 114.545 -166.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.65 -26.3 67.74 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.139 0.976 . . . . 0.0 111.262 -169.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -82.18 -4.18 56.5 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.916 -1.04 . . . . 0.0 112.311 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 62.5 mt -66.97 161.75 23.53 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.943 1.247 . . . . 0.0 108.66 169.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -124.23 116.22 22.33 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.73 -171.81 39.46 Favored Glycine 0 N--CA 1.447 -0.596 0 O-C-N 124.42 1.075 . . . . 0.0 110.742 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -87.8 166.6 14.48 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' C ' HD13 ' A' ' 21' ' ' LEU . 12.2 m-85 -126.43 136.01 52.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.178 1.391 . . . . 0.0 107.283 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -153.24 164.4 38.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.545 1.138 . . . . 0.0 109.687 -174.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.4 m -144.58 163.42 33.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.824 0.821 . . . . 0.0 112.453 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 t -148.62 157.22 43.31 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.884 1.274 . . . . 0.0 107.89 172.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -114.46 114.14 25.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 57' ' ' ALA . 5.9 mt -98.52 132.91 43.57 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 171.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -85.46 132.55 34.19 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 163.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 51.3 tttt -73.31 93.73 1.94 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 126.695 1.998 . . . . 0.0 108.514 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.9 m -95.02 115.01 26.89 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.786 0.834 . . . . 0.0 109.173 -176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.56 -158.94 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.85 1.66 . . . . 0.0 108.888 -167.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 33.8 mtt 23.19 -76.32 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.147 2.979 . . . . 0.0 116.458 162.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 169.66 168.24 31.31 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -163.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -65.2 152.15 44.37 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.282 0.541 . . . . 0.0 110.12 -173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.25 44.05 2.8 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-O 118.915 -0.936 . . . . 0.0 112.259 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -156.67 164.72 37.83 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.499 1.65 . . . . 0.0 107.94 169.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.6 p -131.26 159.94 36.36 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.74 162.04 17.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 124.452 1.101 . . . . 0.0 108.847 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.72 146.57 32.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 128.575 2.75 . . . . 0.0 106.374 169.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.43 151.55 22.73 Favored Glycine 0 CA--C 1.518 0.224 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 167.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -11.84 4.33 Favored Glycine 0 C--O 1.225 -0.419 0 C-N-CA 127.283 2.373 . . . . 0.0 117.893 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t0 95.59 -42.77 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 130.434 3.494 . . . . 0.0 108.037 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -70.79 157.81 89.39 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 127.674 2.389 . . . . 0.0 111.771 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -89.65 29.95 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.555 3.503 . . . . 0.0 112.692 -170.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -175.56 76.35 0.02 OUTLIER 'General case' 0 C--O 1.238 0.494 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -140.44 143.46 35.58 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 127.873 2.469 . . . . 0.0 105.955 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -76.47 128.83 35.55 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -175.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.28 146.91 30.17 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -135.52 151.28 50.19 Favored 'General case' 0 CA--C 1.523 -0.059 0 C-N-CA 122.942 0.497 . . . . 0.0 110.835 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 68.2 t -65.17 112.1 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 167.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -70.57 -42.72 70.73 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.863 1.665 . . . . 0.0 110.377 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.3 p -151.87 157.44 41.87 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.076 0.951 . . . . 0.0 109.57 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.7 t -92.72 141.7 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 159.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.03 122.07 86.22 Favored Pre-proline 0 C--O 1.237 0.413 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.44 146.23 97.31 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.442 1.428 . . . . 0.0 108.778 169.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 67.76 -2.59 1.35 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.536 1.534 . . . . 0.0 113.25 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.5 163.68 39.1 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.524 1.059 . . . . 0.0 111.484 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.75 -27.76 75.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 123.113 2.542 . . . . 0.0 112.996 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.018 0.527 . . . . 0.0 110.081 176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.2 87.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.534 -0.746 . . . . 0.0 109.686 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.47 -19.12 62.98 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 119.101 0.864 . . . . 0.0 112.748 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.54 -4.91 59.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 120.162 1.346 . . . . 0.0 111.429 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.92 -24.27 1.98 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.17 2.319 . . . . 0.0 113.252 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -87.07 -35.33 18.77 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -157.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tpp -69.79 128.69 37.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -129.9 166.54 19.81 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.5 m -90.85 142.01 28.22 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 -16.6 58.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.691 -1.06 . . . . 0.0 112.361 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.482 ' HB3' HD13 ' A' ' 102' ' ' LEU . 84.3 m-20 -55.39 139.84 41.83 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.523 1.129 . . . . 0.0 109.837 -177.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.6 t -93.49 123.25 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.409 1.084 . . . . 0.0 108.835 -175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.08 119.91 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.555 1.542 . . . . 0.0 108.285 172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.91 -57.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.938 171.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -134.3 152.94 52.09 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 50.7 mt -130.25 128.36 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 t30 59.63 -73.47 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.145 2.978 . . . . 0.0 111.994 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -157.51 40.51 0.3 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.68 0.792 . . . . 0.0 110.85 165.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.38 132.52 70.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 126.615 1.966 . . . . 0.0 108.736 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.2 p -72.53 111.73 7.96 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.703 1.601 . . . . 0.0 111.779 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.49 5.6 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 117.745 -1.121 . . . . 0.0 113.847 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.79 -18.44 62.71 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 121.383 1.901 . . . . 0.0 114.214 -167.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.31 4.69 19.88 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.583 -1.121 . . . . 0.0 112.934 170.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.48 162.97 22.04 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.707 1.753 . . . . 0.0 109.965 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 41.0 p -70.67 142.71 51.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -60.04 -22.67 62.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.372 -0.83 . . . . 0.0 110.391 166.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.11 -54.58 45.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 120.7 -1.25 . . . . 0.0 111.883 167.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.34 -49.86 67.78 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 124.882 1.273 . . . . 0.0 109.792 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 t -61.01 -41.18 88.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 120.037 -1.664 . . . . 0.0 112.182 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 70.5 t -64.4 -37.03 78.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 120.661 -1.274 . . . . 0.0 109.66 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -35.45 81.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.48 1.036 . . . . 0.0 110.003 176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.12 -45.16 86.22 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.355 1.062 . . . . 0.0 108.258 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -64.29 -41.42 96.88 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.996 0.816 . . . . 0.0 111.322 176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -68.98 -25.43 64.52 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.438 0.563 . . . . 0.0 112.24 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -66.35 -18.17 65.2 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.025 0.829 . . . . 0.0 111.994 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 t -84.36 115.85 62.3 Favored Pre-proline 0 C--O 1.234 0.285 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -76.69 170.06 20.59 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 CA-C-N 120.716 1.291 . . . . 0.0 110.783 174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.61 139.72 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 124.629 1.172 . . . . 0.0 108.029 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 85.29 -0.99 88.76 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 117.504 -1.72 . . . . 0.0 113.657 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -100.04 172.58 7.12 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 120.038 1.919 . . . . 0.0 108.482 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 p -131.87 159.62 38.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 123.642 0.777 . . . . 0.0 110.052 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.4 m -134.29 155.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.839 173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.84 159.21 21.42 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 168.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.9 mt -146.06 141.61 27.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.4 t -121.75 118.12 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 67' ' ' ASP . 8.8 mt -109.26 168.74 9.16 Favored 'General case' 0 C--O 1.237 0.402 0 O-C-N 123.907 0.755 . . . . 0.0 109.871 174.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.9 t -121.75 143.67 49.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.909 1.284 . . . . 0.0 107.67 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.553 ' HB2' HD11 ' A' ' 21' ' ' LEU . 13.4 ttm180 -127.25 130.33 49.42 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.729 1.211 . . . . 0.0 111.68 -163.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 128.05 -21.85 5.47 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -70.16 139.01 87.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 123.965 0.906 . . . . 0.0 109.176 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.37 178.45 7.56 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.402 2.068 . . . . 0.0 110.735 167.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.21 157.98 20.75 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.306 160.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.0 140.43 49.98 Favored 'Trans proline' 0 N--CA 1.438 -1.742 0 N-CA-C 108.307 -1.459 . . . . 0.0 108.307 165.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -62.98 132.58 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 151.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.67 110.44 49.28 Favored Pre-proline 0 C--N 1.332 -0.171 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.52 -22.36 21.3 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.48 1.454 . . . . 0.0 112.88 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.98 -61.27 1.94 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.889 1.276 . . . . 0.0 109.434 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -157.27 106.27 1.87 Allowed Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.093 1.357 . . . . 0.0 108.692 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.03 -10.13 7.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.429 2.753 . . . . 0.0 113.824 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 141.18 97.98 0.0 OUTLIER 'General case' 0 C--N 1.344 0.36 0 C-N-CA 130.0 3.32 . . . . 0.0 109.336 -166.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.7 m-80 -129.89 176.45 8.03 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.376 1.87 . . . . 0.0 108.813 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.3 m -162.92 163.99 26.06 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.251 2.22 . . . . 0.0 108.878 162.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.0 -159.39 32.31 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.086 1.327 . . . . 0.0 112.811 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -80.76 60.29 7.8 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.689 3.593 . . . . 0.0 112.288 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.16 132.61 50.91 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 155.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.5 p -71.84 163.54 27.65 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 163.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.025 0 CA-C-O 117.421 -1.766 . . . . 0.0 109.03 178.847 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -74.63 -163.68 0.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.347 1.459 . . . . 0.0 110.78 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.4 m -119.46 -170.24 1.9 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.6 1.56 . . . . 0.0 107.58 161.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.5 175.56 21.63 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.2 m -57.4 147.83 25.01 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.077 0.465 . . . . 0.0 111.215 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.5 t -84.69 -123.5 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.79 -168.39 38.51 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.44 -77.72 0.57 Allowed 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 163.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.02 159.52 16.96 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.572 0.701 . . . . 0.0 110.843 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.8 m -78.77 -112.35 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.555 1.542 . . . . 0.0 111.715 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 147.13 -57.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 131.509 3.924 . . . . 0.0 111.798 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 14' ' ' SER . 32.6 t70 -142.76 20.78 1.99 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.797 0.439 . . . . 0.0 111.387 -166.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 61.49 -17.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.47 2.308 . . . . 0.0 114.132 -164.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 12' ' ' ASP . 0.4 OUTLIER -60.3 -23.42 64.17 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.942 2.497 . . . . 0.0 112.43 -178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -80.83 -16.12 54.57 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.419 1.087 . . . . 0.0 112.474 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.8 mt -77.02 154.28 33.61 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.397 0.999 . . . . 0.0 109.13 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -130.01 99.57 5.13 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.83 176.11 39.89 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 126.359 1.933 . . . . 0.0 110.079 -166.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 42.2 m -98.64 133.79 42.48 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 117.798 0.799 . . . . 0.0 109.177 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.603 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 16.6 m-85 -101.12 142.65 32.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.387 1.075 . . . . 0.0 110.052 -176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.77 166.64 32.24 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.097 1.759 . . . . 0.0 109.372 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.7 p -147.1 156.54 43.08 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.849 1.26 . . . . 0.0 111.039 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 t -139.43 157.12 46.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.656 1.582 . . . . 0.0 107.862 168.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.09 111.63 24.33 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.067 1.347 . . . . 0.0 107.554 170.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.64 135.21 40.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.792 1.178 . . . . 0.0 108.391 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -83.67 151.56 25.22 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.416 0.627 . . . . 0.0 110.073 167.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -79.27 69.42 5.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.941 1.297 . . . . 0.0 109.378 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -98.29 170.25 9.0 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.464 1.105 . . . . 0.0 108.646 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 49.62 -92.54 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.993 2.117 . . . . 0.0 111.548 -171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.2 ptm -118.9 4.3 11.48 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.33 1.452 . . . . 0.0 111.657 -172.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.78 -176.76 35.16 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -151.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -64.99 149.15 50.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.034 -1.083 . . . . 0.0 110.983 -161.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.98 40.12 3.09 Favored Glycine 0 C--O 1.223 -0.538 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.53 -176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -146.24 166.22 26.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.167 1.483 . . . . 0.0 109.108 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 p -128.87 159.46 35.71 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.277 1.431 . . . . 0.0 108.371 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.45 162.38 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.839 1.256 . . . . 0.0 109.423 -172.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 tt -134.76 155.08 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.735 2.014 . . . . 0.0 108.034 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.01 155.05 21.38 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 129.606 3.479 . . . . 0.0 111.049 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.1 -93.39 0.02 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 117.294 -2.384 . . . . 0.0 108.292 142.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -159.33 -65.43 0.08 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 170.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.09 166.9 28.95 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.934 1.694 . . . . 0.0 110.819 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.38 45.22 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 124.041 3.16 . . . . 0.0 111.872 -164.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -157.21 34.47 0.28 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.316 1.447 . . . . 0.0 109.181 -168.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -139.43 173.62 11.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.953 1.301 . . . . 0.0 113.13 -167.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -88.71 112.89 23.68 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 125.381 1.472 . . . . 0.0 110.493 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 mt -81.9 134.67 35.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG2' HG22 ' A' ' 68' ' ' VAL . 27.9 mt-30 -128.22 156.96 42.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.63 0.65 . . . . 0.0 111.06 176.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.96 104.4 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 166.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -54.82 -50.03 69.58 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 125.505 1.522 . . . . 0.0 109.145 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 152.4 18.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.856 0.862 . . . . 0.0 109.206 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.5 t -104.04 130.18 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.74 130.28 68.02 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.83 46.09 2.17 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.808 3.005 . . . . 0.0 113.36 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -160.54 43.65 0.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.317 1.847 . . . . 0.0 109.905 164.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.67 166.6 22.96 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 120.718 -1.239 . . . . 0.0 112.443 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.63 -22.07 64.91 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.563 2.175 . . . . 0.0 112.397 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.8 2.8 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.962 0.905 . . . . 0.0 109.838 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.06 70.28 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.014 0.926 . . . . 0.0 111.004 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.0 -20.14 65.83 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 117.641 -1.171 . . . . 0.0 112.892 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -99.33 -30.41 12.24 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.483 1.492 . . . . 0.0 112.05 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 78.3 -16.88 6.89 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.329 1.442 . . . . 0.0 114.431 166.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -69.87 -15.87 63.15 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.514 1.157 . . . . 0.0 111.144 175.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.94 133.67 43.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 166.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.08 176.62 8.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 162.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.3 m -72.39 154.37 40.94 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.56 56.48 25.05 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' HB3' HD13 ' A' ' 102' ' ' LEU . 3.0 m-20 -128.92 151.49 49.6 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.983 2.113 . . . . 0.0 105.652 175.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG22 ' HG2' ' A' ' 47' ' ' GLN . 44.1 t -101.26 127.16 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 121.401 1.91 . . . . 0.0 109.706 -171.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.88 130.2 36.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.551 1.14 . . . . 0.0 108.589 174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 17.4 t -106.4 -61.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.518 1.527 . . . . 0.0 109.211 174.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -128.83 157.76 40.61 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.397 1.079 . . . . 0.0 109.223 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mt -128.79 117.11 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 169.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 47.77 -82.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 128.564 2.746 . . . . 0.0 112.075 -161.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.45 13.7 1.78 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.514 1.526 . . . . 0.0 111.111 -170.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.22 120.9 55.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.47 104.8 2.41 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 168.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.6 m -101.52 3.5 10.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 C-N-CA 123.28 0.632 . . . . 0.0 111.851 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 78' ' ' LEU . 1.6 pp -58.45 -17.48 21.14 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -132.81 35.61 2.29 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 126.14 1.828 . . . . 0.0 109.016 170.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -103.16 165.66 10.89 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.306 1.053 . . . . 0.0 108.548 161.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.02 161.64 16.47 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.972 0.909 . . . . 0.0 109.546 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.93 -14.58 23.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.5 1.52 . . . . 0.0 111.934 167.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.13 -67.56 0.43 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-N 120.476 1.489 . . . . 0.0 109.478 167.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -56.01 -45.4 79.09 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 123.439 0.696 . . . . 0.0 111.075 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 t -63.11 -41.59 93.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 120.292 -1.505 . . . . 0.0 111.447 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.2 t -65.9 -37.34 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 120.87 -1.144 . . . . 0.0 109.731 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -39.07 93.57 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.426 1.466 . . . . 0.0 109.939 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 mt -59.28 -51.1 71.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.667 1.587 . . . . 0.0 108.164 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.38 -42.33 88.08 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 119.019 0.827 . . . . 0.0 112.483 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -68.41 -30.88 69.89 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 121.423 -0.798 . . . . 0.0 111.008 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -70.02 -2.55 13.02 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.5 114.63 56.25 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -78.81 179.07 6.83 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.072 2.515 . . . . 0.0 110.931 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.35 152.06 7.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.58 1.152 . . . . 0.0 109.137 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.08 -25.78 6.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 124.286 0.946 . . . . 0.0 111.956 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -84.33 142.25 30.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.42 1.11 . . . . 0.0 109.289 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.63 150.48 28.93 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.694 1.598 . . . . 0.0 108.234 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.9 m -141.31 141.21 31.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -84.18 155.97 22.3 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.0 mt -142.62 150.08 39.8 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.42 126.47 58.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.599 HD13 ' HB3' ' A' ' 67' ' ' ASP . 14.5 mt -119.65 169.5 10.04 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 124.356 1.035 . . . . 0.0 110.265 175.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 49.9 t -133.48 117.5 17.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.836 0.855 . . . . 0.0 111.213 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -85.53 139.41 31.49 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.115 -0.99 . . . . 0.0 110.339 -165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.98 -4.8 16.25 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.073 -0.848 . . . . 0.0 113.582 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.67 117.97 68.88 Favored Pre-proline 0 CA--C 1.526 0.057 0 CA-C-N 119.372 1.586 . . . . 0.0 107.53 163.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.16 177.23 3.88 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.576 2.184 . . . . 0.0 111.709 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mt -54.48 149.09 22.07 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.613 173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.52 126.24 13.88 Favored 'Trans proline' 0 N--CA 1.444 -1.389 0 C-N-CA 122.668 2.245 . . . . 0.0 107.33 167.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -66.29 135.19 54.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 163.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -119.4 92.57 46.04 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -65.52 -16.65 54.81 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 121.946 1.764 . . . . 0.0 113.265 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -60.36 -43.94 96.05 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.606 1.562 . . . . 0.0 111.081 177.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 35.29 92.68 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 129.474 3.109 . . . . 0.0 114.772 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.45 -8.42 20.71 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.852 2.368 . . . . 0.0 115.074 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 159.49 -62.92 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 129.595 3.158 . . . . 0.0 108.131 168.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 69.24 162.52 0.22 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.673 2.789 . . . . 0.0 110.168 -169.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 93.6 p -159.03 158.29 32.84 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.378 -0.826 . . . . 0.0 109.696 162.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.4 140.39 11.0 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.3 -171.51 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.056 3.17 . . . . 0.0 111.15 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.0 p -65.09 81.62 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.281 1.433 . . . . 0.0 110.453 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 87.7 p -146.3 179.68 7.35 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.248 -0.907 . . . . 0.0 109.909 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 N-CA-C 104.859 -3.296 . . . . 0.0 104.859 162.706 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.007 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -51.69 142.78 13.97 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.726 1.61 . . . . 0.0 112.561 -167.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -60.54 160.6 8.73 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 161.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.82 -168.84 28.69 Favored Glycine 0 CA--C 1.521 0.438 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -167.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 m 65.9 112.5 0.03 OUTLIER 'General case' 0 C--O 1.236 0.37 0 C-N-CA 127.502 2.321 . . . . 0.0 109.834 -168.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.9 p -125.15 164.85 19.35 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.473 1.909 . . . . 0.0 108.034 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.53 -161.57 17.31 Favored Glycine 0 CA--C 1.519 0.293 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.94 72.17 1.21 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 173.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 10' ' ' THR . 27.8 t80 52.71 165.12 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 130.99 3.716 . . . . 0.0 114.261 -168.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 m -82.32 -99.36 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.377 1.471 . . . . 0.0 112.102 -175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 117.83 -32.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 1 C-N-CA 136.151 5.781 . . . . 0.0 114.167 172.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -125.52 13.63 8.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.507 1.048 . . . . 0.0 111.721 -173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 64.3 -20.3 0.07 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.851 2.86 . . . . 0.0 115.399 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 m -64.27 -22.13 66.84 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.312 0.96 . . . . 0.0 112.32 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -97.83 20.64 11.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.724 1.21 . . . . 0.0 112.073 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.0 mt -70.88 -159.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.333 -0.855 . . . . 0.0 109.759 162.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -64.04 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.055 1.342 . . . . 0.0 111.661 -177.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.55 -13.69 0.05 OUTLIER Glycine 0 CA--C 1.511 -0.168 0 N-CA-C 120.181 2.832 . . . . 0.0 120.181 159.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.4 m -86.18 127.38 34.72 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -127.95 123.4 34.76 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.773 1.629 . . . . 0.0 108.165 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 154.83 41.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.994 1.718 . . . . 0.0 107.977 -173.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.6 m -145.6 152.79 40.25 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 122.584 0.354 . . . . 0.0 110.757 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.52 157.94 39.1 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.963 1.705 . . . . 0.0 108.118 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.7 m -127.15 119.34 26.25 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.354 1.462 . . . . 0.0 107.935 168.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.0 mt -97.98 150.39 21.42 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -83.12 158.24 22.48 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 157.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 24.0 tptt -77.1 98.32 5.0 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.5 m -126.1 151.86 46.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 118.686 0.675 . . . . 0.0 111.793 -159.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 60.4 -79.87 0.02 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 128.251 2.62 . . . . 0.0 110.957 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.4 mtt -149.43 71.62 1.12 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.421 2.289 . . . . 0.0 107.432 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 73.79 176.14 33.06 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -68.82 123.69 21.65 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 121.458 -1.025 . . . . 0.0 109.357 -170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.22 51.52 2.1 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.744 1.164 . . . . 0.0 112.775 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -145.57 165.93 27.23 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.394 1.877 . . . . 0.0 106.321 160.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.4 p -131.8 166.44 21.55 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.462 -0.773 . . . . 0.0 109.279 166.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -121.29 161.32 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.837 1.655 . . . . 0.0 107.422 -172.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 tt -133.05 150.25 32.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 126.786 2.035 . . . . 0.0 106.702 172.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.22 151.8 22.43 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.391 1.948 . . . . 0.0 108.702 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.03 -55.85 9.99 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-O 119.357 -0.691 . . . . 0.0 112.611 -158.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.79 -41.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.505 1.922 . . . . 0.0 107.859 166.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.59 164.97 14.58 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 125.223 1.409 . . . . 0.0 111.707 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.1 19.19 0.43 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 125.106 3.871 . . . . 0.0 116.218 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.58 5.61 0.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.22 1.008 . . . . 0.0 113.252 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -72.28 155.33 40.31 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.331 0.969 . . . . 0.0 108.413 163.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -71.96 168.41 18.06 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.806 0.812 . . . . 0.0 110.509 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.65 133.85 54.98 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.714 1.606 . . . . 0.0 107.254 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -128.49 151.82 48.97 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.11 121.96 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -76.74 -41.92 43.16 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 125.959 1.704 . . . . 0.0 110.501 176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.2 p -156.99 161.93 39.58 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.304 1.041 . . . . 0.0 110.432 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.3 t -126.43 120.42 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 126.542 1.937 . . . . 0.0 105.811 169.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.6 mm -75.49 131.38 77.55 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.22 152.04 82.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.668 2.245 . . . . 0.0 109.648 173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.9 t70 53.92 23.17 3.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.908 0.861 . . . . 0.0 111.924 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.29 163.73 13.15 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.527 1.537 . . . . 0.0 109.712 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.4 -32.54 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.761 2.307 . . . . 0.0 111.865 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.44 -40.88 80.95 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.882 -0.58 . . . . 0.0 111.119 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.01 -44.04 81.33 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.263 0.625 . . . . 0.0 110.596 177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -61.13 -46.72 89.41 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.298 0.499 . . . . 0.0 110.216 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -62.32 -31.31 71.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.036 0.534 . . . . 0.0 111.223 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.97 -18.69 29.93 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 125.474 1.511 . . . . 0.0 113.49 160.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.7 mptt -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 118.111 0.955 . . . . 0.0 110.675 175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 8.5 tpp -65.43 123.71 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -171.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -136.01 163.69 29.72 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.239 1.016 . . . . 0.0 108.363 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -88.21 142.56 27.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -167.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.41 -12.96 36.6 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 117.849 -1.528 . . . . 0.0 112.512 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.467 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.7 m-20 -68.91 148.89 49.54 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.677 2.238 . . . . 0.0 108.098 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -95.3 125.75 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.115 1.366 . . . . 0.0 109.268 -169.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.11 110.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 125.406 1.482 . . . . 0.0 107.422 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.02 -58.82 3.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.585 0.707 . . . . 0.0 109.664 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.07 155.22 50.43 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.916 1.286 . . . . 0.0 107.851 -172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 mt -127.08 113.7 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 169.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 t30 69.88 -61.67 0.44 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 129.484 3.114 . . . . 0.0 112.27 173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -157.71 5.7 0.13 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.756 1.622 . . . . 0.0 111.682 174.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.8 t -104.55 131.32 53.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 O-C-N 120.313 -1.492 . . . . 0.0 107.376 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.9 t -78.27 116.55 18.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.74 5.3 7.06 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 122.961 0.504 . . . . 0.0 111.576 -175.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -31.59 35.44 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.364 1.866 . . . . 0.0 113.138 -172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.22 61.1 0.64 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 106.153 -2.779 . . . . 0.0 106.153 169.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -111.82 162.94 14.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 124.329 1.052 . . . . 0.0 109.834 156.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.27 151.61 41.3 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -55.47 -29.81 59.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.088 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.96 71.25 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 120.307 1.412 . . . . 0.0 112.268 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -76.57 -57.21 3.99 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.0 t -52.72 -41.62 39.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.484 2.713 . . . . 0.0 112.909 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.5 t -69.62 -28.37 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 120.553 -1.342 . . . . 0.0 110.361 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -35.74 73.14 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 120.439 1.472 . . . . 0.0 108.154 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.69 -36.39 67.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.214 1.005 . . . . 0.0 110.317 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -73.0 -29.6 63.16 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.721 -1.237 . . . . 0.0 111.684 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -77.81 -19.3 55.21 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.378 0.671 . . . . 0.0 112.237 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.6 m -71.24 -7.5 47.32 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.885 1.274 . . . . 0.0 113.382 175.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.01 102.85 19.14 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.306 1.043 . . . . 0.0 108.259 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.7 170.43 16.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.279 1.986 . . . . 0.0 111.221 169.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 27.9 mt -66.95 142.17 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 125.238 1.415 . . . . 0.0 107.774 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.82 -2.57 87.3 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 119.103 -0.832 . . . . 0.0 113.049 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -101.53 171.63 7.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.716 1.258 . . . . 0.0 108.976 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -143.91 155.43 44.08 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.137 2.175 . . . . 0.0 108.211 -177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.3 m -138.81 148.24 24.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -82.82 153.38 25.21 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.2 mt -138.17 147.36 43.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 t -127.68 116.45 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.2 mt -109.96 164.12 12.91 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 173.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -117.65 138.15 52.17 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 164.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.06 156.14 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 126.354 1.862 . . . . 0.0 110.095 168.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 114.05 -16.18 20.57 Favored Glycine 0 CA--C 1.519 0.312 0 CA-C-O 118.663 -1.076 . . . . 0.0 114.03 157.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -83.53 140.04 41.35 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 118.884 1.342 . . . . 0.0 108.784 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.97 176.87 9.47 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.63 2.887 . . . . 0.0 110.074 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.7 mt -67.58 145.3 98.19 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -72.61 -39.4 2.65 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 121.931 1.754 . . . . 0.0 111.053 -178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -60.22 107.92 0.72 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.166 0.986 . . . . 0.0 108.661 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -89.71 106.22 13.46 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.89 -25.87 11.69 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 120.831 1.021 . . . . 0.0 111.244 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -67.69 -49.22 63.84 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.382 -0.824 . . . . 0.0 111.319 -169.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -146.28 87.91 6.42 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.51 -24.61 11.87 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.473 1.449 . . . . 0.0 113.661 -153.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 174.5 87.97 0.0 OUTLIER 'General case' 0 C--O 1.235 0.301 0 C-N-CA 129.596 3.158 . . . . 0.0 103.109 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 58.88 -179.49 0.08 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.319 1.848 . . . . 0.0 112.739 -165.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -124.25 150.41 45.35 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.7 1.6 . . . . 0.0 108.093 166.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.93 -173.89 53.35 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.449 0.468 . . . . 0.0 112.497 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.62 132.83 36.89 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.549 2.166 . . . . 0.0 108.675 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.0 p -82.84 68.18 9.21 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.848 0.859 . . . . 0.0 109.068 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.6 m -68.54 -178.48 1.14 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.09 0.956 . . . . 0.0 110.86 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.428 0 N-CA-C 107.554 -2.218 . . . . 0.0 107.554 178.09 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.836 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -80.69 171.03 15.55 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.707 1.203 . . . . 0.0 110.26 -173.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 m -82.18 173.79 11.79 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 120.409 -1.432 . . . . 0.0 108.904 153.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.46 -100.44 2.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 106.219 -2.752 . . . . 0.0 106.219 150.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 m -152.97 -165.5 2.2 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.203 1.801 . . . . 0.0 106.239 162.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -150.49 109.9 3.99 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 160.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -155.73 153.42 24.74 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.505 1.526 . . . . 0.0 110.02 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 tt -112.97 -80.14 0.59 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 117.913 0.857 . . . . 0.0 109.012 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -87.46 169.16 12.46 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.4 m -88.4 -120.39 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.912 1.285 . . . . 0.0 108.759 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 146.77 -47.64 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.582 1 C-N-CA 133.127 4.571 . . . . 0.0 106.62 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -123.92 124.75 43.3 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -170.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.31 -9.25 3.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.363 1.465 . . . . 0.0 113.422 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -69.99 -21.29 63.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.223 1.009 . . . . 0.0 111.657 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.05 -22.86 63.03 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.11 -0.994 . . . . 0.0 111.092 174.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.0 mt -73.52 152.43 40.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.314 0.578 . . . . 0.0 110.575 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -129.67 111.06 12.3 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.914 2.086 . . . . 0.0 105.597 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.07 -144.85 5.13 Favored Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.8 m -136.61 152.39 50.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 151.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.63 142.83 33.64 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.286 1.434 . . . . 0.0 108.824 -172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.414 HD11 ' HB2' ' A' ' 104' ' ' ARG . 2.0 mp -141.21 165.52 27.3 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.789 0.836 . . . . 0.0 109.168 -171.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 m -152.47 154.69 36.02 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.131 0.491 . . . . 0.0 111.865 172.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 t -154.2 158.42 40.29 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.33 1.852 . . . . 0.0 107.621 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.4 m -121.58 111.97 17.89 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.421 1.488 . . . . 0.0 107.182 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -101.83 131.88 47.91 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.808 -0.557 . . . . 0.0 109.738 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -83.51 132.97 34.91 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.633 1.573 . . . . 0.0 109.466 172.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 33.1 tptt -62.38 107.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.32 1.448 . . . . 0.0 107.86 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.4 t -133.69 -127.9 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.48 1.512 . . . . 0.0 108.021 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -55.25 102.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.314 1.446 . . . . 0.0 110.542 -177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 36.2 mtm 45.31 67.88 0.66 Allowed 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.134 1.374 . . . . 0.0 110.622 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 70.15 -126.9 17.18 Favored Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -104.63 141.79 35.81 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.77 40.27 1.83 Allowed Glycine 0 CA--C 1.532 1.123 0 CA-C-O 119.666 -0.519 . . . . 0.0 112.579 -178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -142.71 162.58 35.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.468 1.634 . . . . 0.0 109.11 163.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.4 p -123.91 152.23 42.66 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.246 1.818 . . . . 0.0 107.632 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.64 161.99 17.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 124.16 0.984 . . . . 0.0 108.478 -173.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -135.71 158.84 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 127.698 2.399 . . . . 0.0 106.126 169.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.7 152.53 22.15 Favored Glycine 0 C--O 1.237 0.282 0 C-N-CA 126.025 1.774 . . . . 0.0 108.68 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.06 -77.18 0.14 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 123.754 0.692 . . . . 0.0 112.612 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -170.21 -50.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.658 0.729 . . . . 0.0 110.302 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -101.07 166.1 13.01 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.558 1.543 . . . . 0.0 111.169 -171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.25 43.81 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.778 3.652 . . . . 0.0 110.772 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -171.0 23.15 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.735 2.014 . . . . 0.0 110.79 -173.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -113.26 167.84 10.22 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.983 0.913 . . . . 0.0 109.107 171.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -78.46 160.99 27.41 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.475 0.655 . . . . 0.0 110.967 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 25.6 mt -124.75 132.07 53.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 127.009 2.124 . . . . 0.0 106.552 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.9 mt-30 -130.39 155.97 45.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.2 t -68.42 112.34 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 165.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -59.9 -49.62 76.96 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.51 1.124 . . . . 0.0 108.686 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 65' ' ' THR . 3.9 m -157.58 146.39 19.55 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 124.767 1.227 . . . . 0.0 108.474 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.51 143.24 12.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 159.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 22.2 mm -71.54 135.9 83.73 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 172.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.72 137.66 25.18 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.365 1.377 . . . . 0.0 109.523 166.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 51.61 67.62 0.93 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.431 1.092 . . . . 0.0 111.327 -171.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -145.37 175.01 25.17 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.414 -0.804 . . . . 0.0 111.844 171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -59.99 -35.55 92.79 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.931 2.421 . . . . 0.0 112.221 -172.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' A' ' 63' ' ' MET . . . -67.3 -36.57 81.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.892 1.277 . . . . 0.0 111.714 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.88 67.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.36 0.664 . . . . 0.0 109.897 175.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -58.02 -45.88 86.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.638 1.175 . . . . 0.0 111.472 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -68.44 -24.46 64.73 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.022 0.529 . . . . 0.0 110.862 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 66.82 15.19 64.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 124.678 1.132 . . . . 0.0 113.815 169.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -85.01 -73.7 0.42 Allowed 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.405 -170.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' A' ' 57' ' ' ALA . 0.1 OUTLIER -79.94 159.3 26.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -138.37 160.16 40.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 123.243 1.497 . . . . 0.0 111.518 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 50' ' ' SER . 55.0 m -60.0 133.78 56.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.693 -1.139 . . . . 0.0 109.606 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.31 -14.67 64.04 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.282 1.42 . . . . 0.0 113.765 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -63.21 150.87 41.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.379 1.59 . . . . 0.0 109.531 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG22 ' HG2' ' A' ' 47' ' ' GLN . 38.2 t -96.22 127.54 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.366 1.466 . . . . 0.0 108.959 -176.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -68.46 117.96 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.924 1.289 . . . . 0.0 107.641 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.88 -60.54 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.569 170.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -132.0 148.86 52.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -171.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.0 mt -130.71 130.8 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 53.02 -85.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.754 2.422 . . . . 0.0 112.449 -177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.61 9.99 2.9 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 119.768 1.167 . . . . 0.0 112.712 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.26 132.53 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 125.321 1.448 . . . . 0.0 109.118 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 37.9 t -71.68 98.44 1.92 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -98.42 8.47 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.908 0.883 . . . . 0.0 110.705 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.46 HD12 ' C ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -56.25 -21.51 24.09 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -169.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -129.24 22.73 5.0 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 126.096 1.808 . . . . 0.0 111.692 169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.08 161.82 30.48 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.739 1.769 . . . . 0.0 109.116 166.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.17 144.63 48.48 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 173.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -55.06 -37.3 66.57 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 123.706 0.802 . . . . 0.0 109.692 166.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.77 -30.96 69.23 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.577 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -79.43 -50.26 11.08 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.602 1.092 . . . . 0.0 110.065 173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.23 -39.44 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 125.068 1.347 . . . . 0.0 111.432 -176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 75.5 t -66.25 -40.58 87.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 120.851 -1.156 . . . . 0.0 109.735 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -31.32 70.97 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.073 0.851 . . . . 0.0 110.682 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.97 -46.6 70.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.126 1.77 . . . . 0.0 109.482 174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -63.06 -37.38 86.99 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.994 0.816 . . . . 0.0 109.959 177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.2 -24.46 62.22 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.515 -0.741 . . . . 0.0 112.112 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.6 t -70.83 -0.22 8.6 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.422 1.089 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.2 t -100.12 101.84 15.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.09 168.01 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.596 1.53 . . . . 0.0 110.919 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.7 142.12 12.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.13 -11.61 35.45 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.589 -1.117 . . . . 0.0 113.69 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -84.58 154.24 22.73 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 120.478 2.139 . . . . 0.0 107.465 165.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -126.03 157.53 37.69 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 125.057 1.343 . . . . 0.0 109.338 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.66 147.21 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -83.39 150.5 26.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.7 mt -141.44 139.81 33.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.3 t -120.87 123.2 69.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 171.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.8 mt -115.96 164.37 14.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 123.958 0.786 . . . . 0.0 110.172 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 16.9 t -115.89 119.86 37.32 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 165.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.414 ' HB2' HD11 ' A' ' 21' ' ' LEU . 7.0 ttm180 -74.35 156.27 37.27 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.668 1.187 . . . . 0.0 107.993 163.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 109.84 -4.35 30.58 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 119.009 0.822 . . . . 0.0 113.309 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -103.35 126.8 31.17 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.41 172.52 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.393 2.062 . . . . 0.0 111.689 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.3 mt -65.15 142.68 98.65 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 167.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.35 -45.97 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.695 2.264 . . . . 0.0 111.25 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.69 117.68 7.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.953 0.901 . . . . 0.0 108.849 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -79.41 108.58 8.99 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 125.852 1.661 . . . . 0.0 108.799 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -81.41 -21.73 6.16 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.745 1.63 . . . . 0.0 111.497 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -64.46 -25.79 68.16 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.361 1.064 . . . . 0.0 111.329 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.1 100.25 2.32 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.93 -51.79 1.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.116 1.878 . . . . 0.0 110.144 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.22 -74.2 0.06 Allowed 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 125.848 1.659 . . . . 0.0 107.764 169.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 90.67 88.76 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 129.72 3.208 . . . . 0.0 111.006 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.4 m -60.11 118.54 6.45 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.723 0.409 . . . . 0.0 109.948 168.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.09 167.97 16.03 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 154.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.39 133.35 24.22 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.354 2.036 . . . . 0.0 110.964 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 89.0 p -145.93 148.63 33.0 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.726 0.81 . . . . 0.0 109.589 161.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 75.7 m -159.27 169.4 24.14 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.945 2.498 . . . . 0.0 106.314 168.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.609 0 N-CA-C 106.888 -2.485 . . . . 0.0 106.888 -175.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.9 m -133.37 179.66 6.07 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.913 1.685 . . . . 0.0 111.258 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.2 t 57.83 -163.94 0.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.869 1.668 . . . . 0.0 110.438 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.48 152.14 21.1 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.25 153.37 47.82 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.162 1.785 . . . . 0.0 108.262 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 m -132.93 159.1 40.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.747 1.619 . . . . 0.0 108.104 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 47.83 64.27 3.05 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -161.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.01 103.7 3.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 175.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.476 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 19.3 t80 -54.57 162.45 1.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.299 1.439 . . . . 0.0 111.206 177.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 HG23 ' HB2' ' A' ' 15' ' ' GLN . 9.1 m -74.02 -110.84 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.511 1.124 . . . . 0.0 112.369 177.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 134.61 -51.93 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 1 C-N-CA 134.296 5.039 . . . . 0.0 109.939 -175.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -125.26 22.49 7.81 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -165.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.17 -11.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.804 2.042 . . . . 0.0 114.922 -168.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.8 t -62.75 -31.53 72.49 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.99 1.716 . . . . 0.0 112.605 -169.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HB2' HG23 ' A' ' 10' ' ' THR . 9.3 mm-40 -72.91 -11.95 60.78 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 30.8 mt -69.39 145.58 52.76 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 119.908 1.231 . . . . 0.0 109.944 -173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -96.2 142.41 28.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 160.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.58 -173.71 23.35 Favored Glycine 0 N--CA 1.449 -0.5 0 O-C-N 123.988 0.805 . . . . 0.0 112.812 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.7 m -106.53 129.02 54.55 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 168.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -80.21 133.87 36.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.433 HD11 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -145.23 174.47 11.06 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.323 1.449 . . . . 0.0 109.005 177.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 90.4 p -151.04 163.25 39.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.243 0.217 . . . . 0.0 110.615 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 t -154.47 158.04 39.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.96 0.886 . . . . 0.0 108.636 166.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.7 m -114.84 117.83 31.81 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 167.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.58 138.5 36.58 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -90.95 129.82 36.94 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 169.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.95 103.58 0.18 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.008 1.323 . . . . 0.0 107.441 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 t -129.51 165.83 20.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.523 1.529 . . . . 0.0 107.779 -172.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 44.05 -73.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.733 3.213 . . . . 0.0 113.273 -167.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.5 ptp -142.74 5.94 1.59 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.089 1.756 . . . . 0.0 113.43 -170.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.23 -126.18 2.44 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 120.851 1.66 . . . . 0.0 111.599 -172.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.91 145.98 46.21 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.976 0.91 . . . . 0.0 109.253 173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.55 36.23 2.98 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.374 -0.681 . . . . 0.0 111.856 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -149.07 169.09 21.44 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.099 1.45 . . . . 0.0 108.883 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -131.77 154.21 49.31 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.373 1.069 . . . . 0.0 108.439 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.81 160.58 17.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 124.597 1.159 . . . . 0.0 107.898 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 tt -125.25 162.03 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.722 2.009 . . . . 0.0 107.207 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.76 150.7 19.37 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 107.338 -2.305 . . . . 0.0 107.338 171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.64 -63.16 3.31 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-O 118.952 -0.916 . . . . 0.0 112.285 -172.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.14 -49.27 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 128.453 2.701 . . . . 0.0 109.09 164.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -89.79 160.7 40.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.399 1.48 . . . . 0.0 112.39 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.97 51.83 3.23 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 125.082 3.855 . . . . 0.0 110.812 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -166.69 4.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.901 2.08 . . . . 0.0 110.921 -170.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -102.5 154.49 19.05 Favored 'General case' 0 CA--C 1.519 -0.213 0 O-C-N 120.632 -1.292 . . . . 0.0 109.126 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.57 137.43 33.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.162 0.985 . . . . 0.0 108.741 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mt -94.82 113.12 24.83 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.382 1.873 . . . . 0.0 109.173 -174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -100.72 157.27 16.82 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 122.104 2.229 . . . . 0.0 111.207 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.7 t -61.08 115.59 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 160.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.85 -55.11 36.93 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.36 -0.838 . . . . 0.0 109.142 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.9 m -159.66 154.29 24.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 123.973 0.909 . . . . 0.0 109.582 170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.08 133.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 160.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.3 135.15 66.1 Favored Pre-proline 0 N--CA 1.446 -0.639 0 C-N-CA 125.872 1.669 . . . . 0.0 107.574 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.12 147.51 84.09 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 121.509 1.472 . . . . 0.0 109.074 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 64.3 24.25 13.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.038 0.935 . . . . 0.0 112.509 167.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.97 176.54 19.9 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.798 1.666 . . . . 0.0 112.478 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.25 -12.36 25.37 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.734 2.956 . . . . 0.0 113.497 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.16 -50.71 12.38 Favored 'General case' 0 CA--C 1.527 0.081 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 168.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.32 -54.76 41.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.688 0.795 . . . . 0.0 109.971 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -68.94 -15.4 63.48 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.326 0.966 . . . . 0.0 113.473 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -70.9 -38.56 73.0 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.227 1.376 . . . . 0.0 109.415 166.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.04 -28.94 13.66 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 125.045 1.307 . . . . 0.0 113.057 167.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -93.63 -12.67 28.88 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.201 1.5 . . . . 0.0 113.836 -160.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.0 ttm -90.53 144.84 25.39 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 120.976 -1.077 . . . . 0.0 108.417 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -137.06 179.04 6.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 124.523 1.129 . . . . 0.0 108.181 171.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.1 m -93.93 149.4 21.27 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.1 5.92 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -165.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.776 ' HB3' HD13 ' A' ' 102' ' ' LEU . 0.5 OUTLIER -134.76 157.07 47.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 172.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 40.0 t -113.46 114.03 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 126.86 2.064 . . . . 0.0 108.351 -167.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -60.26 115.4 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 125.247 1.419 . . . . 0.0 108.089 171.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -101.95 -54.55 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 124.12 0.887 . . . . 0.0 109.974 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -135.16 154.25 51.69 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.288 1.435 . . . . 0.0 108.684 -172.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.401 HG13 HG21 ' A' ' 77' ' ' VAL . 46.4 mt -135.01 129.2 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t30 51.22 -89.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.898 2.479 . . . . 0.0 110.896 -178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -135.14 28.51 3.44 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.396 1.453 . . . . 0.0 112.023 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.3 t -125.98 133.52 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 120.904 -1.123 . . . . 0.0 109.293 -173.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.35 106.45 12.37 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.879 1.272 . . . . 0.0 110.322 173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 HG13 ' A' ' 72' ' ' ILE . 28.7 m -108.47 5.18 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.188 0.995 . . . . 0.0 112.784 -171.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -56.06 -32.04 63.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -167.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.41 14.63 13.28 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.612 1.577 . . . . 0.0 110.739 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -68.65 161.85 27.27 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 173.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.8 p -73.23 145.85 45.9 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -53.38 -41.77 66.23 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 124.117 0.967 . . . . 0.0 109.113 168.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.86 -30.26 63.68 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.326 0.966 . . . . 0.0 113.462 175.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.79 -53.87 6.66 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 120.288 1.404 . . . . 0.0 109.435 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.4 t -56.0 -39.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 126.395 1.878 . . . . 0.0 111.662 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.1 -38.36 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 O-C-N 120.93 -1.106 . . . . 0.0 110.068 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -37.26 81.8 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 120.148 1.34 . . . . 0.0 109.182 177.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.18 -39.41 92.84 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.659 1.184 . . . . 0.0 109.16 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -69.24 -45.02 70.79 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.95 0.795 . . . . 0.0 111.904 171.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.07 -29.45 70.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.904 0.775 . . . . 0.0 112.106 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 53.6 p -56.69 -25.56 54.42 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.263 1.025 . . . . 0.0 113.548 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.8 t -84.05 109.24 17.66 Favored Pre-proline 0 C--O 1.238 0.453 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -162.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.75 170.19 14.52 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.635 1.556 . . . . 0.0 110.419 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.2 mt -63.29 144.64 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.71 -4.05 53.33 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 117.654 -1.637 . . . . 0.0 113.99 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -86.52 175.94 8.09 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.867 1.834 . . . . 0.0 108.735 166.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.48 162.75 28.5 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.996 1.318 . . . . 0.0 109.999 170.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.04 150.37 24.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 125.331 1.452 . . . . 0.0 108.708 165.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -83.16 159.4 22.05 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 173.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -145.95 143.75 29.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.81 129.85 74.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 168.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.776 HD13 ' HB3' ' A' ' 67' ' ' ASP . 27.1 mt -118.47 171.13 8.37 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 124.296 0.997 . . . . 0.0 110.369 168.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 12.3 t -131.04 119.87 22.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.908 1.283 . . . . 0.0 108.344 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HB2' HD11 ' A' ' 21' ' ' LEU . 18.9 ttm180 -91.11 140.94 29.34 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 125.181 1.393 . . . . 0.0 110.467 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 134.85 -38.01 1.87 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 124.178 0.894 . . . . 0.0 111.008 172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -60.91 120.1 50.74 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 123.56 0.744 . . . . 0.0 109.316 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.11 177.08 4.71 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.646 2.231 . . . . 0.0 111.802 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.23 151.78 95.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.955 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.98 -49.73 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.517 2.144 . . . . 0.0 110.334 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -81.26 119.27 23.42 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.82 130.63 23.1 Favored Pre-proline 0 C--O 1.231 0.102 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 167.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.17 -12.99 28.33 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.496 2.131 . . . . 0.0 113.507 -176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.32 -44.11 38.28 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.963 0.905 . . . . 0.0 110.736 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.452 ' HA ' HD21 ' A' ' 117' ' ' ASN . 1.8 p-10 -151.37 76.51 7.66 Favored Pre-proline 0 CA--C 1.523 -0.089 0 O-C-N 121.648 -0.658 . . . . 0.0 109.637 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.6 -14.43 36.58 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.427 1.418 . . . . 0.0 111.607 172.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 143.03 118.05 0.0 OUTLIER 'General case' 0 C--N 1.345 0.384 1 C-N-CA 133.54 4.736 . . . . 0.0 106.622 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.452 HD21 ' HA ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER 168.06 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 128.452 2.701 . . . . 0.0 109.765 -178.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.15 132.36 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.489 1.515 . . . . 0.0 112.216 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 171.02 -112.91 0.47 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.09 149.54 58.6 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 CA-C-N 120.263 2.031 . . . . 0.0 110.261 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.98 176.73 12.27 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 159.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.9 t -147.26 136.58 22.6 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.437 0 N-CA-C 106.86 -2.496 . . . . 0.0 106.86 -173.64 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.859 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m 44.33 -135.3 0.58 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 117.476 -1.249 . . . . 0.0 110.091 -164.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -52.06 158.28 1.12 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.23 -97.36 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.4 m 42.66 78.44 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.365 1.866 . . . . 0.0 111.026 -176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 p -135.08 177.37 7.86 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.699 1.199 . . . . 0.0 110.338 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.29 175.75 37.39 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.338 0.97 . . . . 0.0 112.599 169.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 tp -143.47 -72.41 0.29 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.503 -0.76 . . . . 0.0 109.284 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -67.29 152.17 46.19 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.227 1.013 . . . . 0.0 109.497 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -74.51 -97.97 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.048 1.339 . . . . 0.0 113.928 -174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.1 mtp-105 116.67 -34.61 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.495 1 C-N-CA 136.112 5.765 . . . . 0.0 110.913 177.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -146.02 18.73 1.42 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.732 0.777 . . . . 0.0 112.674 -161.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB1' ' CZ ' ' A' ' 20' ' ' PHE . . . 62.3 -22.32 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 129.034 2.934 . . . . 0.0 114.749 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.7 t -74.17 -6.26 46.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 120.364 1.438 . . . . 0.0 113.433 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -80.41 -22.64 41.02 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 119.625 -1.922 . . . . 0.0 111.159 164.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 mt -66.41 146.15 54.89 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -131.52 124.54 30.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 128.85 177.99 15.15 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 -166.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 86.1 m -93.17 155.43 17.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.747 0.784 . . . . 0.0 110.655 -171.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.444 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 12.7 m-85 -106.44 132.28 52.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.876 1.67 . . . . 0.0 109.344 -175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 165.64 12.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.913 1.285 . . . . 0.0 108.475 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 88.5 p -139.02 149.79 45.06 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.6 1.16 . . . . 0.0 109.019 160.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -155.05 157.15 37.12 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 m -130.31 105.96 8.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.3 mt -98.42 134.83 40.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -82.6 145.62 29.6 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -71.55 95.37 1.4 Allowed 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 m -84.04 -166.45 1.42 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 127.548 2.339 . . . . 0.0 110.021 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -58.85 -24.58 62.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -165.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -133.07 53.19 2.03 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.35 -123.86 26.33 Favored Glycine 0 N--CA 1.441 -0.995 0 O-C-N 121.332 -0.855 . . . . 0.0 111.505 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -109.97 136.56 49.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.3 51.43 4.37 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 118.415 0.552 . . . . 0.0 112.169 -176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.46 173.27 13.28 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.01 1.324 . . . . 0.0 108.781 165.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.7 p -134.58 159.62 40.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.206 1.403 . . . . 0.0 108.811 175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.76 159.51 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 125.078 1.351 . . . . 0.0 109.658 -174.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -134.83 155.46 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 128.954 2.902 . . . . 0.0 106.853 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -135.99 152.25 20.99 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.936 1.731 . . . . 0.0 109.128 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -46.91 -75.6 0.17 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.373 1.463 . . . . 0.0 111.801 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -169.92 -46.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.473 1.509 . . . . 0.0 108.22 173.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -97.3 167.67 11.52 Favored Pre-proline 0 C--O 1.24 0.573 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -167.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.44 55.46 3.65 Favored 'Trans proline' 0 C--N 1.351 0.668 1 C-N-CA 125.312 4.008 . . . . 0.0 111.234 172.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -168.88 -8.27 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.956 1.302 . . . . 0.0 112.973 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -90.09 162.79 15.15 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.13 -0.981 . . . . 0.0 112.783 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -66.22 134.31 52.44 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.121 -1.4 . . . . 0.0 108.442 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.442 ' CD1' HG21 ' A' ' 85' ' ' VAL . 16.8 mt -104.45 135.88 45.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.571 -1.641 . . . . 0.0 106.571 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -130.25 153.68 48.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 119.203 0.91 . . . . 0.0 110.947 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -63.0 119.29 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 165.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.8 tttm -71.2 -50.32 34.33 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.985 1.714 . . . . 0.0 110.16 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.8 m -152.31 152.6 32.32 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.041 1.736 . . . . 0.0 108.295 168.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.48 136.27 24.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 160.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.95 142.88 91.12 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.62 141.82 17.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.676 1.584 . . . . 0.0 111.016 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 46.84 68.52 0.61 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.814 1.646 . . . . 0.0 110.765 -174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.41 175.4 26.78 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.944 1.259 . . . . 0.0 110.415 173.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -64.68 -33.22 55.66 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.598 2.198 . . . . 0.0 112.7 -167.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.69 74.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.45 -38.28 80.32 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.406 1.083 . . . . 0.0 111.517 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -67.69 -34.55 77.11 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.19 0.596 . . . . 0.0 112.536 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.32 -33.84 75.04 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.751 0.786 . . . . 0.0 109.169 171.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.2 -6.03 6.04 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 126.987 2.232 . . . . 0.0 114.209 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -65.57 -45.75 82.08 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.163 0.981 . . . . 0.0 109.246 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 7.3 tpp -65.63 122.75 17.95 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.835 0.854 . . . . 0.0 109.25 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -134.04 159.94 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.668 1.587 . . . . 0.0 108.897 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 14.5 m -78.06 149.55 33.93 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.786 -1.196 . . . . 0.0 108.436 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.41 -8.44 77.22 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 123.87 0.748 . . . . 0.0 113.71 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -74.41 158.18 34.36 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.143 1.472 . . . . 0.0 110.25 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.0 t -109.68 130.02 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.305 1.842 . . . . 0.0 108.741 -176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.93 126.71 39.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.112 1.365 . . . . 0.0 108.231 174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.409 HG11 ' HB2' ' A' ' 13' ' ' ALA . 2.6 t -110.78 -54.67 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.858 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -135.06 142.03 46.24 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -118.11 112.32 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.9 t30 71.97 -68.86 0.2 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.268 3.027 . . . . 0.0 111.322 168.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -156.47 24.77 0.35 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 110.756 170.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.3 t -119.05 132.27 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 O-C-N 120.491 -1.381 . . . . 0.0 107.513 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 t -69.78 116.38 10.1 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.987 0.915 . . . . 0.0 108.716 168.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.09 5.37 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.771 0.829 . . . . 0.0 111.787 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' C ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -55.12 -24.01 23.77 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.21 22.94 5.27 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.856 1.693 . . . . 0.0 110.529 173.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -75.69 158.47 32.28 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.352 1.576 . . . . 0.0 109.894 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 t -77.14 149.1 35.66 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.3 t-160 -55.24 -41.38 72.07 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.811 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.51 -32.3 62.78 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 120.379 1.445 . . . . 0.0 112.403 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -80.34 -47.8 13.93 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 118.86 0.754 . . . . 0.0 110.866 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG21 ' CD1' ' A' ' 46' ' ' LEU . 4.1 t -59.0 -42.82 87.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 O-C-N 120.711 -1.243 . . . . 0.0 110.703 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.58 -44.8 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.324 172.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.26 -37.89 84.74 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 120.629 1.558 . . . . 0.0 111.167 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.8 mt -60.93 -50.52 73.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.212 1.405 . . . . 0.0 108.362 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -64.79 -39.98 94.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.661 0.784 . . . . 0.0 112.211 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -67.01 -34.25 77.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.444 0.698 . . . . 0.0 110.168 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 m -70.53 -3.81 19.83 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.9 t -84.38 116.58 65.71 Favored Pre-proline 0 C--O 1.24 0.587 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -60.86 157.23 39.24 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.741 2.294 . . . . 0.0 110.896 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 78.9 mt -59.85 139.21 19.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -13.11 59.17 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 117.424 -1.764 . . . . 0.0 114.299 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -84.21 167.16 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.834 2.317 . . . . 0.0 108.241 167.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.33 163.56 22.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.655 1.182 . . . . 0.0 110.008 166.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.0 146.25 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.398 1.479 . . . . 0.0 107.777 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -83.82 156.51 22.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.485 1.114 . . . . 0.0 109.524 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.48 109.59 4.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.5 t -89.3 121.15 39.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 12.7 mt -116.52 163.77 15.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 124.11 0.881 . . . . 0.0 110.804 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.0 t -116.95 126.73 53.37 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.999 1.32 . . . . 0.0 108.563 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -76.52 156.84 32.59 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.454 1.502 . . . . 0.0 110.552 165.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 120.31 -21.93 8.56 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.808 1.194 . . . . 0.0 113.507 159.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -76.52 159.65 79.05 Favored Pre-proline 0 C--O 1.241 0.649 0 CA-C-N 118.364 1.082 . . . . 0.0 109.888 175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.23 178.31 6.74 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.986 2.458 . . . . 0.0 111.786 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.1 151.83 94.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 164.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.72 -25.13 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.761 1.641 . . . . 0.0 111.433 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -118.94 100.75 7.57 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.357 3.063 . . . . 0.0 106.033 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -82.7 103.5 2.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 C-N-CA 124.591 1.157 . . . . 0.0 108.34 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -77.44 -6.75 16.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.106 1.87 . . . . 0.0 112.432 -174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.18 -24.17 43.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.801 1.641 . . . . 0.0 112.754 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -95.53 118.59 66.11 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.05 -16.46 52.4 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.601 2.201 . . . . 0.0 113.649 -172.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 144.44 -27.91 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 131.5 3.92 . . . . 0.0 110.466 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . 0.269 5.4 p30 40.0 -122.24 0.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.125 1.77 . . . . 0.0 110.73 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.7 m 37.01 51.58 1.0 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.963 2.505 . . . . 0.0 115.949 170.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.79 155.08 7.37 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.588 160.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.86 163.51 28.61 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.754 2.303 . . . . 0.0 110.494 166.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 71.4 m 56.99 -176.42 0.06 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.844 1.258 . . . . 0.0 113.889 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.5 m -108.98 -52.05 2.81 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.061 1.344 . . . . 0.0 111.006 -172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.705 0 N-CA-C 104.64 -3.384 . . . . 0.0 104.64 165.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.727 0 N-CA-C 110.124 -1.191 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.9 p -63.99 166.9 6.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 163.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.0 t -152.53 -55.09 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.64 -161.77 20.66 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.406 1.479 . . . . 0.0 109.729 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . 0.304 89.6 p 59.9 88.78 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 129.348 3.059 . . . . 0.0 112.913 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -130.16 -7.31 4.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.717 1.607 . . . . 0.0 113.038 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.44 177.31 48.23 Favored Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -173.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.75 -82.74 0.4 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -166.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.431 ' CG ' ' N ' ' A' ' 10' ' ' THR . 88.0 t80 -82.8 179.14 7.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.333 1.453 . . . . 0.0 110.537 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 88.0 m -102.31 -106.25 0.26 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.827 1.651 . . . . 0.0 110.297 176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 138.41 -48.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 133.851 4.86 . . . . 0.0 110.597 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -123.54 17.26 9.65 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.043 0.838 . . . . 0.0 113.217 -165.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 58.66 -10.9 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.957 2.903 . . . . 0.0 115.184 -176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.1 p -75.92 -15.75 60.14 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.157 -1.589 . . . . 0.0 113.739 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.09 -16.85 63.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.96 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.01 162.9 28.64 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.535 1.061 . . . . 0.0 110.844 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 51.4 mmtt -126.46 135.3 51.19 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.994 2.118 . . . . 0.0 106.142 167.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.33 -158.4 27.64 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 -164.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.2 m -128.4 143.09 50.95 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.527 1.131 . . . . 0.0 108.403 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.438 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.9 m-85 -88.87 134.99 33.76 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 123.567 0.747 . . . . 0.0 109.387 170.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.2 OUTLIER -113.09 171.64 7.42 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.042 1.737 . . . . 0.0 108.301 173.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 58.4 p -147.72 153.35 39.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.431 0.693 . . . . 0.0 109.538 162.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.73 158.18 40.6 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 125.069 1.348 . . . . 0.0 107.393 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 97' ' ' SER . 11.1 m -131.16 117.03 18.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 168.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.91 144.76 26.53 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -82.48 145.12 29.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 163.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -72.04 93.18 1.37 Allowed 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.7 m -80.66 -165.62 0.92 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.831 1.253 . . . . 0.0 110.785 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.33 -47.12 66.23 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.766 1.627 . . . . 0.0 112.764 -166.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 59.1 mtt -116.43 62.8 0.71 Allowed 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.171 0.988 . . . . 0.0 108.421 171.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.24 -118.1 8.38 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.129 164.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.82 137.66 54.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.47 40.92 2.03 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 118.911 -0.939 . . . . 0.0 112.702 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -145.35 162.05 38.16 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 119.68 1.74 . . . . 0.0 109.439 174.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 37.8 p -124.46 158.24 33.29 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 170.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.74 162.06 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.919 1.288 . . . . 0.0 108.019 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tt -134.77 141.74 42.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 168.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.26 152.16 23.1 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.48 -2.648 . . . . 0.0 106.48 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.18 3.9 9.6 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-O 118.474 -1.181 . . . . 0.0 114.986 -172.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 t70 74.1 -37.17 0.36 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 127.877 2.471 . . . . 0.0 111.643 -174.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.58 135.46 92.78 Favored Pre-proline 0 N--CA 1.451 -0.403 0 C-N-CA 123.557 0.743 . . . . 0.0 109.286 172.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.22 41.65 0.79 Allowed 'Trans proline' 0 CA--C 1.543 0.973 1 C-N-CA 126.263 4.642 . . . . 0.0 112.396 -175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -160.55 -2.58 0.06 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.565 1.546 . . . . 0.0 112.828 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -75.83 148.62 38.25 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 120.507 -1.37 . . . . 0.0 108.082 166.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -76.62 143.07 40.41 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.036 1.334 . . . . 0.0 109.12 172.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 mt -88.3 141.81 28.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.345 1.058 . . . . 0.0 109.854 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HG2' HG22 ' A' ' 68' ' ' VAL . 33.5 mt-30 -130.95 154.87 47.68 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.612 1.165 . . . . 0.0 110.575 169.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.9 t -64.46 107.53 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 120.584 -1.322 . . . . 0.0 107.776 171.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.74 -53.8 53.62 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 125.497 1.519 . . . . 0.0 109.288 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.4 p -154.46 161.41 41.7 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.391 0.276 . . . . 0.0 110.388 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.55 126.4 65.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.53 132.12 89.54 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -64.86 158.7 49.67 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.176 1.917 . . . . 0.0 110.359 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 59.4 -4.85 0.08 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.838 2.055 . . . . 0.0 114.049 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.57 172.71 43.09 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.582 1.563 . . . . 0.0 113.509 -165.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -66.83 -27.73 43.7 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.355 2.037 . . . . 0.0 112.533 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.29 -44.63 67.97 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.05 74.11 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -57.37 -43.29 83.41 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 123.756 0.822 . . . . 0.0 112.948 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -67.54 -18.87 65.18 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 119.77 1.168 . . . . 0.0 111.191 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.42 -21.26 18.32 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 126.506 2.003 . . . . 0.0 112.75 164.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -80.78 -28.5 36.35 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 117.787 -1.101 . . . . 0.0 111.495 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.2 tpp -74.53 112.9 11.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -134.07 161.37 35.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.4 m -83.59 136.14 34.35 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.52 -5.75 83.63 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.603 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.404 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -66.18 151.28 47.3 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.484 1.642 . . . . 0.0 108.71 170.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.456 HG22 ' HG2' ' A' ' 47' ' ' GLN . 53.4 t -105.29 118.24 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 126.536 1.935 . . . . 0.0 109.084 -168.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -67.21 105.81 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.935 1.694 . . . . 0.0 108.448 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.17 -58.47 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 120.993 0.425 . . . . 0.0 110.062 176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -131.77 146.05 51.94 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -168.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.5 mt -122.44 120.12 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.1 t30 68.75 -68.85 0.17 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.521 2.328 . . . . 0.0 111.488 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.45 25.91 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.655 1.982 . . . . 0.0 110.621 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.5 t -131.17 130.5 63.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 125.386 1.474 . . . . 0.0 108.041 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 p -65.94 126.2 27.81 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.228 0.611 . . . . 0.0 110.349 167.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.92 13.14 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.451 0.7 . . . . 0.0 112.024 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.87 -12.62 59.88 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.01 25.99 4.29 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -90.24 149.58 22.33 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.682 0.753 . . . . 0.0 109.165 -177.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.86 142.0 38.77 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 114.695 -1.138 . . . . 0.0 107.943 -170.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -58.42 -23.41 57.29 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.84 1.656 . . . . 0.0 111.274 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.36 -50.43 71.62 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.321 0.964 . . . . 0.0 110.808 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -72.24 -46.8 54.5 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 123.448 0.699 . . . . 0.0 109.529 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 t -60.63 -41.5 88.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 O-C-N 120.597 -1.314 . . . . 0.0 111.117 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -66.53 -34.62 71.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 O-C-N 120.843 -1.161 . . . . 0.0 110.107 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.14 83.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.779 1.172 . . . . 0.0 109.776 171.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.25 -36.97 77.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.54 1.136 . . . . 0.0 109.739 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.56 -40.94 63.55 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.593 0.757 . . . . 0.0 111.731 174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -56.68 -41.7 77.76 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.013 0.925 . . . . 0.0 110.305 173.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.1 m -65.16 -2.95 3.25 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 t -93.82 110.72 49.29 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 120.747 1.612 . . . . 0.0 108.105 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.24 169.55 21.29 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.449 2.1 . . . . 0.0 111.374 172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.0 mt -70.67 148.63 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 121.385 -0.822 . . . . 0.0 109.328 -172.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.5 -11.07 47.26 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.425 -1.208 . . . . 0.0 113.279 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -84.34 156.89 21.67 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.785 1.792 . . . . 0.0 107.993 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.503 ' HB2' HG22 ' A' ' 24' ' ' THR . 4.0 p -125.96 148.82 49.15 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 124.441 1.096 . . . . 0.0 108.54 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.1 m -135.93 144.64 32.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 123.719 0.808 . . . . 0.0 109.841 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -82.88 155.21 24.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.27 152.14 45.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.3 t -130.05 111.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 172.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.404 HD13 ' HB3' ' A' ' 67' ' ' ASP . 13.8 mt -102.3 168.1 9.55 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.88 171.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 38.6 t -123.48 142.42 51.02 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.473 1.109 . . . . 0.0 108.835 167.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.659 ' HB2' HD21 ' A' ' 21' ' ' LEU . 22.5 ttm180 -116.73 139.65 50.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 110.728 -170.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 125.62 -14.67 7.19 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 124.726 1.155 . . . . 0.0 112.055 168.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -70.54 142.21 88.75 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 166.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.37 173.99 10.7 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.501 2.134 . . . . 0.0 110.03 168.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.35 162.71 30.95 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 123.169 0.588 . . . . 0.0 111.501 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -50.09 122.74 9.71 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.526 2.151 . . . . 0.0 109.003 160.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -67.18 101.1 0.85 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 158.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -79.5 111.0 17.41 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -82.85 -22.23 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.264 1.976 . . . . 0.0 112.24 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -70.92 -65.99 0.67 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.424 1.489 . . . . 0.0 109.823 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -161.58 103.38 1.2 Allowed Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.29 -53.97 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.316 1.344 . . . . 0.0 110.595 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -177.61 74.53 0.02 OUTLIER 'General case' 0 C--O 1.236 0.361 0 C-N-CA 128.228 2.611 . . . . 0.0 105.971 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -52.36 153.76 2.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.743 0.782 . . . . 0.0 112.821 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.9 t -77.9 150.32 34.12 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.29 -162.98 37.6 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 126.243 1.877 . . . . 0.0 111.745 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 81.11 0.7 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.643 2.895 . . . . 0.0 109.947 171.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 7.6 t -79.52 -159.78 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.027 1.331 . . . . 0.0 107.792 160.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.3 m -47.71 135.94 11.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 158.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 117.649 -1.639 . . . . 0.0 109.468 173.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 t -64.25 107.4 1.3 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 161.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.1 m -131.3 9.56 4.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.227 1.011 . . . . 0.0 112.126 -175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.77 174.71 42.82 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 123.819 0.723 . . . . 0.0 112.3 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.8 m -135.24 151.34 50.51 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 109.188 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 t -144.43 -172.17 3.74 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.284 1.034 . . . . 0.0 109.44 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -87.68 -88.67 1.1 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mt -141.84 -70.84 0.35 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 118.124 -0.941 . . . . 0.0 108.827 170.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.01 150.17 4.52 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.427 1.091 . . . . 0.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.6 m -64.51 -113.38 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 128.421 2.688 . . . . 0.0 113.325 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 51.0 mtt-85 140.51 -23.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 1 C-N-CA 133.111 4.565 . . . . 0.0 111.661 177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -126.96 179.1 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.146 1.378 . . . . 0.0 107.639 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.81 -34.5 6.93 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 126.098 1.759 . . . . 0.0 110.429 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -28.7 70.21 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.663 1.12 . . . . 0.0 111.523 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -62.41 -24.33 67.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.002 0.819 . . . . 0.0 112.186 176.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.2 mt -66.14 142.8 57.63 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.102 0.865 . . . . 0.0 111.144 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 127.62 33.21 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 162.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.18 -173.3 36.79 Favored Glycine 0 CA--C 1.523 0.585 0 O-C-N 123.859 0.725 . . . . 0.0 112.721 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 96.7 m -114.08 141.23 47.72 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 167.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -103.0 127.49 50.22 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.71 0.804 . . . . 0.0 110.462 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -115.8 162.08 17.82 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.082 1.753 . . . . 0.0 107.985 177.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.5 p -150.18 146.72 27.03 Favored 'General case' 0 N--CA 1.44 -0.956 0 O-C-N 121.997 -0.439 . . . . 0.0 110.833 162.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.0 t -144.13 157.54 44.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.3 m -117.09 117.18 28.92 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 mt -104.45 145.44 30.27 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -101.58 126.75 48.45 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.473 1.109 . . . . 0.0 109.159 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 25.2 tptt -55.55 109.69 0.59 Allowed 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.664 1.586 . . . . 0.0 110.197 -178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 93.6 p -79.05 -173.65 3.68 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.597 1.159 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -59.63 -15.59 20.07 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.351 1.06 . . . . 0.0 112.747 166.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 38.7 mtt -132.03 49.22 2.34 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.22 1.373 . . . . 0.0 110.221 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 72.7 -109.81 2.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-O 118.637 -1.091 . . . . 0.0 112.026 167.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -121.32 152.78 38.56 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.39 35.52 2.42 Favored Glycine 0 C--O 1.221 -0.701 0 CA-C-O 118.155 -1.358 . . . . 0.0 111.849 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -152.14 167.1 29.62 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 119.668 1.734 . . . . 0.0 108.621 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.8 p -134.06 161.32 35.17 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.25 162.46 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.459 1.104 . . . . 0.0 109.486 -168.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.44 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 14.7 tt -126.7 158.6 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 126.715 2.006 . . . . 0.0 107.468 166.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.65 152.26 22.9 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 108.082 -2.007 . . . . 0.0 108.082 157.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.47 -70.86 0.85 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 124.505 1.05 . . . . 0.0 111.171 -175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.71 -37.91 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -137.0 176.23 2.93 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.578 1.151 . . . . 0.0 110.249 -172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -71.32 54.33 1.8 Allowed 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.501 2.8 . . . . 0.0 112.231 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.49 -9.84 0.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 126.02 1.728 . . . . 0.0 112.361 -176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -110.79 158.01 19.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.395 1.452 . . . . 0.0 108.691 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -83.57 126.58 32.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.927 0.891 . . . . 0.0 109.173 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mt -80.99 139.72 35.62 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -134.22 156.77 47.8 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.294 0.638 . . . . 0.0 110.881 -177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG21 HD11 ' A' ' 102' ' ' LEU . 38.5 t -67.03 114.63 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 170.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 24.1 ttmt -72.42 -51.58 19.73 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.647 1.579 . . . . 0.0 109.916 178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 m -143.78 162.12 36.85 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.28 0.632 . . . . 0.0 109.417 -178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.85 138.91 43.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 162.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 mm -74.83 127.82 86.35 Favored Pre-proline 0 N--CA 1.45 -0.445 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -69.86 133.08 24.54 Favored 'Trans proline' 0 N--CA 1.442 -1.518 0 C-N-CA 121.908 1.739 . . . . 0.0 109.768 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t0 65.48 13.04 8.61 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.32 1.448 . . . . 0.0 111.845 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.44 167.67 37.51 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.181 1.372 . . . . 0.0 111.116 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -63.23 -34.42 68.07 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.44 2.093 . . . . 0.0 112.716 -169.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.95 -40.33 91.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.529 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.46 96.39 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.459 0.704 . . . . 0.0 110.414 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -67.68 -37.43 82.33 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.986 0.812 . . . . 0.0 112.755 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -70.27 -24.89 63.13 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.433 -0.792 . . . . 0.0 110.855 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.76 -16.36 26.63 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 126.865 2.174 . . . . 0.0 113.483 166.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -81.29 -37.09 29.01 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.378 1.589 . . . . 0.0 114.163 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 5.4 tpp -70.01 118.37 12.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.52 166.06 24.08 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.999 0.919 . . . . 0.0 109.025 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.1 m -100.56 98.96 9.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 122.261 1.029 . . . . 0.0 110.491 -150.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 130.66 -6.7 5.87 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.776 1.655 . . . . 0.0 112.322 -175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.679 ' HB3' HD13 ' A' ' 102' ' ' LEU . 2.8 m-20 -68.46 163.15 23.99 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.404 1.102 . . . . 0.0 110.62 177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 68.9 t -111.87 120.64 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.27 1.828 . . . . 0.0 109.552 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.5 mp -69.13 109.45 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 126.467 1.907 . . . . 0.0 108.881 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.8 t -93.68 -51.83 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.406 0.622 . . . . 0.0 110.086 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -134.96 154.59 51.66 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.075 1.35 . . . . 0.0 108.179 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.422 HG13 HG21 ' A' ' 77' ' ' VAL . 54.1 mt -134.86 134.9 53.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 171.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.593 HD21 HG12 ' A' ' 98' ' ' VAL . 20.8 m120 50.46 -92.7 0.02 OUTLIER 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.456 1.902 . . . . 0.0 110.072 -169.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -143.17 20.81 1.92 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.222 2.609 . . . . 0.0 108.971 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -128.87 128.49 67.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 127.325 2.25 . . . . 0.0 107.636 -169.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -76.35 129.46 36.64 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.422 HG21 HG13 ' A' ' 72' ' ' ILE . 30.5 m -130.11 11.07 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.058 1.343 . . . . 0.0 110.964 -176.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -20.93 64.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -168.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.07 33.83 2.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.763 1.649 . . . . 0.0 109.659 167.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -77.22 161.42 28.17 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 119.681 1.74 . . . . 0.0 109.225 165.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.96 151.37 33.69 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 172.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -55.35 -35.13 64.89 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.136 0.974 . . . . 0.0 110.39 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.69 -54.4 38.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.116 0.871 . . . . 0.0 110.606 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -66.88 -48.18 69.53 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.768 0.827 . . . . 0.0 110.846 -174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 t -61.67 -43.1 96.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 125.054 1.341 . . . . 0.0 111.149 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 65.4 t -63.51 -39.62 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 120.982 -1.074 . . . . 0.0 109.363 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -38.82 92.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.876 1.217 . . . . 0.0 110.027 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 38.6 mt -64.12 -31.81 73.14 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 125.134 1.374 . . . . 0.0 111.052 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -77.61 -46.36 22.34 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.06 0.846 . . . . 0.0 111.546 172.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -65.03 -29.86 70.8 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.216 -0.928 . . . . 0.0 111.586 -175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.7 t -63.42 -14.34 49.42 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.535 1.134 . . . . 0.0 112.746 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.3 t -84.26 112.16 39.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 120.409 1.459 . . . . 0.0 107.198 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.96 169.27 22.99 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.79 1.66 . . . . 0.0 110.869 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 31.8 mt -65.06 139.57 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.54 -10.19 62.59 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.083 -0.843 . . . . 0.0 113.699 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -84.23 172.64 11.68 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.419 1.61 . . . . 0.0 108.735 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 p -134.06 156.21 48.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.205 1.002 . . . . 0.0 110.576 -178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 73' ' ' ASN . 28.9 m -139.44 142.53 32.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.06 0.944 . . . . 0.0 108.849 173.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -83.86 143.6 29.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 126.367 1.867 . . . . 0.0 107.228 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.7 mt -144.79 110.87 5.48 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.35 132.07 35.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.679 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.9 mt -119.02 162.89 17.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.998 0.919 . . . . 0.0 109.707 170.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.6 t -127.18 133.96 50.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.996 1.318 . . . . 0.0 108.658 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.502 ' HB2' HD21 ' A' ' 21' ' ' LEU . 10.6 ttm180 -102.4 155.42 18.26 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 126.627 1.971 . . . . 0.0 112.279 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.81 -8.56 63.62 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.351 0.976 . . . . 0.0 112.775 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -68.37 151.55 97.15 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 117.71 0.755 . . . . 0.0 109.604 163.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.5 166.39 28.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.491 2.127 . . . . 0.0 112.104 170.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.8 mt -65.59 157.25 79.67 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.415 1.486 . . . . 0.0 110.417 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.22 -45.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.584 2.189 . . . . 0.0 110.831 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -71.42 109.98 5.75 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -83.89 110.69 27.2 Favored Pre-proline 0 C--O 1.235 0.301 0 C-N-CA 125.224 1.41 . . . . 0.0 107.611 168.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.97 -21.48 6.78 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.054 1.836 . . . . 0.0 111.883 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -83.91 -48.57 9.86 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.182 -163.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -129.38 70.5 81.82 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.062 0.846 . . . . 0.0 108.904 175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.93 -10.75 28.22 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 122.749 2.299 . . . . 0.0 117.04 -152.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 140.95 -11.37 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 130.807 3.643 . . . . 0.0 112.834 -173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.3 165.76 3.37 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.79 -0.569 . . . . 0.0 109.756 161.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 5.1 p -60.47 150.16 32.06 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.445 1.098 . . . . 0.0 110.474 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.35 179.0 51.72 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 123.687 0.66 . . . . 0.0 111.895 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.45 123.05 12.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.236 2.624 . . . . 0.0 109.221 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.6 m -140.45 172.25 12.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.762 1.225 . . . . 0.0 109.366 -170.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.8 p -84.64 -9.01 58.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.52 1.128 . . . . 0.0 112.22 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 C-N-CA 127.153 2.311 . . . . 0.0 107.472 -174.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.895 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m 29.06 85.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.875 2.47 . . . . 0.0 114.628 163.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.3 t -58.71 140.15 55.16 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.49 174.98 23.15 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.67 1.128 . . . . 0.0 111.752 -176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 m -108.86 172.82 6.62 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.59 1.556 . . . . 0.0 110.327 -175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m 59.18 -172.05 0.11 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.926 1.29 . . . . 0.0 111.314 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.48 141.76 3.88 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 mp -102.75 -94.73 0.31 Allowed 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -66.58 153.64 42.52 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.113 0.565 . . . . 0.0 110.109 -176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.9 m -81.76 -109.57 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.018 1.327 . . . . 0.0 112.178 175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.6 mtm105 135.71 -67.39 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.598 1 C-N-CA 133.915 4.886 . . . . 0.0 108.742 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.83 -3.86 9.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.021 -1.445 . . . . 0.0 111.896 -157.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 73.59 -27.31 0.19 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 128.497 2.719 . . . . 0.0 114.713 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.7 m -66.37 -6.44 14.33 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.122 1.328 . . . . 0.0 111.727 161.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -66.63 -19.08 65.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.481 1.513 . . . . 0.0 112.41 163.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.8 mt -91.24 159.18 16.18 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.236 1.38 . . . . 0.0 108.593 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.06 -3.73 13.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -169.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.38 -172.76 38.28 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 126.179 1.847 . . . . 0.0 111.685 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 89.9 m -88.01 156.4 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.463 1.505 . . . . 0.0 108.574 170.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -125.54 130.05 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 124.801 1.241 . . . . 0.0 109.038 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -109.86 173.34 6.37 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 108.172 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 36.3 p -151.21 142.7 23.51 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.422 -0.799 . . . . 0.0 109.405 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 13.3 t -150.62 158.15 43.81 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 121.793 -0.567 . . . . 0.0 109.622 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -121.49 106.0 11.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 107.023 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.86 118.55 34.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -92.41 116.38 28.93 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.2 tptt -42.95 91.97 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 C-N-CA 127.819 2.448 . . . . 0.0 112.298 -171.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -79.52 111.67 16.02 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 166.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 17.34 -83.52 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 130.269 3.428 . . . . 0.0 115.209 -168.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 31.0 mtt -56.38 -21.98 28.34 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.394 1.478 . . . . 0.0 113.463 -174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.73 -124.51 5.42 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 124.829 1.204 . . . . 0.0 110.426 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -103.58 129.64 50.85 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.37 49.04 2.93 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -146.73 171.89 14.46 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.567 1.547 . . . . 0.0 108.356 166.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -134.13 163.38 29.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.606 0.762 . . . . 0.0 109.407 167.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -120.58 162.35 19.31 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 108.44 -169.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.5 tt -132.45 159.91 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 128.244 2.618 . . . . 0.0 107.006 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.16 152.57 22.86 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 128.354 2.883 . . . . 0.0 106.523 167.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.77 -70.54 0.88 Allowed Glycine 0 C--N 1.333 0.385 0 CA-C-N 118.819 1.31 . . . . 0.0 113.091 -171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -173.82 -52.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -97.56 163.41 19.74 Favored Pre-proline 0 N--CA 1.451 -0.4 0 C-N-CA 124.64 1.176 . . . . 0.0 112.619 -170.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -75.1 48.37 2.0 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 125.099 3.866 . . . . 0.0 112.082 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -150.8 -7.27 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.872 1.269 . . . . 0.0 110.497 172.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -93.32 152.44 19.15 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.874 0.761 . . . . 0.0 112.293 -161.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -57.89 134.22 56.13 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.101 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 28.4 mt -100.65 126.61 47.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.022 1.729 . . . . 0.0 106.375 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -130.95 155.05 47.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 119.017 0.826 . . . . 0.0 110.238 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.6 t -67.95 112.37 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.42 -47.94 71.61 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.123 0.969 . . . . 0.0 109.207 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.4 m -155.98 158.53 38.03 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.014 1.326 . . . . 0.0 108.807 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.3 t -108.07 145.01 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 165.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -81.62 128.85 67.88 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.75 160.21 33.91 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.755 1.637 . . . . 0.0 110.221 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 61.4 -12.95 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.996 2.118 . . . . 0.0 114.903 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.46 178.1 54.06 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.667 1.127 . . . . 0.0 112.94 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.87 -37.46 77.45 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.695 2.263 . . . . 0.0 110.79 -176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.47 -35.9 76.04 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.168 0.587 . . . . 0.0 111.649 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.06 -40.97 67.93 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.659 0.784 . . . . 0.0 110.931 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.67 -49.46 76.42 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.06 -35.47 78.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.707 0.289 . . . . 0.0 110.949 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.48 -11.34 39.22 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.878 1.228 . . . . 0.0 113.995 161.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -63.43 -46.01 88.3 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.09 1.445 . . . . 0.0 109.709 168.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 6.5 tpp -66.28 115.91 6.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.37 159.14 42.85 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -87.88 117.85 27.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.162 -159.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.68 -8.25 39.82 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.535 1.54 . . . . 0.0 113.46 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.43 155.02 26.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.438 1.619 . . . . 0.0 109.317 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.1 t -104.35 116.82 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 126.037 1.735 . . . . 0.0 109.375 -167.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -62.05 118.79 4.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 126.659 1.983 . . . . 0.0 108.052 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -105.95 -57.62 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.053 177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.7 150.74 51.75 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.9 mt -127.69 123.29 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 169.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.16 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.478 3.111 . . . . 0.0 110.518 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.39 -6.53 1.36 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.934 1.694 . . . . 0.0 111.952 175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.7 t -88.74 124.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 38.7 t -65.51 120.07 12.21 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -120.4 6.56 6.35 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 C-N-CA 124.699 1.2 . . . . 0.0 110.948 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.49 HD12 ' C ' ' A' ' 78' ' ' LEU 0.26 1.0 OUTLIER -58.62 -25.89 63.15 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -166.21 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.63 11.18 21.29 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.512 2.006 . . . . 0.0 112.368 175.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.11 165.38 24.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 118.321 1.06 . . . . 0.0 110.242 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.7 p -75.85 148.51 38.28 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -60.76 -35.57 76.74 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.581 -0.723 . . . . 0.0 109.436 165.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.3 74.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.34 0.973 . . . . 0.0 111.929 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.84 -55.58 8.19 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 118.188 0.449 . . . . 0.0 110.488 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.37 -39.58 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 127.519 2.328 . . . . 0.0 112.162 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.9 -39.08 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 120.94 -1.1 . . . . 0.0 109.242 172.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -36.46 83.22 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.87 1.214 . . . . 0.0 109.638 177.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.64 -45.6 93.46 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.584 1.153 . . . . 0.0 108.722 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -66.2 -31.01 71.58 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.235 0.614 . . . . 0.0 112.237 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -82.34 -6.65 59.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.056 1.342 . . . . 0.0 112.963 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 68.2 m -91.02 7.61 39.51 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.213 1.405 . . . . 0.0 113.57 172.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.2 t -101.18 107.59 50.99 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.5 172.41 14.49 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.35 2.7 . . . . 0.0 113.33 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 94' ' ' ILE . 4.2 mp -70.94 100.15 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.291 1.436 . . . . 0.0 110.665 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 144.56 -42.09 1.05 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -172.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -84.26 160.75 20.7 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.694 0.759 . . . . 0.0 109.61 -164.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.89 160.54 22.49 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 125.582 1.553 . . . . 0.0 108.474 170.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.11 147.15 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -83.66 157.45 22.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 49.8 mt -146.52 116.27 7.22 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 -175.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.81 123.98 45.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 17.4 mt -108.97 159.01 17.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.794 0.683 . . . . 0.0 110.353 159.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 45.3 t -105.97 136.16 46.13 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.284 1.434 . . . . 0.0 107.661 165.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -81.52 156.23 25.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.231 1.412 . . . . 0.0 112.43 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.31 35.84 7.84 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.11 151.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -117.3 150.42 46.34 Favored Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 161.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.08 171.71 13.25 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.215 1.943 . . . . 0.0 111.208 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.1 mt -68.61 143.22 94.9 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.9 -32.85 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.821 2.347 . . . . 0.0 114.219 -168.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -69.05 109.07 3.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 165.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -82.0 115.66 58.76 Favored Pre-proline 0 C--O 1.236 0.358 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.27 -25.61 4.7 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.213 2.609 . . . . 0.0 111.98 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -71.76 -36.06 70.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.091 0.956 . . . . 0.0 110.866 -169.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -132.98 46.4 2.1 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.289 1.036 . . . . 0.0 112.707 -161.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.73 -11.93 18.31 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.435 2.09 . . . . 0.0 116.141 -153.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -154.09 -76.07 0.11 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.102 1.319 . . . . 0.0 109.427 167.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 70.1 58.02 0.28 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.76 2.024 . . . . 0.0 110.524 -173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 73.4 m -136.21 168.6 19.1 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.633 0.73 . . . . 0.0 112.416 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 145.18 152.38 5.61 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 126.942 2.21 . . . . 0.0 108.609 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.27 -16.11 13.96 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.023 1.815 . . . . 0.0 113.522 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.7 t 50.18 -165.78 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.256 0.935 . . . . 0.0 110.579 -156.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.7 m -157.59 -42.03 0.07 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.15 1.78 . . . . 0.0 108.916 164.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 C-N-CA 128.3 2.857 . . . . 0.0 106.741 -177.106 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.691 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -143.02 160.82 39.63 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 161.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.6 m -147.84 79.6 1.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -174.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.2 115.17 0.54 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.725 -2.55 . . . . 0.0 106.725 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -141.7 117.95 10.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.0 m -64.43 -54.12 37.64 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.635 0.774 . . . . 0.0 109.479 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.0 99.42 2.18 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 104.886 -3.285 . . . . 0.0 104.886 -148.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.77 64.9 0.92 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -174.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 78' ' ' LEU . 15.0 t80 57.67 170.48 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.681 2.792 . . . . 0.0 113.427 -172.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.3 m -81.86 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.551 1.541 . . . . 0.0 110.617 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 145.85 -60.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.667 1 C-N-CA 132.373 4.269 . . . . 0.0 111.398 174.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -106.58 2.37 26.01 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.936 1.294 . . . . 0.0 111.029 -167.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.01 -14.15 0.18 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.8 2.44 . . . . 0.0 113.669 -168.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 m -57.88 -29.16 64.82 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.36 1.064 . . . . 0.0 113.095 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -77.93 -11.97 59.94 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.212 0.605 . . . . 0.0 112.082 -171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 36.7 mt -68.7 166.12 18.03 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.198 0.999 . . . . 0.0 110.342 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -128.0 136.42 51.25 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 175.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.24 -161.49 25.63 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -169.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -107.04 161.52 14.67 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -119.56 121.31 39.07 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.661 1.584 . . . . 0.0 108.142 175.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -145.74 154.07 41.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.376 1.07 . . . . 0.0 110.576 -170.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.8 p -157.14 163.28 39.09 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -165.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.0 t -154.92 157.71 38.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.566 -0.709 . . . . 0.0 111.438 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.0 m -101.33 119.82 39.33 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.225 1.01 . . . . 0.0 108.52 158.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 mt -99.11 159.3 15.07 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.792 1.237 . . . . 0.0 108.125 163.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -103.84 143.52 32.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -66.98 99.35 0.64 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.8 m -88.47 -163.4 0.96 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.377 2.271 . . . . 0.0 108.487 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -48.49 -65.21 0.6 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.942 1.297 . . . . 0.0 110.925 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.44 66.81 1.11 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.2 -106.76 0.61 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 124.818 1.199 . . . . 0.0 113.469 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -124.37 152.25 43.41 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.0 40.15 2.89 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.328 -1.262 . . . . 0.0 111.753 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -154.92 161.47 41.41 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.748 1.774 . . . . 0.0 110.316 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 47.6 p -130.41 159.93 35.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.977 1.311 . . . . 0.0 109.315 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.82 162.63 26.55 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 125.208 1.403 . . . . 0.0 109.973 -170.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 tt -134.18 151.58 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.469 1.508 . . . . 0.0 110.067 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.29 153.37 16.73 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 129.322 3.344 . . . . 0.0 109.333 176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.86 -82.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -174.68 -32.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.028 1.731 . . . . 0.0 109.798 163.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -93.57 162.59 27.14 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.541 1.537 . . . . 0.0 113.473 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.55 43.17 1.47 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 125.086 3.857 . . . . 0.0 112.925 -169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -166.47 12.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.63 1.972 . . . . 0.0 111.683 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 155.13 21.2 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.349 -1.469 . . . . 0.0 110.969 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -85.93 115.74 23.73 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.054 0.942 . . . . 0.0 109.491 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.0 mt -80.79 140.6 35.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.884 0.766 . . . . 0.0 109.502 -171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.422 ' HG2' HG22 ' A' ' 68' ' ' VAL . 39.9 mt-30 -131.63 157.18 44.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.845 0.748 . . . . 0.0 111.231 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.48 111.02 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 168.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -60.76 -54.65 42.63 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.022 0.929 . . . . 0.0 109.328 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.461 ' HA ' HG23 ' A' ' 65' ' ' THR . 53.6 p -154.99 164.45 38.88 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.97 0.508 . . . . 0.0 110.672 169.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.11 145.34 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 160.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.5 123.42 76.65 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 165.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.57 150.95 86.1 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.552 2.168 . . . . 0.0 109.854 171.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.319 1.0 OUTLIER 58.99 -0.7 0.13 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.996 1.718 . . . . 0.0 115.137 -168.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.05 167.18 54.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.48 1.038 . . . . 0.0 112.563 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -68.17 -26.52 36.18 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.952 1.768 . . . . 0.0 112.236 -176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.74 -45.61 78.06 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.781 -0.575 . . . . 0.0 109.807 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.92 97.92 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.572 0.749 . . . . 0.0 110.96 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -69.69 -26.07 64.18 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -69.78 -38.98 76.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 119.47 1.032 . . . . 0.0 109.238 171.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.45 20.39 69.27 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.169 166.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -98.76 -52.05 3.71 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.807 1.804 . . . . 0.0 111.379 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.7 ttm -80.82 146.77 30.75 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.558 1.143 . . . . 0.0 109.961 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -134.09 165.1 25.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 122.385 1.088 . . . . 0.0 110.984 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 50' ' ' SER . 28.0 m -75.17 121.28 21.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.227 1.011 . . . . 0.0 108.656 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.05 -20.37 16.94 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 118.756 -1.025 . . . . 0.0 112.122 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB3' HD13 ' A' ' 102' ' ' LEU . 14.9 m-20 -63.91 150.64 44.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.079 1.439 . . . . 0.0 109.402 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG22 ' HG2' ' A' ' 47' ' ' GLN . 51.3 t -101.45 124.45 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 126.635 1.974 . . . . 0.0 108.813 -171.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.42 128.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 125.353 1.461 . . . . 0.0 107.614 177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.27 -56.85 4.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.119 -1.4 . . . . 0.0 109.899 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -133.09 147.57 52.16 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.324 1.05 . . . . 0.0 108.841 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.0 mt -130.33 122.51 53.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 53.21 -92.63 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 127.35 2.26 . . . . 0.0 109.719 -162.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.61 1.38 8.23 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.37 1.468 . . . . 0.0 111.161 -176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.6 t -111.51 131.08 63.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 -160.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 22.4 p -74.69 123.28 24.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.62 12.77 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.034 0.934 . . . . 0.0 111.049 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -54.33 -35.31 62.55 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -162.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.45 16.35 12.72 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.111 1.339 . . . . 0.0 112.624 173.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.18 164.91 12.29 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.874 1.837 . . . . 0.0 110.666 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 p -70.74 137.96 50.11 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.58 -25.14 64.34 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.594 -0.691 . . . . 0.0 110.546 167.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.51 -57.85 10.86 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.897 1.226 . . . . 0.0 110.31 167.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -59.86 -54.73 42.74 Favored 'General case' 0 C--O 1.217 -0.621 0 C-N-CA 124.574 1.15 . . . . 0.0 110.472 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.4 -42.53 74.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.487 1.515 . . . . 0.0 111.491 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 74.7 t -67.09 -33.98 66.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 O-C-N 120.546 -1.346 . . . . 0.0 110.376 173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.99 -39.57 94.42 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 120.659 1.572 . . . . 0.0 109.361 175.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -61.24 -49.18 78.14 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -64.56 -41.4 96.34 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -55.51 -46.78 76.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.495 0.588 . . . . 0.0 109.585 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.5 p -64.76 -13.55 55.6 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 114.447 1.276 . . . . 0.0 114.447 -166.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.4 t -82.98 110.93 26.25 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 -176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.73 159.95 44.64 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 CA-C-N 120.062 1.058 . . . . 0.0 109.59 -177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 79.8 mt -57.58 126.76 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 102.49 1.83 50.28 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.805 -1.553 . . . . 0.0 114.163 -176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 -112.13 165.11 12.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 121.02 2.41 . . . . 0.0 110.327 168.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.6 p -123.25 164.7 18.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.124 1.37 . . . . 0.0 109.755 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.6 m -138.97 150.14 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.007 1.323 . . . . 0.0 108.314 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.83 154.14 23.66 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 167.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.1 mt -146.24 126.27 13.7 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.37 130.97 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 67' ' ' ASP . 15.1 mt -118.45 169.05 10.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.322 1.014 . . . . 0.0 110.046 170.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 20.6 t -128.37 144.45 51.14 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.5 1.52 . . . . 0.0 108.887 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -125.11 123.16 39.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.432 1.493 . . . . 0.0 112.686 -166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 152.45 -25.44 0.86 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.989 1.28 . . . . 0.0 113.494 169.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -72.66 158.02 87.99 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 118.021 0.911 . . . . 0.0 110.856 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.27 175.79 9.49 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.006 2.471 . . . . 0.0 111.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mt -71.89 159.09 86.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.273 1.029 . . . . 0.0 109.484 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -82.13 -14.14 9.8 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.806 3.004 . . . . 0.0 113.847 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -117.53 121.13 40.14 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 126.883 2.073 . . . . 0.0 106.525 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -80.32 103.99 2.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 124.907 1.283 . . . . 0.0 107.895 172.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.99 -26.83 6.25 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 CA-C-N 120.597 1.249 . . . . 0.0 111.389 -178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.4 -67.61 0.43 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.299 1.44 . . . . 0.0 109.937 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.65 92.95 48.31 Favored Pre-proline 0 N--CA 1.455 -0.202 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.34 -29.74 5.94 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.144 1.229 . . . . 0.0 112.772 -173.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -171.62 -62.21 0.02 OUTLIER 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.842 1.657 . . . . 0.0 109.071 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 66.27 157.1 0.11 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 128.993 2.917 . . . . 0.0 113.354 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t -100.49 171.51 7.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.005 1.322 . . . . 0.0 108.284 165.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.69 -99.14 1.54 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.99 141.92 54.9 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.06 1.84 . . . . 0.0 111.135 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 3.8 m -162.02 179.02 8.32 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.468 2.707 . . . . 0.0 106.996 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.6 t -152.63 169.55 22.42 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.517 0.727 . . . . 0.0 109.683 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 N-CA-C 106.617 -2.593 . . . . 0.0 106.617 -174.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.75 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -62.34 153.3 31.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.152 0.581 . . . . 0.0 110.693 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 t -71.43 166.54 21.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.097 0.959 . . . . 0.0 110.909 -171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.94 79.93 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.1 t -154.56 116.94 4.29 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 168.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m -137.0 179.23 6.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.533 2.333 . . . . 0.0 106.821 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.87 -120.85 17.7 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 105.992 -2.843 . . . . 0.0 105.992 -154.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp 19.87 85.23 0.01 OUTLIER 'General case' 0 C--O 1.238 0.48 0 C-N-CA 130.305 3.442 . . . . 0.0 112.895 174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -54.88 153.16 6.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.33 171.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.624 HG22 ' H ' ' A' ' 11' ' ' ARG . 5.1 m -78.38 -143.69 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.185 2.194 . . . . 0.0 112.108 -176.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.624 ' H ' HG22 ' A' ' 10' ' ' THR . 0.7 OUTLIER -163.02 -69.38 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 147.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.25 22.94 2.65 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.866 2.066 . . . . 0.0 111.911 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 10' ' ' THR . . . 55.89 -6.2 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.486 2.314 . . . . 0.0 114.653 -170.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.0 m -75.41 -24.99 57.2 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.947 1.299 . . . . 0.0 110.628 -168.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.55 -15.77 63.84 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 117.392 -1.29 . . . . 0.0 114.007 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.9 mt -74.64 161.91 29.24 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.253 1.388 . . . . 0.0 110.386 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.87 2.1 3.66 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -165.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.97 -179.27 41.66 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 162.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.4 m -81.82 154.56 25.85 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.438 0.695 . . . . 0.0 109.423 -172.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.43 ' CZ ' ' HB1' ' A' ' 13' ' ' ALA . 6.2 m-85 -111.68 140.73 46.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.607 1.163 . . . . 0.0 108.346 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -122.51 -179.55 4.25 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.034 1.734 . . . . 0.0 107.658 -177.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 60.0 p -145.14 165.61 27.8 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 122.124 -0.36 . . . . 0.0 111.185 163.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.6 t -152.85 157.2 40.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 151.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.1 m -104.82 113.93 27.82 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 160.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mt -98.37 138.03 36.2 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ttpt -82.06 155.21 25.22 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 158.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' CE ' ' HA2' ' A' ' 31' ' ' GLY . 5.6 tptt -58.04 161.19 4.22 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 154.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.4 m -129.66 -78.58 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 159.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.39 132.95 46.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 -170.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 4.5 mmt 63.04 -62.23 0.13 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.06 2.144 . . . . 0.0 111.132 -166.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' HA2' ' CE ' ' A' ' 27' ' ' LYS . . . -169.47 -154.25 9.04 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -170.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -71.12 153.74 42.29 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 163.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.38 35.17 2.43 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 117.842 -1.532 . . . . 0.0 113.134 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.17 163.12 37.95 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.906 2.353 . . . . 0.0 111.268 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 p -125.52 155.1 41.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.112 1.365 . . . . 0.0 109.174 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -121.96 162.32 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.383 1.473 . . . . 0.0 109.921 -173.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 tt -136.76 157.76 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 128.324 2.65 . . . . 0.0 108.186 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.58 152.17 22.81 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.527 2.489 . . . . 0.0 107.966 170.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.09 -71.17 0.81 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.506 1.051 . . . . 0.0 112.725 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 170.27 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.577 1.551 . . . . 0.0 110.691 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -70.74 158.43 87.98 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 120.197 1.362 . . . . 0.0 110.228 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.28 43.31 1.28 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.505 3.47 . . . . 0.0 112.263 -174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -172.48 37.45 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 128.732 2.813 . . . . 0.0 108.669 -169.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -113.54 150.3 33.17 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.96 0.904 . . . . 0.0 108.762 167.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 m-30 -74.91 127.33 32.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 122.081 0.943 . . . . 0.0 109.112 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 11.2 mt -81.37 142.78 32.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.435 ' HG2' HG22 ' A' ' 68' ' ' VAL . 53.3 mt-30 -142.49 162.35 35.69 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.674 0.789 . . . . 0.0 110.865 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.17 114.49 3.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -63.02 -50.06 72.17 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.61 0.641 . . . . 0.0 109.285 176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.08 154.19 17.04 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.181 0.926 . . . . 0.0 110.095 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 51.4 t -103.75 121.42 55.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 167.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.51 129.24 90.38 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -85.85 48.24 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.782 2.988 . . . . 0.0 112.605 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -165.59 57.98 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.981 2.112 . . . . 0.0 107.694 -178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.12 171.22 44.07 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 121.104 -0.997 . . . . 0.0 112.632 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.72 -25.28 54.01 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.387 2.058 . . . . 0.0 112.174 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.39 -32.02 70.78 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.984 0.811 . . . . 0.0 111.235 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.13 -56.29 12.16 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.202 1.001 . . . . 0.0 108.746 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.08 -29.36 69.11 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -172.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -66.67 -26.75 67.19 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.726 -0.609 . . . . 0.0 110.927 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.94 -14.73 9.78 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.93 1.729 . . . . 0.0 113.437 169.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -83.59 -26.86 29.66 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.325 -1.103 . . . . 0.0 111.385 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.9 tpp -89.36 130.79 35.68 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.403 0.681 . . . . 0.0 110.173 -172.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -144.0 166.2 25.62 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 125.795 1.638 . . . . 0.0 108.861 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.3 m -87.95 144.37 26.59 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.029 -1.441 . . . . 0.0 107.145 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.54 21.72 57.62 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.823 1.192 . . . . 0.0 112.396 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -115.2 144.05 44.29 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.962 1.381 . . . . 0.0 107.721 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 47' ' ' GLN . 69.5 t -98.45 118.35 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.248 1.819 . . . . 0.0 110.062 -162.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.65 110.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.498 1.519 . . . . 0.0 108.871 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 3.5 t -96.13 -59.94 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.344 0.593 . . . . 0.0 109.796 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -128.71 158.49 38.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.011 1.324 . . . . 0.0 107.566 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.7 mt -141.1 122.93 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 23.3 t30 65.05 -81.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 127.413 2.285 . . . . 0.0 110.489 168.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.74 36.35 1.16 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.432 1.093 . . . . 0.0 110.554 174.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.44 132.62 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 120.425 -1.422 . . . . 0.0 109.422 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.7 p -77.82 110.13 12.43 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.755 0.822 . . . . 0.0 109.368 165.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -113.67 -3.47 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -54.16 -31.18 51.88 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.03 1.286 . . . . 0.0 114.414 -164.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -123.76 28.56 5.41 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.506 1.527 . . . . 0.0 111.008 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 172.22 13.31 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 164.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.1 p -90.04 153.25 20.71 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -54.93 -36.45 65.28 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.119 1.368 . . . . 0.0 109.741 170.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.87 -64.49 0.79 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.382 1.073 . . . . 0.0 110.902 174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -68.73 -35.87 77.69 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.763 -174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.58 -40.27 87.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 O-C-N 120.548 -1.345 . . . . 0.0 111.265 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.69 -43.59 96.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -40.28 84.79 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.165 0.893 . . . . 0.0 110.499 176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.3 mt -64.87 -41.06 95.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.589 1.556 . . . . 0.0 109.265 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -71.21 -39.19 71.9 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.476 1.034 . . . . 0.0 111.177 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -60.88 -36.95 80.52 Favored 'General case' 0 C--N 1.341 0.211 0 CA-C-N 118.814 0.734 . . . . 0.0 110.406 173.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.4 t -59.81 -13.24 9.64 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.052 1.741 . . . . 0.0 113.539 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.1 t -87.58 110.59 35.61 Favored Pre-proline 0 C--O 1.239 0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -57.86 160.15 15.87 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.729 1.619 . . . . 0.0 111.736 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.27 138.25 20.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 158.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.86 14.92 76.53 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 117.396 -1.78 . . . . 0.0 113.677 -175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -122.73 162.58 21.74 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 121.032 2.416 . . . . 0.0 111.413 165.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.72 155.14 30.49 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.665 1.986 . . . . 0.0 111.334 171.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.38 157.42 39.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 125.322 1.449 . . . . 0.0 109.172 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -82.87 158.69 22.59 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 mt -145.71 145.83 31.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 175.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.3 t -123.8 125.81 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.7 mt -112.85 165.05 12.68 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.345 1.028 . . . . 0.0 110.931 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.4 t -119.46 143.91 47.26 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.417 1.487 . . . . 0.0 108.288 168.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -100.77 155.85 17.68 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 127.446 2.298 . . . . 0.0 111.485 -178.09 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.47 -2.73 74.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.41 -1.217 . . . . 0.0 114.102 170.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -103.02 103.09 31.86 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 168.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.28 -174.72 1.49 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.769 2.979 . . . . 0.0 113.05 -170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.5 mt -65.57 146.03 99.0 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 125.612 1.565 . . . . 0.0 109.964 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.92 -45.38 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.712 2.942 . . . . 0.0 110.786 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -63.49 106.39 0.92 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.065 1.746 . . . . 0.0 107.475 174.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -81.9 108.83 12.4 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 168.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -68.05 -17.32 45.9 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 120.784 1.316 . . . . 0.0 111.795 173.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -61.69 2.43 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 109.832 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -148.55 81.67 7.78 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -69.87 -44.19 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.03 1.82 . . . . 0.0 112.768 -167.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.12 -48.13 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.968 0.907 . . . . 0.0 110.554 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 52.68 68.81 0.77 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.984 1.713 . . . . 0.0 111.576 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.6 t -128.95 151.73 49.35 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.598 1.159 . . . . 0.0 108.274 171.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.05 -107.46 0.61 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 105.421 -3.072 . . . . 0.0 105.421 153.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.71 72.38 4.48 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 124.852 3.701 . . . . 0.0 111.439 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 5.3 p -141.52 69.29 1.33 Allowed 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.502 1.521 . . . . 0.0 108.562 173.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.9 m -145.89 172.96 12.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.677 2.391 . . . . 0.0 108.222 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.8 0 N-CA-C 104.289 -3.524 . . . . 0.0 104.289 164.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.674 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 t -65.14 107.09 1.45 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.343 1.457 . . . . 0.0 108.19 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 p -143.01 -177.91 5.57 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.304 1.442 . . . . 0.0 109.443 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.41 -94.91 0.1 OUTLIER Glycine 0 C--N 1.336 0.565 0 N-CA-C 108.631 -1.787 . . . . 0.0 108.631 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.8 p -150.6 143.62 24.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.034 0.934 . . . . 0.0 108.626 166.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.39 158.72 44.28 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.177 0.991 . . . . 0.0 109.907 168.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.96 176.04 16.63 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.224 1.392 . . . . 0.0 110.881 176.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt -113.87 -83.98 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -63.45 158.19 21.41 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.72 0.808 . . . . 0.0 109.873 171.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 15' ' ' GLN . 11.6 m -73.07 -116.7 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.07 2.148 . . . . 0.0 111.041 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 137.92 -76.13 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.38 1 C-N-CA 134.271 5.028 . . . . 0.0 106.195 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -95.22 10.95 34.15 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' H ' HG22 ' A' ' 10' ' ' THR . . . 68.64 -27.74 0.15 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 119.762 -1.836 . . . . 0.0 113.394 -170.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 t -69.12 17.73 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.362 1.465 . . . . 0.0 113.249 170.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' HB2' HG23 ' A' ' 10' ' ' THR . 19.5 mm100 -115.2 -11.04 12.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.882 1.673 . . . . 0.0 110.702 168.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 33.4 mt -70.83 162.54 29.02 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -138.58 131.14 29.03 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 124.932 1.293 . . . . 0.0 107.925 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.22 -133.47 4.14 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 94.1 m -133.11 152.53 51.95 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -109.82 145.91 35.93 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.007 0.821 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -130.02 170.29 14.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.243 2.217 . . . . 0.0 107.682 179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.2 t -152.97 154.35 34.81 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 121.883 -0.511 . . . . 0.0 109.833 159.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -144.53 157.68 44.11 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.411 1.485 . . . . 0.0 109.154 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 97' ' ' SER . 6.8 m -124.28 114.73 19.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 170.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.1 mt -98.62 146.71 25.56 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -82.46 132.16 35.21 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 161.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 70.9 tttt -67.25 100.88 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.977 1.311 . . . . 0.0 107.84 169.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.3 m -89.45 -92.69 0.12 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.047 -173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -105.87 130.2 53.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 45.7 mtt 58.62 -54.49 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.671 2.388 . . . . 0.0 114.869 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . -175.48 -167.41 34.51 Favored Glycine 0 N--CA 1.449 -0.449 0 O-C-N 120.744 -1.222 . . . . 0.0 110.808 -148.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -86.02 152.21 23.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.55 24.65 0.95 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.743 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.54 167.82 21.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.823 1.811 . . . . 0.0 108.307 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -125.77 159.88 31.22 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.452 1.501 . . . . 0.0 107.568 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.21 157.29 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 122.13 0.967 . . . . 0.0 110.333 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.4 tt -131.02 147.66 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.282 2.233 . . . . 0.0 105.734 165.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.37 21.78 Favored Glycine 0 CA--C 1.507 -0.448 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 154.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.83 -70.06 1.08 Allowed Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -165.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -173.09 -43.77 0.01 OUTLIER 'General case' 0 C--O 1.238 0.479 0 O-C-N 124.116 0.539 . . . . 0.0 111.377 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 161.12 26.44 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.331 1.052 . . . . 0.0 111.324 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.99 44.83 1.39 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.962 3.775 . . . . 0.0 111.522 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -16.31 1.04 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.089 0.955 . . . . 0.0 111.507 169.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -84.19 130.37 34.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -59.82 147.14 39.28 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 122.172 0.986 . . . . 0.0 111.086 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.2 mt -91.73 132.58 36.29 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 113.353 -1.749 . . . . 0.0 106.689 173.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -129.46 152.87 48.53 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.851 0.86 . . . . 0.0 109.012 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.9 t -62.66 113.58 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 168.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -61.86 -55.0 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.765 1.626 . . . . 0.0 109.667 -178.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.536 ' HA ' HG23 ' A' ' 65' ' ' THR . 4.3 m -155.31 151.17 27.67 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.85 1.66 . . . . 0.0 108.051 168.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -89.63 123.96 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 163.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -74.45 127.78 86.94 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.75 156.4 66.08 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.894 1.729 . . . . 0.0 109.933 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.1 t70 76.43 -27.52 0.18 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 127.281 2.232 . . . . 0.0 113.269 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.19 166.6 50.22 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.848 1.213 . . . . 0.0 112.267 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.35 -20.08 48.99 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 122.229 1.953 . . . . 0.0 112.95 -171.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.38 -51.23 54.47 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.667 -0.646 . . . . 0.0 109.536 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.34 89.27 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.249 1.02 . . . . 0.0 110.426 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -67.57 -21.05 65.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -87.2 -34.73 18.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.227 1.376 . . . . 0.0 109.963 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.71 -10.67 55.83 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.392 1.472 . . . . 0.0 114.37 167.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -77.89 -8.53 58.21 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.953 1.377 . . . . 0.0 113.799 -177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.7 ttm -118.25 139.92 50.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.709 1.604 . . . . 0.0 108.98 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -133.77 172.12 13.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.769 1.271 . . . . 0.0 109.111 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.551 HG22 HD21 ' A' ' 108' ' ' LEU . 71.9 m -78.28 127.28 32.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.73 -15.82 40.81 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.531 1.062 . . . . 0.0 113.667 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HB3' HD13 ' A' ' 102' ' ' LEU . 4.3 m-20 -57.13 143.8 37.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.436 1.118 . . . . 0.0 109.708 175.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -97.23 121.3 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.29 1.836 . . . . 0.0 109.456 -170.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.0 mp -66.03 110.83 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.399 1.879 . . . . 0.0 108.971 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -92.77 -62.26 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -136.43 141.24 43.58 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.581 1.152 . . . . 0.0 109.366 -167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.3 mt -119.05 125.55 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 59.48 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 128.538 2.735 . . . . 0.0 112.18 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.77 11.94 2.47 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 119.171 0.896 . . . . 0.0 111.244 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.9 t -114.85 153.48 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 120.344 -1.473 . . . . 0.0 109.032 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 10.0 p -87.12 138.72 31.25 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 119.352 0.978 . . . . 0.0 109.585 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 m -134.08 5.2 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.117 0.967 . . . . 0.0 111.924 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -66.14 -22.29 66.37 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 -163.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.87 66.95 0.53 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 104.834 -3.306 . . . . 0.0 104.834 157.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -121.94 168.94 11.31 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.637 167.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 p -74.49 136.47 42.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -54.32 -32.11 55.83 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.417 0.687 . . . . 0.0 110.589 162.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.32 -40.18 89.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.455 1.025 . . . . 0.0 112.407 174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -77.23 -44.84 28.5 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.219 0.918 . . . . 0.0 109.955 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.0 t -59.95 -42.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 O-C-N 120.179 -1.575 . . . . 0.0 111.205 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.02 -32.45 58.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 120.738 -1.226 . . . . 0.0 110.792 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -44.56 94.89 Favored 'General case' 0 C--O 1.226 -0.15 0 O-C-N 121.47 -0.769 . . . . 0.0 109.215 169.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.13 -36.23 81.43 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.106 0.962 . . . . 0.0 109.701 -166.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -69.83 -22.81 63.26 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -87.67 -18.41 29.63 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.982 -1.074 . . . . 0.0 110.971 175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -65.07 -17.34 64.37 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.472 -0.768 . . . . 0.0 112.639 168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 t -84.57 121.72 74.89 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 124.884 1.274 . . . . 0.0 107.762 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -62.3 159.82 33.75 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.014 1.809 . . . . 0.0 112.31 167.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 6.7 mt -61.33 152.11 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 121.184 -0.947 . . . . 0.0 109.316 162.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.05 -9.47 38.83 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.693 1.616 . . . . 0.0 113.154 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -95.55 163.5 13.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 120.18 1.99 . . . . 0.0 108.975 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.44 ' HB2' HG22 ' A' ' 24' ' ' THR . 20.8 p -116.08 146.78 41.94 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.986 0.914 . . . . 0.0 110.191 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.91 145.12 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 122.843 0.457 . . . . 0.0 109.919 168.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -83.34 157.21 22.65 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 mt -145.94 114.23 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.0 t -89.69 127.36 42.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 168.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 67' ' ' ASP . 19.2 mt -121.96 168.89 11.38 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.272 0.983 . . . . 0.0 110.551 173.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 53.2 t -126.55 141.55 51.83 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.819 1.247 . . . . 0.0 109.742 171.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.669 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -111.28 155.76 22.52 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 128.653 2.781 . . . . 0.0 109.609 -179.591 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 118.75 -30.95 5.72 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 125.68 1.61 . . . . 0.0 110.993 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -67.73 139.06 93.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 124.504 1.122 . . . . 0.0 110.214 174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -71.39 171.67 15.7 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.245 1.963 . . . . 0.0 111.191 166.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 65' ' ' THR . 20.0 mt -66.3 161.89 53.35 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 126.028 1.731 . . . . 0.0 109.896 173.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.62 -43.39 0.47 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 121.662 1.575 . . . . 0.0 111.581 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -78.93 145.86 33.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.65 1.18 . . . . 0.0 109.304 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -110.56 92.69 14.59 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.87 -16.6 29.38 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.149 1.233 . . . . 0.0 112.236 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.85 -56.04 18.36 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.311 0.96 . . . . 0.0 109.328 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -169.33 113.96 0.52 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.899 -1.048 . . . . 0.0 108.789 168.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -86.66 -17.42 3.38 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.826 2.35 . . . . 0.0 114.445 -172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 167.56 67.95 0.0 OUTLIER 'General case' 0 C--N 1.346 0.416 0 C-N-CA 127.516 2.326 . . . . 0.0 106.032 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 66.98 167.93 0.23 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.517 2.327 . . . . 0.0 113.878 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.4 t -143.73 -178.63 6.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 122.921 1.343 . . . . 0.0 112.24 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.87 159.61 32.92 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 127.592 2.52 . . . . 0.0 107.939 159.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.55 156.96 53.46 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.195 1.93 . . . . 0.0 109.593 172.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.8 t -160.58 115.17 2.18 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 p -139.12 -164.34 1.64 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.307 1.843 . . . . 0.0 108.453 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 146.798 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.775 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -148.18 148.76 30.9 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m 48.55 44.59 20.95 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.7 1.2 . . . . 0.0 111.102 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.12 -99.3 1.23 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.694 0.664 . . . . 0.0 111.574 -166.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m 66.65 -64.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.497 1.919 . . . . 0.0 112.34 -167.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 126.92 29.37 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.433 1.493 . . . . 0.0 111.344 -172.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.0 97.11 0.62 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 123.564 0.602 . . . . 0.0 112.355 171.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.46 -15.87 55.72 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.886 174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -70.3 163.28 26.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.196 0.907 . . . . 0.0 109.852 170.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.2 m -85.76 -104.46 0.06 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.222 1.009 . . . . 0.0 112.13 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 119.32 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 1 C-N-CA 134.879 5.272 . . . . 0.0 110.8 -172.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -126.38 6.55 7.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -158.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 61.95 -1.43 0.36 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 129.264 3.025 . . . . 0.0 115.74 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.8 t -84.04 -16.52 43.6 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.082 1.31 . . . . 0.0 110.975 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -27.98 67.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 117.024 -1.465 . . . . 0.0 111.913 169.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.1 mt -66.73 138.06 57.12 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.462 1.483 . . . . 0.0 108.124 -163.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -106.48 126.29 52.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.6 -174.09 30.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 126.844 2.164 . . . . 0.0 108.323 -167.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.7 m -95.38 160.4 14.55 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.41 ' C ' HD23 ' A' ' 21' ' ' LEU . 6.5 m-85 -118.39 131.13 56.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 122.374 1.083 . . . . 0.0 108.31 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -153.34 163.14 40.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -169.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.33 155.85 43.99 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.6 t -148.38 157.36 43.43 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.928 161.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.3 m -109.32 114.87 28.92 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 57' ' ' ALA . 3.3 mt -98.32 144.64 27.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -89.16 141.42 28.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 165.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 16.3 tptt -72.75 101.44 3.1 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.6 p -74.68 -175.72 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.027 0.83 . . . . 0.0 109.827 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -51.42 -31.76 24.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.278 1.431 . . . . 0.0 112.65 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.9 mtp -107.86 14.25 25.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.04 1.736 . . . . 0.0 111.766 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 90.85 -110.48 3.82 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -123.2 152.34 41.33 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.702 1.251 . . . . 0.0 110.138 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.86 25.84 5.7 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.433 1.016 . . . . 0.0 112.944 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -144.56 173.27 11.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.001 1.401 . . . . 0.0 107.506 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -135.64 159.62 41.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.28 1.032 . . . . 0.0 108.624 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.37 162.04 24.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.519 1.128 . . . . 0.0 108.933 -177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.1 tt -132.62 156.68 42.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 127.419 2.287 . . . . 0.0 107.423 172.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.62 153.08 23.41 Favored Glycine 0 N--CA 1.461 0.358 0 C-N-CA 127.909 2.671 . . . . 0.0 107.672 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -62.51 -75.01 0.35 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -172.39 -59.46 0.02 OUTLIER 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.12 0.968 . . . . 0.0 110.956 -168.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -88.51 163.33 36.5 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 126.745 2.018 . . . . 0.0 109.937 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -76.94 48.25 2.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.88 3.053 . . . . 0.0 110.948 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -154.46 -9.83 0.14 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 117.418 -1.277 . . . . 0.0 114.265 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -67.31 143.56 56.34 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-N 120.753 1.615 . . . . 0.0 109.85 169.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -78.58 125.72 29.76 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.26 138.57 34.57 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.218 1.807 . . . . 0.0 108.613 -176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -127.93 153.2 46.95 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.017 0.371 . . . . 0.0 110.972 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.9 t -65.76 111.3 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 169.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -60.49 -48.86 79.92 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 125.685 1.594 . . . . 0.0 110.983 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 m -160.92 150.44 17.1 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.355 1.862 . . . . 0.0 107.306 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 62.7 t -101.83 121.75 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 163.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.96 128.76 84.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.28 152.21 82.28 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.268 1.979 . . . . 0.0 110.332 173.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t70 63.59 -15.31 0.07 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.369 2.268 . . . . 0.0 113.369 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.78 161.5 46.53 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 120.265 -1.522 . . . . 0.0 111.581 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.2 -20.93 55.85 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.379 2.053 . . . . 0.0 113.193 -173.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' A' ' 25' ' ' LEU . . . -69.09 -51.11 42.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.287 0.635 . . . . 0.0 110.842 171.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.79 90.02 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.446 0.567 . . . . 0.0 110.11 175.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -65.15 -6.59 9.58 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.588 1.155 . . . . 0.0 113.973 175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -92.11 -20.02 21.7 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.686 1.584 . . . . 0.0 110.982 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.14 32.08 82.99 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 124.826 1.203 . . . . 0.0 114.333 170.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -136.19 -39.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 112.739 -169.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 23.0 ttm -89.9 140.28 29.77 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -137.27 168.7 19.12 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 125.713 1.883 . . . . 0.0 110.801 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 23.3 m -78.88 160.4 27.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.87 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.25 -19.3 13.76 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.691 1.138 . . . . 0.0 112.614 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 102' ' ' LEU . 1.8 m-20 -70.88 152.97 43.12 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.868 1.334 . . . . 0.0 110.805 -173.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.3 t -102.63 131.71 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.435 1.894 . . . . 0.0 108.347 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.4 mp -76.71 126.73 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 125.751 1.62 . . . . 0.0 108.305 173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 t -103.19 -60.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 124.815 1.246 . . . . 0.0 109.556 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -134.5 153.05 52.13 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.392 1.077 . . . . 0.0 108.917 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.5 mt -126.45 108.65 19.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 72.36 -61.95 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 128.824 2.849 . . . . 0.0 110.542 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -149.19 -25.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.859 2.064 . . . . 0.0 110.477 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.83 131.27 34.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.243 1.417 . . . . 0.0 108.981 -168.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 45.9 t -65.05 131.89 47.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.899 0.88 . . . . 0.0 108.824 165.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.67 5.47 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 C-N-CA 123.375 0.67 . . . . 0.0 111.187 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.86 -24.25 66.79 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.51 1.124 . . . . 0.0 111.67 -164.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.16 53.54 0.75 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 166.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -95.86 158.48 15.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 156.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 t -76.05 156.41 33.98 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -56.23 -27.08 53.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.986 -1.007 . . . . 0.0 111.485 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.96 -52.51 65.19 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.082 1.31 . . . . 0.0 110.722 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -69.7 -42.79 73.59 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.914 0.486 . . . . 0.0 109.819 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.4 t -67.08 -38.42 81.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 O-C-N 120.294 -1.503 . . . . 0.0 111.549 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.32 -40.34 88.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 121.138 -0.976 . . . . 0.0 109.315 171.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -32.34 73.8 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.933 1.242 . . . . 0.0 111.091 177.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.29 -46.83 75.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -64.85 -40.11 94.64 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.056 0.844 . . . . 0.0 111.265 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.25 -33.65 75.96 Favored 'General case' 0 C--O 1.231 0.104 0 O-C-N 121.343 -0.848 . . . . 0.0 111.551 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 70.2 m -56.98 -22.99 42.61 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.886 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 t -84.0 114.06 51.82 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -176.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -82.93 167.0 14.62 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.415 2.743 . . . . 0.0 111.848 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.4 98.96 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.772 1.629 . . . . 0.0 108.473 -170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 138.18 -17.11 3.39 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 125.045 1.307 . . . . 0.0 112.65 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -84.16 164.96 18.83 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 p -120.48 147.2 45.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 109.111 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.1 138.92 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.536 0.734 . . . . 0.0 109.163 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -83.87 153.81 23.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.269 1.428 . . . . 0.0 109.404 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.4 mt -144.1 109.37 5.09 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.84 121.3 38.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.463 HD13 ' HB3' ' A' ' 67' ' ' ASP . 7.5 mt -118.57 160.81 21.12 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 124.508 1.13 . . . . 0.0 109.92 175.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -107.53 119.17 38.68 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 168.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.59 ' HB2' HD21 ' A' ' 21' ' ' LEU . 16.6 ttm180 -84.32 126.02 32.81 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.675 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 123.69 -3.47 9.35 Favored Glycine 0 N--CA 1.463 0.44 0 CA-C-O 119.2 -0.778 . . . . 0.0 114.096 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -65.8 142.67 98.24 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 163.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.66 175.34 8.98 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.353 2.035 . . . . 0.0 109.866 165.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.35 161.43 42.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 167.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -80.61 -40.14 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.357 2.038 . . . . 0.0 111.656 172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -120.51 142.01 49.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.223 2.209 . . . . 0.0 109.247 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.04 107.18 54.32 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 125.52 1.528 . . . . 0.0 110.2 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.5 -20.4 14.02 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.217 1.944 . . . . 0.0 112.588 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -68.47 -35.21 77.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 117.884 -1.055 . . . . 0.0 110.866 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -123.19 90.36 50.45 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 125.62 1.568 . . . . 0.0 107.861 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -74.1 -34.53 4.9 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.773 1.648 . . . . 0.0 111.226 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -159.74 -44.73 0.05 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 m120 65.81 138.84 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 127.822 2.449 . . . . 0.0 112.758 -175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.0 m -174.82 113.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.406 1.482 . . . . 0.0 109.902 166.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -81.55 129.19 8.89 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 159.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.57 -9.49 24.08 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.223 2.615 . . . . 0.0 113.082 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 m -152.02 -48.45 0.11 Allowed 'General case' 0 C--O 1.225 -0.197 0 O-C-N 121.189 -0.944 . . . . 0.0 110.553 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.2 t -153.68 -16.58 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.853 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -173.123 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 107.619 -2.192 . . . . 0.0 107.619 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -145.81 172.7 12.93 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.09 0.945 . . . . 0.0 109.014 -167.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -149.66 157.92 43.69 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 157.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.83 151.47 27.97 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -159.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.5 m -154.9 76.08 0.99 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.466 1.506 . . . . 0.0 108.85 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.8 m -66.95 162.79 21.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.793 -0.567 . . . . 0.0 111.362 172.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.86 -114.22 0.41 Allowed Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 106.331 -2.708 . . . . 0.0 106.331 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.93 -45.55 1.04 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 167.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -54.63 155.42 4.15 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 122.785 1.279 . . . . 0.0 111.084 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.6 m -81.54 -107.18 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 125.898 1.679 . . . . 0.0 110.295 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 130.88 -44.72 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.458 1 C-N-CA 134.363 5.065 . . . . 0.0 110.427 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -124.66 18.14 8.75 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -161.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.69 -3.5 0.05 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.914 2.086 . . . . 0.0 114.873 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 t -66.42 -43.25 86.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 120.721 -1.237 . . . . 0.0 111.171 -171.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -78.33 7.09 6.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -171.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.4 mt -73.68 164.75 26.23 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.391 -1.443 . . . . 0.0 108.558 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -129.35 -1.78 5.01 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.14 174.07 55.29 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 120.91 -1.119 . . . . 0.0 110.58 170.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 55.0 m -86.03 150.41 24.48 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.038 0.919 . . . . 0.0 108.838 172.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -100.39 147.43 25.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 125.673 1.589 . . . . 0.0 109.811 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 mp -140.36 163.84 31.72 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.252 1.021 . . . . 0.0 109.975 -172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.1 p -147.43 119.93 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.147 0.579 . . . . 0.0 112.263 -174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -127.59 150.68 49.61 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.4 m -119.36 114.96 23.16 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -98.8 134.98 40.92 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -82.86 140.87 32.66 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 166.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -65.27 101.14 0.52 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 169.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.9 m -142.51 158.44 43.67 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.134 1.374 . . . . 0.0 111.546 -169.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 m120 63.42 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 127.346 2.259 . . . . 0.0 110.048 173.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 35.7 mtt -141.15 88.42 2.16 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 154.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.78 -110.41 3.15 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.851 173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -125.95 140.33 52.72 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.702 1.251 . . . . 0.0 109.445 174.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.5 38.89 2.29 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.381 0.991 . . . . 0.0 112.413 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.65 169.1 20.39 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.9 p -131.55 166.07 22.21 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.08 162.24 25.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 109.021 -171.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.1 tt -136.71 154.93 32.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 126.581 1.952 . . . . 0.0 107.706 167.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.69 152.22 22.0 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.0 -2.84 . . . . 0.0 106.0 161.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -49.38 -67.8 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 124.574 1.083 . . . . 0.0 111.563 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -165.79 -30.12 0.03 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.764 1.226 . . . . 0.0 110.766 160.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -116.18 168.87 7.84 Favored Pre-proline 0 C--O 1.237 0.413 0 C-N-CA 124.675 1.19 . . . . 0.0 112.156 -167.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.22 75.4 4.65 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.25 2.633 . . . . 0.0 108.509 175.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -169.2 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.501 1.92 . . . . 0.0 109.341 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -80.2 137.93 36.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.533 0.682 . . . . 0.0 109.505 176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -70.97 130.49 41.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.385 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 mt -81.81 137.15 35.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.564 1.146 . . . . 0.0 108.8 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -136.77 151.86 49.67 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.516 0.726 . . . . 0.0 110.799 -171.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -62.85 112.43 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 171.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -66.37 -52.96 41.5 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.043 1.737 . . . . 0.0 110.273 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 m -150.84 149.95 30.32 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.345 1.458 . . . . 0.0 107.587 171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.08 120.03 40.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 160.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.75 128.6 93.93 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.57 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.07 1.847 . . . . 0.0 110.147 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.47 56.41 2.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.532 1.533 . . . . 0.0 111.77 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.08 167.3 24.71 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.138 1.351 . . . . 0.0 110.079 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -69.18 -18.31 39.77 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.077 1.851 . . . . 0.0 113.739 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.35 4.58 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.19 -37.27 54.33 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.798 1.639 . . . . 0.0 111.557 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -79.77 -14.1 58.95 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.604 -1.189 . . . . 0.0 113.711 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -84.1 -22.25 31.19 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 121.832 2.105 . . . . 0.0 111.441 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.52 30.14 71.2 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.897 163.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -122.05 -26.01 4.83 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.78 1.79 . . . . 0.0 112.701 176.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 24.9 ttm -86.65 141.61 28.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.644 1.178 . . . . 0.0 108.388 175.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -131.25 169.29 16.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 122.48 1.133 . . . . 0.0 108.047 165.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 28.7 m -65.3 145.1 56.63 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.774 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.08 -18.47 44.58 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.518 1.056 . . . . 0.0 113.918 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.32 143.59 55.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.996 1.398 . . . . 0.0 109.987 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -96.14 120.98 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.183 1.393 . . . . 0.0 109.249 -169.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.2 mp -71.15 114.1 8.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.266 1.426 . . . . 0.0 107.994 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.57 -60.4 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.157 0.983 . . . . 0.0 109.696 172.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.66 149.74 52.17 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -174.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -120.89 120.95 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.5 t30 64.52 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.971 1.708 . . . . 0.0 108.284 -172.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -138.89 -10.63 1.32 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.79 1.636 . . . . 0.0 111.34 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.6 t -68.18 127.07 29.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.135 1.374 . . . . 0.0 107.614 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.8 t -71.78 128.17 34.91 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 168.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.22 17.4 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 125.773 1.629 . . . . 0.0 109.02 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -35.93 76.46 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 120.719 -1.238 . . . . 0.0 112.251 -166.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -124.45 38.82 2.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 126.225 1.869 . . . . 0.0 108.638 173.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.16 170.0 16.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.283 1.041 . . . . 0.0 110.255 167.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -74.92 139.94 43.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 164.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -52.31 -45.72 65.68 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.913 0.885 . . . . 0.0 109.33 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.57 -22.29 43.91 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.31 -51.71 5.42 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 119.51 1.05 . . . . 0.0 111.187 173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 t -55.17 -36.21 38.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.129 2.172 . . . . 0.0 111.437 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 55.9 t -63.38 -41.19 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 123.873 0.869 . . . . 0.0 110.416 171.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -36.92 82.93 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 108.658 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.5 mt -65.49 -38.31 89.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.969 0.908 . . . . 0.0 110.006 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.4 -30.13 65.74 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.407 1.003 . . . . 0.0 111.247 174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -64.71 -37.04 86.24 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.294 0.952 . . . . 0.0 110.123 171.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.7 p -66.58 -6.17 14.22 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.4 t -90.78 103.83 7.89 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.89 167.14 27.95 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.866 1.711 . . . . 0.0 111.869 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.6 mt -58.88 122.57 9.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.698 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.68 -11.65 46.18 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.956 -1.469 . . . . 0.0 113.891 175.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -83.51 162.01 21.04 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.419 1.609 . . . . 0.0 108.719 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.0 138.02 50.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.244 1.018 . . . . 0.0 110.92 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.2 m -129.05 142.66 43.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 C-N-CA 124.36 1.064 . . . . 0.0 109.118 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -82.61 159.16 22.78 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -143.95 114.57 7.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 177.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.45 115.52 29.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mt -107.96 164.27 12.42 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 124.029 0.83 . . . . 0.0 109.068 174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.0 t -121.95 129.42 52.49 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.392 1.477 . . . . 0.0 107.15 166.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.56 ' HB2' HD11 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -74.55 156.81 36.45 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.488 1.915 . . . . 0.0 109.606 173.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.48 -10.48 73.24 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-O 119.164 -0.798 . . . . 0.0 114.13 149.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -64.28 137.63 97.18 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 150.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.22 175.73 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.253 2.635 . . . . 0.0 109.827 173.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 22.6 mt -59.8 162.33 9.64 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 122.682 0.393 . . . . 0.0 109.955 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.36 -48.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.012 1.808 . . . . 0.0 111.888 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -109.98 129.2 55.7 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.346 1.459 . . . . 0.0 108.862 -175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -111.63 115.8 51.03 Favored Pre-proline 0 N--CA 1.451 -0.412 0 C-N-CA 125.488 1.515 . . . . 0.0 108.19 -177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.91 -15.88 29.44 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 121.244 1.296 . . . . 0.0 110.967 160.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -90.72 -7.09 53.47 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.371 1.068 . . . . 0.0 112.249 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.08 -48.94 83.16 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 116.912 -1.518 . . . . 0.0 111.577 173.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.63 -63.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.864 1.709 . . . . 0.0 111.63 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 163.18 110.13 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 127.883 2.473 . . . . 0.0 107.126 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -142.55 -134.08 0.1 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 167.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -170.68 89.04 0.13 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 121.111 1.778 . . . . 0.0 109.157 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.93 157.18 27.02 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 121.336 -0.853 . . . . 0.0 112.431 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.22 62.13 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.849 3.033 . . . . 0.0 111.803 -178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.4 m -59.99 150.23 29.7 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.58 0.752 . . . . 0.0 109.949 163.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.1 m 166.46 127.11 0.01 OUTLIER 'General case' 0 C--O 1.236 0.38 0 C-N-CA 128.697 2.799 . . . . 0.0 107.99 170.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 115.853 -2.637 . . . . 0.0 110.64 169.353 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.574 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 t -158.59 165.67 33.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.3 t -156.54 101.8 2.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 168.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.94 179.24 53.39 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.9 t -146.66 177.05 9.38 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.356 0.598 . . . . 0.0 110.14 174.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.6 m -123.61 170.77 10.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 127.185 2.194 . . . . 0.0 108.814 -172.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.24 -174.86 46.74 Favored Glycine 0 CA--C 1.52 0.401 0 O-C-N 120.945 -1.097 . . . . 0.0 111.075 -176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.78 -90.94 0.37 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 159.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -64.02 159.04 20.98 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 128.187 2.595 . . . . 0.0 110.829 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 m -85.43 -112.7 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.47 2.308 . . . . 0.0 110.924 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 142.66 -71.64 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 1 C-N-CA 134.021 4.928 . . . . 0.0 108.838 -177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -102.35 14.57 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.15 0.98 . . . . 0.0 113.509 -167.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 71.58 -12.21 0.66 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.44 2.296 . . . . 0.0 113.814 -171.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 m -67.04 -29.45 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.211 1.004 . . . . 0.0 111.552 -171.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -83.44 0.61 45.45 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 118.88 -0.581 . . . . 0.0 112.204 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.6 mt -70.45 140.53 52.0 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 162.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 tptt -105.74 132.09 52.3 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.45 -165.57 31.44 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -170.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -135.07 136.53 42.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 70' ' ' VAL . 22.7 m-85 -102.84 149.12 24.81 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.838 0.855 . . . . 0.0 110.099 -168.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.83 169.02 18.84 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.874 2.069 . . . . 0.0 108.664 172.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.22 142.35 42.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.926 1.29 . . . . 0.0 108.929 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -141.26 157.2 45.54 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 121.607 -0.683 . . . . 0.0 109.274 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.1 m -131.59 106.49 8.22 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 mt -97.97 156.33 16.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -106.79 138.23 43.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HE3' ' HA2' ' A' ' 31' ' ' GLY . 10.1 tttt -61.43 103.45 0.31 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.502 1.521 . . . . 0.0 110.355 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 56.7 p -83.03 -173.11 4.52 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.637 1.108 . . . . 0.0 110.489 174.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.92 -37.78 61.16 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.647 1.179 . . . . 0.0 112.237 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 21.2 ptm -105.05 13.14 31.33 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.911 1.285 . . . . 0.0 113.42 -175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.609 ' HA2' ' HE3' ' A' ' 27' ' ' LYS . . . 97.16 -106.36 3.33 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 170.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -125.28 152.2 44.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 172.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.77 39.46 3.02 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 111.351 -0.699 . . . . 0.0 111.351 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -148.92 166.41 28.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.616 1.208 . . . . 0.0 108.323 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.9 p -135.45 154.5 51.42 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.248 1.419 . . . . 0.0 107.705 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mp -119.51 160.76 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 123.838 0.855 . . . . 0.0 109.835 -170.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -136.05 159.82 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 128.601 2.76 . . . . 0.0 107.388 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.64 152.2 21.16 Favored Glycine 0 C--N 1.333 0.364 0 N-CA-C 107.659 -2.176 . . . . 0.0 107.659 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.15 -76.77 0.17 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 119.407 -0.663 . . . . 0.0 112.356 -174.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -171.38 -28.1 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.752 1.276 . . . . 0.0 113.112 -171.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.54 167.58 22.12 Favored Pre-proline 0 C--O 1.238 0.482 0 C-N-CA 124.729 1.212 . . . . 0.0 110.821 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.85 35.66 0.26 Allowed 'Trans proline' 0 CA--C 1.546 1.106 1 C-N-CA 125.753 4.302 . . . . 0.0 113.961 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -149.31 -15.79 0.29 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.563 1.545 . . . . 0.0 112.282 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -71.96 165.61 23.85 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 122.063 0.935 . . . . 0.0 111.065 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -71.17 157.5 38.04 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.993 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 35.2 mt -116.33 133.43 56.03 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 127.606 2.363 . . . . 0.0 107.521 175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -130.62 154.05 48.29 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.519 0.728 . . . . 0.0 111.784 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.3 t -67.95 109.71 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 165.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -63.2 -43.31 98.53 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.732 1.613 . . . . 0.0 110.935 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.22 142.39 13.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.867 1.667 . . . . 0.0 108.824 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG21 ' HA ' ' A' ' 64' ' ' GLU . 19.7 t -92.01 122.67 43.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 161.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.17 132.44 63.15 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 125.096 1.358 . . . . 0.0 107.786 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.1 168.36 14.15 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.738 1.626 . . . . 0.0 110.924 175.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.27 28.0 17.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 0.0 111.238 170.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.02 177.8 16.43 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.055 1.788 . . . . 0.0 113.943 -171.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.72 -28.22 9.9 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.808 2.339 . . . . 0.0 111.904 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.6 59.79 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.19 -32.05 72.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.658 0.783 . . . . 0.0 112.779 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -77.56 -19.72 55.23 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.402 1.001 . . . . 0.0 113.296 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.3 -42.36 14.68 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.84 0.856 . . . . 0.0 109.776 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.72 2.5 60.94 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.993 1.282 . . . . 0.0 114.508 171.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -84.01 -7.16 59.47 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.736 1.768 . . . . 0.0 112.7 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.8 ttp -122.31 141.1 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.753 1.621 . . . . 0.0 109.358 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.828 ' HA ' HG21 ' A' ' 51' ' ' VAL . 3.6 pt-20 -140.93 -179.06 5.85 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 124.461 1.104 . . . . 0.0 110.065 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 HD21 ' A' ' 108' ' ' LEU . 71.3 m -88.49 133.96 33.99 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.849 1.26 . . . . 0.0 109.613 -173.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.28 -14.04 59.79 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.404 1.478 . . . . 0.0 112.323 -177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.536 ' HB3' HD13 ' A' ' 102' ' ' LEU . 29.5 m-20 -60.35 148.25 37.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.982 0.913 . . . . 0.0 110.809 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.0 t -99.33 122.86 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.651 1.58 . . . . 0.0 108.606 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.452 ' HA ' HD22 ' A' ' 102' ' ' LEU . 4.7 mp -74.59 106.36 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 C-N-CA 124.272 1.029 . . . . 0.0 109.28 174.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.494 HG21 ' CE2' ' A' ' 20' ' ' PHE . 6.7 t -80.75 -57.6 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 175.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -132.14 149.54 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.073 0.949 . . . . 0.0 108.914 -171.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -124.65 116.39 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 104.861 -2.274 . . . . 0.0 104.861 170.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.41 -57.05 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 130.624 3.569 . . . . 0.0 113.941 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -164.42 6.38 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 127.466 2.306 . . . . 0.0 111.611 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.5 t -108.92 128.31 64.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 125.009 1.324 . . . . 0.0 108.295 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.4 p -78.27 87.13 4.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.919 0.888 . . . . 0.0 110.746 176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 1.82 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.963 0.905 . . . . 0.0 112.08 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.26 -17.95 45.63 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -167.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.71 22.64 7.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.787 1.184 . . . . 0.0 111.307 171.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -96.06 167.72 11.05 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.697 1.249 . . . . 0.0 110.444 -175.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.3 p -72.12 138.59 47.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 -177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -53.37 -44.84 68.92 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.705 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.87 -36.02 69.59 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 120.583 1.538 . . . . 0.0 113.477 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -66.07 -56.98 8.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.893 0.877 . . . . 0.0 109.688 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.59 -42.94 52.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 128.191 2.596 . . . . 0.0 111.633 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.19 -38.93 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 O-C-N 120.734 -1.229 . . . . 0.0 108.871 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -33.74 75.02 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 121.306 -0.871 . . . . 0.0 111.267 175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 75.2 mt -62.99 -50.8 69.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.955 1.302 . . . . 0.0 108.743 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.64 -40.09 93.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.393 0.542 . . . . 0.0 110.957 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -69.5 -31.78 70.24 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.482 -0.761 . . . . 0.0 111.715 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 55.4 p -70.07 -0.46 7.68 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.024 0.829 . . . . 0.0 113.141 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.2 t -84.4 112.45 41.84 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 168.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.21 175.29 10.46 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.971 1.78 . . . . 0.0 112.037 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 15.3 mt -59.73 150.49 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.671 1.188 . . . . 0.0 108.17 176.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.86 -15.69 51.17 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.246 1.403 . . . . 0.0 112.334 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -96.29 164.2 12.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.419 1.609 . . . . 0.0 110.792 -171.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.2 p -132.28 155.61 48.02 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.899 2.479 . . . . 0.0 108.553 171.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.2 m -141.86 147.69 21.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.129 0.971 . . . . 0.0 109.971 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.68 153.54 21.67 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 50.8 mt -141.04 148.87 40.92 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.04 118.94 39.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.536 HD13 ' HB3' ' A' ' 67' ' ' ASP . 9.0 mt -114.41 165.79 12.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 124.095 0.872 . . . . 0.0 110.15 178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.5 t -127.32 124.6 39.1 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.269 1.428 . . . . 0.0 108.133 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -102.73 132.44 48.88 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.413 1.885 . . . . 0.0 108.649 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 121.34 11.61 6.07 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.712 0.672 . . . . 0.0 112.45 -173.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -103.84 130.98 22.44 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 160.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -70.77 172.54 13.42 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.549 2.166 . . . . 0.0 111.669 172.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.415 HD21 HG22 ' A' ' 65' ' ' THR . 10.7 mt -70.82 152.5 95.1 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -81.46 -28.56 2.23 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 123.347 2.698 . . . . 0.0 111.558 175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -80.33 105.23 11.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -100.71 107.8 50.66 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -81.47 -24.95 4.05 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 121.84 1.693 . . . . 0.0 114.007 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.54 -62.39 1.62 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.848 0.859 . . . . 0.0 109.092 -170.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -164.02 73.95 1.72 Allowed Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.28 1.432 . . . . 0.0 108.489 -175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.81 -42.0 21.72 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.433 2.756 . . . . 0.0 112.531 -172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.51 108.18 0.8 Allowed 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -141.74 167.74 21.43 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.897 0.879 . . . . 0.0 109.997 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.8 m -136.18 102.09 4.89 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 165.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.18 154.99 52.38 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 170.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.32 173.86 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.37 2.047 . . . . 0.0 110.359 171.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.5 t -120.83 118.8 30.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 167.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.8 m 59.53 -169.33 0.14 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.124 0.97 . . . . 0.0 110.832 -164.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.784 0 C-N-CA 127.801 2.62 . . . . 0.0 106.733 -177.466 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 p -104.07 140.69 37.4 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.047 1.339 . . . . 0.0 110.284 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 m -58.58 -50.28 74.39 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.06 -81.99 0.98 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 107.469 -2.252 . . . . 0.0 107.469 -163.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 t -59.82 158.06 11.17 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.212 0.529 . . . . 0.0 111.281 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.8 t -99.01 -37.06 9.51 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.121 1.368 . . . . 0.0 109.674 169.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.59 162.01 16.64 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -157.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp 39.48 87.81 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.33 1.852 . . . . 0.0 111.283 -163.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 10' ' ' THR 0.271 27.5 t80 57.98 -148.41 0.48 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.867 1.267 . . . . 0.0 108.929 177.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.433 ' N ' ' CD1' ' A' ' 9' ' ' PHE . 25.1 m -127.6 -98.49 0.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 126.589 1.956 . . . . 0.0 109.945 -173.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 121.09 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 1 C-N-CA 135.112 5.365 . . . . 0.0 109.786 171.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.41 0.43 24.84 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -168.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 62.72 -24.68 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.841 2.856 . . . . 0.0 114.178 -169.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.9 t -57.59 -34.28 69.07 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.527 1.131 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -80.78 7.47 10.3 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.018 0.527 . . . . 0.0 112.392 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 28.3 mt -77.23 170.61 16.23 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.495 -1.378 . . . . 0.0 110.287 171.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -132.01 105.1 7.19 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.154 1.381 . . . . 0.0 109.26 -175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.37 -179.22 25.39 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.232 1.396 . . . . 0.0 111.561 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 m -77.9 134.78 37.85 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.484 0.713 . . . . 0.0 109.306 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -95.24 138.62 32.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.936 0.894 . . . . 0.0 108.648 169.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.01 173.47 12.87 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.792 1.237 . . . . 0.0 109.696 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.5 p -145.59 170.33 16.65 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 173.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.0 t -155.94 155.56 33.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.363 1.065 . . . . 0.0 109.977 159.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.8 m -102.69 115.19 30.08 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.777 1.231 . . . . 0.0 108.523 163.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -101.37 137.33 39.85 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 171.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 ttpt -81.68 137.23 35.45 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 166.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -64.72 108.83 1.83 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 165.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.8 t -137.16 161.95 34.76 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.3 t30 56.31 -91.0 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.564 1.946 . . . . 0.0 112.642 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 7.8 ptm -138.47 30.14 2.38 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.656 1.582 . . . . 0.0 110.72 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.3 176.47 21.37 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 125.181 1.372 . . . . 0.0 110.693 -174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -64.73 147.88 52.22 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.162 -0.61 . . . . 0.0 109.896 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.45 33.37 1.82 Allowed Glycine 0 C--O 1.222 -0.637 0 CA-C-O 119.182 -0.788 . . . . 0.0 112.469 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -149.81 164.3 35.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.734 1.767 . . . . 0.0 108.465 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.7 p -132.93 154.84 50.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.0 mp -117.61 159.19 17.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.857 1.263 . . . . 0.0 108.58 -174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.7 tt -121.75 164.12 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.922 2.089 . . . . 0.0 107.559 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.07 151.85 17.52 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.2 -14.12 55.66 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.844 -0.976 . . . . 0.0 113.563 168.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.2 t0 80.52 -36.99 0.14 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.623 2.769 . . . . 0.0 109.93 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -72.46 167.61 31.25 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 125.709 1.604 . . . . 0.0 111.225 166.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -100.63 32.22 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.379 3.386 . . . . 0.0 113.256 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -158.24 37.62 0.25 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.157 0.983 . . . . 0.0 109.954 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -130.54 153.79 48.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 122.324 1.059 . . . . 0.0 112.537 -165.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -74.78 116.87 15.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.249 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.81 124.15 29.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -115.26 151.94 33.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.324 0.965 . . . . 0.0 109.81 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.46 118.99 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 120.707 -1.246 . . . . 0.0 107.819 165.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.38 -52.11 43.95 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 126.643 1.977 . . . . 0.0 109.72 176.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -157.76 153.52 26.69 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.647 1.179 . . . . 0.0 109.644 174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 54.1 t -96.97 113.8 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 164.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.93 130.97 87.74 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.505 1.922 . . . . 0.0 108.192 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.89 161.65 40.95 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.378 2.052 . . . . 0.0 111.192 174.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 57.61 10.09 0.95 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.431 2.293 . . . . 0.0 113.042 -173.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -97.51 161.19 21.28 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.587 1.565 . . . . 0.0 110.553 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.96 -25.12 74.05 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 112.837 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.28 -41.17 70.35 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 118.769 -0.634 . . . . 0.0 111.212 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.1 -40.75 95.02 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.469 0.708 . . . . 0.0 110.38 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -66.58 -43.22 85.55 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.29 0.636 . . . . 0.0 110.981 177.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.28 -38.77 88.58 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.266 1.026 . . . . 0.0 111.164 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.0 -5.89 11.77 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.686 2.088 . . . . 0.0 115.347 169.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.76 -39.08 87.74 Favored 'General case' 0 CA--C 1.522 -0.117 0 O-C-N 121.292 -1.122 . . . . 0.0 109.963 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 18.5 tpp -67.6 131.77 46.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.526 1.131 . . . . 0.0 108.595 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -134.87 161.74 34.36 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.906 0.86 . . . . 0.0 108.727 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.6 m -74.15 156.92 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.44 6.6 70.88 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.537 -0.59 . . . . 0.0 112.481 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.416 ' HB3' HD13 ' A' ' 102' ' ' LEU . 65.6 m-20 -83.88 162.66 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.827 1.814 . . . . 0.0 109.562 168.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -116.54 125.73 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 127.185 2.194 . . . . 0.0 108.388 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -73.72 105.21 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 126.917 2.087 . . . . 0.0 108.459 173.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -84.08 -57.5 4.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.811 0.815 . . . . 0.0 109.768 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -135.59 139.89 44.21 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -165.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.8 mt -120.16 133.76 65.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 58.51 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 127.756 2.423 . . . . 0.0 113.776 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -150.06 21.97 0.86 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.598 1.559 . . . . 0.0 109.77 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.67 152.51 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.157 1.383 . . . . 0.0 108.205 -162.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.6 p -87.06 137.59 32.22 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.087 0.955 . . . . 0.0 109.805 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.84 15.28 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.275 1.43 . . . . 0.0 110.49 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.57 -31.92 66.63 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.252 -0.88 . . . . 0.0 113.315 -159.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -127.93 49.2 0.93 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 125.6 1.571 . . . . 0.0 109.41 170.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -99.16 170.28 8.8 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.303 1.041 . . . . 0.0 112.016 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -79.2 133.39 36.69 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 120.579 -1.325 . . . . 0.0 108.535 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.88 -40.44 66.6 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 117.86 -1.067 . . . . 0.0 111.273 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.0 -40.29 76.31 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 120.76 1.618 . . . . 0.0 112.074 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -73.23 -46.37 50.64 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.019 0.928 . . . . 0.0 110.288 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.48 -41.8 93.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 124.286 1.034 . . . . 0.0 110.769 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.5 t -61.45 -42.79 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.216 172.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -43.61 75.5 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.11 0.868 . . . . 0.0 110.055 173.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.9 mt -66.14 -37.91 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.149 0.98 . . . . 0.0 109.701 -174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' HE1' HD21 ' A' ' 100' ' ' LEU . 49.6 m-85 -70.2 -32.16 69.94 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.923 -0.486 . . . . 0.0 112.014 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -69.14 -33.38 73.35 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.287 0.948 . . . . 0.0 110.987 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.9 m -58.91 -16.11 16.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.895 1.278 . . . . 0.0 113.749 -177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.6 110.2 25.57 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 125.763 1.625 . . . . 0.0 107.85 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.25 168.23 21.48 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.419 2.079 . . . . 0.0 110.535 174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 96.0 mt -52.29 125.98 7.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 164.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.11 -27.57 19.56 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.122 -1.376 . . . . 0.0 112.734 176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.03 145.34 28.55 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.463 2.131 . . . . 0.0 108.286 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.14 162.09 13.18 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.379 1.072 . . . . 0.0 110.078 171.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.6 m -137.27 157.96 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 125.081 1.352 . . . . 0.0 109.291 174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -95.03 156.59 16.25 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 123.745 0.653 . . . . 0.0 110.489 171.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.424 HD21 ' HE1' ' A' ' 89' ' ' PHE . 19.6 mt -143.86 132.99 22.96 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 171.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.1 t -98.97 123.19 51.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 160.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 67' ' ' ASP . 2.5 mt -108.19 160.7 15.62 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.248 0.967 . . . . 0.0 109.062 171.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 34.6 t -118.92 121.71 40.59 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 168.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -76.06 156.24 34.11 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.435 1.094 . . . . 0.0 108.653 161.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 116.75 -20.78 11.71 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 117.836 -1.536 . . . . 0.0 114.329 162.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -81.22 141.46 49.92 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 120.254 2.027 . . . . 0.0 107.94 165.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.97 170.27 20.5 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.32 2.013 . . . . 0.0 111.109 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.73 165.08 13.3 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.69 169.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -95.39 -22.3 0.2 Allowed 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.944 2.429 . . . . 0.0 112.78 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -119.67 126.93 52.32 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.626 2.77 . . . . 0.0 108.359 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -106.51 121.85 43.87 Favored Pre-proline 0 C--O 1.238 0.478 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 171.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -61.06 -58.07 0.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.987 2.458 . . . . 0.0 110.598 169.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.53 -74.75 0.1 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.661 1.184 . . . . 0.0 110.743 -169.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -128.81 65.74 73.66 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.099 1.36 . . . . 0.0 111.349 -162.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.42 -0.92 8.92 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 125.007 3.805 . . . . 0.0 114.6 -178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 162.97 79.88 0.0 OUTLIER 'General case' 0 C--O 1.233 0.218 0 C-N-CA 130.548 3.539 . . . . 0.0 105.949 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -135.54 126.51 27.74 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 57.0 p -141.34 155.46 45.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.914 0.387 . . . . 0.0 110.503 174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -103.24 101.17 2.02 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 117.85 -1.528 . . . . 0.0 109.325 177.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.42 168.52 17.73 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.094 1.862 . . . . 0.0 110.338 170.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.3 t -148.77 121.64 8.74 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.7 t 64.32 177.76 0.18 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.901 1.28 . . . . 0.0 110.849 -163.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.614 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 142.288 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -81.81 -27.66 33.54 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.483 1.141 . . . . 0.0 111.527 173.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 t -65.89 138.69 58.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.46 174.3 45.0 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 -173.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -167.21 178.61 5.52 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.6 t -65.18 168.72 6.41 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.221 0.608 . . . . 0.0 110.392 166.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -108.3 156.68 15.65 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.07 91.97 1.67 Allowed 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.809 1.244 . . . . 0.0 107.971 177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.7 t80 53.1 172.57 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.928 2.891 . . . . 0.0 112.738 -172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 m -77.59 -118.49 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.121 1.368 . . . . 0.0 110.2 176.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 135.73 -23.11 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.803 1 C-N-CA 134.215 5.006 . . . . 0.0 113.283 175.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -142.14 15.57 2.07 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.85 1.205 . . . . 0.0 113.637 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 60.5 -6.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.735 2.014 . . . . 0.0 114.514 -174.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -73.8 -25.95 60.38 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.634 -1.291 . . . . 0.0 111.995 -172.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.09 -11.06 60.75 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.544 1.065 . . . . 0.0 112.532 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -68.2 140.18 56.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.27 0.941 . . . . 0.0 109.652 -172.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -117.81 113.22 21.48 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 -176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.82 -175.27 30.66 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 112.742 -2.026 . . . . 0.0 109.006 -158.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.0 m -125.38 139.26 53.82 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -104.34 137.81 41.68 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.769 1.628 . . . . 0.0 110.411 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 175.55 12.4 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.562 1.945 . . . . 0.0 108.999 172.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.7 p -135.09 170.36 16.02 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.168 0.987 . . . . 0.0 110.413 175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -149.61 153.41 37.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.994 1.318 . . . . 0.0 107.883 170.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.6 m -115.83 105.49 12.75 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.04 132.7 44.16 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -82.87 146.44 28.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -77.65 76.71 4.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.381 1.072 . . . . 0.0 108.252 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.9 t -63.01 115.22 4.22 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 46.5 -91.72 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.673 2.389 . . . . 0.0 112.486 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.1 mtp -53.29 -56.09 19.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.612 2.365 . . . . 0.0 111.067 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.72 176.6 21.45 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -148.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -75.98 125.62 29.46 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.55 55.06 3.72 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.453 0.549 . . . . 0.0 112.056 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -143.02 157.97 44.04 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 161.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -125.78 157.87 36.39 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.43 162.92 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.901 1.281 . . . . 0.0 109.36 -169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.445 ' HB ' ' HE3' ' A' ' 49' ' ' LYS . 16.3 tt -126.36 146.49 32.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.905 1.682 . . . . 0.0 107.964 171.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.27 151.23 22.1 Favored Glycine 0 N--CA 1.447 -0.619 0 O-C-N 124.442 1.089 . . . . 0.0 111.064 167.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 44' ' ' GLU . . . -51.44 -82.86 0.04 OUTLIER Glycine 0 CA--C 1.52 0.367 0 C-N-CA 128.874 3.13 . . . . 0.0 112.512 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.44 -34.09 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.409 1.084 . . . . 0.0 112.424 -170.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -122.26 165.15 21.96 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.056 1.342 . . . . 0.0 110.492 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.53 47.4 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 124.158 3.238 . . . . 0.0 112.624 -173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -164.58 16.01 0.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.962 2.105 . . . . 0.0 112.128 -172.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' H ' ' HG3' ' A' ' 44' ' ' GLU . 1.5 pp20? -91.62 165.63 13.23 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.538 2.335 . . . . 0.0 111.634 171.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -104.75 118.18 35.91 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.473 1.109 . . . . 0.0 110.336 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.8 mt -80.0 129.46 34.51 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -128.69 154.25 46.51 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.306 1.042 . . . . 0.0 110.46 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.01 114.81 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HE3' ' HB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -68.22 -52.18 37.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.462 1.505 . . . . 0.0 110.414 -179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.1 m -156.65 151.12 25.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.575 1.15 . . . . 0.0 108.991 172.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.5 t -91.62 127.26 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 168.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -70.55 131.8 87.85 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -68.26 163.18 37.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.171 1.914 . . . . 0.0 111.2 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 41.35 49.92 3.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.031 1.732 . . . . 0.0 112.091 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -141.1 175.7 22.07 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 125.391 1.472 . . . . 0.0 110.744 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.87 -22.8 31.05 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.814 2.343 . . . . 0.0 113.425 -168.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.22 -51.19 11.36 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.076 0.853 . . . . 0.0 109.04 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.71 -48.98 79.29 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.655 1.182 . . . . 0.0 110.314 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -59.64 -36.31 76.12 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.91 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -74.85 -20.85 59.58 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.235 0.925 . . . . 0.0 112.01 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.62 7.41 61.16 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.183 1.373 . . . . 0.0 115.723 163.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -87.48 -20.66 26.25 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.22 1.51 . . . . 0.0 111.35 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 25.8 ttm -110.98 143.92 40.9 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.716 1.606 . . . . 0.0 109.668 -169.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.08 -179.18 5.94 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.43 1.492 . . . . 0.0 108.312 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.8 m -95.54 158.42 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.36 0.664 . . . . 0.0 109.613 -171.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.83 -14.73 24.24 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.481 0.563 . . . . 0.0 111.966 -175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' HD13 ' A' ' 102' ' ' LEU . 12.4 m-20 -64.35 151.69 43.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.117 0.967 . . . . 0.0 109.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.9 t -107.23 121.0 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.686 1.595 . . . . 0.0 107.999 -168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.7 mp -74.76 129.32 36.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.62 -58.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.447 1.092 . . . . 0.0 110.953 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.92 151.27 50.72 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.349 0.66 . . . . 0.0 109.933 -175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -132.25 117.03 30.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.23 -73.04 0.05 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 127.839 2.456 . . . . 0.0 110.026 -170.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -147.51 -10.73 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.1 1.76 . . . . 0.0 110.685 173.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -75.07 123.73 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.46 1.504 . . . . 0.0 107.977 -172.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.9 p -67.5 110.13 3.51 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.414 0.686 . . . . 0.0 109.344 168.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.45 8.63 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.718 -0.614 . . . . 0.0 111.805 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 1.6 pp -55.19 -33.87 63.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -165.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.79 17.26 10.98 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 120.025 1.284 . . . . 0.0 111.397 172.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -73.16 158.06 36.0 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 p -82.74 146.47 28.99 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -174.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -56.53 -32.74 65.4 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.145 0.978 . . . . 0.0 110.821 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.47 -57.79 10.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 121.097 -1.002 . . . . 0.0 110.896 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -67.36 -43.25 81.93 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 121.39 0.614 . . . . 0.0 109.559 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.99 -41.79 87.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 119.839 -1.788 . . . . 0.0 111.198 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.45 -39.44 80.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.295 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -35.22 80.21 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.38 0.991 . . . . 0.0 110.144 178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 36.2 mt -64.7 -45.51 86.31 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.047 1.739 . . . . 0.0 109.011 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -61.08 -32.6 72.25 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.513 -0.742 . . . . 0.0 111.247 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -79.75 -19.79 47.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.082 -1.011 . . . . 0.0 112.831 174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 45.8 m -75.12 -6.16 48.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.267 1.427 . . . . 0.0 111.984 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -85.03 116.67 66.41 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.65 178.58 7.21 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.286 1.991 . . . . 0.0 111.133 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 mt -62.93 144.68 14.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.013 0.925 . . . . 0.0 109.345 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.46 -2.83 51.48 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-O 118.309 -1.273 . . . . 0.0 114.7 167.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -84.22 164.9 18.8 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 119.651 1.726 . . . . 0.0 107.788 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.9 p -127.8 134.24 49.46 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 118.773 0.715 . . . . 0.0 110.23 175.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.8 m -107.95 146.88 13.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.4 148.01 27.54 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 167.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.0 mt -146.69 132.84 19.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 -174.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.25 130.47 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.56 1.544 . . . . 0.0 108.221 173.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.71 HD13 ' HB3' ' A' ' 67' ' ' ASP . 11.1 mt -117.7 164.94 14.22 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 124.324 1.015 . . . . 0.0 110.389 167.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 52.7 t -129.1 132.27 47.38 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.271 1.429 . . . . 0.0 108.433 167.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -104.28 122.29 45.1 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 126.465 1.906 . . . . 0.0 110.573 -172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 138.04 5.08 1.67 Allowed Glycine 0 N--CA 1.464 0.502 0 CA-C-O 119.225 -0.764 . . . . 0.0 114.835 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -91.75 149.03 38.42 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 118.772 1.286 . . . . 0.0 108.237 167.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.58 168.29 24.73 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.139 1.893 . . . . 0.0 110.987 -177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.3 mt -78.77 144.0 63.65 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.16 -24.67 10.84 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.702 2.935 . . . . 0.0 112.159 169.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -119.58 100.41 7.25 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.902 1.681 . . . . 0.0 108.943 171.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 113.42 32.21 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 167.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -75.19 -15.37 20.37 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.825 2.35 . . . . 0.0 114.725 -169.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -119.49 -32.71 4.26 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.021 1.328 . . . . 0.0 108.615 172.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 t0 66.01 175.5 0.06 OUTLIER Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.484 1.114 . . . . 0.0 109.381 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -87.92 -13.72 3.77 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.679 2.253 . . . . 0.0 110.924 173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 154.88 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.302 1 C-N-CA 132.084 4.154 . . . . 0.0 106.733 170.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 66.61 158.17 0.12 Allowed 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 126.551 1.94 . . . . 0.0 111.27 -169.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.8 t 46.27 31.21 1.17 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.415 1.486 . . . . 0.0 112.087 -169.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -68.26 -94.94 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.776 0.703 . . . . 0.0 112.355 -157.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.01 99.24 0.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.687 0 CA-C-N 120.038 1.919 . . . . 0.0 109.24 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.3 m -155.92 169.82 23.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.786 2.035 . . . . 0.0 108.571 167.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.5 p -133.87 71.61 1.46 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.6 0.714 . . . . 0.0 110.472 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.854 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -62.75 171.11 2.22 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.057 0.928 . . . . 0.0 110.443 172.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.5 t -133.85 121.56 21.95 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 -65.5 2.78 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 124.595 1.093 . . . . 0.0 111.38 -171.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.0 t -127.46 75.98 1.63 Allowed 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 -175.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.4 t -65.63 140.29 58.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.81 139.88 14.83 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.52 -63.37 0.43 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.67 1.188 . . . . 0.0 109.544 170.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -69.77 155.68 40.16 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.336 0.516 . . . . 0.0 110.374 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' HA ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -73.31 -117.91 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.484 2.314 . . . . 0.0 112.841 178.26 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.436 ' H ' ' HB ' ' A' ' 10' ' ' THR . 8.7 mtt180 134.06 -16.23 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 1 C-N-CA 134.581 5.153 . . . . 0.0 111.827 177.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -145.45 13.21 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HB1' ' HZ ' ' A' ' 20' ' ' PHE . . . 59.62 4.6 0.56 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.31 1.444 . . . . 0.0 114.415 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -18.41 32.37 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.534 -1.354 . . . . 0.0 111.947 -174.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.85 -18.33 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.99 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.81 157.72 9.21 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.692 1.133 . . . . 0.0 110.299 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -129.12 93.12 3.51 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.723 1.209 . . . . 0.0 109.796 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.09 -129.72 1.57 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 125.252 1.406 . . . . 0.0 110.041 173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.4 m -136.17 145.72 46.08 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 125.933 1.693 . . . . 0.0 108.459 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.456 ' HZ ' ' HB1' ' A' ' 13' ' ' ALA . 11.0 m-85 -90.43 144.23 26.0 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.426 0.69 . . . . 0.0 110.401 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -120.08 165.82 14.22 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.021 2.128 . . . . 0.0 107.734 173.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.5 p -147.19 162.79 38.16 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.347 0.659 . . . . 0.0 109.945 155.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.75 157.46 38.05 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 170.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.8 m -120.11 108.22 13.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.14 134.56 40.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -82.24 151.19 26.94 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 166.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -85.45 100.99 12.25 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 168.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 t -64.08 -53.56 47.8 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -159.97 -71.35 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.317 1.047 . . . . 0.0 110.234 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 ptp -50.84 -40.84 56.94 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 127.198 2.199 . . . . 0.0 113.595 -175.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.83 -125.63 1.89 Allowed Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 106.382 -2.687 . . . . 0.0 106.382 -169.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -125.86 145.87 50.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 118.26 1.03 . . . . 0.0 109.82 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.9 46.98 3.72 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.134 0.873 . . . . 0.0 113.353 -174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -148.54 163.95 35.67 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.402 1.481 . . . . 0.0 107.62 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.9 p -126.19 163.55 22.91 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 165.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.61 158.86 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.018 1.327 . . . . 0.0 108.281 -168.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.3 tt -129.24 145.03 36.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.033 1.733 . . . . 0.0 107.926 175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.98 151.63 22.63 Favored Glycine 0 CA--C 1.518 0.237 0 N-CA-C 107.265 -2.334 . . . . 0.0 107.265 171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -50.91 -71.06 0.7 Allowed Glycine 0 CA--C 1.523 0.536 0 CA-C-N 117.945 0.872 . . . . 0.0 113.423 -172.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.23 -45.55 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.276 1.03 . . . . 0.0 109.495 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -113.48 165.7 12.81 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.17 1.788 . . . . 0.0 110.919 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -79.32 66.79 8.75 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.651 2.901 . . . . 0.0 112.16 176.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -140.18 -2.09 1.49 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.754 0.822 . . . . 0.0 110.221 146.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -99.35 137.27 38.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 O-C-N 120.481 -1.387 . . . . 0.0 110.215 -152.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -59.22 123.71 17.58 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.757 0.823 . . . . 0.0 111.481 -167.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.3 mt -81.32 128.8 34.22 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -134.06 152.66 51.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.346 0.976 . . . . 0.0 110.637 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.34 113.14 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -68.55 -58.18 4.68 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 65' ' ' THR . 69.0 m -154.5 158.81 40.44 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.959 1.304 . . . . 0.0 109.519 163.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.7 138.2 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 126.1 1.76 . . . . 0.0 107.256 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 141.12 67.93 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.25 28.2 0.4 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.731 3.621 . . . . 0.0 115.693 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -152.85 -10.23 0.17 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.204 2.202 . . . . 0.0 111.328 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.52 158.79 46.02 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -168.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.49 -21.69 70.9 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.384 1.389 . . . . 0.0 110.486 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.47 -54.39 46.34 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.353 1.461 . . . . 0.0 111.501 168.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.3 -50.08 71.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.272 1.029 . . . . 0.0 109.463 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -72.78 -22.7 60.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.245 -0.883 . . . . 0.0 112.838 -170.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.37 -12.12 60.99 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.834 1.197 . . . . 0.0 111.351 169.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.64 25.83 74.28 Favored Glycine 0 CA--C 1.525 0.664 0 O-C-N 121.053 -1.03 . . . . 0.0 113.293 167.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.6 mttt -128.54 -32.64 2.15 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.293 1.047 . . . . 0.0 113.525 -170.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 22.8 ttm -95.01 134.66 37.44 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.21 167.67 21.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.627 1.203 . . . . 0.0 110.675 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 50' ' ' SER . 23.5 m -86.76 117.73 25.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 125.587 1.555 . . . . 0.0 108.604 -168.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 109.85 -11.98 32.24 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.491 1.043 . . . . 0.0 112.411 -171.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -65.89 146.56 54.59 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 119.271 1.535 . . . . 0.0 108.647 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -103.39 115.69 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 126.346 1.858 . . . . 0.0 108.817 -169.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.84 125.01 24.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 C-N-CA 125.607 1.563 . . . . 0.0 107.847 176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.0 -55.94 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 124.281 1.033 . . . . 0.0 110.3 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -129.67 149.68 51.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.49 126.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.7 t30 67.08 -81.43 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 109.258 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -152.16 20.02 0.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.784 1.233 . . . . 0.0 111.342 168.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.58 123.47 55.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.1 p -62.74 120.84 12.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 163.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.2 m -125.58 13.7 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 123.384 0.674 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -61.51 -10.9 8.82 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -166.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.36 9.57 4.08 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.928 1.252 . . . . 0.0 111.406 165.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -71.62 159.5 34.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 119.967 1.883 . . . . 0.0 111.147 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.3 t -83.2 154.61 24.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.17 0.588 . . . . 0.0 109.906 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -55.28 -41.63 72.53 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 116.886 -1.53 . . . . 0.0 109.416 170.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.61 -32.38 41.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.505 1.957 . . . . 0.0 112.671 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -83.12 -47.49 11.58 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.195 0.521 . . . . 0.0 111.951 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.1 t -63.4 -28.62 45.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 120.272 -1.517 . . . . 0.0 112.022 177.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.8 -44.0 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.501 -1.375 . . . . 0.0 108.438 167.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.9 88.98 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 120.143 1.338 . . . . 0.0 109.3 -177.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 85' ' ' VAL . 13.4 mt -66.63 -44.82 80.98 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.353 1.861 . . . . 0.0 109.805 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -69.89 -36.43 75.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.026 0.83 . . . . 0.0 110.26 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.2 mm100 -70.3 -17.06 63.08 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.695 0.798 . . . . 0.0 110.946 174.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.6 t -96.22 39.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.193 1.797 . . . . 0.0 110.797 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -125.67 113.8 25.0 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 163.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.67 172.65 14.0 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.125 1.217 . . . . 0.0 110.075 172.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.2 mp -60.06 145.13 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.3 21.03 68.16 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 119.244 -0.754 . . . . 0.0 112.929 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -130.58 169.92 14.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.665 1.233 . . . . 0.0 108.704 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.08 161.39 31.12 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.845 1.258 . . . . 0.0 110.976 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.3 m -133.47 147.7 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.589 1.156 . . . . 0.0 108.221 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -83.41 156.9 22.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.34 110.67 5.08 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.11 122.59 40.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 173.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.92 167.31 10.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 123.953 0.783 . . . . 0.0 110.354 170.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 17.3 t -125.79 129.19 48.94 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.662 1.185 . . . . 0.0 108.139 165.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.595 ' HB2' HD21 ' A' ' 21' ' ' LEU . 5.3 ttm180 -79.84 155.59 27.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.709 1.604 . . . . 0.0 107.184 166.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.17 -19.82 4.83 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.094 -0.837 . . . . 0.0 113.934 169.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.14 156.42 39.01 Favored Pre-proline 0 C--O 1.236 0.365 0 CA-C-N 118.726 1.263 . . . . 0.0 109.793 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.38 179.06 3.75 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.969 1.779 . . . . 0.0 110.196 165.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.66 154.33 94.87 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.819 161.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.08 -30.92 12.89 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.643 173.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -80.24 148.57 30.75 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.398 2.279 . . . . 0.0 110.014 174.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -132.15 115.92 15.36 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.68 -13.97 24.57 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.489 1.459 . . . . 0.0 111.844 163.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -59.79 -73.34 0.09 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.847 1.659 . . . . 0.0 110.407 -176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -120.48 79.73 29.5 Favored Pre-proline 0 C--O 1.235 0.312 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.01 -28.66 23.8 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 120.985 1.124 . . . . 0.0 111.61 -163.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -161.58 -28.77 0.05 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.989 1.316 . . . . 0.0 111.17 161.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 p30 48.07 -153.62 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.25 1.82 . . . . 0.0 111.842 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 89.7 p 57.43 -178.49 0.06 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 128.78 2.832 . . . . 0.0 115.757 165.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 143.64 -125.37 2.5 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.516 -1.714 . . . . 0.0 112.084 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -50.54 -41.05 54.12 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 124.129 3.219 . . . . 0.0 114.736 -169.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 60.7 p -147.53 168.34 22.2 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.439 0.696 . . . . 0.0 109.653 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -107.43 141.3 39.03 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 150.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.335 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -164.296 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 m -127.97 92.12 3.4 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.331 1.452 . . . . 0.0 107.326 -173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.1 m -73.38 171.49 13.0 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.878 1.271 . . . . 0.0 113.185 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.12 90.18 0.61 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.226 -2.349 . . . . 0.0 107.226 163.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.5 m -64.7 170.4 4.16 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.524 0.73 . . . . 0.0 112.173 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.1 m -68.11 157.43 35.32 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.889 159.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 107.85 137.56 8.34 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 107.251 -2.34 . . . . 0.0 107.251 -169.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 45.94 83.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.499 2.32 . . . . 0.0 110.938 -171.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.438 ' CG ' ' N ' ' A' ' 10' ' ' THR 0.261 34.1 t80 58.76 -150.62 0.43 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.578 2.351 . . . . 0.0 110.383 177.732 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' A' ' 9' ' ' PHE . 28.4 m -118.53 -107.06 0.38 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 129.475 3.11 . . . . 0.0 108.295 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 131.42 -70.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 1 C-N-CA 134.433 5.093 . . . . 0.0 108.757 169.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.39 -0.35 52.36 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.001 0.819 . . . . 0.0 113.171 -173.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 79.52 -11.71 1.16 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.839 2.856 . . . . 0.0 112.569 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.8 m -72.06 -19.28 61.85 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -166.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -79.29 -12.78 59.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.855 0.752 . . . . 0.0 112.414 173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.8 mt -70.15 142.74 52.49 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -125.26 122.85 38.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.51 -122.61 1.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 91.2 m -135.57 136.66 41.29 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -91.44 143.87 26.16 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.758 1.623 . . . . 0.0 110.522 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.48 166.78 31.62 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 125.959 1.703 . . . . 0.0 109.551 172.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.2 p -146.34 124.47 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.674 0.79 . . . . 0.0 110.696 -172.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.9 t -124.46 157.23 35.71 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 118.946 0.794 . . . . 0.0 109.101 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.5 m -114.59 112.72 23.37 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 170.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.55 150.86 21.26 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -103.91 149.68 24.87 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -84.2 102.6 12.74 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.6 m -61.73 -56.93 14.43 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.086 0.555 . . . . 0.0 110.316 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -151.36 -82.07 0.1 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.315 0.646 . . . . 0.0 109.521 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 55.3 mtt -62.05 -49.68 75.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.814 0.846 . . . . 0.0 109.143 -176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 180.0 -162.06 28.23 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -164.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -83.03 149.43 26.95 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.09 30.17 2.4 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 118.974 -0.904 . . . . 0.0 113.354 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -135.38 165.5 25.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 119.457 1.628 . . . . 0.0 108.49 172.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 p -123.36 154.41 39.0 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 125.006 1.322 . . . . 0.0 107.829 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.51 156.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.077 0.951 . . . . 0.0 108.619 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.54 149.63 32.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.449 2.3 . . . . 0.0 106.452 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.84 152.34 23.04 Favored Glycine 0 C--N 1.33 0.212 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 172.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -48.23 -80.74 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 124.454 1.026 . . . . 0.0 112.725 176.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 178.49 -62.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.739 1.216 . . . . 0.0 110.431 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -82.26 166.49 36.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.438 1.095 . . . . 0.0 112.507 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.79 57.57 5.69 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 124.224 3.283 . . . . 0.0 111.344 175.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -156.45 -4.69 0.11 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.725 1.61 . . . . 0.0 113.354 171.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -95.28 165.86 12.18 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.133 0.968 . . . . 0.0 111.947 -174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -84.55 160.34 20.5 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.183 1.393 . . . . 0.0 111.16 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 29.8 mt -124.68 138.23 54.31 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 126.399 1.88 . . . . 0.0 108.184 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.428 ' HG2' HG22 ' A' ' 68' ' ' VAL . 47.6 mt-30 -134.42 155.24 50.65 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.35 0.977 . . . . 0.0 111.044 173.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.02 109.81 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 166.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -65.46 -50.01 66.97 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.906 1.683 . . . . 0.0 109.982 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.7 m -148.31 158.48 44.12 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 107.147 170.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.9 t -102.44 128.65 54.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 103.903 -2.629 . . . . 0.0 103.903 158.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.02 118.95 71.55 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 105.542 -2.022 . . . . 0.0 105.542 173.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.31 135.27 45.76 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 172.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.3 t0 73.67 0.29 3.59 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.114 1.766 . . . . 0.0 112.617 -175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.45 163.77 53.03 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.289 -1.507 . . . . 0.0 109.822 165.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.59 -4.91 9.15 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.045 2.497 . . . . 0.0 114.769 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.87 -49.16 6.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.235 0.925 . . . . 0.0 109.919 172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.07 -42.31 90.04 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.984 0.514 . . . . 0.0 110.588 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.37 -25.24 68.2 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 118.256 -0.878 . . . . 0.0 112.086 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -79.34 -40.75 29.49 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.456 1.025 . . . . 0.0 109.943 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.38 52.93 14.76 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 125.036 1.303 . . . . 0.0 113.019 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -126.04 -58.9 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 170.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.23 161.45 27.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 119.19 0.905 . . . . 0.0 109.264 173.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -143.38 173.52 11.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 167.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -74.8 144.61 43.44 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.926 -167.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.92 81.79 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.434 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -64.89 142.86 58.29 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.897 1.849 . . . . 0.0 108.472 169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 47' ' ' GLN . 76.2 t -97.9 120.87 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.376 1.87 . . . . 0.0 108.868 -169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.9 mp -69.49 118.07 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.18 -54.11 7.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 123.434 0.694 . . . . 0.0 109.996 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.47 144.88 48.34 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mt -122.99 111.37 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.3 t30 67.21 -53.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 129.48 3.112 . . . . 0.0 114.378 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -164.22 6.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.383 2.273 . . . . 0.0 111.247 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.5 t -110.63 121.34 63.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 125.449 1.499 . . . . 0.0 107.66 -173.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.4 p -66.09 120.24 12.82 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 164.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.05 7.87 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 123.457 0.703 . . . . 0.0 111.89 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.06 -9.11 43.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 129.448 3.099 . . . . 0.0 112.506 -170.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.13 54.47 0.66 Allowed Glycine 0 C--N 1.334 0.463 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 158.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -115.08 157.83 22.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.99 0.895 . . . . 0.0 111.561 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.8 t -77.3 137.63 38.9 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.42 1.088 . . . . 0.0 108.991 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -58.41 -36.24 73.27 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.03 -1.462 . . . . 0.0 109.622 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.42 -33.02 41.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.737 1.608 . . . . 0.0 112.694 177.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.12 -46.38 15.01 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 123.36 0.664 . . . . 0.0 111.149 176.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' HD12 ' A' ' 88' ' ' LEU . 2.9 t -61.54 -34.62 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 O-C-N 119.163 -2.211 . . . . 0.0 111.664 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.02 -44.48 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.617 1.167 . . . . 0.0 108.98 170.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -35.6 81.57 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.435 1.016 . . . . 0.0 110.973 176.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 85' ' ' VAL . 44.1 mt -62.97 -49.07 76.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -67.48 -42.38 83.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.625 0.77 . . . . 0.0 111.6 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -62.92 -34.75 78.11 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.32 -0.862 . . . . 0.0 109.834 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.1 t -75.31 27.26 0.1 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.601 1.56 . . . . 0.0 112.418 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.2 t -114.33 106.2 53.02 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 166.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.67 164.99 1.93 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.423 2.748 . . . . 0.0 113.979 168.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.22 151.47 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 165.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.71 -0.89 60.12 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.861 -0.966 . . . . 0.0 112.566 178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -94.12 165.41 12.64 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 119.354 1.577 . . . . 0.0 108.175 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -128.63 163.13 25.71 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.069 1.348 . . . . 0.0 109.357 165.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -141.82 148.32 20.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 125.46 1.504 . . . . 0.0 107.986 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.65 152.87 24.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.701 1.601 . . . . 0.0 109.222 172.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 mt -144.71 115.52 7.78 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.7 t -89.54 122.85 41.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 170.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.15 161.65 15.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 124.152 0.907 . . . . 0.0 109.556 168.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -119.35 119.59 34.41 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 166.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -81.24 147.15 30.09 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 124.187 0.995 . . . . 0.0 108.43 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 124.3 -18.52 7.34 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-O 118.375 -1.236 . . . . 0.0 114.625 161.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -70.44 139.13 86.59 Favored Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 119.694 1.747 . . . . 0.0 107.587 161.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.23 172.09 12.73 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.459 1.44 . . . . 0.0 110.543 168.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.68 158.22 61.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.668 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.25 -37.11 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.627 2.218 . . . . 0.0 112.015 -177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -119.9 132.44 55.54 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.22 1.808 . . . . 0.0 109.324 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -95.11 99.13 3.96 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 125.537 1.535 . . . . 0.0 108.548 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -71.44 -23.74 23.33 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 120.929 1.368 . . . . 0.0 111.94 176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -75.71 -23.0 56.08 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.617 1.967 . . . . 0.0 112.449 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.74 77.14 7.21 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.4 -18.94 5.64 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.748 2.299 . . . . 0.0 114.899 -171.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -166.29 -58.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.801 1.64 . . . . 0.0 111.742 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.6 p30 51.16 179.29 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.861 3.264 . . . . 0.0 115.273 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.3 t -131.54 169.82 15.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 127.379 2.271 . . . . 0.0 105.381 152.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.61 -79.82 0.49 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 166.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.12 151.97 44.91 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.055 1.837 . . . . 0.0 110.594 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.1 m -163.55 -177.83 5.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.328 3.051 . . . . 0.0 106.097 167.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 m -105.6 157.78 17.16 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.004 0.82 . . . . 0.0 109.483 174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -176.839 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.789 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -61.25 166.7 3.6 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 118.063 0.931 . . . . 0.0 112.278 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -127.16 142.11 51.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.012 0.925 . . . . 0.0 110.444 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.23 149.34 16.84 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 p -129.29 176.53 7.86 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.599 1.559 . . . . 0.0 110.562 -165.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.8 t -133.66 -91.67 0.35 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 169.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.16 114.37 6.68 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 175.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.61 77.99 1.6 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 174.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -61.5 157.04 17.99 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.845 0.858 . . . . 0.0 109.867 176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.3 m -78.2 -121.67 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.657 1.583 . . . . 0.0 111.355 -178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mtt180 160.97 -74.04 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 130.925 3.69 . . . . 0.0 109.108 171.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -118.73 22.92 11.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.687 1.232 . . . . 0.0 110.971 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HB2' ' CG1' ' A' ' 70' ' ' VAL . . . 70.24 -23.87 0.16 Allowed 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 128.17 2.588 . . . . 0.0 113.881 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -65.04 -13.21 57.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.631 1.172 . . . . 0.0 112.86 174.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -67.26 -22.19 65.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.443 1.097 . . . . 0.0 112.444 166.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.05 148.64 30.99 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.996 1.271 . . . . 0.0 109.048 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.3 mmmt -112.81 -0.31 14.99 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.49 -168.56 32.72 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.066 1.317 . . . . 0.0 112.578 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 157.89 33.72 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 124.871 1.268 . . . . 0.0 109.535 -169.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -125.39 129.04 49.09 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.652 0.781 . . . . 0.0 109.375 174.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.72 168.4 17.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 126.917 2.087 . . . . 0.0 108.415 -178.562 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.9 p -142.99 175.84 9.54 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 121.438 0.637 . . . . 0.0 111.199 160.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.406 HG21 ' HE2' ' A' ' 63' ' ' MET . 8.5 t -155.19 157.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 170.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.2 m -127.12 105.35 8.52 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.29 136.37 37.86 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ttpt -87.48 123.41 32.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.07 125.07 12.81 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.598 1.559 . . . . 0.0 108.236 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.13 -173.74 3.95 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 173.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -59.78 -54.55 45.01 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.717 -1.239 . . . . 0.0 111.087 -171.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 61.5 mtp -78.25 13.93 1.35 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.922 1.289 . . . . 0.0 113.545 172.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.16 -147.16 18.48 Favored Glycine 0 C--N 1.331 0.306 0 O-C-N 120.136 -1.602 . . . . 0.0 110.48 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -88.84 146.89 24.69 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 56' ' ' PRO . . . -86.8 42.28 3.15 Favored Glycine 0 C--O 1.222 -0.605 0 CA-C-O 118.945 -0.92 . . . . 0.0 111.705 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -148.43 166.96 26.56 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 119.3 1.55 . . . . 0.0 109.321 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 p -127.28 158.81 36.21 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 126.215 1.806 . . . . 0.0 107.935 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.85 162.72 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.586 1.954 . . . . 0.0 107.283 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.6 tt -138.68 159.98 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 125.787 1.635 . . . . 0.0 108.26 178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.23 154.08 23.8 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 128.802 3.096 . . . . 0.0 110.384 -174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.36 -82.99 0.21 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.482 1.039 . . . . 0.0 111.898 172.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -177.16 -15.74 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.77 2.028 . . . . 0.0 111.243 -174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -125.73 153.11 73.12 Favored Pre-proline 0 C--N 1.342 0.27 0 O-C-N 120.154 -1.591 . . . . 0.0 111.652 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.42 51.35 0.18 Allowed 'Trans proline' 0 CA--C 1.55 1.31 1 C-N-CA 125.388 4.058 . . . . 0.0 113.949 168.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -158.43 13.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.096 -1.628 . . . . 0.0 109.516 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -74.89 160.47 30.59 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 127.411 2.285 . . . . 0.0 110.774 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -93.39 112.61 24.56 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 18.9 mt -81.37 112.75 18.94 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.68 155.0 30.69 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.7 t -61.23 116.34 2.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 170.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -65.53 -54.38 28.97 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.768 1.227 . . . . 0.0 109.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HA ' HG23 ' A' ' 65' ' ' THR . 13.8 m -155.53 161.42 40.9 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.993 1.317 . . . . 0.0 108.049 171.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.48 140.59 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 161.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -81.97 132.11 54.91 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.0 160.51 48.28 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.864 2.376 . . . . 0.0 110.845 177.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.8 t70 60.09 -18.31 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.434 2.294 . . . . 0.0 114.26 -172.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.95 173.67 41.59 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.592 1.568 . . . . 0.0 114.181 -171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HG2' ' H ' ' A' ' 33' ' ' GLY . 58.0 Cg_endo -66.52 -32.07 40.34 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.939 3.093 . . . . 0.0 111.41 -171.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.47 87.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.878 0.871 . . . . 0.0 110.742 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.91 -46.33 65.64 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.888 0.875 . . . . 0.0 109.732 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -62.47 -42.66 99.64 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.268 0.94 . . . . 0.0 112.249 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -69.79 -6.06 29.67 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.894 0.77 . . . . 0.0 111.371 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.27 29.93 63.68 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.691 1.139 . . . . 0.0 113.465 165.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -136.17 -0.79 2.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.768 1.227 . . . . 0.0 111.982 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.406 ' HE2' HG21 ' A' ' 23' ' ' THR . 25.9 tpp -111.29 137.16 49.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.482 1.513 . . . . 0.0 107.069 169.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -134.75 167.71 20.36 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.722 0.809 . . . . 0.0 108.941 166.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.456 HG23 ' HA ' ' A' ' 50' ' ' SER . 43.3 m -77.18 159.68 29.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.495 1.118 . . . . 0.0 109.437 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.95 39.87 96.79 Favored Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' HD13 ' A' ' 102' ' ' LEU . 11.9 m-20 -132.26 152.88 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.595 1.158 . . . . 0.0 108.074 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.5 117.6 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 118.17 -0.919 . . . . 0.0 109.688 -161.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 69' ' ' ILE . 4.1 mp -66.8 138.63 22.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 171.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' ALA . 10.2 t -122.33 -54.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.03 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -133.37 149.83 51.84 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.435 1.094 . . . . 0.0 108.699 -175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -125.58 126.9 71.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 174.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 44.86 -93.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.1 2.16 . . . . 0.0 110.795 -159.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -124.25 -7.36 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.195 1.398 . . . . 0.0 111.483 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.7 t -87.37 139.82 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -173.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -77.44 130.3 36.86 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.132 -0.98 . . . . 0.0 109.003 169.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.94 10.61 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.458 1.503 . . . . 0.0 111.445 170.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.0 -42.68 60.51 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.686 -1.259 . . . . 0.0 113.284 -167.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -115.08 36.22 4.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 127.176 2.322 . . . . 0.0 109.905 -178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -93.83 -158.86 0.65 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 117.806 0.803 . . . . 0.0 109.683 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.7 t -119.93 143.98 47.69 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.641 1.11 . . . . 0.0 109.031 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -53.78 -42.41 68.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.532 2.333 . . . . 0.0 110.589 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.96 -29.23 68.28 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.831 0.741 . . . . 0.0 111.983 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -82.58 -54.85 4.85 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.373 1.069 . . . . 0.0 109.271 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.97 -44.04 26.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 130.053 3.341 . . . . 0.0 112.382 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.46 -32.8 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 120.459 -1.4 . . . . 0.0 109.652 174.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -34.69 71.99 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.65 1.114 . . . . 0.0 109.435 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.5 -42.96 95.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.985 1.314 . . . . 0.0 109.823 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -62.46 -19.15 63.23 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.291 1.036 . . . . 0.0 112.778 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -91.98 -11.37 36.26 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.819 1.248 . . . . 0.0 113.109 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.8 m -75.0 12.8 0.78 Allowed 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.775 -1.203 . . . . 0.0 112.996 161.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.09 93.22 14.73 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.63 140.77 13.4 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.911 3.074 . . . . 0.0 109.57 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 5.1 mp -52.01 125.43 5.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 118.987 0.812 . . . . 0.0 109.232 -164.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.3 -16.44 11.71 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.46 1.981 . . . . 0.0 113.417 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -94.83 173.65 7.49 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 119.778 1.789 . . . . 0.0 109.756 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 m -127.94 167.02 17.22 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.042 2.537 . . . . 0.0 108.193 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.32 148.85 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 124.468 1.107 . . . . 0.0 108.596 161.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.4 152.44 25.02 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 167.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 mt -146.47 119.74 8.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.85 129.22 41.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 67' ' ' ASP . 10.3 mt -112.05 156.7 21.77 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 124.361 1.038 . . . . 0.0 109.4 166.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 42.6 t -116.06 128.29 55.57 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 168.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -84.62 156.35 21.6 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.138 0.975 . . . . 0.0 109.582 171.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 117.03 6.3 14.07 Favored Glycine 0 N--CA 1.461 0.356 0 C-N-CA 123.835 0.731 . . . . 0.0 114.391 163.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -119.46 133.9 23.8 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.53 -178.42 1.51 Allowed 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.143 2.562 . . . . 0.0 111.15 176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.42 158.02 83.64 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.578 0.751 . . . . 0.0 111.086 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.31 -26.9 7.0 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.849 2.366 . . . . 0.0 112.662 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -119.57 142.79 48.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.594 1.957 . . . . 0.0 108.091 174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -130.91 92.9 32.58 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 124.427 1.091 . . . . 0.0 108.968 -169.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -78.57 -5.42 14.82 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.339 2.693 . . . . 0.0 113.306 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -72.96 -37.07 67.22 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.354 -1.466 . . . . 0.0 109.709 171.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.5 78.01 76.43 Favored Pre-proline 0 C--O 1.235 0.316 0 C-N-CA 125.661 1.584 . . . . 0.0 108.719 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.44 -63.62 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 124.023 3.149 . . . . 0.0 112.098 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.28 60.02 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.662 1.585 . . . . 0.0 106.943 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 81.2 136.18 0.06 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 128.319 2.648 . . . . 0.0 108.34 -164.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.35 74.85 1.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.641 1.576 . . . . 0.0 108.408 -171.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -116.72 63.32 0.37 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.099 -1.389 . . . . 0.0 113.493 -173.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.08 158.39 52.38 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 120.55 2.175 . . . . 0.0 109.286 165.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.1 m -136.53 172.39 13.08 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.499 1.12 . . . . 0.0 110.318 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 57.1 m -140.45 147.47 39.7 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.285 1.434 . . . . 0.0 109.08 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.65 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 119.98 . . . . . . . . 0 0 . 1 stop_ save_